datetime,title,source,link,sentiment_class,sentiment_score
6/30/2006 2:27:00 PM,"Vertex Pharmaceuticals and Tibotec Pharmaceuticals, a Johnson & Johnson Company, Announce Plans for Global Health Initiative to Increase Worldwide Prevention, Diagnosis and Treatment of HCV",PR Newswire,/news/stocks/vertex-pharmaceuticals-and-tibotec-pharmaceuticals-a-johnson-&-johnson-company-announce-plans-for-global-health-initiative-to-increase-worldwide-prevention-diagnosis-and-treatment-of-hcv-1001238385,positive,0.8177626729011536
12/20/2006 11:37:00 PM,Johnson & Johnson Completes Acquisition of Pfizer Consumer Healthcare,PR Newswire,/news/stocks/johnson-johnson-completes-acquisition-of-pfizer-consumer-healthcare-1002273502,neutral,0.8553050756454468
9/23/2016 6:40:21 PM,"BRIEF-Janssen Biotech submits application for approval of sirukumab in U.S. for rheumatoid arthritis (GSK, JNJ)",Reuters,/news/stocks/brief-janssen-biotech-submits-application-for-approval-of-sirukumab-in-u-s-for-rheumatoid-arthritis-gsk-jnj-1001416187,positive,0.7556676268577576
9/23/2016 10:30:23 PM,"BRIEF-Achillion announces data from phase 2 trial for combination treatment for Genotype 1 Treatment-Na√Øve HCV (ACHN, JNJ)",Reuters,/news/stocks/brief-achillion-announces-data-from-phase-2-trial-for-combination-treatment-for-genotype-1-treatment-naive-hcv-achn-jnj-1001416124,positive,0.546350359916687
9/26/2016 6:20:22 PM,BRIEF-Janssen Biotech says FDA approves STELARA (ustekinumab) (JNJ),Reuters,/news/stocks/brief-janssen-biotech-says-fda-approves-stelara-ustekinumab-jnj-1001418635,positive,0.8015379905700684
9/26/2016 7:30:22 PM,FDA approves J&J's autoimmune drug Stelara for Crohn's disease (JNJ),Reuters,/news/stocks/fda-approves-j&js-autoimmune-drug-stelara-for-crohns-disease-jnj-1001418766,positive,0.7212366461753845
9/28/2016 4:50:21 PM,BRIEF-Tracon Pharmaceuticals announces a strategic licensing collaboration for two Janssen Oncology assets and a $5 mln equity investment from Johnson & Johnson Innovation - JJDC Inc (JNJ),Reuters,/news/stocks/brief-tracon-pharmaceuticals-announces-a-strategic-licensing-collaboration-for-two-janssen-oncology-assets-and-a-$5-mln-equity-investment-from-johnson-&-johnson-innovation-jjdc-inc-jnj-1001423841,positive,0.8204428553581238
10/3/2016 10:10:21 AM,"Novartis psoriasis drug maintains efficacy after 4 years - study (JNJ, AMGN)",Reuters,/news/stocks/novartis-psoriasis-drug-maintains-efficacy-after-4-years-study-jnj-amgn-1001431486,positive,0.9123478531837463
10/3/2016 11:00:21 AM,"J&J psoriasis drug tops placebo, Humira in late stage study (JNJ)",Reuters,/news/stocks/j&j-psoriasis-drug-tops-placebo-humira-in-late-stage-study-jnj-1001431490,neutral,0.8518204689025879
10/3/2016 11:30:24 AM,"Morphosys moves closer to getting first antibody drug on market (MOR, BAYN, JNJ)",Reuters,/news/stocks/morphosys-moves-closer-to-getting-first-antibody-drug-on-market-mor-bayn-jnj-1001431705,positive,0.8469604253768921
10/3/2016 12:10:22 PM,"Big Pharma vs Big Pharma in court battles over biosimilar drugs (SAN, SHP, BIIB, JNJ, MRK, LLY, PFE, AMGN)",Reuters,/news/stocks/big-pharma-vs-big-pharma-in-court-battles-over-biosimilar-drugs-san-shp-biib-jnj-mrk-lly-pfe-amgn-1001431817,negative,0.6420660018920898
10/3/2016 2:20:21 PM,"RPT-Big Pharma vs Big Pharma in court battles over biosimilar drugs (SAN, SHP, BIIB, JNJ, MRK, LLY, PFE, AMGN)",Reuters,/news/stocks/rpt-big-pharma-vs-big-pharma-in-court-battles-over-biosimilar-drugs-san-shp-biib-jnj-mrk-lly-pfe-amgn-1001432682,negative,0.5524700284004211
10/5/2016 1:10:26 AM,"UPDATE 3-J&J warns diabetic patients: Insulin pump vulnerable to hacking (JNJ, MDT, PFE)",Reuters,/news/stocks/update-3-j&j-warns-diabetic-patients-insulin-pump-vulnerable-to-hacking-jnj-mdt-pfe-1001436547,negative,0.590557873249054
10/5/2016 11:30:22 AM,"BRIEF-U.S. FDA warns about the risk of Hepatitis B (BMY, GILD, JNJ, MRK)",Reuters,/news/stocks/brief-u-s-fda-warns-about-the-risk-of-hepatitis-b-bmy-gild-jnj-mrk-1001436685,negative,0.5751607418060303
10/5/2016 1:30:24 PM,"PRESS DIGEST - Wall Street Journal - Oct 5 (CRM, BLK, 8630, ENH, JNJ)",Reuters,/news/stocks/press-digest-wall-street-journal-oct-5-crm-blk-8630-enh-jnj-1001436934,neutral,0.9358034729957581
10/5/2016 10:20:21 PM,BRIEF-U.S. Department of Homeland Security warns on vulnerabilities in J&J insulin pumps (JNJ),Reuters,/news/stocks/brief-u-s-department-of-homeland-security-warns-on-vulnerabilities-in-j&j-insulin-pumps-jnj-1001439013,negative,0.8893702030181885
10/7/2016 2:40:27 PM,"BRIEF-Astrazeneca divests rights to Rhinocort Aqua outside US (AZN, JNJ)",Reuters,/news/stocks/brief-astrazeneca-divests-rights-to-rhinocort-aqua-outside-us-azn-jnj-1001442619,neutral,0.9346606135368347
10/10/2016 12:40:22 AM,"BRIEF-Genmab  says U.S. FDA grants priority review for daratumumab in relapsed multiple myeloma (GEN, JNJ)",Reuters,/news/stocks/brief-genmab-says-u-s-fda-grants-priority-review-for-daratumumab-in-relapsed-multiple-myeloma-gen-jnj-1001444863,positive,0.8637728095054626
10/11/2016 10:50:23 PM,"BRIEF-FDA concludes Xarelto clinical trial results not affected by Alere's INRatio (ALR, JNJ, BAYN)",Reuters,/news/stocks/brief-fda-concludes-xarelto-clinical-trial-results-not-affected-by-aleres-inratio-alr-jnj-bayn-1001450092,negative,0.47679513692855835
10/11/2016 11:00:20 PM,"U.S. FDA clears Xarelto blood thinner despite faulty trial device (BAYN, ALR, JNJ, PFE)",Reuters,/news/stocks/u-s-fda-clears-xarelto-blood-thinner-despite-faulty-trial-device-bayn-alr-jnj-pfe-1001450199,positive,0.5444695949554443
10/17/2016 12:40:22 PM,"Wall St Week Ahead-Investors seek profit turnaround to drive stocks higher (JNJ, MSFT, GE, BAC)",Reuters,/news/stocks/wall-st-week-ahead-investors-seek-profit-turnaround-to-drive-stocks-higher-jnj-msft-ge-bac-1001458024,positive,0.9386282563209534
10/18/2016 2:40:23 AM,"Pfizer set to start shipping Remicade biosimilar next month (JNJ, 068270, PFE)",Reuters,/news/stocks/pfizer-set-to-start-shipping-remicade-biosimilar-next-month-jnj-068270-pfe-1001460992,neutral,0.8869039416313171
10/18/2016 8:20:19 AM,"UPDATE 1-Pfizer set to start shipping Remicade biosimilar next month (JNJ, 068270, PFE)",Reuters,/news/stocks/update-1-pfizer-set-to-start-shipping-remicade-biosimilar-next-month-jnj-068270-pfe-1001461028,neutral,0.6134659051895142
10/18/2016 2:30:22 PM,J&J quarterly sales rise 4.2 pct (JNJ),Reuters,/news/stocks/j&j-quarterly-sales-rise-4-2-pct-jnj-1001462296,positive,0.9228764176368713
10/18/2016 2:50:20 PM,BRIEF-Johnson & Johnson reports Q3 EPS $1.53 (JNJ),Reuters,/news/stocks/brief-johnson-&-johnson-reports-q3-eps-$1-53-jnj-1001462388,neutral,0.7418519258499146
10/18/2016 2:50:20 PM,"UPDATE 1-J&J quarterly revenue, profit edge past Street (JNJ)",Reuters,/news/stocks/update-1-j&j-quarterly-revenue-profit-edge-past-street-jnj-1001462383,positive,0.7051847577095032
10/18/2016 4:30:21 PM,BRIEF-Ortho Regenerative announces changes in executive leadership (JNJ),Reuters,/news/stocks/brief-ortho-regenerative-announces-changes-in-executive-leadership-jnj-1001462692,neutral,0.847599983215332
10/18/2016 8:30:24 PM,J&J says stable patients likely to stay with Remicade (JNJ),Reuters,/news/stocks/j&j-says-stable-patients-likely-to-stay-with-remicade-jnj-1001463054,positive,0.8047939538955688
10/18/2016 10:40:20 PM,"UPDATE 4-J&J shares lose ground on fears of Pfizer's answer to Remicade (JNJ, PFE)",Reuters,/news/stocks/update-4-j&j-shares-lose-ground-on-fears-of-pfizers-answer-to-remicade-jnj-pfe-1001463467,negative,0.965657651424408
10/20/2016 11:38:23 PM,BRIEF-J&J sets quarterly cash dividend of $0.80 per share (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-sets-quarterly-cash-dividend-of-080-per-share-2016-10,neutral,0.8878346681594849
10/25/2016 3:52:21 PM,BRIEF-Janssen Therapeutics receives funding from a special RFA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-therapeutics-receives-funding-from-a-special-rfa-2016-10,positive,0.6761131882667542
11/8/2016 1:36:17 PM,BRIEF-British artificial intelligence firm announces license agreement with Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-british-artificial-intelligence-firm-announces-license-agreement-with-janssen-2016-11,positive,0.8021382093429565
11/9/2016 6:28:14 PM,"Drug stocks rip higher after Trump's upset victory signals easing pressure on prices (MRK, PFE, AMGN, JNJ, AGN, ABBV, SNY, NVS, AZN, GSK, IBB)",Business Insider,http://www.businessinsider.com/drug-company-stocks-morning-after-election-2016-11,positive,0.9015564918518066
11/9/2016 10:16:20 PM,"J&J vaccine plus Gilead immune booster shows promise as HIV fighter (JNJ, GILD)",Reuters,http://www.businessinsider.com/r-jj-vaccine-plus-gilead-immune-booster-shows-promise-as-hiv-fighter-2016-11,positive,0.9299513697624207
11/10/2016 5:06:17 PM,"BRIEF-Genmab says combination of drugs from J&J, Amgen will be tested in study (GEN, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-says-combination-of-drugs-from-jj-amgen-will-be-tested-in-study-2016-11,neutral,0.5980863571166992
11/10/2016 5:40:18 PM,"BRIEF-Janssen reports clinical trial collaboration and supply agreement with Amgen to evaluate Daratumumab in combination with Carfilzomib (AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-janssen-reports-clinical-trial-collaboration-and-supply-agreement-with-amgen-to-evaluate-daratumumab-in-combination-with-carfilzomib-2016-11,positive,0.923663854598999
11/14/2016 8:22:18 AM,"J&J arthritis drug goes up against Humira, with mixed results (JNJ)",Reuters,http://www.businessinsider.com/r-jj-arthritis-drug-goes-up-against-humira-with-mixed-results-2016-11,positive,0.8876294493675232
11/14/2016 12:22:20 PM,"Drugmakers improve access for poor, GSK ranked top (GSK, JNJ, MRK)",Reuters,http://www.businessinsider.com/r-drugmakers-improve-access-for-poor-gsk-ranked-top-2016-11,positive,0.8904621005058289
11/14/2016 8:22:19 PM,The Novartis house that Vasella built gets extreme makeover (JNJ),Reuters,http://www.businessinsider.com/r-the-novartis-house-that-vasella-built-gets-extreme-makeover-2016-11,positive,0.5357675552368164
11/14/2016 10:14:20 PM,BRIEF-Janssen Pharma says new late-stage results from pioneer AF-PCI study meets main goal (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-pharma-says-new-late-stage-results-from-pioneer-af-pci-study-meets-main-goal-2016-11,positive,0.7444349527359009
11/15/2016 2:36:18 AM,"BRIEF-Paulson & Co cuts share stake in Alexion Pharmaceuticals, Johnson & Johnson (ALXN, FDX, EBAY, JNJ)",Reuters,http://www.businessinsider.com/r-brief-paulson--co-cuts-share-stake-in-alexion-pharmaceuticals-johnson--johnson-2016-11,neutral,0.5103525519371033
11/15/2016 1:32:20 PM,RPT-The Novartis house that Vasella built gets extreme makeover (JNJ),Reuters,http://www.businessinsider.com/r-rpt-the-novartis-house-that-vasella-built-gets-extreme-makeover-2016-11,positive,0.7606018781661987
11/15/2016 4:20:21 PM,BRIEF-Janssen's Guselkumab shows promise in psoriatic arthritis treatment in Phase 2 trial (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssens-guselkumab-shows-promise-in-psoriatic-arthritis-treatment-in-phase-2-trial-2016-11,positive,0.9494246244430542
11/16/2016 1:24:18 PM,BRIEF-Samsung Biologics says it wins $261.8 mln order from Cilag GmbH International (JNJ),Reuters,http://www.businessinsider.com/r-brief-samsung-biologics-says-it-wins-2618-mln-order-from-cilag-gmbh-international-2016-11,positive,0.9363553524017334
11/16/2016 10:24:21 PM,BRIEF-Janssen announces data from two late-stage studies for sirukumab in RA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-announces-data-from-two-late-stage-studies-for-sirukumab-in-ra-2016-11,neutral,0.5289672613143921
11/17/2016 3:26:32 PM,BRIEF-Janssen submits application to FDA seeking approval of anti-interleukin-23 monoclonal antibody guselkumab (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-submits-application-to-fda-seeking-approval-of-anti-interleukin-23-monoclonal-antibody-guselkumab-2016-11,positive,0.8378111124038696
11/21/2016 10:56:52 PM,"BRIEF-Genmab announces U.S. FDA approval of Darzalex (Daratumumab) for relapsed multiple myeloma (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-announces-us-fda-approval-of-darzalex-daratumumab-for-relapsed-multiple-myeloma-2016-11,positive,0.6350855827331543
11/25/2016 5:56:17 AM,J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg (JNJ),Reuters,http://www.businessinsider.com/r-jj-makes-takeover-approach-for-swiss-drugmaker-actelion--bloomberg-2016-11,neutral,0.8654661774635315
11/25/2016 5:56:17 AM,BRIEF-J&J said to make takeover approach for Swiss drugmaker Actelion - Bloomberg (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-said-to-make-takeover-approach-for-swiss-drugmaker-actelion---bloomberg-2016-11,neutral,0.86323481798172
11/25/2016 7:28:21 AM,"UPDATE 1-J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg (JNJ, ABT)",Reuters,http://www.businessinsider.com/r-update-1-jj-makes-takeover-approach-for-swiss-drugmaker-actelion--bloomberg-2016-11,neutral,0.7884467244148254
11/25/2016 11:28:18 AM,"Costly leukaemia pill wins UK green light after price cut (JNJ, PFE, BMY, 4523)",Reuters,http://www.businessinsider.com/r-costly-leukaemia-pill-wins-uk-green-light-after-price-cut-2016-11,positive,0.9057520627975464
11/25/2016 6:02:43 PM,"CONFIRMED: Johnson & Johnson is looking to buy a nearly $20 billion drugmaker (ATLN, JNJ)",Business Insider,http://www.businessinsider.com/actelion-confirms-johnson-and-johnson-offer-2016-11,positive,0.5861833095550537
11/25/2016 6:54:20 PM,"US STOCKS-Wall St hit record highs as consumer staples, techs gain (JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-hit-record-highs-as-consumer-staples-techs-gain-2016-11,positive,0.896360456943512
11/25/2016 6:54:20 PM,BRIEF-J&J confirms discussions with Actelion regarding potential deal (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-confirms-discussions-with-actelion-regarding-potential-deal-2016-11,neutral,0.8629754185676575
11/25/2016 6:54:20 PM,Actelion confirms Johnson & Johnson approach (JNJ),Reuters,http://www.businessinsider.com/r-actelion-confirms-johnson--johnson-approach-2016-11,neutral,0.8747125267982483
11/28/2016 3:11:41 PM,The drugmaker that Johnson & Johnson is looking to buy could significantly boost its takeover price,Reuters,http://www.businessinsider.com/r-actelions-ambitious-independent-minded-ceo-will-drive-up-takeover-price-2016-11,positive,0.9367398023605347
11/29/2016 10:20:15 AM,"PRESS DIGEST- Financial Times - Nov 29 (TSCO, BT., JNJ, SPD)",Reuters,http://www.businessinsider.com/r-press-digest--financial-times---nov-29-2016-11,neutral,0.9384834170341492
11/29/2016 12:02:07 PM,"Actelion shares plunge on report it eyes ""complicated"" J&J deal (JNJ)",Reuters,http://www.businessinsider.com/r-actelion-shares-plunge-on-report-it-eyes-complicated-jj-deal-2016-11,negative,0.9600857496261597
11/29/2016 12:02:07 PM,"Swiss stocks - Factors to watch on Nov.29 (PAXN, AIRE, VCH, ESUN, ALPN, COPN, JNJ)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-nov29-2016-11,neutral,0.9435597062110901
11/29/2016 1:36:10 PM,European shares steady as firmer banks offset weaker miners (JNJ),Reuters,http://www.businessinsider.com/r-european-shares-steady-as-firmer-banks-offset-weaker-miners-2016-11,positive,0.7399144172668457
11/29/2016 4:56:10 PM,BRIEF-Depuy Synthes says new UK joint registry data confirms positive early results for Depuy Synthes Attune Knee system (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-says-new-uk-joint-registry-data-confirms-positive-early-results-for-depuy-synthes-attune-knee-system-2016-11,positive,0.9483932852745056
11/29/2016 8:10:05 PM,"BRIEF-Actelion has given J&J access to some of its financial information as part of the deal negotiations - Bloomberg, citing sources (JNJ)",Reuters,http://www.businessinsider.com/r-brief-actelion-has-given-jj-access-to-some-of-its-financial-information-as-part-of-the-deal-negotiations---bloomberg-citing-sources-2016-11,neutral,0.9194818735122681
11/30/2016 2:00:05 PM,"BRIEF-Achillion announces initiation of patient dosing by Janssen in phase 2B study (ACHN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-achillion-announces-initiation-of-patient-dosing-by-janssen-in-phase-2b-study-2016-11,neutral,0.89764004945755
11/30/2016 5:30:05 PM,Rejecting J&J could leave Actelion with 'lot of explaining to do',Reuters,http://www.businessinsider.com/r-rejecting-jj-could-leave-actelion-with-lot-of-explaining-to-do-2016-11,negative,0.9575982093811035
12/1/2016 12:04:06 PM,"Swiss stocks - Factors to watch on Dec 1 (STMN, JNJ, ESUN, FORN)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-dec-1-2016-12,neutral,0.9368701577186584
12/2/2016 3:14:03 AM,Johnson & Johnson hit with over $1 bln verdict on hip implants (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnson-hit-with-over-1-bln-verdict-on-hip-implants-2016-12,positive,0.4837183654308319
12/2/2016 5:32:09 AM,UPDATE 1-Johnson & Johnson hit with over $1 bln verdict on hip implants (JNJ),Reuters,http://www.businessinsider.com/r-update-1-johnson--johnson-hit-with-over-1-bln-verdict-on-hip-implants-2016-12,negative,0.8009530305862427
12/2/2016 6:34:06 PM,EU health regulator warns some hep C drugs could reactivate hep B,Reuters,http://www.businessinsider.com/r-eu-health-regulator-warns-some-hep-c-drugs-could-reactivate-hep-b-2016-12,negative,0.942558765411377
12/2/2016 7:16:03 PM,"UPDATE 1-EU health regulator warns some hep C drugs could reactivate hep B (JNJ, BMY, GILD)",Reuters,http://www.businessinsider.com/r-update-1-eu-health-regulator-warns-some-hep-c-drugs-could-reactivate-hep-b-2016-12,negative,0.9269317388534546
12/2/2016 8:24:03 PM,"Actelion's silence has hedge funds betting big on J&J deal (MON, JNJ, SUN, SIK, SGO)",Reuters,http://www.businessinsider.com/r-actelions-silence-has-hedge-funds-betting-big-on-jj-deal-2016-12,neutral,0.7748870253562927
12/5/2016 1:00:05 AM,"RPT-Actelion's silence has hedge funds betting big on J&J deal (MON, JNJ, SUN, SIK, SGO)",Reuters,http://www.businessinsider.com/r-rpt-actelions-silence-has-hedge-funds-betting-big-on-jj-deal-2016-12,neutral,0.5816996693611145
12/5/2016 3:36:06 AM,Novartis CEO plays down prospects for Actelion bid: Blick,Reuters,http://www.businessinsider.com/r-novartis-ceo-plays-down-prospects-for-actelion-bid-blick-2016-12,negative,0.9057374596595764
12/5/2016 11:56:05 PM,"BRIEF-Sanofi to explore counterbid for Actelion amid J&J talks - Bloomberg, citing sources (JNJ, SAN)",Reuters,http://www.businessinsider.com/r-brief-sanofi-to-explore-counterbid-for-actelion-amid-jj-talks---bloomberg-citing-sources-2016-12,neutral,0.899666965007782
12/6/2016 12:18:07 AM,"Sanofi exploring bid for Actelion amid J&J talks - Bloomberg (SAN, JNJ)",Reuters,http://www.businessinsider.com/r-sanofi-exploring-bid-for-actelion-amid-jj-talks---bloomberg-2016-12,neutral,0.897873044013977
12/6/2016 5:40:10 AM,"UPDATE 1-Sanofi exploring bid for Actelion amid J&J talks - Bloomberg (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-update-1-sanofi-exploring-bid-for-actelion-amid-jj-talks---bloomberg-2016-12,neutral,0.8939583897590637
12/6/2016 12:00:07 PM,"DEALTALK-Trump's corporate tax holiday could spur pharma M&A (JNJ, AGN, MSFT, ACAD, MRK, LLY, PFE, AMGN, AAPL, BMY, INCY, GILD)",Reuters,http://www.businessinsider.com/r-dealtalk-trumps-corporate-tax-holiday-could-spur-pharma-ma-2016-12,negative,0.8780286312103271
12/6/2016 2:02:03 PM,"RPT-DEALTALK-Trump's corporate tax holiday could spur pharma M&A (JNJ, AGN, MSFT, ACAD, MRK, LLY, PFE, AMGN, AAPL, BMY, INCY, GILD)",Reuters,http://www.businessinsider.com/r-rpt-dealtalk-trumps-corporate-tax-holiday-could-spur-pharma-ma-2016-12,negative,0.9314910769462585
12/6/2016 7:06:03 PM,BRIEF-Janssen Research & Development reports final Phase 2 data for ibrutinib (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-research--development-reports-final-phase-2-data-for-ibrutinib-2016-12,neutral,0.931959867477417
12/6/2016 7:26:03 PM,BRIEF-AbbVie reports positive Phase 2 data for ibrutinib in cGVHD patients (JNJ),Reuters,http://www.businessinsider.com/r-brief-abbvie-reports-positive-phase-2-data-for-ibrutinib-in-cgvhd-patients-2016-12,positive,0.9509865045547485
12/8/2016 5:54:04 PM,"BUZZ-DJI: On a run (XLI, DIA, GS, AAPL, JNJ)",Reuters,http://www.businessinsider.com/r-buzz-dji-on-a-run-2016-12,neutral,0.9234012365341187
12/9/2016 3:49:52 PM,"Under Trump, the medical device industry will likely be the first to benefit from tax cuts",Reuters,http://www.businessinsider.com/r-under-trump-congress-likely-to-pull-plug-on-medical-device-tax-2016-12,positive,0.8367525935173035
12/14/2016 1:34:03 AM,BRIEF-Johnson & Johnson says it has ended discussions with Actelion (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-it-has-ended-discussions-with-actelion-2016-12,neutral,0.5986455082893372
12/14/2016 1:44:07 AM,J&J ends takeover talks with Actelion (JNJ),Reuters,http://www.businessinsider.com/r-jj-ends-takeover-talks-with-actelion-2016-12,neutral,0.7260899543762207
12/14/2016 2:10:07 AM,UPDATE 1-J&J ends takeover talks with Actelion (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-ends-takeover-talks-with-actelion-2016-12,neutral,0.6688501834869385
12/14/2016 3:40:03 AM,BRIEF-Actelion says in discussions with another party regarding possible strategic transaction (JNJ),Reuters,http://www.businessinsider.com/r-brief-actelion-says-in-discussions-with-another-party-regarding-possible-strategic-transaction-2016-12,neutral,0.866497278213501
12/14/2016 4:14:03 PM,"BRIEF-FDA clears wireless integration for WellDoc, Lifescan project (JNJ)",Reuters,http://www.businessinsider.com/r-brief-fda-clears-wireless-integration-for-welldoc-lifescan-project-2016-12,neutral,0.5928311944007874
12/15/2016 7:08:03 AM,"PRESS DIGEST- Wall Street Journal - Dec 15 (YHOO, VZ, VIV, MS, VOW3, SAN, JNJ)",Reuters,http://www.businessinsider.com/r-press-digest--wall-street-journal---dec-15-2016-12,neutral,0.9451293349266052
12/15/2016 2:52:03 PM,BRIEF-Veritex Holdings public offering of 3.9 mln shares priced at $22.50/share,Reuters,http://www.businessinsider.com/r-brief-veritex-holdings-public-offering-of-39-mln-shares-priced-at-2250/share-2016-12,neutral,0.9330973625183105
12/16/2016 6:02:03 AM,Sanofi discusses $275 per Actelion share for potential deal: Bloomberg,Reuters,http://www.businessinsider.com/r-sanofi-discusses-275-per-actelion-share-for-potential-deal-bloomberg-2016-12,neutral,0.9365375638008118
12/23/2016 10:49:48 PM,"Johnson & Johnson's on-again, off-again pursuit of Actelion is back on (JNJ, ALIOF)",Business Insider Contributor ,http://www.businessinsider.com/johnson-and-johnsons-actelion-pharmaceuticals-aquisition-2016-12,neutral,0.9141700267791748
12/28/2016 1:18:05 PM,"BRIEF-Achillion announces clinical milestone for the advancement of JNJ-4178 (ACHN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-achillion-announces-clinical-milestone-for-the-advancement-of-jnj-4178-2016-12,neutral,0.7802304625511169
12/29/2016 11:00:05 PM,"BRIEF-Mylan launches generic Concerta tablets (JNJ, MYL)",Reuters,http://www.businessinsider.com/r-brief-mylan-launches-generic-concerta-tablets-2016-12,neutral,0.85675448179245
12/30/2016 7:52:03 AM,"Swiss stocks - Factors to watch on Friday (JNJ, ALPN)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-friday-2016-12,neutral,0.9132986664772034
1/3/2017 12:48:03 PM,BRIEF-Johnson & Johnson announces quarterly dividend for Q1 2017 (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-announces-quarterly-dividend-for-q1-2017-2017-1,neutral,0.5994924902915955
1/3/2017 7:32:06 PM,BRIEF-J&J's DePuy Synthes acquires technology from Interventional Spine Inc (JNJ),Reuters,http://www.businessinsider.com/r-brief-jjs-depuy-synthes-acquires-technology-from-interventional-spine-inc-2017-1,neutral,0.6874579191207886
1/4/2017 7:00:05 AM,Judge halves $1 bln award in J&J hip implants case (JNJ),Reuters,http://www.businessinsider.com/r-judge-halves-1-bln-award-in-jj-hip-implants-case-2017-1,negative,0.7102116346359253
1/6/2017 8:10:03 AM,"J&J, Actelion approach Swiss takeover board over deal structure -paper (JNJ, SAN)",Reuters,http://www.businessinsider.com/r-jj-actelion-approach-swiss-takeover-board-over-deal-structure--paper-2017-1,neutral,0.9358848333358765
1/11/2017 2:44:03 PM,"BRIEF-Bird Rock Bio receives approval to start first in human clinical trial for Namacizumab, enters into agreement with GE Healthcare for process development and scale-up to provide clinical phase...",Reuters,http://www.businessinsider.com/r-brief-bird-rock-bio-receives-approval-to-start-first-in-human-clinical-trial-for-namacizumab-enters-into-agreement-with-ge-healthcare-for-process-development-and-scale-up-to-provide-clinical-phase-2-cgmp-material-2017-1,positive,0.8995557427406311
1/11/2017 7:16:03 PM,"UPDATE 1-Trump says pharmaceutical companies ""getting away with murder"" (MYL, LMT, BA, PFE, JNJ, GILD, IBB)",Reuters,http://www.businessinsider.com/r-update-1-trump-says-pharmaceutical-companies-getting-away-with-murder-2017-1,neutral,0.8361963629722595
1/12/2017 1:48:06 AM,BRIEF-Orthocell announces collaboration with Johnson & Johnson (JNJ),Reuters,http://www.businessinsider.com/r-brief-orthocell-announces-collaboration-with-johnson--johnson-2017-1,neutral,0.8055617809295654
1/14/2017 6:42:15 AM,Johnson & Johnson will begin disclosing drug price increases (JNJ),Business Insider Contributor ,http://www.businessinsider.com/johnson-and-johnson-drug-price-increases-2017-1,neutral,0.8093872666358948
1/20/2017 8:40:07 AM,"INSIGHT-Sanofi's M&A misses frustrate some investors in drugmaker (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-insight-sanofis-ma-misses-frustrate-some-investors-in-drugmaker-2017-1,negative,0.8617128133773804
1/20/2017 2:54:10 PM,BRIEF-Ethicon Endo-Surgery announces acquisition of Megadyne Medical Products (JNJ),Reuters,http://www.businessinsider.com/r-brief-ethicon-endo-surgery-announces-acquisition-of-megadyne-medical-products-2017-1,neutral,0.9411489963531494
1/23/2017 9:30:05 AM,UPDATE 1-Actelion's Opsumit drug missed trial endpoint - doctor (JNJ),Reuters,http://www.businessinsider.com/r-update-1-actelions-opsumit-drug-missed-trial-endpoint---doctor-2017-1,negative,0.7979819178581238
1/23/2017 2:40:07 PM,"UPDATE 1-Silgan buys WestRock's dispensers unit for about $1 bln (SLGN, CPB, JNJ, KR, PEP)",Reuters,http://www.businessinsider.com/r-update-1-silgan-buys-westrocks-dispensers-unit-for-about-1-bln-2017-1,neutral,0.9023759961128235
1/23/2017 3:54:05 PM,"Trump to company executives: We think we can cut regulations by 75 pct (JNJ, GLW, IP, LMT, WHR, TSLA)",Reuters,http://www.businessinsider.com/r-trump-to-company-executives-we-think-we-can-cut-regulations-by-75-pct-2017-1,positive,0.7173717617988586
1/23/2017 5:50:05 PM,"CEO's discussed tax, regulations and trade with Trump -Liveris (DOW, JNJ, GLW, IP, LMT, X, WHR, TSLA)",Reuters,http://www.businessinsider.com/r-ceos-discussed-tax-regulations-and-trade-with-trump--liveris-2017-1,neutral,0.9446430802345276
1/24/2017 12:58:05 PM,BRIEF-Johnson & Johnson reports Q4 adj. earnings $1.58 per share (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-reports-q4-adj-earnings-158-per-share-2017-1,neutral,0.8149958252906799
1/24/2017 4:26:05 PM,BRIEF-J&J sees 2017 effective tax rate 19-20 percent (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-sees-2017-effective-tax-rate-19-20-percent-2017-1,neutral,0.8811612725257874
1/25/2017 2:04:05 PM,"BRIEF-Pacira Pharmaceuticals collaborates with Depuy Synthes to support promotion, education and training of exparel in orthopedics (PCRX, JNJ)",Reuters,http://www.businessinsider.com/r-brief-pacira-pharmaceuticals-collaborates-with-depuy-synthes-to-support-promotion-education-and-training-of-exparel-in-orthopedics-2017-1,positive,0.7992506623268127
1/26/2017 9:08:05 AM,UPDATE 1-Johnson & Johnson to buy Actelion for $30 bln (JNJ),Reuters,http://www.businessinsider.com/r-update-1-johnson--johnson-to-buy-actelion-for-30-bln-2017-1,neutral,0.8952932953834534
1/26/2017 10:28:15 AM,Johnson & Johnson will buy Swiss biotech firm Actelion for $30 billion (JNJ),Reuters,http://www.businessinsider.com/r-update-1-johnson-johnson-to-buy-actelion-for-30-bln-2017-1,neutral,0.928566575050354
1/26/2017 1:45:57 PM,"10 things you need to know before the opening bell (SPY, SPX, QQQ, DIA, RBS, JNJ, EBAY)",Business Insider,http://www.businessinsider.com/opening-bell-january-26-2017-2017-1,neutral,0.9463074803352356
1/26/2017 3:35:20 PM,"10 things you need to know today (SPY, SPX, QQQ, DIA, RBS, JNJ, EBAY)",Business Insider,http://markets.businessinsider.com/news/stocks/opening-bell-january-26-2017-2017-1-1001697085,neutral,0.9414228796958923
1/26/2017 4:22:05 PM,BRIEF-DePuy Synthes receives FDA clearance for cement-augmented pedicle screw systems (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-receives-fda-clearance-for-cement-augmented-pedicle-screw-systems-2017-1,positive,0.9357061982154846
1/26/2017 6:24:08 PM,Advisers could land $100 million payday from Actelion sale (JNJ),Reuters,http://www.businessinsider.com/r-advisers-could-land-100-million-payday-from-actelion-sale-2017-1,neutral,0.8311047554016113
1/26/2017 6:40:13 PM,"M&A boost helps European shares stay at one-year high (JNJ, STM, DGE, RBS)",Reuters,http://www.businessinsider.com/r-ma-boost-helps-european-shares-stay-at-one-year-high-2017-1,positive,0.9373507499694824
1/26/2017 10:22:49 PM,"STOCKS GO NOWHERE: Here's what you need to know (CAT, VZ, CHTR, JNJ)",Business Insider,http://www.businessinsider.com/closing-bell-january-26-2017-2017-1,neutral,0.9421433806419373
1/26/2017 10:52:53 PM,"STOCKS GO NOWHERE: Here's what you need to know (CAT, VZ, CHTR, JNJ)",Business Insider,http://markets.businessinsider.com/news/stocks/closing-bell-january-26-2017-2017-1-1001699144,neutral,0.9421433806419373
1/27/2017 2:56:06 PM,UPDATE 1-Drugmaker AbbVie's quarterly revenue misses estimates (JNJ),Reuters,http://www.businessinsider.com/r-update-1-drugmaker-abbvies-quarterly-revenue-misses-estimates-2017-1,neutral,0.7552086114883423
1/27/2017 10:08:06 PM,J&J loses venue fight for talc lawsuits in Missouri,Reuters,http://www.businessinsider.com/r-jj-loses-venue-fight-for-talc-lawsuits-in-missouri-2017-1,negative,0.8434723019599915
1/27/2017 10:30:08 PM,BRIEF-Fitch affirms Johnson & Johnson's IDR at 'AAA'; outlook stable (JNJ),Reuters,http://www.businessinsider.com/r-brief-fitch-affirms-johnson--johnsons-idr-at-aaa-outlook-stable-2017-1,positive,0.8439351916313171
1/31/2017 2:34:07 PM,"Actelion, Syngenta takeovers set to shake up Swiss SMI index",Reuters,http://www.businessinsider.com/r-actelion-syngenta-takeovers-set-to-shake-up-swiss-smi-index-2017-1,neutral,0.901752233505249
1/31/2017 3:16:07 PM,BRIEF-ChemDiv announces multi-year hit identification collaboration with Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-chemdiv-announces-multi-year-hit-identification-collaboration-with-janssen-2017-1,positive,0.8433255553245544
1/31/2017 3:18:04 PM,"BUZZ-DJI: Post-election rally on shaky ground (BA, IBM, AAPL, GS, DIA, DIS, JNJ)",Reuters,http://www.businessinsider.com/r-buzz-dji-post-election-rally-on-shaky-ground-2017-1,negative,0.9288178086280823
1/31/2017 4:10:07 PM,"Trump meets with drugmakers, seeks lower prices, U.S. production (MRK, JNJ, CELG, LLY, AMGN)",Reuters,http://www.businessinsider.com/r-trump-meets-with-drugmakers-seeks-lower-prices-us-production-2017-1,neutral,0.6421651840209961
1/31/2017 7:06:07 PM,"UPDATE 3-Trump pushes drugmakers for lower prices, more U.S. production (JNJ, MRK, LLY, AMGN, CELG)",Reuters,http://www.businessinsider.com/r-update-3-trump-pushes-drugmakers-for-lower-prices-more-us-production-2017-1,positive,0.9094677567481995
1/31/2017 9:30:07 PM,"UPDATE 4-Trump pushes drugmakers for lower prices, more U.S. production (JNJ, MRK, LLY, AMGN, CELG)",Reuters,http://www.businessinsider.com/r-update-4-trump-pushes-drugmakers-for-lower-prices-more-us-production-2017-1,positive,0.9122521281242371
1/31/2017 10:40:10 PM,"UPDATE 1-Roche said to consider options for Diabetes unit- Bloomberg (JNJ, BAYN, KKR, 6752)",Reuters,http://www.businessinsider.com/r-update-1-roche-said-to-consider-options-for-diabetes-unit--bloomberg-2017-1,neutral,0.8831453919410706
2/1/2017 11:40:10 PM,"BRIEF-J&J says upon termination of transaction agreement, under some circumstances, Actelion may be obligated to pay co a fee (JNJ)",Reuters,http://www.businessinsider.com/r-brief-jj-says-upon-termination-of-transaction-agreement-under-some-circumstances-actelion-may-be-obligated-to-pay-co-a-fee-2017-2,neutral,0.9037541151046753
2/2/2017 2:36:04 PM,BRIEF-Janssen Human Microbiome Institute announces multiple collaborations to accelerate translation of microbiome science into health solutions (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-human-microbiome-institute-announces-multiple-collaborations-to-accelerate-translation-of-microbiome-science-into-health-solutions-2017-2,positive,0.9068922996520996
2/6/2017 5:38:08 PM,BRIEF-Renova Therapeutics enters into agreement to receive Stresscopin investigational new drug file from Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-renova-therapeutics-enters-into-agreement-to-receive-stresscopin-investigational-new-drug-file-from-janssen-2017-2,positive,0.9044328927993774
2/8/2017 10:06:11 AM,"UPDATE 1-Drugmaker Sanofi sees weak 2017 earnings, not in hurry for M&A (SAN, JNJ, REGN, PFE, AMGN)",Reuters,http://www.businessinsider.com/r-update-1-drugmaker-sanofi-sees-weak-2017-earnings-not-in-hurry-for-ma-2017-2,negative,0.9732018709182739
2/8/2017 5:08:09 PM,"BRIEF-Bayer late-stage rivaroxaban trial meets primary endpoint early (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-bayer-late-stage-rivaroxaban-trial-meets-primary-endpoint-early-2017-2,positive,0.7147147059440613
2/8/2017 7:54:11 PM,Bayer's blood thinner also effective for artery disease,Reuters,http://www.businessinsider.com/r-bayers-blood-thinner-also-effective-for-artery-disease-2017-2,positive,0.5573179125785828
2/10/2017 7:22:09 AM,"Purdue seeks rule that would give it edge in Canadian painkiller market (JNJ, TEVA)",Reuters,http://www.businessinsider.com/r-purdue-seeks-rule-that-would-give-it-edge-in-canadian-painkiller-market-2017-2,positive,0.84174644947052
2/10/2017 1:08:09 PM,"RPT-Purdue seeks rule that would give it edge in Canadian painkiller market (JNJ, TEVA)",Reuters,http://www.businessinsider.com/r-rpt-purdue-seeks-rule-that-would-give-it-edge-in-canadian-painkiller-market-2017-2,positive,0.8095101714134216
2/10/2017 2:30:09 PM,EMA panel recommends that use of Actelion's Uptravi may continue,Reuters,http://www.businessinsider.com/r-ema-panel-recommends-that-use-of-actelions-uptravi-may-continue-2017-2,neutral,0.8507855534553528
2/10/2017 2:54:10 PM,UPDATE 1-EMA panel says that use of Actelion's Uptravi may continue (JNJ),Reuters,http://www.businessinsider.com/r-update-1-ema-panel-says-that-use-of-actelions-uptravi-may-continue-2017-2,neutral,0.8388012647628784
2/10/2017 7:04:09 PM,"BRIEF-Bayer says phase III compass study shows efficacy of Xarelto (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-bayer-says-phase-iii-compass-study-shows-efficacy-of-xarelto-2017-2,positive,0.8654781579971313
2/13/2017 1:36:10 PM,BRIEF-Akebia Therapeutics provides update on Janssen deal (JNJ),Reuters,http://www.businessinsider.com/r-brief-akebia-therapeutics-provides-update-on-janssen-deal-2017-2,neutral,0.9410772323608398
2/14/2017 7:58:10 AM,"Actelion, being bought by J&J, says FY profit rose 26 pct (JNJ)",Reuters,http://www.businessinsider.com/r-actelion-being-bought-by-jj-says-fy-profit-rose-26-pct-2017-2,positive,0.9521745443344116
2/14/2017 8:18:10 AM,"UPDATE 1-Actelion, being bought by J&J, says FY core net income rose 27 pct (JNJ)",Reuters,http://www.businessinsider.com/r-update-1-actelion-being-bought-by-jj-says-fy-core-net-income-rose-27-pct-2017-2,positive,0.9543126821517944
2/15/2017 1:00:10 AM,"BRIEF-Paulson & Co takes share stake in Achaogen, dissolves in J&J (JNJ)",Reuters,http://www.businessinsider.com/r-brief-paulson--co-takes-share-stake-in-achaogen-dissolves-in-jj-2017-2,neutral,0.8606706261634827
2/15/2017 1:12:12 PM,Integra LifeSciences To Buy J & J Codman Neurosurgery Business For $1.045 Bln ,RTTNews,/news/stocks/integra-lifesciences-to-buy-j-j-codman-neurosurgery-business-for-1-045-bln-1001752636,neutral,0.9287640452384949
2/15/2017 1:38:11 PM,"BRIEF-Integra Lifesciences plans to acquire Codman neurosurgery business from Johnson & Johnson for $1.045 bln (IART, JNJ)",Reuters,http://www.businessinsider.com/r-brief-integra-lifesciences-plans-to-acquire-codman-neurosurgery-business-from-johnson--johnson-for-1045-bln-2017-2,neutral,0.9182142615318298
2/15/2017 1:44:11 PM,"UPDATE 1-Integra offers to buy J&J's Codman neurosurgery business (JNJ, IART)",Reuters,http://www.businessinsider.com/r-update-1-integra-offers-to-buy-jjs-codman-neurosurgery-business-2017-2,neutral,0.8232860565185547
2/15/2017 2:46:10 PM,"BRIEF-Integra Lifesciences says Depuy Synthes entitled to get termination fee of $60 million if co fails to complete deal (IART, JNJ)",Reuters,http://www.businessinsider.com/r-brief-integra-lifesciences-says-depuy-synthes-entitled-to-get-termination-fee-of-60-million-if-co-fails-to-complete-deal-2017-2,negative,0.932358980178833
2/15/2017 3:06:13 PM,BRIEF-X-Chem expands collaboration with Janssen in inflammatory diseases (JNJ),Reuters,http://www.businessinsider.com/r-brief-x-chem-expands-collaboration-with-janssen-in-inflammatory-diseases-2017-2,positive,0.9437580704689026
2/15/2017 3:18:10 PM,BRIEF-Trianni signs licensing agreement with Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-trianni-signs-licensing-agreement-with-janssen-2017-2,positive,0.9083475470542908
2/16/2017 7:50:11 AM,Actelion says J&J's $280 per share offer to start March 3 (JNJ),Reuters,http://www.businessinsider.com/r-actelion-says-jjs-280-per-share-offer-to-start-march-3-2017-2,neutral,0.9319970607757568
2/16/2017 9:44:10 AM,UPDATE 1-Actelion says J&J's $280 per share offer to start March 3 (JNJ),Reuters,http://www.businessinsider.com/r-update-1-actelion-says-jjs-280-per-share-offer-to-start-march-3-2017-2,neutral,0.9252786636352539
2/16/2017 9:52:10 AM,BRIEF-Swiss Takeover Commission OKs J&J offer for Actelion (JNJ),Reuters,http://www.businessinsider.com/r-brief-swiss-takeover-commission-oks-jj-offer-for-actelion-2017-2,neutral,0.9184219241142273
2/16/2017 11:04:12 AM,"UPDATE 2-How Sanofi lost out to J&J in $30 bln battle for Actelion (SAN, JNJ)",Reuters,http://www.businessinsider.com/r-update-2-how-sanofi-lost-out-to-jj-in-30-bln-battle-for-actelion-2017-2,neutral,0.762464702129364
2/17/2017 1:08:10 PM,"EU mergers and takeovers (Feb 17) (6753, 2354, TKA, JNJ, TECD, AVT, SIE, MENT, NKT, AKE, KKR, 6501, 6581, 2502, ABI, 2317, 005930, HAR, MCRO, GFK, COL, BEAV, MQG, PETG, FFH, AIG, AHL1V, 8031, GAM,...",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-feb-17-2017-2,neutral,0.9484500288963318
2/17/2017 4:20:11 PM,BRIEF-Ethicon announces agreement to acquire Torax Medical (JNJ),Reuters,http://www.businessinsider.com/r-brief-ethicon-announces-agreement-to-acquire-torax-medical-2017-2,neutral,0.5858911871910095
2/21/2017 3:32:12 PM,"EU mergers and takeovers (Feb 21) (MAERSK , ACA, UCG, JNJ, TECD, AVT, SIE, MENT, NKT, AKE, KKR, 6501, 6581, 2502, ABI, 2317, 005930, HAR, MCRO, GFK, COL, BEAV, MQG, PETG, FFH, AIG, AHL1V, 8031,...",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-feb-21-2017-2,neutral,0.9490551948547363
2/22/2017 6:42:12 PM,"Genmab and J&J's cancer drug set for blockbuster sales this year (GEN, JNJ, GILD, AMGN)",Reuters,http://www.businessinsider.com/r-genmab-and-jjs-cancer-drug-set-for-blockbuster-sales-this-year-2017-2,neutral,0.5978713035583496
2/22/2017 7:36:13 PM,"EU mergers and takeovers (Feb 22) (KKR, 6501, 6581, JNJ, ABT, TECD, AVT, SIE, MENT, NKT, AKE, 2502, ABI, 2317, 005930, HAR, MCRO, GFK, COL, BEAV, MQG, PETG, FFH, AIG, AHL1V, 8031, GAM, BX, NG.",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-feb-22-2017-2,neutral,0.950030505657196
2/22/2017 9:00:12 PM,"Genmab's Darzalex could achieve peak annual sales of $9 bln -CEO (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-genmabs-darzalex-could-achieve-peak-annual-sales-of-9-bln--ceo-2017-2,neutral,0.5465621948242188
2/22/2017 9:28:12 PM,"UPDATE 1-Genmab and J&J's cancer drug set for blockbuster sales this year (GEN, JNJ, GILD, AMGN)",Reuters,http://www.businessinsider.com/r-update-1-genmab-and-jjs-cancer-drug-set-for-blockbuster-sales-this-year-2017-2,positive,0.7297854423522949
2/23/2017 5:48:17 PM,Trump tells CEOs he plans to bring back millions of jobs,Reuters,http://www.businessinsider.com/r-trump-tells-ceos-he-plans-to-bring-back-millions-of-jobs-2017-2,neutral,0.7233962416648865
2/23/2017 5:52:12 PM,"UPDATE 1-Trump tells CEOs he plans to bring back millions of jobs (GE, LMT, DOW, IP, F, JNJ, GLW, MRK, CAT, MMM, X, ADM, GD, WHR, 067900)",Reuters,http://www.businessinsider.com/r-update-1-trump-tells-ceos-he-plans-to-bring-back-millions-of-jobs-2017-2,neutral,0.6531824469566345
2/24/2017 1:44:12 PM,"BRIEF-EMA recommends approval of Daiichi Sankyo's anticoagulant (4568, JNJ, GEN)",Reuters,http://www.businessinsider.com/r-brief-ema-recommends-approval-of-daiichi-sankyos-anticoagulant-2017-2,neutral,0.7681345343589783
2/27/2017 4:05:00 PM,Ortho Clinical Diagnostics Awarded Top Honor for Global Excellence in Customer Service,PR Newswire,/news/stocks/ortho-clinical-diagnostics-awarded-top-honor-for-global-excellence-in-customer-service-1001786515,positive,0.930317223072052
2/27/2017 4:53:00 PM,Ortho Clinical Diagnostics Awarded Top Honor for Global Excellence in Customer Service,PR Newswire,/news/stocks/ortho-clinical-diagnostics-awarded-top-honor-for-global-excellence-in-customer-service-1001786683,positive,0.930317223072052
2/27/2017 8:50:13 PM,"J&J says kept drug price increases below 10 pct since 2012 (JNJ, MRK, AGN, NOVO )",Reuters,http://www.businessinsider.com/r-jj-says-kept-drug-price-increases-below-10-pct-since-2012-2017-2,neutral,0.710149884223938
2/27/2017 11:30:13 PM,BRIEF-Johnson & Johnson says received a subpoena in Feb. from the U.S. attorney's office for the District of Massachusetts (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-received-a-subpoena-in-feb-from-the-us-attorneys-office-for-the-district-of-massachusetts-2017-2,neutral,0.41793951392173767
2/28/2017 12:22:24 AM,The world's biggest drugmaker just pulled back the curtain on drug pricing (JNJ),Business Insider,http://www.businessinsider.com/johnson-and-johnson-breakdown-on-drug-pricing-2017-2,negative,0.47075819969177246
3/3/2017 9:42:20 AM,"UPDATE 1-Japan's GPIF posts record $92 bln quarterly gain thanks to stock rally (8306, 9433, JNJ, MSFT, 7267, 9432, 7203, XOM, AAPL)",Reuters,http://www.businessinsider.com/r-update-1-japans-gpif-posts-record-92-bln-quarterly-gain-thanks-to-stock-rally-2017-3,positive,0.9298763275146484
3/3/2017 2:00:22 PM,"BRIEF-Johnson & Johnson's Janssen says new results from second phase 3 study show significant efficacy of guselkumab (JNJ, PFE)",Reuters,http://www.businessinsider.com/r-brief-johnson--johnsons-janssen-says-new-results-from-second-phase-3-study-show-significant-efficacy-of-guselkumab-2017-3,positive,0.9449673891067505
3/3/2017 10:40:20 PM,J&J wins fourth trial in talc product liability lawsuits,Reuters,http://www.businessinsider.com/r-jj-wins-fourth-trial-in-talc-product-liability-lawsuits-2017-3,positive,0.8023357391357422
3/3/2017 11:04:20 PM,UPDATE 1-J&J wins trial in talc product liability lawsuits (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-wins-trial-in-talc-product-liability-lawsuits-2017-3,positive,0.8895725607872009
3/6/2017 10:00:21 AM,BRIEF-Janssen provides Nuevolution with further technology access fee payment (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-provides-nuevolution-with-further-technology-access-fee-payment-2017-3,positive,0.596637487411499
3/6/2017 1:44:21 PM,UPDATE 1-TG Therapeutics' leukemia drug clears hurdle in key study (JNJ),Reuters,http://www.businessinsider.com/r-update-1-tg-therapeutics-leukemia-drug-clears-hurdle-in-key-study-2017-3,positive,0.7508825659751892
3/7/2017 1:25:00 PM,"Drug Makers Stocks Under Scanner -- Pfizer, Merck, AbbVie, and Johnson & Johnson",PR Newswire,/news/stocks/drug-makers-stocks-under-scanner-pfizer-merck-abbvie-and-johnson-johnson-1001810747,negative,0.6821759343147278
3/7/2017 4:30:22 PM,"US STOCKS-Wall St slips as Trump tweet pummels drug stocks (JNJ, DISH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-slips-as-trump-tweet-pummels-drug-stocks-2017-3,negative,0.9550221562385559
3/7/2017 5:56:21 PM,"US STOCKS-Wall St pares losses as techs offset pharma decline (JNJ, AAPL, MSFT, DISH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-pares-losses-as-techs-offset-pharma-decline-2017-3,negative,0.9129453897476196
3/8/2017 5:42:22 PM,"INSIGHT-'It's like kumbaya': Trump's genial private meetings with CEOs jar with public attacks (JNJ, MRK, LLY, CELG, AMGN, GM, F, CPB, TGT, LUV, UAL, DAL)",Reuters,http://www.businessinsider.com/r-insight-its-like-kumbaya-trumps-genial-private-meetings-with-ceos-jar-with-public-attacks-2017-3,neutral,0.8371438384056091
3/9/2017 5:54:22 PM,"US STOCKS-S&P, Dow on track to snap 3-day losing streak as banks gain (JNJ, AAPL, AIG)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-on-track-to-snap-3-day-losing-streak-as-banks-gain-2017-3,positive,0.6732839345932007
3/9/2017 7:44:22 PM,"US STOCKS-Wall St fights to hold on to gains as oil slips again (CVX, JNJ, AAPL, SIG)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-fights-to-hold-on-to-gains-as-oil-slips-again-2017-3,negative,0.8606255054473877
3/9/2017 9:46:22 PM,"US STOCKS-Wall St slips as energy shares fall further; banks pare gains (JNJ, AAPL)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-slips-as-energy-shares-fall-further-banks-pare-gains-2017-3,negative,0.9649677872657776
3/9/2017 10:52:27 PM,US STOCKS-Wall St ends up slightly; energy shares rebound (JNJ),Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-ends-up-slightly-energy-shares-rebound-2017-3,positive,0.690545380115509
3/9/2017 11:12:25 PM,"GLOBAL MARKETS-Oil prices slump amid ample supply, gold falls (UKX, BP., BLT, GLEN, JNJ, XOM, WFC)",Reuters,http://www.businessinsider.com/r-global-markets-oil-prices-slump-amid-ample-supply-gold-falls-2017-3,negative,0.9673621654510498
3/13/2017 4:17:00 PM,Ortho Clinical Diagnostics Announces Expansion Of Global Agreement With Astute Medical For NephroCheck Test,PR Newswire,/news/stocks/ortho-clinical-diagnostics-announces-expansion-of-global-agreement-with-astute-medical-for-nephrocheck-test-1001829909,positive,0.9417601227760315
3/13/2017 4:35:00 PM,Ortho Clinical Diagnostics Announces Expansion Of Global Agreement With Astute Medical For NephroCheck Test,PR Newswire,/news/stocks/ortho-clinical-diagnostics-announces-expansion-of-global-agreement-with-astute-medical-for-nephrocheck-test-1001829985,positive,0.9417601227760315
3/14/2017 7:00:00 AM,Johnson & Johnson Names Winners of First Africa Innovation Challenge,PR Newswire,/news/stocks/johnson-johnson-names-winners-of-first-africa-innovation-challenge-1001831566,positive,0.5122091770172119
3/14/2017 12:56:24 PM,"BRIEF-Pacira says phase 4 study shows its drug reduces opioid consumption and postsurgical pain in patients undergoing total knee arthroplasty (PCRX, JNJ)",Reuters,http://www.businessinsider.com/r-brief-pacira-says-phase-4-study-shows-its-drug-reduces-opioid-consumption-and-postsurgical-pain-in-patients-undergoing-total-knee-arthroplasty-2017-3,positive,0.9368368983268738
3/14/2017 4:30:50 PM,"An experimental vaccine could leave the world far better prepared for the next Ebola outbreak (JNJ, BAVA, MRK)",Reuters,http://www.businessinsider.com/r-two-part-ebola-vaccine-offers-long-lasting-protection-2017-3,positive,0.7419745922088623
3/14/2017 5:40:24 PM,"RPT-Two-part Ebola vaccine offers long-lasting protection (JNJ, BAVA, MRK)",Reuters,http://www.businessinsider.com/r-rpt-two-part-ebola-vaccine-offers-long-lasting-protection-2017-3,positive,0.7164944410324097
3/15/2017 8:22:45 AM,BRIEF-Actelion says drug discovery business to be called Idorsia (JNJ),Reuters,http://www.businessinsider.com/r-brief-actelion-says-drug-discovery-business-to-be-called-idorsia-2017-3,neutral,0.9464208483695984
3/15/2017 1:50:42 PM,BRIEF-J&J CEO Alex Gorsky's 2016 total compensation $26.9 mln (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-ceo-alex-gorskys-2016-total-compensation-269-mln-2017-3,neutral,0.9235908389091492
3/18/2017 3:18:46 PM,"J&J and Bayer's Xarelto cuts recurrence of dangerous blood clots in study (JNJ, BAYN, PFE)",Reuters,http://www.businessinsider.com/r-jj-and-bayers-xarelto-cuts-recurrence-of-dangerous-blood-clots-in-study-2017-3,positive,0.6829153299331665
3/19/2017 9:12:46 PM,Newer type 2 diabetes drugs show heart protective quality in study,Reuters,http://www.businessinsider.com/r-newer-type-2-diabetes-drugs-show-heart-protective-quality-in-study-2017-3,positive,0.7342519164085388
3/23/2017 1:40:45 PM,BRIEF-Johnson & Johnson says to pause all YouTube digital advertising globally (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-to-pause-all-youtube-digital-advertising-globally-2017-3,negative,0.5520287752151489
3/23/2017 1:54:45 PM,"J&J latest to suspend ads from YouTube over offensive videos (JNJ, VZ, T, MKS)",Reuters,http://www.businessinsider.com/r-jj-latest-to-suspend-ads-from-youtube-over-offensive-videos-2017-3,negative,0.8619785308837891
3/23/2017 2:16:50 PM,"UPDATE 1-J&J latest to suspend ads from YouTube over offensive videos (JNJ, VZ, T, MKS)",Reuters,http://www.businessinsider.com/r-update-1-jj-latest-to-suspend-ads-from-youtube-over-offensive-videos-2017-3,negative,0.875616729259491
3/24/2017 4:42:45 AM,YouTube's bid to grab TV dollars imperiled by advertiser revolt,Reuters,http://www.businessinsider.com/r-youtubes-bid-to-grab-tv-dollars-imperiled-by-advertiser-revolt-2017-3,negative,0.4682460427284241
3/28/2017 3:30:49 PM,Twitter to let advertisers buy video ads on Periscope,Reuters,http://www.businessinsider.com/r-twitter-to-let-advertisers-buy-video-ads-on-periscope-2017-3,neutral,0.9287564158439636
3/28/2017 3:52:49 PM,"BRIEF-Ligand announces licensing partner Janssen has filed an IND for an antibody discovered using the OmniAB Technology (LGND, JNJ)",Reuters,http://www.businessinsider.com/r-brief-ligand-announces-licensing-partner-janssen-has-filed-an-ind-for-an-antibody-discovered-using-the-omniab-technology-2017-3,negative,0.6084758639335632
3/28/2017 7:06:47 PM,"US STOCKS-Dow on track to snap 8-day losing streak as banks gain (BAC, GS, JPM, AAPL, GM, TSLA, 700)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-on-track-to-snap-8-day-losing-streak-as-banks-gain-2017-3,positive,0.7082516551017761
3/28/2017 7:06:47 PM,U.S. senator launches probe into five top opioid drugmakers,Reuters,http://www.businessinsider.com/r-us-senator-launches-probe-into-five-top-opioid-drugmakers-2017-3,negative,0.6439034342765808
3/28/2017 8:40:47 PM,"UPDATE 1-U.S. senator launches probe into five top opioid drugmakers (JNJ, MYL, DEPO)",Reuters,http://www.businessinsider.com/r-update-1-us-senator-launches-probe-into-five-top-opioid-drugmakers-2017-3,neutral,0.801138699054718
3/29/2017 8:23:58 AM,"Johnson & Johnson just launched a $100,000 burnout prevention bootcamp for CEOs (JNJ)",Business Insider,http://www.businessinsider.com/johnson-johnson-ceos-burnt-out-2017-3,neutral,0.831941545009613
3/29/2017 8:26:49 AM,"PRESS DIGEST- New York Times business news - March 29 (005930, 9984, 700, TSLA, BLK)",Reuters,http://www.businessinsider.com/r-press-digest--new-york-times-business-news---march-29-2017-3,neutral,0.9367400407791138
3/30/2017 7:04:50 PM,"BRIEF-Genmab A/S says Phase II study in NHL will not proceed (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-a-s-says-phase-ii-study-in-nhl-will-not-proceed-2017-3,neutral,0.671899676322937
3/31/2017 1:30:48 AM,"DEALS-Trump helps make cross-border M&A great again (JNJ, ULVR, AKZA, PPG, RB., MJN, BARC, BAC)",Reuters,http://www.businessinsider.com/r-deals-trump-helps-make-cross-border-ma-great-again-2017-3,positive,0.9029463529586792
3/31/2017 7:00:00 AM,Johnson & Johnson Publishes Interim Result for Actelion Tender Offer and Declares the Tender Offer Successful,PR Newswire,/news/stocks/johnson-&-johnson-publishes-interim-result-for-actelion-tender-offer-and-declares-the-tender-offer-successful-1001550374,neutral,0.9372537732124329
3/31/2017 7:12:02 AM,Johnson & Johnson Announces Interim Result For Actelion Tender Offer ,RTTNews,/news/stocks/johnson-johnson-announces-interim-result-for-actelion-tender-offer-1001884307,neutral,0.8401279449462891
3/31/2017 7:50:50 AM,"Swiss stocks - Factors to watch on March 31 (JNJ, HELN, SIK)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-march-31-2017-3,neutral,0.9281013607978821
3/31/2017 12:14:48 PM,"Deals of the day-Mergers and acquisitions (AVGO, 6502, JNJ, CM, PVTB, BX, 10015031, ROSN, MNZS, BN, 2881)",Reuters,http://www.businessinsider.com/r-deals-of-the-day-mergers-and-acquisitions-2017-3,neutral,0.9431670308113098
4/4/2017 5:58:00 PM,"Ortho Clinical Diagnostics to Present Data on Early Detection Of Acute Kidney Injury, Total Lab Automation and Transfusion Medicine at MEDLAB Asia Pacific 2017",PR Newswire,/news/stocks/ortho-clinical-diagnostics-to-present-data-on-early-detection-of-acute-kidney-injury-total-lab-automation-and-transfusion-medicine-at-medlab-asia-pacific-2017-1001895502,neutral,0.8306337594985962
4/5/2017 8:12:50 AM,"Swiss stocks - Factors to watch on April 5 (JNJ, GAM, LECN, VONN, VAHN)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-april-5-2017-4,neutral,0.9365664124488831
4/5/2017 1:10:52 PM,"Actelion shareholders back R&D spinoff, keep J&J deal on track (JNJ)",Reuters,http://www.businessinsider.com/r-actelion-shareholders-back-rd-spinoff-keep-jj-deal-on-track-2017-4,neutral,0.8215876817703247
4/6/2017 2:20:52 AM,Experts want special clinics to prescribe ketamine as antidepressant,Reuters,http://www.businessinsider.com/r-experts-want-special-clinics-to-prescribe-ketamine-as-antidepressant-2017-4,neutral,0.7272270321846008
4/6/2017 3:16:53 PM,U.S. trade group hacked with Chinese software ahead of Xi summit,Reuters,http://www.businessinsider.com/r-us-trade-group-hacked-with-chinese-software-ahead-of-xi-summit-2017-4,negative,0.7569940686225891
4/7/2017 12:36:57 PM,BRIEF-PeptiDream enters into collaboration with Janssen Pharmaceuticals (JNJ),Reuters,http://www.businessinsider.com/r-brief-peptidream-enters-into-collaboration-with-janssen-pharmaceuticals-2017-4,positive,0.6593182682991028
4/7/2017 1:58:53 PM,EMA gives green light to Actelion's Uptravi after safety review,Reuters,http://www.businessinsider.com/r-ema-gives-green-light-to-actelions-uptravi-after-safety-review-2017-4,positive,0.8601609468460083
4/7/2017 2:18:12 PM,PeptiDream Reports Discovery Collaboration Agreement With Janssen ,RTTNews,/news/stocks/peptidream-reports-discovery-collaboration-agreement-with-janssen-1001906569,positive,0.9011737108230591
4/10/2017 12:10:00 PM,"Drug Makers Stocks on Investors' Radar -- Pfizer, Merck, Johnson & Johnson, and AbbVie",PR Newswire,/news/stocks/drug-makers-stocks-on-investors-radar-pfizer-merck-johnson-johnson-and-abbvie-1001909734,neutral,0.9021657705307007
4/10/2017 2:14:58 PM,"BRIEF-Geron Corp and Janssen Research & Development LLC has completed second internal data reviews of Imerge and Imbark (GERN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-geron-corp-and-janssen-research--development-llc-has-completed-second-internal-data-reviews-of-imerge-and-imbark-2017-4,neutral,0.5242330431938171
4/11/2017 10:37:10 AM,"Swiss billionaire Wyss gets nearly 10 pct of Molecular Partners (JNJ, AGN)",Reuters,http://www.businessinsider.com/r-swiss-billionaire-wyss-gets-nearly-10-pct-of-molecular-partners-2017-4,positive,0.7452710270881653
4/12/2017 1:22:17 PM,BRIEF-Phagelux announces collaboration with Johnson & Johnson Innovation for new antibacterial solution (JNJ),Reuters,http://www.businessinsider.com/r-brief-phagelux-announces-collaboration-with-johnson--johnson-innovation-for-new-antibacterial-solution-2017-4,positive,0.90478515625
4/17/2017 2:33:07 PM,BRIEF-Janssen receives Health Canada approval of Darzalex by priority review (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-receives-health-canada-approval-of-darzalex-by-priority-review-2017-4,positive,0.6957789659500122
4/18/2017 12:40:00 PM,Johnson & Johnson Reports 2017 First-Quarter Results:,PR Newswire,/news/stocks/johnson-johnson-reports-2017-first-quarter-results-1001926238,neutral,0.6684457659721375
4/18/2017 12:48:12 PM,Johnson & Johnson Q1 Profit Rises 4%,RTTNews,/news/stocks/johnson-johnson-q1-profit-rises-4-1001926265,positive,0.9225357174873352
4/18/2017 12:59:08 PM,BRIEF-Johnson & Johnson Q1 earnings per share $1.61 (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-q1-earnings-per-share-161-2017-4,neutral,0.7361226677894592
4/18/2017 1:01:05 PM,J&J's quarterly sales rise 1.6 pct (JNJ),Reuters,http://www.businessinsider.com/r-jjs-quarterly-sales-rise-16-pct-2017-4,positive,0.9426905512809753
4/18/2017 1:21:06 PM,"BRIEF-Genmab Q1 net sales of Darzalex at $255 million (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-q1-net-sales-of-darzalex-at-255-million-2017-4,neutral,0.9397628307342529
4/18/2017 1:21:06 PM,UPDATE 1-J&J revenue misses on lower-than-expected pharmaceutical sales (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-revenue-misses-on-lower-than-expected-pharmaceutical-sales-2017-4,negative,0.9700552225112915
4/18/2017 1:35:33 PM,Johnson & Johnson Q1 Profit Tops Estimates; Lifts FY17 View ,RTTNews,/news/stocks/johnson-johnson-q1-profit-tops-estimates-lifts-fy17-view-1001926523,positive,0.9269739389419556
4/18/2017 1:41:08 PM,"US STOCKS-Futures dip as investors weigh tax cut delays, earnings (BAC, GS, UNH, JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-dip-as-investors-weigh-tax-cut-delays-earnings-2017-4,negative,0.9665840864181519
4/18/2017 1:55:03 PM,"UPDATE 1-Cardinal Health to buy Medtronic units for $6.1 bln (CAH, MDT, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-cardinal-health-to-buy-medtronic-units-for-61-bln-2017-4,neutral,0.6708343625068665
4/18/2017 2:00:00 PM,5 Stocks to Watch as Canada Gets Hooked on Cannabis,PR Newswire,/news/stocks/5-stocks-to-watch-as-canada-gets-hooked-on-cannabis-1001926681,neutral,0.8382819890975952
4/18/2017 3:33:03 PM,"US STOCKS-Wall St set to open lower as earnings gather pace (GS, BAC, MS, WFC, JPM, UNH, JNJ, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-lower-as-earnings-gather-pace-2017-4,negative,0.9630159735679626
4/18/2017 3:53:03 PM,BRIEF-Johnson & Johnson sees Actelion adding 35-50 cents to 2018 EPS (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-sees-actelion-adding-35-50-cents-to-2018-eps-2017-4,positive,0.7297106981277466
4/18/2017 3:57:05 PM,"EU mergers and takeovers (April 18) (COL, LEA, JNJ, KKR, SAF, RR., BOL, VIV, 6752, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, TEF, CS, LIN)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-18-2017-4,neutral,0.9517852663993835
4/18/2017 4:39:03 PM,"US STOCKS-Wall St falls as Goldman, J&J results disappoint (JNJ, GS, MS, WFC, BAC, NFLX, UNH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-falls-as-goldman-jj-results-disappoint-2017-4,negative,0.9683998823165894
4/18/2017 6:07:05 PM,"US STOCKS-Weak Goldman, J&J results drag down Wall Street (JNJ, GS, BAC, NFLX, UNH)",Reuters,http://www.businessinsider.com/r-us-stocks-weak-goldman-jj-results-drag-down-wall-street-2017-4,negative,0.9657508134841919
4/18/2017 6:53:06 PM,"WRAPUP 2-U.S. housing starts drop; automobiles undercut factory output (GS, JNJ)",Reuters,http://www.businessinsider.com/r-wrapup-2-us-housing-starts-drop-automobiles-undercut-factory-output-2017-4,negative,0.9723931550979614
4/18/2017 7:13:05 PM,"US STOCKS-Wall St down as Goldman, J&J's results disappoint (JNJ, GS, BAC, NFLX, UNH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-down-as-goldman-jjs-results-disappoint-2017-4,negative,0.9671811461448669
4/18/2017 8:49:03 PM,"US STOCKS-Wall Sheet falls as Goldman, J&J weigh (JNJ, CAH, BAC, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-sheet-falls-as-goldman-jj-weigh-2017-4,negative,0.9542616605758667
4/18/2017 9:36:48 PM,Johnson & Johnson Leading The Pharmaceutical Sector Lower ,RTTNews,/news/stocks/johnson-johnson-leading-the-pharmaceutical-sector-lower-1001928365,neutral,0.8997347950935364
4/18/2017 10:27:03 PM,"US STOCKS-Goldman Sachs, J&J pull Wall Street lower (JNJ, CAH, MDT, BAC)",Reuters,http://www.businessinsider.com/r-us-stocks-goldman-sachs-jj-pull-wall-street-lower-2017-4,negative,0.925189197063446
4/19/2017 1:55:06 PM,"US STOCKS-Futures rise as earnings take center stage (MS, AXP, EBAY, QCOM, GS, JNJ, IBM)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-rise-as-earnings-take-center-stage-2017-4,positive,0.9277714490890503
4/19/2017 4:51:04 PM,"EU mergers and takeovers (April 19) (EDF, AREVA, SAF, RR., BOL, VIV, KKR, 6752, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, TEF, CS, LIN, JNJ)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-19-2017-4,neutral,0.9514936804771423
4/20/2017 4:51:04 PM,"BRIEF-Genmab to present seven abstracts at annual ASCO meeting (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-to-present-seven-abstracts-at-annual-asco-meeting-2017-4,neutral,0.9337683916091919
4/20/2017 6:31:07 PM,"EU mergers and takeovers (April 20) (RR., 3653, SAF, AVGO, BRCD, BOL, VIV, KKR, 6752, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, TEF, CS, LIN, JNJ, EDF, AREVA)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-20-2017-4,neutral,0.9519568085670471
4/21/2017 3:15:05 PM,"UPDATE 1-Valeant prices psoriasis treatment at $3,500 per month (VRX, LLY, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-valeant-prices-psoriasis-treatment-at-3500-per-month-2017-4,neutral,0.928935170173645
4/21/2017 9:51:09 PM,"EMA panel recommends nod for Sanofi, Regeneron's arthritis drug (SAN, REGN, JNJ, LLY, INCY)",Reuters,http://www.businessinsider.com/r-ema-panel-recommends-nod-for-sanofi-regenerons-arthritis-drug-2017-4,neutral,0.6911617517471313
4/21/2017 10:13:04 PM,"BRIEF-FDA approves Renflexis, biosimilar to Remicade (MRK, JNJ)",Reuters,http://www.businessinsider.com/r-brief-fda-approves-renflexis-biosimilar-to-remicade-2017-4,positive,0.7194560170173645
4/22/2017 2:51:04 AM,"U.S. FDA approves Samsung Bioepis' copy of J&J's Remicade -company (JNJ, AMGN, MRK, PFE, 068270)",Reuters,http://www.businessinsider.com/r-us-fda-approves-samsung-bioepis-copy-of-jjs-remicade--company-2017-4,neutral,0.630279004573822
4/24/2017 10:12:54 AM,Janssen Holding Acquires 92.51% Of Actelion ,RTTNews,/news/stocks/janssen-holding-acquires-92-51-of-actelion-1001940983,neutral,0.9372010231018066
4/24/2017 12:21:05 PM,"India to expand access to J&J's TB drug this year (JNJ, 4578)",Reuters,http://www.businessinsider.com/r-india-to-expand-access-to-jjs-tb-drug-this-year-2017-4,positive,0.9059771299362183
4/24/2017 1:11:08 PM,"RPT-INSIGHT-NASH: The next untapped pharma market gives investors many options (PFE, BMY, GILD, AGN, MRK, JNJ, DRRX)",Reuters,http://www.businessinsider.com/r-rpt-insight-nash-the-next-untapped-pharma-market-gives-investors-many-options-2017-4,neutral,0.8234217762947083
4/24/2017 3:21:10 PM,"EU mergers and takeovers (April 24) (6752, KKR, GE, BHI, BOL, VIV, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, TEF, CS, LIN, JNJ, EDF, AREVA)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-24-2017-4,neutral,0.9505015015602112
4/24/2017 5:05:05 PM,"J&J, Novartis and Takeda in talks for Brazil's Hypermarcas, sources say (JNJ, 4502, HYPE3, BBDC4)",Reuters,http://www.businessinsider.com/r-jj-novartis-and-takeda-in-talks-for-brazils-hypermarcas-sources-say-2017-4,neutral,0.7104385495185852
4/24/2017 5:31:10 PM,"UPDATE 1-J&J, Novartis and Takeda in talks for Brazil's Hypermarcas -sources (JNJ, 4502, HYPE3, BBDC4)",Reuters,http://www.businessinsider.com/r-update-1-jj-novartis-and-takeda-in-talks-for-brazils-hypermarcas--sources-2017-4,neutral,0.4952557384967804
4/24/2017 5:35:06 PM,"EMERGING MARKETS-Brazil real, Mexico peso strengthen on French vote (HYPE3, JNJ, 4502)",Reuters,http://www.businessinsider.com/r-emerging-markets-brazil-real-mexico-peso-strengthen-on-french-vote-2017-4,positive,0.9186445474624634
4/24/2017 7:39:00 PM,Johnson & Johnson to Host Pharmaceutical Business Review,PR Newswire,/news/stocks/johnson-johnson-to-host-pharmaceutical-business-review-1001943321,neutral,0.9419376850128174
4/24/2017 8:17:06 PM,"UPDATE 1-NASH: The next untapped pharma market gives investors many options (PFE, BMY, GILD, AGN, MRK, JNJ, DRRX)",Reuters,http://www.businessinsider.com/r-update-1-nash-the-next-untapped-pharma-market-gives-investors-many-options-2017-4,neutral,0.7897851467132568
4/25/2017 3:11:10 PM,"Japan's Otsuka aims to apply for TB drug approval in India in 90 days (4578, JNJ)",Reuters,http://www.businessinsider.com/r-japans-otsuka-aims-to-apply-for-tb-drug-approval-in-india-in-90-days-2017-4,neutral,0.7043418288230896
4/25/2017 3:11:10 PM,"US STOCKS-Wall St set to open higher as earnings take center stage (CAT, MCD, BIIB, CNC, T, TSN)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-higher-as-earnings-take-center-stage-2017-4,positive,0.9364098906517029
4/25/2017 5:29:10 PM,"EU mergers and takeovers (April 25) (BOL, VIV, SAF, 600115, EDF, 8058, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, KKR, TEF, CS, LIN, JNJ, AREVA, GE, BHI)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-25-2017-4,neutral,0.9509918689727783
4/26/2017 10:46:06 PM,"Digital ad spend jumps 22 percent to $72.5 bln in 2016 -report (VZ, JNJ)",Reuters,http://www.businessinsider.com/r-digital-ad-spend-jumps-22-percent-to-725-bln-in-2016--report-2017-4,positive,0.9336728453636169
4/27/2017 7:59:06 AM,BRIEF-Actelion says J&J deal on track to close towards end of Q2 (JNJ),Reuters,http://www.businessinsider.com/r-brief-actelion-says-jj-deal-on-track-to-close-towards-end-of-q2-2017-4,neutral,0.80719393491745
4/27/2017 10:01:11 AM,"UPDATE 1-Strong pharma unit drives Bayer earnings beat (BAYN, MON, JNJ, PFE, BMY)",Reuters,http://www.businessinsider.com/r-update-1-strong-pharma-unit-drives-bayer-earnings-beat-2017-4,positive,0.9419052600860596
4/27/2017 5:29:06 PM,BRIEF-J&J increase qtrly dividend by 5 pct to $0.84 per share (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-increase-qtrly-dividend-by-5-pct-to-084-per-share-2017-4,positive,0.9150404930114746
4/28/2017 12:49:07 PM,"CORRECTED-UPDATE 2-Valeant prices psoriasis treatment at $3,500 per month (April 21) (VRX, LLY, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-corrected-update-2-valeant-prices-psoriasis-treatment-at-3500-per-month-april-21-2017-4,neutral,0.9364179372787476
4/28/2017 3:05:09 PM,"Global med-tech firms, India locked in tussle after stent price sting (ABT, BSX, JNJ, MDT, ABBOTINDIA)",Reuters,http://www.businessinsider.com/r-global-med-tech-firms-india-locked-in-tussle-after-stent-price-sting-2017-4,negative,0.9078989028930664
4/28/2017 3:21:07 PM,"Deals of the day-Mergers and acquisitions (SIE, BBD., AKZA, PPG, 1880, 9437, OML, KOTAKBANK, BAYN, MON, ZC, SAF, KKR, TTS, APO, 600887, DG, SU, ATL, ALV)",Reuters,http://www.businessinsider.com/r-deals-of-the-day-mergers-and-acquisitions-2017-4,neutral,0.9414942264556885
4/28/2017 3:51:09 PM,"BRIEF-Genmab announces new late stage combination study of Daratumumab in multiple myeloma (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-announces-new-late-stage-combination-study-of-daratumumab-in-multiple-myeloma-2017-4,neutral,0.6000754833221436
4/28/2017 4:41:09 PM,"EU mergers and takeovers (April 28) (BMW, DAI, PAH3, F, RTO, 6201, 2354, VIV, TIT, KKR, TEF, CS, LIN, JNJ, EDF, AREVA, GE, BHI, SAF, 600115, 8058, ANA)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-28-2017-4,neutral,0.9512503743171692
4/28/2017 10:53:12 PM,BRIEF-Janssen Research & Development submits supplemental application to FDA to update prescribing information for Xarelto (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-research--development-submits-supplemental-application-to-fda-to-update-prescribing-information-for-xarelto-2017-4,neutral,0.9072039127349854
5/1/2017 2:13:00 PM,Johnson & Johnson Introduces Two New Interactive Experiences Showcasing More Than 130 Years Of Healthcare Innovation,PR Newswire,/news/stocks/johnson-johnson-introduces-two-new-interactive-experiences-showcasing-more-than-130-years-of-healthcare-innovation-1001965506,neutral,0.7012905478477478
5/3/2017 10:30:04 PM,"Bayer, J&J win first product liability trial over Xarelto (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-bayer-jj-win-first-product-liability-trial-over-xarelto-2017-5,positive,0.9143950343132019
5/3/2017 11:10:05 PM,"UPDATE 1-Bayer, J&J win first trial over Xarelto bleeding risks (BAYN, JNJ, BMY)",Reuters,http://www.businessinsider.com/r-update-1-bayer-jj-win-first-trial-over-xarelto-bleeding-risks-2017-5,positive,0.914478063583374
5/5/2017 2:44:03 AM,J&J ordered to pay $110 million in talc product liability trial (JNJ),Reuters,http://www.businessinsider.com/r-jj-ordered-to-pay-110-million-in-talc-product-liability-trial-2017-5,negative,0.7930090427398682
5/5/2017 3:54:05 AM,UPDATE 1-J&J ordered to pay $110 million in U.S. talc-powder trial (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-ordered-to-pay-110-million-in-us-talc-powder-trial-2017-5,negative,0.7285087704658508
5/5/2017 5:00:52 AM,Johnson & Johnson Ordered To Pay $110 Mln In Talc-Powder Trial ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-110-mln-in-talc-powder-trial-1001982133,negative,0.9337189793586731
5/5/2017 8:03:00 PM,Johnson & Johnson to Participate in the 2017 UBS Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-2017-ubs-global-healthcare-conference-1001985138,neutral,0.7879927158355713
5/6/2017 3:02:05 AM,BRIEF-Janssen Pharmaceuticals says evidence shows oral invokana 300 mg demonstrates comparable A1C reduction (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-pharmaceuticals-says-evidence-shows-oral-invokana-300-mg-demonstrates-comparable-a1c-reduction-2017-5,positive,0.9349144697189331
5/8/2017 11:06:03 PM,"BRIEF-J&J says in March 2017, New Jersey attorney general division of consumer affairs issued subpoena to Janssen Pharmaceuticals (JNJ)",Reuters,http://www.businessinsider.com/r-brief-jj-says-in-march-2017-new-jersey-attorney-general-division-of-consumer-affairs-issued-subpoena-to-janssen-pharmaceuticals-2017-5,neutral,0.5453412532806396
5/9/2017 1:20:04 AM,J&J discloses U.S. probe related to arthritis drugs (JNJ),Reuters,http://www.businessinsider.com/r-jj-discloses-us-probe-related-to-arthritis-drugs-2017-5,neutral,0.9005398750305176
5/10/2017 6:10:02 PM,"UPDATE 1-Sanofi says has no ""absolute need"" to do acquisitions (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-update-1-sanofi-says-has-no-absolute-need-to-do-acquisitions-2017-5,neutral,0.910224974155426
5/11/2017 8:16:00 PM,Johnson & Johnson to Participate in the Jefferies 2017 Global Healthcare Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-the-jefferies-2017-global-healthcare-conference-668201,neutral,0.7815353274345398
5/12/2017 7:46:05 PM,"EU mergers and takeovers (May 12) (AVGO, BRCD, KKR, TEF, LIN, 2354, JNJ, EDF, AREVA, VIV, TIT, GE, BHI, SAF, 600115, 8058, ANA, RTO, QCOM, NXPI, 600626, RHI, MAGG3)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-12-2017-5,neutral,0.9510487914085388
5/15/2017 12:15:00 PM,"Drug Makers Stocks Under Scanner -- Alliqua BioMedical, AbbVie, Johnson & Johnson, and Merck",PR Newswire,/news/stocks/drug-makers-stocks-under-scanner-alliqua-biomedical-abbvie-johnson-johnson-and-merck-1002012055,negative,0.48083749413490295
5/15/2017 12:26:05 PM,"U.S. companies push hard for lower tax rate on offshore profits (AAPL, MSFT, PFE, GE, JNJ, MRK, XOM, IBM, CSCO)",Reuters,http://www.businessinsider.com/r-us-companies-push-hard-for-lower-tax-rate-on-offshore-profits-2017-5,positive,0.5808886289596558
5/15/2017 2:14:03 PM,"Israel's BiomX raises $24 mln in private funding round (JNJ, 4502)",Reuters,http://www.businessinsider.com/r-israels-biomx-raises-24-mln-in-private-funding-round-2017-5,positive,0.8530305027961731
5/15/2017 3:54:07 PM,BRIEF-Depuy Synthes awarded U.S. Department of Defense contract for orthopaedic products (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-awarded-us-department-of-defense-contract-for-orthopaedic-products-2017-5,positive,0.9144743084907532
5/15/2017 6:06:07 PM,"EU mergers and takeovers (May 15) (2354, GS, RF, JLL, NK, JNJ, EDF, AREVA, VIV, TIT, GE, BHI, SAF, 600115, 8058, ANA, RTO, QCOM, NXPI, 600626, RHI, MAGG3)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-15-2017-5,neutral,0.9514480233192444
5/15/2017 6:40:05 PM,BRIEF-J&J appoints Jane Griffiths to head Actelion unit (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-appoints-jane-griffiths-to-head-actelion-unit-2017-5,neutral,0.935839831829071
5/15/2017 7:30:02 PM,"South Korea's Celltrion sees rapid take-off for Roche drug copy (068270, JNJ, MRK)",Reuters,http://www.businessinsider.com/r-south-koreas-celltrion-sees-rapid-take-off-for-roche-drug-copy-2017-5,positive,0.874291181564331
5/15/2017 9:26:05 PM,"US STOCKS-Wall St hit records as technology, energy stocks rise (JNJ, CSCO, SYMC, XOM, CVX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-hit-records-as-technology-energy-stocks-rise-2017-5,positive,0.6504130959510803
5/15/2017 9:53:40 PM,Johnson & Johnson Posting Strong Gain On Upgrade By JPMorgan ,RTTNews,/news/stocks/johnson-johnson-posting-strong-gain-on-upgrade-by-jpmorgan-1002014293,positive,0.9370560050010681
5/16/2017 5:16:09 AM,"UPDATE 1-New York county sues Purdue, J&J over opioid marketing (JNJ, TEVA, ENDP)",Reuters,http://www.businessinsider.com/r-update-1-new-york-county-sues-purdue-jj-over-opioid-marketing-2017-5,negative,0.8443046808242798
5/16/2017 5:36:10 PM,BRIEF-Livanova announces Thad Huston as chief financial officer (JNJ),Reuters,http://www.businessinsider.com/r-brief-livanova-announces-thad-huston-as-chief-financial-officer-2017-5,neutral,0.9332249760627747
5/17/2017 1:26:03 AM,"U.S. FDA warns of foot, leg amputations with J&J diabetes drug (JNJ, LLY, AZN)",Reuters,http://www.businessinsider.com/r-us-fda-warns-of-foot-leg-amputations-with-jj-diabetes-drug-2017-5,negative,0.8133896589279175
5/17/2017 12:44:00 PM,Johnson & Johnson Showcases Strong Pipeline of Transformational Medicines at its Pharmaceutical Business Review Meeting,PR Newswire,/news/stocks/johnson-&-johnson-showcases-strong-pipeline-of-transformational-medicines-at-its-pharmaceutical-business-review-meeting-683092,positive,0.8726393580436707
5/17/2017 1:16:07 PM,BRIEF-J&J says expects more than 10 new products to launch or file for regulatory approval by 2021 (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-says-expects-more-than-10-new-products-to-launch-or-file-for-regulatory-approval-by-2021-2017-5,neutral,0.6700347065925598
5/17/2017 4:18:55 PM,The world's largest drugmaker thinks it has 11 billion-dollar drugs in the pipeline ‚Äî here's what they treat (JNJ),Business Insider,http://www.businessinsider.com/johnson-and-johnson-blockbuster-drug-potentials-by-2021-2017-5,neutral,0.8844574093818665
5/18/2017 12:20:07 PM,Johnson & Johnson offers EU concessions over Actelion deal (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnson-offers-eu-concessions-over-actelion-deal-2017-5,positive,0.9152176976203918
5/18/2017 5:10:09 PM,"EU mergers and takeovers (May 18) (JNJ, IJ, EDF, AREVA, VIV, TIT, GE, BHI, SAF, 600115, 8058, ANA, RTO, QCOM, NXPI, 600626, RHI, MAGG3, GS, RF, JLL, NK)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-18-2017-5,neutral,0.9512693285942078
5/19/2017 2:30:05 AM,"For millions of Chinese with rare diseases, some relief in sight (CELG, BMY, JNJ, SHP, SAN, PFE, MRK, SAPL, ALXN)",Reuters,http://www.businessinsider.com/r-for-millions-of-chinese-with-rare-diseases-some-relief-in-sight-2017-5,positive,0.8676333427429199
5/19/2017 7:12:03 AM,"Janssen files suit in U.S. to block sale of Samsung Bioepis' Remicade copy (JNJ, AMGN)",Reuters,http://www.businessinsider.com/r-janssen-files-suit-in-us-to-block-sale-of-samsung-bioepis-remicade-copy-2017-5,negative,0.7900747060775757
5/19/2017 8:36:03 PM,"EU mergers and takeovers (May 19) (SAF, 600115, EDF, 8058, 521, C14, BX, AREVA, VIV, TIT, GE, BHI, ANA, RTO, QCOM, NXPI, 600626, JNJ, IJ, RHI, MAGG3, GS, RF, JLL, NK)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-19-2017-5,neutral,0.9508469104766846
5/22/2017 4:36:02 PM,"Cross-border M&A between U.S. and European firms at 10 year high (HUN, ULVR, UNA, JNJ, AKZA, PPG, RB., MJN)",Reuters,http://www.businessinsider.com/r-cross-border-ma-between-us-and-european-firms-at-10-year-high-2017-5,positive,0.7715176343917847
5/23/2017 12:52:02 PM,"UPDATE 1-UK competition watchdog accuses Merck of obstructing biosimilars (MRK, 068270, PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-uk-competition-watchdog-accuses-merck-of-obstructing-biosimilars-2017-5,negative,0.9463047385215759
5/23/2017 7:50:05 PM,"EU mergers and takeovers (May 23) (9101, 9104, 9107, FTI, LIN, RDSA, EDF, AREVA, VIV, TIT, GE, BHI, ANA, RTO, QCOM, NXPI, 600626, JNJ, IJ, RHI, MAGG3, GS, RF, JLL, NK, 521, C14, BX)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-23-2017-5,neutral,0.9489671587944031
5/24/2017 7:26:05 PM,J&J settles drug manufacturing probe by U.S. states for $33 million (JNJ),Reuters,http://www.businessinsider.com/r-jj-settles-drug-manufacturing-probe-by-us-states-for-33-million-2017-5,negative,0.5074766874313354
5/24/2017 8:24:05 PM,UPDATE 1-J&J settles drug manufacturing probe by U.S. states for $33 mln (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-settles-drug-manufacturing-probe-by-us-states-for-33-mln-2017-5,negative,0.8491985201835632
5/25/2017 11:32:16 AM,Biotech Stocks Facing FDA Decision In June ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-june-1002042040,neutral,0.7687883973121643
5/30/2017 11:30:07 AM,"Novartis has assets to sell, investors wary of what it might buy (GSK, MRK, BMY, AZN, JNJ)",Reuters,http://www.businessinsider.com/r-novartis-has-assets-to-sell-investors-wary-of-what-it-might-buy-2017-5,negative,0.7272352576255798
5/30/2017 11:30:07 AM,"RPT-Novartis has assets to sell, investors wary of what it might buy (GSK, MRK, BMY, AZN, JNJ)",Reuters,http://www.businessinsider.com/r-rpt-novartis-has-assets-to-sell-investors-wary-of-what-it-might-buy-2017-5,negative,0.5483752489089966
5/30/2017 1:36:07 PM,BRIEF-Protagonist Therapeutics signs deal with J&J to develop bowel drug (JNJ),Reuters,http://www.businessinsider.com/r-brief-protagonist-therapeutics-signs-deal-with-jj-to-develop-bowel-drug-2017-5,positive,0.7576749920845032
5/30/2017 2:12:06 PM,BRIEF-Protagonist Therapeutics says will be responsible for conduct of Phase 1 clinical trial for PTG-200 (JNJ),Reuters,http://www.businessinsider.com/r-brief-protagonist-therapeutics-says-will-be-responsible-for-conduct-of-phase-1-clinical-trial-for-ptg-200-2017-5,neutral,0.8610716462135315
5/30/2017 3:14:05 PM,US STOCKS-Wall St set to open lower as investors digest data (JNJ),Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-lower-as-investors-digest-data-2017-5,negative,0.9522609710693359
5/30/2017 4:30:08 PM,"US STOCKS-Wall St opens slightly lower as investors digest data (JNJ, ATW, ESV)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-opens-slightly-lower-as-investors-digest-data-2017-5,negative,0.9535783529281616
5/31/2017 3:58:05 PM,"US STOCKS-Wall St flat as oil offsets gains in tech, healthcare (JNJ, EXAS)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-oil-offsets-gains-in-tech-healthcare-2017-5,positive,0.8157609701156616
5/31/2017 5:48:06 PM,"Ohio is suing 5 drug companies over the opioid crisis (JNJ, ENDP, TEVA, AGN)",Reuters,http://www.businessinsider.com/r-update-1-ohio-sues-five-drug-companies-over-opioid-crisis-2017-5,negative,0.9027554988861084
5/31/2017 6:40:25 PM,"EU mergers and takeovers (May 31) (GE, BHI, 9984, FIG, RTO, QCOM, NXPI, JNJ, IJ, RHI, MAGG3, GS, RF, JLL, NK, 2317, RDSA, 521, C14, BX, 9101, 9104, 9107, FTI, LIN)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-31-2017-5,neutral,0.95195472240448
6/1/2017 7:12:03 AM,"PRESS DIGEST - Wall Street Journal - June 1 (GS, JNJ, TEVA, AGN, ENDP)",Reuters,http://www.businessinsider.com/r-press-digest---wall-street-journal---june-1-2017-6,neutral,0.9428988695144653
6/1/2017 4:56:05 PM,"EU mergers and takeovers (June 1) (HLDX, GS, UG, GM, BNP, GLE, DG, DUFN, MQG, RTO, QCOM, NXPI, JNJ, IJ, RHI, MAGG3, RF, JLL, NK, 9984, 2317, RDSA, 521, C14, BX, FIG, 9101, 9104, 9107, FTI, LIN)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-june-1-2017-6,neutral,0.9509334564208984
6/1/2017 10:12:08 PM,"BRIEF-‚ÄçJanssen Sciences Ireland UC -VIIV Healthcare made regulatory submissions to EMA,FDA for dolutegravir and rilpivirine‚Äã (JNJ)",Reuters,http://www.businessinsider.com/r-brief-janssen-sciences-ireland-uc--viiv-healthcare-made-regulatory-submissions-to-emafda-for-dolutegravir-and-rilpivirine-2017-6,positive,0.6352947354316711
6/2/2017 12:01:23 PM,State Sues Big Pharma For Opioid Carnage ,RTTNews,/news/stocks/state-sues-big-pharma-for-opioid-carnage-1002062739,negative,0.8716984391212463
6/3/2017 1:46:06 PM,Study shows early Zytiga use improves prostate cancer survival (JNJ),Reuters,http://www.businessinsider.com/r-study-shows-early-zytiga-use-improves-prostate-cancer-survival-2017-6,positive,0.9448680877685547
6/3/2017 10:24:05 PM,UPDATE 1-Early use of J&J's Zytiga extends prostate cancer survival (JNJ),Reuters,http://www.businessinsider.com/r-update-1-early-use-of-jjs-zytiga-extends-prostate-cancer-survival-2017-6,positive,0.9290523529052734
6/6/2017 1:18:08 AM,"MOVES-Credit Suisse hires Rapkin for healthcare investment banking (JPM, JNJ, FRE, AKRX, UNH, HCA, DVA)",Reuters,http://www.businessinsider.com/r-moves-credit-suisse-hires-rapkin-for-healthcare-investment-banking-2017-6,neutral,0.788608968257904
6/8/2017 1:30:03 AM,"Trump FBI nominee's corporate legal work could exclude him from some probes (JNJ, T, DBK, CVS, GM, WFC, GSK, 7312, LMT)",Reuters,http://www.businessinsider.com/r-trump-fbi-nominees-corporate-legal-work-could-exclude-him-from-some-probes-2017-6,neutral,0.6087557077407837
6/8/2017 10:06:03 AM,"Actelion antibiotic misses mark on one study, hits it on another (JNJ)",Reuters,http://www.businessinsider.com/r-actelion-antibiotic-misses-mark-on-one-study-hits-it-on-another-2017-6,negative,0.5205848217010498
6/8/2017 1:20:08 PM,"EU mergers and takeovers (June 8) (RTO, DD, FMC, BNP, CBK, SAZ, QCOM, NXPI, JNJ, IJ, RHI, MAGG3, GS, RF, JLL, NK, 9984, 2317, RDSA, 521, C14, BX, MQG, FIG, 9101, 9104, 9107, FTI, LIN, UG, GM, GLE,...",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-june-8-2017-6,neutral,0.949635922908783
6/8/2017 11:32:08 PM,"UPDATE 1-U.S. FDA asks Endo to withdraw Opana ER opioid; shares fall (ENDP, TEVA, JNJ, AGN)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-asks-endo-to-withdraw-opana-er-opioid-shares-fall-2017-6,negative,0.9687212705612183
6/9/2017 1:32:05 PM,EU approves J&J purchase of Actelion subject to conditions (JNJ),Reuters,http://www.businessinsider.com/r-eu-approves-jj-purchase-of-actelion-subject-to-conditions-2017-6,neutral,0.9130038619041443
6/9/2017 4:58:05 PM,BRIEF-ClinicalTrials.gov says Janssen's study of niraparib suspends recruitment (JNJ),Reuters,http://www.businessinsider.com/r-brief-clinicaltrialsgov-says-janssens-study-of-niraparib-suspends-recruitment-2017-6,negative,0.9026325941085815
6/9/2017 5:30:00 PM,"Johnson & Johnson Announces Expected Settlement of Actelion Tender Offer on June 16, 2017",PR Newswire,/news/stocks/johnson-johnson-announces-expected-settlement-of-actelion-tender-offer-on-june-16-2017-1002082475,neutral,0.8994849920272827
6/9/2017 5:58:05 PM,Johnson & Johnson expects to complete of Actelion offer on June 16 (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnson-expects-to-complete-of-actelion-offer-on-june-16-2017-6,neutral,0.9290798306465149
6/9/2017 6:28:05 PM,UPDATE 1-Johnson & Johnson expects to complete Actelion purchase on June 16 (JNJ),Reuters,http://www.businessinsider.com/r-update-1-johnson--johnson-expects-to-complete-actelion-purchase-on-june-16-2017-6,neutral,0.9039185047149658
6/9/2017 6:52:03 PM,"BRIEF-J&J Spokesperson says study enrollment in Niraparib is on temporary hold, anticipates re-opening enrollment soon ‚Äç‚Äã (JNJ)",Reuters,http://www.businessinsider.com/r-brief-jj-spokesperson-says-study-enrollment-in-niraparib-is-on-temporary-hold-anticipates-re-opening-enrollment-soon--2017-6,negative,0.8825733065605164
6/9/2017 6:52:03 PM,"EU mergers and takeovers (June 9) (JNJ, GS, RF, FMC, DD, EDF, QCOM, NXPI, IJ, RHI, MAGG3, JLL, NK, 9984, 2317, RDSA, 521, C14, BX, MQG, FIG, 9101, 9104, 9107, FTI, LIN, UG, GM, BNP, GLE, DG, DUFN,...",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-june-9-2017-6,neutral,0.9505598545074463
6/9/2017 8:34:05 PM,"BRIEF-Johnson & Johnson says expects settlement of Actelion tender offer on June 16, 2017 (JNJ)",Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-expects-settlement-of-actelion-tender-offer-on-june-16-2017-2017-6,neutral,0.9162540435791016
6/12/2017 12:54:05 PM,BRIEF-Tesaro says Janssen updated clinicaltrials.gov website to reflect janssen had placed temporary enrollment hold in the galahad ‚Äç‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-tesaro-says-janssen-updated-clinicaltrialsgov-website-to-reflect-janssen-had-placed-temporary-enrollment-hold-in-the-galahad--2017-6,negative,0.8051663041114807
6/12/2017 1:48:04 PM,"BRIEF-Qualcomm announces agreement with Lifescan Inc (QCOM, JNJ)",Reuters,http://www.businessinsider.com/r-brief-qualcomm-announces-agreement-with-lifescan-inc-2017-6,positive,0.6171525120735168
6/12/2017 5:08:03 PM,"BRIEF-Metlife names Susan Podlogar Chief Human Resources Officer (MET, JNJ)",Reuters,http://www.businessinsider.com/r-brief-metlife-names-susan-podlogar-chief-human-resources-officer-2017-6,neutral,0.931138813495636
6/12/2017 11:12:05 PM,"Bayer, J&J win second U.S. trial over Xarelto bleeding risks (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-bayer-jj-win-second-us-trial-over-xarelto-bleeding-risks-2017-6,positive,0.8135440945625305
6/12/2017 11:52:03 PM,"UPDATE 1-Bayer, J&J win second U.S. trial over Xarelto bleeding risks (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-bayer-jj-win-second-us-trial-over-xarelto-bleeding-risks-2017-6,positive,0.881312370300293
6/13/2017 12:30:07 AM,"J&J diabetes drug shows heart benefit in large safety study (JNJ, LLY, AZN)",Reuters,http://www.businessinsider.com/r-jj-diabetes-drug-shows-heart-benefit-in-large-safety-study-2017-6,positive,0.9117715358734131
6/13/2017 3:15:13 AM,J&J And Bayer Win Second Trial On Xarelto Bleeding Risks ,RTTNews,/news/stocks/j-j-and-bayer-win-second-trial-on-xarelto-bleeding-risks-1002087149,positive,0.8353490829467773
6/13/2017 3:26:08 PM,BRIEF-Pulmatrix licenses novel drug candidates from Respivert (JNJ),Reuters,http://www.businessinsider.com/r-brief-pulmatrix-licenses-novel-drug-candidates-from-respivert-2017-6,positive,0.7570543885231018
6/14/2017 1:18:03 PM,Johnson & Johnson's flu drug succeeds in mid-stage trial (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnsons-flu-drug-succeeds-in-mid-stage-trial-2017-6,positive,0.9390735626220703
6/14/2017 1:18:03 PM,"BRIEF-Janssen says Phase 3 data shows anti-TNF Alpha Simponi Aria significantly improved arthritis, skin manifestations (JNJ)",Reuters,http://www.businessinsider.com/r-brief-janssen-says-phase-3-data-shows-anti-tnf-alpha-simponi-aria-significantly-improved-arthritis-skin-manifestations-2017-6,positive,0.9413670301437378
6/14/2017 1:28:06 PM,"BRIEF-J&J says Pimodivir alone or in combination with oseltamivir demonstrated a significant reduction in viral load in adults with Influenza A (JNJ, VRTX)",Reuters,http://www.businessinsider.com/r-brief-jj-says-pimodivir-alone-or-in-combination-with-oseltamivir-demonstrated-a-significant-reduction-in-viral-load-in-adults-with-influenza-a-2017-6,positive,0.9265515804290771
6/14/2017 1:48:06 PM,"UPDATE 1-Johnson & Johnson's flu drug succeeds in mid-stage trial (JNJ, VRTX)",Reuters,http://www.businessinsider.com/r-update-1-johnson--johnsons-flu-drug-succeeds-in-mid-stage-trial-2017-6,positive,0.9179572463035583
6/14/2017 2:34:07 PM,BRIEF-Johnson & Johnson says are working with medical University of South Carolina (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-are-working-with-medical-university-of-south-carolina-2017-6,positive,0.519882321357727
6/14/2017 4:10:07 PM,"US STOCKS-Wall St flat as banks fall after weak data; Fed eyed (JNJ, MSFT, HRB)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-banks-fall-after-weak-data-fed-eyed-2017-6,negative,0.9519543051719666
6/14/2017 5:32:03 PM,"US STOCKS-Weak data weighs on bank stocks; Fed rate decision looms (XOM, CVX, JNJ, MSFT, HRB)",Reuters,http://www.businessinsider.com/r-us-stocks-weak-data-weighs-on-bank-stocks-fed-rate-decision-looms-2017-6,negative,0.9598982334136963
6/14/2017 6:44:14 PM,BRIEF-Janssen presents long term phase 3 efficacy and safety data of Sirukumab (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-presents-long-term-phase-3-efficacy-and-safety-data-of-sirukumab-2017-6,neutral,0.7520217895507812
6/14/2017 6:58:05 PM,"US STOCKS-Oil drop, weak data weigh on Wall St; Fed move looms (XOM, CVX, JNJ, ALXN, BIIB, HRB)",Reuters,http://www.businessinsider.com/r-us-stocks-oil-drop-weak-data-weigh-on-wall-st-fed-move-looms-2017-6,negative,0.9595026969909668
6/14/2017 10:46:04 PM,BRIEF-Minerva Neurosciences enters amendment to co-development and license agreement with Janssen Pharmaceutica NV (JNJ),Reuters,http://www.businessinsider.com/r-brief-minerva-neurosciences-enters-amendment-to-co-development-and-license-agreement-with-janssen-pharmaceutica-nv-2017-6,positive,0.8471894264221191
6/15/2017 1:04:03 AM,"Google bets on European biotech drugs, backs new fund (GSK, SAN, JNJ, AAPL, MSFT, GEN)",Reuters,http://www.businessinsider.com/r-google-bets-on-european-biotech-drugs-backs-new-fund-2017-6,neutral,0.8159472942352295
6/15/2017 8:08:03 PM,"U.S. state attorneys general probe opioid drug companies (JNJ, ENDP, TEVA, AGN)",Reuters,http://www.businessinsider.com/r-us-state-attorneys-general-probe-opioid-drug-companies-2017-6,neutral,0.7005864977836609
6/16/2017 7:10:19 AM,Johnson & Johnson Closes Acquisition Of Actelion ,RTTNews,/news/stocks/johnson-johnson-closes-acquisition-of-actelion-1002098255,neutral,0.8984819054603577
6/16/2017 9:38:05 AM,Actelion spin-off Idorsia makes market debut at 10 Sfr per share (JNJ),Reuters,http://www.businessinsider.com/r-actelion-spin-off-idorsia-makes-market-debut-at-10-sfr-per-share-2017-6,neutral,0.6085532307624817
6/16/2017 7:54:06 PM,"BRIEF-Genmab says U.S. FDA approves darzalex in combination with pomalidomide and dexamethasone for relapsed or refractory multiple myeloma (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-says-us-fda-approves-darzalex-in-combination-with-pomalidomide-and-dexamethasone-for-relapsed-or-refractory-multiple-myeloma-2017-6,positive,0.8985927104949951
6/20/2017 2:00:00 PM,"Douglas Wallace, Ph.D., Wins 2017 Dr. Paul Janssen Award for Biomedical Research",PR Newswire,/news/stocks/douglas-wallace-ph-d-wins-2017-dr-paul-janssen-award-for-biomedical-research-1002107304,positive,0.6373104453086853
6/20/2017 4:42:05 PM,"Exxon, BP support Republican elders' climate proposal (XOM, RDSA, FP, GM, JNJ, PEP, BP.)",Reuters,http://www.businessinsider.com/r-exxon-bp-support-republican-elders-climate-proposal-2017-6,neutral,0.5689086318016052
6/20/2017 10:20:00 PM,Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-second-quarter-results-1002109462,neutral,0.9199506044387817
6/21/2017 1:18:03 AM,"U.S. Supreme Court ruling threatens massive talc litigation against J&J (JNJ, BMY, BAYN, GSK, MCK)",Reuters,http://www.businessinsider.com/r-us-supreme-court-ruling-threatens-massive-talc-litigation-against-jj-2017-6,negative,0.9487156271934509
6/21/2017 1:10:09 PM,"RPT-U.S. Supreme Court ruling threatens massive talc litigation against J&J (JNJ, BMY, BAYN, GSK, MCK)",Reuters,http://www.businessinsider.com/r-rpt-us-supreme-court-ruling-threatens-massive-talc-litigation-against-jj-2017-6,negative,0.9463071823120117
6/21/2017 4:00:00 PM,S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017,PR Newswire,/news/stocks/s-p-500-buybacks-fall-17-5-year-over-year-to-133-1-billion-for-q1-2017-1002112472,negative,0.9629760980606079
6/21/2017 4:02:05 PM,"US STOCKS-Wall St slightly higher on healthcare; oil steadies (UNH, JNJ, ADBE)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-slightly-higher-on-healthcare-oil-steadies-2017-6,positive,0.8904520869255066
6/21/2017 4:12:07 PM,"Missouri attorney general sues opioid manufacturers (JNJ, ENDP)",Reuters,http://www.businessinsider.com/r-missouri-attorney-general-sues-opioid-manufacturers-2017-6,negative,0.7802485227584839
6/21/2017 5:30:03 PM,"UPDATE 1-Missouri attorney general sues opioid manufacturers (JNJ, ENDP, TEVA, AGN)",Reuters,http://www.businessinsider.com/r-update-1-missouri-attorney-general-sues-opioid-manufacturers-2017-6,negative,0.7807036638259888
6/22/2017 2:04:00 PM,Johnson & Johnson Releases 2016 Health for Humanity Report,PR Newswire,/news/stocks/johnson-johnson-releases-2016-health-for-humanity-report-1002115911,neutral,0.9283784031867981
6/22/2017 5:42:03 PM,"US STOCKS-Gains in healthcare stocks lift Wall Street (UNH, JNJ, GILD, ACN)",Reuters,http://www.businessinsider.com/r-us-stocks-gains-in-healthcare-stocks-lift-wall-street-2017-6,positive,0.933037281036377
6/22/2017 7:18:05 PM,"US STOCKS-Wall St rises on oil rebound, gains in healthcare stocks (UNH, JNJ, GILD, ACN, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-rises-on-oil-rebound-gains-in-healthcare-stocks-2017-6,positive,0.9358311295509338
6/22/2017 9:10:08 PM,"US STOCKS-Wall St rises on oil rebound, gains in healthcare stocks (JNJ, GILD, ACN, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-rises-on-oil-rebound-gains-in-healthcare-stocks-2017-6,positive,0.9242173433303833
6/26/2017 12:10:00 PM,"Breakfast Technical Briefing on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson",PR Newswire,/news/stocks/breakfast-technical-briefing-on-drug-makers-stocks-pfizer-merck-abbvie-and-johnson-johnson-1002123019,neutral,0.9454298615455627
6/28/2017 2:54:03 PM,BRIEF-FDA grants priority review of Xarelto SNDA to reduce risk of recurrent VTE (JNJ),Reuters,http://www.businessinsider.com/r-brief-fda-grants-priority-review-of-xarelto-snda-to-reduce-risk-of-recurrent-vte-2017-6,positive,0.9021918773651123
6/29/2017 4:52:03 PM,BRIEF-Depuy Synthes announces U.S. Launch of Viper and Expedium Fenestrated Screw Systems (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-announces-us-launch-of-viper-and-expedium-fenestrated-screw-systems-2017-6,neutral,0.7700309753417969
6/29/2017 6:26:06 PM,"U.S. IRS probes drug company-funded patient assistance charity (JNJ, BAYN, TEVA, BIIB)",Reuters,http://www.businessinsider.com/r-us-irs-probes-drug-company-funded-patient-assistance-charity-2017-6,neutral,0.6504509449005127
6/29/2017 10:00:03 PM,"UPDATE 1-U.S. IRS probes drug company-funded patient assistance charity (JNJ, BAYN, TEVA, BIIB)",Reuters,http://www.businessinsider.com/r-update-1-us-irs-probes-drug-company-funded-patient-assistance-charity-2017-6,negative,0.6838722825050354
7/3/2017 8:24:06 AM,"RPT-Big pharma turns to AI to speed drug discovery, GSK signs deal (GSK, MRK, JNJ, SAN, PFE)",Reuters,http://www.businessinsider.com/r-rpt-big-pharma-turns-to-ai-to-speed-drug-discovery-gsk-signs-deal-2017-7,positive,0.6345857381820679
7/4/2017 11:38:03 AM,Australian class action suit filed against Johnson & Johnson over pelvic mesh (JNJ),Reuters,http://www.businessinsider.com/r-australian-class-action-suit-filed-against-johnson--johnson-over-pelvic-mesh-2017-7,negative,0.9190423488616943
7/6/2017 4:36:05 PM,"Robot wars: knee surgery marks new battleground for companies (SYK, SN., ISRG, JNJ)",Reuters,http://www.businessinsider.com/r-robot-wars-knee-surgery-marks-new-battleground-for-companies-2017-7,positive,0.809183657169342
7/7/2017 12:48:03 AM,BRIEF-Capricor Therapeutics retains full rights to CAP-1002 as Janssen Biotech decides not to exercise option (JNJ),Reuters,http://www.businessinsider.com/r-brief-capricor-therapeutics-retains-full-rights-to-cap-1002-as-janssen-biotech-decides-not-to-exercise-option-2017-7,neutral,0.9405417442321777
7/8/2017 8:38:00 AM,Commercial Hydrogen Announces New Board Member,PR Newswire,/news/stocks/commercial-hydrogen-announces-new-board-member-1001831570,neutral,0.884965717792511
7/10/2017 5:40:03 PM,"US STOCKS-Gains in technology stocks prop up Wall St (MSFT, AAPL, NVDA, JNJ, MDT, JPM, WFC, C, UNH, ANF, APO, JOPP)",Reuters,http://www.businessinsider.com/r-us-stocks-gains-in-technology-stocks-prop-up-wall-st-2017-7,positive,0.9320210814476013
7/10/2017 6:52:03 PM,"US STOCKS- Wall St up as technology shares hold gains (MSFT, AAPL, NVDA, JNJ, MDT, JPM, WFC, C, AMZN, UNH, ANF, APO, JOPP)",Reuters,http://www.businessinsider.com/r-us-stocks--wall-st-up-as-technology-shares-hold-gains-2017-7,positive,0.9261106848716736
7/10/2017 10:04:08 PM,"Arena's heart-lung drug meets main goal in mid-stage study (ARNA, JNJ, 4523)",Reuters,http://www.businessinsider.com/r-arenas-heart-lung-drug-meets-main-goal-in-mid-stage-study-2017-7,neutral,0.5955334305763245
7/10/2017 10:46:11 PM,"Here‚Äôs how much the 10 largest pharmaceutical companies spend on R&D (PFE, AMGN, NVS, ROG, MRK, SNY, JNJ, GILD, GSK, ABBV)",Business Insider,http://www.businessinsider.com/largest-pharmaceutical-companies-by-prescription-sales-and-rd-2017-7,neutral,0.9493331909179688
7/11/2017 1:40:07 AM,"FBI director nominee Wray earned $9.2 million in law practice last year (WFC, JNJ, HIL, STI, AAPL, WMT, XOM)",Reuters,http://www.businessinsider.com/r-fbi-director-nominee-wray-earned-92-million-in-law-practice-last-year-2017-7,neutral,0.9108411073684692
7/11/2017 7:34:05 AM,"Sanofi to buy vaccines biotech group Protein Sciences (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-sanofi-to-buy-vaccines-biotech-group-protein-sciences-2017-7,neutral,0.920576810836792
7/13/2017 5:30:08 PM,"US STOCKS-Wall St flat as focus shifts to quarterly earnings (AMZN, MCD, JNJ, CELG, JPM, WFC, C, TGT, WMT, COST, YNDX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-focus-shifts-to-quarterly-earnings-2017-7,negative,0.948654055595398
7/13/2017 10:18:06 PM,BRIEF-Janssen announces FDA approval of Tremfya (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-announces-fda-approval-of-tremfya-2017-7,neutral,0.7978245615959167
7/14/2017 4:00:31 AM,FDA Oks Janssen' Tremfya To Treat Moderate To Severe Plaque Psoriasis ,RTTNews,/news/stocks/fda-oks-janssen-tremfya-to-treat-moderate-to-severe-plaque-psoriasis-1002173036,positive,0.7919977903366089
7/14/2017 11:42:03 AM,"BRIEF-Morphosys CEO sees 5 months of guselkumab royalties this year (MOR, JNJ)",Reuters,http://www.businessinsider.com/r-brief-morphosys-ceo-sees-5-months-of-guselkumab-royalties-this-year-2017-7,neutral,0.8257079124450684
7/14/2017 1:48:03 PM,"Novartis stocks drug cabinet with ""Big-3"" arthritis blockbusters (AMGN, JNJ, LLY)",Reuters,http://www.businessinsider.com/r-novartis-stocks-drug-cabinet-with-big-3-arthritis-blockbusters-2017-7,neutral,0.8232620358467102
7/14/2017 7:01:00 PM,"Affinion Group, Inc. to Hold Informational Call to Discuss Results for the Quarter Ended June 30, 2017",PR Newswire,/news/stocks/affinion-group-inc-to-hold-informational-call-to-discuss-results-for-the-quarter-ended-june-30-2017-1001855621,neutral,0.9400336146354675
7/17/2017 1:26:05 PM,"US STOCKS-Futures little changed ahead of big earnings (BAC, MS, GS, MSFT, IBM, JNJ, NFLX, BLK, PG)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-little-changed-ahead-of-big-earnings-2017-7,neutral,0.7586191296577454
7/17/2017 2:52:11 PM,"US STOCKS-Wall St set to open flat in run-up to big earnings (BAC, MS, GS, MSFT, IBM, JNJ, NFLX, BLK, PG)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-flat-in-run-up-to-big-earnings-2017-7,negative,0.7558087706565857
7/17/2017 3:54:09 PM,"US STOCKS-Wall St opens flat as investors await big earnings (MSFT, IBM, JNJ, NFLX, JPM, C, WFC, BAC, MS, GS, BLK, BGC)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-opens-flat-as-investors-await-big-earnings-2017-7,negative,0.9206968545913696
7/17/2017 5:12:03 PM,"US STOCKS-Wall St holds steady as investors await big earnings (MSFT, IBM, JNJ, NFLX, AAPL, JPM, C, WFC, BAC, MS, GS, BLK, BGC)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-holds-steady-as-investors-await-big-earnings-2017-7,positive,0.8487838506698608
7/17/2017 7:02:03 PM,"US STOCKS-Wall St slightly up as earnings season picks up pace (MSFT, IBM, JNJ, NFLX, JPM, C, WFC, BAC, MS, GS, BLK, AMZN)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-slightly-up-as-earnings-season-picks-up-pace-2017-7,positive,0.9406326413154602
7/17/2017 7:08:08 PM,BRIEF-J&J sets quarterly cash dividend of $0.84 per share (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-sets-quarterly-cash-dividend-of-084-per-share-2017-7,neutral,0.8822190165519714
7/18/2017 12:46:20 PM,Johnson & Johnson Q2 Earnings Rise 3%,RTTNews,/news/stocks/johnson-johnson-q2-earnings-rise-3-1002181984,positive,0.9425033926963806
7/18/2017 1:06:13 PM,BRIEF-Johnson & Johnson Q2 earnings per share $1.40 (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-q2-earnings-per-share-140-2017-7,neutral,0.7388387322425842
7/18/2017 1:06:13 PM,J&J reports dip in quarterly profit (JNJ),Reuters,http://www.businessinsider.com/r-jj-reports-dip-in-quarterly-profit-2017-7,negative,0.9687397480010986
7/18/2017 1:19:46 PM,Genmab To Receive Royalties On DARZALEX Sales From Janssen Biotech - Quick Facts ,RTTNews,/news/stocks/genmab-to-receive-royalties-on-darzalex-sales-from-janssen-biotech-quick-facts-1002182141,neutral,0.8217276930809021
7/18/2017 1:22:08 PM,UPDATE 1-J&J raises 2017 profit forecast; Q2 earnings beat Street (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-raises-2017-profit-forecast-q2-earnings-beat-street-2017-7,positive,0.555794894695282
7/18/2017 1:22:08 PM,"US STOCKS-Futures flat as investors gauge big companies' earnings (UNH, JNJ, IBM, UAL, NFLX, BAC, JPM, WFC, C, HOG)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-flat-as-investors-gauge-big-companies-earnings-2017-7,negative,0.9574077129364014
7/18/2017 1:36:13 PM,"Johnson & Johnson Q2 Profit Down, But Adj. EPS Tops View; Lifts 2017 Outlook ",RTTNews,/news/stocks/johnson-johnson-q2-profit-down-but-adj-eps-tops-view-lifts-2017-outlook-1002182245,negative,0.8215458989143372
7/18/2017 3:08:04 PM,"US STOCKS-Wall St set to open lower on tepid earnings, policy gridlock (BAC, GS, JPM, WFC, C, HOG, UNH, JNJ, IBM, UAL, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-lower-on-tepid-earnings-policy-gridlock-2017-7,negative,0.965699315071106
7/18/2017 3:52:08 PM,"US STOCKS-Wall St opens lower on dull earnings, healthcare logjam (BAC, GS, JPM, WFC, C, HOG, UNH, JNJ, IBM, UAL, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-opens-lower-on-dull-earnings-healthcare-logjam-2017-7,negative,0.9703838229179382
7/18/2017 10:58:03 PM,"US STOCKS-Nasdaq hits record on Netflix boost; Dow dragged by Goldman (GS, NFLX, JNJ, HOG, CMG)",Reuters,http://www.businessinsider.com/r-us-stocks-nasdaq-hits-record-on-netflix-boost-dow-dragged-by-goldman-2017-7,neutral,0.4824278652667999
7/19/2017 11:58:08 AM,"UPDATE 1-China adds blockbuster drugs to insurance list after price cuts (CELG, JNJ, AZN, NOVO )",Reuters,http://www.businessinsider.com/r-update-1-china-adds-blockbuster-drugs-to-insurance-list-after-price-cuts-2017-7,positive,0.5701706409454346
7/21/2017 1:28:05 PM,BRIEF-EU Medicines Agency recommends approval J&J unit's Symtuza drug for HIV (JNJ),Reuters,http://www.businessinsider.com/r-brief-eu-medicines-agency-recommends-approval-jj-units-symtuza-drug-for-hiv-2017-7,positive,0.5636460781097412
7/21/2017 1:48:03 PM,Janssen-Cilag's HIV drug gets EU regulatory panel's nod (JNJ),Reuters,http://www.businessinsider.com/r-janssen-cilags-hiv-drug-gets-eu-regulatory-panels-nod-2017-7,positive,0.9073716402053833
7/24/2017 10:28:08 AM,BRIEF-Johnson & Johnson announces encouraging first-in-human clinical data for investigational HIV preventive vaccine (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-announces-encouraging-first-in-human-clinical-data-for-investigational-hiv-preventive-vaccine-2017-7,positive,0.9450016021728516
7/24/2017 10:28:09 AM,"HIV fight advances with new drug cocktails, fresh vaccine hopes (GILD, GSK, MRK, JNJ)",Reuters,http://www.businessinsider.com/r-hiv-fight-advances-with-new-drug-cocktails-fresh-vaccine-hopes-2017-7,positive,0.8591094017028809
7/24/2017 2:02:05 PM,"Samsung Bioepis launches U.S. sales of Remicade biosmiliar (JNJ, PFE, AZN)",Reuters,http://www.businessinsider.com/r-samsung-bioepis-launches-us-sales-of-remicade-biosmiliar-2017-7,positive,0.685167670249939
7/24/2017 5:40:07 PM,"US STOCKS-S&P, Dow lower as Johnson & Johnson drags (JNJ, AMZN, HAL, CALM, WBMD, KKR)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-lower-as-johnson--johnson-drags-2017-7,negative,0.9600012302398682
7/24/2017 6:34:03 PM,"GLOBAL MARKETS-U.S. dollar, bond yields climb, with focus on Fed (JNJ)",Reuters,http://www.businessinsider.com/r-global-markets-us-dollar-bond-yields-climb-with-focus-on-fed-2017-7,positive,0.8012131452560425
7/24/2017 7:04:03 PM,"UPDATE 1-Merck, Samsung Bioepis launch discounted U.S. Remicade alternative (MRK, JNJ, PFE, AMGN)",Reuters,http://www.businessinsider.com/r-update-1-merck-samsung-bioepis-launch-discounted-us-remicade-alternative-2017-7,positive,0.5694881677627563
7/24/2017 7:08:03 PM,"US STOCKS-S&P, Dow lower as J&J drags; Nasdaq hits record (JNJ, HAL, CALM, HIBB, DKS, FL, FINL, AMZN)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-lower-as-jj-drags-nasdaq-hits-record-2017-7,negative,0.9148703217506409
7/24/2017 9:18:08 PM,"GLOBAL MARKETS-U.S. dollar, bond yields edge up, with focus on Fed (JNJ)",Reuters,http://www.businessinsider.com/r-global-markets-us-dollar-bond-yields-edge-up-with-focus-on-fed-2017-7,positive,0.9007526636123657
7/24/2017 10:32:03 PM,"US STOCKS-Nasdaq, tech shine as earnings pick up; Dow, S&P lag (NFLX, AMZN, JNJ, HAL, HIBB, DKS, FL, FINL)",Reuters,http://www.businessinsider.com/r-us-stocks-nasdaq-tech-shine-as-earnings-pick-up-dow-sp-lag-2017-7,positive,0.749387264251709
7/25/2017 6:40:05 AM,"PRESS DIGEST- Wall Street Journal - July 25 (005930, JNJ, DAI, BKS)",Reuters,http://www.businessinsider.com/r-press-digest--wall-street-journal---july-25-2017-7,neutral,0.9281356930732727
7/25/2017 2:58:03 PM,BRIEF-Janssen announces Phase 3 pivotal study results for darunavir-based complete treatment regimen (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-announces-phase-3-pivotal-study-results-for-darunavir-based-complete-treatment-regimen-2017-7,positive,0.6402497291564941
7/25/2017 8:38:00 PM,"Report: More than 15,000 Adverse Events Linked to Xarelto in 2016",PR Newswire,/news/stocks/report-more-than-15-000-adverse-events-linked-to-xarelto-in-2016-1002203317,negative,0.5725862979888916
7/27/2017 10:54:03 AM,"UPDATE 1-Bavarian expands J&J deal to HIV and hepatitis B vaccines, shares jump (BAVA, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-bavarian-expands-jj-deal-to-hiv-and-hepatitis-b-vaccines-shares-jump-2017-7,negative,0.48571088910102844
7/27/2017 5:22:06 PM,"US STOCKS-Wall St adds to record rally on strong earnings (VZ, AMGN, JNJ, CELG, UPS, AMZN, INTC, SBUX, MAT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-adds-to-record-rally-on-strong-earnings-2017-7,positive,0.9342145919799805
7/27/2017 7:14:08 PM,"US STOCKS-Wall St trims gains as tech stocks weigh (AAPL, VZ, AMZN, INTC, AMGN, JNJ, CELG, UPS)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-trims-gains-as-tech-stocks-weigh-2017-7,negative,0.5555036067962646
7/27/2017 7:42:05 PM,"U.S. Senator expands opioid probe to distributors, drugmakers (ENDP, TEVA, AGN, JNJ, MYL, DEPO, MCK, ABC, CAH)",Reuters,http://www.businessinsider.com/r-us-senator-expands-opioid-probe-to-distributors-drugmakers-2017-7,positive,0.6637057662010193
7/27/2017 9:12:08 PM,"UPDATE 1-U.S. Senator expands opioid probe to distributors, drugmakers (ENDP, TEVA, AGN, JNJ, MYL, DEPO, MCK, ABC, CAH)",Reuters,http://www.businessinsider.com/r-update-1-us-senator-expands-opioid-probe-to-distributors-drugmakers-2017-7,positive,0.5921249985694885
7/28/2017 2:24:06 PM,"UPDATE 1-AbbVie's profit beats on robust Humira demand (AMGN, CHRS, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-abbvies-profit-beats-on-robust-humira-demand-2017-7,positive,0.9327203631401062
7/31/2017 2:42:03 PM,J&J arthritis drug sirukumab raises safety concerns - FDA staff (JNJ),Reuters,http://www.businessinsider.com/r-jj-arthritis-drug-sirukumab-raises-safety-concerns---fda-staff-2017-7,negative,0.613324761390686
7/31/2017 3:00:04 PM,"UPDATE 1-J&J arthritis drug sirukumab raises safety concerns -FDA staff (JNJ, GSK)",Reuters,http://www.businessinsider.com/r-update-1-jj-arthritis-drug-sirukumab-raises-safety-concerns--fda-staff-2017-7,neutral,0.605063796043396
8/2/2017 9:52:03 PM,U.S. FDA panel votes against approval of J&J arthritis drug (JNJ),Reuters,http://www.businessinsider.com/r-us-fda-panel-votes-against-approval-of-jj-arthritis-drug-2017-8,negative,0.6868828535079956
8/3/2017 6:48:01 AM,"FDA Panel Snubs JNJ, CHMP Seeks More Data From PBYI, TBPH On Watch, AGRX Slumps ",RTTNews,/news/stocks/fda-panel-snubs-jnj-chmp-seeks-more-data-from-pbyi-tbph-on-watch-agrx-slumps-1002228543,negative,0.9060508012771606
8/4/2017 8:17:00 PM,Johnson & Johnson to Participate in Barclays Global Consumer Staples Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-barclays-global-consumer-staples-conference-552971,neutral,0.7722383141517639
8/4/2017 8:28:00 PM,Johnson & Johnson to Participate in the 2017 Wells Fargo 12th Annual Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-2017-wells-fargo-12th-annual-healthcare-conference-1001938540,neutral,0.650172233581543
8/4/2017 10:57:08 PM,"Wall St Week Ahead-Amazon shadow looms large ahead of retail earnings (AMZN, WMT, TGT, WFM, SPTN, DF, MCD, MMM, JNJ, CVS)",Reuters,http://www.businessinsider.com/r-wall-st-week-ahead-amazon-shadow-looms-large-ahead-of-retail-earnings-2017-8,neutral,0.5043409466743469
8/6/2017 7:02:03 PM,"RPT-Wall St Week Ahead-Amazon shadow looms large ahead of retail earnings (AMZN, WMT, TGT, WFM, SPTN, DF, MCD, MMM, JNJ, CVS)",Reuters,http://www.businessinsider.com/r-rpt-wall-st-week-ahead-amazon-shadow-looms-large-ahead-of-retail-earnings-2017-8,neutral,0.6300808787345886
8/7/2017 3:32:06 PM,BRIEF-DePuy Synthes collaborates with Medical Enterprises Distribution to co-market ME1000 (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-collaborates-with-medical-enterprises-distribution-to-co-market-me1000-2017-8,neutral,0.6459330320358276
8/8/2017 9:02:03 PM,"US STOCKS-Wall Street clings to gains with tech leading (AAPL, JNJ, WFC)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-clings-to-gains-with-tech-leading-2017-8,positive,0.9139727354049683
8/9/2017 8:17:03 PM,"BRIEF-Genmab CEO confident to close some tech deals this year (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-ceo-confident-to-close-some-tech-deals-this-year-2017-8,neutral,0.5199080109596252
8/10/2017 7:42:03 AM,"RPT-BRIEF-Genmab CEO confident to close some tech deals this year (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-rpt-brief-genmab-ceo-confident-to-close-some-tech-deals-this-year-2017-8,positive,0.7692722678184509
8/10/2017 12:15:00 PM,"Technical Snapshots for These Drug Makers Stocks -- AbbVie, AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson",PR Newswire,/news/stocks/technical-snapshots-for-these-drug-makers-stocks-abbvie-astrazeneca-bristol-myers-squibb-and-johnson-johnson-1002247897,neutral,0.9072646498680115
8/10/2017 2:02:03 PM,"How AI robots hunt new drugs for crippling nerve disease (IBM, GSK, JNJ, SAN, MRK, MSFT)",Reuters,http://www.businessinsider.com/r-how-ai-robots-hunt-new-drugs-for-crippling-nerve-disease-2017-8,neutral,0.9275450706481934
8/10/2017 7:42:05 PM,"BUZZ- DJI: From hot to not (BA, AAPL, GS, MCD, JNJ, KO, UKX)",Reuters,http://www.businessinsider.com/r-buzz--dji-from-hot-to-not-2017-8,neutral,0.927446722984314
8/14/2017 2:27:08 PM,BRIEF-Cerecor Inc Q2 loss per share $0.14 (JNJ),Reuters,http://www.businessinsider.com/r-brief-cerecor-inc-q2-loss-per-share-014-2017-8,negative,0.9554567337036133
8/14/2017 3:47:00 PM,Johnson & Johnson to Participate in 2017 Morgan Stanley Global Health Care Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-2017-morgan-stanley-global-health-care-conference-1002255625,neutral,0.7506740093231201
8/16/2017 3:12:06 PM,India introduces price controls for knee implants (JNJ),Reuters,http://www.businessinsider.com/r-india-introduces-price-controls-for-knee-implants-2017-8,neutral,0.8472791314125061
8/16/2017 5:57:05 PM,UPDATE 1-India introduces price controls for knee implants (JNJ),Reuters,http://www.businessinsider.com/r-update-1-india-introduces-price-controls-for-knee-implants-2017-8,neutral,0.7967014312744141
8/16/2017 7:42:10 PM,BRIEF-J&J says leaving White House manufacturing council (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-says-leaving-white-house-manufacturing-council-2017-8,negative,0.6883683204650879
8/18/2017 11:37:17 PM,"Bayer, J&J win third U.S. trial over Xarelto bleeding risk (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-bayer-jj-win-third-us-trial-over-xarelto-bleeding-risk-2017-8,positive,0.7195535898208618
8/21/2017 7:52:16 PM,J&J ordered to pay $417 mln in trial over talc cancer risks (JNJ),Reuters,http://www.businessinsider.com/r-jj-ordered-to-pay-417-mln-in-trial-over-talc-cancer-risks-2017-8,negative,0.9205697178840637
8/21/2017 8:22:10 PM,UPDATE 1-J&J ordered to pay $417 mln in trial over talc cancer risks (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-ordered-to-pay-417-mln-in-trial-over-talc-cancer-risks-2017-8,negative,0.7843250036239624
8/21/2017 11:59:52 PM,JNJ To Pay Dearly For Talc-cancer Connection ,RTTNews,/news/stocks/jnj-to-pay-dearly-for-talc-cancer-connection-1002273437,negative,0.5069637894630432
8/22/2017 7:22:03 AM,"PRESS DIGEST-New York Times business news - Aug 22 (VZ, S, T, JNJ)",Reuters,http://www.businessinsider.com/r-press-digest-new-york-times-business-news---aug-22-2017-8,neutral,0.9218644499778748
8/24/2017 7:42:03 AM,"Swiss stocks - Factors to watch on Aug 24 (PFE, JNJ, VONN, SPSN, IMPN, KOMN, WARN, SIK)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-aug-24-2017-8,neutral,0.94305020570755
8/24/2017 5:12:03 PM,"CORRECTED-Florida set to carry out execution with drug not previously used in lethal injections (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-corrected-florida-set-to-carry-out-execution-with-drug-not-previously-used-in-lethal-injections-2017-8,neutral,0.7169983386993408
8/24/2017 10:22:16 PM,BRIEF-Protagonist Therapeutics announces closing of Janssen license (JNJ),Reuters,http://www.businessinsider.com/r-brief-protagonist-therapeutics-announces-closing-of-janssen-license-2017-8,neutral,0.6544486284255981
8/24/2017 11:07:15 PM,"UPDATE 1-Florida to carry out execution with drug not previously used in lethal injections (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-florida-to-carry-out-execution-with-drug-not-previously-used-in-lethal-injections-2017-8,positive,0.5968495607376099
8/25/2017 3:52:03 AM,"Samsung, Biogen version of AbbVie's Humira approved in Europe (BIIB, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-samsung-biogen-version-of-abbvies-humira-approved-in-europe-2017-8,neutral,0.7839427590370178
8/25/2017 7:02:04 AM,"UPDATE 1-Samsung, Biogen version of AbbVie's Humira approved in Europe (BIIB, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-samsung-biogen-version-of-abbvies-humira-approved-in-europe-2017-8,neutral,0.6772649884223938
8/25/2017 1:07:03 PM,"Bavarian Nordic says first milestone payment under new J&J deal could be in 2019 (BAVA, JNJ)",Reuters,http://www.businessinsider.com/r-bavarian-nordic-says-first-milestone-payment-under-new-jj-deal-could-be-in-2019-2017-8,neutral,0.9092164039611816
8/25/2017 1:57:03 PM,"UPDATE 1-Bavarian Nordic says first milestone payment under J&J deal could be in 2019 (BAVA, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-bavarian-nordic-says-first-milestone-payment-under-jj-deal-could-be-in-2019-2017-8,neutral,0.8897899985313416
8/25/2017 2:42:05 PM,BRIEF-Minerva Neurosciences announces European Commission approval of amendment of MIN-202 agreement with Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-minerva-neurosciences-announces-european-commission-approval-of-amendment-of-min-202-agreement-with-janssen-2017-8,positive,0.8413402438163757
8/25/2017 5:27:11 PM,Florida Execution Using New Anesthetic Drug Turns Controversial ,RTTNews,/news/stocks/florida-execution-using-new-anesthetic-drug-turns-controversial-1002285787,positive,0.5833080410957336
8/27/2017 11:27:08 AM,"Bayer, J&J in frame for bigger anti-clotting market opportunity (BAYN, JNJ, PFE, BMY)",Reuters,http://www.businessinsider.com/r-bayer-jj-in-frame-for-bigger-anti-clotting-market-opportunity-2017-8,positive,0.7578007578849792
8/29/2017 2:23:52 PM,Biotech Stocks Facing FDA Decision In September ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-september-1002291346,neutral,0.6874369978904724
8/30/2017 3:42:03 PM,"BUZZ- DJI tight range nears end (, , BA, AAPL, MCD, IBM, GS, UKX, KO, JNJ)",Reuters,http://www.businessinsider.com/r-buzz--dji-tight-range-nears-end-2017-8,neutral,0.8134494423866272
8/31/2017 10:57:08 PM,BRIEF-Macrogenics announces termination of duvortuxizumab collaboration (JNJ),Reuters,http://www.businessinsider.com/r-brief-macrogenics-announces-termination-of-duvortuxizumab-collaboration-2017-8,negative,0.5487404465675354
9/5/2017 3:05:00 PM,National Awards Program Seeking North Carolina's Top Youth Volunteers Of 2018,PR Newswire,/news/stocks/national-awards-program-seeking-north-carolina-s-top-youth-volunteers-of-2018-1001630845,positive,0.7696567177772522
9/7/2017 9:22:14 PM,"New Mexico sues opioid drug manufacturers, distributors (JNJ, AGN, ENDP, TEVA, MCK, ABC, CAH)",Reuters,http://www.businessinsider.com/r-new-mexico-sues-opioid-drug-manufacturers-distributors-2017-9,neutral,0.5287657380104065
9/7/2017 10:02:12 PM,"UPDATE 1-New Mexico sues opioid drug manufacturers, distributors (JNJ, AGN, ENDP, TEVA, MCK, CAH, ABC)",Reuters,http://www.businessinsider.com/r-update-1-new-mexico-sues-opioid-drug-manufacturers-distributors-2017-9,negative,0.818645179271698
9/8/2017 10:37:04 PM,"UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health (MRK, JPM, PG, JNJ, GSK, 4502, ABT, PFE, BAYN, MON, SAN, GIS, RB.)",Reuters,http://www.businessinsider.com/r-update-1-germanys-merck-hires-jp-morgan-to-sell-consumer-health-2017-9,neutral,0.8491859436035156
9/11/2017 8:04:00 AM,Johnson & Johnson Consumer Inc. Debuts New Scientific Data at the European Academy of Dermatology and Venerology Annual Meeting,PR Newswire,/news/stocks/johnson-johnson-consumer-inc-debuts-new-scientific-data-at-the-european-academy-of-dermatology-and-venerology-annual-meeting-1002356606,neutral,0.9253300428390503
9/11/2017 10:07:03 AM,"RPT-UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health (MRK, JPM, PG, JNJ, GSK, 4502, ABT, PFE, BAYN, MON, SAN, GIS, RB.)",Reuters,http://www.businessinsider.com/r-rpt-update-1-germanys-merck-hires-jp-morgan-to-sell-consumer-health-2017-9,neutral,0.7386980056762695
9/11/2017 10:07:03 AM,"BRIEF-Achillion announces termination of worldwide collaboration for hepatitis c with Janssen (ACHN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-achillion-announces-termination-of-worldwide-collaboration-for-hepatitis-c-with-janssen-2017-9,negative,0.5885142683982849
9/11/2017 12:03:25 PM,Medivir Stock Down As Janssen To Discontinue Development Of JNJ-4178 ,RTTNews,/news/stocks/medivir-stock-down-as-janssen-to-discontinue-development-of-jnj-4178-1002357446,negative,0.9666610360145569
9/11/2017 1:52:35 PM,Integra LifeSciences To Sell Certain Neurosurgery Assets To Natus Medical ,RTTNews,/news/stocks/integra-lifesciences-to-sell-certain-neurosurgery-assets-to-natus-medical-1002357885,neutral,0.9467059373855591
9/13/2017 12:25:00 PM,"Breakfast Technical Briefing on Drug Makers Stocks -- AbbVie, AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson",PR Newswire,/news/stocks/breakfast-technical-briefing-on-drug-makers-stocks-abbvie-astrazeneca-bristol-myers-squibb-and-johnson-johnson-1002365439,neutral,0.9458073973655701
9/13/2017 3:00:00 PM,Johnson & Johnson Launches Dr. Paul Janssen Project to Catalyze and Convene Champions of Science Across Generations and Geographies,PR Newswire,/news/stocks/johnson-johnson-launches-dr-paul-janssen-project-to-catalyze-and-convene-champions-of-science-across-generations-and-geographies-1002366163,neutral,0.8003382682800293
9/14/2017 10:02:03 AM,"Astra's Farxiga results may open up type 1 diabetes opportunity (AZN, LLY, JNJ)",Reuters,http://www.businessinsider.com/r-astras-farxiga-results-may-open-up-type-1-diabetes-opportunity-2017-9,positive,0.7758444547653198
9/14/2017 5:32:03 PM,"UPDATE 3-Pfizer, Astellas prostate cancer drug promising in late-stage trial (PFE, 4503, JNJ)",Reuters,http://www.businessinsider.com/r-update-3-pfizer-astellas-prostate-cancer-drug-promising-in-late-stage-trial-2017-9,neutral,0.5101779103279114
9/14/2017 10:32:16 PM,BRIEF-Janssen submits supplemental New Drug Application to U.S. FDA for Zytiga (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-submits-supplemental-new-drug-application-to-us-fda-for-zytiga-2017-9,neutral,0.7976987957954407
9/14/2017 11:15:00 PM,Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results,PR Newswire,/news/stocks/johnson-&-johnson-to-host-investor-conference-call-on-third-quarter-results-675144,neutral,0.9196439981460571
9/15/2017 1:57:03 PM,BRIEF-EU Medicines Agency publishes recommendations for Sept 2017 (JNJ),Reuters,http://www.businessinsider.com/r-brief-eu-medicines-agency-publishes-recommendations-for-sept-2017-2017-9,neutral,0.9158312082290649
9/15/2017 2:07:03 PM,European panel recommends approval of J&J's psoriasis drug (JNJ),Reuters,http://www.businessinsider.com/r-european-panel-recommends-approval-of-jjs-psoriasis-drug-2017-9,positive,0.7224668264389038
9/15/2017 2:12:03 PM,"Samsung Bioepis wins EU endorsement for first Herceptin copy (MYL, BIOCON, 068270, AMGN, JNJ, 4502)",Reuters,http://www.businessinsider.com/r-samsung-bioepis-wins-eu-endorsement-for-first-herceptin-copy-2017-9,positive,0.8877673745155334
9/15/2017 2:42:10 PM,"UPDATE 1-European panel backs Janssen's psoriasis drug (JNJ, MOR)",Reuters,http://www.businessinsider.com/r-update-1-european-panel-backs-janssens-psoriasis-drug-2017-9,positive,0.7663711309432983
9/18/2017 4:00:00 PM,"Q2 2017 S&P 500 Buybacks Fall 9.8% from Q1, to $120.1 Billion",PR Newswire,/news/stocks/q2-2017-s-p-500-buybacks-fall-9-8-from-q1-to-120-1-billion-1002379146,negative,0.9663825035095215
9/19/2017 6:42:09 PM,"BRIEF-NY A.G. Schneiderman, coalition of AGs expand investigation into opioid crisis (AGN, ENDP, JNJ, TEVA, ABC, CAH, MCK)",Reuters,http://www.businessinsider.com/r-brief-ny-ag-schneiderman-coalition-of-ags-expand-investigation-into-opioid-crisis-2017-9,neutral,0.8860936760902405
9/20/2017 3:22:17 PM,PFE Claims J&J Engaged In Unlawful Conduct To Stifle Competition From Inflectra ,RTTNews,/news/stocks/pfe-claims-j-j-engaged-in-unlawful-conduct-to-stifle-competition-from-inflectra-1002387484,negative,0.9421245455741882
9/20/2017 3:42:03 PM,"BRIEF-‚ÄçPfizer files lawsuit against Johnson & Johnson‚Äã (JNJ, PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-files-lawsuit-against-johnson--johnson-2017-9,negative,0.6125765442848206
9/20/2017 3:47:03 PM,"Pfizer sues Johnson & Johnson over Remicade biosimilar (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-pfizer-sues-johnson--johnson-over-remicade-biosimilar-2017-9,negative,0.9202055931091309
9/20/2017 4:22:03 PM,"UPDATE 1-Pfizer files suit against J&J over Remicade contracts (PFE, JNJ, UNH, AET, CI)",Reuters,http://www.businessinsider.com/r-update-1-pfizer-files-suit-against-jj-over-remicade-contracts-2017-9,negative,0.8609937429428101
9/21/2017 7:01:37 AM,"FDA Nod For ABMD, AERI Faces FDA Panel In Oct, IPCI Put On Notice, PFE Sues JNJ ",RTTNews,/news/stocks/fda-nod-for-abmd-aeri-faces-fda-panel-in-oct-ipci-put-on-notice-pfe-sues-jnj-1002392403,neutral,0.8899357914924622
9/21/2017 7:02:03 AM,"PRESS DIGEST - Wall Street Journal - Sept 21 (2498, 6502, AAPL, PFE, JNJ)",Reuters,http://www.businessinsider.com/r-press-digest---wall-street-journal---sept-21-2017-9,neutral,0.9375851154327393
9/21/2017 1:52:03 PM,BRIEF-Provention Bio announces licensing agreements with Janssen for two clinical-stage immunology assets (JNJ),Reuters,http://www.businessinsider.com/r-brief-provention-bio-announces-licensing-agreements-with-janssen-for-two-clinical-stage-immunology-assets-2017-9,positive,0.5359950065612793
9/21/2017 3:07:03 PM,"YOUR MONEY-Three tips for smart dividend ETF plays (BLK, MSFT, JNJ, PEP, MMM, 11)",Reuters,http://www.businessinsider.com/r-your-money-three-tips-for-smart-dividend-etf-plays-2017-9,neutral,0.923095703125
9/22/2017 12:12:14 AM,"RPT-YOUR MONEY-Three tips for smart dividend ETF plays (BLK, MSFT, JNJ, PEP, MMM, 11)",Reuters,http://www.businessinsider.com/r-rpt-your-money-three-tips-for-smart-dividend-etf-plays-2017-9,neutral,0.927291989326477
9/22/2017 10:37:21 PM,U.S. FDA rejects J&J's arthritis drug (JNJ),Reuters,http://www.businessinsider.com/r-us-fda-rejects-jjs-arthritis-drug-2017-9,negative,0.8843920230865479
9/22/2017 11:02:07 PM,"UPDATE 1-U.S. FDA declines to approve J&J arthritis drug (JNJ, SAN, REGN, LLY, PFE)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-declines-to-approve-jj-arthritis-drug-2017-9,negative,0.8860210180282593
9/26/2017 11:52:12 PM,"U.S. picks companies to help make rules for advanced personal health monitors (AAPL, DXCM, 005930, JNJ)",Reuters,http://www.businessinsider.com/r-us-picks-companies-to-help-make-rules-for-advanced-personal-health-monitors-2017-9,neutral,0.8897092938423157
9/27/2017 5:27:06 PM,"FTC allows Integra to buy J&J‚Äôs Codman neuro business, with conditions (IART, JNJ)",Reuters,http://www.businessinsider.com/r-ftc-allows-integra-to-buy-jjs-codman-neuro-business-with-conditions-2017-9,neutral,0.8699829578399658
9/27/2017 6:02:03 PM,"UPDATE 1-U.S. FTC approves Integra purchase of J&J‚Äôs Codman business (IART, JNJ, BABY)",Reuters,http://www.businessinsider.com/r-update-1-us-ftc-approves-integra-purchase-of-jjs-codman-business-2017-9,neutral,0.6064295768737793
9/28/2017 7:52:12 PM,"UPDATE 1-Washington state sues opioid manufacturer Purdue Pharma (TEVA, JNJ, ENDP, AGN)",Reuters,http://www.businessinsider.com/r-update-1-washington-state-sues-opioid-manufacturer-purdue-pharma-2017-9,negative,0.8754125833511353
9/28/2017 8:27:17 PM,"UPDATE 1-Abbott wins U.S. antitrust approval to buy Alere with conditions (ABT, ALR, QDEL, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-abbott-wins-us-antitrust-approval-to-buy-alere-with-conditions-2017-9,positive,0.8061351180076599
9/29/2017 1:52:13 PM,Biotech Stocks Facing FDA Decision In October ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-october-1002845284,neutral,0.6350188851356506
9/29/2017 2:07:03 PM,"Merck to stop development of hepatitis C treatments (MRK, JNJ, GILD)",Reuters,http://www.businessinsider.com/r-merck-to-stop-development-of-hepatitis-c-treatments-2017-9,negative,0.5342980623245239
9/29/2017 6:22:03 PM,"US invests $170 million in late-stage Ebola vaccines, drugs (MRK, JNJ, REGN)",Reuters,http://www.businessinsider.com/r-us-invests-170-million-in-late-stage-ebola-vaccines-drugs-2017-9,neutral,0.8104273676872253
10/2/2017 2:22:03 PM,BRIEF-Janssen submits supplemental new drug application to FDA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-submits-supplemental-new-drug-application-to-fda-2017-10,neutral,0.8841435313224792
10/2/2017 5:52:06 PM,"US STOCKS-Wall Street hits record high on boost from tech, healthcare (JNJ, GILD, MSFT, INTC, XOM, CVX, JWN)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-hits-record-high-on-boost-from-tech-healthcare-2017-10,positive,0.9337397813796997
10/2/2017 7:22:05 PM,"US STOCKS-S&P, Dow at record highs as financials, healthcare climb (JNJ, GILD, JPM, C, XOM, GM, JWN)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-at-record-highs-as-financials-healthcare-climb-2017-10,positive,0.8107299208641052
10/2/2017 10:01:00 PM,Johnson & Johnson Announces Completion of Codman Neurosurgery Divestiture to Integra LifeSciences Holding Corporation,PR Newswire,/news/stocks/johnson-johnson-announces-completion-of-codman-neurosurgery-divestiture-to-integra-lifesciences-holding-corporation-1002055951,neutral,0.9288352131843567
10/5/2017 1:22:03 PM,"BRIEF-J&J diabetes care company Animas to close operations and exit insulin pump market (JNJ, MDT)",Reuters,http://www.businessinsider.com/r-brief-jj-diabetes-care-company-animas-to-close-operations-and-exit-insulin-pump-market-2017-10,negative,0.8190415501594543
10/5/2017 2:37:03 PM,"J&J's diabetes care unit to exit insulin pump business (JNJ, MDT)",Reuters,http://www.businessinsider.com/r-jjs-diabetes-care-unit-to-exit-insulin-pump-business-2017-10,neutral,0.8311066627502441
10/5/2017 2:57:05 PM,"UPDATE 1-J&J's diabetes care unit to exit insulin pump business (JNJ, MDT)",Reuters,http://www.businessinsider.com/r-update-1-jjs-diabetes-care-unit-to-exit-insulin-pump-business-2017-10,neutral,0.7644692063331604
10/5/2017 10:27:14 PM,"BRIEF-Bayer's Navigate Esus study halted early (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-bayers-navigate-esus-study-halted-early-2017-10,negative,0.501599907875061
10/6/2017 7:02:03 AM,"INSIGHT-Awaiting better days, multinationals keep Venezuela units alive - barely (F, CLX, KMB, GIS, GM, CL, JNJ)",Reuters,http://www.businessinsider.com/r-insight-awaiting-better-days-multinationals-keep-venezuela-units-alive---barely-2017-10,neutral,0.8623501062393188
10/6/2017 7:37:03 AM,"RPT-INSIGHT-Awaiting better days, multinationals keep Venezuela units alive - barely (F, CLX, KMB, GIS, GM, CL, JNJ)",Reuters,http://www.businessinsider.com/r-rpt-insight-awaiting-better-days-multinationals-keep-venezuela-units-alive---barely-2017-10,neutral,0.8356157541275024
10/6/2017 7:52:03 AM,"Bayer says Phase III Xarelto study halted early (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-bayer-says-phase-iii-xarelto-study-halted-early-2017-10,negative,0.6563699245452881
10/6/2017 9:57:08 AM,"BRIEF-Bayer keeps forecast for peak Xarelto annual sales (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-bayer-keeps-forecast-for-peak-xarelto-annual-sales-2017-10,neutral,0.8960761427879333
10/6/2017 10:52:03 AM,"UPDATE 1-Bayer sticks by Xarelto sales estimate despite study setback (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-bayer-sticks-by-xarelto-sales-estimate-despite-study-setback-2017-10,positive,0.9136640429496765
10/11/2017 3:42:03 PM,BRIEF-Janssen submits NDA for Apalutamide(ARN-509) to FDA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-submits-nda-for-apalutamidearn-509-to-fda-2017-10,neutral,0.8761672377586365
10/11/2017 4:07:03 PM,"US STOCKS-Wall St treads water; financials drop ahead of reports (KR, JPM, C, GE, JNJ, MU)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-treads-water-financials-drop-ahead-of-reports-2017-10,negative,0.9682649374008179
10/11/2017 5:42:04 PM,"US STOCKS-Wall St flat; financials drop ahead of earnings (JPM, C, WMT, CL, GE, JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-financials-drop-ahead-of-earnings-2017-10,negative,0.9671958088874817
10/11/2017 6:19:38 PM,Johnson & Johnson Posting Notable Gain After Upgrade By Jefferies ,RTTNews,/news/stocks/johnson-johnson-posting-notable-gain-after-upgrade-by-jefferies-1003846253,positive,0.9391953945159912
10/11/2017 7:12:08 PM,"US STOCKS-Dow inches up to record-high on gains in J&J, Wal-Mart (JNJ, WMT, KR, JPM, C, GE)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-inches-up-to-record-high-on-gains-in-jj-wal-mart-2017-10,positive,0.9401460289955139
10/11/2017 9:47:03 PM,"US STOCKS-Wall St ticks higher with eyes on earnings (JNJ, WMT, KR, JPM, C, GE)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-ticks-higher-with-eyes-on-earnings-2017-10,positive,0.8521288633346558
10/11/2017 10:47:07 PM,"US STOCKS-Wall St ticks higher to record close; eyes on earnings, Fed (JNJ, WMT, KR, JPM, C, GE)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-ticks-higher-to-record-close-eyes-on-earnings-fed-2017-10,positive,0.7559757828712463
10/12/2017 4:12:03 PM,"NIH partners 11 drugmakers to accelerate cancer therapy research (BMY, MRK, PFE, JNJ, AMGN, CELG, GILD, GSK)",Reuters,http://www.businessinsider.com/r-nih-partners-11-drugmakers-to-accelerate-cancer-therapy-research-2017-10,positive,0.7635133266448975
10/12/2017 4:40:00 PM,Treasure Investments Corporation Releases Scripophily and Americana Currency Collections for Auctions,PR Newswire,/news/stocks/treasure-investments-corporation-releases-scripophily-and-americana-currency-collections-for-auctions-1001755642,neutral,0.9500933885574341
10/12/2017 6:27:06 PM,"UPDATE 1-US NIH, 11 drugmakers partner to accelerate cancer therapy research (BMY, MRK, PFE, JNJ, AMGN, CELG, GILD, GSK)",Reuters,http://www.businessinsider.com/r-update-1-us-nih-11-drugmakers-partner-to-accelerate-cancer-therapy-research-2017-10,positive,0.8402755856513977
10/12/2017 10:12:15 PM,"UPDATE 1-US NIH, 11 drugmakers partner to accelerate cancer therapy research (BMY, MRK, PFE, JNJ, AMGN, CELG, GILD, GSK)",Reuters,http://www.businessinsider.com/r-update-1-us-nih-11-drugmakers-partner-to-accelerate-cancer-therapy-research-2017-10,positive,0.8402755856513977
10/13/2017 2:07:11 PM,"BRIEF-EU Medicines Agency provides recommendations for October 2017 (AZN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-eu-medicines-agency-provides-recommendations-for-october-2017-2017-10,neutral,0.9348413348197937
10/13/2017 5:42:07 PM,BRIEF-CHMP issues positive opinion on Janssen‚Äôs ZYTIGA (JNJ),Reuters,http://www.businessinsider.com/r-brief-chmp-issues-positive-opinion-on-janssens-zytiga-2017-10,positive,0.9281991124153137
10/13/2017 10:27:08 PM,BRIEF-Johnson & Johnson says FDA approves Stelara for adolescents with moderate to severe plaque psoriasis (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-fda-approves-stelara-for-adolescents-with-moderate-to-severe-plaque-psoriasis-2017-10,positive,0.7206223607063293
10/13/2017 11:07:07 PM,J&J psoriasis drug gets expanded U.S. approval for teens (JNJ),Reuters,http://www.businessinsider.com/r-jj-psoriasis-drug-gets-expanded-us-approval-for-teens-2017-10,positive,0.9335261583328247
10/16/2017 9:07:13 PM,BRIEF-Cerveau Technologies announces research collaboration agreement with Janssen Pharmaceuticals (JNJ),Reuters,http://www.businessinsider.com/r-brief-cerveau-technologies-announces-research-collaboration-agreement-with-janssen-pharmaceuticals-2017-10,positive,0.7313987016677856
10/17/2017 12:40:00 PM,Johnson & Johnson Reports 2017 Third-Quarter Results:,PR Newswire,/news/stocks/johnson-johnson-reports-2017-third-quarter-results-1004608091,neutral,0.5696131587028503
10/17/2017 12:46:47 PM,Johnson & Johnson Q3 Income Rises 11%,RTTNews,/news/stocks/johnson-johnson-q3-income-rises-11-1004608117,positive,0.9358731508255005
10/17/2017 1:14:17 PM,Johnson & Johnson Lifts FY17 Forecast As Q3 Results Top Estimates ,RTTNews,/news/stocks/johnson-johnson-lifts-fy17-forecast-as-q3-results-top-estimates-1004611195,positive,0.8782766461372375
10/17/2017 1:27:08 PM,"UPDATE 1-Pharma business, Actelion buy drive J&J's profit beat (JNJ)",Reuters,http://www.businessinsider.com/r-update-1-pharma-business-actelion-buy-drive-jjs-profit-beat-2017-10,neutral,0.7934022545814514
10/17/2017 1:37:15 PM,"US STOCKS-Futures flat as investors assess earnings from big names (MS, GS, JNJ, UNH, HON, PG, UAL, AA, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-flat-as-investors-assess-earnings-from-big-names-2017-10,negative,0.9617597460746765
10/17/2017 3:02:08 PM,"US STOCKS-Wall St set to open flat as big bank results fail to cheer (JNJ, UNH, HON, PG, UAL, AA, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-flat-as-big-bank-results-fail-to-cheer-2017-10,negative,0.9379503726959229
10/17/2017 3:22:18 PM,"J&J's Puerto Rico plants running, can't rule out shortages (JNJ)",Reuters,http://www.businessinsider.com/r-jjs-puerto-rico-plants-running-cant-rule-out-shortages-2017-10,neutral,0.8570849299430847
10/17/2017 4:17:03 PM,"US STOCKS-Wall St flat as losses in financials offset healthcare gains (GS, MS, UNH, JNJ, AAPL, BA, BBD., NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-losses-in-financials-offset-healthcare-gains-2017-10,positive,0.5201725363731384
10/17/2017 5:47:03 PM,"US STOCKS-Dow breaches 23,000-mark for the first time (UNH, JNJ, GS, MS, GE, MSFT, INTC, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-breaches-23000-mark-for-the-first-time-2017-10,negative,0.5761294364929199
10/17/2017 7:02:03 PM,J&J wins reversal of $72 million verdict over talc cancer risks (JNJ),Reuters,http://www.businessinsider.com/r-jj-wins-reversal-of-72-million-verdict-over-talc-cancer-risks-2017-10,positive,0.8139054775238037
10/17/2017 7:07:03 PM,"US STOCKS-Dow tops 23,000-mark for the first time on strong earnings (UNH, JNJ, GS, MS, GE, MSFT, INTC, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-tops-23000-mark-for-the-first-time-on-strong-earnings-2017-10,positive,0.9433671832084656
10/17/2017 8:12:08 PM,UPDATE 1-J&J wins reversal of $72 mln verdict over talc cancer risks (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-wins-reversal-of-72-mln-verdict-over-talc-cancer-risks-2017-10,positive,0.9042248725891113
10/17/2017 9:37:03 PM,"US STOCKS-Dow hits 23,000-mark, then backs off (GS, UNH, JNJ, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-hits-23000-mark-then-backs-off-2017-10,neutral,0.5544830560684204
10/17/2017 10:47:04 PM,"US STOCKS-Dow pierces 23,000 but finishes below milestone (UNH, JNJ, THC, GS, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-pierces-23000-but-finishes-below-milestone-2017-10,neutral,0.6399703025817871
10/17/2017 11:37:03 PM,"US STOCKS-Dow pierces 23,000 but finishes below milestone (UNH, JNJ, THC, GS, NFLX, IBM)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-pierces-23000-but-finishes-below-milestone-2017-10,neutral,0.5972998142242432
10/18/2017 12:22:03 AM,"US STOCKS-Dow pierces 23,000 but ends below milestone (UNH, JNJ, THC, GS, NFLX, IBM)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-pierces-23000-but-ends-below-milestone-2017-10,neutral,0.8346313834190369
10/18/2017 5:56:27 AM,Johnson & Johnson Wins Reversal Of First St. Louis Talc-Cancer Verdict ,RTTNews,/news/stocks/johnson-johnson-wins-reversal-of-first-st-louis-talc-cancer-verdict-1004718217,positive,0.6789137721061707
10/18/2017 3:02:03 PM,BRIEF-Trovagene's PCM-075 demonstrates Synergy with Zytiga (JNJ),Reuters,http://www.businessinsider.com/r-brief-trovagenes-pcm-075-demonstrates-synergy-with-zytiga-2017-10,positive,0.9102020859718323
10/19/2017 12:27:18 PM,BRIEF-‚ÄçJohnson & Johnson Medical GmbH to acquire Surgical Process Institute‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-medical-gmbh-to-acquire-surgical-process-institute-2017-10,neutral,0.927210807800293
10/19/2017 12:50:00 PM,Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2017,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-fourth-quarter-2017-1004893120,negative,0.7035964131355286
10/19/2017 1:22:07 PM,BRIEF-Arcturus Therapeutics to collaborate with Johnson & Johnson (JNJ),Reuters,http://www.businessinsider.com/r-brief-arcturus-therapeutics-to-collaborate-with-johnson--johnson-2017-10,positive,0.7306007742881775
10/20/2017 10:32:08 PM,BRIEF-Janssen receives two FDA approvals for SIMPONI ARIA for treatment of active psoriatic arthritis (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-receives-two-fda-approvals-for-simponi-aria-for-treatment-of-active-psoriatic-arthritis-2017-10,positive,0.9442425966262817
10/21/2017 2:12:19 AM,California judge tosses $417 mln talc cancer verdict against J&J (JNJ),Reuters,http://www.businessinsider.com/r-california-judge-tosses-417-mln-talc-cancer-verdict-against-jj-2017-10,negative,0.5820430517196655
10/22/2017 4:34:33 AM,California Court Overturns $417 Mln Verdict Linking J&J Baby Powder With Cancer ,RTTNews,/news/stocks/california-court-overturns-417-mln-verdict-linking-j-j-baby-powder-with-cancer-1005201613,negative,0.9265795350074768
10/23/2017 4:17:03 PM,"UPDATE 1-Smith & Nephew to buy Rotation Medical for up to $210 mln (SN., SYK, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-smith--nephew-to-buy-rotation-medical-for-up-to-210-mln-2017-10,neutral,0.8371859192848206
10/23/2017 7:22:03 PM,"US STOCKS-Losses in GE keep Wall St in check (GE, AAPL, INTC, JNJ, CELG, SLB, HAL, MAT)",Reuters,http://www.businessinsider.com/r-us-stocks-losses-in-ge-keep-wall-st-in-check-2017-10,negative,0.9460093975067139
10/24/2017 4:07:03 PM,"US STOCKS-3M, Caterpillar lift Dow to record high (MMM, CAT, UTX, MCD, BAC, JPM, GM, WHR, BIIB, CNC, JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-3m-caterpillar-lift-dow-to-record-high-2017-10,positive,0.9073182344436646
10/24/2017 5:42:03 PM,"US STOCKS-3M, Caterpillar lift Dow to record high (MMM, CAT, UTX, MCD, BIIB, CNC, JNJ, JPM, WHR)",Reuters,http://www.businessinsider.com/r-us-stocks-3m-caterpillar-lift-dow-to-record-high-2017-10,positive,0.9023405313491821
10/24/2017 7:02:06 PM,"US STOCKS-Dow rallies on strong earnings from 3M, Caterpillar (MMM, CAT, MCD, BIIB, CNC, JNJ, BAC, JPM, GM, WHR)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-rallies-on-strong-earnings-from-3m-caterpillar-2017-10,positive,0.9152758121490479
10/25/2017 2:12:15 PM,BRIEF-Janssen Pharmaceutica says Phase 3 Amber study achieved its primary endpoint‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-pharmaceutica-says-phase-3-amber-study-achieved-its-primary-endpoint-2017-10,positive,0.9315751791000366
10/25/2017 2:37:12 PM,"UPDATE 1-Baxter expects $70 mln hit to 4th-qtr sales from Hurricane Maria (BAX, MRK, JNJ, PFE, GSK, MDT, DEPO, AMGN, BMY, LLY, AZN)",Reuters,http://www.businessinsider.com/r-update-1-baxter-expects-70-mln-hit-to-4th-qtr-sales-from-hurricane-maria-2017-10,positive,0.8058141469955444
10/25/2017 5:27:00 PM,Johnson & Johnson to Participate in the 26th Annual Credit Suisse Health Care Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-26th-annual-credit-suisse-health-care-conference-1005589294,positive,0.6029020547866821
10/25/2017 8:11:01 PM,Judge Overturns Verdict In J&J Baby Powder Verdict ,RTTNews,/news/stocks/judge-overturns-verdict-in-j-j-baby-powder-verdict-1005604075,negative,0.9124125838279724
10/30/2017 12:02:08 PM,"Investor group presses U.S. drug companies on opioid controls (ABC, CAH, JNJ)",Reuters,http://www.businessinsider.com/r-investor-group-presses-us-drug-companies-on-opioid-controls-2017-10,neutral,0.9282996654510498
10/30/2017 12:52:15 PM,BRIEF-J&J's Janssen announces Imbruvica as the first approved treatment for chronic graft-versus-host disease granted by Health Canada priority review (JNJ),Reuters,http://www.businessinsider.com/r-brief-jjs-janssen-announces-imbruvica-as-the-first-approved-treatment-for-chronic-graft-versus-host-disease-granted-by-health-canada-priority-review-2017-10,positive,0.7112410068511963
10/30/2017 1:32:07 PM,BRIEF-Johnson & Johnson says FDA approved 10 mg dose of Xarelto for reducing continued risk for recurrent venous thromboembolism‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-fda-approved-10-mg-dose-of-xarelto-for-reducing-continued-risk-for-recurrent-venous-thromboembolism-2017-10,positive,0.9371289014816284
10/30/2017 2:52:12 PM,"UPDATE 1-Investor group presses U.S. drug companies on opioid controls (ABC, CAH, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-investor-group-presses-us-drug-companies-on-opioid-controls-2017-10,neutral,0.9029824137687683
10/31/2017 1:27:08 PM,"BRIEF-Geron announces fast track designation grant for imetelstat (GERN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-geron-announces-fast-track-designation-grant-for-imetelstat-2017-10,positive,0.8084551095962524
10/31/2017 1:47:19 PM,"BRIEF-Halozyme - ‚ÄçJanssen Biotech initiated first phase 3 clinical trial evaluating subcutaneous delivery of Darzalex (HALO, JNJ)",Reuters,http://www.businessinsider.com/r-brief-halozyme---janssen-biotech-initiated-first-phase-3-clinical-trial-evaluating-subcutaneous-delivery-of-darzalex-2017-10,positive,0.7475979328155518
11/2/2017 7:02:03 PM,"U.S. Congress to hold hearing on Allergan tribal patent deal (AGN, JNJ, MYL)",Reuters,http://www.businessinsider.com/r-us-congress-to-hold-hearing-on-allergan-tribal-patent-deal-2017-11,neutral,0.9434607625007629
11/5/2017 12:37:03 AM,"J&J's Stelara shows promise against lupus in study (JNJ, GSK)",Reuters,http://www.businessinsider.com/r-jjs-stelara-shows-promise-against-lupus-in-study-2017-11,positive,0.9360602498054504
11/6/2017 10:42:03 AM,"Bayer in bid to broaden use of anti-clotting drug Xarelto (BAYN, JNJ, MON, PFE, BMY)",Reuters,http://www.businessinsider.com/r-bayer-in-bid-to-broaden-use-of-anti-clotting-drug-xarelto-2017-11,positive,0.8729292154312134
11/6/2017 2:47:03 PM,BRIEF-J&J's Stelara shows positive results in treatment of systemic lupus erythematosus in phase 2 trial (JNJ),Reuters,http://www.businessinsider.com/r-brief-jjs-stelara-shows-positive-results-in-treatment-of-systemic-lupus-erythematosus-in-phase-2-trial-2017-11,positive,0.9519513845443726
11/8/2017 4:27:00 PM,Johnson & Johnson -- Moody's assigns Aaa to J&J's sr. notes; stable outlook,Moodys,/news/bonds/johnson-amp-johnson-moody-s-assigns-aaa-to-j-j-s-sr-notes-stable-outlook-1007303842,positive,0.8219634294509888
11/13/2017 11:07:03 AM,BRIEF-Zymeworks announces license agreement with Johnson & Johnson Innovation (JNJ),Reuters,http://www.businessinsider.com/r-brief-zymeworks-announces-license-agreement-with-johnson--johnson-innovation-2017-11,positive,0.8577176332473755
11/13/2017 2:04:00 PM,Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems,PR Newswire,/news/stocks/johnson-johnson-innovation-launches-digital-beauty-quickfire-challenge-to-tackle-some-of-the-toughest-consumer-skincare-problems-1007872498,positive,0.5811458230018616
11/13/2017 2:04:00 PM,Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems,PR Newswire,/news/stocks/johnson-johnson-innovation-launches-digital-beauty-quickfire-challenge-to-tackle-some-of-the-toughest-consumer-skincare-problems-1007872494,positive,0.5811458230018616
11/13/2017 2:04:00 PM,Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems,PR Newswire,/news/stocks/johnson-&-johnson-innovation-launches-digital-beauty-quickfire-challenge-to-tackle-some-of-the-toughest-consumer-skincare-problems-586831,positive,0.5811458230018616
11/13/2017 2:27:00 PM,Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems,PR Newswire,/news/stocks/johnson-johnson-innovation-launches-digital-beauty-quickfire-challenge-to-tackle-some-of-the-toughest-consumer-skincare-problems-1007874103,positive,0.5811458230018616
11/15/2017 2:12:03 PM,BRIEF-Jannsen Inc says‚Äç Health Canada has approved Tremfya for treatment of adult moderate to severe plaque Psoriasis‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-jannsen-inc-says-health-canada-has-approved-tremfya-for-treatment-of-adult-moderate-to-severe-plaque-psoriasis-2017-11,positive,0.8978723883628845
11/15/2017 5:52:03 PM,"Astellas faces U.S. probe over patient assistance charity support (4503, PFE, JNJ, UTHR, GILD, VRX, CELG)",Reuters,http://www.businessinsider.com/r-astellas-faces-us-probe-over-patient-assistance-charity-support-2017-11,negative,0.8980136513710022
11/20/2017 4:32:03 PM,BRIEF-‚ÄçJanssen-Cilag says European Commission approves expanded use of Zytiga (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-cilag-says-european-commission-approves-expanded-use-of-zytiga-2017-11,positive,0.8050236701965332
11/20/2017 6:47:00 PM,Johnson & Johnson to Participate in the Citi 2017 Global Healthcare Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-the-citi-2017-global-healthcare-conference-520043,neutral,0.7232030034065247
11/21/2017 3:02:03 PM,"J&J multiple myeloma drug succeeds in first-line combination study (JNJ, 4502, CELG)",Reuters,http://www.businessinsider.com/r-jj-multiple-myeloma-drug-succeeds-in-first-line-combination-study-2017-11,positive,0.9370052814483643
11/21/2017 3:52:03 PM,BRIEF-Janssen seeks expanded use of Darzalex from EMA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-seeks-expanded-use-of-darzalex-from-ema-2017-11,positive,0.6892006993293762
11/21/2017 6:37:03 PM,"UPDATE 1-J&J multiple myeloma drug succeeds in first-line combination study (JNJ, GEN, 4502, CELG)",Reuters,http://www.businessinsider.com/r-update-1-jj-multiple-myeloma-drug-succeeds-in-first-line-combination-study-2017-11,positive,0.9371820688247681
11/21/2017 9:12:05 PM,"U.S. FDA approves first two-drug HIV regimen (GSK, 4507, GILD, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-us-fda-approves-first-two-drug-hiv-regimen-2017-11,neutral,0.5633711218833923
11/22/2017 12:22:03 AM,"UPDATE 1-U.S. FDA approves first two-drug HIV regimen from GSK (GSK, PFE, 4507, JNJ, GILD)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-approves-first-two-drug-hiv-regimen-from-gsk-2017-11,neutral,0.49800291657447815
11/22/2017 12:32:03 AM,BRIEF-Janssen announces FDA approval of Juluca for the treatment of HIV-1 infection (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-announces-fda-approval-of-juluca-for-the-treatment-of-hiv-1-infection-2017-11,positive,0.617130696773529
11/28/2017 1:07:03 PM,"New ETF joins fight against sexual harassment in workplace (AAPL, MSFT, JNJ)",Reuters,http://www.businessinsider.com/r-new-etf-joins-fight-against-sexual-harassment-in-workplace-2017-11,neutral,0.864363431930542
11/29/2017 8:12:03 PM,"U.S. says patient charity helped drugmakers, revokes approval (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-us-says-patient-charity-helped-drugmakers-revokes-approval-2017-11,neutral,0.7578294277191162
11/29/2017 9:17:05 PM,"UPDATE 1-U.S. says patient charity helped drugmakers, revokes approval (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-us-says-patient-charity-helped-drugmakers-revokes-approval-2017-11,neutral,0.6831181645393372
11/29/2017 9:52:04 PM,"BRIEF-Genmab Achieves $20 Million Milestone In Daratumumab Collaboration With Janssen (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-achieves-20-million-milestone-in-daratumumab-collaboration-with-janssen-2017-11,positive,0.917867124080658
11/30/2017 8:07:03 AM,Hopes for HIV vaccine buoyed by start of second big trial (JNJ),Reuters,http://www.businessinsider.com/r-hopes-for-hiv-vaccine-buoyed-by-start-of-second-big-trial-2017-11,positive,0.9339703917503357
11/30/2017 11:07:05 AM,"UPDATE 1-New vaccine, long-acting drug trials buoy hopes in HIV fight (JNJ, GSK)",Reuters,http://www.businessinsider.com/r-update-1-new-vaccine-long-acting-drug-trials-buoy-hopes-in-hiv-fight-2017-11,positive,0.852408230304718
11/30/2017 4:08:00 PM,Moody's: Pharma manufacturers and distributors face rising risks related to US opioid crisis,Moodys,/news/bonds/moody-s-pharma-manufacturers-and-distributors-face-rising-risks-related-to-us-opioid-crisis-1010065274,negative,0.9176850914955139
11/30/2017 4:22:03 PM,"BRIEF-Moody's Says Pharma Manufacturers, Distributors Face Rising Risks Related To U.S. Opioid Crisis (ENDP, JNJ, TEVA)",Reuters,http://www.businessinsider.com/r-brief-moodys-says-pharma-manufacturers-distributors-face-rising-risks-related-to-us-opioid-crisis-2017-11,negative,0.7841911315917969
11/30/2017 9:34:00 PM,Johnson & Johnson to Participate in the BMO Capital Markets Healthcare Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-the-bmo-capital-markets-healthcare-conference-552620,neutral,0.824522852897644
12/4/2017 9:07:03 AM,Idorsia to get $230 mln from J&J in latest hypertension deal (JNJ),Reuters,http://www.businessinsider.com/r-idorsia-to-get-230-mln-from-jj-in-latest-hypertension-deal-2017-12,positive,0.8589519262313843
12/5/2017 8:07:04 AM,"BRIEF-Morphosys Says Licensee Janssen Receives Approval For Tremfya In Canada (MOR, JNJ)",Reuters,http://www.businessinsider.com/r-brief-morphosys-says-licensee-janssen-receives-approval-for-tremfya-in-canada-2017-12,positive,0.7642735242843628
12/5/2017 2:52:04 PM,BRIEF-Imbruvica Plus Rituximab Phase 3 Innovate Trial In Rare Waldenstr√∂m's Macroglobulinemia Met Primary Endpoint (JNJ),Reuters,http://www.businessinsider.com/r-brief-imbruvica-plus-rituximab-phase-3-innovate-trial-in-rare-waldenstrms-macroglobulinemia-met-primary-endpoint-2017-12,neutral,0.5463388562202454
12/5/2017 7:02:03 PM,"Jury orders Bayer, J&J to pay $29 million in Xarelto lawsuit (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-jury-orders-bayer-jj-to-pay-29-million-in-xarelto-lawsuit-2017-12,negative,0.842075526714325
12/5/2017 8:37:04 PM,"UPDATE 1-Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-jury-orders-bayer-jj-to-pay-28-million-in-xarelto-lawsuit-2017-12,negative,0.8392754197120667
12/6/2017 2:12:09 PM,"BRIEF-Genomic Health Announces Research Collaboration with Janssen Pharma (GHDX, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genomic-health-announces-research-collaboration-with-janssen-pharma-2017-12,positive,0.5743758082389832
12/7/2017 6:47:04 PM,BRIEF-J&J considers sale of anti-dandruff shampoo Nizoral - Bloomberg (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-considers-sale-of-anti-dandruff-shampoo-nizoral---bloomberg-2017-12,neutral,0.938020646572113
12/10/2017 4:32:03 PM,"'Unheard of' responses to bluebird CAR-T therapy seen in myeloma study (JNJ, CELG, GILD)",Reuters,http://www.businessinsider.com/r-unheard-of-responses-to-bluebird-car-t-therapy-seen-in-myeloma-study-2017-12,neutral,0.7117311954498291
12/14/2017 1:02:03 AM,"Bumper crop of new drugs fails to lift big pharma R&D returns (BION, NOVO , PFE, SAN, GSK, JNJ, AZN, MRK, LLY, BMY, 4502, AMGN, BIIB, CELG, GILD)",Reuters,http://www.businessinsider.com/r-bumper-crop-of-new-drugs-fails-to-lift-big-pharma-rd-returns-2017-12,negative,0.7240322828292847
12/14/2017 7:22:05 PM,"US STOCKS-S&P, Dow flat as healthcare losses offset by tech, media gains (DIS, NFLX, CMCSA, JNJ, VZ, T, CTL)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-flat-as-healthcare-losses-offset-by-tech-media-gains-2017-12,negative,0.6043397784233093
12/14/2017 9:12:03 PM,"US STOCKS-Wall St falls as investors fret about tax bill passage (DIS, NFLX, CMCSA, JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-falls-as-investors-fret-about-tax-bill-passage-2017-12,negative,0.9588493704795837
12/15/2017 2:22:03 AM,"UPDATE 1-Pfizer's Xeljanz gets FDA nod as joint disease treatment (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-pfizers-xeljanz-gets-fda-nod-as-joint-disease-treatment-2017-12,positive,0.8645578622817993
12/19/2017 2:20:00 PM,Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-fourth-quarter-results-1011641653,neutral,0.9188656210899353
12/19/2017 2:30:00 PM,Johnson & Johnson to Participate in 36th Annual JP Morgan Health Care Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-36th-annual-jp-morgan-health-care-conference-1011641907,neutral,0.8051584959030151
12/19/2017 9:32:03 PM,"FDA medical device proposal may skirt the law - legal experts (AAPL, JNJ)",Reuters,http://www.businessinsider.com/r-fda-medical-device-proposal-may-skirt-the-law---legal-experts-2017-12,neutral,0.7522578239440918
12/20/2017 9:57:05 AM,Johnson & Johnson fined 25 mln euros by French competition watchdog (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnson-fined-25-mln-euros-by-french-competition-watchdog-2017-12,negative,0.9592273235321045
12/20/2017 11:42:06 AM,"UPDATE 1-France fines J&J 25 mln euros over painkilller patch (JNJ, TEVA, SAN)",Reuters,http://www.businessinsider.com/r-update-1-france-fines-jj-25-mln-euros-over-painkilller-patch-2017-12,positive,0.7331303358078003
12/20/2017 9:52:03 PM,"UPDATE 1-New Mexico adds Insys, Mallinckrodt to opioid epidemic lawsuit (JNJ, AGN, ENDP, TEVA, MCK, CAH, ABC)",Reuters,http://www.businessinsider.com/r-update-1-new-mexico-adds-insys-mallinckrodt-to-opioid-epidemic-lawsuit-2017-12,neutral,0.8903144001960754
12/20/2017 10:17:04 PM,"BRIEF-U.S. Fda Approves New Diabetes Drug From Merck And Pfizer (MRK, PFE, JNJ, LLY, AZN)",Reuters,http://www.businessinsider.com/r-brief-us-fda-approves-new-diabetes-drug-from-merck-and-pfizer-2017-12,positive,0.7861438989639282
12/20/2017 10:27:06 PM,"U.S. FDA approves new diabetes drug from Merck and Pfizer (MRK, PFE, AZN, JNJ, LLY)",Reuters,http://www.businessinsider.com/r-us-fda-approves-new-diabetes-drug-from-merck-and-pfizer-2017-12,positive,0.8601292371749878
12/20/2017 10:42:03 PM,"UPDATE 1-U.S. FDA approves new diabetes drug from Merck and Pfizer (MRK, PFE, AZN, JNJ, LLY)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-approves-new-diabetes-drug-from-merck-and-pfizer-2017-12,positive,0.873540997505188
12/21/2017 1:22:04 PM,Indian minister writes to Modi urging price caps on 20 medical devices (JNJ),Reuters,http://www.businessinsider.com/r-indian-minister-writes-to-modi-urging-price-caps-on-20-medical-devices-2017-12,negative,0.5550715327262878
12/21/2017 11:37:03 PM,BRIEF-Janssen Enters Collaboration And License Agreement With China's Legend Biotech To Develop CAR-T Cancer Therapy (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-enters-collaboration-and-license-agreement-with-chinas-legend-biotech-to-develop-car-t-cancer-therapy-2017-12,positive,0.9212294816970825
12/22/2017 1:02:03 AM,"BRIEF-Genscript Biotech Says US, Ireland Units ‚Äç& Janssen Biotech Enter Collaboration & License Agreement ‚Äã (JNJ)",Reuters,http://www.businessinsider.com/r-brief-genscript-biotech-says-us-ireland-units--janssen-biotech-enter-collaboration--license-agreement--2017-12,neutral,0.5269078612327576
12/27/2017 4:22:03 PM,"US STOCKS-Wall St little changed; oil drop weighs on energy shares (COP, CVX, NVDA, AAPL, JNJ, PFE, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-little-changed-oil-drop-weighs-on-energy-shares-2017-12,negative,0.7638429403305054
12/27/2017 5:42:08 PM,"US STOCKS-Tech, healthcare stocks prop up Wall Street (AAPL, COP, CVX, JNJ, PFE, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-tech-healthcare-stocks-prop-up-wall-street-2017-12,positive,0.895980179309845
12/27/2017 7:07:03 PM,"US STOCKS-Healthcare, tech stocks prop up Wall Street (MSFT, AAPL, CXO, DVN, UNH, JNJ, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-healthcare-tech-stocks-prop-up-wall-street-2017-12,positive,0.9228543639183044
1/2/2018 12:45:00 PM,Johnson & Johnson Announces Quarterly Dividend for First Quarter 2018,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-first-quarter-2018-1002302613,negative,0.6483057141304016
1/2/2018 12:52:03 PM,BRIEF-Johnson & Johnson Declares Cash Dividend For Q1 2018 Of $0.84 Per Share On Co's Common Stock (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-declares-cash-dividend-for-q1-2018-of-084-per-share-on-cos-common-stock-2018-1,neutral,0.8286543488502502
1/2/2018 2:22:04 PM,BRIEF-Syros Announces Clinical Supply Agreement With Janssen To Evaluate SY-1425 (JNJ),Reuters,http://www.businessinsider.com/r-brief-syros-announces-clinical-supply-agreement-with-janssen-to-evaluate-sy-1425-2018-1,positive,0.8704131245613098
1/2/2018 8:12:05 PM,FDA issues recall on J&J heart device (JNJ),Reuters,http://www.businessinsider.com/r-fda-issues-recall-on-jj-heart-device-2018-1,negative,0.7413671612739563
1/2/2018 8:27:14 PM,BRIEF-FDA Issues Class I Recall Of Reprocessed Agilis Steerable Introducer Sheath By Sterilmed (JNJ),Reuters,http://www.businessinsider.com/r-brief-fda-issues-class-i-recall-of-reprocessed-agilis-steerable-introducer-sheath-by-sterilmed-2018-1,neutral,0.721307098865509
1/3/2018 2:32:03 PM,BRIEF-Landmark Schizophrenia Data Receive FDA Approval For Inclusion In Invega Sustenna (Paliperidone Palmitate) Label (JNJ),Reuters,http://www.businessinsider.com/r-brief-landmark-schizophrenia-data-receive-fda-approval-for-inclusion-in-invega-sustenna-paliperidone-palmitate-label-2018-1,positive,0.9181561470031738
1/3/2018 9:00:00 PM,Dr. Paul Janssen Award for Biomedical Research Issues 2018 Call for Nominations to Celebrate Champions of Science,PR Newswire,/news/stocks/dr-paul-janssen-award-for-biomedical-research-issues-2018-call-for-nominations-to-celebrate-champions-of-science-1012444286,neutral,0.8636709451675415
1/7/2018 3:50:22 PM,New Drugs Approved In December ,RTTNews,/news/stocks/new-drugs-approved-in-december-1012620046,neutral,0.62252277135849
1/9/2018 3:38:00 AM,Small Business Funding Solutions: What to Do Differently in 2018,PR Newswire,/news/stocks/small-business-funding-solutions-what-to-do-differently-in-2018-1001655459,neutral,0.9065392017364502
1/9/2018 3:11:00 PM,Moody's: US pharmaceutical companies' cash holdings set to decline under new tax law,Moodys,/news/bonds/moody-s-us-pharmaceutical-companies-cash-holdings-set-to-decline-under-new-tax-law-1012731176,negative,0.9666052460670471
1/17/2018 9:03:00 PM,"Ortho-Clinical Diagnostics SA -- Moody's affirms Ortho-Clinical's ratings, outlook revised to stable",Moodys,/news/bonds/ortho-clinical-diagnostics-sa-moody-s-affirms-ortho-clinical-s-ratings-outlook-revised-to-stable-1013174029,positive,0.8664421439170837
1/23/2018 9:13:41 AM,"Earnings In Focus: Jan. 23 (FUL, ATI, JNJ, PG, VZ) ",RTTNews,/news/stocks/earnings-in-focus-jan-23-ful-ati-jnj-pg-vz-1013685346,neutral,0.926611065864563
1/23/2018 12:40:00 PM,Johnson & Johnson Reports 2017 Fourth-Quarter Results:,PR Newswire,/news/stocks/johnson-&-johnson-reports-2017-fourth-quarter-results--694806,neutral,0.5244165062904358
1/23/2018 12:45:25 PM,Johnson & Johnson Q4 Earnings Rise 10%,RTTNews,/news/stocks/johnson-johnson-q4-earnings-rise-10-1013703855,positive,0.9386103749275208
1/23/2018 1:27:38 PM,Johnson & Johnson Q4 Results Top Estimates; Sees FY18 Profit Above View ,RTTNews,/news/stocks/johnson-johnson-q4-results-top-estimates-sees-fy18-profit-above-view-1013707581,positive,0.7121533155441284
1/23/2018 6:01:00 PM,Forty of the Nation's Most Promising Young Scientists Named Finalists in Regeneron Science Talent Search 2018,PR Newswire,/news/stocks/forty-of-the-nation-s-most-promising-young-scientists-named-finalists-in-regeneron-science-talent-search-2018-1001688777,positive,0.7973156571388245
1/25/2018 5:59:00 PM,Bayer Shares the Risk with Cotton Farmers,PR Newswire,/news/stocks/bayer-shares-the-risk-with-cotton-farmers-703862,neutral,0.8673564791679382
1/31/2018 8:18:00 PM,Johnson & Johnson to Participate in the Leerink Partners 7th Annual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-leerink-partners-7th-annual-global-healthcare-conference-1014710803,neutral,0.5705137848854065
2/1/2018 2:30:00 PM,MeiraGTx Receives Rare Pediatric Disease Designation for A002 for the Treatment of Achromatopsia Due to Mutations in the CNGB3 Gene,PR Newswire,/news/stocks/meiragtx-receives-rare-pediatric-disease-designation-for-a002-for-the-treatment-of-achromatopsia-due-to-mutations-in-the-cngb3-gene-1001718908,positive,0.8510876297950745
2/7/2018 4:58:00 PM,Johnson & Johnson to Participate in RBC Capital Markets 2018 Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-rbc-capital-markets-2018-global-healthcare-conference-1015054422,neutral,0.8583294153213501
2/8/2018 2:30:00 PM,Janssen and Johnson & Johnson to Provide Webcast Presentation on Phase 3 Data for Apalutamide and the Janssen Prostate Cancer Strategy and Portfolio,PR Newswire,/news/stocks/janssen-and-johnson-johnson-to-provide-webcast-presentation-on-phase-3-data-for-apalutamide-and-the-janssen-prostate-cancer-strategy-and-portfolio-1015121273,neutral,0.9098448753356934
2/8/2018 4:10:00 PM,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Johnson & Johnson (JNJ)",PR Newswire,/news/stocks/shareholder-alert-bronstein-gewirtz-grossman-llc-announces-investigation-of-johnson-johnson-jnj-1015127765,negative,0.5646177530288696
2/8/2018 5:41:00 PM,Johnson & Johnson to Participate in the 2018 CAGNY Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-2018-cagny-conference-1015133630,neutral,0.8189842700958252
2/9/2018 6:48:07 AM,"FDA Nod For JNJ, CORI Awaits Results In Q2, MDGL's HeFH Data Fails To Impress ",RTTNews,/news/stocks/fda-nod-for-jnj-cori-awaits-results-in-q2-mdgl-s-hefh-data-fails-to-impress-1015183062,negative,0.7770132422447205
2/9/2018 4:30:00 PM,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline: April 9, 2018",PR Newswire,/news/stocks/shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-investors-of-class-action-against-johnson-johnson-jnj-lead-plaintiff-deadline-april-9-2018-1015222120,neutral,0.7567868232727051
2/9/2018 4:30:00 PM,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline: April 9, 2018",PR Newswire,/news/stocks/shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-investors-of-class-action-against-johnson-johnson-jnj-lead-plaintiff-deadline-april-9-2018-1015222116,neutral,0.7567868232727051
2/16/2018 4:03:00 PM,Johnson & Johnson Consumer Presents New Scientific Research At 2018 American Academy of Dermatology Annual Meeting,PR Newswire,/news/stocks/johnson-johnson-consumer-presents-new-scientific-research-at-2018-american-academy-of-dermatology-annual-meeting-1016029591,neutral,0.926368236541748
2/20/2018 2:53:00 AM,J&J Reportedly Explores Sale Of $2 Bln Sterilization Division ,RTTNews,/news/stocks/j-j-reportedly-explores-sale-of-2-bln-sterilization-division-1016384446,neutral,0.8254995346069336
2/20/2018 10:43:00 PM,Johnson & Johnson to Participate in Cowen 38th Annual Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-cowen-38th-annual-healthcare-conference-1016490049,neutral,0.8185364007949829
2/23/2018 3:00:00 PM,"Milliman: Public pension funding improves by $60 billion, funded ratio climbs to 73.1% in 2017 Q4",PR Newswire,/news/stocks/milliman-public-pension-funding-improves-by-60-billion-funded-ratio-climbs-to-73-1-in-2017-q4-1001785596,positive,0.9482225179672241
3/5/2018 3:22:13 PM,New Drugs Approved In February ,RTTNews,/news/stocks/new-drugs-approved-in-february-1018015655,neutral,0.6458379030227661
3/6/2018 8:52:00 PM,Johnson & Johnson to Participate in Barclays Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-barclays-global-healthcare-conference-1018169448,neutral,0.8034944534301758
3/8/2018 10:33:00 PM,"Judge's Order Sets 1,200 Xarelto Product Liability Lawsuits for Separate Jury Trials",PR Newswire,/news/stocks/judge-s-order-sets-1-200-xarelto-product-liability-lawsuits-for-separate-jury-trials-1018455278,neutral,0.5915199518203735
3/13/2018 6:59:00 PM,"Lifshitz & Miller LLP Announces Investigation of 8point3 Energy Partners LP, Grandpoint Capital, Inc., Hardinge Inc., Johnson & Johnson, LJM Funds Management Ltd., Nationstar Mortgage Holdings Inc.",PR Newswire,/news/stocks/lifshitz-miller-llp-announces-investigation-of-8point3-energy-partners-lp-grandpoint-capital-inc-hardinge-inc-johnson-johnson-ljm-funds-management-ltd-nationstar-mortgage-holdings-inc-1002161243,neutral,0.5804712176322937
3/16/2018 12:30:00 PM,"Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1018849153,neutral,0.6222513914108276
3/16/2018 12:30:00 PM,"Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1018849140,neutral,0.6222513914108276
3/16/2018 12:30:00 PM,"Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1018849144,neutral,0.6222513914108276
3/16/2018 12:30:00 PM,"Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1018849145,neutral,0.6222513914108276
3/16/2018 12:38:52 PM,J&J Gets Binding Offer From Platinum Equity To Buy LifeScan Unit For $2.1 Bln ,RTTNews,/news/stocks/j-j-gets-binding-offer-from-platinum-equity-to-buy-lifescan-unit-for-2-1-bln-1018849187,positive,0.7488362193107605
3/19/2018 5:25:00 PM,Syracuse Creative Agency Expands into Southern Tier,PR Newswire,/news/stocks/syracuse-creative-agency-expands-into-southern-tier-1002179054,positive,0.7053853273391724
3/20/2018 2:24:00 PM,Johnson & Johnson to Host Investor Conference Call on First-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-first-quarter-results-1018945975,neutral,0.9213519096374512
3/20/2018 9:15:00 PM,Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson,PR Newswire,/news/stocks/dominic-j-caruso-to-retire-as-chief-financial-officer-of-johnson-johnson-1018958892,neutral,0.837142288684845
4/3/2018 1:54:24 PM,Will These Drugs Reach Blockbuster Status? ,RTTNews,/news/stocks/will-these-drugs-reach-blockbuster-status-1020339832,neutral,0.7288854122161865
4/6/2018 6:24:53 AM,"J&J, Imerys Ordered To Pay $37 Mln In Case Over Talc Cancer Risks ",RTTNews,/news/stocks/j-j-imerys-ordered-to-pay-37-mln-in-case-over-talc-cancer-risks-1020647379,negative,0.9513900876045227
4/10/2018 10:15:00 PM,Horizon Technology Finance Announces Renewal of Credit Facility,PR Newswire,/news/stocks/horizon-technology-finance-announces-renewal-of-credit-facility-564055,neutral,0.6117017269134521
4/11/2018 2:53:47 AM,FDA Approves First Contact Lens With Light-adaptive Technology ,RTTNews,/news/stocks/fda-approves-first-contact-lens-with-light-adaptive-technology-1021112699,positive,0.6364917159080505
4/17/2018 12:40:00 PM,Johnson & Johnson Reports 2018 First-Quarter Results:,PR Newswire,/news/stocks/johnson-&-johnson-reports-2018-first-quarter-results--1001599660,neutral,0.6633397936820984
4/17/2018 12:50:28 PM,Johnson & Johnson Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q1-adjusted-earnings-beat-estimates-1021431007,positive,0.7109442949295044
4/17/2018 1:02:11 PM,Johnson & Johnson Increases Sales Guidance; Plans Supply Chain Actions ,RTTNews,/news/stocks/johnson-johnson-increases-sales-guidance-plans-supply-chain-actions-1021431726,neutral,0.7756677865982056
4/18/2018 12:41:00 AM,FreeBackgroundCheck.org Announces Members Area Upgrades,PR Newswire,/news/stocks/freebackgroundcheck-org-announces-members-area-upgrades-1001600515,neutral,0.9393547773361206
4/24/2018 2:00:00 PM,Unison Reports Fast Company Growth Supported by Strategic Hires and New Market Expansion,PR Newswire,/news/stocks/unison-reports-fast-company-growth-supported-by-strategic-hires-and-new-market-expansion-1001957720,positive,0.9533326029777527
4/24/2018 10:01:00 PM,Johnson & Johnson to Participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-2018-deutsche-bank-43rd-annual-health-care-conference-1022160611,neutral,0.7847021222114563
4/26/2018 4:26:00 PM,Johnson & Johnson Announces Dividend Increase of 7.1%,PR Newswire,/news/stocks/johnson-johnson-announces-dividend-increase-of-7-1-1022412658,positive,0.9099469184875488
4/28/2018 5:35:58 AM,Biotech Stocks Facing FDA Decision In May ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-may-1022627793,neutral,0.8298412561416626
4/30/2018 2:47:38 PM,Cytori Updates On US Manufacturing And EU Approval Plans For ATI-0918 ,RTTNews,/news/stocks/cytori-updates-on-us-manufacturing-and-eu-approval-plans-for-ati-0918-1022889295,neutral,0.9124888181686401
5/2/2018 6:00:00 PM,Johnson & Johnson to Host Consumer and Medical Devices Business Review,PR Newswire,/news/stocks/johnson-johnson-to-host-consumer-and-medical-devices-business-review-1001658284,neutral,0.8828185200691223
5/3/2018 7:18:00 PM,Johnson & Johnson to Participate in the 2018 UBS Global Health Care Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-the-2018-ubs-global-health-care-conference-657014,neutral,0.7828725576400757
5/5/2018 2:00:00 PM,New Phase 3 Data Show Esketamine Nasal Spray Demonstrated Rapid Improvements in Depressive Symptoms in Patients with Treatment-Resistant Depression,PR Newswire,/news/stocks/new-phase-3-data-show-esketamine-nasal-spray-demonstrated-rapid-improvements-in-depressive-symptoms-in-patients-with-treatment-resistant-depression-1023481483,positive,0.9534634947776794
5/5/2018 2:09:03 PM,A depression drug that researchers have called 'the most important discovery in half a century' just got a big lift (JNJ),Business Insider,http://www.businessinsider.com/depression-medication-treatment-ketamine-2018-5,positive,0.9335405826568604
5/7/2018 10:53:00 PM,LifeScan Global Corporation -- Moody's assigns B2 CFR to LifeScan Global Corporation,Moodys,/news/bonds/lifescan-global-corporation-moody-s-assigns-b2-cfr-to-lifescan-global-corporation-1023685176,neutral,0.8689334392547607
5/8/2018 7:47:04 AM,"It's Raining FDA Approvals, MSON Muscling Up, RDHL To Report Data In Aug. ",RTTNews,/news/stocks/it-s-raining-fda-approvals-mson-muscling-up-rdhl-to-report-data-in-aug-1023720441,neutral,0.8559165596961975
5/29/2018 4:15:14 AM,Juries Weigh Cases Over Alleged Harms Of Johnson & Johnson Baby Powder ,RTTNews,/news/stocks/juries-weigh-cases-over-alleged-harms-of-johnson-johnson-baby-powder-1025660907,negative,0.8484252691268921
5/29/2018 4:53:00 PM,Johnson & Johnson to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-goldman-sachs-39th-annual-global-healthcare-conference-1025725224,neutral,0.631097674369812
6/1/2018 9:05:50 AM,"Celgene Appoints J&J's David Elkins As EVP, CFO, Succeeding Peter Kellogg ",RTTNews,/news/stocks/celgene-appoints-j-j-s-david-elkins-as-evp-cfo-succeeding-peter-kellogg-1026083080,neutral,0.9313220977783203
6/5/2018 2:00:00 PM,Johnson & Johnson Announces Progress Toward Health for Humanity Goals,PR Newswire,/news/stocks/johnson-johnson-announces-progress-toward-health-for-humanity-goals-1026560176,positive,0.6456706523895264
6/6/2018 10:46:00 PM,Johnson & Johnson Announces Binding Offer from Fortive Corporation to Acquire Advanced Sterilization Products (ASP),PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-fortive-corporation-to-acquire-advanced-sterilization-products-asp-1026756589,positive,0.5574843287467957
6/6/2018 11:07:28 PM,Fortive Offers To Buy J&J's Advance Sterilization Product Biz For $2.8 Bln ,RTTNews,/news/stocks/fortive-offers-to-buy-j-j-s-advance-sterilization-product-biz-for-2-8-bln-1026757669,neutral,0.8704679012298584
6/7/2018 4:07:00 PM,ISG Awarded IT Services Contract by State of Texas,PR Newswire,/news/stocks/isg-awarded-it-services-contract-by-state-of-texas-1001772800,positive,0.9326004981994629
6/12/2018 10:01:00 PM,"Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-acceptance-of-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1026886164,positive,0.5235773324966431
6/12/2018 10:01:00 PM,"Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-acceptance-of-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1026886155,positive,0.5235773324966431
6/12/2018 10:01:00 PM,"Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-acceptance-of-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1026886154,positive,0.5235773324966431
6/12/2018 10:01:00 PM,"Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-acceptance-of-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1002095213,positive,0.5235773324966431
6/12/2018 10:19:22 PM,Johnson & Johnson Accepts Platinum Equity's Offer To Buy LifeScan For $2.1 Bln ,RTTNews,/news/stocks/johnson-johnson-accepts-platinum-equity-s-offer-to-buy-lifescan-for-2-1-bln-1026886960,neutral,0.6177775263786316
6/15/2018 2:30:00 AM,"Kyros Law is Investigating Claims on Behalf of Invokana users: 1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations and Heart Complications Filed.",PR Newswire,/news/stocks/kyros-law-is-investigating-claims-on-behalf-of-invokana-users-1-100-invokana-lawsuits-alleging-diabetic-ketoacidosis-kidney-injury-amputations-and-heart-complications-filed-1027052699,negative,0.9272688627243042
6/15/2018 11:00:00 PM,LifeScan Global Corporation -- Moody's downgrades LifeScan Global's term loan B rating to B2 from B1,Moodys,/news/bonds/lifescan-global-corporation-moody-s-downgrades-lifescan-global-s-term-loan-b-rating-to-b2-from-b1-1027141162,negative,0.7477317452430725
6/18/2018 2:27:00 PM,FDA Approves the Next Generation of Customized LASIK Treatment with iDESIGN Refractive Studio,PR Newswire,/news/stocks/fda-approves-the-next-generation-of-customized-lasik-treatment-with-idesign-refractive-studio-1027167302,positive,0.714745283126831
6/18/2018 2:39:34 PM,Johnson & Johnson Vision: FDA Approves IDESIGN Refractive Studio - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-vision-fda-approves-idesign-refractive-studio-quick-facts-1027167394,neutral,0.6914620995521545
6/19/2018 11:09:23 AM,Alliance Pharma To Buy Rights To J&J's Nizoral In APAC For ¬£60 Mln; Stock Up ,RTTNews,/news/stocks/alliance-pharma-to-buy-rights-to-j-j-s-nizoral-in-apac-for-60-mln-stock-up-1027192834,positive,0.5135791897773743
6/19/2018 4:04:00 PM,Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-second-quarter-results-1027202865,neutral,0.9199506044387817
6/28/2018 11:23:31 AM,STADA Buys EMEA Rights To J&J's Medicated Anti-dandruff Shampoo Nizoral ,RTTNews,/news/stocks/stada-buys-emea-rights-to-j-j-s-medicated-anti-dandruff-shampoo-nizoral-1027325596,neutral,0.8361603617668152
7/13/2018 3:19:58 AM,J&J Ordered To Pay $4.69 Bln In Baby Powder Case ,RTTNews,/news/stocks/j-j-ordered-to-pay-4-69-bln-in-baby-powder-case-1027364374,negative,0.9527512788772583
7/13/2018 12:51:07 PM,"10 things you need to know before the opening bell (SPY, SPX, QQQ, DIA, JNJ, T, JPM, WFC, C)",Business Insider,http://www.businessinsider.com/stock-market-news-opening-bell-july-13-2018-2018-7,neutral,0.9483835697174072
7/13/2018 5:01:00 PM,Johnson & Johnson -- Moody's: Talc award against J&J is credit negative,Moodys,/news/bonds/johnson-johnson-moody-s-talc-award-against-j-j-is-credit-negative-1027366484,neutral,0.8539798259735107
7/13/2018 9:33:56 PM,Johnson & Johnson Posting Notable Loss But Well Off Lows ,RTTNews,/news/stocks/johnson-johnson-posting-notable-loss-but-well-off-lows-1027367008,negative,0.7864543199539185
7/16/2018 3:01:24 PM,Here's what to expect from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnsonjohnson-stock-q2-earnings-preview-1027369916,neutral,0.9278756976127625
7/17/2018 12:52:30 PM,Johnson & Johnson Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q2-adjusted-earnings-beat-estimates-1027373268,positive,0.6643651127815247
7/17/2018 12:56:53 PM,Johnson & Johnson Updates FY18 Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-updates-fy18-outlook-quick-facts-1027373283,neutral,0.9300280809402466
7/17/2018 10:49:00 PM,"MedPlast Holdings, Inc. -- Moody's assigns B2 CFR to MedPlast Holdings, Inc.",Moodys,/news/bonds/medplast-holdings-inc-moody-s-assigns-b2-cfr-to-medplast-holdings-inc-1027375790,neutral,0.8620074391365051
9/18/2018 9:23:35 AM,"Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam ",RTTNews,/news/stocks/pharma-companies-avoid-3-8-bln-in-tax-per-year-says-oxfam-1027542053,positive,0.7368786931037903
10/2/2018 6:20:14 AM,Johnson & Johnson Closes Sale Of LifeScan Business To Platinum Equity ,RTTNews,/news/stocks/johnson-johnson-closes-sale-of-lifescan-business-to-platinum-equity-1027581261,neutral,0.9371858239173889
10/4/2018 9:19:00 AM,"Moody's: Biosimilars a growing challenge biotech drugs, with European market developing more quickly than the US",Moodys,/news/bonds/moody-s-biosimilars-a-growing-challenge-biotech-drugs-with-european-market-developing-more-quickly-than-the-us-1027589140,positive,0.8536537885665894
10/4/2018 2:21:26 PM,Arrowhead Enters $3.7 Bln License And Collaboration Deals With Janssen ,RTTNews,/news/stocks/arrowhead-enters-3-7-bln-license-and-collaboration-deals-with-janssen-1027590345,positive,0.8035467863082886
10/15/2018 3:01:24 PM,Here's what to expect from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnsonjohnson-quarter-earnings-preview-q3-1027616785,neutral,0.9278756976127625
10/16/2018 12:46:13 PM,Johnson & Johnson Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q3-adjusted-earnings-beat-estimates-1027620272,positive,0.6677963137626648
10/16/2018 1:08:25 PM,Johnson & Johnson Boosts FY18 Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-boosts-fy18-outlook-quick-facts-1027620458,positive,0.9030036926269531
10/23/2018 9:38:23 AM,Johnson & Johnson To Buy Remaining Stake In Japan's Ci:z In ¬•230 Bln Deal ,RTTNews,/news/stocks/johnson-johnson-to-buy-remaining-stake-in-japan-s-ci-z-in-230-bln-deal-1027642569,neutral,0.9374688267707825
12/13/2018 3:48:06 AM,J&J Reportedly Willing To Pay $400 Million-Plus In Hip-Device Cases ,RTTNews,/news/stocks/j-j-reportedly-willing-to-pay-400-million-plus-in-hip-device-cases-1027804575,positive,0.7556559443473816
12/14/2018 6:24:50 AM,Janssen's Daratumumab SNDA In Japan Triggers $2 Mln Milestone Payment To Genmab ,RTTNews,/news/stocks/janssen-s-daratumumab-snda-in-japan-triggers-2-mln-milestone-payment-to-genmab-1027808788,positive,0.8004550337791443
12/14/2018 5:12:11 PM,Johnson & Johnson tumbles after report says it knew for decades that its baby powder contained asbestos (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-baby-powder-asbestos-sinks-stock-2018-12-1027810884,negative,0.9652000665664673
12/14/2018 6:31:57 PM,J&J Posting Steep Loss On Reported Knowledge Of Asbestos In Baby Powder ,RTTNews,/news/stocks/j-j-posting-steep-loss-on-reported-knowledge-of-asbestos-in-baby-powder-1027811132,negative,0.9719220995903015
12/14/2018 7:00:05 PM,"Almost $40 billion has been erased from Johnson & Johnson's market value, but JPMorgan says the selling is overdone (JNJ)",Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-stock-sell-off-an-overreaction-jpmorgan-2018-12-1027811184,negative,0.9599596261978149
12/14/2018 7:11:05 PM,Johnson & Johnson Down 8% On Report Of Asbestos In Baby Powder ,RTTNews,/news/stocks/johnson-johnson-down-8-on-report-of-asbestos-in-baby-powder-1027811213,negative,0.9697104096412659
12/18/2018 1:30:18 AM,"Johnson & Johnson Authorizes $5 Billion Buyback, Reaffirms FY Guidance ",RTTNews,/news/stocks/johnson-johnson-authorizes-5-billion-buyback-reaffirms-fy-guidance-1027815688,positive,0.7668439745903015
1/11/2019 1:18:23 PM,Johnson & Johnson Issues Update On Offer For Ci:z Holdings - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-issues-update-on-offer-for-ci-z-holdings-quick-facts-1027861865,neutral,0.9423622488975525
1/18/2019 4:01:31 PM,"J&J, Apple To Collaborate In Research Study Involving Apple Watch ",RTTNews,/news/stocks/j-j-apple-to-collaborate-in-research-study-involving-apple-watch-1027879765,positive,0.7520684599876404
1/21/2019 3:01:26 PM,Johnson Johnson earnings preview: what to expect,Markets Insider Automation,/news/stocks/johnsonjohnson-stock-quarter-earnings-preview-q4-1027882798,neutral,0.9182448983192444
1/22/2019 12:44:25 PM,Johnson & Johnson Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q4-adjusted-earnings-beat-estimates-1027885249,positive,0.7201697826385498
1/22/2019 1:40:53 PM,Johnson & Johnson Q4 Results Top Estimates ,RTTNews,/news/stocks/johnson-johnson-q4-results-top-estimates-1027885557,neutral,0.802109956741333
1/22/2019 2:36:04 PM,Johnson & Johnson is sliding after guidance comes up short (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-revenue-profit-earnings-stock-price-2019-1-1027885862,negative,0.9650335311889648
1/23/2019 4:14:01 AM,J&J Reaches $120 Mln Settlement With 46 Attorneys General Over Hip Implants ,RTTNews,/news/stocks/j-j-reaches-120-mln-settlement-with-46-attorneys-general-over-hip-implants-1027887817,negative,0.7279551029205322
2/5/2019 2:30:56 AM,J&J Reportedly Agrees To Resolve Most Pinnacle Hip-Device Lawsuits ,RTTNews,/news/stocks/j-j-reportedly-agrees-to-resolve-most-pinnacle-hip-device-lawsuits-1027922794,positive,0.9198147058486938
2/5/2019 4:52:00 PM,Johnson & Johnson -- Moody's -  Talc-related lawsuits could increase risk to Johnson & Johnson‚Äôs strong credit profile,Moodys,/news/bonds/johnson-johnson-moody-s-talc-related-lawsuits-could-increase-risk-to-johnson-johnson-s-strong-credit-profile-1027926321,negative,0.8645673990249634
2/12/2019 8:51:06 PM,A depression drug that's been called 'the most important discovery in half a century' just got a big step closer to FDA approval (JNJ),Business Insider,https://www.businessinsider.com/new-depression-drug-esketamine-jnj-fda-closer-approval-2019-1,positive,0.8670377731323242
2/13/2019 3:21:04 PM,Johnson & Johnson is buying a Silicon Valley surgical-robotics startup for $3.4 billion (JNJ),Business Insider,https://www.businessinsider.com/johnson-and-johnson-acquires-auris-health-surgical-robots-for-34-billion-2019-2,neutral,0.8551905155181885
2/13/2019 3:26:18 PM,J&J's Ethicon Agrees To Acquire Auris Health For About $3.4 Billion In Cash ,RTTNews,/news/stocks/j-j-s-ethicon-agrees-to-acquire-auris-health-for-about-3-4-billion-in-cash-1027949736,neutral,0.8269580006599426
2/15/2019 10:07:00 PM,Johnson & Johnson International Fin Svc Co -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson,Moodys,/news/bonds/johnson-johnson-international-fin-svc-co-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-johnson-johnson-1027957857,neutral,0.8249446153640747
2/21/2019 2:39:04 PM,Johnson & Johnson was subpoenaed by the DOJ and the SEC over baby powder safety (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-baby-powder-subpoena-doj-sec-queries-stock-falls-2019-2-1027972093,negative,0.9070895314216614
2/27/2019 4:51:26 AM,Biotech Stocks Facing FDA Decision In March ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-march-1027987182,neutral,0.7348430156707764
3/6/2019 2:03:05 AM,"Regulators just approved the first new depression drug since the 1980s, and some see blockbuster potential (JNJ)",Business Insider,https://www.businessinsider.com/esketamine-depression-drug-approved-fda-johnson-johnson-antidepressant-2019-2,positive,0.6488023400306702
3/6/2019 3:01:45 AM,FDA Okays Janssen's Nasal Spray Medication For Treatment-resistant Depression ,RTTNews,/news/stocks/fda-okays-janssen-s-nasal-spray-medication-for-treatment-resistant-depression-1028007062,positive,0.6918241381645203
3/8/2019 6:36:06 PM,"Dispensed: Change at the FDA, insurance startup financials for 2018, and the first new depression drug in 35 years",Business Insider,https://www.businessinsider.com/dispensed-weekly-healthcare-newsletter-march-8-2019-3,neutral,0.7338265180587769
3/14/2019 9:25:14 PM,Johnson & Johnson Ordered To Pay $29 Mln In Latest Talcum Cancer Case ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-29-mln-in-latest-talcum-cancer-case-1028032239,negative,0.9402385354042053
3/22/2019 6:02:00 AM,Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook,Moodys,/news/bonds/alcon-inc-moody-s-assigns-baa2-issuer-rating-to-alcon-stable-outlook-1028050916,positive,0.8087852597236633
3/25/2019 11:44:00 AM,Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook,Moodys,/news/bonds/alcon-inc-moody-s-assigns-baa2-issuer-rating-to-alcon-stable-outlook-1028055051,positive,0.8087852597236633
3/25/2019 7:41:59 PM,"Bayer, Johnson & Johnson To Pay $775 Mln To Settle Xarelto Lawsuits ",RTTNews,/news/stocks/bayer-johnson-johnson-to-pay-775-mln-to-settle-xarelto-lawsuits-1028056729,neutral,0.6797999143600464
4/4/2019 5:16:01 AM,10 Best Selling Drugs Of 2018 ,RTTNews,/news/stocks/10-best-selling-drugs-of-2018-1028084412,neutral,0.7440219521522522
4/15/2019 3:01:27 PM,Johnson Johnson is about to announce earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnsonjohnson-stock-price-q1-earnings-preview-1028110928,neutral,0.9342256188392639
4/16/2019 12:49:25 PM,Johnson & Johnson Q1 adjusted earnings of $2.10 per share,RTTNews,/news/stocks/johnson-johnson-q1-adjusted-earnings-of-2-10-per-share-1028113977,neutral,0.8321962356567383
4/16/2019 3:15:04 PM,Johnson & Johnson's net earnings dropped 14% in the first-quarter (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-q1-earnings-shares-rise-after-earnings-beat-2019-4-1028115029,negative,0.9747445583343506
5/1/2019 8:39:00 PM,Jabil Inc. -- Moody's upgrades Jabil to Baa3; outlook stable,Moodys,/news/bonds/jabil-inc-moody-s-upgrades-jabil-to-baa3-outlook-stable-1028159025,positive,0.936163604259491
5/9/2019 5:06:55 AM,"Takeda To Sell Dry Eye Drug, Surgical Patch To Novartis, J&J For Up To $5.7 Bln ",RTTNews,/news/stocks/takeda-to-sell-dry-eye-drug-surgical-patch-to-novartis-j-j-for-up-to-5-7-bln-1028184178,neutral,0.7471129894256592
5/15/2019 12:58:12 PM,J&J Plans To Execute All Levers Of Capital Allocation Strategy ,RTTNews,/news/stocks/j-j-plans-to-execute-all-levers-of-capital-allocation-strategy-1028202651,neutral,0.7490691542625427
6/3/2019 10:51:00 PM,"Moody's  ‚Äì Ability to absorb opioid-related lawsuits will vary widely among drug makers, distributors",Moodys,/news/bonds/moody-s-ability-to-absorb-opioid-related-lawsuits-will-vary-widely-among-drug-makers-distributors-1028250300,neutral,0.9185123443603516
6/12/2019 8:22:08 PM,Dow Jones Today: Stocks Are Spinning Their Wheels,InvestorPlace,/news/stocks/dow-jones-today-stocks-are-spinning-their-wheels-1028275487,neutral,0.6641082763671875
6/20/2019 6:48:34 PM,5 Boring Stocks to Buy This Summer,InvestorPlace,/news/stocks/5-boring-stocks-to-buy-this-summer-1028296950,neutral,0.8615565299987793
6/24/2019 3:04:56 PM,How Chinese Culture Could Affect the Future of 3M Stock,InvestorPlace,/news/stocks/chinese-culture-future-3m-stock-1028303878,neutral,0.8320540189743042
6/24/2019 10:31:00 PM,LifeScan Global Corporation -- Moody's announces completion of a periodic review of ratings of LifeScan Global Corporation,Moodys,/news/bonds/lifescan-global-corporation-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-lifescan-global-corporation-1028303411,neutral,0.8798283338546753
6/25/2019 4:46:38 PM,3 Healthcare Stocks to Buy With the Market Near All-Time Highs,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-with-the-market-near-all-time-highs-1028307938,positive,0.6229506731033325
6/25/2019 7:51:21 PM,3 Biopharma Stocks to Buy for Income,InvestorPlace,/news/stocks/3-biopharma-stocks-to-buy-for-income-1028307925,neutral,0.9193856716156006
6/27/2019 1:10:05 PM,"Microsoft Stock Is Overvalued, but Still a Solid Long-Term Bet",InvestorPlace,/news/stocks/microsoft-stock-long-term-bet-1028315914,positive,0.9156025052070618
7/10/2019 5:55:21 PM,Is Shopify Stock Getting Ahead of Its Fundamentals?,InvestorPlace,/news/stocks/is-shopify-stock-getting-ahead-of-its-fundamentals-1028344461,neutral,0.5952984094619751
7/12/2019 7:34:31 PM,Johnson & Johnson Baby Powder News: JNJ Stock Drops on Investigation,InvestorPlace,/news/stocks/johnson-johnson-baby-powder-news-jnj-stock-1028350343,negative,0.9527471661567688
7/12/2019 7:39:04 PM,J&J tumbles amid reports the DOJ launched a criminal investigation into whether it lied about its baby powder's cancer risks (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-stock-price-reaction-reported-doj-investigation-baby-powder-2019-7-1028349902,negative,0.9607987403869629
7/12/2019 7:46:29 PM,4 Healthcare Stocks That Are Feeling Sick ¬†,InvestorPlace,/news/stocks/4-healthcare-stocks-that-are-feeling-sick-1028350342,negative,0.7167681455612183
7/12/2019 8:16:12 PM,"4 Top Stock Trades for Monday:JNJ, SQ, ILMN, ACB",InvestorPlace,/news/stocks/4-top-stock-trades-for-mondayjnj-sq-ilmn-acb-1028350340,neutral,0.9313158988952637
7/12/2019 8:31:29 PM,Dow Jones Today: A Fantastic Friday,InvestorPlace,/news/stocks/dow-jones-today-a-fantastic-friday-1028350337,neutral,0.860231876373291
7/13/2019 3:41:26 PM,Johnson & Johnson Stock Sinks As U.S. Probes Baby Powder ,RTTNews,/news/stocks/johnson-johnson-stock-sinks-as-u-s-probes-baby-powder-1028350459,negative,0.9420632719993591
7/15/2019 1:11:14 PM,Johnson & Johnson Stock Facing Negative Catalysts Ahead of Q2 Results,InvestorPlace,/news/stocks/johnson-johnson-stock-facing-negative-catalysts-ahead-of-q2-results-1028354769,negative,0.9701735973358154
7/15/2019 1:24:12 PM,"Monday‚Äôs Vital Data: Johnson & Johnson, Ford and Square",InvestorPlace,/news/stocks/mondays-vital-data-options-trading-johnson-johnson-ford-and-square-1028354768,neutral,0.9225239157676697
7/15/2019 3:01:21 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what to expect,Markets Insider Automation,/news/stocks/johnsonjohnson-q2-earnings-preview-1028352611,neutral,0.9338979721069336
7/15/2019 8:22:50 PM,"Dow Jones Today: China, Earnings Anticipation Stall Stocks on Monday",InvestorPlace,/news/stocks/dow-jones-today-china-earnings-anticipation-stall-stocks-on-monday-1028354735,negative,0.933067798614502
7/16/2019 12:46:35 PM,Johnson & Johnson Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q2-adjusted-earnings-beat-estimates-1028355756,positive,0.6643651127815247
7/16/2019 12:57:32 PM,Johnson & Johnson Boosts FY19 Sales Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-boosts-fy19-sales-outlook-quick-facts-1028355784,positive,0.9110943675041199
7/16/2019 5:17:49 PM,"Johnson & Johnson Earnings: JNJ Stock Dips Despite Q2 Beat, Raised Guidance",InvestorPlace,/news/stocks/johnson-johnson-earnings-beat-estimates-jnj-stock-down-1028358971,negative,0.9404560327529907
7/16/2019 7:18:20 PM,"5 Top Stock Trades for Wednesday: JNJ, WFC, UBER, APRN, ROKU",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-jnj-wfc-uber-aprn-roku-1028358956,neutral,0.928128182888031
7/16/2019 7:35:06 PM,Judge To Weigh $17 Bln Opioid Case Against Johnson & Johnson ,RTTNews,/news/stocks/judge-to-weigh-17-bln-opioid-case-against-johnson-johnson-1028357861,negative,0.6183766722679138
7/16/2019 8:17:35 PM,Dow Jones Today: Earnings Disappointments,InvestorPlace,/news/stocks/dow-jones-today-earnings-disappointments-1028358952,negative,0.9578291177749634
7/17/2019 4:18:52 PM,These 6 SPDR ETFs and Amazon Tell Me the Rally Is Over,InvestorPlace,/news/stocks/these-6-spdr-etfs-and-amazon-tell-me-the-rally-is-over-1028363024,neutral,0.5278092622756958
7/22/2019 6:55:40 PM,5 Dow Jones Stocks to Sell Before the Market Slumps,InvestorPlace,/news/stocks/5-dow-jones-stocks-to-sell-before-the-market-slumps-1028374199,neutral,0.6780312657356262
7/23/2019 3:14:49 PM,Opioid Crisis: Trials As Well As Tribulations ,RTTNews,/news/stocks/opioid-crisis-trials-as-well-as-tribulations-1028376600,neutral,0.8198065161705017
7/24/2019 1:29:03 PM,Johnson & Johnson Could Turn Around After its Strong Earnings,InvestorPlace,/news/stocks/johnson-johnson-could-turn-around-after-strong-earnings-1028383028,positive,0.9476338028907776
7/24/2019 1:51:29 PM,Is Johnson & Johnson Stock Losing Its Shine?,InvestorPlace,/news/stocks/is-johnson-johnson-stock-losing-its-shine-1028383025,negative,0.9468407034873962
7/26/2019 7:55:03 AM,Janssen's Late-stage Study On Relapsing Multiple Sclerosis Meets Primary Goal ,RTTNews,/news/stocks/janssen-s-late-stage-study-on-relapsing-multiple-sclerosis-meets-primary-goal-1028387423,neutral,0.8806391954421997
7/26/2019 1:47:39 PM,Janssen Gets CHMP Positive Opinion For Stelara - Quick Facts ,RTTNews,/news/stocks/janssen-gets-chmp-positive-opinion-for-stelara-quick-facts-1028388259,positive,0.900870144367218
7/29/2019 12:26:47 PM,Why Johnson & Johnson Stock Isn‚Äôt a Buy‚Ä¶ Yet,InvestorPlace,/news/stocks/why-johnson-johnson-stock-isnt-a-buy-yet-1028395885,neutral,0.9194797873497009
7/29/2019 7:52:04 PM,"5 Top Stock Trades for Tuesday: SHOP, NFLX, JNJ",InvestorPlace,/news/stocks/5-top-stock-trades-for-tuesday-shop-nflx-jnj-1028395850,neutral,0.9231194257736206
8/5/2019 8:35:43 PM,Stock Market Today: Time to Hope for ‚ÄòTurnaround Tuesday‚Äô,InvestorPlace,/news/stocks/stock-market-today-time-to-hope-for-turnaround-tuesday-1028419252,positive,0.5932321548461914
8/14/2019 11:10:21 AM,JNJ Stock Is a Way Better Investment Than Bonds or CDs,InvestorPlace,/news/stocks/jnj-stock-is-a-way-better-investment-than-bonds-or-cds-1028447984,positive,0.6679383516311646
8/15/2019 4:05:03 PM,3 Stocks to Buy on Almost Any Dip,InvestorPlace,/news/stocks/3-stocks-to-buy-on-almost-any-dip-1028451497,neutral,0.8289896845817566
8/16/2019 6:35:00 PM,Jabil Inc. -- Moody's assigns Prime-3 short term rating to Jabil's new $1.8 billion commercial paper program,Moodys,/news/bonds/jabil-inc-moody-s-assigns-prime-3-short-term-rating-to-jabil-s-new-1-8-billion-commercial-paper-program-1028453311,neutral,0.7579611539840698
8/20/2019 7:11:01 PM,"3 Healthcare Stocks to Trade: UNH, JNJ and PFE",InvestorPlace,/news/stocks/3-healthcare-stocks-to-trade-unh-jnj-and-pfe-1028461453,neutral,0.9377426505088806
8/21/2019 1:43:28 PM,"Johnson & Johnson Stock Is a Gamble, but an Interesting One",InvestorPlace,/news/stocks/johnson-johnson-stock-is-a-gamble-but-an-interesting-one-1028464947,neutral,0.910966157913208
8/22/2019 8:29:08 PM,"Stock Market Today: Boeing Takes Flight, Manufacturing Slumps",InvestorPlace,/news/stocks/stock-market-today-boeing-takes-flight-manufacturing-slumps-1028468412,negative,0.964020311832428
8/23/2019 6:37:40 PM,Will Lawsuits Sink Johnson & Johnson Stock?,InvestorPlace,/news/stocks/lawsuits-jnj-stock-probably-not-1028470702,negative,0.619310200214386
8/26/2019 12:47:29 PM,Biotech Stocks Facing FDA Decision In September 2019 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-september-2019-1028472695,neutral,0.827918291091919
8/26/2019 8:26:00 PM,Dow Jones Today: The Return of Trade Optimism,InvestorPlace,/news/stocks/the-dow-jones-industrial-surged-monday-amid-nice-trade-chatter-1028475023,neutral,0.8377541303634644
8/26/2019 8:34:50 PM,"Stock Market Today: Biotech in Focus, Trade Talks Steady Stocks",InvestorPlace,/news/stocks/stock-market-today-biotech-in-focus-trade-talks-steady-stocks-1028475022,positive,0.5053701400756836
8/26/2019 11:57:28 PM,Johnson & Johnson Ordered To Pay $572 Million For Oklahoma Opioid Crisis ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-572-million-for-oklahoma-opioid-crisis-1028474595,negative,0.8509125113487244
8/27/2019 1:18:47 PM,J2 Global Unit Acquires BabyCenter From Johnson & Johnson - Quick Facts ,RTTNews,/news/stocks/j2-global-unit-acquires-babycenter-from-johnson-johnson-quick-facts-1028476166,neutral,0.9020527601242065
8/27/2019 3:18:05 PM,J&J was ordered to pay $572 million for helping fuel the opioid epidemic. The company's market cap increased $15 billion in response. (JNJ),Business Insider,https://www.businessinsider.com/johnson-and-johnson-572-million-opioid-crisis-settlement-stock-price-2019-8,positive,0.6815382242202759
8/27/2019 4:40:22 PM,J&J Opioid Ruling 2019: 13 Things to Know,InvestorPlace,/news/stocks/jj-opioid-ruling-2019-13-things-to-know-1028478913,neutral,0.9326829314231873
8/27/2019 5:12:04 PM,The $572 million fine Johnson & Johnson has to pay for its role in the opioid epidemic is only 4% of its annual profit (JNJ),Business Insider,https://www.businessinsider.com/johnson-and-johnson-judgement-small-part-of-2018-profit-2019-8,neutral,0.7802305221557617
8/27/2019 8:12:28 PM,"5 Top Stock Trades for Wednesday: CMG, SBUX, JNJ",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-cmg-sbux-jnj-1028478901,neutral,0.9212616682052612
8/27/2019 8:13:44 PM,"Dow Jones Today: Not Much Activity, But That‚Äôs OK",InvestorPlace,/news/stocks/dow-stocks-were-mostly-sluggish-today-and-thats-alright-1028478900,neutral,0.7978512644767761
8/28/2019 5:26:00 PM,Johnson & Johnson International Fin Svc Co -- Moody's affirms J&J at Aaa; revises outlook to negative,Moodys,/news/bonds/johnson-johnson-international-fin-svc-co-moody-s-affirms-j-j-at-aaa-revises-outlook-to-negative-1028481456,positive,0.4767858684062958
8/30/2019 3:37:52 PM,3 Large-Cap Stocks to Sell in September,InvestorPlace,/news/stocks/3-large-cap-stocks-sell-september-1028488909,neutral,0.9143410325050354
8/30/2019 5:43:28 PM,It‚Äôs Time to Short Johnson & Johnson Stock,InvestorPlace,/news/stocks/its-time-to-short-johnson-johnson-stock-1028488901,neutral,0.8511731028556824
9/4/2019 3:35:01 PM,EU Okays Expanded Use Of Janssen's STELARA ,RTTNews,/news/stocks/eu-okays-expanded-use-of-janssen-s-stelara-1028498117,positive,0.856008768081665
9/5/2019 8:16:39 PM,"Dow Jones Today: Finally, Some Relief on the Trade Front",InvestorPlace,/news/stocks/dow-stocks-were-boosted-by-some-good-news-on-the-trade-front-1028504009,positive,0.700654923915863
9/10/2019 2:55:17 PM,10 Healthcare Stocks to Buy Despite the Headlines,InvestorPlace,/news/stocks/10-healthcare-stocks-to-buy-despite-the-headlines-1028514931,neutral,0.4967133402824402
9/16/2019 9:48:58 AM,OxyContin Maker Purdue Pharma Files For Bankruptcy Protection ,RTTNews,/news/stocks/oxycontin-maker-purdue-pharma-files-for-bankruptcy-protection-1028525612,negative,0.7636474370956421
9/18/2019 10:40:19 AM,"JNJ Stock Is Undervalued, but Not Compelling Given These Headwinds",InvestorPlace,/news/stocks/jnj-stock-undervalued-not-compelling-headwinds-1028536192,positive,0.6562452912330627
9/19/2019 4:10:24 PM,Buy This If You Like Johnson & Johnson Stock But Hate the Lawsuits ¬†,InvestorPlace,/news/stocks/buy-this-if-you-like-johnson-johnson-stock-but-hate-the-lawsuits-1028539745,neutral,0.893789529800415
9/20/2019 12:44:35 PM,There‚Äôs a Lot More Trouble Looming for JNJ Stock Than You Might Think,InvestorPlace,/news/stocks/damage-johnson-and-johnson-1028542274,negative,0.7565025091171265
9/20/2019 3:58:30 PM,3 Dow Stocks That Could Keep Going Lower,InvestorPlace,/news/stocks/3-dow-stocks-that-could-keep-going-lower-mmm-wba-jnj-1028542254,neutral,0.7490242719650269
9/20/2019 7:17:16 PM,Should Johnson & Johnson Investors Worry About Opioid Lawsuits?,InvestorPlace,/news/stocks/should-johnson-johnson-investors-worry-about-opioid-lawsuits-1028542244,neutral,0.5976393818855286
9/23/2019 7:25:20 PM,Long-Term Investors Should Consider Buying SHOP Stock Near $250,InvestorPlace,/news/stocks/long-term-investors-should-consider-buying-shop-stock-near-250-1028546632,neutral,0.8542308211326599
9/24/2019 1:58:02 PM,Why Contrarians May Want to Take a Look at JNJ Stock,InvestorPlace,/news/stocks/why-contrarians-may-want-to-take-a-look-at-jnj-stock-1028550815,neutral,0.9324420094490051
9/24/2019 5:57:56 PM,6 Dow Jones Industrial Average Stocks to Buy Right Now,InvestorPlace,/news/stocks/6-dow-jones-industrial-average-stocks-to-buy-right-now-1028550791,neutral,0.9204747676849365
9/26/2019 2:47:18 PM,Don‚Äôt Ignore the Johnson and Johnson Pharmaceutical Pipeline,InvestorPlace,/news/stocks/johnson-johnson-drug-pipeline-underappreciated-1028558195,neutral,0.8949279189109802
9/27/2019 10:27:19 AM,Should You Buy Johnson & Johnson Stock in October?,InvestorPlace,/news/stocks/should-you-buy-johnson-johnson-stock-in-october-1028560688,neutral,0.9365558624267578
9/27/2019 7:34:40 PM,7 Big Biotech Stocks to Watch,InvestorPlace,/news/stocks/7-big-biotech-stocks-to-watch-1028560645,neutral,0.93013596534729
9/30/2019 5:20:47 PM,Can Johnson and Johnson Stock Overcome Opiod Implications?,InvestorPlace,/news/stocks/can-johnson-and-johnson-stock-overcome-opiod-implications-1028565214,neutral,0.8496935367584229
10/1/2019 11:44:44 AM,Johnson & Johnson Can Overcome Its Legal Issues,InvestorPlace,/news/stocks/legal-issues-problem-johnson-johnson-stock-1028569362,positive,0.8247596621513367
10/1/2019 2:24:43 PM,Negative Press Presents a Buying Opportunity with JNJ Stock,InvestorPlace,/news/stocks/negative-press-opportunity-jnj-stock-1028569347,negative,0.8843151926994324
10/1/2019 5:27:02 PM,Microsoft Stock Is Still a Good Pick for One Type of Investor,InvestorPlace,/news/stocks/valuations-msft-serve-investor-well-1028569331,neutral,0.8058502674102783
10/2/2019 3:21:33 AM,J&J Settles With Two Ohio Counties Ahead Of Upcoming Opioid Trial ,RTTNews,/news/stocks/j-j-settles-with-two-ohio-counties-ahead-of-upcoming-opioid-trial-1028569091,negative,0.5459232926368713
10/2/2019 5:42:04 PM,"Johnson & Johnson climbs after settling two opioid epidemic lawsuits, allowing it to avoid an upcoming federal trial (JNJ)",Business Insider,https://www.businessinsider.com/johnson-and-johnson-stock-price-jumps-on-opioid-lawsuit-settlement-2019-10,positive,0.9377744197845459
10/2/2019 8:11:19 PM,Stock Market Today: October Rolls in With a Bang,InvestorPlace,/news/stocks/stock-market-today-october-rolls-in-with-a-bang-1028572822,positive,0.8455447554588318
10/2/2019 8:12:57 PM,"Dow Jones Today: Houston, We‚Äôve Got a Growth Problem",InvestorPlace,/news/stocks/more-slack-data-points-stung-the-dow-jones-today-1028572821,positive,0.5470170974731445
10/3/2019 12:45:55 PM,3 Reasons Why Johnson and Johnson Stock Will Get Back on Track,InvestorPlace,/news/stocks/3-reasons-johnson-and-johnson-jnj-will-rally-1028575957,neutral,0.8375353217124939
10/3/2019 1:57:00 PM,3 Things Investors Should Know About the Opioid Lawsuits Against Johnson & Johnson,InvestorPlace,/news/stocks/jnj-stock-opioid-lawsuits-1028575952,neutral,0.9274178743362427
10/7/2019 6:51:22 PM,Why Johnson & Johnson Stock Is Not a Screaming Buy,InvestorPlace,/news/stocks/johnson-johnson-jnj-stock-not-screaming-buy-1028581887,neutral,0.9226393103599548
10/9/2019 3:55:12 AM,J&J Ordered To Pay $8 Bln In Case Over Male Breast Growth On Anti-psychotic Drug ,RTTNews,/news/stocks/j-j-ordered-to-pay-8-bln-in-case-over-male-breast-growth-on-anti-psychotic-drug-1028585334,negative,0.960385262966156
10/9/2019 3:57:05 PM,J&J slides after jury orders it to pay $8 billion in male breast-growth case (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/jnj-stock-price-falls-risperdal-male-breast-growth-jury-decision-2019-10-1028587229,negative,0.9606561660766602
10/9/2019 6:22:30 PM,Jury: JNJ Must Pay $8 Billion Over Male Breast Growth Tied to Risperdal Drug,InvestorPlace,/news/stocks/jnj-must-pay-8-billion-in-risperdal-lawsuit-1028588698,neutral,0.5017294883728027
10/9/2019 8:07:10 PM,Stock Market Today: Johnson & Johnson Gets Served Again,InvestorPlace,/news/stocks/stock-market-today-jnj-gets-served-again-1028588690,positive,0.5680555701255798
10/9/2019 9:40:00 PM,Johnson & Johnson -- Moody's: Risperdal verdict adds to J&J's litigation risk,Moodys,/news/bonds/johnson-johnson-moody-s-risperdal-verdict-adds-to-j-j-s-litigation-risk-1028588177,negative,0.9389442801475525
10/11/2019 4:03:26 PM,Johnson & Johnson Stock Has Limited Upside,InvestorPlace,/news/stocks/johnson-and-johnson-stock-mixed-bag-limited-upside-1028594594,negative,0.9101839065551758
10/11/2019 8:17:27 PM,Stock Market Today: Let‚Äôs Make a Deal,InvestorPlace,/news/stocks/stock-market-today-lets-make-a-deal-1028594574,neutral,0.90934818983078
10/14/2019 3:01:15 PM,Here's what to expect from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnsonjohnson-q3-quarterly-earnings-preview-stock-1028596463,neutral,0.9278756976127625
10/14/2019 4:51:27 PM,Should Investors Buy Shopify Stock After Its Recent Decline?,InvestorPlace,/news/stocks/should-investors-buy-shopify-stock-after-its-recent-decline-1028597930,negative,0.6758782863616943
10/14/2019 7:59:43 PM,Johnson and Johnson Stock Still Significantly Undervalued,InvestorPlace,/news/stocks/johnson-stock-significantly-undervalued-1028597917,negative,0.9186542630195618
10/14/2019 8:26:33 PM,Stock Market Today: Stocks Hit Snooze Ahead of Earnings,InvestorPlace,/news/stocks/stock-market-today-stocks-hit-snooze-ahead-of-earnings-1028597915,negative,0.5712859630584717
10/15/2019 6:30:00 AM,Johnson & Johnson to Host Earnings Call,Accesswire,/news/stocks/johnson-johnson-to-host-earnings-call-1028602062,neutral,0.9404258728027344
10/15/2019 7:41:02 AM,"RETA Surges On Trial Data, RVNC On Track, All Eyes On RLMD Today ",RTTNews,/news/stocks/reta-surges-on-trial-data-rvnc-on-track-all-eyes-on-rlmd-today-1028598042,positive,0.5599368810653687
10/15/2019 12:50:05 PM,Johnson & Johnson Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q3-adjusted-earnings-beat-estimates-1028598775,positive,0.6677963137626648
10/15/2019 1:00:00 PM,Johnson & Johnson Boosts FY19 Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-boosts-fy19-outlook-quick-facts-1028598788,positive,0.9181007146835327
10/15/2019 3:53:53 PM,"Johnson & Johnson Stock Has Good Numbers, But Bad Verdicts",InvestorPlace,/news/stocks/johnson-johnson-stock-has-good-numbers-but-bad-verdicts-1028601982,negative,0.9627055525779724
10/15/2019 8:16:30 PM,Stock Market Today: Bring on the Earnings¬†,InvestorPlace,/news/stocks/stock-market-today-bring-on-the-earnings-1028601963,neutral,0.9211692214012146
10/15/2019 8:33:27 PM,Dow Jones Today: Earnings Boosts Across the Board,InvestorPlace,/news/stocks/dow-jones-today-earnings-boosts-across-the-board-1028601962,positive,0.9234065413475037
10/16/2019 4:26:00 AM,Major Drug Distributors In Talks To Settle Opioid Litigation For $18 Bln : WSJ ,RTTNews,/news/stocks/major-drug-distributors-in-talks-to-settle-opioid-litigation-for-18-bln-wsj-1028601751,neutral,0.6609823703765869
10/16/2019 2:16:08 PM,Missouri Appeals Court Reverses $110 Mln Talc Verdict Against J&J ,RTTNews,/news/stocks/missouri-appeals-court-reverses-110-mln-talc-verdict-against-j-j-1028603481,negative,0.9093306660652161
10/18/2019 1:35:01 PM,"J&J Offers $4 Bln, Teva $15 Bln To Settle Opioid Claims Ahead Of Trial ",RTTNews,/news/stocks/j-j-offers-4-bln-teva-15-bln-to-settle-opioid-claims-ahead-of-trial-1028610613,neutral,0.8724139928817749
10/18/2019 2:55:44 PM,Johnson & Johnson Consumer Recalls Single Lot Of Baby Powder In U.S. ,RTTNews,/news/stocks/johnson-johnson-consumer-recalls-single-lot-of-baby-powder-in-u-s-1028610926,negative,0.951125979423523
10/18/2019 3:03:31 PM,Trade Johnson and Johnson Stock to New Highs,InvestorPlace,/news/stocks/trade-johnson-and-johnson-stock-to-new-highs-1028611576,positive,0.7441663146018982
10/18/2019 3:30:03 PM,3 Earnings Reports to Watch Next Week,InvestorPlace,/news/stocks/earnings-reports-to-watch-next-week-earnings-calendar-1028224242,neutral,0.8911256790161133
10/18/2019 3:39:03 PM,Johnson & Johnson recalled a batch of baby powder after a test found asbestos. The company says the product is safe. (JNJ),Business Insider,https://www.businessinsider.com/johnson-and-johnson-jnj-baby-powder-recall-asbestos-in-talc-2019-10,neutral,0.777511715888977
10/18/2019 7:59:28 PM,"5 Top Stock Trades for Monday: BA, MSFT, JNJ, SNAP, AXP",InvestorPlace,/news/stocks/5-top-stock-trades-for-monday-ba-msft-jnj-snap-axp-1028612006,neutral,0.9286305904388428
10/18/2019 8:07:43 PM,Stock Market Today: High-Growth Hiccup Causes Worries,InvestorPlace,/news/stocks/stock-market-today-high-growth-hiccup-causes-worries-1028612005,negative,0.9477108716964722
10/18/2019 8:22:05 PM,"Dow Jones Today: Not Upbeat, But Not Too Downbeat",InvestorPlace,/news/stocks/dow-jones-today-not-upbeat-but-not-too-downbeat-1028612172,neutral,0.46953463554382324
10/21/2019 1:20:59 PM,Case Closed: Johnson and Johnson Stock Is a Short,InvestorPlace,/news/stocks/case-closed-johnson-and-johnson-stock-is-a-short-1028615525,neutral,0.5142791271209717
10/21/2019 1:25:49 PM,"Monday‚Äôs Vital Data: Johnson & Johnson, Coca-Cola and Boeing",InvestorPlace,/news/stocks/mondays-vital-data-johnson-johnson-coca-cola-and-boeing-1028615524,neutral,0.8904938697814941
10/22/2019 11:24:06 AM,"3 Big Stock Charts for Tuesday: Johnson & Johnson, Adobe, and Applied Materials",InvestorPlace,/news/stocks/3-big-stock-charts-tuesday-johnson-johnson-adobe-applied-materials-1028618545,neutral,0.9328401684761047
10/22/2019 12:20:31 PM,Litigation Dip Is a Buying Opportunity for Johnson and Johnson Stock,InvestorPlace,/news/stocks/buy-the-litigation-dip-in-jnj-stock-1028619588,neutral,0.676546573638916
10/22/2019 5:50:49 PM,7 Safe Stocks to Buy and Hold Through 2020,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-and-hold-through-2020-1028620495,neutral,0.9206299781799316
10/22/2019 6:58:47 PM,Splunk Stock Could Hit New 2019 Lows,InvestorPlace,/news/stocks/splunk-stock-could-hit-new-2019-lows-1028620786,negative,0.9572836756706238
10/23/2019 12:04:34 PM,Trade of the Day: Johnson and Johnson Stock‚Äôs Dip Is Signal for the Bulls,InvestorPlace,/news/stocks/trade-of-the-day-johnson-and-johnson-stocks-dip-is-signal-for-the-bulls-1028622955,negative,0.8398705124855042
10/23/2019 6:24:39 PM,2 Sells and 1 Buy in Opioid Stocks,InvestorPlace,/news/stocks/2-sells-and-1-buy-in-opioid-stocks-1028624856,neutral,0.866977870464325
10/24/2019 8:00:00 PM,Johnson & Johnson -- Moody's: J&J's proposed opioid agreement credit negative,Moodys,/news/bonds/johnson-johnson-moody-s-j-j-s-proposed-opioid-agreement-credit-negative-1028629001,neutral,0.8436589241027832
10/25/2019 11:10:52 AM,Investors Should Short JNJ Stock and Buy Boeing Stock,InvestorPlace,/news/stocks/investors-should-short-jnj-stock-buy-boeing-stock-1028631236,neutral,0.9138069748878479
10/28/2019 6:00:19 PM,Can Johnson and Johnson Survive this Latest Controversy?,InvestorPlace,/news/stocks/can-johnson-and-johnson-survive-this-latest-controversy-1028636605,neutral,0.8497632741928101
10/29/2019 5:28:44 PM,7 Dividend Stocks That Could Struggle to Continue Payout Hikes,InvestorPlace,/news/stocks/7-dividend-stocks-payout-hikes-1028641102,negative,0.895197331905365
10/29/2019 8:31:06 PM,Dow Jones Today: Struggling at the Highs,InvestorPlace,/news/stocks/merck-and-pfizer-boosted-the-dow-jones-today-thanks-to-upped-guidance-1028641490,negative,0.9591389298439026
10/30/2019 2:56:02 PM,Johnson & Johnson Says New Tests Found No Asbestos In Baby Powder ,RTTNews,/news/stocks/johnson-johnson-says-new-tests-found-no-asbestos-in-baby-powder-1028644202,neutral,0.769643247127533
10/30/2019 7:45:08 PM,"4 Top Stock Trades for Thursday: FB, JNJ, EA,¬†AMD",InvestorPlace,/news/stocks/4-top-stock-trades-for-thursday-fb-jnj-ea-amd-1028645841,neutral,0.9283625483512878
10/30/2019 8:21:32 PM,Stock Market Today: Fed Cuts Rates as Stocks Hit Record Highs,InvestorPlace,/news/stocks/stock-market-today-fed-cuts-rates-as-stocks-hit-record-highs-1028645840,negative,0.9478957056999207
10/30/2019 8:24:41 PM,Dow Jones Today: Another Tepid Reaction to a Fed Rate Cut,InvestorPlace,/news/stocks/the-fed-provided-a-modest-assist-to-the-dow-jones-today-1028645839,negative,0.8353987336158752
10/31/2019 10:12:04 PM,Ethicon Recalls ECHELON FLEX ENDOPATH Staplers ,RTTNews,/news/stocks/ethicon-recalls-echelon-flex-endopath-staplers-1028650012,neutral,0.9224827289581299
11/5/2019 5:56:46 PM,Consider Purchasing Microsoft Stock While It Is Still a Buy,InvestorPlace,/news/stocks/consider-purchasing-microsoft-stock-buy-1028661616,neutral,0.9336426854133606
11/12/2019 4:56:00 PM,Jabil Inc. -- Moody's announces completion of a periodic review of ratings of Jabil Inc.,Moodys,/news/bonds/jabil-inc-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-jabil-inc-1028681878,neutral,0.8464629650115967
11/13/2019 3:35:57 PM,Should Investors Buy Pfizer Stock Before Next Year‚Äôs Huge Shake Up?,InvestorPlace,/news/stocks/should-investors-buy-pfizer-stock-before-next-years-huge-shake-up-1028686378,neutral,0.9238095283508301
11/13/2019 7:34:42 PM,Should Investors Add Johnson & Johnson Stock to Their Shopping Lists?,InvestorPlace,/news/stocks/should-investors-add-johnson-johnson-stock-to-their-shopping-lists-1028686949,neutral,0.9315012097358704
11/18/2019 4:39:09 PM,9 Tantalizing Dividend Stocks for 2020,InvestorPlace,/news/stocks/9-tantalizing-dividend-stocks-for-2020-1028697526,neutral,0.8452246785163879
11/19/2019 3:04:26 PM,"Rebounding Teva Stock Could Climb Higher, But Risks Remain",InvestorPlace,/news/stocks/rebounding-teva-stock-climb-higher-but-risks-remain-1028700876,positive,0.9010089039802551
11/19/2019 3:24:11 PM,Reduced Opioid Payout Is No Reason to Buy Johnson and Johnson Stock,InvestorPlace,/news/stocks/payout-buy-johnson-and-johnson-stock-1028701422,neutral,0.7671211361885071
11/20/2019 9:22:07 PM,Stock Market Today: Is It Time to Get Worried?¬†,InvestorPlace,/news/stocks/stock-market-today-is-it-time-to-get-worried-1028706167,neutral,0.6108418107032776
11/20/2019 9:32:09 PM,Dow Jones Today: Investors Desperate for a Trade Deal,InvestorPlace,/news/stocks/dow-jones-today-investors-desperate-for-a-trade-deal-1028706165,neutral,0.7805258631706238
11/21/2019 4:31:08 PM,J&J Subsidiary Ethicon Loses Class Action Suit In Australia ,RTTNews,/news/stocks/j-j-subsidiary-ethicon-loses-class-action-suit-in-australia-1028708636,negative,0.9066476821899414
11/22/2019 9:31:54 PM,"Dow Jones Today: Trade Progress Pushes Stocks, Healthcare Helps Dow",InvestorPlace,/news/stocks/dow-jones-today-trade-progress-pushes-stocks-healthcare-helps-dow-1028712595,positive,0.9252077341079712
11/26/2019 3:44:36 PM,7 Unsteady Stocks Investors Should Consider Selling Before 2020,InvestorPlace,/news/stocks/7-stocks-to-sell-investors-selling-2020-1028719195,neutral,0.8592532873153687
12/4/2019 9:36:35 PM,Dow Jones Today: A Trade Redemption Story,InvestorPlace,/news/stocks/dow-jones-today-a-trade-redemption-story-1028738868,neutral,0.9136745929718018
12/5/2019 9:29:26 PM,Dow Jones Today: Trade Influenced Stocks More Than Impeachment News,InvestorPlace,/news/stocks/dow-jones-today-trade-influenced-stocks-more-than-impeachment-news-1028742731,neutral,0.7652247548103333
12/6/2019 2:06:42 PM,10 Stocks That Should Be Every Young Investor‚Äôs First Choice,InvestorPlace,/news/stocks/10-stocks-that-should-be-every-young-investors-first-choice-1028326562,neutral,0.9038464426994324
12/9/2019 3:55:21 AM,Janssen To Buy Investigational Bermekimab From XBiotech ,RTTNews,/news/stocks/janssen-to-buy-investigational-bermekimab-from-xbiotech-1028745938,neutral,0.8363292217254639
12/12/2019 1:09:45 PM,9 Best Dividend Stocks to Buy for Every Investor,InvestorPlace,/news/stocks/best-dividend-stocks-buy-every-investment-strategy-1028237147,neutral,0.8878699541091919
12/17/2019 9:25:49 PM,Stock Market Today: Roku‚Äôs CFO Stepping Down; Buy Microsoft?,InvestorPlace,/news/stocks/stock-market-today-roku-cfo-buy-microsoft-stock-1028770587,neutral,0.6185457706451416
12/17/2019 9:32:10 PM,Dow Jones Today: Stocks Continue Building Momentum,InvestorPlace,/news/stocks/dow-jones-today-stocks-continue-building-momentum-1028770586,positive,0.9442622065544128
12/19/2019 7:03:33 PM,Why Microsoft Stock Might Take a Pause in 2020,InvestorPlace,/news/stocks/why-microsoft-stock-might-take-a-pause-in-2020-1028777014,neutral,0.9024617075920105
12/19/2019 9:23:44 PM,Dow Jones Today: The Great Melt Up Continues,InvestorPlace,/news/stocks/stocks-advanced-again-as-some-surprises-lifted-the-dow-jones-today-1028777572,negative,0.8627320528030396
12/20/2019 12:58:16 PM,Johnson & Johnson To Acquire Remaining Stake In Verb Surgical - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-to-acquire-remaining-stake-in-verb-surgical-quick-facts-1028778683,neutral,0.9402570128440857
12/20/2019 4:09:49 PM,7 Best Vanguard ETFs for 2020,InvestorPlace,/news/stocks/7-best-vanguard-etfs-2020-1028779761,neutral,0.777714192867279
12/20/2019 6:50:00 PM,"LifeScan Global Corporation -- Moody's revises LifeScan's outlook to negative, affirms B2 CFR",Moodys,/news/bonds/lifescan-global-corporation-moody-s-revises-lifescan-s-outlook-to-negative-affirms-b2-cfr-1028779871,negative,0.5515670776367188
12/23/2019 11:40:50 AM,"After Moving Higher, Apple May Stop Bearing Fruit While It Corrects",InvestorPlace,/news/stocks/moving-higher-apple-stock-corrects-1028782105,neutral,0.5009092688560486
12/26/2019 10:01:54 AM,Embattled TEVA Has Made Headlines for All of the Wrong Reasons,InvestorPlace,/news/stocks/embattled-teva-has-made-headlines-for-all-of-the-wrong-reasons-1028785016,negative,0.8971841335296631
1/3/2020 12:40:18 PM,Stay on the Sidelines as the Future Looks Potentially Bleak for Teva Stock,InvestorPlace,/news/stocks/future-looks-bleak-teva-stock-1028793227,negative,0.619173526763916
1/3/2020 6:38:44 PM,"After Lackluster 2019, Pfizer Stock Could Rebound in 2020",InvestorPlace,/news/stocks/after-lackluster-2019-pfizer-stock-could-rebound-in-2020-1028793896,positive,0.95452880859375
1/6/2020 5:18:24 PM,7 Investing Resolutions to Follow in 2020,InvestorPlace,/news/stocks/7-investing-resolutions-to-follow-in-2020-1028797249,neutral,0.9337491393089294
1/6/2020 7:03:48 PM,A 2019 Review of Dow Jones Stocks (And What 2020 May Bring),InvestorPlace,/news/stocks/a-2019-review-of-dow-jones-stocks-and-what-2020-may-bring-1028797244,neutral,0.9407529830932617
1/7/2020 4:27:34 PM,Ignore the Analysts: Johnson & Johnson Faces Serious Legal Liability,InvestorPlace,/news/stocks/johnson-johnson-stock-serious-legal-liability-1028800497,negative,0.9379374980926514
1/7/2020 9:35:58 PM,Dow Jones Today: Middle East Focus Factors Into The Equation Again,InvestorPlace,/news/stocks/boeing-supported-the-dow-jones-today-as-a-most-of-the-index-dropped-1028801231,neutral,0.9064909219741821
1/8/2020 2:47:00 PM,The Diagnosis for Teva Stock Still Looks Grim,InvestorPlace,/news/stocks/the-diagnosis-for-teva-stock-still-looks-grim-1028803509,neutral,0.47886982560157776
1/8/2020 5:33:00 PM,"Jabil Inc. -- Moody's rates Jabil's new notes Baa3, outlook stable",Moodys,/news/bonds/jabil-inc-moody-s-rates-jabil-s-new-notes-baa3-outlook-stable-1028803822,neutral,0.877144455909729
1/8/2020 6:03:01 PM,Scandal-Ridden Teva Pharmaceutical Is Fishing for a Bottom,InvestorPlace,/news/stocks/scandals-opioid-teva-stock-fishing-bottom-1028804210,neutral,0.578175961971283
1/10/2020 4:51:43 PM,3 Biotech Stocks to Bank on for Buyouts in 2020,InvestorPlace,/news/stocks/3-biotech-stocks-buyouts-2020-1028809868,neutral,0.8042187690734863
1/10/2020 5:08:08 PM,7 Healthcare Stocks to Buy or Sell As Pricing Pressures Mount,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-or-sell-as-pricing-pressures-mount-1028809866,negative,0.7713853120803833
1/10/2020 5:18:36 PM,Should Investors Buy Johnson & Johnson Stock Prior to Earnings?,InvestorPlace,/news/stocks/should-investors-buy-johnson-johnson-stock-prior-to-earnings-1028810096,neutral,0.9430213570594788
1/13/2020 9:21:57 PM,Dow Jones Today: Tech Lifts Stocks as Trade Deal Signing Nears,InvestorPlace,/news/stocks/dow-jones-today-tech-lifts-stocks-as-trade-deal-signing-nears-1028814122,positive,0.8567448258399963
1/14/2020 7:02:00 PM,Johnson & Johnson -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson,Moodys,/news/bonds/johnson-johnson-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-johnson-johnson-1028817171,neutral,0.8684382438659668
1/15/2020 4:37:07 PM,Pfizer Stock Offers Good Value to Patient Investors,InvestorPlace,/news/stocks/pfizer-stock-offers-good-value-investors-1028820483,positive,0.7911888957023621
1/21/2020 9:24:41 PM,Dow Jones Today: China Virus Provides an Excuse for Sellers to Sell,InvestorPlace,/news/stocks/dow-jones-today-china-virus-provides-an-excuse-for-sellers-to-sell-1028834066,neutral,0.6959265470504761
1/22/2020 12:35:41 PM,Johnson & Johnson Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q4-adjusted-earnings-beat-estimates-1028835192,positive,0.7201697826385498
1/22/2020 1:32:43 PM,Johnson & Johnson Q4 Profit Beats Estimates; Adj. Operational Sales Up 3.4% ,RTTNews,/news/stocks/johnson-johnson-q4-profit-beats-estimates-adj-operational-sales-up-3-4-1028835473,positive,0.9367613792419434
1/22/2020 5:20:08 PM,Johnson & Johnson Stock Will Continue To Rally Into 2020,InvestorPlace,/news/stocks/jnj-stock-will-continue-to-rally-into-2020-1028837164,positive,0.9441300630569458
1/22/2020 8:16:02 PM,Johnson & Johnson Earnings: JNJ Stock Ticks Lower on Q4 Results,InvestorPlace,/news/stocks/johnson-johnson-earnings-drop-jnj-stock-1028837410,negative,0.9628430008888245
1/22/2020 9:16:11 PM,Stock Market Today: Apple‚Äôs New iPhone; Tesla at $100 Billion,InvestorPlace,/news/stocks/stock-market-today-apples-new-iphone-tesla-at-100-billion-1028837680,neutral,0.876200795173645
1/22/2020 9:16:44 PM,Dow Jones Today: Stocks Still Rise Despite Mixed Bag With Earnings,InvestorPlace,/news/stocks/dow-jones-today-stocks-still-rise-despite-mixed-bag-with-earnings-1028837679,positive,0.9261823892593384
1/27/2020 9:26:45 PM,Stock Market Today: Beyond Meat Grows Partnerships; Coronavirus Cure?,InvestorPlace,/news/stocks/stock-market-today-beyond-meat-grows-partnerships-coronavirus-cure-1028848288,neutral,0.8881843686103821
1/27/2020 9:29:18 PM,"Dow Jones Today: Virus Spreads, Impeachment Proceedings Infect Stocks",InvestorPlace,/news/stocks/defensives-lead-the-dow-jones-today-but-not-much-else-worked-1028848287,negative,0.9115419387817383
1/28/2020 5:42:09 PM,J&J CEO Alex Gorsky testifies that he trusted internal experts as the company remains embroiled in legal disputes over baby powder (JNJ),Business Insider,https://www.businessinsider.com/jj-ceo-alex-gorsky-baby-powder-claims-trusted-internal-experts-2020-1,negative,0.49435073137283325
1/29/2020 1:27:00 PM,Did Investors Miss Their Chance with Shopify Stock?,InvestorPlace,/news/stocks/did-investors-miss-chance-shopify-stock-1028855888,negative,0.7138838768005371
1/30/2020 4:40:54 PM,How Disease Outbreaks Affect Stock Prices,InvestorPlace,/news/stocks/how-disease-outbreaks-affect-stock-prices-1028860905,neutral,0.9026890397071838
1/31/2020 3:57:33 AM,Johnson & Johnson Ordered To Pay $344 Mln In California Pelvic Mesh Case ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-344-mln-in-california-pelvic-mesh-case-1028861914,negative,0.9497367739677429
2/4/2020 12:30:56 PM,Johnson & Johnson Stock Looks Like a Safe Place to Hide Out,InvestorPlace,/news/stocks/jnj-stock-looks-safe-place-hide-1028871756,neutral,0.8869535326957703
2/5/2020 4:43:16 PM,Coronavirus cases remain modest in U.S.,Seeking Alpha,https://seekingalpha.com/news/3538634-coronavirus-cases-remain-modest-in-u-s?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.44815027713775635
2/6/2020 1:13:09 PM,Why Johnson & Johnson Is Deceptively Boring,InvestorPlace,/news/stocks/why-jnj-stock-is-deceptively-boring-1028881947,neutral,0.7666885256767273
2/6/2020 10:59:27 PM,Johnson & Johnson told to pay $750M in New Jersey talc case,Seeking Alpha,https://seekingalpha.com/news/3539564-johnson-johnson-told-to-pay-750m-in-new-jersey-talc-case?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8817005157470703
2/7/2020 1:19:14 PM,Can JNJ Stock Keep on Its Current Growth Track?,InvestorPlace,/news/stocks/can-jnj-stock-keep-growing-1028885182,neutral,0.6111001968383789
2/7/2020 2:47:42 PM,Key events next week - healthcare,Seeking Alpha,https://seekingalpha.com/news/3539712-key-events-next-week-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9446426630020142
2/7/2020 4:30:20 PM,Coronavirus cases inch up in U.S. but still very light,Seeking Alpha,https://seekingalpha.com/news/3539753-coronavirus-cases-inch-up-in-u-s-still-light?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7748233675956726
2/7/2020 6:53:04 PM,Johnson & Johnson Ordered To Pay $750 Mln In New Jersey Baby Powder Case ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-750-mln-in-new-jersey-baby-powder-case-1028885636,negative,0.9327622652053833
2/7/2020 7:09:24 PM,With Alibaba Stock the Waiting Is the Hardest Part,InvestorPlace,/news/stocks/with-alibaba-stock-the-waiting-is-the-hardest-part-1028885754,neutral,0.8417931199073792
2/10/2020 8:35:52 PM,"Coronavirus outbreak continues to spread, still largely restricted to Hubei province",Seeking Alpha,https://seekingalpha.com/news/3540190-coronavirus-outbreak-continues-to-spread-still-largely-restricted-to-hubei-province?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.42718005180358887
2/11/2020 3:59:54 PM,7 Low-Volatility Stocks to Buy In Jittery Times,InvestorPlace,/news/stocks/7-low-volatility-stocks-to-buy-in-jittery-times-1028894771,neutral,0.7698942422866821
2/13/2020 10:01:01 AM,Is the Bad News Already Baked into Boeing Stock? Maybe,InvestorPlace,/news/stocks/boeing-stock-appears-to-be-on-the-mend-and-may-be-a-tepid-buy-here-1028902147,neutral,0.568627119064331
2/13/2020 7:25:33 PM,3 Dow Jones Industrial Average Stocks to Sell,InvestorPlace,/news/stocks/3-dow-jones-industrial-average-stocks-to-sell-1028904779,neutral,0.9174600839614868
2/13/2020 9:23:53 PM,Dow Jones Today: Coronavirus Controversy Reemerges,InvestorPlace,/news/stocks/dow-jones-today-coronavirus-controversy-reemerges-1028905225,negative,0.5799030661582947
2/14/2020 12:14:37 PM,J&J's Stelara shows positive action in late-stage Crohn's study,Seeking Alpha,https://seekingalpha.com/news/3542140-j-and-js-stelara-shows-positive-action-in-late-stage-crohns-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9358772039413452
2/14/2020 9:20:40 PM,Dow Jones Today: A Day for Safe Havens,InvestorPlace,/news/stocks/dow-jones-today-a-day-for-safe-havens-1028908217,neutral,0.8009316921234131
2/18/2020 12:57:08 PM,Opioid-related payouts to less than expected - NYT,Seeking Alpha,https://seekingalpha.com/news/3542632-opioid-related-payouts-to-less-expected-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9246280193328857
2/19/2020 4:55:25 PM,Molecular Templates up 8% on ETB advancement,Seeking Alpha,https://seekingalpha.com/news/3543320-molecular-templates-up-8-on-etb-advancement?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9509281516075134
2/21/2020 2:32:53 PM,Dems attack Trump over stalled efforts to lower drug prices,Seeking Alpha,https://seekingalpha.com/news/3544481-dems-attack-trump-over-stalled-efforts-to-lower-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9021158814430237
2/24/2020 4:18:27 PM,3 Healthcare Stocks to Buy This Year,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-this-year-1028932507,neutral,0.834185779094696
2/27/2020 2:36:23 PM,Fighting The Deadly Coronavirus ,RTTNews,/news/stocks/fighting-the-deadly-coronavirus-1028945765,neutral,0.888126015663147
3/2/2020 4:32:41 PM,J&J gene therapy nabs accelerated review status in Europe for vision loss disorder,Seeking Alpha,https://seekingalpha.com/news/3547547-j-and-j-gene-therapy-nabs-accelerated-review-status-in-europe-for-vision-loss-disorder?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6769646406173706
3/2/2020 5:51:53 PM,FDA OKs Sanofi drug for previously treated multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3547590-fda-oks-sanofi-drug-for-previously-treated-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5526725053787231
3/3/2020 12:01:05 AM,"J&J should separate CEO and chairman roles, shareholder says",Seeking Alpha,https://seekingalpha.com/news/3547836-j-and-j-should-separate-ceo-and-chairman-roles-shareholder-says?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9245536923408508
3/3/2020 6:42:24 PM,"Coronavirus plays - vaccines, drugs & infection control products",Seeking Alpha,https://seekingalpha.com/news/3548189-coronavirus-plays-vaccines-drugs-infection-control-products?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9463247656822205
3/3/2020 9:31:46 PM,Dow Jones Today: Misery Returns as Fed Cuts Fail to Save the Day,InvestorPlace,/news/stocks/dow-jones-today-misery-returns-as-fed-cuts-fail-to-save-the-day-1028961702,negative,0.944536566734314
3/4/2020 1:50:04 PM,5 ETFs That Will Help Lower Your Taxes,InvestorPlace,/news/stocks/5-etfs-that-will-help-lower-your-taxes-1028628623,neutral,0.7150943279266357
3/4/2020 4:22:38 PM,8 Stocks to Buy in March for a Coronavirus Rebound,InvestorPlace,/news/stocks/8-stocks-to-buy-in-march-for-a-coronavirus-rebound-1028965222,neutral,0.6642287969589233
3/4/2020 9:15:44 PM,"Dow Jones Today: Primary Results, Stimulus Speculation Prove Potent",InvestorPlace,/news/stocks/dow-jones-today-primary-results-stimulus-speculation-prove-potent-1028966188,positive,0.5126903057098389
3/5/2020 12:37:07 PM,New sell-side coverage - healthcare,Seeking Alpha,https://seekingalpha.com/news/3548949-new-sell-side-coverage-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8478834629058838
3/9/2020 2:43:27 PM,ViiV Healthcare reports positive data on less-frequent dosing of HIV regimen,Seeking Alpha,https://seekingalpha.com/news/3549766-viiv-healthcare-reports-positive-data-on-less-frequent-dosing-of-hiv-regimen?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9549173712730408
3/9/2020 8:31:49 PM,Biotech Stocks: Coronavirus Response Shows How Far We‚Äôve Come ‚Ä¶,InvestorPlace,/news/stocks/biotech-stocks-coronavirus-response-how-far-we-have-come-1028978308,positive,0.5701414942741394
3/10/2020 2:29:46 PM,Its Powerful Pipeline Shows Pfizer Stock Is Undervalued by 15%,InvestorPlace,/news/stocks/pfe-stock-is-undervalued-by-at-least-15-1028981675,positive,0.8663237690925598
3/10/2020 3:30:36 PM,9 Recession-Proof Stocks to Disinfect the Coronavirus,InvestorPlace,/news/stocks/9-recession-proof-stocks-to-disinfect-the-coronavirus-1028982558,neutral,0.7820132970809937
3/11/2020 4:06:44 PM,MMM Is a Free Cash Flow Giant Poised to Do Well This Year,InvestorPlace,/news/stocks/mmm-stock-free-cash-flow-giant-1028986979,positive,0.943481981754303
3/12/2020 12:07:00 PM,"Moody's ‚Äì More opioid settlements likely in 2020, with mainly negative credit impact for defendants",Moodys,/news/bonds/moody-s-more-opioid-settlements-likely-in-2020-with-mainly-negative-credit-impact-for-defendants-1028989071,negative,0.8975091576576233
3/12/2020 3:27:26 PM,3 Stocks to Buy That Will Dodge Any Volatile Market,InvestorPlace,/news/stocks/3-stocks-to-buy-that-will-dodge-any-volatile-market-1028990968,neutral,0.7573485374450684
3/13/2020 2:00:29 PM,J&J launches COVID-19 vaccine program,Seeking Alpha,https://seekingalpha.com/news/3551589-j-and-j-launches-covidminus-19-vaccine-program?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7495694756507874
3/13/2020 3:00:51 PM,J&J Collaborates With BIDMC To Accelerate COVID-19 Vaccine Development ,RTTNews,/news/stocks/j-j-collaborates-with-bidmc-to-accelerate-covid-19-vaccine-development-1028994178,positive,0.8792005181312561
3/13/2020 5:57:01 PM,There‚Äôs Still Time To Buy the Dip in Shopify Stock,InvestorPlace,/news/stocks/theres-still-time-to-buy-the-dip-in-shopify-stock-1028995279,neutral,0.7664797902107239
3/16/2020 11:14:02 AM,U.S. stocks set to gap down at open,Seeking Alpha,https://seekingalpha.com/news/3551922-u-s-stocks-set-to-gap-down-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9542070627212524
3/16/2020 2:58:00 PM,Darunavir unlikely to be effective against COVID-19 - J&J,Seeking Alpha,https://seekingalpha.com/news/3552069-darunavir-unlikely-to-be-effective-against-covidminus-19-j-and-j?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8082852959632874
3/16/2020 3:17:06 PM,10 Do‚Äôs and Don‚Äôts for Avoiding the Coronavirus,InvestorPlace,/news/stocks/10-dos-and-donts-for-avoiding-the-coronavirus-1029000781,neutral,0.7038609981536865
3/16/2020 4:02:41 PM,7 Dividend Stocks to Watch for Stable Income,InvestorPlace,/news/stocks/7-dividend-stocks-to-watch-for-stable-income-1029000778,neutral,0.8340675234794617
3/17/2020 11:34:20 AM,"3 Big Stock Charts for Tuesday: Johnson & Johnson, J.M. Smucker, and Zscaler",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-johnson-johnson-j-m-smucker-and-zscaler-1029004002,neutral,0.9265962243080139
3/17/2020 1:22:25 PM,Use Johnson & Johnson for Quick Income,InvestorPlace,/news/stocks/use-johnson-johnson-for-quick-income-1029004683,neutral,0.9382829666137695
3/17/2020 4:34:34 PM,J&J Says No Proof To Support Use Of Darunavir For COVID-19 ,RTTNews,/news/stocks/j-j-says-no-proof-to-support-use-of-darunavir-for-covid-19-1029004811,neutral,0.8870718479156494
3/19/2020 6:16:38 AM,"FDA Says No To Epilepsy Drug, IMV Advances COVID-19 Vaccine, ISEE Delays Study ",RTTNews,/news/stocks/fda-says-no-to-epilepsy-drug-imv-advances-covid-19-vaccine-isee-delays-study-1029011073,neutral,0.4814072549343109
3/19/2020 5:00:38 PM,Profit-taking pressures Moderna after Hahn comments on vaccine timeline,Seeking Alpha,https://seekingalpha.com/news/3553448-profit-taking-pressures-moderna-after-hahn-comments-on-vaccine-timeline?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9628137350082397
3/20/2020 11:40:07 AM,"TSLA Stock Didn‚Äôt Catch an Unlucky Break, Its Luck Just Ran Out",InvestorPlace,/news/stocks/tsla-stock-luck-ran-out-1029017044,neutral,0.7425306439399719
3/20/2020 3:23:46 PM,Key events next week - healthcare,Seeking Alpha,https://seekingalpha.com/news/3553839-key-events-next-week-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9446426630020142
3/23/2020 5:14:44 PM,Why Shopify Stock Is a Buy on This Pullback,InvestorPlace,/news/stocks/why-shopify-stock-is-a-buy-on-this-pullback-1029024220,neutral,0.8993768095970154
3/24/2020 12:58:32 PM,J&J finance chief warns on reliability of guidance amid Covid-19 outbreak,Seeking Alpha,https://seekingalpha.com/news/3554647-j-and-j-finance-chief-warns-on-reliability-of-guidance-amid-covidminus-19-outbreak?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9380119442939758
3/27/2020 2:19:32 PM,CHMP thumbs up for label extensions in Europe,Seeking Alpha,https://seekingalpha.com/news/3555893-chmp-thumbs-up-for-label-extensions-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7633073925971985
3/30/2020 11:31:28 AM,J&J picks lead Covid-19 vaccine candidate; shares up 4% premarket,Seeking Alpha,https://seekingalpha.com/news/3556197-j-and-j-picks-lead-covidminus-19-vaccine-candidate-shares-up-4-premarket?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8969966769218445
3/30/2020 1:58:25 PM,Johnson & Johnson Identifies Lead COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/johnson-johnson-identifies-lead-covid-19-vaccine-candidate-1029044192,neutral,0.5822137594223022
3/30/2020 3:15:04 PM,"J&J just sped up the timeline for its coronavirus vaccine, and said it could be ready for emergency use early next year (JNJ)",Business Insider,https://www.businessinsider.com/jj-coronavirus-vaccine-research-timeline-and-emergency-use-2020-3,neutral,0.7420625686645508
3/30/2020 3:38:45 PM,7 Stocks to Buy for a Dovish Federal Reserve,InvestorPlace,/news/stocks/7-stocks-to-buy-dovish-federal-reserve-1029045589,neutral,0.6505237817764282
3/30/2020 7:03:03 PM,Johnson & Johnson News: JNJ Stock Jumps 8% on Coronavirus Vaccine Hopes,InvestorPlace,/news/stocks/johnson-johnson-news-coronavirus-vaccine-jnj-stock-up-1029046271,positive,0.9072996973991394
3/30/2020 8:00:15 PM,Johnson & Johnson surges 9% after saying its coronavirus vaccine will begin human testing by September (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnsonjohnson-stock-price-gains-coronavirus-vaccine-timeline-human-testing-september-2020-3-1029045913,positive,0.9268049597740173
3/30/2020 8:16:47 PM,Stock Market Today: Healthcare Stocks Leads the Way; Buy Zoom?,InvestorPlace,/news/stocks/stock-market-today-healthcare-stocks-leads-the-way-buy-zoom-1029046564,neutral,0.8414233326911926
3/30/2020 8:42:07 PM,"Dow Jones Today: Healthcare Help, Hopes Worst May be Over Lift Stocks",InvestorPlace,/news/stocks/dow-jones-today-healthcare-help-hopes-worst-may-be-over-lift-stocks-1029046563,negative,0.4387768507003784
3/31/2020 6:03:52 AM,"AMRN Loses Legal Fight, AKRO Awaits Big Day, JNJ's Covid-19 Vaccine Study In Sep ",RTTNews,/news/stocks/amrn-loses-legal-fight-akro-awaits-big-day-jnj-s-covid-19-vaccine-study-in-sep-1029046989,neutral,0.7181839346885681
3/31/2020 11:32:18 AM,"3 Big Stock Charts for Tuesday: Abbott Laboratories, Johnson & Johnson, and Regeneron Pharmaceuticals",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-abbott-laboratories-johnson-johnson-and-regeneron-pharmaceuticals-1029048681,neutral,0.9266859889030457
3/31/2020 7:33:07 PM,'Like warp speed': J&J's top scientist told us how the pharma giant plans to rapidly test a potential coronavirus vaccine and pump out 1 billion doses (JNJ),Premium,/news/stocks/jj-coronavirus-vaccine-interview-timetable-testing-manufacturing-2020-3,neutral,0.5138798952102661
4/1/2020 11:50:43 AM,7 Biotech Stocks to Buy That Could Beat the Coronavirus,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-that-could-beat-the-coronavirus-1028882437,positive,0.6657763719558716
4/1/2020 2:24:14 PM,Any COVID-19 Vaccine Upside Already Is Built Into MRNA Stock,InvestorPlace,/news/stocks/covid-19-upside-built-into-mrna-stock-1029055594,neutral,0.9224926233291626
4/1/2020 3:04:17 PM,Avoid Buying General Electric Despite Upside Potential,InvestorPlace,/news/stocks/avoid-buying-ge-stock-despite-upside-potential-1029055588,neutral,0.8984320759773254
4/1/2020 8:49:52 PM,J&J postpones medical device review,Seeking Alpha,https://seekingalpha.com/news/3557541-j-and-j-postpones-medical-device-review?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6637698411941528
4/2/2020 8:20:35 PM,Dow Jones Today: Stocks Backflip as Unemployment Picture Darkens,InvestorPlace,/news/stocks/dow-jones-today-stocks-backflip-as-unemployment-picture-darkens-1029060946,negative,0.9544925093650818
4/2/2020 9:00:17 PM,Fate Therapeutics up 23% after-hours on J&J cell therapy deal,Seeking Alpha,https://seekingalpha.com/news/3558035-fate-therapeutics-up-23-after-hours-on-j-and-j-cell-therapy-deal?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9480671286582947
4/3/2020 4:37:17 AM,"Fate Therapeutics Seals Deal With JNJ For Cancer Immunotherapies, Stock Jumps ",RTTNews,/news/stocks/fate-therapeutics-seals-deal-with-jnj-for-cancer-immunotherapies-stock-jumps-1029061143,neutral,0.8077492117881775
4/6/2020 2:38:38 PM,Healthcare firms pile on initiatives as COVID-19 pandemic advances,Seeking Alpha,https://seekingalpha.com/news/3558642-healthcare-firms-pile-on-initiatives-covidminus-19-pandemic-advances?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5490664839744568
4/6/2020 6:26:48 PM,Moderna Emerges as Coronavirus Vaccine Leader,InvestorPlace,/news/stocks/moderna-is-soaring-on-covid-19-hopes-but-those-hopes-are-risky-1029069273,neutral,0.8007519841194153
4/8/2020 3:30:48 PM,"Amazon, Nike and Goldfish big winners in teen survey",Seeking Alpha,https://seekingalpha.com/news/3559378-amazon-nike-and-goldfish-big-winners-in-teen-survey?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.49395206570625305
4/8/2020 6:59:50 PM,Piper Sandler Survey: Top Teen Brands for Spring 2020,InvestorPlace,/news/stocks/top-teen-brands-for-spring-2020-1029077615,neutral,0.8951521515846252
4/9/2020 5:20:58 PM,Dividend Investors Should Buy Johnson & Johnson Stock On Pullbacks,InvestorPlace,/news/stocks/dividend-investors-should-buy-jnj-stock-on-pullbacks-1029081336,neutral,0.9200429916381836
4/10/2020 7:25:11 PM,J&J drops deal for Takeda's TachoSil surgical patch,Seeking Alpha,https://seekingalpha.com/news/3559944-j-and-j-drops-deal-for-takedas-tachosil-surgical-patch?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7350336313247681
4/13/2020 3:01:20 PM,What Wall Street expects from Johnson Johnson's earnings,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-quarter-earnings-preview-q1-1029085741,neutral,0.9296786785125732
4/13/2020 4:07:20 PM,"INO Stock May Fade After the Virus, but It Could Rocket to $20 First",InvestorPlace,/news/stocks/ino-stock-could-rocket-20-1029086362,positive,0.5253953337669373
4/13/2020 8:23:31 PM,Stock Market Today: Amazon Hiring Spree; Disney Turmoil?,InvestorPlace,/news/stocks/stock-market-today-amazon-hiring-spree-disney-turmoil-1029087117,negative,0.924579918384552
4/13/2020 8:42:28 PM,Dow Jones Today: Stocks Decline Anticipating Q1 Earnings,InvestorPlace,/news/stocks/dow-jones-today-stocks-decline-anticipating-q1-earnings-1029087115,negative,0.971025288105011
4/13/2020 9:30:21 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3560221-notable-earnings-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8660829067230225
4/13/2020 9:30:48 PM,Johnson & Johnson Q1 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3560239-johnson-and-amp-johnson-q1-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7770804762840271
4/14/2020 11:19:02 AM,J&J delivers strong Q1 but lowers guidance amid COVID-19 headwinds,Seeking Alpha,https://seekingalpha.com/news/3560398-j-and-j-delivers-strong-q1-lowers-guidance-amid-covidminus-19-headwinds?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9727838635444641
4/14/2020 12:36:30 PM,Johnson & Johnson Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q1-adjusted-earnings-beat-estimates-1029088737,positive,0.7109442949295044
4/14/2020 1:25:39 PM,J&J Q1 Results Top Estimates; Cuts 2020 Outlook Due To COVID-19 Impact ,RTTNews,/news/stocks/j-j-q1-results-top-estimates-cuts-2020-outlook-due-to-covid-19-impact-1029088933,negative,0.9379528164863586
4/14/2020 6:38:47 PM,Johnson & Johnson Earnings: JNJ Stock Jumps 5% on Strong Q1,InvestorPlace,/news/stocks/johnson-johnson-earnings-boost-jnj-stock-up-1029091260,positive,0.9420449733734131
4/14/2020 8:46:49 PM,Stock Market Today: Earnings Season Begins; Chesapeake Reverse Split,InvestorPlace,/news/stocks/stock-market-today-earnings-season-begins-chesapeake-reverse-split-1029091585,neutral,0.6685770750045776
4/14/2020 8:49:16 PM,"5 Top Stock Trades for Wednesday: BAC, GS, JNJ, SPCE, SHOP",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-bac-gs-jnj-spce-shop-1029091584,neutral,0.930719792842865
4/14/2020 11:03:00 PM,Johnson & Johnson -- Moody's: Coronavirus will temporarily pressure J&J's earnings,Moodys,/news/bonds/johnson-johnson-moody-s-coronavirus-will-temporarily-pressure-j-j-s-earnings-1029091502,negative,0.9345195293426514
4/15/2020 11:40:35 AM,"2 Pros, 2 Cons for Investing in Moderna as It Develops Coronavirus Vaccine",InvestorPlace,/news/stocks/mrna-stock-and-coronavirus-vaccine-1029093779,neutral,0.862103283405304
4/15/2020 11:48:29 AM,"3 Big Stock Charts for Wednesday: Apple, Paypal, and Johnson & Johnson",InvestorPlace,/news/stocks/3-big-stock-charts-for-wednesday-apple-paypal-and-johnson-johnson-1029093778,neutral,0.8999086022377014
4/15/2020 3:13:45 PM,RemeGen candidate Fast Track'd for lupus,Seeking Alpha,https://seekingalpha.com/news/3560931-remegen-candidate-fast-trackd-for-lupus?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7099933624267578
4/15/2020 4:48:31 PM,5 Stocks to Buy For Big Gains On CARES Act Stimulus,InvestorPlace,/news/stocks/5-stocks-to-buy-for-big-gains-on-cares-act-stimulus-1029095722,positive,0.7233676910400391
4/15/2020 7:22:26 PM,Johnson & Johnson Stock Is Your Shelter From the Storm,InvestorPlace,/news/stocks/jnj-stock-shelter-from-storm-coronavirus-1029096024,neutral,0.9029497504234314
4/16/2020 3:19:42 PM,10 Best Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/10-best-stocks-to-buy-and-hold-forever-1028240913,neutral,0.9141502976417542
4/20/2020 1:46:26 PM,"Trading at 52-Week Highs, LLY Stock Is Already Priced to Perfection",InvestorPlace,/news/stocks/hold-off-overvalued-lly-stock-1029107790,positive,0.5579317808151245
4/20/2020 6:09:37 PM,Money flow spikes in COVID-19 vaccine players amid rush for early data,Seeking Alpha,https://seekingalpha.com/news/3562210-money-flow-spikes-in-covidminus-19-vaccine-players-amid-rush-for-early-data?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7037739753723145
4/21/2020 7:56:51 PM,FDA OK new use of AbbVie's Imbruvica,Seeking Alpha,https://seekingalpha.com/news/3562765-fda-ok-new-use-of-abbvies-imbruvica?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6404169797897339
4/22/2020 11:38:49 AM,BofA likes Johnson & Johnson in premarket analyst action,Seeking Alpha,https://seekingalpha.com/news/3562964-bofa-likes-johnson-johnson-in-premarket-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7967442870140076
4/23/2020 11:30:59 AM,Moderna Faces Tough Threats in the Short and Long Term,InvestorPlace,/news/stocks/moderna-faces-tough-threats-in-the-short-and-long-term-1029122410,positive,0.47916990518569946
4/23/2020 10:53:28 PM,"Big universities, others to return $350M of PPP loans: coronavirus briefing",Seeking Alpha,https://seekingalpha.com/news/3564009-big-universities-others-to-return-350m-of-ppp-loans-coronavirus-briefing?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7768115997314453
4/24/2020 3:20:52 AM,J&J to partner with Emergent Bio on coronavirus vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/3564016-j-and-j-to-partner-emergent-bio-on-coronavirus-vaccine-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7191790342330933
4/24/2020 5:05:19 AM,J&J To Expand Manufacturing Capabilities For COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/j-j-to-expand-manufacturing-capabilities-for-covid-19-vaccine-candidate-1029125206,positive,0.9349794983863831
4/24/2020 7:43:19 AM,"SAVA Gets Funding For AD Drug, JNJ Hits All-time High, ENZ On Watch ",RTTNews,/news/stocks/sava-gets-funding-for-ad-drug-jnj-hits-all-time-high-enz-on-watch-1029125551,positive,0.8711333274841309
4/24/2020 1:26:36 PM,J&J files U.S. applications for expanded use of IV golimumab,Seeking Alpha,https://seekingalpha.com/news/3564182-j-and-j-files-u-s-applications-for-expanded-use-of-iv-golimumab?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9041344523429871
4/24/2020 8:14:04 PM,Stock Market Today: Facebook vs. Zoom; AT&T CEO Leaves,InvestorPlace,/news/stocks/stock-market-today-facebook-vs-zoom-att-ceo-leaves-1029128556,neutral,0.8927866220474243
4/27/2020 8:35:40 AM,Heartburn meds for COVID-19? NY is trying it,Seeking Alpha,https://seekingalpha.com/news/3564475-heartburn-meds-for-covidminus-19-ny-is-trying?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.830352783203125
4/27/2020 10:10:49 AM,J&J files application in Japan for subcutaneous formulation of Darzalex,Seeking Alpha,https://seekingalpha.com/news/3564504-j-and-j-files-application-in-japan-for-subcutaneous-formulation-of-darzalex?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5003952383995056
4/27/2020 1:52:56 PM,Don‚Äôt Let Negative Data Dissuade You from Gilead Sciences,InvestorPlace,/news/stocks/dont-let-negative-data-dissuade-you-from-gilead-sciences-1029133468,neutral,0.642347514629364
4/27/2020 7:16:56 PM,J&J must face talc lawsuits - New Jersey court,Seeking Alpha,https://seekingalpha.com/news/3564835-j-and-j-must-face-talc-lawsuits-new-jersey-court?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.727220356464386
4/27/2020 7:52:32 PM,How to Invest With Deflation on the Horizon,InvestorPlace,/news/stocks/how-to-invest-with-deflation-on-horizon-1029134529,neutral,0.8992782831192017
4/28/2020 9:01:07 AM,The AbbVie Buyout is Not a Sure Thing for Allergan Stock Investors,InvestorPlace,/news/stocks/the-abbvie-buyout-is-not-a-sure-thing-for-allergan-stock-investors-1029137151,neutral,0.9339046478271484
4/28/2020 11:28:34 AM,"3 Big Stock Charts for Tuesday: Johnson & Johnson, Merck, and Bristol-Myers Squibb",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-johnson-johnson-merck-and-bristol-myers-squibb-1029137983,neutral,0.9059586524963379
4/28/2020 11:32:55 AM,Wells softens view on Edwards Lifesciences in premarket analyst action,Seeking Alpha,https://seekingalpha.com/news/3565181-wells-softens-view-on-edwards-lifesciences-in-premarket-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7519434094429016
4/28/2020 11:44:49 AM,UBS heads to sidelines on J&J after big rally,Seeking Alpha,https://seekingalpha.com/news/3565191-ubs-heads-to-sidelines-on-j-and-j-after-big-rally?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7344503402709961
4/28/2020 12:51:00 PM,9 Healthcare Stocks to Buy Even After the Coronavirus Fades,InvestorPlace,/news/stocks/9-healthcare-stocks-buy-even-after-coronavirus-1029139171,positive,0.5128858089447021
4/28/2020 4:56:14 PM,"Pfizer to make ""hundreds of millions"" doses of COVID-19 vaccine next year - CEO",Seeking Alpha,https://seekingalpha.com/news/3565400-pfizer-to-make-hundreds-of-millions-doses-of-covidminus-19-vaccine-next-year-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.82470703125
4/28/2020 9:37:18 PM,9 Stocks to Buy to Weather the Recession,InvestorPlace,/news/stocks/9-stocks-to-buy-to-weather-the-recession-1029055060,neutral,0.7990170121192932
4/29/2020 12:51:50 AM,COVID-19 vaccine could be ready for emergency use by fall,Seeking Alpha,https://seekingalpha.com/news/3565740-covidminus-19-vaccine-be-ready-for-emergency-use-fall?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8471663594245911
4/29/2020 6:00:46 PM,What Lies Ahead for Vaccine Development and INO Stock in May?,InvestorPlace,/news/stocks/what-lies-ahead-for-vaccine-development-and-ino-stock-in-may-1029146509,neutral,0.9380713105201721
4/30/2020 10:00:55 AM,"Moderna Stock Is Near Highs, But Faces Risk",InvestorPlace,/news/stocks/moderna-stock-is-near-highs-but-faces-risk-1029149020,positive,0.7244863510131836
5/1/2020 2:58:48 AM,Shot Roster: COVID-19 Vaccines In Human Trials ,RTTNews,/news/stocks/shot-roster-covid-19-vaccines-in-human-trials-1029154136,neutral,0.8697240948677063
5/1/2020 2:27:51 PM,10 Dow Jones Stocks to Keep Your Portfolio Afloat,InvestorPlace,/news/stocks/10-dow-jones-stocks-to-keep-your-portfolio-afloat-1029155699,neutral,0.8516220450401306
5/1/2020 6:41:32 PM,FDA OKs subcutaneous version of J&J's Darzalex,Seeking Alpha,https://seekingalpha.com/news/3567772-fda-oks-subcutaneous-version-of-j-and-js-darzalex?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.816594660282135
5/4/2020 12:55:21 PM,iBio Stock Is Too Risky,InvestorPlace,/news/stocks/ibio-is-in-the-coronavirus-vaccine-mix-but-its-still-risky-1029160950,neutral,0.5480600595474243
5/5/2020 6:18:48 PM,3 Healthcare Stocks Popping Off Support,InvestorPlace,/news/stocks/3-healthcare-stocks-popping-off-support-1029167820,negative,0.923445463180542
5/5/2020 8:35:00 PM,"LifeScan Global Corporation -- Moody's downgrades LifeScan's CFR to B3, stable outlook",Moodys,/news/bonds/lifescan-global-corporation-moody-s-downgrades-lifescan-s-cfr-to-b3-stable-outlook-1029167567,negative,0.747166633605957
5/7/2020 8:42:45 PM,Dow Jones Today: Jobless Claims Soar But Stocks Do Too,InvestorPlace,/news/stocks/tech-lifted-the-dow-jones-today-as-nasdaq-goes-green-on-the-year-1029180374,negative,0.8955984115600586
5/11/2020 5:59:24 PM,7 Winning Stocks and 3 Losing Stocks to Watch Right Now,InvestorPlace,/news/stocks/winning-stocks-losing-stocks-watch-right-now-coronavirus-1029188685,neutral,0.8666112422943115
5/12/2020 12:38:10 PM,7 Dividend Stocks That You Can Still Bank On,InvestorPlace,/news/stocks/7-dividend-stocks-that-you-can-still-bank-on-1029192814,neutral,0.9323615431785583
5/13/2020 1:45:18 PM,7 Tech Industry Dividend Stocks for Growth and Income,InvestorPlace,/news/stocks/7-tech-industry-dividend-stocks-1028478920,neutral,0.9232314825057983
5/13/2020 3:05:47 PM,FDA accepts Arbor Pharma application for ADHD med AR19,Seeking Alpha,https://seekingalpha.com/news/3573965-fda-accepts-arbor-pharma-application-for-adhd-med-ar19?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.735662043094635
5/14/2020 8:10:17 PM,Halozyme bags $15M milestone from J&J under Enhanze license,Seeking Alpha,https://seekingalpha.com/news/3574681-halozyme-bags-15m-milestone-from-j-and-j-under-enhanze-license?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7907900214195251
5/18/2020 1:13:47 PM,"If You‚Äôre Bullish on the Internet, Be Bullish on Shopify Stock",InvestorPlace,/news/stocks/if-youre-bullish-on-the-internet-be-bullish-on-shopify-stock-1029211448,neutral,0.9331527352333069
5/18/2020 8:30:31 PM,Dow Jones Today: Vaccine News And Fed Talk Powered Markets Higher,InvestorPlace,/news/stocks/dow-jones-today-vaccine-news-and-fed-talk-powered-markets-higher-1029212694,neutral,0.8665387630462646
5/19/2020 9:09:36 PM,Does Moderna Stock‚Äôs Rally Hold Up Under the Microscope?,InvestorPlace,/news/stocks/mrna-stock-rally-microscope-coronavirus-vaccine-1029217325,neutral,0.8170806765556335
5/20/2020 4:32:25 AM,Johnson & Johnson To Stop Selling Talc-based Baby Powder In North America ,RTTNews,/news/stocks/johnson-johnson-to-stop-selling-talc-based-baby-powder-in-north-america-1029217492,negative,0.7780947089195251
5/20/2020 8:58:59 PM,Dow Jones Today: Pent Up Demand and Reopening in Sight,InvestorPlace,/news/stocks/dow-jones-today-pent-up-demand-and-reopening-in-sight-1029221833,positive,0.691218376159668
5/21/2020 9:16:53 AM,The Virus Vaccine Race is Fueling Moderna Stock to New Highs,InvestorPlace,/news/stocks/the-virus-vaccine-race-is-fueling-moderna-stock-to-new-highs-1029222715,positive,0.7002803683280945
5/21/2020 1:54:41 PM,7 Dow Jones Stocks to Buy With Fortress-Like Balance Sheets,InvestorPlace,/news/stocks/7-dow-jones-stocks-to-buy-with-fortress-like-balance-sheets-1029223935,neutral,0.911354124546051
5/21/2020 3:00:43 PM,The Rewards Outweigh the Risks for Moderna Stock,InvestorPlace,/news/stocks/the-rewards-outweigh-the-risks-for-moderna-stock-1029224348,positive,0.8328329920768738
5/27/2020 11:48:12 AM,Why Did Lincoln Park Capital Just Buy a Million Shares of iBio Stock?,InvestorPlace,/news/stocks/why-lincoln-park-capital-bought-million-shares-ibio-stock-1029237335,neutral,0.9287682771682739
5/29/2020 11:34:37 AM,European advisory group backs J&J Ebola vaccine regimen,Seeking Alpha,https://seekingalpha.com/news/3578594-european-advisory-group-backs-j-and-j-ebola-vaccine-regimen?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8582984209060669
5/29/2020 3:33:21 PM,J&J Gets Positive CHMP Opinion For Investigational Preventive Ebola Vaccine Regimen ,RTTNews,/news/stocks/j-j-gets-positive-chmp-opinion-for-investigational-preventive-ebola-vaccine-regimen-1029263538,positive,0.9437631964683533
5/29/2020 4:34:10 PM,"'99%' chance Covid-19 vaccine will be effective, Sinovac claims",Seeking Alpha,https://seekingalpha.com/news/3578690-99-percent-chance-covidminus-19-vaccine-will-be-effective-sinovac-claims?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9143039584159851
6/2/2020 11:35:10 AM,Sanofi's isatuximab OK'd in Europe for multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3579477-sanofis-isatuximab-okd-in-europe-for-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5782667994499207
6/2/2020 1:16:22 PM,The Best 5 Stocks to Buy on the Next Dip,InvestorPlace,/news/stocks/5-stocks-to-buy-next-dip-1029273033,neutral,0.8994381427764893
6/4/2020 6:37:03 AM,"List Of 'Operation Warp Speed' Finalists, SAVA To Reassess AD Study Results; KZR Jumps  On MISSION ",RTTNews,/news/stocks/list-of-operation-warp-speed-finalists-sava-to-reassess-ad-study-results-kzr-jumps-on-mission-1029279089,neutral,0.5100427269935608
6/5/2020 1:52:42 PM,China in thick of race for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3580791-china-in-thick-of-race-for-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7481112480163574
6/8/2020 4:08:25 PM,Inovio Slumps as Its Setbacks Pile Up,InvestorPlace,/news/stocks/inovio-slumps-as-its-setbacks-pile-up-1029289728,negative,0.9717625379562378
6/8/2020 4:14:39 PM,The Odds For Long Shot Inovio Stock Just Got Longer,InvestorPlace,/news/stocks/the-odds-for-long-shot-ino-stock-just-got-longer-1029290046,neutral,0.5252544283866882
6/9/2020 3:10:56 PM,Aggressive Investors Can Do Much Better Than Merck Stock,InvestorPlace,/news/stocks/aggressive-investors-better-mrk-stock-1029293865,positive,0.729252278804779
6/9/2020 3:49:54 PM,7 Pharmaceutical Stocks to Buy for Post-Pandemic Gains,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-buy-coronavirus-gains-1029293862,neutral,0.8380299210548401
6/10/2020 1:54:15 PM,Johnson & Johnson accelerates start of COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3581918-johnson-johnson-accelerates-start-of-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5126861929893494
6/10/2020 3:19:36 PM,Three key studies of COVID-19 vaccines to launch in summer,Seeking Alpha,https://seekingalpha.com/news/3581971-three-key-studies-of-covidminus-19-vaccines-to-launch-in-summer?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.812157928943634
6/10/2020 4:04:48 PM,Johnson & Johnson To Begin First-in-human Trial Of COVID-19 Vaccine Candidate In July ,RTTNews,/news/stocks/johnson-johnson-to-begin-first-in-human-trial-of-covid-19-vaccine-candidate-in-july-1029297243,neutral,0.6364561319351196
6/11/2020 3:22:25 PM,Momentum mover candidates on a down market day,Seeking Alpha,https://seekingalpha.com/news/3582348-momentum-mover-candidates-on-down-market-day?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5710694789886475
6/14/2020 1:10:57 AM,Barron's touts eight dividend stocks for the COVID-19 recession,Seeking Alpha,https://seekingalpha.com/news/3582836-barrons-touts-eight-dividend-stocks-for-covidminus-19-recession?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9437114596366882
6/14/2020 1:10:57 AM,Barron's touts eight dividend stocks for the covid recession,Seeking Alpha,https://seekingalpha.com/news/3582836-barrons-touts-eight-dividend-stocks-for-covid-recession?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9435603022575378
6/15/2020 9:49:26 AM,Janssen: Long-term Trial Shows TREMFYA As Efficacious Therapy In Plaque Psoriasis ,RTTNews,/news/stocks/janssen-long-term-trial-shows-tremfya-as-efficacious-therapy-in-plaque-psoriasis-1029307015,positive,0.8997485041618347
6/15/2020 1:37:36 PM,Band-Aid To Launch Black And Brown Bandages For Diverse Skin ,RTTNews,/news/stocks/band-aid-to-launch-black-and-brown-bandages-for-diverse-skin-1029307775,neutral,0.7087942957878113
6/15/2020 4:56:24 PM,5 Cheap Growth Stocks With Attractive Dividend Yields,InvestorPlace,/news/stocks/5-cheap-growth-stocks-attractive-dividend-yields-1029309729,positive,0.5384670495986938
6/16/2020 5:49:43 PM,Pfizer and Merck's diabetes med Steglatro shows mixed results in cardiovascular outcomes study,Seeking Alpha,https://seekingalpha.com/news/3583523-pfizer-and-mercks-diabetes-med-steglatro-shows-mixed-results-in-cardiovascular-outcomes-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9532430171966553
6/18/2020 10:16:36 AM,"3 Pros, 3 Cons For Buying iBio Stock Right Now",InvestorPlace,/news/stocks/3-pros-cons-of-buying-ibio-stock-right-now-1029321599,neutral,0.9115537405014038
6/18/2020 2:08:10 PM,Stay Safe on the Sidelines With Inovio Stock,InvestorPlace,/news/stocks/pandemic-fading-hold-off-ino-stock-1029322421,neutral,0.8275737762451172
6/18/2020 4:05:39 PM,10 Robotics Stocks on the Technological Cutting Edge,InvestorPlace,/news/stocks/10-robotics-stocks-cutting-edge-1029322986,neutral,0.4710162878036499
6/18/2020 6:06:48 PM,3 Reasons Clorox Stock Is a Buy Right Now,InvestorPlace,/news/stocks/3-reasons-clorox-clx-stock-is-a-buy-right-now-1029323448,neutral,0.8860664963722229
6/18/2020 6:07:14 PM,3 Dow Jones Companies to Buy as Markets Get Volatile,InvestorPlace,/news/stocks/3-dow-jones-companies-to-buy-as-markets-get-volatile-1029323447,neutral,0.9084373712539673
6/22/2020 12:00:59 PM,Ride Out the Choppy Seas and Buy Royal Caribbean,InvestorPlace,/news/stocks/ride-out-the-choppy-seas-and-buy-royal-caribbean-rcl-stock-1029329112,neutral,0.9230866432189941
6/23/2020 9:15:26 PM,J&J Damages Cut By More Than Half In Talcum Powder Cancer Suit ,RTTNews,/news/stocks/j-j-damages-cut-by-more-than-half-in-talcum-powder-cancer-suit-1029335440,negative,0.7916203737258911
6/26/2020 2:16:18 AM,10 Recession-Proof Stocks to Weather the Storm,InvestorPlace,/news/stocks/10-stocks-to-buy-to-weather-the-recession-1029173355,positive,0.7430044412612915
6/26/2020 1:59:03 PM,Alibaba Stock Won‚Äôt Be Left Behind Smaller Rivals Forever,InvestorPlace,/news/stocks/alibaba-stock-wont-be-left-behind-smaller-rivals-forever-1029346118,neutral,0.9094232320785522
6/30/2020 3:56:56 AM,9 All-Around Dividend Stocks to Tough It Out,InvestorPlace,/news/stocks/best-dividend-stocks-to-buy-for-every-investor-1028788633,neutral,0.8424761891365051
6/30/2020 2:47:33 PM,3 Reasons to Buy the Ad Boycott Dip in FB Stock,InvestorPlace,/news/stocks/3-reasons-buy-ad-boycott-dip-fb-stock-1029355526,neutral,0.8457436561584473
7/2/2020 2:04:27 PM,Buy Opko Stock For Two Ways to Play the Ongoing Pandemic,InvestorPlace,/news/stocks/buy-opko-stock-for-two-ways-to-play-the-ongoing-pandemic-1029363124,neutral,0.8705251812934875
7/2/2020 5:02:06 PM,"Keep an Eye on Royalty Pharma Stock, 2020‚Äôs Biggest IPO",InvestorPlace,/news/stocks/keep-eye-rprx-stock-2020-1029363917,neutral,0.9034902453422546
7/6/2020 10:40:08 AM,Royalty Pharma Stock Is Likely to Reach New Highs in the Coming Years,InvestorPlace,/news/stocks/rprx-stock-is-likely-to-reach-new-highs-coming-years-1029368649,positive,0.915957510471344
7/6/2020 1:07:37 PM,Emergent Signs 5-yr Manufacturing Deal For Johnson & Johnson's COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/emergent-signs-5-yr-manufacturing-deal-for-johnson-johnson-s-covid-19-vaccine-candidate-1029368443,positive,0.9271517992019653
7/6/2020 5:56:43 PM,7 Healthcare ETFs Which Should Continue Growing Into 2021,InvestorPlace,/news/stocks/7-healthcare-etfs-growing-into-2021-1029369965,positive,0.5999974608421326
7/6/2020 6:43:12 PM,Moderna Stock Has a Bright Future After the Coronavirus,InvestorPlace,/news/stocks/moderna-mrna-stock-coronavirus-vaccine-drug-discovery-1029370223,positive,0.7788194417953491
7/6/2020 7:05:00 PM,Jabil Inc. -- Moody's assigns Baa3 to Jabil's new senior notes,Moodys,/news/bonds/jabil-inc-moody-s-assigns-baa3-to-jabil-s-new-senior-notes-1029369827,neutral,0.8179425597190857
7/10/2020 5:10:55 PM,INO Stock Could Receive Operation Warp Speed Funding Soon,InvestorPlace,/news/stocks/ino-stock-could-receive-operation-warp-speed-funding-soon-1029384591,positive,0.646456778049469
7/10/2020 7:19:51 PM,A Safer Way to Play IBio Stock Could Spread Like the Coronavirus¬†,InvestorPlace,/news/stocks/a-safer-way-to-play-ibio-stock-could-spread-like-the-coronavirus-1029384769,neutral,0.8445013761520386
7/14/2020 1:13:14 PM,"With Earnings in Sight, Johnson & Johnson Stock Looks Perfectly Healthy",InvestorPlace,/news/stocks/with-earnings-in-sight-jnj-stock-looks-perfectly-healthy-1029392989,positive,0.7061179876327515
7/14/2020 1:19:36 PM,Quick Income from a Put Write on Johnson & Johnson,InvestorPlace,/news/stocks/quick-income-from-a-put-write-on-johnson-johnson-1029392988,neutral,0.7121955156326294
7/15/2020 3:01:26 PM,What Wall Street expects from Johnson Johnson's earnings,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-quarter-earnings-preview-q2-1029397198,neutral,0.9296786785125732
7/16/2020 12:44:01 PM,Johnson & Johnson Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q2-adjusted-earnings-beat-estimates-1029400773,positive,0.6643651127815247
7/16/2020 12:59:11 PM,Johnson & Johnson Boosts FY20 Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-boosts-fy20-outlook-quick-facts-1029400798,positive,0.9036999940872192
7/16/2020 6:28:20 PM,JNJ Stock: 4 Things to Know About Johnson & Johnson Q2 Earnings,InvestorPlace,/news/stocks/jnj-stock-johnson-johnson-q2-earnings-1029403303,neutral,0.9325655698776245
7/17/2020 1:55:45 PM,3 Best Long-Term Stocks to Set and Forget,InvestorPlace,/news/stocks/the-best-long-term-stocks-feature-growth-and-lower-volatility-1029405444,neutral,0.8802531361579895
7/21/2020 5:25:42 PM,4 Top Blue-Chip Stocks for Peace of Mind,InvestorPlace,/news/stocks/4-top-blue-chip-stocks-for-peace-of-mind-1029416248,neutral,0.8331031203269958
7/22/2020 12:27:19 PM,The Curtain Is Coming Down on Inovio Pharmaceuticals‚Äô Vaccine Candidate,InvestorPlace,/news/stocks/curtain-coming-down-on-ino-stock-1029420801,neutral,0.5067700147628784
7/22/2020 1:54:28 PM,Sell Overpriced Novavax Stock While You Still Can,InvestorPlace,/news/stocks/why-you-should-sell-nvax-stock-while-you-still-can-1029420794,neutral,0.9357196688652039
7/23/2020 10:31:35 AM,History and Competition Suggest Caution Toward Inovio Stock,InvestorPlace,/news/stocks/history-competition-caution-ino-stock-1029424603,neutral,0.8366190195083618
7/27/2020 1:25:18 PM,iBio Stock Has Tripled in a Few Weeks. Here‚Äôs What‚Äôs Next,InvestorPlace,/news/stocks/ibio-stock-tripled-now-what-1029434265,neutral,0.9211769700050354
7/28/2020 2:07:24 PM,Sintx Joins List of Highly Speculative Covid-19 Plays,InvestorPlace,/news/stocks/sintx-technologies-stock-speculative-covid-19-play-1029439555,neutral,0.8739500641822815
7/29/2020 3:53:42 PM,5 Dental Stocks to Buy For Big Smiles As Coronavirus Fears Ease,InvestorPlace,/news/stocks/5-dental-stocks-to-buy-for-big-smiles-as-coronavirus-fears-ease-1029446842,neutral,0.6891564130783081
7/30/2020 11:26:46 AM,Buy Exxon Stock at $44 Before It Recovers,InvestorPlace,/news/stocks/xom-stock-exxon-mobil-recover-soon-1029451792,neutral,0.9399980902671814
7/30/2020 11:58:29 AM,J&J's Single Dose COVID-19 Vaccine Candidate Shows Robust Protection In Pre-clinical Studies ,RTTNews,/news/stocks/j-j-s-single-dose-covid-19-vaccine-candidate-shows-robust-protection-in-pre-clinical-studies-1029449823,positive,0.9487558603286743
7/30/2020 12:14:19 PM,A More Sustainable Business Model Doesn‚Äôt Make iBio Stock Less Risky,InvestorPlace,/news/stocks/sustainable-business-model-ibio-stock-risky-1029451784,neutral,0.561090350151062
8/3/2020 2:54:47 PM,5 Healthcare Stocks for Good (Portfolio) Health,InvestorPlace,/news/stocks/5-healthcare-stocks-for-good-portfolio-health-1029462755,neutral,0.8538072109222412
8/4/2020 3:55:00 PM,Emergent BioSolutions Inc. -- Moody's assigns Ba2 CFR to Emergent BioSolutions,Moodys,/news/bonds/emergent-biosolutions-inc-moody-s-assigns-ba2-cfr-to-emergent-biosolutions-1029467707,neutral,0.6268324851989746
8/4/2020 5:08:35 PM,Don‚Äôt Count on Inovio To Deliver a Covid-19 Vaccine,InvestorPlace,/news/stocks/dont-count-on-inovio-pharmaceuticals-ino-stock-covid-19-vaccine-1029478836,neutral,0.8281461596488953
8/5/2020 4:21:00 AM,Emergent BioSolutions Inc. -- Moody's assigns Ba2 CFR to Emergent BioSolutions,Moodys,/news/bonds/emergent-biosolutions-inc-moody-s-assigns-ba2-cfr-to-emergent-biosolutions-1029469394,neutral,0.6268324851989746
8/5/2020 2:48:51 PM,Janssen Pharma Enters Deal With U.S. Government On 100 Mln Doses Of COVID-19 Vaccine ,RTTNews,/news/stocks/janssen-pharma-enters-deal-with-u-s-government-on-100-mln-doses-of-covid-19-vaccine-1029472652,positive,0.8292241096496582
8/6/2020 12:10:24 PM,"As a Vaccine Looks More Likely, Moderna Stock Still Is a Good Bet",InvestorPlace,/news/stocks/vaccine-looks-likely-mrna-stock-still-is-a-good-bet-1029478835,positive,0.6246476173400879
8/6/2020 1:38:49 PM,The Best Dividend Stocks to Buy in 9 Sectors,InvestorPlace,/news/stocks/the-best-dividend-stocks-to-buy-in-9-sectors-1029478830,neutral,0.7222041487693787
8/6/2020 5:51:20 PM,5 Biotech Stocks That Offer Long-Term Growth and Value,InvestorPlace,/news/stocks/5-biotech-stocks-that-offer-long-term-growth-and-value-1029479695,neutral,0.710562527179718
8/7/2020 9:09:38 PM,The Top 7 Blue-Chip Stocks for the Rest of 2020,InvestorPlace,/news/stocks/the-top-7-blue-chip-stocks-for-the-rest-of-2020-1029497294,neutral,0.9131118655204773
8/12/2020 5:59:57 AM,U.S. Reaches Deal With Moderna For 100 Million Doses Of COVID-19 Vaccine ,RTTNews,/news/stocks/u-s-reaches-deal-with-moderna-for-100-million-doses-of-covid-19-vaccine-1029494061,positive,0.819267988204956
8/12/2020 3:25:00 PM,The 10 Top Stocks to Buy and Hold Into 2021,InvestorPlace,/news/stocks/the-10-top-stocks-to-buy-and-hold-into-2021-1029497764,neutral,0.9069890975952148
8/12/2020 7:30:33 PM,7 of the Best Index Funds to Buy on the Market Today,InvestorPlace,/news/stocks/7-of-the-best-index-funds-to-buy-on-the-market-today-1029498343,neutral,0.7787944078445435
8/14/2020 4:38:20 PM,10 Nasdaq Stocks to Buy and Hold for the Long Haul,InvestorPlace,/news/stocks/10-nasdaq-stocks-to-buy-and-hold-for-the-long-haul-1029505887,neutral,0.8678790330886841
8/19/2020 12:46:56 PM,Johnson & Johnson To Acquire Momenta Pharmaceuticals - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-to-acquire-momenta-pharmaceuticals-quick-facts-1029516037,neutral,0.9386734366416931
8/19/2020 2:39:01 PM,Momenta Pharmaceuticals spikes 69% after agreeing to $6.5 billion Johnson & Johnson takeover,Business Insider,https://www.businessinsider.com/momenta-pharmaceuticals-stock-price-johnson-johnson-acquisition-deal-autoimmune-drugs-2020-8,positive,0.9197977781295776
8/19/2020 5:26:00 PM,Johnson & Johnson -- Moody's affirms J&J's Aaa rating; negative outlook,Moodys,/news/bonds/johnson-johnson-moody-s-affirms-j-j-s-aaa-rating-negative-outlook-1029517573,negative,0.90389484167099
8/19/2020 5:29:31 PM,Buying iBio As a Vaccine Winner Is a Waste of Money,InvestorPlace,/news/stocks/ibio-stock-is-a-waste-of-money-as-covid-19-vaccine-winner-1029518046,negative,0.5068500638008118
8/19/2020 6:46:01 PM,Momenta Pharmaceuticals News: MNTA Stock Rockets 69% on JNJ Deal,InvestorPlace,/news/stocks/momenta-pharmaceuticals-news-sends-mnta-stock-soaring-1029518297,positive,0.7791570425033569
8/20/2020 8:43:27 AM,"JNJ Acquires MNTA, FDA Strikes Down BMRN's Gene Therapy, BLRX's GENESIS On Track, TPTX On Watch ",RTTNews,/news/stocks/jnj-acquires-mnta-fda-strikes-down-bmrn-s-gene-therapy-blrx-s-genesis-on-track-tptx-on-watch-1029519157,negative,0.8946519494056702
8/20/2020 6:17:00 PM,Johnson & Johnson -- Moody's assigns Aaa to J&J's sr. notes; outlook negative,Moodys,/news/bonds/johnson-johnson-moody-s-assigns-aaa-to-j-j-s-sr-notes-outlook-negative-1029521758,positive,0.5004882216453552
8/21/2020 5:34:04 AM,Amgen : FDA Approves New KYPROLIS For Multiple Myeloma ,RTTNews,/news/stocks/amgen-fda-approves-new-kyprolis-for-multiple-myeloma-1029522678,positive,0.8566518425941467
8/21/2020 10:31:25 AM,There Are Still Too Many Risks In iBio Stock,InvestorPlace,/news/stocks/still-too-many-risks-ibio-stock-1029523762,negative,0.5564557909965515
8/21/2020 3:31:12 PM,Eli Lilly (Still) Looks Like the Best Buy in Large-Cap Pharma,InvestorPlace,/news/stocks/lly-stock-still-looks-like-best-buy-large-cap-pharma-1029524567,positive,0.805871844291687
8/21/2020 4:04:40 PM,7 Safe Stocks to Buy That Can Shrug Off the Growing Volatility,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-that-can-shrug-off-the-growing-volatility-1029524563,neutral,0.6372416615486145
8/24/2020 11:19:04 PM,20 Stable Stocks to Buy If You‚Äôre Still Betting on America to Thrive,InvestorPlace,/news/stocks/20-stocks-to-buy-if-youre-betting-on-america-1029203418,neutral,0.8488995432853699
8/25/2020 7:05:31 PM,"Inovio Stock Is a Sideshow, Not a Serious Investment",InvestorPlace,/news/stocks/inovio-stock-is-a-sideshow-not-a-serious-investment-1029533338,neutral,0.9258228540420532
8/26/2020 11:16:15 AM,Buyout Excitement Is Already Priced Into Momenta Pharmaceuticals,InvestorPlace,/news/stocks/buyout-excitement-is-already-priced-into-momenta-pharmaceuticals-stock-1029535445,neutral,0.7021473050117493
8/26/2020 12:04:28 PM,3 Key Questions to Ask Before Buying Novavax,InvestorPlace,/news/stocks/3-key-questions-before-buying-nvax-stock-1029535441,neutral,0.9474856853485107
8/26/2020 7:42:20 PM,CureVac Is a Bet on a Safe and Effective Vaccine,InvestorPlace,/news/stocks/curevac-stock-bet-on-covid-19-vaccine-could-produce-68-percent-roi-1029537603,neutral,0.7192504405975342
8/26/2020 9:30:05 PM,30 Dividend Stocks to Buy Now for 20 Years of Income Growth,InvestorPlace,/news/stocks/30-dividend-stocks-to-buy-for-20-years-of-income-growth-1029537832,neutral,0.8688682317733765
8/27/2020 11:35:20 AM,"After a 30% Surge, Is It Time to Buy iBio Stock Again?¬†",InvestorPlace,/news/stocks/after-a-30-surge-is-it-time-to-buy-ibio-stock-again-1029539794,neutral,0.8548688888549805
8/28/2020 2:10:18 PM,7 Companies That Should Split Their Stocks,InvestorPlace,/news/stocks/7-companies-should-have-stock-splits-following-apple-tesla-1029544430,neutral,0.9034325480461121
8/31/2020 6:18:04 PM,Why Johnson & Johnson Remains a Risky Bet,InvestorPlace,/news/stocks/johnson-johnson-jnj-stock-remains-a-risky-bet-despite-its-financial-condition-1029549615,neutral,0.8753113150596619
8/31/2020 11:44:00 PM,Jabil Inc. -- Moody's affirms Jabil's Baa3 senior unsecured rating; outlook stable,Moodys,/news/bonds/jabil-inc-moody-s-affirms-jabil-s-baa3-senior-unsecured-rating-outlook-stable-1029549821,positive,0.7816984057426453
9/2/2020 11:30:52 AM,Bet on Wild Swings in the Market With the SPXL ETF,InvestorPlace,/news/stocks/bet-on-wild-swings-in-the-market-with-spxl-stock-1029555951,neutral,0.8576704859733582
9/2/2020 2:21:45 PM,4 Pharmaceutical Stocks With Deep Pipelines,InvestorPlace,/news/stocks/4-pharmaceutical-stocks-deep-pipelines-coronavirus-1029557234,neutral,0.6847981810569763
9/2/2020 2:36:56 PM,"At This Point, iBioPharma Is a Flash in the Pandemic",InvestorPlace,/news/stocks/at-this-point-ibio-stock-is-a-flash-in-the-pandemic-1029557232,neutral,0.5494212508201599
9/3/2020 12:54:31 PM,10 Blue-Chip Stocks Ideal for Any Investor,InvestorPlace,/news/stocks/10-blue-chip-stocks-ideal-for-any-investor-1029560529,neutral,0.8295893669128418
9/4/2020 11:10:20 PM,COVID-19 vaccine developers prepare joint pledge on safety - WSJ,Seeking Alpha,https://seekingalpha.com/news/3611895-covidminus-19-vaccine-developers-prepare-joint-pledge-on-safety-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5112402439117432
9/7/2020 6:19:22 PM,Trump considers 'decoupling' U.S. from China,Seeking Alpha,https://seekingalpha.com/news/3611949-trump-considers-decoupling-u-s-from-china?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8527777194976807
9/8/2020 3:33:54 AM,EC OKs expanded use of J&J's Imbruvica + Rituximab for leukemia,Seeking Alpha,https://seekingalpha.com/news/3611954-ec-oks-expanded-use-of-j-and-js-imbruvica-rituximab-for-leukemia?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8966847062110901
9/9/2020 2:36:39 PM,The Top 7 Healthcare Stocks You Should Be Watching,InvestorPlace,/news/stocks/the-top-7-healthcare-stocks-you-should-be-watching-1029355520,neutral,0.9079741835594177
9/10/2020 11:42:10 AM,"As Its Vaccine Dreams Fade, Inovio Stock Will Keep Retreating",InvestorPlace,/news/stocks/ino-stock-retreating-vaccine-1029577589,neutral,0.8797112703323364
9/10/2020 1:15:35 PM,"Carnival Is Not Going Bankrupt, But Only Risk-Tolerant Investors Should Buy CCL Stock",InvestorPlace,/news/stocks/go-long-on-ccl-stock-if-you-can-stomach-a-bit-of-risk-1029578640,neutral,0.9305047392845154
9/14/2020 5:13:03 PM,7 Coronavirus Vaccine Stocks to Watch as Approval Nears,InvestorPlace,/news/stocks/7-coronavirus-vaccine-stocks-watch-approval-hopefully-nears-1029587809,neutral,0.8405250310897827
9/17/2020 2:51:41 PM,6 Dividend Stocks To Buy For Stable Yield And Growth Potential,InvestorPlace,/news/stocks/6-dividend-stocks-to-buy-for-stable-yield-and-growth-potential-1029599920,neutral,0.6477484703063965
9/18/2020 9:31:13 AM,20/20 GeneSystems Stock: Leveraging AI for More Accurate Cancer Screening,InvestorPlace,/news/stocks/20-20-genesystems-stock-leveraging-ai-for-more-accurate-cancer-screening-1029601945,neutral,0.7066354751586914
9/18/2020 1:51:10 PM,Why Novartis‚Äô Absence From the Covid-19 Vaccine Race Is a Benefit,InvestorPlace,/news/stocks/novartis-stock-absence-covid-19-vaccine-race-benefit-1029602941,neutral,0.8497923016548157
9/18/2020 3:04:05 PM,6 Long-Term Stocks to See You Through the Bad Times,InvestorPlace,/news/stocks/6-long-term-stocks-to-see-you-through-the-bad-times-1029603332,neutral,0.8930366635322571
9/18/2020 3:24:21 PM,"Europe Signs Deal With Sanofi, GSK To Secure Up To 300 Mln COVID-19 Vaccine Doses ",RTTNews,/news/stocks/europe-signs-deal-with-sanofi-gsk-to-secure-up-to-300-mln-covid-19-vaccine-doses-1029602745,positive,0.9281327128410339
9/21/2020 6:21:15 PM,Healthcare stocks plunge amid broad market rout as Ruth Bader Ginsburg's death creates uncertainty around Obamacare,Business Insider,https://www.businessinsider.com/healthcare-stock-prices-ruth-bader-ginsburg-death-obamacare-uncertainty-insurance-2020-9,negative,0.9551382660865784
9/21/2020 6:28:06 PM,Compass Pathways IPO: 5 Things for Potential CMPS Investors to Know,InvestorPlace,/news/stocks/compass-pathways-ipo-5-things-for-potential-cmps-investors-to-know-1029608581,neutral,0.929078996181488
9/22/2020 5:19:01 PM,"Keep An Eye On Novavax, But Keep Your Money In Your Pocket",InvestorPlace,/news/stocks/keep-an-eye-on-novavax-nvax-stock-but-keep-your-money-in-your-pocket-1029612589,neutral,0.9306748509407043
9/23/2020 12:05:31 PM,There Simply Isn‚Äôt Enough Good News for iBio,InvestorPlace,/news/stocks/simply-not-enough-good-news-ibio-stock-1029615057,neutral,0.6294525861740112
9/23/2020 1:00:21 PM,JNJ Initiates Pivotal Global Phase 3 Clinical Trial Of Janssen's COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/jnj-initiates-pivotal-global-phase-3-clinical-trial-of-janssen-s-covid-19-vaccine-candidate-1029614548,positive,0.6510143876075745
9/23/2020 1:06:52 PM,Johnson & Johnson News: JNJ Stock Pops on Late-Stage Vaccine Trials,InvestorPlace,/news/stocks/johnson-johnson-news-jnj-stock-pops-on-late-stage-vaccine-trials-1029615936,positive,0.6677085161209106
9/23/2020 5:08:22 PM,Aggressive Investors Have No Excuse for Not Owning Moderna,InvestorPlace,/news/stocks/aggressive-investors-have-no-excuse-for-not-owning-moderna-mrna-stock-at-this-stage-of-the-game-cseo-1029616770,neutral,0.9145838618278503
9/23/2020 8:57:04 PM,"4 Top Stock Trades for Thursday: NKE, CHWY, JNJ, WORK",InvestorPlace,/news/stocks/4-top-stock-trades-for-thursday-nke-chwy-jnj-work-1029617227,neutral,0.9376518726348877
9/24/2020 7:21:39 AM,"JNJ Begins Phase 3 COVID-19 Vaccine Trial, Another Headstone In Alzheimer's Graveyard, PFE On Watch ",RTTNews,/news/stocks/jnj-begins-phase-3-covid-19-vaccine-trial-another-headstone-in-alzheimer-s-graveyard-pfe-on-watch-1029617682,neutral,0.8442924618721008
9/24/2020 10:10:57 AM,7 of the Best Penny Stocks to Buy Now,InvestorPlace,/news/stocks/7-of-the-best-penny-stocks-to-buy-now-1029330493,neutral,0.8300976157188416
9/25/2020 9:16:35 AM,Patient Investors Will Stick With Very Cheap Bristol-Myers Squibb Stock,InvestorPlace,/news/stocks/bmy-stock-worth-46-percent-more-based-on-history-and-comps-1029623231,neutral,0.847294270992279
9/25/2020 5:00:08 PM,NVAX Stock: Novavax Rallies After Entering Phase 3 Vaccine Trials,InvestorPlace,/news/stocks/nvax-stock-novavax-rallies-after-entering-phase-3-vaccine-trials-1029623831,positive,0.9303556084632874
9/28/2020 12:40:39 PM,Inovio Stock Still Has Real Promise Despite Faltering in Vaccine Race,InvestorPlace,/news/stocks/ino-stock-promising-despite-vaccine-race-1029627233,positive,0.9424541592597961
9/29/2020 2:48:42 PM,Deep Diving the Complex Narrative Behind Novavax,InvestorPlace,/news/stocks/deep-diving-complex-narrative-nvax-stock-novavax-cseo-1029632023,neutral,0.9314523935317993
9/29/2020 6:52:00 PM,Jabil Inc. -- Moody's announces completion of a periodic review of ratings of Jabil Inc.,Moodys,/news/bonds/jabil-inc-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-jabil-inc-1029632178,neutral,0.8464629650115967
9/30/2020 12:55:36 PM,The 7 Best 401k Investments to Enrich Your Retirement,InvestorPlace,/news/stocks/the-7-best-401k-investments-to-enrich-your-retirement-1029635832,neutral,0.8017430901527405
10/1/2020 5:00:25 AM,Novavax Gains With Start of Phase 3 Vaccine Trial,InvestorPlace,/news/stocks/nvax-stock-gains-with-phase-3-trial-1029641338,positive,0.948647141456604
10/2/2020 12:09:03 PM,"If You‚Äôre Not a Speculator, You Should Avoid iBio",InvestorPlace,/news/stocks/if-youre-not-a-speculator-you-should-avoid-ibio-1029643897,neutral,0.8941294550895691
10/2/2020 4:12:40 PM,The Real Value in Novavax Goes Beyond the Coronavirus,InvestorPlace,/news/stocks/influenza-vaccine-gives-nvax-stock-value-cseo-1029645075,neutral,0.902147114276886
10/2/2020 5:01:29 PM,iBio Is a Pure Spec Play That Remains a Day Trader‚Äôs Delight,InvestorPlace,/news/stocks/ibio-stock-is-a-pure-spec-play-that-remains-a-day-traders-delight-1029645068,neutral,0.8930778503417969
10/5/2020 1:00:54 PM,7 Sizzling Hot Stocks to Buy Now Amid Even Hotter Politics,InvestorPlace,/news/stocks/7-hot-stocks-to-buy-amid-even-hotter-politics-1029648698,neutral,0.8602465391159058
10/5/2020 2:24:00 PM,Smith & Nephew plc -- Moody's assigns Baa2 issuer rating to Smith & Nephew plc; outlook stable,Moodys,/news/bonds/smith-nephew-plc-moody-s-assigns-baa2-issuer-rating-to-smith-nephew-plc-outlook-stable-1029648147,neutral,0.7283353805541992
10/5/2020 2:25:32 PM,This Is Why I‚Äôd Still Avoid IBio for Now,InvestorPlace,/news/stocks/this-is-why-id-still-avoid-vaccine-stock-ibio-for-now-cseo-1029649209,neutral,0.9063957333564758
10/5/2020 2:41:00 PM,Smith & Nephew plc -- Moody's assigns Baa2 issuer rating to Smith & Nephew plc; outlook stable,Moodys,/news/bonds/smith-nephew-plc-moody-s-assigns-baa2-issuer-rating-to-smith-nephew-plc-outlook-stable-1029648241,neutral,0.7283353805541992
10/5/2020 5:43:41 PM,Moderna Is Ready To Rally After 2-Month Market Correction,InvestorPlace,/news/stocks/moderna-mrna-stock-is-ready-to-rally-after-2-month-market-correction-1029649495,positive,0.9448305368423462
10/5/2020 6:28:38 PM,Investors Should Proceed With Caution in Sorrento Stock,InvestorPlace,/news/stocks/investors-should-proceed-with-caution-in-sorrento-stock-1029662225,neutral,0.8986226320266724
10/6/2020 2:12:30 PM,FDA Ad Com this month to clarify COVID-19 vaccine authorization requirements,Seeking Alpha,https://seekingalpha.com/news/3620151-fda-ad-com-this-month-to-clarify-covidminus-19-vaccine-authorization-requirements?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9083845615386963
10/6/2020 2:15:27 PM,J&J's Biosense Webster gets FDA nod for ablation catheter for atrial fibrillation,Seeking Alpha,https://seekingalpha.com/news/3620137-j-and-js-biosense-webster-gets-fda-nod-for-ablation-catheter-for-atrial-fibrillation?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8641647696495056
10/6/2020 2:44:51 PM,The 7 Best New Stocks From 2020 to Buy Now,InvestorPlace,/news/stocks/the-7-best-new-stocks-from-2020-to-buy-now-1029653691,neutral,0.8444295525550842
10/6/2020 3:22:31 PM,"Psychedelics the ""next big thing"" in treating mental health disorders",Seeking Alpha,https://seekingalpha.com/news/3619871-psychedelics-next-big-thing-in-treating-mental-health-disorders?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8302556872367859
10/6/2020 6:12:37 PM,The Deep Price Pullback Is Your Signal to Buy Novavax,InvestorPlace,/news/stocks/the-deep-price-pullback-is-your-signal-to-buy-nvax-stock-1029654462,neutral,0.8166105151176453
10/6/2020 6:36:01 PM,Get Out of IBIO Stock Before It‚Äôs Too Late,InvestorPlace,/news/stocks/get-out-of-ibio-stock-before-its-too-late-cseo-1029658676,neutral,0.9056562185287476
10/6/2020 9:13:19 PM,7 High-Growth Value Stocks for a Post-Pandemic Future,InvestorPlace,/news/stocks/7-value-stocks-to-buy-post-pandemic-future-1029654705,neutral,0.7316830158233643
10/7/2020 9:31:16 AM,5 Blue-chip Stocks to Buy on a Discount to Fortify Portfolios,InvestorPlace,/news/stocks/wmt-pfe-jpm-ko-jnj-5-blue-chip-stocks-to-buy-1029656064,neutral,0.8645324110984802
10/7/2020 12:28:15 PM,Inovio Pharmaceuticals Does Not Need Any More Misfortune,InvestorPlace,/news/stocks/ino-stock-needs-change-fortunes-1029657681,neutral,0.9155681133270264
10/7/2020 2:11:17 PM,Does Sorrento Therapeutics Meet the ‚ÄòSAD‚Äô Criteria for Vaccines?,InvestorPlace,/news/stocks/does-srne-stock-meet-sad-criteria-for-covid-vaccines-1029657676,neutral,0.82896488904953
10/7/2020 4:27:48 PM,7 Biotech Stocks To Buy For Profit From The Vaccine Crunch,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-for-profit-from-the-vaccine-crunch-1029658673,neutral,0.8608304262161255
10/8/2020 11:28:38 AM,Spinal Elements to issue 7.7M shares in IPO at $13-$15 per share,Seeking Alpha,https://seekingalpha.com/news/3620718-spinal-elements-to-issue-7_7m-shares-in-ipo-13-15-per-share?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9327147603034973
10/8/2020 11:55:08 AM,The Risk-to-Reward Proposition for Sorrento Has Gone Bad,InvestorPlace,/news/stocks/the-risk-to-reward-proposition-for-sorrento-therapeutics-srne-stock-has-gone-negative-1029661288,positive,0.5604219436645508
10/8/2020 12:04:17 PM,J&J to supply up to 400M doses of COVID-19 vaccine in Europe,Seeking Alpha,https://seekingalpha.com/news/3620741-j-and-j-to-supply-up-to-400m-doses-of-covidminus-19-vaccine-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5544474124908447
10/8/2020 2:10:04 PM,Johnson & Johnson: European Commission Approves Agreement To Supply COVID-19 Vaccine ,RTTNews,/news/stocks/johnson-johnson-european-commission-approves-agreement-to-supply-covid-19-vaccine-1029661273,positive,0.9138830900192261
10/9/2020 10:45:57 AM,7 Index Funds to Hold Through Thick and Thin,InvestorPlace,/news/stocks/7-index-funds-to-hold-through-thick-and-thin-1029665545,neutral,0.43010345101356506
10/9/2020 12:13:20 PM,7 Stocks You Can Buy to Help Save the Planet,InvestorPlace,/news/stocks/esg-investing-7-stocks-buy-help-save-the-planet-environment-1029621059,neutral,0.8986084461212158
10/9/2020 7:00:01 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3621193-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8980498313903809
10/12/2020 8:38:11 AM,Janssen reports long-term results from late-stage IM-UNITI study in inflammatory bowel disease,Seeking Alpha,https://seekingalpha.com/news/3621286-janssen-reports-long-term-results-from-late-stage-im-uniti-study-in-inflammatory-bowel?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5382959842681885
10/12/2020 10:48:20 AM,Head of Operation Warp Speed sees emergency authorization vaccine request around Thanksgiving,Seeking Alpha,https://seekingalpha.com/news/3621297-head-of-operation-warp-speed-sees-emergency-authorization-vaccine-request-around-thanksgiving?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8216392397880554
10/12/2020 3:01:20 PM,Here's what Wall Street expects from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnson_johnson-q3-earnings-preview-stock-1029669986,neutral,0.9130298495292664
10/12/2020 3:35:50 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3621436-notable-earnings-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8660829067230225
10/12/2020 5:12:04 PM,Johnson & Johnson Q3 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3621474-johnson-johnson-q3-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7508316040039062
10/12/2020 7:06:31 PM,Novavax Is Incredibly Risky but Worth a Small Allocation,InvestorPlace,/news/stocks/nvax-stock-is-incredibly-risky-but-worth-a-small-allocation-1029671346,neutral,0.8218441009521484
10/12/2020 8:17:47 PM,Q3 earnings ringing in; FactSet sees drop in earnings across sectors,Seeking Alpha,https://seekingalpha.com/news/3621517-q3-earnings-ringing-in-factset-sees-drop-in-earnings-across-sectors?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9727945923805237
10/12/2020 8:58:31 PM,7 Highly Rated Pharmaceutical Stocks for Q4,InvestorPlace,/news/stocks/7-highly-rated-pharmaceutical-stocks-for-q4-1029679826,neutral,0.8309605121612549
10/12/2020 11:30:42 PM,Johnson & Johnson sued over Auris Health payouts,Seeking Alpha,https://seekingalpha.com/news/3621554-johnson-johnson-sued-over-auris-health-payouts?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9539359211921692
10/13/2020 2:33:03 AM,J&J vaccine study paused due to unexplained illness in participant,Seeking Alpha,https://seekingalpha.com/news/3621557-j-and-j-vaccine-study-paused-due-to-unexplained-illness-in-participant?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9313557147979736
10/13/2020 5:14:47 AM,J&J Pauses Late-stage COVID-19 Vaccine Trial On Unexplained Illness ,RTTNews,/news/stocks/j-j-pauses-late-stage-covid-19-vaccine-trial-on-unexplained-illness-1029671663,negative,0.7113332748413086
10/13/2020 8:32:35 AM,First case of COVID-19 reinfection confirmed in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3621570-first-case-of-covidminus-19-reinfection-confirmed-in-u-s?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7349666357040405
10/13/2020 10:41:23 AM,"Johnson & Johnson beats on earnings, raises FY20 guidance",Seeking Alpha,https://seekingalpha.com/news/3621594-johnson-johnson-beats-on-earnings-raises-fy20-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.853324294090271
10/13/2020 11:12:02 AM,J&J Darzalex sales up 44%; FY20 outlook raise tops consensus,Seeking Alpha,https://seekingalpha.com/news/3621605-j-and-j-darzalex-sales-up-44-fy20-outlook-raise-tops-consensus?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9510959386825562
10/13/2020 12:44:27 PM,Johnson & Johnson Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q3-adjusted-earnings-beat-estimates-1029673178,positive,0.6677963137626648
10/13/2020 1:26:14 PM,Johnson & Johnson Q3 Results Top Estimates; Boosts FY20 Outlook ,RTTNews,/news/stocks/johnson-johnson-q3-results-top-estimates-boosts-fy20-outlook-1029673428,positive,0.9335116744041443
10/13/2020 2:57:02 PM,Johnson & Johnson falls despite earnings beat after pausing COVID-19 vaccine trial over 'unexplained illness',Business Insider,https://www.businessinsider.com/johnson-and-johnson-stock-price-jnj-earnings-covid19-vaccine-illness-2020-10,negative,0.9676206111907959
10/13/2020 3:35:23 PM,Novavax Stock Stalemate Is About to Catch Fire,InvestorPlace,/news/stocks/nvax-stock-stalemate-is-about-to-catch-fire-1029675475,neutral,0.6122857928276062
10/13/2020 3:37:22 PM,Johnson & Johnson Earnings: JNJ Stock Ticks Lower as Vaccine Trial Pause Overshadows Q3 Beat,InvestorPlace,/news/stocks/johnson-johnson-earnings-jnj-stock-ticks-lower-as-vaccine-trial-pause-overshadows-q3-beat-1029675474,negative,0.9665097594261169
10/13/2020 4:30:12 PM,Inovio Stock Is a Great Long Setup for an Overreaction Trade,InvestorPlace,/news/stocks/ino-stock-is-a-great-long-setup-for-an-overreaction-trade-1029675876,neutral,0.6810618042945862
10/14/2020 8:31:39 AM,"LLY Pauses COVID-19 Antibody Trial, JNJ Boosts Annual Outlook, Double Whammy For GOSS ",RTTNews,/news/stocks/lly-pauses-covid-19-antibody-trial-jnj-boosts-annual-outlook-double-whammy-for-goss-1029677498,positive,0.9347586035728455
10/14/2020 1:03:22 PM,Health care holding up despite COVID setbacks: At the Open,Seeking Alpha,https://seekingalpha.com/news/3622071-health-care-holding-up-despite-covid-setbacks-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.786237895488739
10/15/2020 11:30:19 PM,9 Stocks to Buy for a Wild Ride in October,InvestorPlace,/news/stocks/9-stocks-to-buy-for-a-wild-ride-in-july-1029381606,neutral,0.7964709997177124
10/16/2020 11:58:35 AM,Biden Town Hall: 4 Key Investing Takeaways,InvestorPlace,/news/stocks/biden-town-hall-4-key-investing-takeaways-1029688135,neutral,0.9202543497085571
10/16/2020 1:03:00 PM,7 Short-Term Stocks to Make a Quick Buck,InvestorPlace,/news/stocks/7-short-term-stocks-to-buy-for-quick-buck-1029688757,neutral,0.8304800987243652
10/16/2020 2:37:50 PM,GSK Says Viiv Healthcare Gets Positive CHMP Opinion For Long-acting HIV Regimen ,RTTNews,/news/stocks/gsk-says-viiv-healthcare-gets-positive-chmp-opinion-for-long-acting-hiv-regimen-1029688318,positive,0.9543236494064331
10/16/2020 5:53:26 PM,Can Cytonics Pivot Successfully to Covid-19 Therapeutics?,InvestorPlace,/news/stocks/cytonics-stock-pivot-coronavirus-therapeutics-1029689508,neutral,0.7348710298538208
10/16/2020 5:53:36 PM,Novavax Stock Looks Volatile As Vaccine Enthusiasm Wanes,InvestorPlace,/news/stocks/nvax-stock-looks-volatile-as-vaccine-enthusiasm-wanes-1029689507,negative,0.9606714248657227
10/16/2020 7:30:50 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3622976-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8980498313903809
10/19/2020 4:58:50 PM,Pfizer and Moderna pivotal studies on COVID-19 vaccines near enrollment targets,Seeking Alpha,https://seekingalpha.com/news/3623326-pfizer-and-moderna-pivotal-studies-on-covidminus-19-vaccines-near-enrollment-targets?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9210037589073181
10/19/2020 5:25:37 PM,Why the FDA‚Äôs Inquiry of Inovio Is More Critical Than You Think,InvestorPlace,/news/stocks/why-fda-inquiry-very-critical-ino-stock-1029694935,neutral,0.9059136509895325
10/19/2020 5:50:56 PM,The Low-Hanging Fruit for Covid-19 Vaccines Is Gone for iBio,InvestorPlace,/news/stocks/ibio-stock-no-more-low-hanging-fruit-1029694932,neutral,0.8469914793968201
10/20/2020 7:18:42 AM,Moderna not far behind Pfizer on vaccine emergency authorization,Seeking Alpha,https://seekingalpha.com/news/3623490-moderna-not-far-behind-pfizer-on-vaccine-emergency-authorization?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.628637969493866
10/21/2020 2:10:42 PM,OxyContin maker Purdue Pharma to plead guilty to three criminal charges,Seeking Alpha,https://seekingalpha.com/news/3624251-oxycontin-maker-purdue-pharma-to-plead-guilty-to-three-criminal-charges?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7724969983100891
10/21/2020 4:35:08 PM,"While Risky, Sorrento Therapeutics Has Many Options to Win",InvestorPlace,/news/stocks/while-risky-sorrento-therapeutics-has-many-options-to-win-1029706542,neutral,0.8506827354431152
10/21/2020 5:43:16 PM,FDA Ad Com tomorrow on development/authorization of COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3624369-fda-ad-com-tomorrow-on-development-authorization-of-covidminus-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9219728708267212
10/21/2020 7:49:40 PM,Key U.S. COVID-19 vaccine trials set to resume,Seeking Alpha,https://seekingalpha.com/news/3624430-key-u-s-covidminus-19-vaccine-trials-set-to-resume?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.78973388671875
10/21/2020 7:50:43 PM,Sorrento Therapeutics Is a Vaccine Movie That Investors Have Already Seen,InvestorPlace,/news/stocks/lack-of-covid-19-focus-could-hinder-srne-stock-1029706960,neutral,0.8901837468147278
10/21/2020 9:05:18 PM,J&J's daratumumab extends survival in first-line multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3624549-j-and-js-daratumumab-extends-survival-in-first-line-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9460108280181885
10/22/2020 5:31:38 PM,Is It Too Late for Novavax to Profit From a Covid-19 Vaccine?,InvestorPlace,/news/stocks/is-it-too-late-for-novavax-to-profit-from-a-covid-19-vaccine-1029712056,neutral,0.8273957371711731
10/22/2020 6:08:42 PM,Time Is Running Out on Inovio as Other Vaccine Candidates Advance,InvestorPlace,/news/stocks/time-is-running-out-on-ino-stock-as-other-vaccine-candidates-advance-1029712050,neutral,0.8938280940055847
10/22/2020 6:21:39 PM,Johnson & Johnson declares $1.01 dividend,Seeking Alpha,https://seekingalpha.com/news/3624985-johnson-johnson-declares-1_01-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.930496871471405
10/23/2020 3:25:03 PM,FDA getting cold feet on EUA nod for COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3625386-fda-getting-cold-feet-on-eua-nod-for-covidminus-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4357944428920746
10/23/2020 6:23:01 PM,Can Novavax Stock Overcome Growing Vaccine Distrust?,InvestorPlace,/news/stocks/novavax-nvax-stock-not-a-win-on-astrazeneca-blunder-1029716054,positive,0.4967081546783447
10/23/2020 10:11:16 PM,J&J to resume pivotal study of COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3625481-j-and-j-to-resume-pivotal-study-of-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7863702774047852
10/26/2020 10:41:53 AM,"Fauci Says Covid Vaccine's Safety, Efficacy Will Be Known By Dec ",RTTNews,/news/stocks/fauci-says-covid-vaccine-s-safety-efficacy-will-be-known-by-dec-1029719925,neutral,0.8476759791374207
10/26/2020 5:03:44 PM,3 Blue Chip Stocks to Buy for Safe Dividends,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-for-safe-dividends-1029722331,neutral,0.914421558380127
10/27/2020 1:34:57 PM,7 Cheap Index Funds for the Careful Investor,InvestorPlace,/news/stocks/7-cheap-index-funds-to-buy-for-the-careful-investor-1029728195,neutral,0.9057947993278503
10/27/2020 9:10:05 PM,Don‚Äôt Be Fazed by the Recent Market Volatility,InvestorPlace,/news/stocks/why-im-not-fazed-by-the-recent-market-volatility-1029729497,neutral,0.8584649562835693
10/28/2020 11:52:24 AM,Vaccine Hopeful Novavax Could Be Worth a Shot,InvestorPlace,/news/stocks/vaccine-hopeful-novavax-could-be-worth-a-shot-1029734122,positive,0.6186032891273499
10/28/2020 4:39:57 PM,"U.S. COVID-19 cases on the rise, key vaccine data expected in November",Seeking Alpha,https://seekingalpha.com/news/3627364-u-s-covidminus-19-cases-on-rise-key-vaccine-data-expected-in-november?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5762868523597717
10/29/2020 11:53:30 AM,IBIO Stock Remains a Speculative Biopharma Play,InvestorPlace,/news/stocks/ibio-stock-remains-a-speculative-biopharma-play-1029741060,neutral,0.8162075877189636
10/29/2020 4:46:15 PM,Why Palantir May Be a Solid Covid-19 Play,InvestorPlace,/news/stocks/why-palantir-may-be-a-solid-covid-19-play-1029742932,neutral,0.7000255584716797
10/30/2020 10:44:17 AM,"Protagonist Therapeutics, Janssen advance oral IL-23 receptor antagonists program",Seeking Alpha,https://seekingalpha.com/news/3628947-protagonist-therapeutics-janssen-advance-oral-ilminus-23-receptor-antagonists-program?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8172658681869507
10/30/2020 3:21:03 PM,Regeneron : IDMC Recommends To Hold Enrollment In Hospitalized High Risk COVID-19 Patients ,RTTNews,/news/stocks/regeneron-idmc-recommends-to-hold-enrollment-in-hospitalized-high-risk-covid-19-patients-1029746946,neutral,0.8544443249702454
10/30/2020 6:43:02 PM,J&J to test coronavirus vaccine in youngsters,Seeking Alpha,https://seekingalpha.com/news/3629207-j-and-j-to-test-coronavirus-vaccine-in-youngsters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8158524632453918
10/31/2020 6:00:00 AM,"Vaccine developers take varied approaches to COVID-19, next-gen platforms may not be better than more traditional technologies",Seeking Alpha,https://seekingalpha.com/news/3629098-vaccine-developers-take-varied-approaches-to-covidminus-19-next-gen-platforms-may-not-be?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7795729041099548
11/2/2020 12:14:11 PM,J&J files U.S. application for twice yearly dosing of schizophrenia med,Seeking Alpha,https://seekingalpha.com/news/3629520-j-and-j-files-u-s-application-for-twice-yearly-dosing-of-schizophrenia-med?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8925284743309021
11/2/2020 1:14:27 PM,A Lot of News Isn‚Äôt Necessarily Good News for Sorrento Therapeutics,InvestorPlace,/news/stocks/lot-news-good-news-srne-stock-1029754095,neutral,0.8521669507026672
11/2/2020 4:11:03 PM,5 Industries Biden Would Destroy as President,InvestorPlace,/news/stocks/election-stocks-sell-5-industries-threatened-biden-victory-1029754646,neutral,0.8998603820800781
11/2/2020 8:19:18 PM,7 Hot Stocks¬†To Buy With Mega-Cap Status,InvestorPlace,/news/stocks/7-hot-stocks-to-buy-with-mega-cap-status-1029755365,neutral,0.8822280168533325
11/3/2020 1:04:10 PM,Sorrento Therapeutics Is Charming But Read the Label,InvestorPlace,/news/stocks/srne-stock-charming-but-read-label-1029758584,neutral,0.8833617568016052
11/3/2020 6:32:00 PM,Brazil on board with resumption of J&J COVID-19 vaccine study,Seeking Alpha,https://seekingalpha.com/news/3630627-brazil-on-board-resumption-of-j-and-j-covidminus-19-vaccine-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8493174314498901
11/3/2020 8:13:53 PM,J&J strikes out with appeal of $2.1B talc judgement in Missouri,Seeking Alpha,https://seekingalpha.com/news/3630709-j-and-j-strikes-out-appeal-of-2_1b-talc-judgement-in-missouri?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8745059967041016
11/5/2020 2:46:54 PM,India races ahead with COVID-19 vaccine as AstraZeneca deliveries lag,Seeking Alpha,https://seekingalpha.com/news/3632254-india-races-ahead-covidminus-19-vaccine-astrazeneca-deliveries-lag?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8641549348831177
11/5/2020 8:06:56 PM,Cytonics: Invest In A Startup That‚Äôs Targeting Osteoarthritis,InvestorPlace,/news/stocks/cytonics-invest-in-a-startup-thats-targeting-osteoarthritis-1029772608,neutral,0.8583499193191528
11/6/2020 1:49:30 PM,J&J to host device update November 19,Seeking Alpha,https://seekingalpha.com/news/3633158-j-and-j-to-host-device-update-november-19?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9328522086143494
11/6/2020 3:34:01 PM,Drug wholesalers and J&J agree to tentative $26B deal to settle opioid lawsuits,Seeking Alpha,https://seekingalpha.com/news/3633211-drug-wholesalers-and-j-and-j-agree-to-tentative-26b-deal-to-settle-opioid-lawsuits?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9239859580993652
11/7/2020 5:30:00 AM,Biogen's long and winding road in Alzheimer's hits wall,Seeking Alpha,https://seekingalpha.com/news/3633230-biogens-long-and-winding-road-in-alzheimers-hits-wall?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5482171773910522
11/9/2020 11:08:28 AM,5 Real Estate Stocks to Buy for a Hot Housing Market,InvestorPlace,/news/stocks/5-real-estate-stocks-to-buy-for-a-hot-housing-market-dhi-are-invh-low-tsco-1029780301,neutral,0.8556706309318542
11/9/2020 12:07:49 PM,"Pfizer/BioNTech COVID-19 vaccine 90% effective, U.S. EUA application expected this month",Seeking Alpha,https://seekingalpha.com/news/3633509-pfizer-biontech-covidminus-19-vaccine-90-effective-u-s-eua-application-expected-this-month?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8656366467475891
11/9/2020 6:32:14 PM,Don‚Äôt Expect Massive Short-Term Gains in Novavax Stock Right Now,InvestorPlace,/news/stocks/dont-expect-massive-short-term-gains-in-novavax-nvax-stock-1029783007,positive,0.5166051983833313
11/9/2020 6:52:11 PM,"Despite Ethical Issues, Palantir Is a Can‚Äôt-Miss Opportunity",InvestorPlace,/news/stocks/despite-ethical-issues-pltr-stock-is-a-cant-miss-opportunity-1029783005,neutral,0.5794508457183838
11/9/2020 8:30:43 PM,3 Dividend Stocks With Super-Safe Payouts,InvestorPlace,/news/stocks/3-dividend-stocks-with-super-safe-payouts-jnj-1029783354,neutral,0.8441782593727112
11/10/2020 1:02:00 PM,Novavax Steals Some of Pfizer‚Äôs Thunder With Fast Track Designation,InvestorPlace,/news/stocks/novavax-nvax-stock-steals-pfizers-thunder-with-fast-track-designation-1029786505,neutral,0.7748197913169861
11/10/2020 7:24:22 PM,7 Dividend Stocks To Buy For Post-Election Volatility,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-for-post-election-volatility-1029789073,neutral,0.914745032787323
11/11/2020 2:24:45 PM,9 Outbreak-Fueled Stocks to Buy This Week,InvestorPlace,/news/stocks/stocks-to-buy-this-week-second-coronavirus-wave-1029421408,neutral,0.7889733910560608
11/11/2020 4:50:34 PM,7 Biotech Penny Stocks Worth a Gamble,InvestorPlace,/news/stocks/7-biotech-stocks-to-gamble-with-1029793010,neutral,0.7899959087371826
11/11/2020 6:40:36 PM,Good News for Society Isn‚Äôt Necessarily So for Slack Stock,InvestorPlace,/news/stocks/good-news-for-society-is-not-great-for-slack-stock-1029793372,neutral,0.8632275462150574
11/12/2020 9:49:16 AM,"Amid cold-storage hurdle, Sanofi and J&J may beat logistical challenges",Seeking Alpha,https://seekingalpha.com/news/3635295-amid-cold-storage-hurdle-sanofi-and-j-and-j-may-beat-logistical-challenges?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9465422630310059
11/12/2020 12:22:36 PM,J&J files applications for subcutaneous Darzalex in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3635397-j-and-j-files-applications-for-subcutaneous-darzalex-in-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9177826642990112
11/12/2020 6:48:30 PM,Emergent BioSolutions in focus on upcoming 60 Minutes episode,Seeking Alpha,https://seekingalpha.com/news/3635657-emergent-biosolutions-in-focus-on-upcoming-60-minutes-episode?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8982795476913452
11/13/2020 4:29:50 PM,Acceleron's sotatercept shows positive action in mid-stage pulmonary arterial hypertension studies,Seeking Alpha,https://seekingalpha.com/news/3636208-accelerons-sotatercept-shows-positive-action-in-mid-stage-pulmonary-arterial-hypertension?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9302709102630615
11/13/2020 6:05:40 PM,7 Value Stocks That Could Make You the Next Warren Buffett,InvestorPlace,/news/stocks/7-value-stocks-that-could-make-you-the-next-warren-buffett-1029802378,neutral,0.9161631464958191
11/13/2020 8:00:17 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3636251-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8980498313903809
11/14/2020 5:00:41 PM,"J&J, U.S. Expand Agreement To Support Next Phase Of COVID-19 Vaccine R&D ",RTTNews,/news/stocks/j-j-u-s-expand-agreement-to-support-next-phase-of-covid-19-vaccine-r-d-1029803409,positive,0.8206350803375244
11/15/2020 5:29:46 PM,J&J expands partnership with HHS in COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3636401-j-and-j-expands-partnership-hhs-in-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9431540966033936
11/16/2020 8:45:14 AM,COVID-19 Vaccines - The Blues And Ease Of Cold Storage ,RTTNews,/news/stocks/covid-19-vaccines-the-blues-and-ease-of-cold-storage-1029804652,neutral,0.8237765431404114
11/16/2020 12:20:35 PM,"Moderna shares jump 12% as COVID-19 vaccine shows 94.5% efficacy, expects EUA submission shortly",Seeking Alpha,https://seekingalpha.com/news/3636472-moderna-shares-jump-12-covidminus-19-vaccine-shows-94_5-efficacy-expects-eua-submission?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9234066009521484
11/16/2020 12:49:36 PM,"Moderna's COVID-19 vaccine candidate has longer shelf life, to remain stable at 2¬∞ to 8¬∞C",Seeking Alpha,https://seekingalpha.com/news/3636496-modernas-covidminus-19-vaccine-candidate-longer-shelf-life-to-remain-stable-2-to-8-c?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.838863730430603
11/16/2020 4:00:50 PM,7 Vanguard Funds With Ultra Low Expenses,InvestorPlace,/news/stocks/7-vanguard-funds-with-ultra-low-expenses-1029807476,neutral,0.8676201701164246
11/17/2020 7:55:22 AM,J&J tests new two-dose regimen for COVID-19 vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/3636937-j-and-j-tests-new-two-dose-regimen-for-covidminus-19-vaccine-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5661361217498779
11/17/2020 8:10:16 AM,"ADMP Snubbed Again, FDA Delay's Decision On BMY's Liso-cel, MRNA's COVID-19 Vaccine 94.5% Effective ",RTTNews,/news/stocks/admp-snubbed-again-fda-delay-s-decision-on-bmy-s-liso-cel-mrna-s-covid-19-vaccine-94-5-effective-1029809234,positive,0.8710686564445496
11/17/2020 11:45:38 AM,Is messenger RNA technology in COVID-19 a new tool to success?,Seeking Alpha,https://seekingalpha.com/news/3636976-is-messenger-rna-technology-in-covidminus-19-new-tool-to-success?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7902470827102661
11/17/2020 3:10:41 PM,7 Pharmaceutical Stocks to Buy for 2021 and Beyond¬†,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-to-buy-for-2021-and-beyond-1029811903,neutral,0.9023516178131104
11/17/2020 7:36:43 PM,Sell Novavax Stock After Its Huge Gain,InvestorPlace,/news/stocks/sell-novavax-stock-after-its-huge-gain-1029813268,neutral,0.8138293623924255
11/17/2020 9:22:53 PM,J&J expects data for U.S. authorization of COVID-19 vaccine by February - Reuters,Seeking Alpha,https://seekingalpha.com/news/3637280-j-and-j-expects-data-for-u-s-authorization-of-covidminus-19-vaccine-february-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9262532591819763
11/19/2020 10:01:06 AM,5 Index Funds That Belong In Any Portfolio Seeking Diversification,InvestorPlace,/news/stocks/5-index-funds-vfiax-vgt-vti-swppx-gold-that-help-you-sleep-soundly-1029819756,neutral,0.9354580640792847
11/19/2020 10:02:20 AM,FDA plans early advisory meetings in December to discuss COVID-19 vaccines - CNBC,Seeking Alpha,https://seekingalpha.com/news/3637799-fda-plans-early-advisory-meetings-in-december-to-discuss-covidminus-19-vaccines-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9308125376701355
11/19/2020 6:40:32 PM,CDC warns against Thanksgiving travel amid COVID spike,Seeking Alpha,https://seekingalpha.com/news/3638052-cdc-warns-against-thanksgiving-travel-amid-covid-spike?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8023210763931274
11/20/2020 7:59:23 AM,"EU may approve BioNtech, Moderna vaccines in December, could pay $10B for doses",Seeking Alpha,https://seekingalpha.com/news/3638224-eu-may-approve-biontech-moderna-vaccines-in-december-pay-10b-for-doses?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5250725746154785
11/20/2020 1:02:28 PM,Inovio Gets the Go-Ahead But It‚Äôs Probably Too Late,InvestorPlace,/news/stocks/ino-stock-gets-go-ahead-but-probably-too-late-1029824918,neutral,0.8834110498428345
11/20/2020 5:50:42 PM,7 Hot Stocks to Buy Before 2021 Ushers in Change,InvestorPlace,/news/stocks/7-of-the-hot-stocks-to-buy-before-2021-ushers-in-change-1029826116,neutral,0.90118008852005
11/22/2020 2:12:08 PM,Vaccine access and distribution a big topic at G20,Seeking Alpha,https://seekingalpha.com/news/3638524-vaccine-access-and-distribution-big-topic-g20?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8874894380569458
11/23/2020 8:02:44 AM,"All eyes on AstraZeneca-Oxford shot after strong Pfizer, Moderna results",Seeking Alpha,https://seekingalpha.com/news/3638538-all-eyes-on-astrazeneca-oxford-shot-after-strong-pfizer-moderna-results?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7594829201698303
11/23/2020 5:40:46 PM,Slack Shares Might Start to Slack Off,InvestorPlace,/news/stocks/slack-stock-shares-might-start-to-slack-off-1029831155,negative,0.9355032444000244
11/23/2020 7:17:19 PM,Johnson & Johnson sized up favorably after positive medical devices update,Seeking Alpha,https://seekingalpha.com/news/3638793-johnson-johnson-sized-up-favorably-after-positive-medical-devices-update?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9473861455917358
11/24/2020 2:50:06 PM,Johnson & Johnson Is an Excellent Dividend Growth Stock,InvestorPlace,/news/stocks/johnson-johnson-is-an-excellent-dividend-1029834845,positive,0.895185112953186
11/24/2020 7:21:41 PM,"Pfizer, Moderna Lead the Vaccine Race: Here‚Äôs Where 7 Other Top Vaccine Stocks Stand",InvestorPlace,/news/stocks/7-biotech-stocks-locked-in-the-race-for-a-vaccine-1029836075,neutral,0.90046626329422
11/25/2020 8:49:37 AM,Purdue Pharma pleads guilty to criminal opioid crisis charges,Seeking Alpha,https://seekingalpha.com/news/3639300-purdue-pharma-pleads-guilty-to-criminal-opioid-crisis-charges?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7081249356269836
11/25/2020 6:06:07 PM,Overlook Novavax at the Risk of Incurring an Opportunity Cost,InvestorPlace,/news/stocks/overlook-nvax-stock-at-your-own-risk-1029839833,negative,0.5209406018257141
11/25/2020 8:47:28 PM,AstraZeneca skids another 2% as confusion remains over vaccine,Seeking Alpha,https://seekingalpha.com/news/3639522-astrazeneca-skids-another-2-confusion-remains-over-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9577128887176514
11/30/2020 11:55:00 AM,"The Case for iBio Stock Is Real, but Leaves a Key Question Unanswered",InvestorPlace,/news/stocks/ibio-stock-presents-investors-with-key-question-1029848699,neutral,0.8902007341384888
12/2/2020 1:15:24 PM,Just Say No to Inovio Pharmaceuticals Stock,InvestorPlace,/news/stocks/just-say-no-to-inovio-pharmaceuticals-stock-1029858306,neutral,0.9311157464981079
12/2/2020 1:46:56 PM,J&J acquires rights to gene therapy for vision loss disorder,Seeking Alpha,https://seekingalpha.com/news/3640789-j-and-j-acquires-rights-to-gene-therapy-for-vision-loss-disorder?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.757938802242279
12/2/2020 1:49:15 PM,Kinnate Biopharma increases IPO size by 25% to $213M,Seeking Alpha,https://seekingalpha.com/news/3640795-kinnate-biopharma-increases-ipo-size-25-to-213m?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9479063153266907
12/3/2020 6:37:33 AM,"BCRX Awaits FDA Decision, JNJ On Watch, Pfizer/BioNTech's COVID-19 Vaccine Gets Green Light In UK ",RTTNews,/news/stocks/bcrx-awaits-fda-decision-jnj-on-watch-pfizer-biontech-s-covid-19-vaccine-gets-green-light-in-uk-1029860123,positive,0.8735625743865967
12/3/2020 8:55:24 AM,U.S. could immunize one-third of population within three months,Seeking Alpha,https://seekingalpha.com/news/3641217-u-s-immunize-one-third-of-population-within-three-months?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8466516733169556
12/3/2020 8:55:24 AM,U.S. could immunize third of population within three months,Seeking Alpha,https://seekingalpha.com/news/3641217-u-s-immunize-third-of-population-within-three-months?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8187562227249146
12/3/2020 10:16:13 AM,7 Undervalued Stocks to Snap Up Today,InvestorPlace,/news/stocks/undervalued-stocks-are-out-there-including-some-familiar-names-1029860944,positive,0.5279105305671692
12/3/2020 12:12:52 PM,J&J files U.S. application for bispecific antibody for type of lung cancer,Seeking Alpha,https://seekingalpha.com/news/3641279-j-and-j-files-u-s-application-for-bispecific-antibody-for-type-of-lung-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7342573404312134
12/3/2020 12:20:28 PM,J&J sells ex-U.S. rights to transdermal contraceptive patch to Gedeon Richter,Seeking Alpha,https://seekingalpha.com/news/3641284-j-and-j-sells-ex-u-s-rights-to-transdermal-contraceptive-patch-to-gedeon-richter?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9155998826026917
12/3/2020 6:53:40 PM,3 Dividend Stocks for Big Total Returns in 2021,InvestorPlace,/news/stocks/3-dividend-stocks-for-big-total-returns-in-2021-abbv-jnj-mdt-1029863076,positive,0.7688313126564026
12/4/2020 6:32:46 AM,"FDA Nod For BCRX - Decision In Japan, Europe Next, ENLV Soars On COVID Trial Data, STRO Abuzz ",RTTNews,/news/stocks/fda-nod-for-bcrx-decision-in-japan-europe-next-enlv-soars-on-covid-trial-data-stro-abuzz-1029863959,positive,0.6276439428329468
12/4/2020 12:55:11 PM,Sell-siders bullish on Moderna COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3641671-sell-siders-bullish-on-moderna-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4227280914783478
12/4/2020 6:26:02 PM,J&J's daratumumab shows clinical benefit in multiple myeloma study,Seeking Alpha,https://seekingalpha.com/news/3641796-j-and-js-daratumumab-shows-clinical-benefit-in-multiple-myeloma-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9369552135467529
12/7/2020 10:52:00 AM,Moody's - Outlook for global pharmaceutical industry revised to positive as COVID-19 vaccines and treatments boost earnings,Moodys,/news/bonds/moody-s-outlook-for-global-pharmaceutical-industry-revised-to-positive-as-covid-19-vaccines-and-treatments-boost-earnings-1029868484,positive,0.9331789612770081
12/7/2020 5:20:23 PM,Johnson & Johnson sees positive data from pair of multiple myeloma approaches at ASH,Seeking Alpha,https://seekingalpha.com/news/3642175-johnson-johnson-sees-positive-data-from-pair-of-multiple-myeloma-approaches-ash?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9478275179862976
12/8/2020 8:41:39 AM,U.K. rolls out COVID-19 vaccine to public - report,Seeking Alpha,https://seekingalpha.com/news/3642355-u-k-rolls-out-covidminus-19-vaccine-to-public-report?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7050285339355469
12/8/2020 7:03:42 PM,7 Blue-Chip Stocks You Can Trust,InvestorPlace,/news/stocks/blue-chip-stocks-7-blue-chip-stocks-you-can-trust-1029874779,neutral,0.911331057548523
12/9/2020 9:07:53 AM,"U.S. banks on J&J, AstraZeneca for vaccine delivery, inoculation expected by mid 2021 - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3642766-u-s-banks-on-j-and-j-astrazeneca-for-vaccine-delivery-inoculation-expected-mid-2021-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8593605160713196
12/9/2020 9:07:53 AM,"U.S. banks on J&J, AstraZeneca shots to vaccinate Americans",Seeking Alpha,https://seekingalpha.com/news/3642766-u-s-banks-on-j-and-j-astrazeneca-shots-to-vaccinate-americans?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7953997850418091
12/9/2020 3:30:11 PM,Investment Breakdown: The Best Stock in Each Sector of the Market,InvestorPlace,/news/stocks/breakdown-the-best-stock-in-each-sector-of-the-market-1029878480,neutral,0.883594274520874
12/10/2020 10:01:49 AM,7 Cheap Stocks Under $20 To Buy That Span Industries,InvestorPlace,/news/stocks/7-cheap-stocks-to-buy-now-under-20-to-buy-that-span-industry-doyu-znga-arcc-hbi-veco-pdce-bcov-1029880669,neutral,0.8280788660049438
12/11/2020 1:15:04 PM,Janssen: CHMP Recommends Expanded Use Of SPRAVATO - Quick Facts ,RTTNews,/news/stocks/janssen-chmp-recommends-expanded-use-of-spravato-quick-facts-1029885074,neutral,0.6914960145950317
12/12/2020 11:05:53 PM,J&J cuts the size of its COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3643900-j-and-j-cuts-size-of-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9489516019821167
12/12/2020 11:06:41 PM,J&J cuts the size of its COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3643901-j-and-j-cuts-size-of-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9489516019821167
12/14/2020 11:55:50 AM,Novavax Far From Finished In the Race for a Vaccine,InvestorPlace,/news/stocks/novavax-far-from-finished-in-the-race-for-a-vaccine-nvax-stock-1029889699,positive,0.7044731378555298
12/14/2020 5:48:04 PM,8 Retirement Stocks You Can Rely On,InvestorPlace,/news/stocks/8-retirement-investments-you-can-rely-on-1029891268,neutral,0.9319970607757568
12/15/2020 6:35:20 AM,First COVID-19 shot given in U.S. as roll-out begins - WSJ,Seeking Alpha,https://seekingalpha.com/news/3644277-first-covidminus-19-shot-given-in-u-s-roll-out-begins-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7453952431678772
12/15/2020 2:16:41 PM,7 Value Stocks Ready for Rotation,InvestorPlace,/news/stocks/7-value-stocks-ready-for-rotation-1029894555,neutral,0.8775709867477417
12/15/2020 2:49:15 PM,Veracyte broadens the collaboration with JNJ in early cancer detection,Seeking Alpha,https://seekingalpha.com/news/3644460-veracyte-broadens-collaboration-jnj-in-early-cancer-detection?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.850814938545227
12/15/2020 3:56:35 PM,7 Undervalued Stocks That You Shouldn‚Äôt Pass On,InvestorPlace,/news/stocks/7-undervalued-stocks-that-you-shouldnt-pass-on-1029895193,neutral,0.8288981318473816
12/15/2020 4:01:00 PM,Johnson & Johnson -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson,Moodys,/news/bonds/johnson-johnson-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-johnson-johnson-1029894522,neutral,0.8684382438659668
12/16/2020 8:59:10 AM,American public to get vaccine by end of February - HHS Secretary Azar,Seeking Alpha,https://seekingalpha.com/news/3644749-american-public-to-get-vaccine-end-of-february-hhs-secretary-azar?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8035693168640137
12/16/2020 8:59:10 AM,Most of American public may get vaccine by end of February - HHS Secretary Azar,Seeking Alpha,https://seekingalpha.com/news/3644749-of-american-public-may-get-vaccine-end-of-february-hhs-secretary-azar?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8804348707199097
12/16/2020 10:47:45 AM,Micro-cap oncology biotech Scopus Biopharma prices downsized $2.75M IPO,Seeking Alpha,https://seekingalpha.com/news/3644762-micro-cap-oncology-biotech-scopus-biopharma-prices-downsized-2_75m-ipo?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.45263922214508057
12/17/2020 12:49:50 PM,"The Vaccine Race Is Far From Over, And That‚Äôs Good News for Novavax",InvestorPlace,/news/stocks/vaccine-race-far-from-over-good-news-for-nvax-stock-1029902118,positive,0.9128113985061646
12/17/2020 6:51:04 PM,7 Long-Term Stocks for Buffett-Like Investors,InvestorPlace,/news/stocks/7-long-term-stocks-for-buffett-like-investors-1029904001,neutral,0.9292078614234924
12/18/2020 4:23:05 AM,J&J says late-stage COVID vaccine trial fully enrolled,Seeking Alpha,https://seekingalpha.com/news/3645594-j-and-j-says-late-stage-covid-vaccine-trial-fully-enrolled?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.49625274538993835
12/18/2020 11:33:08 AM,EU set to rollout COVID-19 vaccine from December 27 - NYT,Seeking Alpha,https://seekingalpha.com/news/3645629-eu-set-to-rollout-covidminus-19-vaccine-from-december-27-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5515877604484558
12/18/2020 4:21:54 PM,7 of the Best Dividend Aristocrats on the Market¬†,InvestorPlace,/news/stocks/7-of-the-best-stocks-with-dividends-to-own-dividend-aristocrats-1029907361,neutral,0.746008038520813
12/21/2020 9:13:37 AM,GSK: ViiV Healthcare's Vocabria Gets EU Approval To Be Used With Janssen's Rekambys And Edurant ,RTTNews,/news/stocks/gsk-viiv-healthcare-s-vocabria-gets-eu-approval-to-be-used-with-janssen-s-rekambys-and-edurant-1029909538,positive,0.893198549747467
12/21/2020 10:07:08 AM,"ViiV, Janssen's cabotegravir + rilpivirine wins marketing approval in Europe for HIV treatment",Seeking Alpha,https://seekingalpha.com/news/3646055-viiv-janssens-cabotegravir-rilpivirine-wins-marketing-approval-in-europe-for-hiv-treatment?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9421626329421997
12/21/2020 8:00:47 PM,"Janssen, begins rolling submission of marketing application for BCMA Car-T therapy in multiple myeloma",Seeking Alpha,https://seekingalpha.com/news/3646305-janssen-begins-rolling-submission-of-marketing-application-for-bcma-car-t-therapy-in-multiple?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8480440974235535
12/22/2020 12:32:35 AM,"'Pennies: Going In Raw' Hosts Hugh Henne, Dan Deity Join Benzinga's Power Hour",Benzinga,/news/stocks/pennies-going-in-raw-hosts-hugh-henne-dan-deity-join-benzinga-s-power-hour-1029912354,neutral,0.9095208644866943
12/22/2020 10:00:56 AM,Will vaccines work against the U.K. coronavirus variant?,Seeking Alpha,https://seekingalpha.com/news/3646502-will-vaccines-work-against-u-k-coronavirus-variant?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8574072122573853
12/22/2020 12:55:04 PM,Health Canada OK's JNJ unit Janssen's Darzalex combination regimen in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3646563-health-canada-oks-jnj-unit-janssens-darzalex-combination-regimen-in-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.83840411901474
12/22/2020 4:34:09 PM,Veracyte and Bayer collaborate in precision oncology; shares jump +17%,Seeking Alpha,https://seekingalpha.com/news/3646727-veracyte-and-bayer-collaborate-in-precision-oncology-shares-jumpplus-17?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9163143038749695
12/22/2020 5:09:32 PM,4 Dividend Stocks to Help You Prepare for Retirement,InvestorPlace,/news/stocks/4-stocks-with-dividend-to-help-you-prepare-for-retirement-kn-qdf-stor-wba-1029914787,neutral,0.8927888870239258
12/23/2020 3:49:06 PM,The 12 Best Stocks to Buy for a Whole New Year of Returns in 2021,InvestorPlace,/news/stocks/12-best-stocks-to-buy-for-a-whole-new-year-of-returns-in-2021-1029866334,neutral,0.6599867939949036
12/28/2020 11:35:55 AM,"As Vaccine Excitement Fades, Buy the Pullback in Pfizer",InvestorPlace,/news/stocks/vaccine-excitement-fades-buy-pullback-pfizer-pfe-stock-1029921274,neutral,0.8600406646728516
12/29/2020 12:53:33 PM,EMA says AstraZeneca/Oxford COVID-19 jab unfit for January approval,Seeking Alpha,https://seekingalpha.com/news/3647663-ema-says-astrazeneca-oxford-covidminus-19-jab-unfit-for-january-approval?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7875822186470032
12/29/2020 5:47:41 PM,Is Now a Good Time to Buy Moderna Stock?,InvestorPlace,/news/stocks/is-now-a-good-time-to-buy-moderna-stock-1029923962,neutral,0.9269354343414307
12/30/2020 10:01:36 AM,7 Great Index Funds To Help Investors Minimize Risk in a Volatile World,InvestorPlace,/news/stocks/7-great-index-funds-to-help-investors-minimize-risk-in-a-volatile-world-1029924929,neutral,0.7723696827888489
12/31/2020 3:16:42 PM,8 Dental Stocks If You Want to Clean Up,InvestorPlace,/news/stocks/8-dental-stocks-to-buy-if-you-want-to-clean-up-1029927337,neutral,0.9182092547416687
12/31/2020 7:19:38 PM,Why Pfizer is the Cheapest Coronavirus Vaccine Play,InvestorPlace,/news/stocks/pfe-stock-pfizer-does-not-include-value-biontech-and-vaccine-1029927517,neutral,0.868235170841217
12/31/2020 9:34:42 PM,COVID-19 vaccine makers: Looking back on 2020 seeking insights for 2021,Seeking Alpha,https://seekingalpha.com/news/3648143-covidminus-19-vaccine-makers-looking-back-on-2020-seeking-insights-for-2021?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7941462397575378
1/1/2021 1:07:48 PM,Israel leads world in COVID vaccinations per capita,Seeking Alpha,https://seekingalpha.com/news/3648167-israel-leads-world-in-covid-vaccinations-per-capita?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5381579995155334
1/4/2021 1:32:36 PM,Johnson & Johnson declares $1.01 dividend,Seeking Alpha,https://seekingalpha.com/news/3648294-johnson-johnson-declares-1_01-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.930496871471405
1/5/2021 7:36:32 PM,7 Coronavirus Stocks to Buy to Make Mass Vaccination Possible,InvestorPlace,/news/stocks/7-coronavirus-stocks-to-buy-to-make-mass-vaccination-possible-1029935369,neutral,0.8918884992599487
1/6/2021 1:30:57 PM,"The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping",Benzinga,/news/stocks/the-daily-biotech-pulse-aerpio-reviews-strategic-options-hologic-goes-shopping-1029936895,neutral,0.9425970911979675
1/7/2021 2:20:50 PM,"The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration",Benzinga,/news/stocks/the-daily-biotech-pulse-curevac-covid-19-vaccine-deal-argenx-out-licenses-neuromuscular-disorder-drug-xencor-s-oncology-collaboration-1029940542,neutral,0.875293493270874
1/8/2021 11:02:18 AM,Oncology Biotech company Cullinan Management prices upsized IPO above expected range,Seeking Alpha,https://seekingalpha.com/news/3649849-oncology-biotech-company-cullinan-management-prices-upsized-ipo-above-expected-range?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8862261176109314
1/8/2021 12:06:38 PM,EU secures 300M more doses of Pfizer-BioNTech jab,Seeking Alpha,https://seekingalpha.com/news/3649872-eu-secures-300m-doses-of-pfizer-biontech-jab?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9031215906143188
1/8/2021 1:25:06 PM,"The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-sarepta-gene-therapy-study-readout-novavax-vaccine-supply-deal-2-ipos-1029943328,neutral,0.9024239182472229
1/8/2021 3:41:14 PM,"As Competition Rises, the Bull Case for Moderna Stock Is Beginning to Fade",InvestorPlace,/news/stocks/bull-case-mrna-stock-beginning-to-fade-1029944159,neutral,0.6915837526321411
1/8/2021 5:44:30 PM,SPY Stock Is Headed Higher Over Time,InvestorPlace,/news/stocks/spy-stock-is-headed-higher-over-time-1029944373,positive,0.8601378798484802
1/11/2021 12:56:47 PM,JNJ‚Äôs single-dose COVID-19 vaccine viewed favorably by analysts,Seeking Alpha,https://seekingalpha.com/news/3650208-jnj-s-single-dose-covidminus-19-vaccine-viewed-favorably-analysts?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9441753625869751
1/11/2021 3:32:35 PM,NVAX Stock Is Worth a Small Position but Vaccine Race Is Tightening,InvestorPlace,/news/stocks/nvax-stock-is-worth-a-small-position-but-vaccine-race-is-tightening-1029956501,neutral,0.5928688645362854
1/11/2021 4:19:50 PM,Stocks That Hit 52-Week Highs On Monday,Benzinga,/news/stocks/stocks-that-hit-52-week-highs-on-monday-1029956096,neutral,0.6719289422035217
1/11/2021 4:59:22 PM,The Top 7 Pharmaceutical Stocks for the Next 10 Years¬†,InvestorPlace,/news/stocks/the-top-7-pharmaceutical-stocks-for-the-next-10-years-1029956488,neutral,0.8569135665893555
1/11/2021 6:22:46 PM,Novavax executives sold $46M worth company shares in 2020 ‚Äì Reuters,Seeking Alpha,https://seekingalpha.com/news/3650426-novavax-executives-sold-46m-worth-company-shares-in-2020-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9496198296546936
1/11/2021 8:36:50 PM,8 Value Stocks That Could Perform Surprisingly Well In 2021,InvestorPlace,/news/stocks/8-value-stocks-that-could-perform-surprisingly-well-in-2021-1029957111,positive,0.8532679080963135
1/12/2021 1:49:49 PM,South Korea nears deal to buy Novavax COVID-19 Vaccines - report,Seeking Alpha,https://seekingalpha.com/news/3650682-south-korea-nears-deal-to-buy-novavax-covidminus-19-vaccines-report?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.585419774055481
1/12/2021 2:15:54 PM,"The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue",Benzinga,/news/stocks/the-daily-biotech-pulse-gsk-vir-to-start-covid-19-antibody-study-novartis-in-licenses-beigene-s-cancer-drug-earnings-preannouncements-continue-1029959657,neutral,0.925715982913971
1/12/2021 7:05:42 PM,The 7 Best Startups You Can Buy on SeedInvest Right Now,InvestorPlace,/news/stocks/the-7-best-startups-you-can-buy-on-seedinvest-right-now-invest-in-startups-1029798071,neutral,0.9125548005104065
1/12/2021 10:22:17 PM,JNJ's COVID-19 jab could receive emergency approval by next month: Official,Seeking Alpha,https://seekingalpha.com/news/3650838-jnjs-covidminus-19-jab-receive-emergency-approval-next-month-official?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6049840450286865
1/13/2021 1:25:58 PM,Johnson & Johnson's Imbruvica combo OK'd in Canada in CLL setting,Seeking Alpha,https://seekingalpha.com/news/3651021-johnson-johnsons-imbruvica-combo-okd-in-canada-in-cll-setting?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8355762958526611
1/13/2021 1:35:02 PM,ESSA Pharma and Janssen to test combo treatments in prostate cancer setting,Seeking Alpha,https://seekingalpha.com/news/3651023-essa-pharma-and-janssen-to-test-combo-treatments-in-prostate-cancer-setting?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5366947650909424
1/13/2021 4:42:10 PM,"Johnson & Johnson vaccine results to arrive, supply lags - NYT",Seeking Alpha,https://seekingalpha.com/news/3651149-johnson-johnson-vaccine-results-to-arrive-supply-lags-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9454994201660156
1/13/2021 4:42:10 PM,"Johnson & Johnson vaccine results to arrive, supply lags - NYT (Updated)",Seeking Alpha,https://seekingalpha.com/news/3651149-johnson-johnson-vaccine-results-to-arrive-supply-lags-nyt-updated?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7761892676353455
1/13/2021 7:51:59 PM,7 Pharmaceutical Stocks With Exciting Plans for 2021,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-with-exciting-plans-for-2021-1029966098,neutral,0.7265647649765015
1/13/2021 10:47:43 PM,JNJ‚Äôs COVID-19 vaccine data published in Medical Journal,Seeking Alpha,https://seekingalpha.com/news/3651315-jnj-s-covidminus-19-vaccine-data-published-in-medical-journal?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9214857220649719
1/14/2021 10:41:17 AM,"5 Stocks To Watch For January 14, 2021",Benzinga,/news/stocks/5-stocks-to-watch-for-january-14-2021-1029967453,neutral,0.8921884894371033
1/14/2021 11:15:53 AM,"Johnson & Johnson's Covid-19 Vaccine Safe, Well-tolerated ",RTTNews,/news/stocks/johnson-johnson-s-covid-19-vaccine-safe-well-tolerated-1029967588,positive,0.8248220682144165
1/14/2021 12:09:08 PM,"A Peek Into The Markets: US Stock Futures Mostly Higher Ahead Of Jobless Claims, Fed's Powell Speech",Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mostly-higher-ahead-of-jobless-claims-fed-s-powell-speech-1029967735,positive,0.6287519335746765
1/14/2021 1:56:59 PM,"The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates",Benzinga,/news/stocks/the-daily-biotech-pulse-alexion-pauses-covid-19-study-nantkwest-readout-organogenesis-jumps-on-guidance-trial-updates-1029968277,neutral,0.9080523252487183
1/14/2021 5:59:22 PM,7 Great Index Funds To Buy With Super Low Fees,InvestorPlace,/news/stocks/7-great-index-funds-with-super-low-fees-1029970330,neutral,0.902972400188446
1/14/2021 8:34:12 PM,Invitae teams up with healthcare giants to develop MRD detection panel,Seeking Alpha,https://seekingalpha.com/news/3651590-invitae-teams-up-healthcare-giants-to-develop-mrd-detection-panel?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7389798164367676
1/14/2021 9:32:48 PM,Netflix Stock Remains Well Ahead of the Competition,InvestorPlace,/news/stocks/netflix-nflx-stock-remains-well-ahead-of-the-competition-1029971027,positive,0.8825384974479675
1/15/2021 1:32:12 PM,"The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges",Benzinga,/news/stocks/the-daily-biotech-pulse-dbv-s-positive-fda-feedback-pfizer-s-cancer-drug-gets-label-expansion-applied-dna-covid-testing-volume-surges-1029972538,positive,0.9414129853248596
1/15/2021 8:01:15 PM,Genmab's therapy for AL amyloidosis receives FDA approval,Seeking Alpha,https://seekingalpha.com/news/3651950-genmabs-therapy-for-al-amyloidosis-receives-fda-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8854876756668091
1/19/2021 4:50:45 PM,"Why Aclaris, Tenax, Gritstone, Merus, Minerva And Celyad Are Rallying Today",Benzinga,/news/stocks/why-aclaris-tenax-gritstone-merus-minerva-and-celyad-are-rallying-today-1029982313,positive,0.6973776817321777
1/19/2021 8:27:33 PM,B.Riley downgrades Arcturus on 'broken narrative' for its ARCT-021 COVID-19 vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/3652405-briley-downgrades-arcturus-on-broken-narrative-for-its-arct-021-covid-19-vaccine-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9456908702850342
1/19/2021 8:48:27 PM,The 7 Best Stocks To Buy In The Dow Jones¬†Today,InvestorPlace,/news/stocks/the-7-best-stocks-to-buy-in-the-dow-jones-today-1029983307,neutral,0.8546462655067444
1/20/2021 1:32:35 PM,"The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-greenlights-merck-s-heart-failure-drug-histogen-hit-with-clinical-hold-aptorum-gets-nod-for-commencing-human-study-1029985849,neutral,0.4865671396255493
1/20/2021 3:24:21 PM,The 7 Best Healthcare Stocks to Buy for 2021,InvestorPlace,/news/stocks/the-7-best-healthcare-stocks-to-buy-for-2021-1029987247,neutral,0.8175721168518066
1/20/2021 4:03:11 PM,9 Beginner Stocks for First-Time Investors,InvestorPlace,/news/stocks/9-beginner-stocks-for-first-time-investors-to-buy-1029987242,neutral,0.9392744898796082
1/20/2021 4:52:55 PM,Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today,InvestorPlace,/news/stocks/covid-19-vaccine-5-pharma-stocks-headlines-today-nvax-stock-bntx-stock-1029987235,neutral,0.7466533780097961
1/21/2021 7:32:45 AM,"Addex, Janssen Pharma on go with Phase 2a study of JNJ-40411813 (ADX71149) in epilepsy",Seeking Alpha,https://seekingalpha.com/news/3652974-addex-janssen-pharma-on-go-with-phase-2a-study-of-jnj-40411813-adx71149-in-epilepsy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5288490056991577
1/21/2021 2:05:24 PM,"The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping",Benzinga,/news/stocks/the-daily-biotech-pulse-addex-jumps-on-positive-data-for-out-licensed-drug-covid-19-vaccine-developer-inovio-announces-150m-follow-on-offering-boston-scientific-goes-shopping-1029990203,positive,0.772029459476471
1/21/2021 2:59:40 PM,Epilepsy Drug News: Why Addex Therapeutics (ADXN) Stock Is Soaring Today,InvestorPlace,/news/stocks/epilepsy-drug-news-why-addex-therapeutics-adxn-stock-is-soaring-today-1029991037,positive,0.9405460357666016
1/22/2021 4:51:44 AM,FDA OK's Janssen's HIV drug combo Cabenuva,Seeking Alpha,https://seekingalpha.com/news/3653426-fda-oks-janssens-hiv-drug-combo-cabenuva?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5732328295707703
1/22/2021 9:20:13 AM,Why is the U.S. vaccine rollout taking longer than expected?,Seeking Alpha,https://seekingalpha.com/news/3653444-why-is-us-vaccine-rollout-taking-longer-than-expected?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6498690843582153
1/22/2021 1:22:34 PM,"The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa",Benzinga,/news/stocks/the-daily-biotech-pulse-fluidigm-s-saliva-based-covid-test-approved-in-europe-china-backs-amarin-s-vascepa-1029993832,neutral,0.8599370121955872
1/22/2021 10:13:36 PM,The Best 4 Pharmaceutical Stocks to Buy in Any Climate,InvestorPlace,/news/stocks/the-best-4-pharmaceutical-stocks-to-buy-in-any-climate-1030014921,neutral,0.7539843320846558
1/22/2021 10:36:45 PM,"'Halftime Report' Picks For January 22: Apple, KLA And More",Benzinga,/news/stocks/halftime-report-picks-for-january-22-apple-kla-and-more-1029995458,neutral,0.9432129859924316
1/23/2021 3:14:04 PM,"The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-24-30-j-j-lilly-to-kickstart-big-pharma-earnings-amgen-fda-decision-and-more-1029996049,positive,0.6939190030097961
1/24/2021 3:01:22 PM,Johnson Johnson earnings preview: what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-q4-earnings-preview-stock-1029996631,neutral,0.9182448983192444
1/24/2021 3:46:36 PM,COVID vaccines for kids? Trials are underway,Seeking Alpha,https://seekingalpha.com/news/3653738-covid-vaccines-for-kids-trials-are-underway?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.901797354221344
1/25/2021 3:43:35 PM,5 Biden-Friendly Warren Buffett Stocks to Load Up On,InvestorPlace,/news/stocks/5-biden-friendly-warren-buffett-stocks-to-load-up-on-ko-gm-jnj-tmus-mco-1030000374,positive,0.815793514251709
1/25/2021 6:19:43 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3654000-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8660829067230225
1/25/2021 6:27:17 PM,Johnson & Johnson Q4 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3654012-johnson-amp-johnson-q4-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7879979610443115
1/25/2021 10:21:16 PM,"4 Top Stock Trades for Tuesday: GME, CLX, JNJ, MCD",InvestorPlace,/news/stocks/4-top-stock-trades-for-tuesday-gme-clx-jnj-mcd-1030001230,neutral,0.9240514039993286
1/26/2021 11:00:58 AM,Can GameStop Short Squeeze Bring Down The Market? What The Experts Are Saying,Benzinga,/news/stocks/can-gamestop-short-squeeze-bring-down-the-market-what-the-experts-are-saying-1030003051,neutral,0.6139844655990601
1/26/2021 11:44:00 AM,"Johnson & Johnson EPS beats by $0.03, beats on revenue, guides FY21 above consensus",Seeking Alpha,https://seekingalpha.com/news/3654230-johnson-amp-johnson-eps-beats-by-003-beats-on-revenue-guides-fy21-above-consensus?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9039775729179382
1/26/2021 12:11:30 PM,"J&J tops Q4 forecast, guides FY2021 outlook above consensus",Seeking Alpha,https://seekingalpha.com/news/3654249-jj-tops-q4-forecast-guides-fy2021-outlook-above-consensus?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8779662251472473
1/26/2021 12:46:16 PM,Johnson & Johnson Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q4-adjusted-earnings-beat-estimates-1030003402,positive,0.7201697826385498
1/26/2021 12:59:52 PM,Johnson & Johnson Projects 2021 Adjusted Operational EPS Growth Of 16.4% - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-projects-2021-adjusted-operational-eps-growth-of-16-4-quick-facts-1030003424,positive,0.9125191569328308
1/26/2021 1:53:45 PM,MeiraGTx's AAV-CNGA3 Fast Track'd in U.S. for inherited retinal disease,Seeking Alpha,https://seekingalpha.com/news/3654336-meiragtxs-aav-cnga3-fast-trackd-in-us-for-inherited-retinal-disease?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8919894695281982
1/26/2021 2:07:40 PM,"The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market",Benzinga,/news/stocks/the-daily-biotech-pulse-novartis-misses-j-j-beats-in-big-pharma-earnings-vaccine-developer-curevac-taps-equity-market-1030004007,positive,0.7611163258552551
1/26/2021 4:16:59 PM,"Johnson & Johnson expects to release COVID-19 vaccine results next week, CFO tells CNBC",Seeking Alpha,https://seekingalpha.com/news/3654321-johnson-johnson-expects-to-release-covid-19-vaccine-results-next-week-cfo-tells-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8813976049423218
1/26/2021 5:38:19 PM,JNJ earnings release brightens U.S. biopharma outlook - BofA,Seeking Alpha,https://seekingalpha.com/news/3654484-jnj-earnings-release-brightens-us-biopharma-outlook-bofa?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.36322590708732605
1/27/2021 8:56:46 AM,"AGIO's ACTIVATE-T Hits Goals, EDSA Catches Eye, JNJ Provides Rosy Outlook, VXRT On Watch ",RTTNews,/news/stocks/agio-s-activate-t-hits-goals-edsa-catches-eye-jnj-provides-rosy-outlook-vxrt-on-watch-1030008289,positive,0.8746796250343323
1/27/2021 1:35:59 PM,"The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement",Benzinga,/news/stocks/the-daily-biotech-pulse-sorrento-immutep-surge-on-covid-19-study-data-t2-biosystems-sinks-on-preannouncement-1030009241,neutral,0.8347623944282532
1/27/2021 2:15:11 PM,"As It Hits $100M In Assets Under Management, XOUT Proves Exclusion Matters",Benzinga,/news/etf/as-it-hits-100m-in-assets-under-management-xout-proves-exclusion-matters-1030009668,positive,0.45896294713020325
1/27/2021 2:19:05 PM,10 Biggest Price Target Changes For Wednesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-wednesday-1030009667,neutral,0.8142693638801575
1/27/2021 2:41:14 PM,First Psychedelics ETF Debuts On NEO Exchange,Benzinga,/news/stocks/first-psychedelics-etf-debuts-on-neo-exchange-1030009809,neutral,0.9312703609466553
1/27/2021 3:52:54 PM,"Johnson & Johnson could have 'tens of millions' of COVID-19 doses by end of February, Gottlieb says",Seeking Alpha,https://seekingalpha.com/news/3654948-johnson-johnson-could-have-tens-of-millions-of-covid-19-doses-by-end-of-march-gottlieb-says?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7929227948188782
1/27/2021 6:43:34 PM,7 Reliable Index Funds To Set And Forget For The Long Term,InvestorPlace,/news/stocks/7-reliable-index-funds-to-set-and-forget-for-the-long-term-1030011503,neutral,0.8705222010612488
1/28/2021 5:03:51 PM,How to Ride the Covid-19 Bull with Moderna,InvestorPlace,/news/stocks/how-to-ride-covid-19-bull-moderna-stock-1030016518,neutral,0.9071888327598572
1/29/2021 12:02:52 AM,"Major pharma set for strong 2021, and trading at a 35% discount to market - J.P. Morgan",Seeking Alpha,https://seekingalpha.com/news/3655985-major-pharma-set-for-strong-2021-and-trading-at-a-35-discount-to-market-jp-morgan?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.795691192150116
1/29/2021 10:20:35 AM,"Once approved, J&J to initiate U.S. supply of COVID-19 vaccine with 2M doses - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3656030-once-approved-jj-to-initiate-us-supply-of-covid-19-vaccine-with-2m-doses-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49992233514785767
1/29/2021 1:16:24 PM,Johnson & Johnson COVID-19 vaccine 66% effective in global trial,Seeking Alpha,https://seekingalpha.com/news/3656132-johnson-johnson-covid-19-vaccine-66-effective-in-global-trial?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9030652046203613
1/29/2021 1:46:43 PM,"Moderna, BioNTech, Pfizer surge after JNJ COVID-19 vaccine data",Seeking Alpha,https://seekingalpha.com/news/3656159-moderna-biontech-pfizer-surge-after-jnj-covid-19-vaccine-data?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7786167860031128
1/29/2021 1:53:34 PM,NVAX Stock: Why Novavax Shares Are Shooting Higher Today,InvestorPlace,/news/stocks/nvax-stock-why-novavax-shares-are-shooting-higher-today-1030020363,positive,0.8415889143943787
1/29/2021 2:19:28 PM,Inovio climbs in premarket after JNJ COVID-19 vaccine data,Seeking Alpha,https://seekingalpha.com/news/3656197-inovio-climbs-in-premarket-after-jnj-covid-19-vaccine-data?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8005198836326599
1/29/2021 2:31:10 PM,"J&J COVID-19 Vaccine Shows Complete Protection Against Hospitalization, 28 Days Post-vaccination ",RTTNews,/news/stocks/j-j-covid-19-vaccine-shows-complete-protection-against-hospitalization-28-days-post-vaccination-1030019893,positive,0.9198630452156067
1/29/2021 3:33:02 PM,Dow slides 200 points on concerns of retail investors' speculative trading,Business Insider,https://www.businessinsider.com/stock-market-news-today-indexes-reddit-trader-speculation-vaccine-data-2021-1,negative,0.9311950206756592
1/29/2021 6:19:49 PM,JNJ COVID-19 vaccine will be a key contributor to normalcy ‚Äì BofA,Seeking Alpha,https://seekingalpha.com/news/3656303-jnj-covid-19-vaccine-will-be-key-contributor-for-normalcy-bofa?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6369916200637817
1/29/2021 8:30:31 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3656322-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8980498313903809
1/30/2021 7:19:15 PM,"The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-merck-pfizer-in-earnings-mix-plus-adamas-mallinckrodt-fda-decisions-ipos-and-more-1030022250,neutral,0.8783654570579529
1/31/2021 2:31:04 PM,Don‚Äôt Overlook These 3 Dividend Kings,InvestorPlace,/news/stocks/dont-overlook-these-3-dividend-kings-1030023138,neutral,0.898318350315094
2/1/2021 1:05:13 PM,"Moderna cut to underperform at BofA, with sales estimates 'unrealistic'",Seeking Alpha,https://seekingalpha.com/news/3656554-moderna-downgraded-to-underperform-at-bofa-citing-valuation?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9607189893722534
2/1/2021 3:09:27 PM,CanSino to further advance late-stage trial for COVID-19 shot after interim analysis,Seeking Alpha,https://seekingalpha.com/news/3656650-cansino-to-further-advance-late-stage-trial-for-covid-19-shot-after-interim-analysis?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8015663027763367
2/1/2021 4:40:03 PM,7 Blue Chip Stocks to Help Prepare For Your Retirement,InvestorPlace,/news/stocks/7-blue-chip-stocks-help-prepare-your-retirement-1030028811,neutral,0.8655566573143005
2/1/2021 6:29:28 PM,Moderna Analyst: Unrealistic COVID-19 Vaccine Expectations Create Unfavorable Setup,Benzinga,/news/stocks/moderna-analyst-unrealistic-covid-19-vaccine-expectations-create-unfavorable-setup-1030028936,negative,0.9562427401542664
2/2/2021 9:58:12 AM,"Dosing underway in Janssen, Exonate's study of EXN 407 in diabetic macular oedema",Seeking Alpha,https://seekingalpha.com/news/3657037-dosing-underway-in-janssen-exonates-study-of-exn-407-in-diabetic-macular-oedema?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.600929856300354
2/2/2021 3:09:53 PM,8 Dividend Stocks With a Decade of Dividend Increases,InvestorPlace,/news/stocks/8-dividend-stocks-decade-dividend-increases-jnj-sjm-por-bokf-iff-o-avgo-cmcsa-1030034395,neutral,0.8395258784294128
2/2/2021 3:09:53 PM,8 Dividend Stocks With a Decade of Dividend Increases,InvestorPlace,/news/stocks/8-dividend-stocks-decade-dividend-increases-1030033865,neutral,0.8395258784294128
2/2/2021 4:22:56 PM,7 Stocks to Buy for the Long Run,InvestorPlace,/news/stocks/7-stocks-to-buy-for-the-long-run-1030034388,neutral,0.8695150017738342
2/2/2021 9:11:16 PM,JNJ receives FDA approval for monofocal intraocular lens,Seeking Alpha,https://seekingalpha.com/news/3657456-jnj-receives-fda-approval-for-monofocal-intraocular-lens?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9305832982063293
2/3/2021 10:16:07 AM,Read the Label Carefully Before Gambling on Ocugen Stock,InvestorPlace,/news/stocks/read-label-carefully-ocgn-stock-1030037523,neutral,0.9292657375335693
2/4/2021 12:52:45 PM,"Sana prices upsized IPO at $25, above the expected range, trades today",Seeking Alpha,https://seekingalpha.com/news/3658334-sana-prices-upsized-ipo-at-25-above-the-expected-range-trades-today?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8467883467674255
2/4/2021 10:55:26 PM,Johnson & Johnson applies for emergency use OK for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3658893-johnson-johnson-applies-for-emergency-use-ok-for-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8062295317649841
2/5/2021 2:55:57 AM,J&J Seeks FDA Emergency Authorization For World's First Single-dose Covid-19 Vaccine ,RTTNews,/news/stocks/j-j-seeks-fda-emergency-authorization-for-world-s-first-single-dose-covid-19-vaccine-1030046218,positive,0.7679904699325562
2/5/2021 8:38:02 AM,"JNJ Single-shot COVID-19 Vaccine At FDA Altar, KPTI Expands Xpovio's Footprint, OTLK On Track ",RTTNews,/news/stocks/jnj-single-shot-covid-19-vaccine-at-fda-altar-kpti-expands-xpovio-s-footprint-otlk-on-track-1030047435,positive,0.9038210511207581
2/5/2021 10:23:40 AM,"8 Stocks To Watch For February 5, 2021",Benzinga,/news/stocks/8-stocks-to-watch-for-february-5-2021-1030047675,neutral,0.8677323460578918
2/5/2021 11:13:17 AM,Bolt Biotherapeutics raises $230M in IPO,Seeking Alpha,https://seekingalpha.com/news/3658964-bolt-biotherapeutics-raises-230m-in-ipo?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6293282508850098
2/5/2021 11:58:38 AM,"Cell therapy biotech Vor Biopharma prices upsized IPO at $18/share, trades today",Seeking Alpha,https://seekingalpha.com/news/3658982-cell-therapy-biotech-vor-biopharma-prices-upsized-ipo-at-18share-trades-today?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8695681095123291
2/5/2021 1:44:38 PM,"The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-files-for-covid-19-vaccine-approval-zimmer-biomet-s-spin-off-ipo-deluge-hits-street-1030048263,neutral,0.7921035885810852
2/5/2021 7:23:28 PM,3 Downtrodden Stocks to Buy as the Crowds Return,InvestorPlace,/news/stocks/3-downtrodden-stocks-to-buy-as-the-crowds-return-1030049778,neutral,0.754991888999939
2/9/2021 12:16:24 PM,JNJ‚Äôs Erleada yields positive data in late-stage trial for prostate cancer,Seeking Alpha,https://seekingalpha.com/news/3659881-jnjs-erleada-yields-positive-data-in-late-stage-trial-for-prostate-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9539297223091125
2/9/2021 1:50:53 PM,7 Blue-Chip Stocks With Gains and Pedigree,InvestorPlace,/news/stocks/7-blue-chip-stocks-with-gains-and-pedigree-1030061482,positive,0.7797935009002686
2/9/2021 6:27:58 PM,7 Safe Stocks for Reddit‚Äôs WSB Bull Gang,InvestorPlace,/news/stocks/7-safe-stocks-for-reddits-wsb-bull-gang-rkt-ibm-baba-mmm-jnj-ko-net-1030062358,neutral,0.9133846759796143
2/10/2021 7:56:54 AM,"South Africa to discontinue AstraZeneca vaccine, will give J&J shots",Seeking Alpha,https://seekingalpha.com/news/3660358-south-africa-to-discontinue-astrazeneca-vaccine-will-give-jj-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9134740233421326
2/10/2021 9:02:19 AM,Expect annual COVID shots for the next several years - Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3660361-expect-annual-covid-shots-for-the-next-several-years-johnson-johnson?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8858146667480469
2/10/2021 6:10:49 PM,PhaseBio shares spike 22% in afternoon trading,Seeking Alpha,https://seekingalpha.com/news/3660706-phasebio-shares-spike-22-in-afternoon-trading?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9363283514976501
2/10/2021 8:45:02 PM,JNJ cloud transition leads BTIG to raise Model N to buy,Seeking Alpha,https://seekingalpha.com/news/3660770-jnj-cloud-transition-leads-btig-to-raise-model-n-to-buy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5770919919013977
2/11/2021 1:40:41 PM,AC Immune and JNJ‚Äôs Alzheimer‚Äôs jab succeeds in early-stage study,Seeking Alpha,https://seekingalpha.com/news/3661202-ac-immune-and-jnjs-alzheimers-jab-succeeds-in-early-stage-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.860028862953186
2/11/2021 2:16:05 PM,AC Immune's Alzheimer's Vaccine Candidate Elicit Response In Early-Stage Study; Shares Rally,Benzinga,/news/stocks/ac-immune-s-alzheimer-s-vaccine-candidate-elicit-response-in-early-stage-study-shares-rally-1030072705,positive,0.8289857506752014
2/11/2021 3:14:41 PM,ACIU Stock: Why AC Immune Shares Are Rocketing Higher Today,InvestorPlace,/news/stocks/aciu-stock-why-ac-immune-shares-are-rocketing-higher-today-1030073976,positive,0.8638255596160889
2/11/2021 5:11:17 PM,Cardiff Oncology's Onvansertib Combo Associated With Two-Fold Increase Disease Control Rate In Prostate Cancer Study,Benzinga,/news/stocks/cardiff-oncology-s-onvansertib-combo-associated-with-two-fold-increase-disease-control-rate-in-prostate-cancer-study-1030073754,negative,0.45165932178497314
2/11/2021 5:25:26 PM,COVID-19 vaccination to cover 75% of U.S. adults by mid-summer: Morgan Stanley,Seeking Alpha,https://seekingalpha.com/news/3661304-covid-19-vaccination-to-cover-three-quarters-of-us-adults-by-summer-morgan-stanley?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6417351365089417
2/11/2021 8:57:13 PM,Biden to announce a deal for another 200M doses of COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3661377-biden-to-announce-a-deal-for-another-200m-doses-of-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7597878575325012
2/13/2021 9:00:00 PM,"Pharmas engaged in Alzheimer's, the 'holy grail' of drug development",Seeking Alpha,https://seekingalpha.com/news/3661766-pharmas-engaged-in-alzheimers-the-holy-grail-of-drug-development?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8926675915718079
2/15/2021 12:42:46 PM,South Africa gives green light to J&J's vaccine implementation study,Seeking Alpha,https://seekingalpha.com/news/3661980-south-africa-gives-green-light-to-jjs-vaccine-implementation-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8674966096878052
2/16/2021 3:18:43 PM,Novavax U.S. trial enrollment for COVID-19 shot is nearing completion: CEO,Seeking Alpha,https://seekingalpha.com/news/3662269-novavax-us-trial-enrollment-for-covid-19-shot-is-nearing-completion-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6466667056083679
2/16/2021 6:07:34 PM,JNJ files for conditional approval for COVID-19 vaccine in Europe,Seeking Alpha,https://seekingalpha.com/news/3662377-jnj-seeks-conditional-approval-for-covid-19-vaccine-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7011618614196777
2/17/2021 7:56:35 PM,7 Blue-Chip Stocks That Aren‚Äôt a Gamble,InvestorPlace,/news/stocks/7-blue-chip-stocks-that-arent-a-gamble-1030094166,neutral,0.9075456857681274
2/18/2021 11:45:43 AM,COVID-19 vaccine developers to benefit from supply constraints and uneven distribution,Seeking Alpha,https://seekingalpha.com/news/3663356-covid-19-vaccine-developers-to-benefit-from-supply-constraints-and-uneven-distribution?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7471149563789368
2/18/2021 2:23:25 PM,Here's Why High Dividend Stocks Remain An Attractive Choice,Benzinga,/news/stocks/here-s-why-high-dividend-stocks-remain-an-attractive-choice-1030097073,neutral,0.7893074750900269
2/18/2021 7:55:46 PM,NVAX Stock Is the Most Undervalued Vaccine Maker for Endemic Covid-19,InvestorPlace,/news/stocks/nvax-stock-most-undervalued-vaccine-maker-endemic-covid-19-1030099038,negative,0.6225305795669556
2/19/2021 12:59:04 PM,JNJ seeks WHO emergency use nod for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3663893-jnj-seeks-who-emergency-use-nod-for-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8651226162910461
2/19/2021 2:02:36 PM,Johnson & Johnson Seeks Emergency WHO Nod For Single-dose COVID-19 Vaccine ,RTTNews,/news/stocks/johnson-johnson-seeks-emergency-who-nod-for-single-dose-covid-19-vaccine-1030101439,neutral,0.7020782232284546
2/20/2021 3:36:28 PM,"The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings",Benzinga,/news/stocks/the-week-ahead-in-biotech-j-j-vaccine-adcom-meeting-sarepta-fda-decision-and-plenty-of-earnings-1030104010,neutral,0.8801166415214539
2/21/2021 4:18:07 AM,A new model shows U.S. could reach COVID-19 herd immunity by July,Seeking Alpha,https://seekingalpha.com/news/3664177-a-new-model-shows-us-could-reach-covid-19-herd-immunity-by-july?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6344992518424988
2/22/2021 11:32:32 AM,Sanofi to support JNJ in manufacturing of COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3664218-sanofi-to-support-jnj-in-manufacturing-of-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8440607190132141
2/22/2021 2:07:58 PM,Six stocks hedge funds and mutual funds love (and 20 they don't): At the Open,Seeking Alpha,https://seekingalpha.com/news/3664311-six-stocks-hedge-funds-and-mutual-funds-love?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9283661842346191
2/23/2021 2:25:13 AM,"J&J sets aside $3.9B for talc verdict, settlements",Seeking Alpha,https://seekingalpha.com/news/3664687-jj-sets-aside-39b-for-talc-verdict-settlements?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9045208692550659
2/23/2021 3:38:06 AM,"Johnson & Johnson Sets Aside $3.9 Bln For Baby Powder Verdict, Settlements ",RTTNews,/news/stocks/johnson-johnson-sets-aside-3-9-bln-for-baby-powder-verdict-settlements-1030109923,neutral,0.7789364457130432
2/23/2021 5:41:49 PM,Johnson & Johnson plans 20M COVID-19 vaccine doses by end of March,Seeking Alpha,https://seekingalpha.com/news/3665028-johnson-johnson-plans-20m-covid-19-vaccine-doses-by-end-of-march?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9038833379745483
2/23/2021 7:02:29 PM,Why You Should Keep Your Distance from Ocugen Stock,InvestorPlace,/news/stocks/ocgn-stock-stay-your-distance-from-ocugen-1030114797,neutral,0.9112825393676758
2/24/2021 1:17:19 PM,RLFTF: Why Little-Known Relief Therapeutics Is Climbing Today,InvestorPlace,/news/stocks/rlftf-why-little-known-relief-therapeutics-is-climbing-today-brpa-stock-1030119085,positive,0.606799304485321
2/24/2021 1:44:53 PM,FDA staff finds J&J COVID vaccine effective ahead of review,Seeking Alpha,https://seekingalpha.com/news/3665494-jnj-covid-19-vaccine-fda-releases-briefing-documents-ahead-of-review?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9339909553527832
2/24/2021 3:03:19 PM,What Will the Stock Market Do Today? 4 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-big-stories-rfltf-stock-wkhs-stock-fsr-stock-1030119078,neutral,0.928909957408905
2/24/2021 4:08:48 PM,"United Airlines, Royal Caribbean lead travel and leisure stocks higher",Seeking Alpha,https://seekingalpha.com/news/3665590-united-airlines-royal-caribbean-lead-travel-and-leisure-stocks-higher?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9054601788520813
2/24/2021 5:52:47 PM,"Airline Stocks: 2 Big Reasons AAL, DAL and UAL Stock Are Soaring Today",InvestorPlace,/news/stocks/airline-stocks-2-big-reasons-aal-dal-and-ual-stock-are-soaring-today-1030119942,negative,0.5683374404907227
2/24/2021 7:57:21 PM,ABNB Stock: Why Airbnb Is Booking Big Gains Today,InvestorPlace,/news/stocks/abnb-stock-why-airbnb-is-booking-big-gains-today-q4-earnings-1030120277,positive,0.907372236251831
2/25/2021 7:29:12 AM,Johnson & Johnson Single-dose COVID Vaccine Safe And Effective: FDA ,RTTNews,/news/stocks/johnson-johnson-single-dose-covid-vaccine-safe-and-effective-fda-1030121922,neutral,0.7928737998008728
2/25/2021 3:22:19 PM,5 Surefire Stocks If the Market Crashes,InvestorPlace,/news/stocks/5-surefire-stocks-if-the-market-crash-1030125308,neutral,0.8703123927116394
2/26/2021 12:00:07 PM,J&J‚Äôs COVID-19 vaccine set to undergo FDA review; EU review set for early March,Seeking Alpha,https://seekingalpha.com/news/3667041-jjs-covid-19-vaccine-set-to-undergo-fda-review-eu-review-set-for-early-march?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8958114981651306
2/26/2021 2:16:52 PM,"The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida",Benzinga,/news/stocks/the-daily-biotech-pulse-adcom-test-awaits-j-j-s-covid-19-vaccine-lilly-to-supply-additional-antibody-therapy-doses-to-us-regulatory-setback-for-tricida-1030129439,negative,0.9285117387771606
2/26/2021 3:20:06 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-hmbl-tsnp-stock-tsnpd-jnj-abnb-stock-1030130462,neutral,0.9298974871635437
2/26/2021 10:10:23 PM,Johnson & Johnson rises as COVID-19 vaccine clears FDA panel vote,Seeking Alpha,https://seekingalpha.com/news/3667371-johnson-johnson-rises-as-covid-19-vaccine-clears-fda-panel-vote?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6096550226211548
2/27/2021 3:53:56 PM,FDA Says 'rapidly Works Toward' Emergency Use Approval Of J&J's Single-shot COVID-19 Vaccine ,RTTNews,/news/stocks/fda-says-rapidly-works-toward-emergency-use-approval-of-j-j-s-single-shot-covid-19-vaccine-1030131785,positive,0.895912230014801
2/27/2021 11:21:57 PM,Johnson & Johnson COVID-19 vaccine wins FDA's emergency-use approval,Seeking Alpha,https://seekingalpha.com/news/3667403-johnson-johnson-covid-19-vaccine-wins-fdas-emergency-use-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.920475423336029
2/28/2021 3:04:59 AM,JNJ to deliver fewer COVID-19 vaccine doses amid production problems: FT,Seeking Alpha,https://seekingalpha.com/news/3667406-jnj-to-deliver-fewer-covid-19-vaccine-doses-amid-production-problems-ft?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.787112832069397
2/28/2021 5:52:51 AM,FDA Authorizes Emergency Use Of Johnson & Johnson's Single-dose COVID-19 Vaccine ,RTTNews,/news/stocks/fda-authorizes-emergency-use-of-johnson-johnson-s-single-dose-covid-19-vaccine-1030131930,neutral,0.8950533270835876
3/1/2021 6:05:10 AM,CDC recommends JNJ's single-shot COVID-19 vaccine in U.S.,Seeking Alpha,https://seekingalpha.com/news/3667418-cdc-recommends-jnjs-first-single-shot-covid-19-vaccine-in-us?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6686905026435852
3/1/2021 11:51:19 AM,JNJ COVID-19 vaccine distribution started: McKesson,Seeking Alpha,https://seekingalpha.com/news/3667462-jnj-covid-19-vaccine-distribution-started-mckesson?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9332539439201355
3/1/2021 12:02:57 PM,A Peek Into The Markets: US Stock Futures Rise; J&J Secures Emergency Authorization for Covid-19 Vaccine,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-rise-j-j-secures-emergency-authorization-for-covid-19-vaccine-1030134387,positive,0.8418804407119751
3/1/2021 1:58:08 PM,"Here's Why Apple, Microsoft, Disney, Plug Power Are Moving",Benzinga,/news/stocks/here-s-why-apple-microsoft-disney-plug-power-are-moving-1030134973,neutral,0.9387088418006897
3/1/2021 3:16:25 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-warren-buffett-bitcoin-nio-stock-doge-ccl-sos-1030136574,neutral,0.9298974871635437
3/1/2021 4:13:09 PM,Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Receives FDA Approval For COVID-19 Vaccine,Benzinga,/news/stocks/mid-morning-market-update-markets-open-higher-johnson-johnson-receives-fda-approval-for-covid-19-vaccine-1030136012,positive,0.9409385919570923
3/1/2021 5:02:52 PM,"What's Moving The Market Monday? US, Asian Stocks Higher, Europe Stocks Lower",Benzinga,/news/stocks/what-s-moving-the-market-monday-us-asian-stocks-higher-europe-stocks-lower-1030136260,positive,0.45953086018562317
3/1/2021 6:16:55 PM,Mid-Day Market Update: Dow Jumps Over 600 Points; CorMedix Shares Plummet,Benzinga,/news/stocks/mid-day-market-update-dow-jumps-over-600-points-cormedix-shares-plummet-1030136675,negative,0.9594452381134033
3/1/2021 7:11:23 PM,7 Value Stocks Ready for the Next 10 Years,InvestorPlace,/news/stocks/7-value-stocks-ready-for-the-next-10-years-1030136985,neutral,0.8458632230758667
3/1/2021 8:37:10 PM,Mid-Afternoon Market Update: Crud Oil Down Over 1%; Morphic Shares Spike Higher,Benzinga,/news/stocks/mid-afternoon-market-update-crud-oil-down-over-1-morphic-shares-spike-higher-1030137126,negative,0.9100154638290405
3/1/2021 10:11:05 PM,3 Penny Stocks To Buy According To Top Stock Market Analysts,Benzinga,/news/stocks/3-penny-stocks-to-buy-according-to-top-stock-market-analysts-1030137366,neutral,0.8910472989082336
3/1/2021 10:59:00 PM,Johnson & Johnson -- Moody's: J&J vaccine emergency authorization is credit positive,Moodys,/news/bonds/johnson-johnson-moody-s-j-j-vaccine-emergency-authorization-is-credit-positive-1030137651,neutral,0.8211055397987366
3/2/2021 1:21:01 PM,Merck to help Johnson & Johnson in COVID-19 vaccine production,Seeking Alpha,https://seekingalpha.com/news/3668226-merck-to-help-johnson-johnson-in-covid-19-vaccine-production?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6223598122596741
3/2/2021 3:00:28 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-warren-wealth-tax-gme-rkt-stock-1030141280,neutral,0.9298974871635437
3/2/2021 10:01:45 PM,Merck to receive $269 million for production of COVID-19 vaccines and drugs,Seeking Alpha,https://seekingalpha.com/news/3668535-merck-to-receive-269-million-for-production-of-covid-19-vaccines-and-drugs?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.826619565486908
3/2/2021 10:11:13 PM,"Texas, Mississippi roll back mask mandates, pandemic business restrictions",Seeking Alpha,https://seekingalpha.com/news/3668542-texas-mississippi-roll-back-mask-mandates-pandemic-business-restrictions?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.828334629535675
3/3/2021 1:46:17 PM,"The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study",Benzinga,/news/stocks/the-daily-biotech-pulse-kempharm-adhd-drug-gets-the-nod-medicinova-shelves-vaccine-study-1030144928,neutral,0.7064564228057861
3/3/2021 2:31:53 PM,7 Blue-Chip Stocks That May Be Perfect For Retirement,InvestorPlace,/news/stocks/7-blue-chip-stocks-that-may-be-perfect-for-retirement-1030146050,neutral,0.8465080857276917
3/3/2021 4:18:10 PM,7 Stocks for Any Retiree to Consider,InvestorPlace,/news/stocks/7-stocks-for-any-retiree-to-consider-1030146542,neutral,0.9370338320732117
3/3/2021 4:31:27 PM,JNJ takes its talc verdict battle to U.S. Supreme Court,Seeking Alpha,https://seekingalpha.com/news/3668841-jnj-takes-its-talc-verdict-battle-to-supreme-court?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8683721423149109
3/3/2021 5:02:46 PM,"U.S. government to provide $100M to Merck, J&J to double COVID-19 vaccine output",Seeking Alpha,https://seekingalpha.com/news/3668862-us-government-to-provide-100m-to-merck-johnson-and-johnson-to-double-covid-19-vaccine-output?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9191230535507202
3/3/2021 8:12:22 PM,JNJ cut to hold at CFRA citing reopening trade and lack of catalysts,Seeking Alpha,https://seekingalpha.com/news/3669029-jnj-cut-to-hold-at-cfra-citing-reopening-trade-and-lack-of-catalysts?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9283292889595032
3/4/2021 1:50:49 PM,Big Tech and non-tech valuations may be closer than they appear: At the Open,Seeking Alpha,https://seekingalpha.com/news/3669326-big-tech-and-non-tech-valuations?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.739954948425293
3/4/2021 5:45:36 PM,Avoid Johnson & Johnson Shares Like the Plague,InvestorPlace,/news/stocks/jnj-stock-avoid-johnson-johnson-shares-like-the-plague-1030152096,neutral,0.8476836681365967
3/4/2021 7:38:08 PM,Johnson & Johnson Is One of the Best Healthcare Plays on the Market,InvestorPlace,/news/stocks/jnj-stock-is-one-of-the-best-healthcare-on-the-market-1030152430,positive,0.5902024507522583
3/5/2021 2:29:28 PM,JNJ receives Health Canada approval for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3669924-jnj-receives-health-canada-approval-for-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8766623735427856
3/5/2021 3:27:45 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-oil-stocks-opec-gme-reddit-ipo-1030155707,neutral,0.925952672958374
3/5/2021 4:50:37 PM,7 Mega-Cap Stocks Standing Above the Fray,InvestorPlace,/news/stocks/7-mega-cap-stocks-standing-above-the-fray-1030155694,positive,0.6427066922187805
3/5/2021 8:15:12 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3669995-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8980498313903809
3/5/2021 8:55:23 PM,Carnival Is Climbing Too High Too Fast,InvestorPlace,/news/stocks/ccl-stock-moving-too-high-too-fast-1030156156,neutral,0.562494695186615
3/8/2021 11:15:46 AM,Is Ocugen Worth $18 or Just a Couple of Bucks?,InvestorPlace,/news/stocks/is-ocgn-stock-worth-18-or-just-a-couple-of-bucks-1030159343,neutral,0.933696448802948
3/8/2021 4:25:05 PM,Sell Inovio While You Still Can,InvestorPlace,/news/stocks/sell-ino-stock-while-you-still-can-1030160441,neutral,0.9125025868415833
3/8/2021 5:51:34 PM,"Biden event with J&J, Merck moved over Emergent controversy - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3670344-biden-event-with-jj-merck-moved-over-emergent-controversy-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7927650213241577
3/8/2021 8:58:27 PM,Johnson & Johnson Is a Stock to Buy and Hold Forever,InvestorPlace,/news/stocks/jnj-stock-johnson-johnson-is-a-stock-to-buy-and-hold-forever-1030161050,neutral,0.9522393941879272
3/9/2021 4:03:06 PM,Supply issues may impact J&J EU COVID-19 vaccine supply goal - Reuters,Seeking Alpha,https://seekingalpha.com/news/3670757-supply-issues-may-impact-johnson-and-johnson-q2-eu-covid-19-vaccine-supply-goal-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5972877144813538
3/9/2021 9:42:55 PM,Market Recap: The Real Driver Behind Today‚Äôs Strength,InvestorPlace,/news/stocks/market-recap-the-real-driver-behind-tuesday-market-strength-1030166121,neutral,0.867275059223175
3/10/2021 12:38:38 PM,Pfizer/BioNTech to supply extra 4M vaccine doses to EU to tackle virus border clusters,Seeking Alpha,https://seekingalpha.com/news/3671111-pfizerbiontech-to-supply-extra-4m-vaccine-doses-to-eu-to-tackle-virus-border-clusters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.74142986536026
3/10/2021 2:58:14 PM,Biden to order 100 million additional J&J COVID-19 vaccine doses - NBC News,Seeking Alpha,https://seekingalpha.com/news/3671220-biden-to-order-100-million-additional-jj-covid-19-vaccine-doses-nbc-news?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7856124043464661
3/11/2021 12:51:15 PM,More Doses Of Johnson & Johnson's Covid-19 Vaccine For US ,RTTNews,/news/stocks/more-doses-of-johnson-johnson-s-covid-19-vaccine-for-us-1030172649,neutral,0.875821590423584
3/11/2021 1:28:47 PM,JNJ‚Äôs COVID-19 vaccine recommended for European approval,Seeking Alpha,https://seekingalpha.com/news/3671687-jnjs-covid-19-vaccine-recommended-for-european-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7996922731399536
3/11/2021 4:22:47 PM,Johnson & Johnson' Single-dose COVID-19 Vaccine Recommended For Use In EU ,RTTNews,/news/stocks/johnson-johnson-single-dose-covid-19-vaccine-recommended-for-use-in-eu-1030174234,neutral,0.6332625150680542
3/11/2021 4:46:06 PM,J&J's COVID-19 vaccine gets European Commission conditional marketing authorization,Seeking Alpha,https://seekingalpha.com/news/3671830-jjs-covid-19-vaccine-gets-european-commission-conditional-marketing-authorization?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4969604015350342
3/11/2021 9:05:27 PM,Why UAL Stock Will Continue to Fly High,InvestorPlace,/news/stocks/ual-stock-why-united-airlines-will-continue-to-fly-high-1030175430,neutral,0.8989877104759216
3/11/2021 9:08:32 PM,JNJ to produce up to 3 billion COVID-19 vaccine doses in 2022,Seeking Alpha,https://seekingalpha.com/news/3671942-jnj-to-produce-up-to-3-billion-covid-19-vaccine-doses-in-2022?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.525436282157898
3/11/2021 9:44:40 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-cpng-stock-ocgn-stock-stimulus-1030175736,neutral,0.9254742860794067
3/12/2021 3:27:50 AM,Johnson & Johnson's Single-dose COVID-19 Vaccine Gets Conditional Marketing Authorization In EU ,RTTNews,/news/stocks/johnson-johnson-s-single-dose-covid-19-vaccine-gets-conditional-marketing-authorization-in-eu-1030175963,positive,0.7321781516075134
3/12/2021 9:30:53 AM,Biden says all U.S. adults to be eligible for vaccines by May 1,Seeking Alpha,https://seekingalpha.com/news/3672131-biden-says-all-us-adults-to-be-eligible-for-vaccines-by-may-1?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8409744501113892
3/12/2021 10:01:15 AM,7 of the Best Value Stocks on the Market Today,InvestorPlace,/news/stocks/7-of-the-best-value-stocks-on-the-market-today-1030177716,neutral,0.8045744299888611
3/12/2021 11:17:58 AM,Novavax (NVAX) shares continue to climb after robust COVID-19 vaccine data,Seeking Alpha,https://seekingalpha.com/news/3672149-novavax-nvax-shares-continue-to-climb-on-covid-19-vaccine-data?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9462754726409912
3/12/2021 3:07:40 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-ride-stock-nvax-stock-infrastructure-nflx-1030179712,neutral,0.9298974871635437
3/12/2021 4:40:51 PM,WHO authorizes Johnson & Johnson vaccine for emergency use worldwide,Seeking Alpha,https://seekingalpha.com/news/3672319-who-authorizes-johnson-johnson-vaccine-for-emergency-use-worldwide?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9355335831642151
3/12/2021 4:43:05 PM,7 Healthcare Stocks to Buy and Hold for the Long Term,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-and-hold-for-the-long-term-1030180655,neutral,0.9046280980110168
3/12/2021 6:28:30 PM,Johnson & Johnson's Single-Shot COVID Vaccine Issued Emergency Use Listing By WHO ,RTTNews,/news/stocks/johnson-johnson-s-single-shot-covid-vaccine-issued-emergency-use-listing-by-who-1030180848,neutral,0.9342151284217834
3/12/2021 10:06:30 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-vaccines-nvax-wkhs-ride-stock-chpt-stock-nfts-1030182966,neutral,0.9254742860794067
3/14/2021 5:40:20 AM,"Big Pharma is pushing back the pandemic, but its stocks are cheap - Barron's",Seeking Alpha,https://seekingalpha.com/news/3672437-big-pharma-is-pushing-back-the-pandemic-but-its-stocks-are-cheap-barrons?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6729751825332642
3/15/2021 10:16:28 AM,Ocugen Needs Pieces To Fall Into Place Before It‚Äôs a Solid Vaccine Play,InvestorPlace,/news/stocks/ocgn-stock-is-purely-a-speculative-covid-19-vaccine-play-1030203068,neutral,0.8894944787025452
3/15/2021 12:02:14 PM,Takeda to support manufacturing of JNJ's COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3672551-takeda-to-support-manufacturing-of-jnjs-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5085364580154419
3/15/2021 12:24:06 PM,The Top Reason to Consider iBio Stock in the Long Term,InvestorPlace,/news/stocks/the-top-reason-to-consider-ibio-stock-in-the-long-term-1030204312,neutral,0.8988122940063477
3/15/2021 4:30:50 PM,8 of the Best Index Funds With Ultra-Low Fees,InvestorPlace,/news/stocks/8-of-the-best-index-funds-with-ultra-low-fees-1030206599,positive,0.6150596737861633
3/15/2021 6:18:28 PM,Sell Ocugen Stock Now Before It Sinks Even Further,InvestorPlace,/news/stocks/sell-ocgn-stock-now-before-it-sinks-even-further-1030207527,neutral,0.9194988012313843
3/15/2021 6:19:30 PM,Ocugen plans to sell 100M doses of COVID-19 vaccine in U.S. in 2021 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3672781-ocugen-plans-to-sell-100m-doses-of-covid-19-vaccine-in-us-in-2021-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6109232306480408
3/15/2021 6:59:36 PM,OCGN Stock: Red-Hot Ocugen Eyes U.S. Vaccine Launch in Q2,InvestorPlace,/news/stocks/ocgn-stock-red-hot-ocugen-eyes-u-s-vaccine-launch-in-q2-1030207522,neutral,0.8990408778190613
3/15/2021 8:12:07 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-ocgn-stock-sndl-ccl-aal-tlry-amc-stock-1030208455,neutral,0.9254742860794067
3/16/2021 10:41:48 AM,J&J's Tremfya shows efficacy in psoriatic arthritis study through two years,Seeking Alpha,https://seekingalpha.com/news/3672990-jnjs-jnj-tremfya-shows-efficacy-in-late-stage-psoriatic-arthritis-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9286270141601562
3/16/2021 1:17:20 PM,"The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study",Benzinga,/news/stocks/the-daily-biotech-pulse-fulgent-nabs-cdc-contract-enzo-rallies-solid-biosciences-releases-gene-therapy-data-moderna-begins-pediatric-vaccine-study-1030214585,neutral,0.8733964562416077
3/16/2021 2:35:36 PM,Investing in Moderna Has Little Upside At This Point,InvestorPlace,/news/stocks/investing-in-mrna-stock-has-little-upside-at-this-point-1030215865,neutral,0.9287043213844299
3/17/2021 3:55:14 PM,7 Growth Stocks With Compelling Stories,InvestorPlace,/news/stocks/7-growth-stocks-with-compelling-stories-1030220806,neutral,0.5747277140617371
3/18/2021 6:28:52 PM,Microvision Isn‚Äôt the Second Coming,InvestorPlace,/news/stocks/microvision-mvis-stock-isnt-the-second-coming-1030225541,neutral,0.919971764087677
3/19/2021 12:35:38 PM,FDA approves Johnson & Johnson's multiple sclerosis drug ponesimod,Seeking Alpha,https://seekingalpha.com/news/3674381-fda-approves-johnson-johnson-multiple-sclerosis-drug-ponvory-ponesimod?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5450823903083801
3/19/2021 1:42:55 PM,Ocugen Stock Is Not One to Trust With Nest Egg Funds,InvestorPlace,/news/stocks/ocgn-stock-ocugen-not-one-to-trust-with-nest-egg-funds-1030228419,neutral,0.930368185043335
3/22/2021 11:47:30 AM,AstraZeneca COVID-19 shot shows 79% efficacy; shares rise 2.5%,Seeking Alpha,https://seekingalpha.com/news/3674697-moderna-and-biontech-lower-after-astrazeneca-releases-us-trial-data-for-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.948603630065918
3/22/2021 2:16:56 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-ev-stocks-cciv-stock-gme-stock-sprt-1030232941,neutral,0.9298974871635437
3/23/2021 1:02:44 PM,3 Key Reasons to Be Bullish on Airbnb Stock,InvestorPlace,/news/stocks/3-key-reasons-to-be-bullish-on-airbnb-stock-1030236613,neutral,0.8414599895477295
3/23/2021 3:55:22 PM,Ocugen Looks Very Dicey at Current Levels,InvestorPlace,/news/stocks/ocugen-ocgn-stock-looks-very-dicey-at-current-levels-1030237828,neutral,0.6844015121459961
3/23/2021 4:46:16 PM,Drug pricing legislation introduced by Sanders weighs on pharmas,Seeking Alpha,https://seekingalpha.com/news/3675361-drug-pricing-legislation-introduced-by-sanders-weighs-on-pharmas?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8964444398880005
3/23/2021 6:34:36 PM,JNJ COVID-19 vaccine deliveries to rise as Catalent facility in Indiana gets FDA nod,Seeking Alpha,https://seekingalpha.com/news/3675408-jnj-covid-19-vaccine-deliveries-to-rise-as-catalent-facility-in-indiana-gets-fda-nod?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9461833238601685
3/24/2021 9:23:46 AM,EU set to curb COVID-19 vaccine export to U.K. - Reuters,Seeking Alpha,https://seekingalpha.com/news/3675539-eu-set-to-curb-covid-19-vaccines-export-to-uk-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.48424291610717773
3/24/2021 7:25:44 PM,7 Value Stocks Everyone Is Ignoring,InvestorPlace,/news/stocks/7-value-stocks-everyone-is-ignoring-1030242954,neutral,0.9038962125778198
3/25/2021 11:40:48 AM,"Ocugen Stock Has Way More Downside, Even After This Deep Correction",InvestorPlace,/news/stocks/ocgn-stock-more-downside-deep-correction-1030245902,neutral,0.5247417092323303
3/25/2021 3:55:26 PM,Biden to announce new vaccine goal of 200M shots - CNBC,Seeking Alpha,https://seekingalpha.com/news/3676327-biden-to-announce-new-vaccine-goal-of-200m-shots-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8850841522216797
3/26/2021 12:48:45 PM,J&J's multiple sclerosis drug Ponvory receives positive CHMP opinion,Seeking Alpha,https://seekingalpha.com/news/3676745-johnson-johnson-multiple-sclerosis-drug-ponvory-receives-positive-chmp-opinion?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9393585324287415
3/26/2021 2:02:46 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-gme-stock-nio-stock-wework-ipo-1030250431,neutral,0.9298974871635437
3/26/2021 3:53:41 PM,Is Approval Even Enough for Ocugen Stock?,InvestorPlace,/news/stocks/for-ocgn-stock-question-whether-approval-enough-1030250787,neutral,0.8683006167411804
3/26/2021 6:30:51 PM,9 First Stocks a New Investor Should Buy,InvestorPlace,/news/stocks/9-first-stocks-new-investor-should-buy-1030251108,neutral,0.8350264430046082
3/26/2021 9:17:45 PM,White House considers lifting IP protections for vaccines - CNBC,Seeking Alpha,https://seekingalpha.com/news/3676977-white-house-considers-lifting-ip-protections-for-vaccines-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7832401990890503
3/28/2021 6:12:53 AM,Barron's touts 10 stocks to build retirement income stream,Seeking Alpha,https://seekingalpha.com/news/3677018-barrons-touts-10-stocks-to-build-retirement-income-stream?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.873960018157959
3/29/2021 8:15:24 AM,JNJ to supply up to 400M doses of COVID-19 vaccine to Africa,Seeking Alpha,https://seekingalpha.com/news/3677033-jnj-to-supply-up-to-400m-doses-of-covid-19-vaccine-to-africa?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5018505454063416
3/29/2021 10:57:30 AM,Johnson & Johnson To Supply Up To 400 Mln Doses Of COVID-19 Vaccine Candidate To Africa ,RTTNews,/news/stocks/johnson-johnson-to-supply-up-to-400-mln-doses-of-covid-19-vaccine-candidate-to-africa-1030253605,positive,0.597083568572998
3/29/2021 4:33:06 PM,J&J will begin delivering vaccine to Europe on April 19 - AFP,Seeking Alpha,https://seekingalpha.com/news/3677266-johnson-johnson-will-begin-delivering-vaccine-to-europe-on-april-19-afp?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8730617761611938
3/29/2021 6:09:45 PM,Ocugen Stock Will Continue to Climb in Anticipation of Vaccine Launch,InvestorPlace,/news/stocks/ocgn-stock-will-continue-to-climb-in-run-up-to-vaccine-launch-1030255859,positive,0.9484990239143372
3/29/2021 11:56:24 PM,7 Reddit Penny Stocks That Are Moving Higher,InvestorPlace,/news/stocks/7-reddit-penny-stocks-that-are-moving-higher-1030265510,neutral,0.7790468335151672
3/31/2021 4:52:56 PM,10 Great Dividend Stocks Under $25,InvestorPlace,/news/stocks/10-great-dividend-stocks-under-25-1030265503,neutral,0.44902053475379944
3/31/2021 9:57:53 PM,"Manufacturing snafu ruins 15M J&J vaccine doses, delays shipments - New York Times",Seeking Alpha,https://seekingalpha.com/news/3678350-manufacturing-snafu-ruins-15m-johnson-johnson-vaccine-doses-new-york-times?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9419708251953125
4/1/2021 4:30:26 AM,Johnson & Johnson Says COVID-19 Vaccine Batch Fails To Meet Quality Standards ,RTTNews,/news/stocks/johnson-johnson-says-covid-19-vaccine-batch-fails-to-meet-quality-standards-1030266860,negative,0.9674542546272278
4/1/2021 1:32:55 PM,Johnson & Johnson: Ride Out the Tech Selloff with this Dividend King,InvestorPlace,/news/stocks/johnson-johnson-ride-out-the-tech-selloff-with-this-dividend-king-1030269518,neutral,0.7548313140869141
4/1/2021 2:12:16 PM,Emergent‚Äôs plant implicated in vaccine mix-up had issues cited by FDA in 2020: AP,Seeking Alpha,https://seekingalpha.com/news/3678593-emergents-plant-implicated-in-vaccine-mix-up-had-issues-even-in-2020?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8459299802780151
4/1/2021 6:29:05 PM,7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-to-prepare-your-portfolio-for-the-next-pandemic-1030270707,neutral,0.9073497653007507
4/1/2021 6:33:23 PM,Expect American Airlines Stock to Take Off by Summer as Bookings Soar,InvestorPlace,/news/stocks/aal-stock-expect-american-airlines-stock-take-off-bookings-soar-1030270705,positive,0.6062843799591064
4/1/2021 7:51:27 PM,General Electric Will Surge if Spending Plan Goes Through,InvestorPlace,/news/stocks/ge-stock-will-surge-if-spending-plan-goes-through-1030270693,positive,0.690603494644165
4/2/2021 3:15:15 PM,7 Robinhood Stocks Even Billionaires Want in Their Portfolios,InvestorPlace,/news/stocks/7-robinhood-stocks-even-billionaires-want-in-their-portfolios-1030272181,neutral,0.9208254814147949
4/2/2021 4:06:09 PM,American Airlines Stock May Lose More Altitude,InvestorPlace,/news/stocks/american-airlines-stock-may-lose-more-altitude-1030272174,negative,0.9632146954536438
4/4/2021 1:12:36 AM,Tailwinds for air lines as CDC updates travel guidance,Seeking Alpha,https://seekingalpha.com/news/3679001-tailwinds-for-air-lines-as-cdc-updates-travel-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9184091687202454
4/4/2021 1:15:45 AM,Johnson & Johnson inoculates adolescents in COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3679003-johnson-johnson-inoculates-adolescents-in-covid-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7843077778816223
4/4/2021 3:47:01 AM,HHS puts J&J in charge of Emergent BioSolutions plant behind vaccine foul-up - NYT,Seeking Alpha,https://seekingalpha.com/news/3679006-hhs-puts-johnson-johnson-in-charge-of-emergent-biosolutions-plant-behind-vaccine-foul-up-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8852918148040771
4/5/2021 4:06:46 AM,Emergent Bio receives modified task order for expansion of JNJ's COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3679014-emergent-bio-receives-modified-task-order-for-expansion-of-jnjs-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49221137166023254
4/5/2021 12:28:40 PM,Cidara shares gain 15% on antiviral conjugates development deal with Janssen,Seeking Alpha,https://seekingalpha.com/news/3679090-cidara-shares-gain-15-on-antiviral-conjugates-development-deal-with-janssen?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9427723288536072
4/5/2021 1:26:05 PM,"Janssen Pharma Gets Worldwide Rights To Cidara's CD388, Other Influenza Antiviral Conjugates ",RTTNews,/news/stocks/janssen-pharma-gets-worldwide-rights-to-cidara-s-cd388-other-influenza-antiviral-conjugates-1030273393,positive,0.5421965718269348
4/5/2021 2:27:00 PM,3 Consumer Staples Stocks Rising From the Ashes,InvestorPlace,/news/stocks/3-consumer-staples-stocks-rising-from-the-ashes-1030274336,positive,0.8596561551094055
4/5/2021 3:10:04 PM,The 7 Best Startups You Can Buy on Republic Right Now,InvestorPlace,/news/stocks/the-7-best-startups-to-invest-in-on-republic-right-now-1029859065,neutral,0.9151147603988647
4/5/2021 7:28:00 PM,3 Reasons Why the General Electric Comeback Is Real,InvestorPlace,/news/stocks/ge-stock-3-reasons-why-the-general-electric-comeback-is-real-1030274740,neutral,0.9295555949211121
4/6/2021 8:58:28 AM,Fauci says government won't mandate vaccine passports,Seeking Alpha,https://seekingalpha.com/news/3679359-fauci-says-government-wont-mandate-vaccine-passports?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9195986986160278
4/6/2021 9:32:45 AM,EU may reach herd immunity by July 14: Commissioner Thierry Breton,Seeking Alpha,https://seekingalpha.com/news/3679363-eu-may-reach-herd-immunity-by-july-14-commissioner-thierry-breton?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8422363996505737
4/6/2021 2:03:27 PM,8 Retirement Stocks to Buy for Any Market Conditions,InvestorPlace,/news/stocks/8-retirement-stocks-to-buy-for-any-market-conditions-1030277583,neutral,0.9273014068603516
4/6/2021 3:50:56 PM,7 Cheap Stocks That Won‚Äôt Be on Discount for Long,InvestorPlace,/news/stocks/7-cheap-stocks-that-wont-be-on-discount-for-long-linc-jd-cto-intu-bgfv-eqc-gsk-1030278180,neutral,0.8381311893463135
4/6/2021 5:01:57 PM,Emergent plant at center of vaccine troubles had issues in the past - NYT,Seeking Alpha,https://seekingalpha.com/news/3679596-emergent-plant-at-center-of-vaccine-troubles-had-issues-in-the-past-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6422926783561707
4/6/2021 5:58:49 PM,Dividend payment net changes nearly doubled to $18B in Q1,Seeking Alpha,https://seekingalpha.com/news/3679618-sp-dow-jones-indices-dividend-payments-increases-18b-doubled-qq-growth?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9428568482398987
4/7/2021 10:03:19 AM,JNJ inks deal to manufacture contact lenses for myopia in children,Seeking Alpha,https://seekingalpha.com/news/3679721-jnj-inks-deal-to-manufacture-contact-lenses-for-myopia-in-children?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8685439229011536
4/7/2021 3:23:00 PM,Jabil Inc. -- Moody's assigns Baa3 to Jabil's new note offering,Moodys,/news/bonds/jabil-inc-moody-s-assigns-baa3-to-jabil-s-new-note-offering-1030281672,neutral,0.8428987860679626
4/7/2021 6:19:30 PM,7 Great ETFs to Buy Now for Momentum Going Into Q2,InvestorPlace,/news/stocks/7-great-etfs-to-buy-now-for-momentum-going-into-q2-1030283106,positive,0.645748496055603
4/8/2021 11:02:36 AM,AstraZeneca vaccine woes could derail global vaccination drive,Seeking Alpha,https://seekingalpha.com/news/3680226-astrazeneca-vaccine-woes-could-derail-global-vaccination-drive?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9659634232521057
4/8/2021 11:49:26 AM,Ocugen Stock Is an Excellent Day Trade as Long as You Get Out in Time,InvestorPlace,/news/stocks/ocgn-stock-excellent-day-trade-get-out-in-time-1030285246,neutral,0.5905519127845764
4/8/2021 12:15:35 PM,The 7 Best Startups You Can Buy on StartEngine Right Now,InvestorPlace,/news/stocks/the-7-best-equity-crowdfunding-startups-you-can-buy-on-startengine-right-now-1029812989,neutral,0.9054226875305176
4/8/2021 5:49:44 PM,States will begin to feel J&J vaccine pinch with 86% decline in doses next week,Seeking Alpha,https://seekingalpha.com/news/3680469-states-will-begin-to-feel-johnson-johnson-vaccine-pinch-with-86-decline-in-doses-next-week?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7832093238830566
4/8/2021 6:43:55 PM,Johnson & Johnson adverse reaction prompts closure of Colorado COVID-19 vaccine site,Seeking Alpha,https://seekingalpha.com/news/3680484-jnj-covid-19-shot-closes-vaccine-site-in-colorado?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9344580173492432
4/8/2021 10:17:48 PM,Colorado Covid Vaccination Center Shuts Early Due To 11 Adverse Reaction Cases ,RTTNews,/news/stocks/colorado-covid-vaccination-center-shuts-early-due-to-11-adverse-reaction-cases-1030287409,negative,0.9642685651779175
4/9/2021 2:03:56 PM,Johnson & Johnson‚Äôs COVID-19 shot under review in EU over blood clots,Seeking Alpha,https://seekingalpha.com/news/3680703-johnson-johnsons-covid-19-shot-under-review-in-eu-over-blood-clots?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.803882360458374
4/9/2021 2:34:02 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-coinbase-ipo-nio-stock-ppi-1030289838,neutral,0.9298974871635437
4/9/2021 3:59:20 PM,7 Dividend Stocks With 50 Years of Dividend Increases,InvestorPlace,/news/stocks/7-dividend-stocks-with-50-years-of-dividend-increases-1030289825,neutral,0.9167525768280029
4/9/2021 4:53:25 PM,7 Excellent Index Funds With Juicy Dividends for Income Investors,InvestorPlace,/news/stocks/7-excellent-index-funds-with-juicy-dividends-for-income-investors-1030290105,neutral,0.9243807196617126
4/9/2021 8:44:17 PM,JNJ to begin India trial for its COVID-19 vaccine soon,Seeking Alpha,https://seekingalpha.com/news/3680816-jnj-to-begin-trials-for-its-covid-19-vaccine-in-india?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5654166340827942
4/9/2021 9:35:25 PM,Consumer products' Honest Company files for initial public offering,Seeking Alpha,https://seekingalpha.com/news/3680823-consumer-products-honest-company-files-for-initial-public-offering?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9537556171417236
4/10/2021 1:00:15 PM,WOOF Stock: 3 Reasons To Befriend This Recent IPO,InvestorPlace,/news/stocks/woof-stock-3-reasons-to-befriend-this-recent-ipo-1030290873,neutral,0.8351296782493591
4/12/2021 5:02:08 PM,Vaccine Passport Potential Could Boost These 7 Pharmaceutical Stocks,InvestorPlace,/news/stocks/vaccine-passport-potential-could-boost-these-7-pharmaceutical-stocks-1030295137,positive,0.9323841333389282
4/12/2021 5:13:09 PM,Pulmatrix slips 15% after J&J terminates license agreement,Seeking Alpha,https://seekingalpha.com/news/3681040-pulmatrix-slips-15-after-johnson-johnson-terminates-license-agreement?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9681206941604614
4/13/2021 11:10:19 AM,JNJ down after CDC halts the use of its COVID-19 vaccine (Updated),Seeking Alpha,https://seekingalpha.com/news/3681245-jnj-is-down-after-cdc-halts-the-use-of-its-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.855932891368866
4/13/2021 1:28:12 PM,JNJ‚Äôs safety issues lead to gains in other COVID-19 vaccine makers,Seeking Alpha,https://seekingalpha.com/news/3681341-bntx-stock-is-up-after-jnj-safety-issues?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9559531211853027
4/13/2021 1:37:37 PM,JNJ to delay COVID-19 vaccine rollout in Europe,Seeking Alpha,https://seekingalpha.com/news/3681350-johnson-johnson-issues-statement-on-vaccine-pause?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7644458413124084
4/13/2021 1:56:46 PM,Moderna says its vaccine not associated with blood clots; shares up 9%,Seeking Alpha,https://seekingalpha.com/news/3681363-moderna-says-its-vaccine-not-associated-with-blood-clots-shares-up-9?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9219980239868164
4/13/2021 1:59:51 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-coinbase-ipo-jnj-stock-fda-agc-stock-1030299170,neutral,0.9298974871635437
4/13/2021 2:09:54 PM,White House: J&J pause won't significantly impact vaccination efforts (updated),Seeking Alpha,https://seekingalpha.com/news/3681370-white-house-jj-pause-wont-significantly-impact-vaccination-efforts?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8721369504928589
4/13/2021 2:16:36 PM,"The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug",Benzinga,/news/stocks/the-daily-biotech-pulse-leadership-transition-at-amarin-vaccine-setback-for-j-j-fda-nod-for-label-expansion-of-roche-s-asthma-drug-1030298345,positive,0.5212374329566956
4/13/2021 2:48:21 PM,FDA Halts Use Of Johnson & Johnson's COVID-19 Vaccine Over Blood Clot Issues - Quick Facts ,RTTNews,/news/stocks/fda-halts-use-of-johnson-johnson-s-covid-19-vaccine-over-blood-clot-issues-quick-facts-1030298526,negative,0.7311095595359802
4/13/2021 3:35:08 PM,JNJ COVID-19 vaccine pause could be a ‚Äúmatter of days‚Äù: FDA,Seeking Alpha,https://seekingalpha.com/news/3681414-jnj-covid-19-vaccine-pause-could-be-a-matter-of-days-fda?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7652868628501892
4/13/2021 3:36:03 PM,US stocks trade mixed as investors digest March inflation surge and J&J vaccine pause,Business Insider,/news/stocks/stock-market-news-today-march-inflation-data-jnj-vaccine-pause-2021-4,negative,0.861611008644104
4/13/2021 7:36:42 PM,JNJ COVID-19 vaccine use halted in South Africa,Seeking Alpha,https://seekingalpha.com/news/3681494-jnj-covid-19-vaccine-use-halted-in-south-africa?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8443533778190613
4/13/2021 8:45:55 PM,FDA Halts Johnson & Johnson's Covid-19 Vaccine Over Clotting Issues ,RTTNews,/news/stocks/fda-halts-johnson-johnson-s-covid-19-vaccine-over-clotting-issues-1030300274,negative,0.842403769493103
4/13/2021 8:50:02 PM,Pfizer CEO Alfred Bourla says Pfizer ramping production of COVID-19 vaccine (updated),Seeking Alpha,https://seekingalpha.com/news/3681539-ceo-bourla-says-pfizer-ramping-up-production-of-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7775843739509583
4/13/2021 10:03:07 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-xrp-doge-eth-btc-coinbase-ipo-1030300678,neutral,0.9254742860794067
4/14/2021 11:58:27 AM,Denmark to halt the use of AstraZeneca‚Äôs COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3681666-denmark-to-halt-the-use-of-astrazenecas-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6099990606307983
4/14/2021 12:47:21 PM,Pfizer to raise second-quarter EU vaccine deliveries by 25%,Seeking Alpha,https://seekingalpha.com/news/3681700-pfizer-to-raise-second-quarter-eu-vaccine-delivery-target-by-25?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9407769441604614
4/14/2021 1:50:12 PM,EMA expediting review of J&J vaccine amid blood clot cases,Seeking Alpha,https://seekingalpha.com/news/3681740-ema-expediting-review-of-johnson-johnson-vaccine-amid-blood-clot-cases?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.69716876745224
4/14/2021 1:51:00 PM,"The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead",Benzinga,/news/stocks/the-daily-biotech-pulse-novavax-cfo-departs-zai-lab-inks-cancer-drug-collaboration-fda-nod-for-gilead-1030303096,neutral,0.9114655256271362
4/14/2021 5:08:08 PM,JNJ to exclude pregnant women in vaccine trial in South Africa; Other trials remain paused,Seeking Alpha,https://seekingalpha.com/news/3681818-jnj-to-exclude-pregnant-women-in-vaccine-trial-in-south-africa?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8634838461875916
4/14/2021 8:26:22 PM,Widening 'moat' for mRNA vaccines will benefit Moderna - Jefferies,Seeking Alpha,https://seekingalpha.com/news/3681898-widening-moat-for-mrna-vaccines-will-benefit-moderna-jefferies?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9243830442428589
4/14/2021 9:13:43 PM,JNJ and AstraZeneca suffer setback for COVID-19 vaccine deals in Europe,Seeking Alpha,https://seekingalpha.com/news/3681930-jnj-and-astrazeneca-suffer-set-back-for-covid-19-vaccine-deals-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9291510581970215
4/14/2021 11:10:49 PM,EMA Says Johnson & Johnson's COVID-19 Vaccine's Benefits Outweigh Side Effects ,RTTNews,/news/stocks/ema-says-johnson-johnson-s-covid-19-vaccine-s-benefits-outweigh-side-effects-1030305558,positive,0.9493962526321411
4/14/2021 11:53:30 PM,CDC panel postpones vote on J&J shot as it probes blood clots,Seeking Alpha,https://seekingalpha.com/news/3681948-cdc-panel-postpones-vote-on-jj-shot-as-it-probes-blood-clots?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7647817730903625
4/15/2021 12:56:11 PM,"JNJ‚Äôs COVID-19 vaccine woes to benefit mRNA based developers, Needham sizes up telehealth rivals; and more in today‚Äôs analyst action",Seeking Alpha,https://seekingalpha.com/news/3682121-jnjs-covid-19-vaccine-woes-to-benefit-mrna-based-developers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7349246740341187
4/15/2021 1:49:24 PM,"The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-shelves-2-covid-19-studies-bristol-myers-squibb-gets-european-regulatory-nod-inspiremd-s-reverse-split-1030307762,neutral,0.85393887758255
4/15/2021 3:43:38 PM,JNJ COVID-19 vaccine use could involve specific guidelines: Cantor,Seeking Alpha,https://seekingalpha.com/news/3682236-jnj-covid-19-vaccine-use-could-involve-specific-guidelines-cantor?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9465372562408447
4/15/2021 9:11:56 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-dogecoin-price-predictions-qs-stock-1030310657,neutral,0.9254742860794067
4/16/2021 11:43:41 AM,"J&J asked Pfizer, Moderna to help investigate blood clots but declined - WSJ",Seeking Alpha,https://seekingalpha.com/news/3682520-johnson-johnson-asked-pfizer-moderna-to-help-investigate-blood-clots-but-declined-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8816916346549988
4/16/2021 12:12:56 PM,Janssen showcases nipocalimab data in generalized myasthenia gravis at AAN 2021,Seeking Alpha,https://seekingalpha.com/news/3682544-janssen-showcases-nipocalimab-data-in-generalized-myasthenia-gravis-at-aan-2021?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.876347005367279
4/16/2021 5:52:05 PM,7 Reddit Penny Stocks to Buy for a Biotech Boom,InvestorPlace,/news/stocks/7-reddit-penny-stocks-buy-biotech-boom-1030313550,neutral,0.8537745475769043
4/16/2021 6:22:10 PM,No evidence to support link between vaccine and blood clots -- J&J researchers,Seeking Alpha,https://seekingalpha.com/news/3682683-no-evidence-to-support-link-between-vaccine-and-blood-clots-johnson-johnson-researchers?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8681108355522156
4/16/2021 6:46:59 PM,"Moderna, Pfizer vaccine allocations to rise next week as J&J shot suspended",Seeking Alpha,https://seekingalpha.com/news/3682688-moderna-pfizer-vaccine-allocations-to-rise-next-week-as-johnson-johnson-shot-suspended?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9377162456512451
4/16/2021 7:30:09 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3682690-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8980498313903809
4/17/2021 3:25:15 PM,"The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-johnson-johnson-biogen-earnings-neurology-conference-and-ipos-1030314413,neutral,0.9472426176071167
4/18/2021 2:08:03 AM,South African regulator recommends lifting ban on JNJ‚Äôs COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3682764-south-african-regulator-recommends-lifting-ban-on-jnjs-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6372610330581665
4/18/2021 3:01:24 PM,Here's what Wall Street expects from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnson_johnson-stock-q1-earnings-preview-1030315086,neutral,0.9130298495292664
4/18/2021 3:56:30 PM,Fauci expects J&J vaccinations to resume later this week,Seeking Alpha,https://seekingalpha.com/news/3682773-fauci-expects-jj-vaccinations-to-resume-later-this-week?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8982047438621521
4/18/2021 6:22:14 PM,"Barron's Latest Picks And Pans: Amazon, Coinbase, Disney, Johnson & Johnson And More",Benzinga,/news/stocks/barron-s-latest-picks-and-pans-amazon-coinbase-disney-johnson-johnson-and-more-1030315209,neutral,0.945088803768158
4/19/2021 10:45:46 AM,Drugmakers go on trial for opioid epidemic in California,Seeking Alpha,https://seekingalpha.com/news/3682811-drugmakers-go-on-trial-for-opioid-epidemic-in-california?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5263096690177917
4/19/2021 11:58:02 AM,JNJ's Darzalex combo regimen OK'd in Canada for rare blood cell disorder,Seeking Alpha,https://seekingalpha.com/news/3682852-jnjs-darzalex-combo-regimen-okd-in-canada-for-rare-blood-cell-disorder?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7165835499763489
4/19/2021 1:45:06 PM,J&J vaccine was paused because of concerns over treating blood clots - WSJ,Seeking Alpha,https://seekingalpha.com/news/3682959-johnson-johnson-vaccine-was-paused-because-of-concerns-over-treating-blood-clots-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9119871258735657
4/19/2021 3:08:56 PM,Decision On Resuming Johnson & Johnson Vaccine Expected This Week ,RTTNews,/news/stocks/decision-on-resuming-johnson-johnson-vaccine-expected-this-week-1030318065,neutral,0.9358872175216675
4/19/2021 4:03:07 PM,Moderna and BioNTech slide as Fauci predicts resumption of JNJ COVID-19 vaccine use,Seeking Alpha,https://seekingalpha.com/news/3683037-moderna-and-biontech-slides-as-fauci-predicts-resumption-of-jnj-covid-19-vaccine-use?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9417427182197571
4/19/2021 4:21:32 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3683044-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8660829067230225
4/19/2021 6:06:36 PM,Johnson & Johnson Q1 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3683084-johnson-johnson-q1-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6954231858253479
4/19/2021 8:30:30 PM,JNJ will not pursue regulatory submission based on prostate cancer study,Seeking Alpha,https://seekingalpha.com/news/3683157-jnj-will-not-pursue-regulatory-submission-based-on-prostate-cancer-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9475216269493103
4/19/2021 9:07:19 PM,Emergent Bio hurt by second steepest drop for the year as FDA inspects manufacturing site,Seeking Alpha,https://seekingalpha.com/news/3683186-emergent-bio-drops-as-fda-inspects-manufacturing-site?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9655582904815674
4/19/2021 9:28:14 PM,What Did the Stock Market Do today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-dogeday-next-big-crypto-safemoon-1030319772,neutral,0.9254742860794067
4/20/2021 9:47:09 AM,EMA to issue advice on JNJ COVID shot later today,Seeking Alpha,https://seekingalpha.com/news/3683236-ema-to-issue-advice-on-jnj-covid-shot-later-today?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9251764416694641
4/20/2021 10:31:14 AM,"Johnson & Johnson EPS beats by $0.24, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3683261-johnson-and-amp-johnson-eps-beats-0_24-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7135773301124573
4/20/2021 10:48:23 AM,Johnson & Johnson hikes dividend by 5% to $1.06 per share,Seeking Alpha,https://seekingalpha.com/news/3683259-johnson--johnson-hikes-dividend-by-5-to-106-per-share?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.547261118888855
4/20/2021 11:11:51 AM,JNJ raises 2021 guidance and quarterly dividend after Q1 earnings beat consensus,Seeking Alpha,https://seekingalpha.com/news/3683290-jnj-raises-2021-guidance-and-quarterly-dividend-after-q1-earnings-beat-consensus?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5079039335250854
4/20/2021 12:35:10 PM,Johnson & Johnson Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q1-adjusted-earnings-beat-estimates-1030322014,positive,0.7109442949295044
4/20/2021 1:43:16 PM,Johnson & Johnson Q1 Results Top Estimates ,RTTNews,/news/stocks/johnson-johnson-q1-results-top-estimates-1030322385,neutral,0.8381691575050354
4/20/2021 2:06:58 PM,"The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex",Benzinga,/news/stocks/the-daily-biotech-pulse-q1-beat-from-johnson-johnson-kalvista-study-placed-on-hold-european-label-expansion-for-gw-pharma-s-epidiolex-1030322640,neutral,0.7906173467636108
4/20/2021 2:35:07 PM,JNJ COVID-19 vaccine: European Medicines Agency highlights positive benefit-risk,Seeking Alpha,https://seekingalpha.com/news/3683459-jnj-covid-19-vaccine-ema-highlights-positive-benefit-risk?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9490113258361816
4/20/2021 3:29:30 PM,Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology,Benzinga,/news/stocks/remote-monitoring-telemedicine-company-sees-spiked-growth-of-products-and-technology-1030323571,positive,0.8027840256690979
4/20/2021 3:41:41 PM,"JNJ reiterates positive benefit/risk profile of COVID-19 vaccine as CDC probes a ""handful"" of more cases of adverse events",Seeking Alpha,https://seekingalpha.com/news/3683496-jnj-reiterates-positive-benefitrisk-profile-of-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9391221404075623
4/20/2021 4:06:58 PM,J&J to resume vaccine rollout in Europe following EMA review (updated),Seeking Alpha,https://seekingalpha.com/news/3683506-johnson-johnson-to-resume-vaccine-rollout-in-europe-following-ema-review?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.839363157749176
4/20/2021 4:27:10 PM,Ocugen‚Äôs Outlook Is Still Very Bleak,InvestorPlace,/news/stocks/ocgn-stock-outlook-is-still-very-bleak-1030324938,neutral,0.7953066229820251
4/20/2021 8:00:03 PM,EMA Says J&J Covid Vaccine's Benefits Outweigh Rare Blood Clot Risks ,RTTNews,/news/stocks/ema-says-j-j-covid-vaccine-s-benefits-outweigh-rare-blood-clot-risks-1030324875,positive,0.9520763754844666
4/20/2021 9:07:08 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-airline-stocks-cruise-stocks-1030325540,neutral,0.9254742860794067
4/20/2021 9:16:20 PM,"5 Top Stock Trades for Wednesday: UAL, JNJ, PG, KSU, IBM",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-ual-jnj-pg-ksu-ibm-1030325539,neutral,0.931175172328949
4/21/2021 9:48:47 AM,JNJ's VERITAS Vision System secures FDA clearance and CE mark,Seeking Alpha,https://seekingalpha.com/news/3683786-jnjs-veritas-vision-system-secures-fda-clearance-and-ce-mark?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9008580446243286
4/21/2021 12:25:48 PM,OCGN Stock: The Huge COVAXIN News Sending Ocugen Climbing Today,InvestorPlace,/news/stocks/ocgn-stock-the-huge-covaxin-news-sending-ocugen-climbing-today-1030329624,positive,0.9418376684188843
4/21/2021 12:48:26 PM,COVID-19 vaccine supply to exceed demand in the coming weeks - report,Seeking Alpha,https://seekingalpha.com/news/3683891-vaccine-supply-to-exceed-demand-in-the-coming-weeks-report?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7725858092308044
4/21/2021 1:19:39 PM,Weekly record for new COVID-19 cases set - WHO,Seeking Alpha,https://seekingalpha.com/news/3683937-weekly-record-for-new-covid-19-cases-set-who?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7298492789268494
4/21/2021 1:55:40 PM,FDA finds multiple deficiencies in inspection of troubled Emergent Biosolutions plant,Seeking Alpha,https://seekingalpha.com/news/3683956-fda-finds-multiple-deficiencies-in-inspection-of-troubled-emergent-biosolutions-plant?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9653455018997192
4/21/2021 2:40:05 PM,Abbott Q1 results highlight pressure on COVID-19 test makers as vaccinations ramp up,Seeking Alpha,https://seekingalpha.com/news/3683988-abbott-q1-results-highlights-pressure-on-covid-19-test-makers?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9643991589546204
4/21/2021 3:09:49 PM,JNJ reiterates commitment to US COVID-19 vaccine deliveries after FDA inspection of Emergent facility,Seeking Alpha,https://seekingalpha.com/news/3684009-jnj-reiterates-commitment-to-us-covid-19-vaccine-deliveries-after-fda-inspection?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9239121675491333
4/21/2021 3:59:50 PM,"EU not taking up options on additional AstraZeneca, J&J vaccines - Reuters",Seeking Alpha,https://seekingalpha.com/news/3684028-eu-not-taking-up-options-on-additional-astrazeneca-johnson-johnson-vaccines-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9373636841773987
4/21/2021 6:41:11 PM,Pressure mounting on Biden administration to waive COVID-19 vaccine patents,Seeking Alpha,https://seekingalpha.com/news/3684145-pressure-mounting-on-biden-administration-to-waive-covid-19-vaccine-patents?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9097448587417603
4/22/2021 11:18:17 AM,Pfizer in talks with India to supply COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3684453-pfizer-in-talks-with-india-to-supply-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8026663064956665
4/22/2021 1:04:23 PM,JNJ COVID-19 vaccine: South Africa to resume rollout,Seeking Alpha,https://seekingalpha.com/news/3684563-jnj-covid-19-vaccine-south-africa-to-resume-rollout?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7008810639381409
4/22/2021 4:47:42 PM,J&J vaccine found effective against COVID-19 variants,Seeking Alpha,https://seekingalpha.com/news/3684700-johnson-johnson-vaccine-found-effective-against-covid-19-variants?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9383882284164429
4/22/2021 7:47:21 PM,House Democrats reintroduce bill to lower drug prices,Seeking Alpha,https://seekingalpha.com/news/3684755-house-democrats-reintroduce-bill-to-lower-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.66143798828125
4/23/2021 10:36:21 AM,Johnson & Johnson COVID-19 Vaccine Could Make Its Way To India By July,Benzinga,/news/stocks/johnson-johnson-covid-19-vaccine-could-make-its-way-to-india-by-july-1030337765,neutral,0.5872176289558411
4/23/2021 10:51:14 AM,India plans to import JNJ's COVID-19 vaccine by July end,Seeking Alpha,https://seekingalpha.com/news/3684994-india-plans-to-import-jnjs-covid-19-vaccine-by-july-end?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6104114651679993
4/23/2021 11:39:04 AM,JNJ COVID-19 vaccine heads for U.S. review today,Seeking Alpha,https://seekingalpha.com/news/3685021-jnj-covid-19-vaccine-heads-for-us-review-today?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8091759085655212
4/23/2021 12:06:48 PM,EU finalizes deal for 1.8B doses of Pfizer-BioNTech COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3685044-eu-finalizes-deal-for-18b-doses-of-pfizer-biontech-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8244158625602722
4/23/2021 2:21:54 PM,"GameStop, AMC, Penny And Crypto Stocks: Top Q1 Trends For Millennials And Gen Z",Benzinga,/news/stocks/gamestop-amc-penny-and-crypto-stocks-top-q1-trends-for-millennials-and-gen-z-1030338567,neutral,0.8205622434616089
4/23/2021 2:41:58 PM,OCGN Stock: The Big COVAXIN News That Prompted 40% Gains in Ocugen,InvestorPlace,/news/stocks/ocgn-stock-the-big-covaxin-news-that-prompted-40-gains-in-ocugen-1030339413,positive,0.9489784836769104
4/23/2021 3:00:27 PM,7 Great ETFs to Buy to Ride Out Rough Seas,InvestorPlace,/news/stocks/7-great-etfs-to-buy-to-ride-out-rough-seas-1030339410,neutral,0.7865896821022034
4/23/2021 3:01:05 PM,8 Dividend Stocks Increasing Payouts in 2021,InvestorPlace,/news/stocks/8-dividend-stocks-increasing-payouts-in-2021-1030339409,positive,0.8952248692512512
4/23/2021 4:16:04 PM,Blood clot cases linked to J&J vaccine rises to 15 - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3685169-blood-clot-cases-linked-to-johnson-johnson-vaccine-rises-to-15-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8762072920799255
4/23/2021 6:45:05 PM,Ocugen Looks Less Interesting With Each Passing Shot,InvestorPlace,/news/stocks/ocgn-stock-looks-less-compelling-as-vaccines-increase-1030339903,negative,0.809840977191925
4/23/2021 8:55:44 PM,CDC advisory committee votes to recommend J&J vaccine with warning (updated),Seeking Alpha,https://seekingalpha.com/news/3685278-cdc-advisory-committee-votes-to-recommend-johnson-johnson-vaccine-following-pause?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9059926867485046
4/23/2021 9:21:35 PM,J&J rekindling plan to sell breast implant division Mentor - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3685283-jj-rekindling-plan-to-sell-breast-implant-division-mentor-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7814666032791138
4/23/2021 11:27:24 PM,FDA and CDC lift J&J vaccine pause (updated),Seeking Alpha,https://seekingalpha.com/news/3685295-fda-and-cdc-lift-jj-vaccine-pause?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7191269993782043
4/24/2021 3:24:00 PM,"The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx",Benzinga,/news/stocks/the-week-ahead-in-biotech-april-25-may-1-fda-decisions-for-sol-gel-protalix-bio-ardelyx-1030340692,neutral,0.9154146313667297
4/24/2021 8:00:00 PM,"What might be behind blood clot risk with AstraZeneca, J&J vaccines?",Seeking Alpha,https://seekingalpha.com/news/3685297-what-might-be-behind-blood-clot-risk-with-johnson-johnson-astrazeneca-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8130072355270386
4/25/2021 5:17:06 AM,Ocugen-partnered COVID-19 vaccine shows efficacy against new variant behind India‚Äôs second wave,Seeking Alpha,https://seekingalpha.com/news/3685312-ocugen-partnered-covid-19-vaccine-shows-efficacy-against-new-variant-in-india?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9454516768455505
4/26/2021 6:26:26 AM,FDA Lifts Pause On Johnson & Johnson's COVID-19 Vaccine ,RTTNews,/news/stocks/fda-lifts-pause-on-johnson-johnson-s-covid-19-vaccine-1030342587,negative,0.6594334244728088
4/26/2021 7:21:45 AM,World pledges medical aid to India amid surging COVID-19 infections,Seeking Alpha,https://seekingalpha.com/news/3685321-world-pledges-medical-aid-to-india-amid-surging-new-infections?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9238783717155457
4/26/2021 12:04:06 PM,Most Americans hesitant about getting J&J vaccine - Washington Post,Seeking Alpha,https://seekingalpha.com/news/3685398-most-americans-hesitant-about-getting-johnson-johnson-vaccine-washington-post?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8801008462905884
4/26/2021 12:08:37 PM,A Peek Into The Markets: US Stock Futures Mixed; Tesla Earnings In Focus,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mixed-tesla-earnings-in-focus-1030344568,negative,0.9162912368774414
4/26/2021 12:25:52 PM,OCGN Stock: The White House News That Has Ocugen Climbing Today,InvestorPlace,/news/stocks/ocgn-stock-the-white-house-news-that-has-ocugen-climbing-today-1030346247,positive,0.759194552898407
4/26/2021 2:38:14 PM,J&J Vaccine Holds Lower Side Effect Risks Than Aspirin: NIH Director ,RTTNews,/news/stocks/j-j-vaccine-holds-lower-side-effect-risks-than-aspirin-nih-director-1030345359,positive,0.5006109476089478
4/26/2021 3:00:47 PM,Decline in new COVID-19 cases could last despite a slowdown in vaccine rollout: Experts,Seeking Alpha,https://seekingalpha.com/news/3685540-decline-in-new-covid-19-cases-could-last-despite-a-slowdown-in-vaccine-rollout-experts?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7110531330108643
4/26/2021 3:18:33 PM,Sanofi Steps In For Fill-Finish 200M Doses Of Moderna's COVID-19 Vaccine,Benzinga,/news/stocks/sanofi-steps-in-for-fill-finish-200m-doses-of-moderna-s-covid-19-vaccine-1030346045,neutral,0.8522771000862122
4/26/2021 4:51:43 PM,Over 9 million doses ready to go into arms as states resume JNJ COVID-19 vaccine use,Seeking Alpha,https://seekingalpha.com/news/3685595-over-9-million-doses-ready-to-go-into-arms-as-states-resume-jnj-covid-19-vaccine-use?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7308801412582397
4/26/2021 5:39:37 PM,7 Undervalued Stocks to Buy Before the Bounce,InvestorPlace,/news/stocks/7-undervalued-stocks-to-buy-before-the-bounce-1030347104,positive,0.48341402411460876
4/26/2021 6:22:32 PM,7 Blue-Chip Stocks Everyone Should Watch,InvestorPlace,/news/stocks/7-blue-chip-stocks-everyone-should-watch-1030347421,neutral,0.9152199029922485
4/27/2021 1:18:05 PM,Health Canada OKs Johnson & Johnson Vision's daily disposable contact lens,Seeking Alpha,https://seekingalpha.com/news/3686091-health-canada-oks-johnson-johnson-visions-daily-disposable-contact-lens?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9043446779251099
4/27/2021 2:21:20 PM,US To Share Up To 60M AstraZeneca COVID-19 Vaccine Doses,Benzinga,/news/stocks/us-to-share-up-to-60m-astrazeneca-covid-19-vaccine-doses-1030351378,positive,0.5798405408859253
4/27/2021 3:45:31 PM,Two more blood clot cases reported with J&J vaccine - Reuters,Seeking Alpha,https://seekingalpha.com/news/3686185-two-more-blood-clot-cases-reported-with-johnson-johnson-vaccine-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8258310556411743
4/27/2021 4:54:02 PM,CDC updates guidance on mask wearing for people fully vaccinated against COVID-19,Seeking Alpha,https://seekingalpha.com/news/3686236-cdc-updates-guidance-on-mask-wearing-for-people-fully-vaccinated-against-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7350119352340698
4/28/2021 12:34:00 AM,"Bayou Intermediate II, LLC -- Moody's assigns a B2 CFR to Bayou Intermediate II, LLC; outlook stable",Moodys,/news/bonds/bayou-intermediate-ii-llc-moody-s-assigns-a-b2-cfr-to-bayou-intermediate-ii-llc-outlook-stable-1030354437,positive,0.5797840356826782
4/28/2021 12:38:00 AM,"Bayou Intermediate II, LLC -- Moody's assigns a B2 CFR to Bayou Intermediate II, LLC; outlook stable",Moodys,/news/bonds/bayou-intermediate-ii-llc-moody-s-assigns-a-b2-cfr-to-bayou-intermediate-ii-llc-outlook-stable-1030354444,positive,0.5797840356826782
4/28/2021 10:00:30 AM,A Couple Of Shots in the Arm for Ocugen Stock,InvestorPlace,/news/stocks/a-couple-of-shots-in-the-arm-for-ocugen-stock-1030356996,neutral,0.6628850698471069
4/28/2021 2:29:03 PM,7 Pharmaceutical Stocks With Dividends in Hand,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-dividends-in-hand-1030359387,neutral,0.926287829875946
4/28/2021 4:15:19 PM,10 Low-Volatility Safe Stocks to Buy Now,InvestorPlace,/news/stocks/10-low-volatility-safe-stocks-to-buy-now-1030359712,neutral,0.8917940258979797
4/28/2021 5:46:21 PM,"California reports nearly 1,400 COVID-19 cases in fully vaccinated people",Seeking Alpha,https://seekingalpha.com/news/3687105-california-records-about-1400-covid-19-cases-in-fully-vaccinated-people?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8088369369506836
4/28/2021 6:02:51 PM,7 Great ETFs to Buy for Dividend-Hungry Investors,InvestorPlace,/news/stocks/7-great-etfs-to-buy-for-dividend-hungry-investors-1030359697,neutral,0.7809272408485413
4/28/2021 8:23:40 PM,Time100 Most Influential Companies: What 61 Publicly Traded Companies Are On The Inaugural List?,Benzinga,/news/stocks/time100-most-influential-companies-what-61-publicly-traded-companies-are-on-the-inaugural-list-1030359837,neutral,0.9378836750984192
4/29/2021 10:00:37 AM,7 Pharmaceutical Stocks To Buy For Valuation Plus Solid Dividends,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-to-buy-for-valuation-plus-solid-dividends-1030363716,positive,0.5524912476539612
4/29/2021 7:06:03 PM,Emergent awaiting FDA OK to release 60M J&J vaccine doses - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3688108-emergent-awaiting-fda-ok-to-release-60m-johnson-johnson-vaccine-doses-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.563715934753418
4/30/2021 10:10:55 AM,Janssen files CAR-T therapy cilta-del application for multiple myeloma in Europe,Seeking Alpha,https://seekingalpha.com/news/3688490-janssen-files-car-t-therapy-cilta-del-application-for-multiple-myeloma-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7648648619651794
4/30/2021 4:46:11 PM,"CDC allocating J&J vaccine again, but still at low numbers",Seeking Alpha,https://seekingalpha.com/news/3688786-cdc-allocating-johnson-johnson-vaccine-again-but-still-at-low-numbers?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8627639412879944
4/30/2021 8:30:28 PM,More than 30% of U.S. population fully vaccinated - CDC,Seeking Alpha,https://seekingalpha.com/news/3688921-more-than-30-of-us-population-fully-vaccinated-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8916819095611572
5/2/2021 7:17:07 PM,"To waive COVID vaccine patents, or not, that is the question",Seeking Alpha,https://seekingalpha.com/news/3689015-to-waive-covid-vaccine-patents-or-not-that-is-the-question?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8193985223770142
5/3/2021 10:00:27 AM,"Despite Covaxin News, Ocugen Stock Remains a Long-Shot for US Use",InvestorPlace,/news/stocks/ocgn-stock-remains-gamble-covaxin-news-notwithstanding-1030377582,positive,0.6979932188987732
5/3/2021 11:58:45 AM,"If You Have Ocugen Stock, Now‚Äôs the Time to Take Profits",InvestorPlace,/news/stocks/ocgn-stock-why-you-should-take-profit-1030378125,neutral,0.937783420085907
5/3/2021 3:03:10 PM,Wells Fargo debuts riskier 'Signature Picks' portfolio with four megacaps featured,Seeking Alpha,https://seekingalpha.com/news/3689265-wells-fargo-debuts-riskier-signature-picks-with-four-megacaps-featured?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6918823719024658
5/3/2021 3:40:55 PM,JNJ‚Äôs COVID-19 vaccine left out in Danish vaccine rollout,Seeking Alpha,https://seekingalpha.com/news/3689298-jnjs-covid-19-vaccine-left-out-in-danish-vaccine-rollout?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6416800618171692
5/3/2021 8:11:11 PM,U.S. COVID-19 vaccine demand dips as vaccination rate climbs,Seeking Alpha,https://seekingalpha.com/news/3689695-us-covid-19-vaccine-demand-dips-as-vaccination-rate-climbs?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9711112976074219
5/3/2021 9:45:39 PM,FDA set to OK Pfizer vaccine for adolescents next week - New York Times,Seeking Alpha,https://seekingalpha.com/news/3689831-fda-set-to-ok-pfizer-vaccine-for-adolescents-next-week-new-york-times?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8780964612960815
5/4/2021 3:25:18 PM,8 Blue-Chip Stocks With Strong Earnings,InvestorPlace,/news/stocks/eight-blue-chip-stocks-strong-earnings-1030385989,positive,0.7799870371818542
5/4/2021 3:40:26 PM,Shares of major drug makers in focus as House committees hold hearings on drug pricing bill,Seeking Alpha,https://seekingalpha.com/news/3690229-shares-of-major-drug-makers-in-focus-as-house-committees-hold-hearings-on-drug-pricing-bill?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6773345470428467
5/4/2021 7:09:14 PM,"Biden says vaccination effort will focus on adolescents, hesitant adults (updated)",Seeking Alpha,https://seekingalpha.com/news/3690452-biden-says-vaccination-effort-will-focus-on-adolescents-hesitant-adults?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9069849848747253
5/5/2021 7:35:46 PM,COVID-19 vaccine makers in the red as U.S. to back waiver of IP protections,Seeking Alpha,https://seekingalpha.com/news/3691449-covid-19-vaccine-makers-in-the-red-as-us-to-back-waiver-of-vaccine-ip-protections?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8418436050415039
5/6/2021 1:42:10 PM,"Weighing in on vaccine patent waivers, Alcon and Ultragenyx upgraded at Citi and more in analyst action",Seeking Alpha,https://seekingalpha.com/news/3692234-weighing-in-on-vaccine-patent-waivers-alcon-and-ultragenyx-upgraded-at-citi-and-more-in-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6439546346664429
5/6/2021 2:10:44 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-ocgn-stock-space-stocks-btc-brphf-1030397159,neutral,0.9298974871635437
5/6/2021 4:03:03 PM,7 Safe Stocks You Can Leave to Your Children,InvestorPlace,/news/stocks/7-safe-stocks-you-can-leave-your-children-1030397799,neutral,0.9264896512031555
5/6/2021 4:39:42 PM,Germany's Merkel opposed to lifting IP protections on vaccines -- Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3692395-germany-merkel-opposed-to-lifting-ip-protections-on-vaccines-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7145797610282898
5/6/2021 7:43:04 PM,Emergent-produced J&J vaccine distribution paused in several countries - NYT,Seeking Alpha,https://seekingalpha.com/news/3692464-emergent-produced-johnson-johnson-vaccine-distribution-paused-in-several-countries-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8662152886390686
5/6/2021 8:41:26 PM,5 Cheap Growth Stocks for Q2 2021,InvestorPlace,/news/stocks/5-cheap-growth-stocks-for-q2-2021-1030399122,neutral,0.8812128305435181
5/7/2021 6:59:18 AM,"JNJ's Tecnis Synergy and Tecnis Synergy Toric II IOLs OK'd in U.S., Canada",Seeking Alpha,https://seekingalpha.com/news/3692955-jnjs-tecnis-synergy-and-tecnis-synergy-toric-ii-iols-okd-in-us-canada?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9265601634979248
5/11/2021 6:48:00 PM,States won‚Äôt receive JNJ COVID-19 vaccine deliveries next week: Politico,Seeking Alpha,https://seekingalpha.com/news/3694765-states-wont-receive-jnj-covid-19-vaccine-deliveries-next-week-politico?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6523022055625916
5/12/2021 12:55:50 PM,FDA OKs Johnson & Johnson Vision's Acuvue Abiliti Overnight lenses for myopia,Seeking Alpha,https://seekingalpha.com/news/3695232-fda-oks-johnson-johnson-visions-acuvue-abiliti-overnight-lenses-for-myopia?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7399803400039673
5/12/2021 12:59:21 PM,Emergent says it is making improvements to troubled Baltimore vaccine plant,Seeking Alpha,https://seekingalpha.com/news/3695230-emergent-says-it-is-making-improvements-to-troubled-baltimore-vaccine-plant?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.839881181716919
5/12/2021 2:23:33 PM,Emergent executives to testify before House coronavirus panel next week,Seeking Alpha,https://seekingalpha.com/news/3695305-emergent-executives-to-testify-before-house-coronavirus-panel-next-week?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.92745041847229
5/12/2021 3:26:19 PM,Ethereum (ETH) Price Predictions: Why Some Analysts Think ETH Will Hit $20K in 2025,InvestorPlace,/news/stocks/ethereum-eth-price-predictions-why-some-analysts-see-20k-in-2025-1030422216,neutral,0.9031866788864136
5/13/2021 1:05:22 PM,Blood clot risk from J&J vaccine 40 times less than dying from COVID,Seeking Alpha,https://seekingalpha.com/news/3695918-blood-clot-risk-from-johnson-johnson-vaccine-40-times-less-than-dying-from-covid?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6046472787857056
5/13/2021 2:23:31 PM,Ocugen Has a Longer Road To Paying off Than People Think,InvestorPlace,/news/stocks/confusing-trading-leaves-ocgn-stock-interesting-1030426929,neutral,0.8299602270126343
5/13/2021 6:41:24 PM,The 7 Best Stocks and Cryptos to Buy in May,InvestorPlace,/news/stocks/the-7-best-stocks-and-cryptos-to-buy-in-may-1030427551,neutral,0.905336320400238
5/14/2021 3:38:44 PM,It Won‚Äôt Take Much for Vaxart Stock to Pop Once Again,InvestorPlace,/news/stocks/vxrt-stock-wont-make-much-to-pop-once-again-1030431453,positive,0.7223114967346191
5/14/2021 5:38:17 PM,J&J vaccines to Latin America could expire before they are fully deployed - FT,Seeking Alpha,https://seekingalpha.com/news/3696723-johnson-johnson-vaccines-to-latin-america-could-expire-before-they-are-fully-deployed-ft?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8514134287834167
5/17/2021 4:35:49 AM,Janssen Pharma's Xarelto + aspirin significantly reduces total ischemic events in peripheral artery disease,Seeking Alpha,https://seekingalpha.com/news/3696894-janssen-pharmas-xarelto-aspirin-significantly-reduces-total-ischemic-events-in-peripheral-artery-disease?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9469411373138428
5/17/2021 11:28:54 AM,AC Immune expands Phase 1b/2a phospho-Tau Alzheimer‚Äôs vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3696962-ac-immune-expands-phase-1b2a-phospho-tau-alzheimers-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7375143766403198
5/17/2021 2:36:18 PM,Supreme Court rejects J&J $70M Risperdal award appeal,Seeking Alpha,https://seekingalpha.com/news/3697202-supreme-court-rejects-jj-70m-risperdal-award-appeal?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6037278771400452
5/17/2021 3:55:02 PM,AC Immune Provides Update On Alzheimer's Disease Vaccine Candidate,Benzinga,/news/stocks/ac-immune-provides-update-on-alzheimer-s-disease-vaccine-candidate-1030437016,neutral,0.9168635010719299
5/17/2021 4:12:11 PM,JNJ to cut vaccine shipments to EU by half this week,Seeking Alpha,https://seekingalpha.com/news/3697248-jnj-to-cut-vaccine-shipments-to-eu-by-half-this-week?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9581864476203918
5/17/2021 5:28:00 PM,U.S. to ship additional 20M vaccine doses abroad in June,Seeking Alpha,https://seekingalpha.com/news/3697271-us-to-ship-additional-20m-vaccine-doses-abroad-abroad-in-june?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6776212453842163
5/17/2021 6:45:29 PM,7 ETFs To Buy if You Want To Try To Outperform Cathie Wood,InvestorPlace,/news/stocks/7-etfs-to-buy-if-you-want-to-try-to-outperform-cathie-wood-1030438262,neutral,0.8164645433425903
5/18/2021 5:14:32 PM,JNJ confirms it is working with Indian company to manufacture COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3697906-jnj-confirms-it-is-working-with-indian-company-to-manufacture-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8927968740463257
5/18/2021 7:54:31 PM,Why Zomedica Doesn‚Äôt Need Reddit,InvestorPlace,/news/stocks/zom-stock-why-zomedica-doesnt-need-reddit-1030443399,neutral,0.9341819286346436
5/19/2021 7:16:02 AM,"AstraZeneca/Oxford's third booster shot induces ""high antibody response"", study shows",Seeking Alpha,https://seekingalpha.com/news/3698071-astrazenecaoxfords-third-booster-shot-induces-high-antibody-response-study-shows?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7038987278938293
5/19/2021 9:01:32 AM,7 Best Biotech Stocks To Buy in 2021 as Innovation Takes Center Stage,InvestorPlace,/news/stocks/7-best-biotech-stocks-to-buy-in-2021-as-innovation-takes-center-stage-1030445426,positive,0.6162685751914978
5/19/2021 1:09:13 PM,India's Biological E To Make Johnson & Johnson's COVID-19 Shots: Reuters,Benzinga,/news/stocks/india-s-biological-e-to-make-johnson-johnson-s-covid-19-shots-reuters-1030445754,neutral,0.9341815114021301
5/19/2021 2:03:56 PM,House report finds Emergent execs given bonuses despite failing to deliver vaccines,Seeking Alpha,https://seekingalpha.com/news/3698231-house-report-details-relationships-with-emergent-and-members-of-congress?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5543920993804932
5/19/2021 3:24:10 PM,Senate Republicans ask Biden to walk back support of waiving vaccine IP protection,Seeking Alpha,https://seekingalpha.com/news/3698273-senate-republicans-ask-biden-to-walk-back-support-of-waiving-vaccine-ip-protection?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6177008152008057
5/19/2021 7:04:34 PM,Stay On The Sidelines With Ocugen Stock,InvestorPlace,/news/stocks/stay-on-the-sidelines-with-ocgn-stock-1030455829,neutral,0.9424134492874146
5/20/2021 2:12:01 PM,"Merck downgraded to hold at Argus, Allogene upped at Truist, and more in today's analyst action",Seeking Alpha,https://seekingalpha.com/news/3698655-merck-downgraded-to-hold-at-argus-allogene-upped-at-truist-and-more-in-todays-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6200345754623413
5/20/2021 5:51:41 PM,JNJ highlights potential of IMBRUVICA as a first-line treatment for leukemia,Seeking Alpha,https://seekingalpha.com/news/3698811-jnj-highlights-potential-of-imbruvica-as-a-first-line-treatment-for-leukemia?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.882768452167511
5/20/2021 6:16:48 PM,Moderna Holds the Key to the Future of mRNA Vaccines,InvestorPlace,/news/stocks/mrna-stock-holds-the-key-to-the-future-of-vaccines-1030452921,neutral,0.8024298548698425
5/20/2021 6:44:51 PM,Legend Biotech spikes on EMA acceptance of marketing application for cilta-cel,Seeking Alpha,https://seekingalpha.com/news/3698833-legend-biotech-spikes-on-ema-acceptance-of-marketing-application-for-cilta-cel?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5788431167602539
5/21/2021 12:36:52 PM,Gavi to purchase 200M J&J vaccine doses for poorer countries,Seeking Alpha,https://seekingalpha.com/news/3699079-gavi-to-purchase-200m-johnson-johnson-vaccine-doses-for-poorer-countries?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7128235101699829
5/21/2021 1:30:02 PM,EMA advisory group backs Janssen's Darzalex for AL amyloidosis and multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3699117-ema-advisory-group-backs-janssens-darzalex-for-al-amyloidosis-and-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7688760161399841
5/21/2021 2:04:27 PM,"Pfizer, Moderna, and J&J pledge more shots for poorer countries - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3699127-pfizer-moderna-and-johnson-johnson-pledge-more-shots-for-poorer-countries-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5725340247154236
5/21/2021 3:02:52 PM,JNJ wins positive opinion in Europe for expanded use of DARZALEX,Seeking Alpha,https://seekingalpha.com/news/3699162-jnj-wins-positive-opinion-in-europe-for-expanded-use-of-darzalex?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9528484344482422
5/21/2021 4:29:21 PM,Janssen Gets Two Positive CHMP Opinions For Darzalex Subcutaneous Formulation Utilizing Enhanze ,RTTNews,/news/stocks/janssen-gets-two-positive-chmp-opinions-for-darzalex-subcutaneous-formulation-utilizing-enhanze-1030455493,positive,0.9291114211082458
5/21/2021 6:37:07 PM,FDA approves J&J's Rybrevant as targeted therapy for NSCLC patient subset,Seeking Alpha,https://seekingalpha.com/news/3699217-fda-approves-johnson-johnson-rybrevant-as-targeted-therapy-for-nsclc-patient-subset?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7996129989624023
5/22/2021 2:16:04 PM,"'Halftime Report' Traders Share Their Thoughts On Target, Home Depot And More",Benzinga,/news/stocks/halftime-report-traders-share-their-thoughts-on-target-home-depot-and-more-1030456782,neutral,0.9369022846221924
5/24/2021 4:51:31 AM,Janssen presents Stelara data from late-stage Seavue study in Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/3699311-janssen-presents-stelara-data-from-late-stage-seavue-study-in-crohns-disease?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8911898732185364
5/24/2021 6:27:23 AM,Johnson & Johnson seeks COVID-19 vaccine approval in Japan - Reuters,Seeking Alpha,https://seekingalpha.com/news/3699315-johnson-johnson-seeks-covid-19-vaccine-approval-in-japan-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6636510491371155
5/24/2021 6:31:26 PM,3 Healthcare Stocks to Buy as the Sector Breaks Out,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-as-the-sector-breaks-out-1030459870,neutral,0.772138774394989
5/25/2021 6:02:06 PM,EU targets more than a billion COVID-19 vaccine doses by September,Seeking Alpha,https://seekingalpha.com/news/3699985-eu-targets-more-than-a-billion-covid-19-vaccine-doses-by-september?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8005648851394653
5/25/2021 7:46:23 PM,"With a Stumbling Track Record, All Signs Say Stay Away from Novavax",InvestorPlace,/news/stocks/nvax-stock-stumbling-track-record-all-signs-say-stay-away-1030464342,negative,0.6971257328987122
5/26/2021 11:10:09 AM,FDA is set to decline new emergency use authorizations for COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3700199-fda-is-set-to-decline-new-emergency-use-authorizations-for-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9127316474914551
5/26/2021 2:02:40 PM,Belgium suspends J&J COVID-19 jab for people under 41 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3700331-belgium-suspends-jj-covid-19-jab-for-people-under-41-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.897201418876648
5/26/2021 3:49:59 PM,7 Top Dividend Stocks Trading at a Discount Worth Snapping Up,InvestorPlace,/news/stocks/7-top-dividend-stocks-trading-discount-worth-snapping-up-1030468041,neutral,0.6840519905090332
5/26/2021 5:13:23 PM,7 Defensive ETFs to Protect Yourself From the Tech Sell-Off,InvestorPlace,/news/stocks/7-defensive-etfs-to-protect-yourself-from-the-tech-sell-off-1030468425,neutral,0.8661174178123474
5/26/2021 6:21:23 PM,FDA May Not Review New COVID-19 Vaccine Emergency Use Requests,Benzinga,/news/stocks/fda-may-not-review-new-covid-19-vaccine-emergency-use-requests-1030468148,neutral,0.7860018014907837
5/26/2021 9:41:26 PM,FDA grants J&J multiple myeloma treatment cilta-cel priority review,Seeking Alpha,https://seekingalpha.com/news/3700574-fda-grants-johnson-johnson-multiple-myeloma-treatment-cilta-cel-priority-review?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7377944588661194
5/27/2021 8:41:14 AM,Here's What Is Going On With Ocugen (OCGN) Stock,Benzinga,/news/stocks/here-s-what-is-going-on-with-ocugen-ocgn-stock-1030469868,neutral,0.8751087784767151
5/27/2021 2:23:09 PM,"The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-vir-glaxosmithkline-covid-19-antibody-treatment-approved-zosano-spikes-on-long-term-migraine-drug-data-decision-day-for-eton-2-ipos-1030471204,positive,0.7421003580093384
5/27/2021 4:22:40 PM,J&J may miss June vaccine supply target for EU - Dutch broadcaster,Seeking Alpha,https://seekingalpha.com/news/3700892-johnson-johnson-may-miss-june-vaccine-supply-target-for-eu-dutch-broadcaster?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9515788555145264
5/27/2021 9:27:56 PM,"COVID-19 vaccines from Pfizer/BioNTech, JNJ and Moderna set for India entry as India clears hurdles",Seeking Alpha,https://seekingalpha.com/news/3701056-covid-19-vaccines-from-pfizerbiontech-jnj-and-moderna-set-for-india-entry?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5801085829734802
5/28/2021 3:59:49 AM,"J&J, FDA close to deal allowing release of vaccine from troubled Emergent plant - WSJ",Seeking Alpha,https://seekingalpha.com/news/3701095-johnson-johnson-fda-close-to-deal-allowing-release-of-vaccine-from-troubled-emergent-plant-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8789600729942322
5/28/2021 12:02:35 PM,Johnson & Johnson COVID-19 vaccine wins UK approval (updated),Seeking Alpha,https://seekingalpha.com/news/3701176-johnson-johnson-covid-19-vaccine-wins-uk-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7129732966423035
5/28/2021 2:01:46 PM,Biden's goal of 70% Covid vaccination by summer may be in reach - NYT,Seeking Alpha,https://seekingalpha.com/news/3701240-bidens-goal-of-70-covid-vaccination-by-summer-may-be-in-reach-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5080475211143494
5/28/2021 3:00:13 PM,Johnson & Johnson's Single Dose COVID-19 Vaccine Approved In U.K. ,RTTNews,/news/stocks/johnson-johnson-s-single-dose-covid-19-vaccine-approved-in-u-k-1030475349,positive,0.9036444425582886
5/30/2021 3:54:17 AM,Companies can require employees to get COVID-19 shot: EEOC,Seeking Alpha,https://seekingalpha.com/news/3701444-companies-can-require-employees-to-get-covid-19-shot-eeoc?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8933735489845276
5/31/2021 7:21:08 PM,JNJ‚Äôs delay in meeting COVID-19 vaccine delivery targets only temporary: EU,Seeking Alpha,https://seekingalpha.com/news/3701477-jnjs-delay-in-meeting-covid-19-vaccine-delivery-targets-only-temporary-eu?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5502573251724243
6/1/2021 11:04:05 AM,JNJ to hear from Supreme Court regarding $2 billion talc verdict,Seeking Alpha,https://seekingalpha.com/news/3701563-jnj-to-hear-from-supreme-court-regarding-2-billion-talc-verdict?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8617753982543945
6/1/2021 1:53:05 PM,Johnson & Johnson slips as supreme court rejects appeal in talc case,Seeking Alpha,https://seekingalpha.com/news/3701717-johnson-johnson-slips-as-supreme-court-rejects-appeal-in-talc-case?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9255298376083374
6/1/2021 7:18:38 PM,7 Best Stocks To Buy To Hedge Against A Potential Downturn,InvestorPlace,/news/stocks/7-best-stocks-to-buy-to-hedge-against-a-potential-downturn-1030484539,neutral,0.8428158164024353
6/1/2021 10:41:40 PM,Supreme Court Dismisses J&J Appeal Against The $2bln Fine ,RTTNews,/news/stocks/supreme-court-dismisses-j-j-appeal-against-the-2bln-fine-1030484758,negative,0.8007763028144836
6/1/2021 11:31:09 PM,Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-june-pdufa-dates-1030484849,neutral,0.9476439952850342
6/2/2021 9:37:50 AM,European countries roll out digital Covid certificate to ease travel - NYT,Seeking Alpha,https://seekingalpha.com/news/3702175-european-countries-roll-out-digital-covid-certificate-to-ease-travel-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5580685138702393
6/2/2021 10:37:13 AM,NIH begins study to evaluate mix-and-match COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3702194-nih-begins-study-to-evaluate-mix-and-match-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5177184343338013
6/2/2021 4:35:00 PM,Johnson & Johnson -- Moody's: Denial of J&J's talc verdict appeal highlights litigation exposures,Moodys,/news/bonds/johnson-johnson-moody-s-denial-of-j-j-s-talc-verdict-appeal-highlights-litigation-exposures-1030487991,negative,0.8894081711769104
6/2/2021 8:03:14 PM,AstraZeneca in talks to shift COVID-19 vaccine production from Emergent-owned facility,Seeking Alpha,https://seekingalpha.com/news/3702588-astrazeneca-in-talks-to-shift-covid-19-vaccine-production-from-emergent-owned-facility?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7416177988052368
6/3/2021 8:06:03 AM,Low-income nations secure additional $2.4B to boost access to COVID-19 vaccines - NYT,Seeking Alpha,https://seekingalpha.com/news/3702752-low-income-nations-secures-additional-24b-to-boost-access-to-covid-19-vaccines-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9480469822883606
6/3/2021 3:48:24 PM,4 Best Defensive ETFs to Protect Your Portfolio,InvestorPlace,/news/stocks/4-best-defensive-etfs-to-protect-your-portfolio-1030492368,neutral,0.8423518538475037
6/3/2021 5:29:36 PM,I Would Hope Inovio Isn‚Äôt Attracting ANY Serious Money,InvestorPlace,/news/stocks/i-would-hope-inovio-and-ino-stock-isnt-attracting-any-serious-money-1030492714,neutral,0.7353726625442505
6/4/2021 7:20:52 PM,"Despite Setbacks, the Future Remains Bright for Novavax Stock",InvestorPlace,/news/stocks/despite-setbacks-the-future-remains-bright-for-novavax-stock-1030496514,positive,0.945648729801178
6/7/2021 7:06:19 AM,Argenx to regain global rights to cusatuzumab from Janssen Pharmaceuticals,Seeking Alpha,https://seekingalpha.com/news/3703535-argenx-to-regain-global-rights-to-cusatuzumab-from-janssen-pharmaceuticals?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6083447337150574
6/7/2021 7:43:19 AM,Argenx To Regain Global Rights To Anti-CD70 Antibody Cusatuzumab From Janssen's Cilag ,RTTNews,/news/stocks/argenx-to-regain-global-rights-to-anti-cd70-antibody-cusatuzumab-from-janssen-s-cilag-1030498269,positive,0.7304446697235107
6/7/2021 8:31:19 AM,"Addex, Janssen initiate Phase 2 study of ADX71149 for epilepsy",Seeking Alpha,https://seekingalpha.com/news/3703540-addex-janssen-initiate-phase-2-study-of-adx71149-for-epilepsy?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6806300282478333
6/7/2021 10:37:17 AM,U.S. to weigh COVID-19 shots for children as vaccination drive reaches milestone,Seeking Alpha,https://seekingalpha.com/news/3703562-us-to-weigh-covid-19-shots-for-children-as-vaccination-drive-reaches-milestone?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7012430429458618
6/7/2021 8:41:33 PM,JNJ faces steep decline in demand for COVID-19 shot in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3703903-jnj-faces-steep-decline-in-demand-for-covid-19-shot-in-the-us?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9712908864021301
6/8/2021 3:18:10 PM,"Could Lilly's donanemab, others for Alzheimer's get a boost from Biogen approval?",Seeking Alpha,https://seekingalpha.com/news/3704152-could-lilly-donanemab-others-for-alzheimers-get-a-boost-from-biogen-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6547849774360657
6/8/2021 5:44:00 PM,There‚Äôs Good Reason to Believe Novavax Will Rise Soon,InvestorPlace,/news/stocks/theres-good-reason-to-believe-nvax-stock-will-rise-soon-1030505029,positive,0.8615055680274963
6/8/2021 8:13:34 PM,JNJ COVID-19 vaccines left unused in U.S.: states urged to seek longer shelf life,Seeking Alpha,https://seekingalpha.com/news/3704323-jnj-covid-19-vaccines-left-unused-in-us-states-urged-to-seek-longer-shelf-life?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4749130606651306
6/9/2021 9:35:12 AM,CDC relaxes COVID-19 travel recommendations to over 100 countries - NYT,Seeking Alpha,https://seekingalpha.com/news/3704419-the-cdc-relaxes-covid-19-travel-recommendations-to-over-100-countries-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5177083015441895
6/9/2021 10:36:44 AM,J&J COVID-19 vaccines at risk of going waste due to expiry in June - NYT,Seeking Alpha,https://seekingalpha.com/news/3704430-jj-covid-19-vaccines-at-risk-of-going-waste-due-to-expiry-in-june-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8846903443336487
6/9/2021 2:30:00 PM,"Johnson & Johnson Releases 2020 Health for Humanity Report Highlighting Performance and Progress on Environmental, Social and Governance Priorities",PR Newswire,/news/stocks/johnson-johnson-releases-2020-health-for-humanity-report-highlighting-performance-and-progress-on-environmental-social-and-governance-priorities-1030507524,positive,0.7032811045646667
6/9/2021 4:59:00 PM,Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-second-quarter-results-1030508454,neutral,0.9199506044387817
6/9/2021 7:43:27 PM,"Roivant's Datavant, Ciox Health To Merge In $7B Deal",Benzinga,/news/stocks/roivant-s-datavant-ciox-health-to-merge-in-7b-deal-1030508950,neutral,0.8998741507530212
6/9/2021 8:08:33 PM,JNJ CEO sees need for COVID-19 booster vaccines with annual flu shots for several years,Seeking Alpha,https://seekingalpha.com/news/3704764-jnj-ceo-sees-need-for-covid-19-booster-vaccines-with-annual-flu-shots-for-several-years?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6647443771362305
6/10/2021 9:48:41 AM,WTO to initiate vaccine supply negotiations amid patent waiver conflict for Covid drugs - Reuters,Seeking Alpha,https://seekingalpha.com/news/3704887-wto-to-initiate-vaccine-supply-negotiations-on-june-17-amid-patent-waiver-conflict-for-covid-drugs-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6895943880081177
6/10/2021 10:56:35 AM,JNJ COVID-19 vaccine: EU to donate extra doses,Seeking Alpha,https://seekingalpha.com/news/3704904-jnj-covid-19-vaccine-eu-to-donate-extra-doses?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5399381518363953
6/10/2021 3:52:38 PM,JNJ COVID-19 vaccine: shelf life extended by one-and-a-half months,Seeking Alpha,https://seekingalpha.com/news/3705103-jnj-covid-19-vaccine-shelf-life-extended-by-one-and-a-half-months?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8830440640449524
6/10/2021 4:15:23 PM,Anti-Meme Stocks: 7 Value Stock Picks for Common Sense Investors,InvestorPlace,/news/stocks/anti-meme-stocks-7-value-stock-picks-for-common-sense-investors-1030513268,neutral,0.9350194334983826
6/11/2021 3:16:57 PM,JNJ will need to trash 60M COVID doses from Emergent plant but can distribute 10M (updated),Seeking Alpha,https://seekingalpha.com/news/3705686-johnson-johnson-will-need-to-discard-60m-covid-doses-made-at-emergent-plant-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.924424946308136
6/14/2021 8:26:35 AM,JNJ/AbbVie's Imbruvica + Venclexta show promising progression-free survival in late-stage blood cancer study,Seeking Alpha,https://seekingalpha.com/news/3705857-jnjabbvies-imbruvicavenclexta-show-promising-progression-free-survival-in-blood-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9435181021690369
6/14/2021 8:55:09 AM,JNJ's DARZALEX combo regime shows significant overall survival benefits in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3705858-jnjs-darzalex-combo-regime-shows-significant-overall-survival-benefits-in-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9518078565597534
6/14/2021 11:11:05 AM,G7 leaders pledge 1B coronavirus vaccines for developing countries,Seeking Alpha,https://seekingalpha.com/news/3705892-g7-leaders-pledge-1b-coronavirus-vaccines-for-developing-countries?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.606145441532135
6/14/2021 5:43:07 PM,"Seeking vaccination boost, NYC launches $100 referral bonus program for organizations",Seeking Alpha,https://seekingalpha.com/news/3706113-seeking-vaccination-boost-nyc-launches-100-referral-bonus-program-for-organizations?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8781468272209167
6/14/2021 6:11:12 PM,Rivals in the red after Novavax posted strong efficacy data for its COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3706122-rivals-in-the-red-after-novavax-posted-strong-efficacy-data-for-its-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9234725832939148
6/15/2021 2:25:26 PM,Hold Merck for Its Solid Dividend and Covid-19 Treatment Prospects,InvestorPlace,/news/stocks/hold-mrk-stock-for-solid-dividend-and-covid-19-treatment-prospects-1030525034,positive,0.8403746485710144
6/15/2021 4:32:32 PM,"Cramer Weighs In On Johnson & Johnson, ViacomCBS And More",Benzinga,/news/stocks/cramer-weighs-in-on-johnson-johnson-viacomcbs-and-more-1030524603,neutral,0.5654656291007996
6/15/2021 5:15:32 PM,"US, EU aim to vaccinate two-thirds of world's population against COVID by end of 2022",Seeking Alpha,https://seekingalpha.com/news/3706544-us-eu-aim-to-vaccinate-two-thirds-of-worlds-population-against-covid-by-end-of-2022?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7000488042831421
6/16/2021 1:50:34 AM,Another 14M J&J vaccine doses from Emergent plant authorized by FDA - Reuters,Seeking Alpha,https://seekingalpha.com/news/3706719-another-14m-johnson-johnson-vaccine-doses-from-emergent-plant-authorized-by-fda-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7550258040428162
6/16/2021 11:04:42 AM,JNJ to miss second quarter target for COVID-19 vaccine deliveries: EU,Seeking Alpha,https://seekingalpha.com/news/3706772-jnj-to-miss-second-quarter-target-for-covid-19-vaccine-deliveries-eu?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9433088898658752
6/16/2021 12:13:20 PM,It‚Äôs Time to Admit Defeat and Dump Ocugen Stock as a Covid Play,InvestorPlace,/news/stocks/ocgn-stock-is-no-covid-play-1030528088,neutral,0.8373419642448425
6/16/2021 4:00:34 PM,Is There Still Upside Potential for Novavax Stock?,InvestorPlace,/news/stocks/is-there-still-upside-potential-for-novavax-stock-1030529164,neutral,0.5518515110015869
6/17/2021 4:40:21 AM,BioNTech CEO Ugur Sahin warns of possible COVID resurgence from Delta variant - Barron's,Seeking Alpha,https://seekingalpha.com/news/3707136-biontech-ceo-sahin-warns-of-possible-covid-resurgence-from-delta-variant-barrons?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8906422257423401
6/17/2021 3:02:39 PM,7 Penny Stocks Under a Penny That Are Worth a Look,InvestorPlace,/news/stocks/7-penny-stocks-under-a-penny-that-are-worth-a-look-1030532972,neutral,0.8783378601074219
6/17/2021 9:13:38 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-bitcoin-ride-stock-cvac-stock-1030533935,neutral,0.9254742860794067
6/19/2021 6:38:00 PM,"The Facebook trade is crowded, but Apple isn't; here's the global list: Alpha Tactics",Seeking Alpha,https://seekingalpha.com/news/3707855-facebook-is-crowded-but-apple-isnt-global-list?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9311836361885071
6/21/2021 8:39:43 AM,CDC warns Delta variant could become dominant in U.S. this summer,Seeking Alpha,https://seekingalpha.com/news/3707964-cdc-warns-delta-variant-could-become-dominant-in-us-this-summer-washington-post?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4572983980178833
6/21/2021 10:00:50 AM,Novavax Is a Long-Term Buy for the Continuing Pandemic,InvestorPlace,/news/stocks/nvax-stock-is-a-long-term-buy-for-the-continuing-pandemic-1030538420,neutral,0.5151988863945007
6/21/2021 6:20:08 PM,China reaches a milestone in COVID-19 vaccination with 1 billion shots,Seeking Alpha,https://seekingalpha.com/news/3708387-china-reaches-a-milestone-in-covid-19-vaccination-with-1-billion-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8285501003265381
6/22/2021 4:58:56 PM,White House to fall short of July 4 Covid vaccination goal - NBC,Seeking Alpha,https://seekingalpha.com/news/3708788-white-house-to-say-us-could-miss-fourth-of-july-goal-in-covid-19-vaccination-nbc-news?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6146946549415588
6/23/2021 6:54:00 AM,Fauci says Delta variant greatest threat to U.S. efforts to eradicate COVID-19,Seeking Alpha,https://seekingalpha.com/news/3708985-fauci-says-delta-variant-greatest-threat-to-united-states-efforts-to-eradicate-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4963110685348511
6/23/2021 3:13:30 PM,J&J Janssen division submits Xarelto NDA for blood clots in children,Seeking Alpha,https://seekingalpha.com/news/3709231-johnson-johnson-janssen-division-submits-xarelto-nda-for-blood-clots-in-children?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8870202302932739
6/23/2021 3:25:01 PM,Citius Shows a Promising Future as Share Prices Keep Going up,Benzinga,/news/stocks/citius-shows-a-promising-future-as-share-prices-keep-going-up-1030547404,positive,0.9269535541534424
6/24/2021 9:45:14 AM,NIH commences COVID-19 vaccine trial in pregnant women - Reuters,Seeking Alpha,https://seekingalpha.com/news/3709428-nih-commences-covid-19-vaccine-trial-in-pregnant-women-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8806933164596558
6/24/2021 10:06:34 AM,U.S. to supply 3M doses on J&J's COVID-19 vaccine to Brazil,Seeking Alpha,https://seekingalpha.com/news/3709435-us-to-supply-3m-doses-on-jjs-covid-19-vaccine-to-brazil?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7517930865287781
6/24/2021 4:35:43 PM,CDC and WHO weigh in on need for COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3709736-cdc-and-who-weigh-in-on-need-for-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7704357504844666
6/25/2021 1:25:02 PM,"Denmark to continuing banning J&J, AstraZeneca vaccines",Seeking Alpha,https://seekingalpha.com/news/3710130-denmark-to-continuing-banning-johnson-johnson-astrazeneca-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6216722130775452
6/26/2021 3:19:47 PM,J&J to stop selling opioid meds as part of $230M settlement with New York,Seeking Alpha,https://seekingalpha.com/news/3710315-johnson-johnson-to-stop-selling-opioid-meds-as-part-of-230m-settlement-with-new-york?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8859215974807739
6/26/2021 4:49:24 PM,Johnson & Johnson Agrees To Settle New York Opioid Lawsuit : Reports ,RTTNews,/news/stocks/johnson-johnson-agrees-to-settle-new-york-opioid-lawsuit-reports-1030556564,neutral,0.643840491771698
6/27/2021 1:06:49 AM,JNJ COVID-19 vaccine and risks from delta variant: experts are already taking booster shots,Seeking Alpha,https://seekingalpha.com/news/3710324-jnj-covid-19-vaccine-and-risks-from-delta-variant-experts-are-already-taking-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7029083371162415
6/28/2021 10:49:54 AM,"5 Stocks To Watch For June 28, 2021",Benzinga,/news/stocks/5-stocks-to-watch-for-june-28-2021-1030557819,neutral,0.9067628383636475
6/28/2021 12:09:06 PM,A Peek Into The Markets: US Stock Futures Mixed; Crude Oil Edges Lower,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mixed-crude-oil-edges-lower-1030558050,positive,0.6249991655349731
6/28/2021 12:44:18 PM,"Pfizer, Moderna mRNA vaccines may result in long-lasting immunity: Study",Seeking Alpha,https://seekingalpha.com/news/3710450-pfizer-moderna-mrna-vaccines-may-result-in-long-lasting-immunity-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8322778940200806
6/28/2021 1:18:54 PM,Gates med research CEO transitioning to head vaccines at J&J - Endpoints,Seeking Alpha,https://seekingalpha.com/news/3710491-gates-med-research-ceo-transitioning-to-head-vaccines-role-at-johnson-johnson--endpoints?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9178781509399414
6/28/2021 5:07:04 PM,JNJ's $260M Settlement Could Serve As Global Opioid Deal Template: Analyst,Benzinga,/news/stocks/jnj-s-260m-settlement-could-serve-as-global-opioid-deal-template-analyst-1030559635,neutral,0.8175238370895386
6/29/2021 9:14:34 AM,"Amid surge in Delta variant, nations impose new restrictions to curb infections",Seeking Alpha,https://seekingalpha.com/news/3710809-amid-surge-in-delta-variant-nations-impose-new-restrictions-to-curb-infections?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.49846258759498596
6/29/2021 4:30:14 PM,"Jury trial against drugmakers, drug distributors over opioids begins in N.Y. (updated)",Seeking Alpha,https://seekingalpha.com/news/3711050-jury-trial-against-drugmakers-drug-distributors-over-opioids-begins-in-ny?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8351988792419434
6/29/2021 5:23:41 PM,JNJ COVID-19 shot shows efficacy against variants in lab-based study: NIH,Seeking Alpha,https://seekingalpha.com/news/3711063-jnj-covid-19-shot-shows-efficacy-against-variants-in-lab-based-study-nih?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8672112226486206
6/29/2021 9:24:57 PM,"New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid",Benzinga,/news/stocks/new-york-takes-drugmakers-drug-retailers-to-legal-trial-over-opioid-1030564453,neutral,0.8192859292030334
6/30/2021 2:51:57 PM,Thailand to purchase 5M Moderna COVID vaccine doses,Seeking Alpha,https://seekingalpha.com/news/3711425-thailand-to-purchase-5m-moderna-covid-vaccine-doses?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6417133808135986
6/30/2021 8:05:08 PM,World Bank to boost financing available for COVID vaccine purchases to $20B,Seeking Alpha,https://seekingalpha.com/news/3711572-world-bank-to-boost-financing-available-for-covid-vaccine-purchase-to-20b?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9494579434394836
6/30/2021 8:27:54 PM,Sell Ocugen Stock Before the Other Shoe Finally Drops,InvestorPlace,/news/stocks/ocgn-stock-sell-ocugen-before-other-shoe-finally-drops-1030569105,neutral,0.9403712153434753
7/1/2021 3:35:29 AM,J&J COVID vaccine may protect against Delta variant - US Surgeon General,Seeking Alpha,https://seekingalpha.com/news/3711660-jj-covid-vaccine-may-protect-against-delta-variant-us-surgeon-general?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8075569272041321
7/1/2021 10:51:13 AM,U.K. COVID-19 cases reach the highest since January as Delta variant becomes dominant,Seeking Alpha,https://seekingalpha.com/news/3711713-uk-covid-19-cases-reach-the-highest-since-january-as-delta-variant-becomes-dominant?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9074463248252869
7/1/2021 9:16:41 PM,WHO chief urges every nation to vaccinate at least 10% of population by September,Seeking Alpha,https://seekingalpha.com/news/3712248-who-chief-urges-every-nation-to-vaccinate-at-least-10-of-population-by-september?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8444909453392029
7/2/2021 1:59:00 AM,Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response,PR Newswire,/news/stocks/positive-new-data-for-johnson-johnson-single-shot-covid-19-vaccine-on-activity-against-delta-variant-and-long-lasting-durability-of-response-1030573808,positive,0.8950040340423584
7/2/2021 3:12:05 AM,J&J Says Data Shows Its Single-shot COVID-19 Vaccine Effective Against Delta And Other Variants ,RTTNews,/news/stocks/j-j-says-data-shows-its-single-shot-covid-19-vaccine-effective-against-delta-and-other-variants-1030573838,positive,0.9483696222305298
7/2/2021 11:34:30 AM,COVAX urges all governments for equal recognition of COVID-19 vaccines for travel,Seeking Alpha,https://seekingalpha.com/news/3712318-covax-urges-all-governments-for-equal-recognition-of-covid-19-vaccines-for-travel?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6579920649528503
7/2/2021 1:14:04 PM,"Gottlleb says OK for vaccinated Americans gather with friends, family for July 4 - CNBC",Seeking Alpha,https://seekingalpha.com/news/3712370-gottlleb-says-ok-for-vaccinated-americans-gather-with-friends-family-for-july-4-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9041554927825928
7/2/2021 1:58:09 PM,COVID-19 response teams being deployed across U.S. to combat Delta variant,Seeking Alpha,https://seekingalpha.com/news/3712399-covid-19-response-teams-being-deployed-across-us-to-combat-delta-variant?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.56116783618927
7/2/2021 4:25:53 PM,"Biden not concerned about major COVID outbreak, but wants to see more vaccinations",Seeking Alpha,https://seekingalpha.com/news/3712520-biden-not-concerned-about-major-covid-outbreak-but-wants-to-see-more-vaccinations?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7372598052024841
7/2/2021 7:33:18 PM,JNJ COVID-19 vaccine snafu at Emergent plant: FDA clears another batch of doses,Seeking Alpha,https://seekingalpha.com/news/3712668-jnj-covid-19-vaccine-snafu-at-emergent-plant-fda-clears-another-batch-of-doses?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6709403991699219
7/4/2021 1:14:17 AM,Scientists not alarmed by deaths due to COVID-19 Delta variant among fully vaccinated,Seeking Alpha,https://seekingalpha.com/news/3712735-deaths-due-to-covid-19-delta-variant-among-fully-vaccinated-scientists-are-not-alarmed?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6125169992446899
7/5/2021 10:00:22 AM,NVAX Stock Is Not For The Faint Of Heart,InvestorPlace,/news/stocks/nvax-stock-is-not-for-the-faint-of-heart-1030578313,neutral,0.9399634599685669
7/6/2021 6:29:48 AM,Israel sees decrease in Pfizer vaccine effectiveness against COVID-19 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3712766-israel-sees-decrease-in-pfizer-vaccine-effectiveness-against-covid-19-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9608821868896484
7/6/2021 10:00:14 AM,"Ocugen Has Had a Good Run, but the Math Says It‚Äôs Over",InvestorPlace,/news/stocks/ocgn-stock-has-had-good-run-but-math-says-its-over-1030581139,positive,0.5612895488739014
7/6/2021 10:01:16 AM,7 Safe Harbor Stocks To Buy Ahead of the Potential Volatility,InvestorPlace,/news/stocks/7-safe-harbor-stocks-to-buy-ahead-potential-volatility-1030581134,neutral,0.7031269073486328
7/6/2021 5:53:53 PM,JNJ to deliver nearly 40M of additional COVID-19 vaccine doses to EU,Seeking Alpha,https://seekingalpha.com/news/3713042-jnj-to-deliver-nearly-40m-of-additional-covid-19-vaccine-doses-to-eu?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7534467577934265
7/6/2021 7:56:28 PM,"Biden ramping up vaccination efforts, focusing on adolescents, pediatricians, and workplaces",Seeking Alpha,https://seekingalpha.com/news/3713077-biden-ramping-up-vaccination-efforts-focusing-on-adolescents-pediatricians-and-workplaces?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8103127479553223
7/7/2021 4:31:44 AM,New Zealand OK's use of J&J COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3713159-new-zealand-oks-use-of-jj-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8985033631324768
7/7/2021 7:47:11 AM,"U.K. Health secretary warns daily COVID-19 cases could reach 100,000",Seeking Alpha,https://seekingalpha.com/news/3713163-uk-health-secretary-warns-daily-covid-19-cases-could-reach-100000?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9133962988853455
7/7/2021 10:49:38 AM,Mid-size pharmaceutical firms lead bigger rivals in acquisitions this year,Seeking Alpha,https://seekingalpha.com/news/3713185-mid-size-pharmaceutical-firms-lead-bigger-rivals-in-acquisitions-this-year?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6112596988677979
7/7/2021 5:13:09 PM,Latest CDC data show COVID-19 Delta variant is now dominant in U.S.,Seeking Alpha,https://seekingalpha.com/news/3713403-latest-cdc-data-show-covid-19-delta-variant-is-now-dominant-in-us?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6076706647872925
7/8/2021 12:09:05 PM,Vor Biopharma teams up with Janssen Biotech to develop leukemia therapy,Seeking Alpha,https://seekingalpha.com/news/3713574-vor-biopharma-teams-up-with-janssen-biotech-to-develop-leukemia-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7620905637741089
7/8/2021 2:42:54 PM,Fifteen states reach agreement with Purdue over bankruptcy plan - NYT,Seeking Alpha,https://seekingalpha.com/news/3713666-fifteen-states-reach-agreement-with-purdue-over-bankruptcy-plan-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8544980883598328
7/8/2021 2:52:13 PM,Global COVID-19 death toll surpasses 4M,Seeking Alpha,https://seekingalpha.com/news/3713684-global-covid-19-death-roll-surpasses-4m?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6976547837257385
7/8/2021 3:28:49 PM,"Vor Biopharma, Janssen Team Up To Develop Combination Therapies For Acute Myeloid Leukemia",Benzinga,/news/stocks/vor-biopharma-janssen-team-up-to-develop-combination-therapies-for-acute-myeloid-leukemia-1030589987,positive,0.6867856979370117
7/8/2021 4:27:00 PM,Stay Away From Low-Growth Organon,InvestorPlace,/news/stocks/low-growth-weak-catalysts-ogn-stock-unattractive-1030590811,neutral,0.9079623818397522
7/8/2021 5:56:17 PM,Scientists weigh in on reimplementation of COVID-19 restrictions in under-vaccinated areas,Seeking Alpha,https://seekingalpha.com/news/3713742-scientists-weigh-in-on-reimplementation-of-covid-19-restrictions-in-under-vaccinated-areas?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7959221005439758
7/8/2021 7:38:27 PM,"House Oversight report says pharmas spend more on buybacks, dividends than R&D",Seeking Alpha,https://seekingalpha.com/news/3713778-house-oversight-report-says-pharmas-spend-more-on-buybacks-dividends-than-research-development?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8492428064346313
7/9/2021 11:35:41 AM,CDC and FDA: No need for COVID-19 booster shots at this time for fully vaccinated,Seeking Alpha,https://seekingalpha.com/news/3713918-cdc-and-fda-there-is-no-need-for-covid-19-booster-shots-at-this-time-for-fully-vaccinated?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8758229613304138
7/9/2021 12:40:27 PM,EMA finds link possible between heart inflammation and mRNA COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3713951-ema-finds-link-possible-between-heart-inflammation-and-mrna-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6032868027687073
7/9/2021 2:00:00 PM,Johnson & Johnson Launches Network of Global Health Discovery Centers that Aim to Speed Up Science and Tackle Pandemic Threats,PR Newswire,/news/stocks/johnson-johnson-launches-network-of-global-health-discovery-centers-that-aim-to-speed-up-science-and-tackle-pandemic-threats-1030592893,positive,0.665253758430481
7/9/2021 2:58:08 PM,7 Travel Stocks to Sell if the Delta Variant Slows the Reopening Rally,InvestorPlace,/news/stocks/7-travel-stocks-to-sell-if-delta-variant-slows-reopening-rally-1030593455,negative,0.8868438601493835
7/9/2021 3:42:37 PM,JNJ posts encouraging three-year data for STELARA in ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/3714032-jnj-posts-encouraging-three-year-data-for-stelara-in-ulcerative-colitis?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9517862200737
7/9/2021 4:02:14 PM,Watch Out for a Selloff in Vaxart Stock,InvestorPlace,/news/stocks/watch-out-for-a-selloff-in-vaxart-stock-1030593691,neutral,0.5398306846618652
7/9/2021 4:53:01 PM,CDC updates guidance for schools recommending indoor masking for unvaccinated children and teachers,Seeking Alpha,https://seekingalpha.com/news/3714051-cdc-updates-guidance-for-schools-recommending-indoor-masking-for-unvaccinated-children-and-teachers?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7573944926261902
7/10/2021 10:51:53 PM,Alector leads weekly healthcare gainers; gene-editing stocks fall after Intellia-driven rally,Seeking Alpha,https://seekingalpha.com/news/3714135-alector-leads-weekly-healthcare-gainers-gene-editing-stocks-fall-after-intellia-driven-rally?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9623830318450928
7/11/2021 2:29:21 AM,"New daily COVID-19 cases exceed 48,000 in U.S., highest since May",Seeking Alpha,https://seekingalpha.com/news/3714138-new-daily-covid-19-cases-exceed-48000-in-us-highest-since-may?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6676768660545349
7/12/2021 10:50:13 AM,"Chinese COVID-19 shots have nearly 70% efficacy against Delta variant, scientist says",Seeking Alpha,https://seekingalpha.com/news/3714180-chinese-covid-19-shots-have-nearly-70-efficacy-against-delta-variant-scientist-says?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.915778398513794
7/12/2021 12:24:53 PM,FDA approves Janssen's Darzalex Faspro combo in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3714230-fda-approves-janssens-darzalex-faspro-combo-in-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7737736105918884
7/12/2021 6:01:46 PM,JNJ vaccine linked to new side effect; FDA to add warning to indicate risk,Seeking Alpha,https://seekingalpha.com/news/3714421-jnj-vaccine-linked-to-new-side-effect-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6179937124252319
7/12/2021 6:29:48 PM,"France to require health pass for bars, cafes, attractions and travel",Seeking Alpha,https://seekingalpha.com/news/3714430-france-to-require-health-pass-for-bars-cafes-attractions-and-travel?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9183841347694397
7/12/2021 9:38:05 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-spce-stock-johnson-and-johnson-1030598854,neutral,0.9254742860794067
7/12/2021 11:36:14 PM,J&J's Covid Vaccine Linked To Rare Neurological Condition; FDA Might Issue Warning ,RTTNews,/news/stocks/j-j-s-covid-vaccine-linked-to-rare-neurological-condition-fda-might-issue-warning-1030598846,neutral,0.6496456861495972
7/13/2021 11:17:08 AM,New warning added to Johnson & Johnson COVID-19 shot to reflect risk of rare side effect,Seeking Alpha,https://seekingalpha.com/news/3714604-new-warning-added-to-jnj-covid-19-shot-to-reflect-risk-of-rare-side-effect?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5404713153839111
7/13/2021 11:44:01 AM,"JNJ, AstraZeneca explore modifications for COVID-19 shots to address clotting risk: WSJ",Seeking Alpha,https://seekingalpha.com/news/3714620-jnj-astrazeneca-explore-modifications-to-covid-19-shots-to-address-clotting-risk-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5176549553871155
7/13/2021 2:05:06 PM,"The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data",Benzinga,/news/stocks/the-daily-biotech-pulse-equillium-issues-positive-regulatory-update-biogen-in-licenses-multiple-sclerosis-drug-aridis-releases-covid-19-antibody-cocktail-data-1030601329,neutral,0.7802436947822571
7/13/2021 3:32:41 PM,"J&J, AstraZeneca Exploring Fixes To Rare Blood Clots Linked To Their Vaccines: WSJ ",RTTNews,/news/stocks/j-j-astrazeneca-exploring-fixes-to-rare-blood-clots-linked-to-their-vaccines-wsj-1030602027,neutral,0.703872561454773
7/13/2021 5:18:16 PM,More data needed on potential side effects of COVID-19 booster shots: CDC official,Seeking Alpha,https://seekingalpha.com/news/3714823-more-data-needed-on-potential-side-effects-of-covid-19-booster-shots-cdc-official?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9113448858261108
7/14/2021 2:07:15 PM,7 Stocks to Buy if You‚Äôre Worried About the Pandemic Like Warren Buffett,InvestorPlace,/news/stocks/7-stocks-to-buy-if-worried-like-warren-buffett-about-pandemic-1030607187,neutral,0.9034628868103027
7/14/2021 5:08:48 PM,"Europe adds warnings on Pfizer, Moderna COVID-19 shots to reflect risk of heart inflammation",Seeking Alpha,https://seekingalpha.com/news/3715227-europe-adds-warnings-on-pfizer-moderna-covid-19-shots-to-reflect-risk-of-heart-inflammation?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8227541446685791
7/14/2021 6:00:21 PM,EMA says too early to determine if COVID booster shots will be needed,Seeking Alpha,https://seekingalpha.com/news/3715240-ema-says-too-early-to-determine-if-covid-booster-shots-will-be-needed?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9369086623191833
7/14/2021 9:30:12 PM,JNJ to recall certain NEUTROGENA and AVEENO sunscreen products citing carcinogen,Seeking Alpha,https://seekingalpha.com/news/3715331-jnj-to-recall-certain-neutrogena-and-aveeno-sunscreen-products-citing-carcinogen?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9445621967315674
7/14/2021 11:00:00 PM,Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA¬Æ and AVEENO¬Æ Aerosol Sunscreen Products Due to the Presence of Benzene,PR Newswire,/news/stocks/johnson-johnson-consumer-inc-issues-voluntary-recall-of-specific-neutrogena-and-aveeno-aerosol-sunscreen-products-due-to-the-presence-of-benzene-1030608381,negative,0.9460067749023438
7/15/2021 12:45:34 AM,Johnson & Johnson Recalls Certain Sunscreen Products Due To Benzene Presence ,RTTNews,/news/stocks/johnson-johnson-recalls-certain-sunscreen-products-due-to-benzene-presence-1030608536,negative,0.9453099966049194
7/15/2021 1:34:43 PM,CDC to discuss need for COVID-19 booster doses in immunocompromised people,Seeking Alpha,https://seekingalpha.com/news/3715544-cdc-to-discuss-need-for-covid-19-booster-doses-in-immunocompromised-people?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8260878324508667
7/15/2021 2:07:56 PM,"The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-galapagos-sinks-on-data-j-j-recalls-sunscreen-products-fibrogen-awaits-adcom-verdict-3-ipos-1030610817,neutral,0.6488537192344666
7/15/2021 4:00:51 PM,CVS Health pulls two sunburn products citing cancer-causing agent,Seeking Alpha,https://seekingalpha.com/news/3715639-cvs-health-pulls-two-sunburn-products?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9619598984718323
7/15/2021 8:35:26 PM,Medtech firm HeartFlow agrees to $2.4B SPAC merger with Longview Acquisition Corp. II,Seeking Alpha,https://seekingalpha.com/news/3715766-heartflow-agrees-to-spac-merger-with-longview-acquisition-corp-ii?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6371515393257141
7/16/2021 2:17:21 PM,MRNA Stock: 10 Things to Know About Moderna as It Gets Ready to Join the S&P 500,InvestorPlace,/news/stocks/mrna-stock-10-things-to-know-about-moderna-as-it-gets-ready-to-join-the-sp-500-1030615504,neutral,0.9003421068191528
7/16/2021 4:10:20 PM,7 Best Dividend Stocks to Buy to Juice Your Portfolio Yield,InvestorPlace,/news/stocks/7-best-dividend-stocks-to-buy-to-juice-your-portfolio-yield-1030615780,neutral,0.8995172381401062
7/16/2021 8:21:41 PM,FDA now investigating cause of benzene contamination in J&J sunscreens,Seeking Alpha,https://seekingalpha.com/news/3716107-fda-now-investigating-cause-of-benzene-contamination-in-jj-sunscreens?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4901566803455353
7/17/2021 8:00:00 PM,"Interest in ""shroom stocks"" rises as investors see potential of psychedelics as therapy",Seeking Alpha,https://seekingalpha.com/news/3716128-interest-in-shroom-stocks-rises-as-investors-see-potential-of-psychedelics-as-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7474524974822998
7/18/2021 4:25:56 PM,"The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-earnings-kickstart-with-j-j-and-biogen-albireo-awaits-fda-decisions-more-ipos-1030617574,positive,0.5948069095611572
7/19/2021 3:56:18 AM,J&J may put talc liabilities into new business that files bankruptcy - Reuters,Seeking Alpha,https://seekingalpha.com/news/3716153-jj-may-put-talc-liabilities-into-new-business-that-files-bankruptcy-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9145602583885193
7/19/2021 5:25:57 AM,Johnson & Johnson Considering Plan To Put Talc Liabilities Into Bankruptcy : Report ,RTTNews,/news/stocks/johnson-johnson-considering-plan-to-put-talc-liabilities-into-bankruptcy-report-1030617774,neutral,0.798870861530304
7/19/2021 3:01:28 PM,Here's what to expect from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnson_johnson-q2-quarterly-earnings-preview-stock-1030620368,neutral,0.9278756976127625
7/19/2021 4:39:12 PM,"Johnson & Johnson declares $1.06 dividend, stock yields 2.6%",Seeking Alpha,https://seekingalpha.com/news/3716448-johnson-and-johnson-declares-1_06-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6645792126655579
7/19/2021 6:35:00 PM,Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2021,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2021-1030621320,negative,0.6737919449806213
7/19/2021 8:21:37 PM,60% of people admitted to hospitals due to COVID-19 are unvaccinated - U.K. chief scientific adviser,Seeking Alpha,https://seekingalpha.com/news/3716576-60-of-people-admitted-to-hospitals-due-to-covid-19-are-unvaccinated-uk-chief-scientific-adviser?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7849387526512146
7/20/2021 2:20:32 AM,"U.S. is said to near $26B opioid settlement with drug distributors, J&J",Seeking Alpha,https://seekingalpha.com/news/3716659-us-is-said-to-near-26b-opioid-settlement-with-drug-distributors-jj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9007072448730469
7/20/2021 1:15:26 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3716864-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8558874130249023
7/20/2021 4:08:50 PM,COVID-19 Delta variant now accounts for 83% of new cases - CDC Director,Seeking Alpha,https://seekingalpha.com/news/3716985-covid-19-delta-variant-now-accounts-for-83-of-new-cases-cdc-director?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8862178921699524
7/20/2021 4:10:18 PM,Three Drug Distributors To Pay Up To $1.18 Bln To Settle New York Opioid Claims ,RTTNews,/news/stocks/three-drug-distributors-to-pay-up-to-1-18-bln-to-settle-new-york-opioid-claims-1030625917,positive,0.4366326928138733
7/20/2021 5:06:36 PM,"JNJ, drug distributors favored on Street as they near $26B opioid settlement with U.S.",Seeking Alpha,https://seekingalpha.com/news/3717024-jnj-drug-distributors-favored-on-street-as-they-near-26b-opioid-settlement-with-us?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4966932237148285
7/20/2021 8:52:56 PM,7 Top Defensive Stocks To Buy For Q2 Earnings Season,InvestorPlace,/news/stocks/7-top-defensive-stocks-to-buy-for-q2-earnings-season-1030627206,neutral,0.867081880569458
7/21/2021 10:31:17 AM,"Johnson & Johnson EPS beats by $0.19, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3717239-johnson-and-johnson-eps-beats-0_19-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7389808893203735
7/21/2021 11:16:44 AM,Johnson & Johnson boosts 2021 guidance after Q2 earnings beat,Seeking Alpha,https://seekingalpha.com/news/3717274-johnson-johnson-boosts-2021-guidance-after-q2-earnings-beat?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.69260573387146
7/21/2021 12:25:00 PM,Johnson & Johnson Reports Q2 2021 Results,PR Newswire,/news/stocks/johnson-johnson-reports-q2-2021-results-1030629526,neutral,0.7140601873397827
7/21/2021 12:34:47 PM,Johnson & Johnson Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q2-adjusted-earnings-beat-estimates-1030629548,positive,0.6643651127815247
7/21/2021 1:08:46 PM,Johnson & Johnson Raises FY21 View Above Market As Q2 Results Top Estimates ,RTTNews,/news/stocks/johnson-johnson-raises-fy21-view-above-market-as-q2-results-top-estimates-1030629771,positive,0.898330569267273
7/21/2021 1:52:07 PM,"The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-novartis-report-solid-results-chembio-soars-on-covid-test-order-lumos-signals-clinical-trial-delay-1030629917,positive,0.8773147463798523
7/21/2021 5:58:30 PM,U.S life expectancy cut by a year and a half in 2020 due to COVID-19,Seeking Alpha,https://seekingalpha.com/news/3717587-us-life-expectancy-cut-by-a-year-and-a-half-in-2020-due-to-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9592798948287964
7/21/2021 8:47:49 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-to-catch-up-on-10-1030632297,neutral,0.9254742860794067
7/21/2021 9:43:35 PM,"4 Top Stock Trades for Thursday: SQ, JNJ, KO, CMG",InvestorPlace,/news/stocks/4-top-stock-trades-for-thursday-sq-jnj-ko-cmg-1030632487,neutral,0.9167636036872864
7/21/2021 11:44:50 PM,"Johnson & Johnson, Drug Distributors Settle $26 Bln Opioid Deal ",RTTNews,/news/stocks/johnson-johnson-drug-distributors-settle-26-bln-opioid-deal-1030632399,positive,0.39798131585121155
7/23/2021 12:18:20 PM,Johnson & Johnson's VERITAS Vision System available globally,Seeking Alpha,https://seekingalpha.com/news/3718535-johnson-johnsons-veritas-vision-system-available-globally?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9313092827796936
7/23/2021 4:16:35 PM,"Snap, Twitter Earnings Impress, Potentially Setting Table For Facebook Next Week",Benzinga,/news/stocks/snap-twitter-earnings-impress-potentially-setting-table-for-facebook-next-week-1030639365,negative,0.7198337912559509
7/23/2021 5:57:32 PM,"Pfizer/BioNTech COVID-19 shot is 39% effective with prevalence of Delta variant, Israel says",Seeking Alpha,https://seekingalpha.com/news/3718702-pfizerbiontech-covid-19-shot-is-39-effective-with-prevalence-of-delta-variant-israel-says?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8483461737632751
7/23/2021 8:17:00 PM,Johnson & Johnson -- Moody's: J&J opioid settlement adds financial leverage but reduces uncertainty,Moodys,/news/bonds/johnson-johnson-moody-s-j-j-opioid-settlement-adds-financial-leverage-but-reduces-uncertainty-1030639924,positive,0.9453245997428894
7/25/2021 3:14:39 AM,COVID-19 cases are rising in every U.S. state amid vaccine hesitancy,Seeking Alpha,https://seekingalpha.com/news/3718822-covid-19-cases-are-rising-in-every-us-state-amid-vaccine-hesitancy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8902134895324707
7/25/2021 3:26:31 PM,"The Week Ahead In Biotech: Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-july-25-31-big-pharma-earnings-iterum-fda-decision-alzheimer-s-conference-ipos-and-more-1030641744,neutral,0.9177687168121338
7/26/2021 10:00:41 AM,3 Blue-Chip Dividend Stocks for a Bear Market,InvestorPlace,/news/stocks/3-blue-chip-dividend-stocks-for-a-bear-market-1030643974,neutral,0.8821025490760803
7/26/2021 10:00:58 AM,Novavax Stock May Not Get the Delta Varient Bump Investors Need,InvestorPlace,/news/stocks/novavax-stock-may-not-get-the-delta-varient-bump-investors-need-1030643966,neutral,0.7728200554847717
7/26/2021 11:21:36 AM,Biden officials contemplate the need of COVID-19 booster shots in vulnerable Americans,Seeking Alpha,https://seekingalpha.com/news/3718902-biden-officials-contemplate-the-need-of-covid-19-booster-shots-in-vulnerable-americans?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8326241374015808
7/26/2021 8:42:19 PM,Data from Israel suggest impact of vaccines on severe COVID-19 despite uptick in cases,Seeking Alpha,https://seekingalpha.com/news/3719325-data-from-israel-highlight-impact-of-vaccines-on-severe-covid-19-despite-uptick-in-cases?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9212674498558044
7/27/2021 10:45:49 AM,"Vaccine mandates announced in NYC, California and Department of Veterans Affairs",Seeking Alpha,https://seekingalpha.com/news/3719480-vaccine-mandates-announced-in-nyc-california-and-department-of-veterans-affairs?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8609797954559326
7/27/2021 2:05:24 PM,Israel to offer COVID-19 vaccines to at-risk children - Jerusalem Post,Seeking Alpha,https://seekingalpha.com/news/3719701-israel-to-offer-covid-19-vaccines-to-at-risk-children-jerusalem-post?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5542251467704773
7/27/2021 6:23:20 PM,7 Cheap Value Stocks to Buy for August 2021,InvestorPlace,/news/stocks/7-cheap-value-stocks-to-buy-for-august-2021-1030652138,neutral,0.9190971255302429
7/27/2021 7:52:39 PM,CDC recommends masks in public spaces in areas with substantial and high COVID-19 transmission,Seeking Alpha,https://seekingalpha.com/news/3719958-cdc-mandates-masks-in-public-spaces-in-areas-with-substantial-high-covid-19-transmission?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8540836572647095
7/27/2021 8:09:11 PM,U.S. is weighing vaccine mandates for all federal employees,Seeking Alpha,https://seekingalpha.com/news/3719984-us-is-weighing-vaccine-mandates-for-all-federal-employees?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8368844389915466
7/27/2021 10:10:00 PM,Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-virtual-wells-fargo-healthcare-conference-1030652364,neutral,0.8388641476631165
7/28/2021 6:10:09 PM,White House tells federal agencies to mandate masks indoors in high COVID areas - Reuters,Seeking Alpha,https://seekingalpha.com/news/3720745-white-house-tells-federal-agencies-to-mandate-masks-indoors-in-high-covid-areas-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8978102207183838
7/28/2021 8:12:09 PM,J&J asked by U.S. House subcommittee to provide info on plans to put talc liabilities into bankruptcy - Reuters,Seeking Alpha,https://seekingalpha.com/news/3720863-j-asked-by-us-house-subcommittee-to-provide-info-on-plans-to-put-talc-liabilities-into-bankruptcy-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9348462224006653
7/29/2021 5:28:16 AM,FDA Extends Shelf-life Of Johnson & Johnson's COVID-19 Vaccine ,RTTNews,/news/stocks/fda-extends-shelf-life-of-johnson-johnson-s-covid-19-vaccine-1030659292,positive,0.6577466726303101
7/29/2021 10:46:54 AM,Emergent to restart COVID-19 vaccine production at Baltimore Plant,Seeking Alpha,https://seekingalpha.com/news/3721278-emergent-to-restart-covid-19-vaccine-production-at-baltimore-plant?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9206724762916565
7/29/2021 5:14:00 PM,"Women Cancer Victims Opposed to Johnson & Johnson's 'Texas Two-Step' Bankruptcy Ploy Urge Passage of Reforms Introduced by Warren, Durbin, Nadler, Blumenthal, and Maloney",PR Newswire,/news/stocks/women-cancer-victims-opposed-to-johnson-johnson-s-texas-two-step-bankruptcy-ploy-urge-passage-of-reforms-introduced-by-warren-durbin-nadler-blumenthal-and-maloney-1030663440,positive,0.7458447217941284
7/29/2021 5:14:59 PM,AstraZeneca and J&J are yet to see need for COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3721739-astrazeneca-and-jj-are-yet-to-see-need-for-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5511700510978699
7/29/2021 8:38:54 PM,7 Best ETFs To Buy Now if You‚Äôre Looking for Safety,InvestorPlace,/news/stocks/7-best-etfs-to-buy-now-for-safety-1030664554,neutral,0.9192031025886536
7/30/2021 8:12:18 AM,Is a third COVID-19 vaccine dose necessary? What you need to know about boosters,Seeking Alpha,https://seekingalpha.com/news/3722140-is-a-third-covid-19-vaccine-dose-necessary-what-you-need-to-know-about-boosters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9243149161338806
7/30/2021 11:00:10 AM,"COVID-19 Delta variant is as contagious as chickenpox, CDC report says - NYT",Seeking Alpha,https://seekingalpha.com/news/3722207-covid-19-delta-variant-is-as-contagious-as-chickenpox-cdc-report-says-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7013028860092163
7/30/2021 12:43:53 PM,FDA OKs Janssen Pharma's Uptravi for intravenous use in adults with PAH,Seeking Alpha,https://seekingalpha.com/news/3722343-fda-oks-janssen-pharmas-uptravi-for-intravenous-use-in-adults-with-pah?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7159885168075562
7/30/2021 1:53:58 PM,"The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-erytech-jumps-on-fast-track-designation-glaxosmithkline-fda-nod-alnylam-s-clinical-collaboration-4-ipos-1030667906,positive,0.7937849760055542
7/30/2021 2:23:34 PM,"Elon Musk, Jeff Bezos & Richard Branson: Which Market Leaders Will Make Up The Cannabis Industry Space Race?",Benzinga,/news/stocks/elon-musk-jeff-bezos-richard-branson-which-market-leaders-will-make-up-the-cannabis-industry-space-race-1030668073,neutral,0.9424588084220886
7/30/2021 5:29:08 PM,Johnson & Johnson agrees to delay bankruptcy plan for talc liabilities,Seeking Alpha,https://seekingalpha.com/news/3722555-johnson-johnson-agrees-to-delay-bankruptcy-plan-for-talc-liabilities?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6680159568786621
7/30/2021 6:30:04 PM,Fully vaccinated people made up 74% of cases in a COVID-19 outbreak in Massachusetts - CDC,Seeking Alpha,https://seekingalpha.com/news/3722589-fully-vaccinated-people-made-up-74-of-cases-in-a-covid-19-outbreak-in-massachusetts-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8357453346252441
8/2/2021 8:06:26 AM,U.S. lockdown unlikely despite surge in Covid cases: Fauci,Seeking Alpha,https://seekingalpha.com/news/3722777-us-lockdown-unlikely-despite-surge-in-covid-cases-fauci?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.42814895510673523
8/2/2021 10:14:30 AM,J&J pulls back proposal for expedited COVID-19 vaccine approval in India,Seeking Alpha,https://seekingalpha.com/news/3722794-jj-pulls-back-proposal-for-expedited-covid-19-vaccine-approval-in-india?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8918823003768921
8/2/2021 11:31:33 AM,"CDC reports over 6,000 COVID-19 hospitalizations in U.S. among fully vaccinated",Seeking Alpha,https://seekingalpha.com/news/3722831-cdc-reports-over-6000-covid-19-hospitalizations-in-us-among-fully-vaccinated?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8329271674156189
8/2/2021 3:33:59 PM,"Pfizer, Moderna raise COVID-19 vaccine prices in the EU",Seeking Alpha,https://seekingalpha.com/news/3723066-pfizer-moderna-raise-covid-19-vaccine-prices-in-the-eu?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7425273656845093
8/2/2021 3:54:58 PM,"Throw in The Towel, Ocugen Stock is Not Coming Back",InvestorPlace,/news/stocks/ocgn-stock-throw-in-towel-not-coming-back-1030677286,neutral,0.762498676776886
8/3/2021 11:12:27 AM,Britain and Germany to offer COVID-19 booster shots; U.S. seeks more data,Seeking Alpha,https://seekingalpha.com/news/3723709-britain-and-germany-to-offer-covid-19-booster-shots-us-waits-for-more-data?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7890748977661133
8/3/2021 2:50:39 PM,"DeBlasio: NYC requiring vaccination proof for restaurants, gyms, and entertainment venues",Seeking Alpha,https://seekingalpha.com/news/3723960-deblasio-nyc-requiring-vaccination-proof-for-restaurants-gyms-and-entertainment-venues?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9112752079963684
8/3/2021 5:01:31 PM,7 Cheap Value Stocks To Buy For August 2021,InvestorPlace,/news/stocks/7-cheap-value-stocks-to-buy-for-august-2021-2-1030684926,neutral,0.9190971255302429
8/4/2021 9:19:16 AM,Final FDA approval for Pfizer's COVID-19 vaccine expected by early September,Seeking Alpha,https://seekingalpha.com/news/3724672-final-fda-approval-for-pfizers-covid-19-vaccine-expected-by-early-september?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7865217328071594
8/4/2021 1:52:10 PM,"The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-s-positive-readout-nrx-strikes-r-d-collaboration-with-mannkind-cerus-invitae-jump-on-earnings-1030688766,positive,0.7550456523895264
8/4/2021 2:37:31 PM,WHO calls for COVID vaccine booster moratorium so poorer countries can get shots,Seeking Alpha,https://seekingalpha.com/news/3724983-who-calls-for-covid-booster-moratorium-so-poorer-countries-can-get-shots-wapo?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5331580638885498
8/4/2021 5:08:27 PM,7 Stocks to Buy for Responsibility and Sustainability,InvestorPlace,/news/stocks/7-stocks-to-buy-for-responsibility-and-sustainability-1030690642,neutral,0.8951489329338074
8/4/2021 6:29:01 PM,"Pfizer, Moderna COVID-19 shots offered in San Francisco to Johnson & Johnson vaccine recipients",Seeking Alpha,https://seekingalpha.com/news/3725234-pfizer-moderna-covid-19-shots-offered-in-san-francisco-to-johnson-johnson-vaccine-recipients?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8261359930038452
8/5/2021 9:48:09 AM,Global COVID-19 cases top 200M as Delta variant rages,Seeking Alpha,https://seekingalpha.com/news/3725762-global-covid-19-cases-top-200m-as-delta-variant-rages?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5814626216888428
8/5/2021 2:07:56 PM,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-reports-positive-keytruda-readout-moderna-slips-despite-q2-beat-bayer-to-buy-vividion-for-up-to-2b-glycomimetics-gets-new-ceo-1030695873,positive,0.8679104447364807
8/5/2021 6:08:03 PM,Fauci warns COVID-19 variants more severe than delta could emerge,Seeking Alpha,https://seekingalpha.com/news/3726300-fauci-warns-covid-19-variants-more-severe-than-delta-could-emerge?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9177864193916321
8/6/2021 10:31:15 AM,Johnson & Johnson COVID-19 shot offers 71% protection when Delta variant dominates - Study,Seeking Alpha,https://seekingalpha.com/news/3726850-johnson-johnson-covid-19-shot-offers-71-protection-when-delta-variant-dominates-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6931595206260681
8/6/2021 10:48:30 AM,Johnson & Johnson seeks emergency use approval of COVID-19 vaccine in India,Seeking Alpha,https://seekingalpha.com/news/3726866-johnson-johnson-seeks-emergency-use-approval-of-covid-19-vaccine-in-india?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7589830756187439
8/6/2021 3:49:09 PM,"Despite Novavax‚Äôs Challenges, NVAX Stock Could Still Pop",InvestorPlace,/news/stocks/nvax-stock-despite-challenges-could-still-pop-from-here-1030702070,positive,0.9330615997314453
8/6/2021 5:32:31 PM,Latest CDC report shows a slight uptick in COVID-19 cases among fully vaccinated,Seeking Alpha,https://seekingalpha.com/news/3727132-latest-cdc-report-shows-a-slight-uptick-in-covid-19-cases-among-fully-vaccinated?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.56436687707901
8/6/2021 8:00:09 PM,Bioethicist Ezekiel Emanuel under consideration for FDA commissioner - Politico,Seeking Alpha,https://seekingalpha.com/news/3727179-bioethicist-ezekiel-emanuel-under-consideration-for-fda-commissioner-politico?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9355555176734924
8/8/2021 7:11:35 PM,India Approves Johnson & Johnson's Single-dose COVID-19 Vaccine ,RTTNews,/news/stocks/india-approves-johnson-johnson-s-single-dose-covid-19-vaccine-1030704408,positive,0.7088826894760132
8/8/2021 9:35:13 PM,Fauci hopes FDA will give full approval for COVID-19 vaccine in next few weeks,Seeking Alpha,https://seekingalpha.com/news/3727253-fauci-hopes-fda-will-give-full-approval-for-covid-19--vaccine-in-next-few-weeks?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7232928276062012
8/9/2021 6:04:30 AM,Pfizer vaccine booster shot has similar side effects to 2nd dose: Israeli survey,Seeking Alpha,https://seekingalpha.com/news/3727278-pfizer-vaccine-booster-shot-has-similar-side-effects-to-2nd-dose-israeli-survey?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8921642899513245
8/9/2021 3:07:00 PM,Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-barclays-global-consumer-staples-virtual-conference-1030708907,neutral,0.8503885865211487
8/9/2021 3:17:59 PM,Why These Biotech Stocks Are Soaring,InvestorPlace,/news/stocks/why-these-biotech-stocks-are-soaring-1030710695,neutral,0.9273127913475037
8/10/2021 8:14:31 AM,Moderna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time,Seeking Alpha,https://seekingalpha.com/news/3727988-moderna-covid-19-vaccine-may-be-better-than-pfizer-against-delta-variant-breakthrough-cases-rise-with-time?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9368888139724731
8/10/2021 12:57:28 PM,COVID-19 during pregnancy associated with higher risk of preterm birth: U.S. Study,Seeking Alpha,https://seekingalpha.com/news/3728176-covid-19-during-pregnancy-associated-with-higher-risk-of-preterm-birth-us-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5115488171577454
8/10/2021 8:40:24 PM,Dr. Scott Gottlieb says current COVID-19 surge could be the ‚Äúfinal wave‚Äù in U.S.,Seeking Alpha,https://seekingalpha.com/news/3728500-dr-scott-gottlieb-says-current-covid-19-surge-could-be-the-final-wave-in-us?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6829950213432312
8/11/2021 10:00:50 AM,Novavax Is Looking More Like a Bet Worth Taking,InvestorPlace,/news/stocks/nvax-stock-is-looking-more-like-a-bet-worth-taking-1030717837,neutral,0.8606452941894531
8/11/2021 4:57:52 PM,7 Biotech Stocks to Buy Amid the Delta Variant‚Äôs Onslaught,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-amid-rising-covid-19-cases-1030719978,neutral,0.5603512525558472
8/11/2021 6:30:41 PM,7 Best Bear Market Stocks to Buy Now in Preparation for a Downturn,InvestorPlace,/news/stocks/7-best-bear-market-stocks-to-buy-now-in-preparation-for-a-downturn-1030720182,neutral,0.7811886072158813
8/12/2021 11:01:31 AM,AstraZeneca COVID-19 shot did not lead to new cases of rare clots after age restrictions - study,Seeking Alpha,https://seekingalpha.com/news/3729425-astrazeneca-covid-19-shot-did-not-lead-to-new-cases-of-rare-clots-after-age-restrictions-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.727138876914978
8/12/2021 3:14:00 PM,Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-morgan-stanley-19th-annual-global-healthcare-conference-1030724612,neutral,0.6497109532356262
8/12/2021 4:07:52 PM,CytoSorbents' Antithrombotic Removal System Scores Second FDA Breakthrough Device Tag,Benzinga,/news/stocks/cytosorbents-antithrombotic-removal-system-scores-second-fda-breakthrough-device-tag-1030724927,positive,0.755981981754303
8/12/2021 11:18:53 PM,Why This Fundamentally Superior Biotech Is Soaring,InvestorPlace,/news/stocks/why-this-fundamentally-superior-biotech-is-soaring-1030735292,neutral,0.8504866361618042
8/13/2021 10:07:10 AM,Pfizer/BioNTech and Moderna win FDA nod for COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3730157-pfizerbiontech-and-moderna-win-fda-nod-in-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9133623838424683
8/13/2021 1:43:02 PM,"The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-s-vaccine-produces-durable-response-against-variants-fda-approves-jazz-s-sleep-disorder-drug-dermata-ipo-1030728962,positive,0.8680633306503296
8/13/2021 7:43:28 PM,Novavax: Bronze Medal May Be Good Enough in COVID Race,InvestorPlace,/news/stocks/nvax-stock-bronze-medal-may-be-good-enough-in-covid-race-1030730157,positive,0.9052911400794983
8/13/2021 9:01:38 PM,"Pfizer, Moderna to enjoy first mover advantage as COVID-19 expected to become endemic",Seeking Alpha,https://seekingalpha.com/news/3730492-pfizer-moderna-to-enjoy-first-mover-advantage-as-covid-19-expected-to-become-endemic?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8873968124389648
8/15/2021 2:52:53 AM,Plans underway in U.S. to widen access to COVID-19 boosters as early as fall - NYT,Seeking Alpha,https://seekingalpha.com/news/3730532-plans-underway-in-us-to-widen-access-to-covid-19-boosters-as-early-as-fall-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.907819390296936
8/16/2021 6:35:52 AM,Texas Supreme Court temporarily halts local mask mandates,Seeking Alpha,https://seekingalpha.com/news/3730569-texas-supreme-court-temporarily-halts-local-mask-mandates?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8446751236915588
8/17/2021 2:28:53 PM,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",Benzinga,/news/stocks/the-daily-biotech-pulse-lilly-reorganizes-business-units-in-neuroscience-focus-helius-medical-spikes-on-breakthrough-designation-ra-medical-sells-dermatology-business-1030738023,neutral,0.9126443266868591
8/18/2021 2:06:17 AM,COVID-19 Delta variant is linked to higher risk of hospitalizations - WHO,Seeking Alpha,https://seekingalpha.com/news/3731680-covid-19-delta-variant-is-linked-to-higher-risk-of-hospitalizations-who?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.42758485674858093
8/18/2021 7:35:29 AM,Los Angeles to require masks at large outdoor events,Seeking Alpha,https://seekingalpha.com/news/3731693-los-angeles-to-require-masks-at-large-outdoor-events-us-transport-mask-mandate-extended?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9152795076370239
8/18/2021 1:37:56 PM,"The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline",Benzinga,/news/stocks/the-daily-biotech-pulse-azurrx-jumps-on-data-agios-regulatory-application-for-mitapivat-accepted-for-priority-review-fda-nod-for-glaxosmithkline-1030741574,positive,0.5053828358650208
8/18/2021 2:28:03 PM,Pfizer's third COVID-19 shot 86% effective in people over 60: Israeli healthcare provider,Seeking Alpha,https://seekingalpha.com/news/3731878-pfizers-third-covid-19-shot-86-effective-in-people-over-60s-israeli-healthcare-provider?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6488713026046753
8/19/2021 8:18:01 AM,Biden administration to require nursing home workers get COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3732117-biden-administration-to-require-nursing-home-workers-get-covid-19-vaccine-amid-delta-surge?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9040305614471436
8/19/2021 11:14:21 AM,Biden's booster shots recommendation questioned by some health experts,Seeking Alpha,https://seekingalpha.com/news/3732172-bidens-booster-shots-recommendation-causes-distress-among-scientists-and-health-experts?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8085072636604309
8/19/2021 11:18:00 PM,"Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022",PR Newswire,/news/stocks/alex-gorsky-to-serve-as-executive-chairman-and-transition-role-of-chief-executive-officer-of-johnson-johnson-to-joaquin-duato-effective-january-3-2022-1030747372,neutral,0.9495426416397095
8/20/2021 2:14:06 AM,Acting FDA head Woodcock ruled out as permanent nominee - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3732564-acting-fda-head-woodcock-ruled-out-as-permanent-nominee-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7850378751754761
8/20/2021 5:00:34 AM,Alex Gorsky To Step Down As J&J's CEO And Joaquin Duato To Take Over CEO Role ,RTTNews,/news/stocks/alex-gorsky-to-step-down-as-j-j-s-ceo-and-joaquin-duato-to-take-over-ceo-role-1030747568,neutral,0.7465004920959473
8/20/2021 8:52:08 AM,Texas Supreme Court to temporarily keep school mask mandates in place,Seeking Alpha,https://seekingalpha.com/news/3732584-texas-supreme-court-to-temporarily-keep-school-mask-mandates-in-place?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7449683547019958
8/20/2021 1:45:43 PM,"The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-announces-ceo-transition-fibrogen-s-roxadustat-approved-in-europe-geovax-sorrento-announce-covid-19-vaccine-data-1030748705,neutral,0.8679832220077515
8/20/2021 1:54:10 PM,"Israel expands COVID-19 booster shot eligibility to people over 40, teachers",Seeking Alpha,https://seekingalpha.com/news/3732705-israel-expands-covid-19-booster-shot-eligibility-to-people-over-40-teachers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5116277933120728
8/20/2021 3:22:23 PM,"Novavax Stock Could Remain a Winner, Despite its ‚ÄòAlso Ran‚Äô Status",InvestorPlace,/news/stocks/nvax-stock-could-remain-winner-despite-also-ran-status-1030749369,positive,0.7404907941818237
8/20/2021 8:36:39 PM,"What Did the Stock Market Do Today, Aug. 20? 3 Big Stories to Catch Up On.",InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-to-catch-up-on-13-2-2-1030749919,neutral,0.931075930595398
8/20/2021 9:30:57 PM,Pfizer/BioNTech COVID-19 vaccine set to win full FDA approval on Monday - NYT,Seeking Alpha,https://seekingalpha.com/news/3732860-pfizerbiontech-covid-19-vaccine-set-to-win-full-fda-approval-on-monday-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6256353855133057
8/22/2021 1:58:42 AM,Pfizer/BioNTech COVID-19 vaccine protection dropped faster than AstraZeneca‚Äôs - study,Seeking Alpha,https://seekingalpha.com/news/3732884-pfizerbiontech-covid-19-vaccine-protection-dropped-faster-than-astrazenecas-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9235166311264038
8/22/2021 3:01:25 PM,"The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-cara-fda-decision-ascendis-earnings-aileron-data-presentation-and-more-1030750711,neutral,0.942092776298523
8/23/2021 8:45:22 PM,COVID-19 vaccine mandates in NYC schools and Pentagon after FDA approval,Seeking Alpha,https://seekingalpha.com/news/3733298-covid-19-vaccine-mandates-in-nyc-schools-and-pentagon-after-full-fda-approval-for-pfizerbiontech-shot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8030844330787659
8/24/2021 11:17:10 AM,Biden calls on companies to require COVID-19 vaccines after Pfizer's FDA approval,Seeking Alpha,https://seekingalpha.com/news/3733404-biden-calls-on-companies-to-require-covid-19-vaccines-after-pfizers-fda-approval?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8398863673210144
8/24/2021 12:06:50 PM,Theravance draws downgrade and target cuts after setback in ulcerative colitis trial,Seeking Alpha,https://seekingalpha.com/news/3733435-theravance-draws-downgrade-and-target-cuts-after-setback-in-ulcerative-colitis-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9538887143135071
8/24/2021 12:16:48 PM,Theravance Stock Plunges As JAK Inhibitor Flops Ulcerative Colitis Study,Benzinga,/news/stocks/theravance-stock-plunges-as-jak-inhibitor-flops-ulcerative-colitis-study-1030754399,negative,0.9535878896713257
8/24/2021 10:05:03 PM,Why BioNTech Is the Better Biotech Buy,InvestorPlace,/news/stocks/why-biontech-is-the-better-biotech-buy-1030759223,neutral,0.8715741038322449
8/24/2021 11:40:00 PM,Ovarian Cancer Victims Ask Court to Block Johnson & Johnson's 'Texas Two-Step' Bankruptcy Plan,PR Newswire,/news/stocks/ovarian-cancer-victims-ask-court-to-block-johnson-johnson-s-texas-two-step-bankruptcy-plan-1030756167,negative,0.7986293435096741
8/25/2021 10:45:43 AM,COVID-19 vaccine protection wanes within six months: U.K. study,Seeking Alpha,https://seekingalpha.com/news/3733837-covid-19-vaccine-protection-wanes-with-six-months-uk-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4411337971687317
8/25/2021 12:45:00 PM,Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine,PR Newswire,/news/stocks/johnson-johnson-announces-data-to-support-boosting-its-single-shot-covid-19-vaccine-1030757202,positive,0.9388585090637207
8/25/2021 1:38:31 PM,J&J COVID-19 Vaccine Booster Dose Rapidly Boosted Spike-binding Antibodies ,RTTNews,/news/stocks/j-j-covid-19-vaccine-booster-dose-rapidly-boosted-spike-binding-antibodies-1030757361,positive,0.9467253684997559
8/25/2021 4:08:19 PM,7 Best Biotech Stocks to Buy in 2021 with Huge Upside,InvestorPlace,/news/stocks/7-best-biotech-stocks-to-buy-in-2021-with-huge-upside-1030758448,positive,0.5626564025878906
8/25/2021 4:33:06 PM,Pfizer/BioNTech start rolling submission for FDA approval of booster COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3734101-pfizerbiontech-start-rolling-submission-for-fda-approval-of-booster-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7656390070915222
8/26/2021 9:17:50 AM,Risk of heart inflammation higher after COVID-19 than post vaccination: Study,Seeking Alpha,https://seekingalpha.com/news/3734298-risk-of-heart-inflammation-higher-after-covid-19-than-post-vaccination-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5795733332633972
8/26/2021 3:15:00 PM,Johnson & Johnson to Participate in the Cantor Virtual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-cantor-virtual-global-healthcare-conference-1030760955,neutral,0.6552423238754272
8/26/2021 6:03:01 PM,"Illinois Gov. Pritzker issues vaccine, masks requirement in healthcare settings, schools",Seeking Alpha,https://seekingalpha.com/news/3734594-illinois-gov-pritzker-issues-vaccine-masks-requirement-in-healthcare-settings-schools?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9364863038063049
8/26/2021 10:30:00 PM,"Johnson & Johnson Seeks Global Nominees for Award Geared at Female Researchers Working in Science, Technology, Engineering, Math, Manufacturing and Design",PR Newswire,/news/stocks/johnson-johnson-seeks-global-nominees-for-award-geared-at-female-researchers-working-in-science-technology-engineering-math-manufacturing-and-design-1030762105,neutral,0.5030309557914734
8/27/2021 10:00:26 AM,Longshot Covid Play Vaxart Stock Is Too Risky at These Prices,InvestorPlace,/news/stocks/longshot-covid-play-vxrt-stock-is-too-risky-at-these-prices-1030763261,neutral,0.7545995116233826
8/27/2021 10:30:00 AM,7 Safe Stocks To Buy for an Increasingly Unstable World,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-for-an-increasingly-unstable-world-1030763320,neutral,0.7229255437850952
8/27/2021 10:55:26 AM,"Singapore nears target of inoculating 80% of population, rolls out COVID-19 test kits",Seeking Alpha,https://seekingalpha.com/news/3734757-singapore-nears-target-of-inoculating-80-of-population-rolls-out-covid-19-test-kits?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.666199803352356
8/27/2021 1:35:25 PM,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration",Benzinga,/news/stocks/the-daily-biotech-pulse-morphosys-incyte-snag-european-nod-immutep-granted-chinese-patent-bolt-biotherapeutics-strike-oncology-collaboration-1030763431,positive,0.51130211353302
8/27/2021 2:45:49 PM,3 Top-Quality Dividend Stocks for a Secure Retirement,InvestorPlace,/news/stocks/3-top-quality-dividend-stocks-for-a-secure-retirement-1030763866,positive,0.5301348567008972
8/30/2021 8:54:01 AM,Fauci says COVID-19 vaccine mandates in school 'a good idea',Seeking Alpha,https://seekingalpha.com/news/3735055-fauci-says-covid-19-vaccine-mandates-in-school-a-good-idea?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7898486256599426
8/30/2021 1:43:57 PM,Novavax Looks Like a Good Stock to Trade,InvestorPlace,/news/stocks/novavax-looks-like-a-good-stock-to-trade-1030767134,positive,0.5665773153305054
8/31/2021 12:45:00 PM,Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa,PR Newswire,/news/stocks/johnson-johnson-and-global-partners-announce-results-from-phase-2b-imbokodo-hiv-vaccine-clinical-trial-in-young-women-in-sub-saharan-africa-1030769172,positive,0.6534813046455383
8/31/2021 1:13:54 PM,Johnson & Johnson: HIV Vaccine Candidate Fails To Provide Protection; To Discontinue Imbokodo Study ,RTTNews,/news/stocks/johnson-johnson-hiv-vaccine-candidate-fails-to-provide-protection-to-discontinue-imbokodo-study-1030769299,negative,0.8308387994766235
8/31/2021 5:41:24 PM,7 Dividend Aristocrat Stocks to Buy in September for Gains and Stability,InvestorPlace,/news/stocks/7-dividend-aristocrat-stocks-to-buy-in-september-for-gains-and-stability-1030770935,neutral,0.7393561601638794
8/31/2021 7:03:00 PM,Outcry Continues to Grow for Johnson & Johnson to Resolve Talc-Cancer Claims After Latest Jury Verdict,PR Newswire,/news/stocks/outcry-continues-to-grow-for-johnson-johnson-to-resolve-talc-cancer-claims-after-latest-jury-verdict-1030770850,positive,0.9081159234046936
8/31/2021 7:28:37 PM,"7 Stocks To Watch For Tech, Fintech and Inflation Catalysts",InvestorPlace,/news/stocks/7-stocks-to-watch-for-tech-fintech-and-inflation-catalysts-1030771062,neutral,0.9173950552940369
8/31/2021 8:25:48 PM,"Novo Nordisk, Pfizer lead monthly gainers among large-cap pharma; Elanco, Amgen trail",Seeking Alpha,https://seekingalpha.com/news/3735840-novo-nordisk-pfizer-lead-monthly-gainers-among-large-cap-pharma-elanco-amgen-trail?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7700791954994202
9/1/2021 10:07:34 AM,"Pennsylvania Gov. Tom Wolf issues mask requirements for schools, child care centers",Seeking Alpha,https://seekingalpha.com/news/3735929-pennsylvania-gov-tom-wolf-issues-mask-requirements-for-schools-child-care-centers?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.890673041343689
9/1/2021 2:56:51 PM,FDA OK's Janssen Pharmaceutical's INVEGA HAFYERA To Treat Adults With Schizophrenia - Quick Facts ,RTTNews,/news/stocks/fda-ok-s-janssen-pharmaceutical-s-invega-hafyera-to-treat-adults-with-schizophrenia-quick-facts-1030773101,positive,0.547626256942749
9/1/2021 4:43:35 PM,WHO warns of a new COVID-19 variant with potential to evade vaccine-driven immunity,Seeking Alpha,https://seekingalpha.com/news/3736184-who-warns-of-a-new-covid-19-variant-with-potential-to-evade-vaccine-driven-immunity?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9303123950958252
9/2/2021 9:06:04 AM,FDA advisory panel to discuss Pfizer's booster shot application on Sept. 17,Seeking Alpha,https://seekingalpha.com/news/3736545-fda-advisory-panel-to-discuss-pfizers-booster-shot-application-on-sept-17?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.916094958782196
9/2/2021 10:44:38 AM,Risk of long COVID reduces by 50% in fully vaccinated people: Study,Seeking Alpha,https://seekingalpha.com/news/3736578-risk-of-long-covid-reduces-by-50-in-fully-vaccinated-people-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5588123202323914
9/2/2021 3:25:30 PM,Moderna COVID-19 booster strategy triggers debate on dose level,Seeking Alpha,https://seekingalpha.com/news/3736801-moderna-covid-19-booster-strategy-leads-to-mixed-views-on-dose-level?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5834462642669678
9/2/2021 5:34:14 PM,7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In¬†,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-before-3-5-trillion-floods-in-1030777655,neutral,0.819796085357666
9/2/2021 8:16:10 PM,Fauci says COVID-19 full vaccine regimen is unlikely to exceed three shots,Seeking Alpha,https://seekingalpha.com/news/3736990-fauci-says-covid-19-full-vaccine-regimen-is-unlikely-to-exceed-three-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7678776383399963
9/2/2021 10:07:00 PM,"Battle Against Johnson & Johnson ""Texas Two-Step"" Ploy Moves to New Jersey",PR Newswire,/news/stocks/battle-against-johnson-johnson-texas-two-step-ploy-moves-to-new-jersey-1030777921,neutral,0.8232706189155579
9/7/2021 4:02:32 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-7-2021-1030784466,negative,0.516502857208252
9/8/2021 10:00:31 AM,Vaxart Stock Is One Vaccine Also-Ran Worth Another Look,InvestorPlace,/news/stocks/vxrt-stock-is-one-vaccine-also-ran-worth-another-look-1030786409,neutral,0.8450997471809387
9/8/2021 10:59:23 AM,"WHO says coronavirus is ‚Äúhere to stay‚Äù, elimination unlikely",Seeking Alpha,https://seekingalpha.com/news/3737810-who-says-coronavirus-is-here-to-stay-elimination-unlikely?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8685397505760193
9/8/2021 11:28:20 AM,"Fed's Kaplan traded millions of dollars in stocks in 2020, including megacaps - WSJ",Seeking Alpha,https://seekingalpha.com/news/3737825-dallas-fed-president-robert-kaplan-traded-millions-in-stocks-in-2020?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9379438757896423
9/8/2021 11:39:46 AM,Pfizer chief scientist rejects criticism on COVID-19 booster push; defends jab‚Äôs potency,Seeking Alpha,https://seekingalpha.com/news/3737836-pfizer-chief-scientist-rejects-criticism-on-covid-19-booster-push-defends-jabs-potency?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6993919014930725
9/8/2021 4:25:03 PM,7 Busted Biotech Stocks Due for a Rebound,InvestorPlace,/news/stocks/7-busted-biotech-stocks-due-for-a-rebound-1030787940,negative,0.5655386447906494
9/8/2021 4:37:46 PM,WHO chief urges richer nations to halt COVID-19 booster shot rollouts till end of the year,Seeking Alpha,https://seekingalpha.com/news/3738021-who-chief-urges-richer-nations-to-halt-covid-19-booster-shot-rollouts-till-end-of-the-year?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6981649398803711
9/10/2021 1:31:21 PM,Endo Shares Move Higher On Settlement Of New York State Opioid Cases,Benzinga,/news/stocks/endo-shares-move-higher-on-settlement-of-new-york-state-opioid-cases-1030792398,positive,0.8947303295135498
9/14/2021 12:30:00 AM,Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases,PR Newswire,/news/stocks/johnson-johnson-ebola-vaccine-regimen-demonstrated-robust-and-durable-immune-response-in-adults-and-children-in-data-published-in-the-lancet-infectious-diseases-1030796874,positive,0.948612630367279
9/14/2021 4:41:59 AM,Johnson & Johnson Ebola Vaccine Data Shows Strong Immune Response ,RTTNews,/news/stocks/johnson-johnson-ebola-vaccine-data-shows-strong-immune-response-1030796943,positive,0.9489777088165283
9/14/2021 1:50:13 PM,"The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-nrx-rises-on-covid-19-drug-collaboration-amgen-s-lung-cancer-drug-conditionally-approved-in-canada-coherus-data-readout-1030798122,positive,0.8988341689109802
9/14/2021 8:42:17 PM,Novavax Has More Room to Run as the Vaccination Push Carries On,InvestorPlace,/news/stocks/nvax-stock-more-room-to-run-as-vaccination-push-carries-on-1030799785,positive,0.6767752170562744
9/14/2021 9:28:13 PM,7 Great Stocks to Buy for an Income-Rich Retirement,InvestorPlace,/news/stocks/7-great-stocks-to-buy-for-an-income-rich-retirement-1030799872,neutral,0.847540557384491
9/15/2021 8:51:37 PM,7 Great Dividend Stocks To Buy In September For Insulation from Volatility,InvestorPlace,/news/stocks/7-great-dividend-stocks-to-buy-in-september-for-insulation-from-volatility-1030803003,neutral,0.8150755763053894
9/16/2021 8:41:05 PM,"With the European Union Buying Doses, Novavax Has Plenty of Upside Left",InvestorPlace,/news/stocks/with-european-union-buying-doses-nvax-stock-plenty-upside-left-1030805836,positive,0.6231839656829834
9/16/2021 11:54:00 PM,Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results-1030805914,neutral,0.9196439981460571
9/17/2021 7:40:14 PM,3 Value Dividend Stocks for High Total Returns,InvestorPlace,/news/stocks/3-value-dividend-stocks-for-high-total-returns-1030807937,positive,0.6146938800811768
9/19/2021 3:46:51 PM,"The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight",Benzinga,/news/stocks/the-week-ahead-in-biotech-sept-19-25-incyte-verrica-fda-decisions-and-conference-presentations-in-the-spotlight-1030808489,neutral,0.9415056109428406
9/20/2021 10:00:23 AM,It‚Äôs OK to Sell the News on Ocugen and Covaxin,InvestorPlace,/news/stocks/sell-the-news-on-ocgn-stock-1030809323,neutral,0.9287483096122742
9/20/2021 12:21:15 PM,Mauna Kea in pact with Lung Cancer Initiative at Johnson & Johnson for biopsy guidance tool,Seeking Alpha,https://seekingalpha.com/news/3741122-mauna-kea-in-pact-with-lung-cancer-initiative-at-johnson-johnson-in-lung-cancer-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6280724406242371
9/20/2021 8:11:00 PM,"Robert Wood Johnson Foundation, NJ -- Moody's assigns initial Aaa issuer rating to Robert Wood Johnson Foundation (NJ); outlook stable",Moodys,/news/bonds/robert-wood-johnson-foundation-nj-moody-s-assigns-initial-aaa-issuer-rating-to-robert-wood-johnson-foundation-nj-outlook-stable-1030810876,neutral,0.5119460225105286
9/20/2021 8:24:00 PM,"Robert Wood Johnson Foundation, NJ -- Moody's assigns initial Aaa issuer rating to Robert Wood Johnson Foundation (NJ); outlook stable",Moodys,/news/bonds/robert-wood-johnson-foundation-nj-moody-s-assigns-initial-aaa-issuer-rating-to-robert-wood-johnson-foundation-nj-outlook-stable-1030810940,neutral,0.5119460225105286
9/20/2021 9:41:00 PM,"Robert Wood Johnson Foundation, NJ -- Moody's assigns initial Aaa issuer rating to Robert Wood Johnson Foundation (NJ); outlook stable",Moodys,/news/bonds/robert-wood-johnson-foundation-nj-moody-s-assigns-initial-aaa-issuer-rating-to-robert-wood-johnson-foundation-nj-outlook-stable-1030811057,neutral,0.5119460225105286
9/21/2021 7:30:37 AM,Fauci says COVID-19 vaccine for kids ages 5 to 11 could be available before Halloween,Seeking Alpha,https://seekingalpha.com/news/3741645-covid-19-vaccine-for-kids-ages-5-to-11-could-be-available-before-halloween?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.865645170211792
9/21/2021 12:30:00 PM,Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.,PR Newswire,/news/stocks/johnson-johnson-announces-real-world-evidence-and-phase-3-data-confirming-strong-and-long-lasting-protection-of-single-shot-covid-19-vaccine-in-the-u-s-1030812150,positive,0.938206672668457
9/21/2021 1:08:01 PM,AC Immune granted U.S. patent covering Alzheimer's Disease candidate,Seeking Alpha,https://seekingalpha.com/news/3741817-ac-immune-granted-us-patent-covering-alzheimers-disease-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8235873579978943
9/21/2021 1:18:50 PM,J&J: Real-world Data Confirms Efficacy Of Vaccine In The U.S.; Booster Shows 94% Protection ,RTTNews,/news/stocks/j-j-real-world-data-confirms-efficacy-of-vaccine-in-the-u-s-booster-shows-94-protection-1030812309,positive,0.9272864460945129
9/21/2021 2:12:37 PM,"India to decline Pfizer/BioNTech, Moderna COVID-19 shots amid local supplies - Reuters",Seeking Alpha,https://seekingalpha.com/news/3741869-india-to-decline-pfizerbiontech-moderna-covid-19-shots-amid-local-supplies-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7918567657470703
9/21/2021 2:20:50 PM,"The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data",Benzinga,/news/stocks/the-daily-biotech-pulse-aprea-jumps-on-esmo-presentation-verrica-sinks-on-regulatory-setback-aerie-ceo-quits-j-j-touts-positive-covid-19-booster-shot-data-1030812654,negative,0.676978349685669
9/21/2021 8:40:12 PM,7 Stocks to Buy Following Vaccine Victories,InvestorPlace,/news/stocks/7-stocks-to-buy-following-vaccine-victories-1030814227,neutral,0.925391674041748
9/22/2021 4:12:01 PM,"After Today's Fed Meeting, Investors Are Stuck With Contradictory Reports On Evergrande And The Debt Ceiling",Benzinga,/news/stocks/after-today-s-fed-meeting-investors-are-stuck-with-contradictory-reports-on-evergrande-and-the-debt-ceiling-1030816331,negative,0.9310271739959717
9/22/2021 5:51:34 PM,Is Ketamine A Psychedelic? Depends On Who You Ask,Benzinga,/news/stocks/is-ketamine-a-psychedelic-depends-on-who-you-ask-1030816611,neutral,0.9043107628822327
9/23/2021 2:55:26 PM,7 Robinhood Stocks to Buy for Newbie Investors,InvestorPlace,/news/stocks/7-robinhood-stocks-to-buy-for-newbie-investors-1030819480,neutral,0.9085613489151001
9/23/2021 4:19:45 PM,7 High-Yield Dividend Stocks That Will Please Any Income Lover,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-please-any-income-lover-1030819743,neutral,0.8400514721870422
9/23/2021 6:50:44 PM,10 Oversold Stocks to Buy for the Final Quarter,InvestorPlace,/news/stocks/10-oversold-stocks-to-buy-for-the-final-quarter-1030820052,negative,0.8969274163246155
9/25/2021 6:58:09 PM,"Barron's Latest Picks And Pans: Healthcare Roundtable Picks, Dividend Aristocrats And More",Benzinga,/news/stocks/barron-s-latest-picks-and-pans-healthcare-roundtable-picks-dividend-aristocrats-and-more-1030823039,neutral,0.935904860496521
9/27/2021 4:22:37 PM,Novavax and the Changing Covid-19 Vaccine Game,InvestorPlace,/news/stocks/nvax-stock-and-the-changing-covid-vaccine-game-1030830062,neutral,0.8475068807601929
9/28/2021 1:00:00 PM,Johnson & Johnson Celebrates COVID-19 Vaccine Science Superheroes,PR Newswire,/news/stocks/johnson-johnson-celebrates-covid-19-vaccine-science-superheroes-1030827585,neutral,0.8800357580184937
9/28/2021 7:30:23 PM,7 Biotech Stocks Entering the Golden Boom Phase,InvestorPlace,/news/stocks/7-biotech-stocks-entering-the-golden-boom-phase-1030829968,neutral,0.7444125413894653
9/30/2021 11:13:47 AM,Meet members of the 2021 IPO class: Healthcare - 1,Seeking Alpha,https://seekingalpha.com/news/3746473-meet-members-of-the-2021-ipo-class-healthcare-1?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9424605965614319
9/30/2021 11:17:26 AM,Meet members of the 2021 IPO class: Healthcare - 2,Seeking Alpha,https://seekingalpha.com/news/3746475-meet-members-of-the-2021-ipo-class-healthcare-2?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.944514811038971
10/1/2021 11:14:01 AM,Pharmacy chains to face first U.S. legal trial related to opioid crisis,Seeking Alpha,https://seekingalpha.com/news/3746868-pharmacy-chains-to-face-first-us-legal-trial-on-opioid-crisis?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5080076456069946
10/1/2021 2:30:32 PM,Merck data for coronavirus pill pressures developers of antibody therapies,Seeking Alpha,https://seekingalpha.com/news/3747028-merck-data-for-coronavirus-pill-pressure-developers-of-antibody-therapies?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8979425430297852
10/3/2021 2:13:12 AM,Moderna COVID-19 shot linked to higher rates of heart inflammation - Canada,Seeking Alpha,https://seekingalpha.com/news/3747415-moderna-covid-19-shot-linked-to-higher-rates-of-heart-inflammation-canada?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4501199722290039
10/4/2021 1:00:15 PM,Merck extends gains after data for COVID-19 pill as vaccine makers retreat,Seeking Alpha,https://seekingalpha.com/news/3748031-merck-extends-gains-after-data-for-covid-19-pill-as-vaccine-makers-retreat?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.891626238822937
10/4/2021 2:21:35 PM,Teva pulls over 2.5M vials of U.S. made drugs after FDA concerns on contamination,Seeking Alpha,https://seekingalpha.com/news/3748104-teva-pulls-over-25m-vials-of-us-made-drugs-after-fda-concerns-on-contamination?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8791776895523071
10/4/2021 4:27:19 PM,"JNJ, Xencor Sign $1.3B Licensing Deal For B-Cell Malignancies-Targeted Bispecific Antibody",Benzinga,/news/stocks/jnj-xencor-sign-1-3b-licensing-deal-for-b-cell-malignancies-targeted-bispecific-antibody-1030841141,positive,0.90573650598526
10/4/2021 5:53:01 PM,It‚Äôs Time To Drop Ocugen Stock While You Still Can,InvestorPlace,/news/stocks/its-time-to-drop-ocugen-ocgn-stock-while-you-still-can-1030841717,negative,0.5398221015930176
10/5/2021 5:05:51 AM,Pfizer/BioNTech's COVID-19 vaccine efficacy wanes after 6 months: Study,Seeking Alpha,https://seekingalpha.com/news/3748432-pfizers-covid-19-vaccine-90-effective-in-preventing-hospitalizations-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8951584100723267
10/5/2021 12:30:00 PM,Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine,PR Newswire,/news/stocks/johnson-johnson-announces-submission-of-emergency-use-authorization-amendment-to-the-u-s-fda-to-support-booster-of-its-single-shot-covid-19-vaccine-1030843189,positive,0.5814054608345032
10/5/2021 12:57:45 PM,Johnson & Johnson Submits Data To FDA To Support Booster Of Single-Shot COVID-19 Vaccine ,RTTNews,/news/stocks/johnson-johnson-submits-data-to-fda-to-support-booster-of-single-shot-covid-19-vaccine-1030843243,neutral,0.7604514956474304
10/5/2021 2:01:45 PM,"The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-files-for-booster-dose-authorization-gemini-restructures-strata-skin-cfo-departs-kaleido-reports-positive-readout-1030843466,neutral,0.42346295714378357
10/5/2021 5:16:48 PM,Merck‚Äôs Good News Doesn‚Äôt End the Bullish Story for Novavax,InvestorPlace,/news/stocks/mercks-good-news-doesnt-end-the-bullish-story-for-novavax-1030844852,neutral,0.3743157684803009
10/6/2021 5:00:00 PM,Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in Nature,PR Newswire,/news/stocks/janssen-announces-novel-mechanism-of-action-that-shows-promise-against-dengue-in-data-published-in-nature-1030847834,positive,0.6799187064170837
10/6/2021 5:58:57 PM,Merck's Oral COVID-19 Treatment Could Be Game-Changer: BofA Analyst,Benzinga,/news/stocks/merck-s-oral-covid-19-treatment-could-be-game-changer-bofa-analyst-1030848005,neutral,0.9073442220687866
10/6/2021 8:08:19 PM,Janssen Pharmaceuticals' New Early-Stage Compound Shows Promise Against Dengue ,RTTNews,/news/stocks/janssen-pharmaceuticals-new-early-stage-compound-shows-promise-against-dengue-1030848355,positive,0.937341034412384
10/8/2021 11:44:04 AM,Novavax Stock Looks Interesting as the World Still Needs Vaccines,InvestorPlace,/news/stocks/novavax-stock-looks-interesting-as-the-world-still-needs-vaccines-1030852726,neutral,0.5224460959434509
10/8/2021 3:43:24 PM,7 Defensive Stocks to Buy and Forget About In Times of Volatility,InvestorPlace,/news/stocks/7-defensive-stocks-to-buy-and-forget-about-in-times-of-volatility-1030853320,neutral,0.9234777688980103
10/8/2021 6:30:13 PM,"Catalyst Watch for next week: JPMorgan leads out big bank earnings; eyes on Plug Power, Alibaba and HubSpot",Seeking Alpha,https://seekingalpha.com/news/3751002-catalyst-watch-for-next-week-jpmorgan-leads-out-big-bank-earnings-eyes-on-plug-power-alibaba-and-hubspot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5077350735664368
10/11/2021 10:45:00 PM,Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-credit-suisse-30th-annual-healthcare-conference-1030857049,positive,0.5094081163406372
10/12/2021 10:00:08 AM,"Novavax Stock Will Find Its Bottom, But Probably not Soon",InvestorPlace,/news/stocks/nvax-stock-will-find-its-bottom-but-probably-not-soon-1030858438,negative,0.696928083896637
10/12/2021 10:00:43 AM,Don‚Äôt Buy Too Much Into the WHO Hype Surrounding Ocugen Stock,InvestorPlace,/news/stocks/ocgn-stock-dont-buy-too-much-into-the-who-hype-1030858436,neutral,0.9197484254837036
10/12/2021 12:45:00 PM,"Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire,  Effective December 31, 2021",PR Newswire,/news/stocks/dr-paul-stoffels-vice-chairman-of-the-executive-committee-and-chief-scientific-officer-of-johnson-johnson-to-retire-effective-december-31-2021-1030858511,neutral,0.8425991535186768
10/12/2021 2:12:28 PM,WHO recommends an additional COVID-19 vaccine for immunocompromised people,Seeking Alpha,https://seekingalpha.com/news/3752012-who-recommends-an-additional-covid-19-vaccine-for-immunocompromised-people?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7509058713912964
10/12/2021 10:15:00 PM,Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations,PR Newswire,/news/stocks/johnson-johnson-announces-jessica-moore-as-vice-president-of-investor-relations-1030860395,neutral,0.9161937832832336
10/13/2021 12:45:00 PM,Johnson & Johnson to Host Business Review Highlighting Pharmaceuticals,PR Newswire,/news/stocks/johnson-johnson-to-host-business-review-highlighting-pharmaceuticals-1030862351,neutral,0.9344196915626526
10/14/2021 7:19:45 PM,Moderna gains with unanimous AdCom backing for COVID-19 booster shot,Seeking Alpha,https://seekingalpha.com/news/3752981-moderna-gains-with-unanimous-adcom-backing-for-covid-19-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9181937575340271
10/14/2021 7:48:29 PM,FDA Panel Convenes To Discuss Requirement Of Moderna Vaccine Booster Shots ,RTTNews,/news/stocks/fda-panel-convenes-to-discuss-requirement-of-moderna-vaccine-booster-shots-1030867537,neutral,0.8871013522148132
10/14/2021 11:55:00 PM,Johnson & Johnson Takes Steps to Equitably Resolve All Current and Future Talc Claims,PR Newswire,/news/stocks/johnson-johnson-takes-steps-to-equitably-resolve-all-current-and-future-talc-claims-1030867970,positive,0.8059071898460388
10/15/2021 4:38:00 AM,Johnson & Johnson Ovarian Cancer Victims Vow Fight to Stop J&J's Bankruptcy Scheme,PR Newswire,/news/stocks/johnson-johnson-ovarian-cancer-victims-vow-fight-to-stop-j-j-s-bankruptcy-scheme-1030868065,positive,0.6764748692512512
10/15/2021 1:44:03 PM,"The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-s-booster-shot-gets-fda-panel-backing-decision-day-for-avadel-silence-therapeutics-strikes-licensing-deal-mink-ipo-1030869318,neutral,0.7786527872085571
10/15/2021 2:43:00 PM,"Johnson & Johnson -- Moody's: J&J talc costs are credit negative, but channeling injunction process will reduce uncertainty",Moodys,/news/bonds/johnson-johnson-moody-s-j-j-talc-costs-are-credit-negative-but-channeling-injunction-process-will-reduce-uncertainty-1030869543,positive,0.6891399621963501
10/15/2021 4:45:33 PM,Health Care Sector Appears to Be a Drag on Positive UnitedHealth Earnings,Benzinga,/news/stocks/health-care-sector-appears-to-be-a-drag-on-positive-unitedhealth-earnings-1030869859,negative,0.9385510683059692
10/15/2021 10:11:00 PM,Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee,PR Newswire,/news/stocks/johnson-johnson-covid-19-vaccine-booster-shot-unanimously-recommended-for-emergency-use-authorization-by-u-s-fda-advisory-committee-1030870403,positive,0.8484929800033569
10/15/2021 10:47:45 PM,FDA Panel Unanimously Recommends J&J Covid Booster Shot ,RTTNews,/news/stocks/fda-panel-unanimously-recommends-j-j-covid-booster-shot-1030870461,neutral,0.7547883987426758
10/17/2021 3:01:19 PM,Here's what to expect from Johnson Johnson's earnings,Markets Insider Automation,/news/stocks/johnson_johnson-q3-earnings-preview-1030871254,neutral,0.9379589557647705
10/18/2021 1:34:17 PM,"The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-18-23-j-j-biogen-kickstart-big-pharma-earnings-regeneron-sanofi-roche-await-fda-decisions-and-ipos-1030873336,neutral,0.7243726849555969
10/18/2021 2:58:07 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3754116-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8660829067230225
10/18/2021 3:47:21 PM,MeiraGTx climbs to a 52-week high after positive mention on Barron‚Äôs,Seeking Alpha,https://seekingalpha.com/news/3754135-meiragtx-climbs-to-a-52-week-high-after-positive-mention-on-barrons?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9303818941116333
10/18/2021 4:46:00 PM,"LifeScan Global Corporation -- Moody's assigns B3 rating to LifeScan's proposed first lien term loan and secured notes, Ba3 to proposed super-priority revolver",Moodys,/news/bonds/lifescan-global-corporation-moody-s-assigns-b3-rating-to-lifescan-s-proposed-first-lien-term-loan-and-secured-notes-ba3-to-proposed-super-priority-revolver-1030874192,neutral,0.6777021884918213
10/19/2021 10:41:12 AM,"5 Stocks To Watch For October 19, 2021",Benzinga,/news/stocks/5-stocks-to-watch-for-october-19-2021-1030876483,neutral,0.9061945676803589
10/19/2021 12:25:00 PM,Johnson & Johnson Reports Q3 2021 Results,PR Newswire,/news/stocks/johnson-johnson-reports-q3-2021-results-1030876705,neutral,0.7926427721977234
10/19/2021 12:29:15 PM,Johnson & Johnson Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q3-adjusted-earnings-beat-estimates-1030876709,positive,0.6677963137626648
10/19/2021 12:58:49 PM,A Peek Into The Markets: US Stock Futures Gain Ahead Of Earnings Reports,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-gain-ahead-of-earnings-reports-1030876820,positive,0.8861261606216431
10/19/2021 1:28:38 PM,Johnson & Johnson Q3 Earnings Top Estimates; Lifts FY21 View Above Market ,RTTNews,/news/stocks/johnson-johnson-q3-earnings-top-estimates-lifts-fy21-view-above-market-1030876942,positive,0.9324821829795837
10/19/2021 2:23:01 PM,"The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio",Benzinga,/news/stocks/the-daily-biotech-pulse-entasis-dermata-spike-higher-on-positive-readouts-j-j-q3-eps-beats-estimates-wave-life-sciences-regains-right-to-cns-portfolio-1030877269,positive,0.9359005689620972
10/19/2021 2:33:19 PM,Will FDA Allow 'mix And Match' Of Covid Booster Shots? ,RTTNews,/news/stocks/will-fda-allow-mix-and-match-of-covid-booster-shots-1030877340,neutral,0.9246797561645508
10/19/2021 4:08:55 PM,Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance,Benzinga,/news/stocks/mid-morning-market-update-markets-open-higher-johnson-johnson-boosts-fy21-guidance-1030878014,positive,0.9436928033828735
10/19/2021 4:32:45 PM,Lower Than Expected Housing Starts and Building Permits Could Be Problems for Homebuilders,Benzinga,/news/stocks/lower-than-expected-housing-starts-and-building-permits-could-be-problems-for-homebuilders-1030878068,negative,0.9702366590499878
10/19/2021 6:10:09 PM,Abbott Laboratories Q3 earnings preview and review,Seeking Alpha,https://seekingalpha.com/news/3755153-abbott-laboratories-q3-earnings-preview-and-review?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8984234929084778
10/19/2021 6:11:39 PM,Mid-Day Market Update: Silver Surges 3%; Galera Therapeutics Shares Plunge,Benzinga,/news/stocks/mid-day-market-update-silver-surges-3-galera-therapeutics-shares-plunge-1030878384,positive,0.8829434514045715
10/19/2021 8:35:47 PM,Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher,Benzinga,/news/stocks/mid-afternoon-market-update-dow-surges-over-100-points-harmony-biosciences-shares-spike-higher-1030878699,positive,0.9215230941772461
10/19/2021 9:10:23 PM,3 Biopharma Stocks To Watch Following Johnson & Johnson's Earnings Beat,Benzinga,/news/stocks/3-biopharma-stocks-to-watch-following-johnson-johnson-s-earnings-beat-1030878749,neutral,0.8914384841918945
10/20/2021 12:45:09 PM,"28 Stocks To Benefit From Inflation, According To Jim Cramer",Benzinga,/news/stocks/28-stocks-to-benefit-from-inflation-according-to-jim-cramer-1030881145,positive,0.9265294075012207
10/20/2021 4:51:39 PM,"Thinking About Buying Stock In Qualcomm, Microsoft, Micron, Johnson & Johnson Or BP?",Benzinga,/news/stocks/thinking-about-buying-stock-in-qualcomm-microsoft-micron-johnson-johnson-or-bp-1030882415,neutral,0.9310547709465027
10/21/2021 12:38:00 AM,Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA,PR Newswire,/news/stocks/johnson-johnson-covid-19-vaccine-booster-shot-authorized-for-emergency-use-by-u-s-fda-1030883560,neutral,0.8381708264350891
10/21/2021 3:51:48 AM,FDA Authorizes Johnson & Johnson And Moderna Booster Shots ,RTTNews,/news/stocks/fda-authorizes-johnson-johnson-and-moderna-booster-shots-1030883612,neutral,0.9288360476493835
10/21/2021 10:42:29 AM,Pfizer/BioNTech COVID vaccine 'highly effective' against Delta variant in Israel study-Reuters,Seeking Alpha,https://seekingalpha.com/news/3755955-pfizerbiontech-covid-vaccine-highly-effective-against-delta-variant-in-israel-study-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8898317217826843
10/21/2021 11:02:39 AM,Pfizer/BioNTech post promising data from late-stage COVID-19 booster study,Seeking Alpha,https://seekingalpha.com/news/3755971-pfizerbiontech-post-promising-data-from-late-stage-covid-19-booster-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9446895718574524
10/21/2021 12:49:12 PM,Moderna leads COVID-19 vaccine makers as Piper Sandler favors its booster shot,Seeking Alpha,https://seekingalpha.com/news/3756089-moderna-leads-covid-19-vaccine-makers-as-piper-sandler-favors-its-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5400649309158325
10/21/2021 2:05:16 PM,"The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-authorizes-moderna-j-j-booster-shots-regulatory-approvals-for-bristol-myers-squibb-sanofi-regeneron-ventyx-ipo-1030885538,neutral,0.8053770065307617
10/21/2021 3:22:09 PM,UK says rare nerve disorder possible side effect of AstraZeneca COVID vaccine,Seeking Alpha,https://seekingalpha.com/news/3756200-uk-says-rare-nerve-disorder-possible-side-effect-of-astrazeneca-covid-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.789067268371582
10/21/2021 4:48:37 PM,7 Safe Stocks to Own to Hedge Against Inflation,InvestorPlace,/news/stocks/7-safe-stocks-to-own-to-hedge-against-inflation-1030886760,neutral,0.9000862836837769
10/21/2021 5:40:58 PM,EU to issue decision on Moderna COVID-19 booster shot next week,Seeking Alpha,https://seekingalpha.com/news/3756271-eu-to-issue-decision-on-moderna-booster-shot-next-week?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.836660623550415
10/21/2021 6:27:10 PM,Sight Sciences shares up 11% after releasing data on TearCare system,Seeking Alpha,https://seekingalpha.com/news/3756283-sights-sciences-shares-up-11-after-releasing-data-on-tearcare-system?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9249030351638794
10/21/2021 8:38:00 PM,Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2021,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-fourth-quarter-2021-1030886959,negative,0.672096312046051
10/22/2021 1:48:00 AM,U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines,PR Newswire,/news/stocks/u-s-cdc-advisory-committee-unanimously-recommends-johnson-johnson-covid-19-vaccine-as-a-booster-for-all-eligible-individuals-who-receive-authorized-covid-19-vaccines-1030887453,positive,0.641250491142273
10/22/2021 3:18:16 AM,CDC Panel Backs Johnson & Johnson COVID-19 Booster Shot ,RTTNews,/news/stocks/cdc-panel-backs-johnson-johnson-covid-19-booster-shot-1030887480,neutral,0.6879391670227051
10/22/2021 1:39:28 PM,Moderna and Johnson & Johnson COVID booster shots now available at Walgreens stores,Seeking Alpha,https://seekingalpha.com/news/3756635-moderna-and-johnson-johnson-covid-booster-shots-now-available-at-walgreens-stores?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8723054528236389
10/22/2021 3:01:56 PM,7 of the Best Dividend Stocks for Passive Income,InvestorPlace,/news/stocks/7-of-the-best-dividend-stocks-for-passive-income-1030889458,neutral,0.5811641216278076
10/22/2021 4:02:03 PM,Walgreens Offers Moderna And Johnson & Johnson COVID-19 Vaccine Booster Shots In U.S. ,RTTNews,/news/stocks/walgreens-offers-moderna-and-johnson-johnson-covid-19-vaccine-booster-shots-in-u-s-1030889295,neutral,0.5392043590545654
10/24/2021 5:45:47 PM,"The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-24-30-eyenovia-ani-pharma-clearside-medical-fda-decisions-merck-bristol-myers-squibb-earnings-ipos-and-more-1030891741,neutral,0.9414971470832825
10/25/2021 5:10:05 PM,EMA committee says Moderna boosters can be used in those 18 and over,Seeking Alpha,https://seekingalpha.com/news/3757582-ema-committee-says-moderna-boosters-can-be-used-in-those-18-and-over?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8141578435897827
10/25/2021 7:20:44 PM,"Novavax is Now a Riskier Play, but Still One to Keep Your Eye On",InvestorPlace,/news/stocks/nvax-stock-is-now-a-riskier-play-but-still-one-to-keep-your-eye-on-1030896008,neutral,0.8857182860374451
10/27/2021 2:19:00 PM,Teva Pharmaceutical Finance Netherlands II BV -- Moody's rates Teva's new unsecured notes offering Ba2,Moodys,/news/bonds/teva-pharmaceutical-finance-netherlands-ii-bv-moody-s-rates-teva-s-new-unsecured-notes-offering-ba2-1030905015,neutral,0.8066307306289673
10/27/2021 2:44:00 PM,Teva Pharma Finance Netherlands III BV -- Moody's rates Teva's new unsecured notes offering Ba2,Moodys,/news/bonds/teva-pharma-finance-netherlands-iii-bv-moody-s-rates-teva-s-new-unsecured-notes-offering-ba2-1030905145,neutral,0.7895199060440063
10/28/2021 11:24:41 AM,"GlaxoSmithKline, Pfizer owned ViiV says EU greenlighted a simpler HIV regimen",Seeking Alpha,https://seekingalpha.com/news/3759886-glaxosmithkline-pfizer-owned-viiv-says-eu-greenlighted-a-simpler-hiv-regimen?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7418090105056763
10/28/2021 2:26:10 PM,"The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-reports-beat-and-raise-quarter-pfizer-biontech-snag-orders-for-additional-vaccine-doses-hcw-cleared-for-phase-1-study-of-pancreatic-cancer-drug-1030910260,positive,0.8363465666770935
10/28/2021 9:56:30 PM,"FDA Restricts Sale, Approves New Labeling Of Breast Implants",Benzinga,/news/stocks/fda-restricts-sale-approves-new-labeling-of-breast-implants-1030911878,neutral,0.6530259251594543
10/29/2021 2:14:43 PM,Aurinia Pharma may be worth $45-$53/share in a potential sale - analyst,Seeking Alpha,https://seekingalpha.com/news/3760897-aurinia-pharma-may-be-worth-45-53share-in-a-potential-sale-analyst?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9303961396217346
10/29/2021 7:00:57 PM,"Catalyst watch for next week: FOMC and OPEC meetings, Beyond Meat hits McDonald's stores and more eyes on crypto",Seeking Alpha,https://seekingalpha.com/news/3760981-catalyst-watch-for-next-week-fomc-and-opec-meetings-beyond-meat-hits-mcdonalds-stores-and-more-eyes-on-crypto?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9212965965270996
11/1/2021 10:00:10 AM,"Novavax Stock Rises as UK Covid Vax Okay Sought, Other Growth Anticipated",InvestorPlace,/news/stocks/novavax-stock-rises-as-uk-covid-vax-okay-sought-other-growth-anticipated-1030920758,positive,0.9438596367835999
11/1/2021 2:01:23 PM,Aurinia Pharma drops after GlaxoSmithKline denies report on potential bid,Seeking Alpha,https://seekingalpha.com/news/3761428-aurinia-pharma-drops-after-glaxosmithkline-denies-report-on-potential-bid?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9460810422897339
11/2/2021 10:57:42 AM,"Teva, Endo among firms beating $50B opioid case in California in an industry first",Seeking Alpha,https://seekingalpha.com/news/3762662-teva-endo-among-firms-beating-50b-opioid-case-in-california-in-an-industry-first?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8367446660995483
11/2/2021 12:21:00 PM,California Judge Rules For Drugmakers In Major Opioid Litigation,Benzinga,/news/stocks/california-judge-rules-for-drugmakers-in-major-opioid-litigation-1030925651,neutral,0.6099185943603516
11/2/2021 12:52:53 PM,"The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-reports-solid-q3-earnings-regulatory-setback-for-legend-lilly-to-supply-additional-covid-19-antibody-cocktails-to-us-1030925781,positive,0.9155564308166504
11/2/2021 3:30:16 PM,Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-november-pdufa-dates-1030927142,neutral,0.9458097219467163
11/2/2021 4:11:31 PM,Ocugen hits six-month high ahead of key WHO meeting on partner‚Äôs COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3763060-ocgn-stock-hits-six-month-high-ahead-of-key-who-meeting-on-partners-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7430821061134338
11/2/2021 6:03:40 PM,7 Stocks to Set Your Sights on as the ‚ÄòHyperinflation‚Äô Debate Stirs Up,InvestorPlace,/news/stocks/7-stocks-to-set-your-sights-on-as-the-hyperinflation-debate-stirs-up-1030927812,neutral,0.874175488948822
11/2/2021 10:00:48 PM,Darzalex sales royalties help propel Halozyme Therapeutics to Q3 2021 earnings beat,Seeking Alpha,https://seekingalpha.com/news/3763536-darzalex-sales-royalties-help-propel-halozyme-therapeutics-to-q3-2021-earnings-beat?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9285274147987366
11/4/2021 1:00:58 PM,Moderna drags COVID-19 vaccine developers lower after slashing outlook,Seeking Alpha,https://seekingalpha.com/news/3765159-moderna-drags-covid-19-vaccine-developers-lower-after-slashing-outlook?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9672327041625977
11/4/2021 4:56:43 PM,7 Safe Stocks that are Immune from China‚Äôs Market Volatility,InvestorPlace,/news/stocks/7-safe-stocks-that-are-immune-from-chinas-market-volatility-1030938455,neutral,0.8009191751480103
11/4/2021 5:27:37 PM,7 Stocks to Buy to Hone in on Ray Dalio‚Äôs Reliable Favorites,InvestorPlace,/news/stocks/7-stocks-to-buy-to-hone-in-on-ray-dalio-reliable-favorites-1030938626,positive,0.7804807424545288
11/4/2021 6:27:12 PM,This Are The 5 Largest European Stocks,Benzinga,/news/stocks/this-are-the-5-largest-european-stocks-1030938555,neutral,0.9295486807823181
11/4/2021 6:40:59 PM,Novavax Looks Primed and Ready for a Vaccine Comeback,InvestorPlace,/news/stocks/nvax-stock-looks-primed-and-ready-for-a-vaccine-comeback-1030938703,positive,0.7199615836143494
11/5/2021 3:44:57 AM,Emergent shares fall 15% after U.S. government ends vaccine contract early,Seeking Alpha,https://seekingalpha.com/news/3765897-emergent-shares-fall-15-after-us-government-ends-vaccine-contract-early?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9653363823890686
11/5/2021 10:00:00 AM,The Novavax Rebound Is Just Warming Up,InvestorPlace,/news/stocks/nvax-stock-rebound-is-just-warming-up-1030942042,neutral,0.7882606983184814
11/5/2021 11:10:23 AM,Pfizer data on COVID-19 pill pressures rival Merck and vaccine developers,Seeking Alpha,https://seekingalpha.com/news/3766005-pfizer-data-on-covid-19-pill-pressure-rival-merck-and-vaccine-developers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.46352189779281616
11/5/2021 8:38:57 PM,Emergent Biosolutions granted FDA clearance for two more COVID-19 vaccine batches,Seeking Alpha,https://seekingalpha.com/news/3766453-emergent-biosolutions-granted-fda-clearance-for-two-more-covid-19-vaccine-batches?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9360599517822266
11/5/2021 9:24:38 PM,See Why Emergent BioSolutions Stock Plunged 37% On Friday?,Benzinga,/news/stocks/see-why-emergent-biosolutions-stock-plunged-37-on-friday-1030943698,negative,0.8557440042495728
11/8/2021 9:52:49 PM,Alkermes slips as Johnson & Johnson moves to end licensing pact,Seeking Alpha,https://seekingalpha.com/news/3767304-alkermes-slips-as-johnson-johnson-moves-to-end-licensing-pact?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9338299036026001
11/9/2021 11:00:39 AM,7 Stocks to Buy That Could Be the Next Trillion-Dollar Company¬†,InvestorPlace,/news/stocks/7-stocks-to-buy-that-could-be-the-next-trillion-dollar-company-1030952970,neutral,0.9256399273872375
11/9/2021 2:13:10 PM,"The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data",Benzinga,/news/stocks/the-daily-biotech-pulse-double-dose-of-positive-tidings-for-merck-alkermes-slips-on-partial-termination-of-j-j-licensing-deal-amgen-migraine-drug-data-1030953661,negative,0.883304238319397
11/9/2021 6:14:33 PM,Oklahoma Supreme Court overturns $465M opioid judgment against J&J - Reuters,Seeking Alpha,https://seekingalpha.com/news/3767931-oklahoma-supreme-court-overturns-465m-opioid-judgment-against-johnson-johnson-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9209859371185303
11/9/2021 8:32:11 PM,OCGN Stock Alert: The Earnings News That Has Ocugen Slipping Today,InvestorPlace,/news/stocks/ocgn-stock-alert-the-earnings-news-that-has-ocugen-slipping-today-1030955404,negative,0.9311999678611755
11/9/2021 10:30:00 PM,Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health Awards,PR Newswire,/news/stocks/johnson-johnson-endows-research-america-outstanding-achievement-in-public-health-awards-1030955761,positive,0.7454636693000793
11/10/2021 4:58:57 PM,7 Defensive Stocks To Add Portfolio Stability in the Fourth Quarter,InvestorPlace,/news/stocks/7-defensive-stocks-to-add-portfolio-stability-in-fourth-quarter-1030960556,positive,0.9144417643547058
11/10/2021 7:35:31 PM,Johnson & Johnson wins court ruling on request to halt tens of thousands of talc lawsuits,Seeking Alpha,https://seekingalpha.com/news/3768884-johnson-johnson-wins-court-ruling-on-request-to-halt-tens-of-thousands-of-talc-lawsuits?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7567015290260315
11/10/2021 10:32:01 PM,J&J agrees to provide its COVID vaccine through COVAX Humanitarian Buffer,Seeking Alpha,https://seekingalpha.com/news/3769224-johnson-johnson-agrees-to-provide-its-covid-vaccine-through-covax-humanitarian-buffer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6167395114898682
11/10/2021 11:14:00 PM,Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World's Most Vulnerable People through Novel Humanitarian Buffer,PR Newswire,/news/stocks/johnson-johnson-enters-into-agreement-to-provide-its-single-shot-covid-19-vaccine-for-the-world-s-most-vulnerable-people-through-novel-humanitarian-buffer-1030961668,positive,0.9293126463890076
11/12/2021 11:29:03 AM,Johnson & Johnson stock jumps on report it will split into two public companies,Seeking Alpha,https://seekingalpha.com/news/3769919-johnson-johnson-stock-jumps-on-report-it-will-split-into-two-public-companies?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8521782755851746
11/12/2021 12:30:00 PM,"Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business",PR Newswire,/news/stocks/johnson-johnson-announces-plans-to-accelerate-innovation-serve-patients-and-consumers-and-unlock-value-through-intent-to-separate-consumer-health-business-1030969511,positive,0.7651340365409851
11/12/2021 1:25:01 PM,J&J Plans To Form Separate Consumer Health Company ,RTTNews,/news/stocks/j-j-plans-to-form-separate-consumer-health-company-1030969749,neutral,0.9515060782432556
11/12/2021 1:40:21 PM,"The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-to-spin-off-consumer-health-business-astrazeneca-earnings-embattled-emergent-to-buy-back-shares-1030969817,neutral,0.8889022469520569
11/12/2021 3:11:19 PM,JNJ Split: 10 Things for Investors to Know About Johnson & Johnson‚Äôs Breakup Plans,InvestorPlace,/news/stocks/jnj-split-10-things-for-investors-to-know-about-johnson-johnsons-breakup-plans-1030970444,neutral,0.9449582695960999
11/12/2021 3:27:10 PM,Johnson & Johnson gains as analysts cheer consumer spinoff,Seeking Alpha,https://seekingalpha.com/news/3770123-johnson-johnson-gains-as-analysts-cheer-consumer-spinoff?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8513226509094238
11/12/2021 3:48:16 PM,SNDL Stock: The Good News That Has Cannabis Play Sundial Growers Heading Higher Today,InvestorPlace,/news/stocks/sndl-stock-the-good-news-that-has-cannabis-play-sundial-growers-heading-higher-today-1030970565,positive,0.9421655535697937
11/12/2021 5:45:42 PM,Biden nominates former commissioner Robert Califf to head FDA,Seeking Alpha,https://seekingalpha.com/news/3770181-biden-nominates-former-commissioner-robert-califf-to-head-fda?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9311440587043762
11/12/2021 8:00:04 PM,"Catalyst watch for next week: Lucid earnings volatility and big events for Qualcomm, ADP, Teladoc and Palo Alto Networks",Seeking Alpha,https://seekingalpha.com/news/3770226-catalyst-watch-for-next-week-lucid-earnings-volatility-and-big-events-for-qualcomm-adp-teladoc-and-palo-alto-networks?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8227661848068237
11/13/2021 3:00:00 PM,Tech Roundup: Disney+ Day leads a week highlighted by streaming TV,Seeking Alpha,https://seekingalpha.com/news/3770330-tech-roundup-disney-day-leads-a-week-highlighted-by-streaming-tv?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.909171998500824
11/14/2021 3:57:21 PM,"The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-nov-14-nov-20-biomarin-fda-decision-tapering-earnings-news-flow-conference-presentations-and-more-1030972118,negative,0.9391728043556213
11/15/2021 8:06:40 PM,Arrowhead posts mid-stage data for hep B candidate advanced by Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3770859-arrowhead-posts-mid-stage-data-for-hep-b-candidate-advanced-by-johnson-johnson?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8940598964691162
11/16/2021 2:04:33 PM,Pfizer moves to allow cheaper COVID-19 pills sending shares of rivals lower,Seeking Alpha,https://seekingalpha.com/news/3771400-pfizer-moves-to-allow-cheaper-covid-19-pills-sending-shares-of-rivals-lower?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9393699169158936
11/17/2021 2:17:11 PM,"Arrowhead, Janssen's JNJ-75220795 in development for NASH",Seeking Alpha,https://seekingalpha.com/news/3771913-arrowhead-janssens-jnj-75220795-in-development-for-nash?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8965556621551514
11/18/2021 2:33:44 PM,J&J expects to file for 14 new drugs by 2025 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3772449-johnson-johnson-janssen-expects-to-file-for-14-new-drugs-by-2025-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8713212013244629
11/19/2021 11:29:05 AM,7 Dividend Stocks to Buy for 2022 and Hold Forever,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-for-2022-and-hold-forever-1030881013,neutral,0.94387286901474
11/19/2021 3:34:38 PM,3 Recent Spin-Off Stocks Worth A Spot in Your Portfolio,InvestorPlace,/news/stocks/3-recent-spin-off-stocks-worth-a-spot-in-your-portfolio-1030991913,neutral,0.8516471982002258
11/22/2021 11:00:16 AM,7 Stocks to Buy for Their Resistance to the 6.2% Monthly Inflation,InvestorPlace,/news/stocks/7-stocks-to-buy-for-their-resistance-to-the-6-2-monthly-inflation-1030994239,positive,0.45518264174461365
11/23/2021 8:16:33 PM,Pfizer's COVID-19 Franchise Could Push Revenue Past $100B In 2022: Analyst,Benzinga,/news/stocks/pfizer-s-covid-19-franchise-could-push-revenue-past-100b-in-2022-analyst-1030999039,positive,0.9382447600364685
11/24/2021 8:29:48 AM,Philogen collaborates with Janssen Biotech to discover small molecule therapeutics,Seeking Alpha,https://seekingalpha.com/news/3774089-philogen-collaborates-with-janssen-biotech-to-discover-small-molecule-therapeutics?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6541990637779236
11/24/2021 11:18:46 AM,EU health agency considers COVID-19 vaccine booster shots for all adults - Reuters,Seeking Alpha,https://seekingalpha.com/news/3774171-eu-health-agency-considers-covid-19-vaccine-booster-shots-for-all-adults-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8619681596755981
11/24/2021 12:52:00 PM,Health Canada approves JNJ's COVID-19 vaccine in people 18 years of age and above,Seeking Alpha,https://seekingalpha.com/news/3774209-health-canada-approves-jnjs-covid-19-vaccine-in-people-18-years-of-age-and-above?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5122625231742859
11/24/2021 2:37:59 PM,Health Canada Approves Johnson & Johnson COVID-19 Vaccine - Quick Facts ,RTTNews,/news/stocks/health-canada-approves-johnson-johnson-covid-19-vaccine-quick-facts-1031000995,neutral,0.637147843837738
11/26/2021 7:30:01 AM,New COVID-19 variant detected in South Africa prompts renewed travel restrictions,Seeking Alpha,https://seekingalpha.com/news/3774462-new-covid-19-variant-detected-in-south-africa-prompts-renewed-travel-restrictions?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9275057911872864
11/26/2021 2:05:34 PM,WHO meets today as new COVID variant poised to become new threat,Seeking Alpha,https://seekingalpha.com/news/3774583-who-meets-today-as-new-covid-variant-poised-to-become-new-threat?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.84183669090271
11/26/2021 2:19:14 PM,U.S. must study data before deciding on travel ban over new COVID-19 variant: Fauci,Seeking Alpha,https://seekingalpha.com/news/3774591-us-must-study-data-before-deciding-on-travel-ban-over-new-covid-19-variant-fauci?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.908190906047821
11/26/2021 2:26:32 PM,Most J&J COVID vaccine recipients switch to another shot for booster - WSJ,Seeking Alpha,https://seekingalpha.com/news/3774595-most-johnson-johnson-covid-vaccine-recipients-switch-to-another-shot-for-booster-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9234043955802917
11/27/2021 6:52:48 PM,Meme stocks and megacaps make UBS list of most and least crowded trades: Alpha Tactics,Seeking Alpha,https://seekingalpha.com/news/3773977-meme-stocks-and-megacaps-make-ubs-list-of-most-and-least-crowded-trades?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9410699605941772
11/28/2021 12:10:44 AM,New COVID-19 variant found in U.K. and Germany; Israel shuts borders for foreigners,Seeking Alpha,https://seekingalpha.com/news/3774702-new-covid-19-variant-found-in-uk-and-germany-israel-shuts-borders-for-foreigners?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6722970008850098
11/28/2021 1:16:20 PM,Moderna says new vaccine for Omicron could be ready for early next year,Seeking Alpha,https://seekingalpha.com/news/3774708-moderna-says-new-vaccine-for-omicron-could-be-ready-for-early-next-year?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6501120924949646
11/29/2021 7:34:54 AM,"Japan, Morocco ban foreign travelers as Omicron spreads; new cases reported in Netherlands, Canada, Australia",Seeking Alpha,https://seekingalpha.com/news/3774719-japan-morocco-bans-foreign-travelers-as-omicron-spreads-new-cases-reported-in-netherlands-canada-australia?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8972809910774231
11/29/2021 8:45:39 AM,U.S. readies fight against Omicron variant but too soon for lockdowns: Fauci,Seeking Alpha,https://seekingalpha.com/news/3774720-us-readies-fight-against-omicron-variant-but-too-soon-for-lockdowns-fauci?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8291778564453125
11/29/2021 12:56:03 PM,Novavax Working On New COVID-19 Vaccine To Combat Omicron Variant,Benzinga,/news/stocks/novavax-working-on-new-covid-19-vaccine-to-combat-omicron-variant-1031008391,positive,0.5156745314598083
11/29/2021 2:35:56 PM,"Vaccine Makers Investigate New Covid Variant, To Adapt Shots If Needed ",RTTNews,/news/stocks/vaccine-makers-investigate-new-covid-variant-to-adapt-shots-if-needed-1031008838,neutral,0.7871174812316895
11/29/2021 4:44:03 PM,J&J researching Omicron-specific COVID vaccine,Seeking Alpha,https://seekingalpha.com/news/3774973-johnson-johnson-researching-omicron-specific-covid-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8317426443099976
11/29/2021 6:19:36 PM,5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market,InvestorPlace,/news/stocks/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market-1031009824,neutral,0.7251963019371033
11/29/2021 7:15:07 PM,Biden to direct regulators to use ‚Äòfastest process available‚Äù to clear vaccines against Omicron,Seeking Alpha,https://seekingalpha.com/news/3775031-biden-to-direct-regulators-to-use-fastest-process-available-to-clear-vaccines-against-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5281205773353577
11/29/2021 9:31:27 PM,"Amid Omicron, CDC now says everyone 18 and older should get COVID booster shot",Seeking Alpha,https://seekingalpha.com/news/3775092-amid-omicron-cdc-now-says-everyone-18-and-older-should-get-covid-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8758246302604675
11/30/2021 3:06:35 AM,CDC Strengthens Booster Recommendation For All Adults Due To Omicron Variant Concerns ,RTTNews,/news/stocks/cdc-strengthens-booster-recommendation-for-all-adults-due-to-omicron-variant-concerns-1031010292,positive,0.6120591163635254
11/30/2021 8:47:49 AM,England to impose mask mandates to curb spread of Omicron - Reuters,Seeking Alpha,https://seekingalpha.com/news/3775168-england-to-impose-mask-mandates-to-curb-spread-omicron-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.756542444229126
11/30/2021 10:55:45 AM,EU expects to approve shot against Omicron in 3-4 months,Seeking Alpha,https://seekingalpha.com/news/3775204-eu-expects-to-approve-shot-against-omicron-in-3-4-months?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5946265459060669
11/30/2021 4:17:16 PM,"FDA working with other agencies, private industry on potential impact from Omicron",Seeking Alpha,https://seekingalpha.com/news/3775445-fda-working-with-other-agencies-private-industry-on-potential-impact-from-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.870381772518158
11/30/2021 7:29:27 PM,7 Drug Stocks to Buy Now While They‚Äôre Still on Sale,InvestorPlace,/news/stocks/7-drug-stocks-to-buy-now-while-theyre-still-on-sale-1031013701,neutral,0.8935649394989014
11/30/2021 7:47:10 PM,Street analysts have mixed views on Omicron impact on COVID vaccines,Seeking Alpha,https://seekingalpha.com/news/3775526-street-analysts-have-mixed-views-on-omicron-impact-on-covid-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9090571999549866
11/30/2021 10:49:08 PM,Have the Markets Overreacted to Omicron?,InvestorPlace,/news/stocks/have-the-markets-overreacted-to-omicron-1031017944,negative,0.8583032488822937
12/1/2021 8:15:42 AM,South African disease expert says Omicron variant could outweigh Delta - Reuters,Seeking Alpha,https://seekingalpha.com/news/3775645-south-african-disease-expert-says-omicron-variant-could-outweigh-delta-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.583076000213623
12/1/2021 5:20:42 PM,"Johnson & Johnson, Amgen win FDA approval for drug combo targeting multiple myeloma",Seeking Alpha,https://seekingalpha.com/news/3775966-johnson-johnson-amgen-win-fda-approval-for-drug-combo-targeting-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9382338523864746
12/1/2021 7:48:03 PM,VXRT Stock: Other Vaccine Stocks Are Gaining But Jim Cramer Just Sent Vaxart Down,InvestorPlace,/news/stocks/vxrt-stock-other-vaccine-stocks-are-gaining-but-jim-cramer-just-sent-vaxart-down-1031017418,positive,0.8836972117424011
12/2/2021 4:36:02 AM,Amgen : FDA Approves Kyprolis Combination Regimen For Multiple Myeloma Treatment ,RTTNews,/news/stocks/amgen-fda-approves-kyprolis-combination-regimen-for-multiple-myeloma-treatment-1031017923,positive,0.8889807462692261
12/2/2021 2:32:57 PM,3 Sickly Covid Stocks to Buy as Omicron Gets Around,InvestorPlace,/news/stocks/3-sickly-covid-stocks-to-buy-1031020211,neutral,0.8426566123962402
12/2/2021 4:06:41 PM,Aurinia Pharmaceuticals gains amid takeover speculation,Seeking Alpha,https://seekingalpha.com/news/3776494-aurinia-pharmaceuticals-gains-on-takeover-speculation?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9189056754112244
12/2/2021 8:09:52 PM,Scientists find reason behind rare blood clots linked to AstraZeneca COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3776636-scientists-find-reason-behind-rare-blood-clots-linked-to-astrazeneca-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7874376773834229
12/2/2021 9:00:37 PM,More Omicron cases found in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3776657-more-omicron-cases-found-in-the-us?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7973805665969849
12/2/2021 9:38:52 PM,Protagonist chooses candidate to advance into phase 2 in collaboration with Janssen,Seeking Alpha,https://seekingalpha.com/news/3776679-protagonist-chooses-candidate-to-advance-into-phase-2-in-collaboration-with-janssen?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8327934741973877
12/3/2021 1:33:09 PM,J&J's Tremfya shows durable response in psoriatric arthritis in late-stage trial,Seeking Alpha,https://seekingalpha.com/news/3776881-johnson-johnson-tremfya-shows-durable-response-in-psoriatric-arthritis-in-late-stage-trial?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9549738764762878
12/3/2021 1:40:11 PM,"The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering",Benzinga,/news/stocks/the-daily-biotech-pulse-protagonist-pulls-plug-on-phase-1-asset-xenon-aces-mid-stage-epilepsy-study-esperion-prices-offering-1031022833,neutral,0.8068124055862427
12/3/2021 3:23:59 PM,"Protagonist To Go Ahead With Oral Peptide PN-235, Discontinues Phase 1 Candidate",Benzinga,/news/stocks/protagonist-to-go-ahead-with-oral-peptide-pn-235-discontinues-phase-1-candidate-1031023141,neutral,0.9019889235496521
12/3/2021 4:15:06 PM,WHO says no evidence yet Omicron requires adjustments to existing COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3776979-who-says-no-evidence-yet-omicron-requires-adjustments-to-existing-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.874561071395874
12/3/2021 7:02:42 PM,House Oversight Committee schedules Dec. 9 hearing on prescription drug prices,Seeking Alpha,https://seekingalpha.com/news/3777032-house-oversight-committee-schedules-dec-9-hearing-on-prescription-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8558976054191589
12/4/2021 1:24:00 AM,Janssen to Showcase Progress on Respiratory Syncytial Virus (RSV) Vaccine Candidate at ESWI 2021,PR Newswire,/news/stocks/janssen-to-showcase-progress-on-respiratory-syncytial-virus-rsv-vaccine-candidate-at-eswi-2021-1031024126,positive,0.5553004741668701
12/5/2021 11:03:00 PM,"Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses",PR Newswire,/news/stocks/johnson-johnson-covid-19-booster-administered-six-months-after-two-dose-regimen-of-bnt162b2-shows-substantial-increase-in-antibody-and-t-cell-responses-1031024672,positive,0.9459744095802307
12/6/2021 2:43:14 AM,Johnson & Johnson Says Its COVID-19 Booster Shows Increase In Antibody And T-cell Responses ,RTTNews,/news/stocks/johnson-johnson-says-its-covid-19-booster-shows-increase-in-antibody-and-t-cell-responses-1031024711,positive,0.9488844275474548
12/6/2021 7:02:43 AM,"J&J's COVID-19 booster shot shows increase in antibody, T-cell responses",Seeking Alpha,https://seekingalpha.com/news/3777145-jjs-covid-19-booster-shot-shows-increase-in-antibody-t-cell-responses?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9259246587753296
12/6/2021 10:59:57 AM,U.S. prepares to fast-track authorization of Omicron COVID vaccines,Seeking Alpha,https://seekingalpha.com/news/3777176-us-prepares-to-fast-track-authorization-of-omicron-covid-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8243824243545532
12/6/2021 2:19:00 PM,NDA for J&J's cilta-cel for multiple myeloma submitted to Japanese regulators,Seeking Alpha,https://seekingalpha.com/news/3777264-nda-for-johnson-johnson-cilta-cel-for-multiple-myeloma-submitted-to-japanese-regulators?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9174817204475403
12/6/2021 8:50:20 PM,Biden calls on Senate to pass legislation to tackle 'outrageously expensive' drug prices,Seeking Alpha,https://seekingalpha.com/news/3777526-biden-call-on-senate-to-pass-legislation-to-tackle-outrageously-expensive-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6551870703697205
12/7/2021 8:37:17 AM,New York City to impose vaccine mandate for all private employees,Seeking Alpha,https://seekingalpha.com/news/3777604-new-york-city-to-impose-vaccine-mandate-for-all-private-employees?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8722470998764038
12/7/2021 11:00:16 AM,7 Stocks to Watch as the Omicron Variant Becomes the Market‚Äôs New Wildcard,InvestorPlace,/news/stocks/7-stocks-to-watch-as-the-omicron-variant-becomes-the-markets-new-wildcard-1031028496,positive,0.5960694551467896
12/7/2021 12:09:33 PM,Johnson & Johnson‚Äôs respiratory syncytial virus candidate shows 80% efficacy,Seeking Alpha,https://seekingalpha.com/news/3777661-johnson-johnsons-respiratory-syncytial-virus-candidate-shows-80-efficacy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8205374479293823
12/7/2021 3:44:01 PM,Legend Biotech rises on filing of marketing application for CAR-T therapy in Japan,Seeking Alpha,https://seekingalpha.com/news/3777831-legend-biotech-rises-on-filing-of-marketing-application-for-car-t-therapy-in-japan?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8494328260421753
12/8/2021 12:01:40 PM,"Pfizer, BioNTech say three vaccine doses neutralize Omicron in early lab tests",Seeking Alpha,https://seekingalpha.com/news/3778159-pfizer-biontech-lower-after-early-data-on-omicrons-impact-on-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8044573068618774
12/8/2021 8:14:45 PM,U.S. COVID-19 cases rise amid vaccine milestone,Seeking Alpha,https://seekingalpha.com/news/3778424-us-covid-19-cases-rise-despite-vaccine-milestone?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7187542915344238
12/8/2021 9:34:06 PM,N.Y. judge issues temporary restraining order on NYC public sector vaccine mandate,Seeking Alpha,https://seekingalpha.com/news/3778474-ny-judge-issues-temporary-restraining-order-on-nyc-public-sector-vaccine-mandate?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9273136258125305
12/9/2021 12:30:00 PM,Johnson & Johnson Appoints Senior Leaders to Executive Committee,PR Newswire,/news/stocks/johnson-johnson-appoints-senior-leaders-to-executive-committee-1031034957,neutral,0.9431011080741882
12/9/2021 2:53:01 PM,Johnson & Johnson makes new Executive Committee appointments,Seeking Alpha,https://seekingalpha.com/news/3778742-johnson-johnson-makes-new-executive-committee-appointments?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8876416683197021
12/9/2021 10:52:49 PM,WHO advisory panel recommends J&J COVID vaccine booster,Seeking Alpha,https://seekingalpha.com/news/3778989-who-advisory-panel-recommends-johnson-johnson-covid-vaccine-booster?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8364190459251404
12/9/2021 11:00:00 PM,World Health Organization Strategic Advisory Group of Experts (SAGE) Interim Recommendation Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster,PR Newswire,/news/stocks/world-health-organization-strategic-advisory-group-of-experts-sage-interim-recommendation-supports-use-of-johnson-johnson-covid-19-vaccine-as-a-booster-1031037203,neutral,0.579677939414978
12/10/2021 11:00:33 AM,Why You Should Buy Moderna Stock at Every Dip,InvestorPlace,/news/stocks/why-you-should-buy-mrna-stock-at-every-dip-1031038543,neutral,0.9308883547782898
12/10/2021 7:08:46 PM,3 Healthcare Stocks for Long-Term Dividend Growth,InvestorPlace,/news/stocks/3-healthcare-stocks-for-long-term-dividend-growth-1031039566,neutral,0.9333980679512024
12/10/2021 7:39:00 PM,Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-fourth-quarter-results-1031039532,neutral,0.9188656210899353
12/10/2021 10:17:58 PM,FDA advisor: Real-world data on current vaccines will determine if Omicron shots needed,Seeking Alpha,https://seekingalpha.com/news/3779324-fda-advisor-real-world-data-on-current-vaccines-will-determine-if-omicron-covbid-shots-needed?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8905699849128723
12/13/2021 7:32:25 PM,Why does Pfizer's $6.7B acquisition of Arena Pharmaceuticals make sense? Etrasimod,Seeking Alpha,https://seekingalpha.com/news/3779629-why-does-pfizer-67b-acquisition-of-arena-pharmaceuticals-make-sense-etrasimod?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9179372191429138
12/13/2021 8:15:41 PM,Supreme Court blocks challenge to N.Y. COVID mandate for healthcare workers (updated),Seeking Alpha,https://seekingalpha.com/news/3779642-supreme-court-blocks-challenge-to-ny-covid-vaccine-mandate-for-health-workers?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7136781215667725
12/13/2021 11:24:29 PM,J&J Talcum Powder Woes Continue As SC Declines To Hear The Company ,RTTNews,/news/stocks/j-j-talcum-powder-woes-continue-as-sc-declines-to-hear-the-company-1031042458,negative,0.9644210934638977
12/14/2021 11:34:08 AM,Johnson & Johnson COVID-19 vaccine study in South Africa finds no Omicron deaths,Seeking Alpha,https://seekingalpha.com/news/3779804-johnson-johnson-covid-19-vaccine-study-in-south-africa-finds-no-omicron-deaths?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7345986366271973
12/14/2021 7:27:38 PM,"10 Stocks to Buy if You Have $5,000 in Starter Money",InvestorPlace,/news/stocks/10-stocks-to-buy-if-you-have-5000-dollars-in-starter-money-1031044495,neutral,0.9384512901306152
12/14/2021 8:04:38 PM,WHO chief says there is a ‚Äúsmall decline‚Äù in effectiveness of COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3780074-who-chief-says-there-is-a-small-decline-in-effectiveness-of-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9691348075866699
12/15/2021 11:19:35 AM,EMA recommends Johnson & Johnson COVID-19 booster shot - Reuters,Seeking Alpha,https://seekingalpha.com/news/3780235-ema-recommends-johnson-johnson-covid-19-booster-shot-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8723169565200806
12/15/2021 12:53:33 PM,EMA Recommends Covid-19 Vaccine Janssen Booster Shot For Adults ,RTTNews,/news/stocks/ema-recommends-covid-19-vaccine-janssen-booster-shot-for-adults-1031046724,neutral,0.8202399611473083
12/15/2021 1:34:01 PM,Study finds COVID booster shots significantly increase Omicron neutralization,Seeking Alpha,https://seekingalpha.com/news/3780324-study-finds-covid-booster-shots-significantly-increase-omicron-neutralization?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9183441400527954
12/15/2021 2:32:00 PM,Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine,PR Newswire,/news/stocks/johnson-johnson-announces-positive-chmp-opinion-for-a-booster-shot-of-its-covid-19-vaccine-1031047251,positive,0.9456380009651184
12/15/2021 2:46:14 PM,Johnson & Johnson Receives Positive CHMP Opinion For Booster Shot Of COVID-19 Vaccine ,RTTNews,/news/stocks/johnson-johnson-receives-positive-chmp-opinion-for-booster-shot-of-covid-19-vaccine-1031047303,positive,0.9420915246009827
12/15/2021 5:27:38 PM,3 Consumer Staples Stocks to Buy for Safety,InvestorPlace,/news/stocks/3-consumer-staples-stocks-to-buy-for-safety-1031048130,neutral,0.9131317138671875
12/16/2021 5:53:14 PM,Legend now up 4% following ADS offering pricing after initially falling,Seeking Alpha,https://seekingalpha.com/news/3780935-legend-now-up-4-following-ads-offering-pricing-after-initially-falling?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9358144402503967
12/16/2021 11:12:30 PM,J&J says its COVID vaccine remains crucial after CDC advisors vote in favor of mRNA shots,Seeking Alpha,https://seekingalpha.com/news/3781137-jj-says-its-covid-vaccine-remains-crucial-after-cdc-advisors-vote-in-favor-of-mrna-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.819200336933136
12/17/2021 3:33:12 AM,"CDC Recommends Pfizer, Moderna COVID-19 Vaccines Over J&J Due To Rare Blood Clots ",RTTNews,/news/stocks/cdc-recommends-pfizer-moderna-covid-19-vaccines-over-j-j-due-to-rare-blood-clots-1031051886,neutral,0.6486043930053711
12/17/2021 9:47:05 AM,Biden warns unvaccinated against Omicron; asks Supreme Court to unblock vaccine mandate,Seeking Alpha,https://seekingalpha.com/news/3781179-biden-warns-unvaccinated-against-omicron-asks-supreme-court-to-lift-covid-19-vaccine-mandate?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6527678966522217
12/17/2021 11:47:41 AM,"Pfizer/BioNTech, Moderna COVID-19 shots get CDC backing ahead of J&J‚Äôs",Seeking Alpha,https://seekingalpha.com/news/3781205-pfizerbiontech-moderna-covid-19-shots-get-cdc-backing-ahead-of-jjs?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5955699682235718
12/17/2021 4:17:57 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-17-2021-1031053650,negative,0.5951846837997437
12/17/2021 10:15:36 PM,"The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More",Benzinga,/news/stocks/the-week-in-cannabis-pfizer-visa-730m+-in-financings-malta-eu-columbia-care-medmen-uruguay-and-more-1031054254,neutral,0.8311688899993896
12/20/2021 8:43:28 AM,U.S. appeals court revives Biden administration‚Äôs COVID-19 vaccine mandate for businesses,Seeking Alpha,https://seekingalpha.com/news/3781502-us-appeals-court-revives-biden-administrations-covid-19-vaccine-mandate-for-businesses?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.46212634444236755
12/20/2021 12:00:05 PM,Moderna leads COVID-19 vaccine makers after booster data on Omicron,Seeking Alpha,https://seekingalpha.com/news/3781536-moderna-leads-covid-19-vaccine-makers-after-booster-data-on-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7139620184898376
12/21/2021 12:00:59 PM,"Meta hits UBS list of most crowded trades, most megacaps still uncrowded: At the Open",Seeking Alpha,https://seekingalpha.com/news/3781908-meta-hits-ubs-list-of-most-crowded-trades-most-megacaps-still-uncrowded?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6971708536148071
12/21/2021 2:11:20 PM,"The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail",Benzinga,/news/stocks/the-daily-biotech-pulse-aldeyra-sinks-on-dry-eye-disease-readout-sanofi-goes-shopping-regulatory-setback-for-aquestive-aridis-touts-pan-coronavirus-antibody-cocktail-1031059051,neutral,0.6017131805419922
12/21/2021 3:50:16 PM,DYAI: Jumpin' Janssen Jamboree,Benzinga,/news/stocks/dyai-jumpin-janssen-jamboree-1031059462,neutral,0.8857550621032715
12/21/2021 5:35:05 PM,Johnson & Johnson nabs two additional pediatric indications for Xarelto,Seeking Alpha,https://seekingalpha.com/news/3782424-johnson-johnson-nabs-two-additional-pediatric-indications-for-xarelto?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5430364608764648
12/21/2021 6:33:44 PM,EMA: Data shows COVID boosters protect against Omicron; altering shots not yet needed,Seeking Alpha,https://seekingalpha.com/news/3782462-ema-data-shows-covid-boosters-protect-against-omicron-altering-shots-not-yet-needed?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.848442018032074
12/21/2021 8:19:03 PM,Biden says country 'not going back to March 2020' in terms of COVID closures (updated),Seeking Alpha,https://seekingalpha.com/news/3782480-biden-says-country-not-going-back-to-march-2020-in-terms-of-covid-closures?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9137389659881592
12/21/2021 9:25:59 PM,"AstraZeneca, Oxford start work on Omicron-specific COVID vaccine - FT",Seeking Alpha,https://seekingalpha.com/news/3782496-astrazeneca-oxford-start-work-on-omicron-specific-covid-vaccine-ft?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7424193024635315
12/22/2021 6:07:58 PM,Study finds mRNA vaccine boosters significantly increase protection against Omicron,Seeking Alpha,https://seekingalpha.com/news/3782789-study-finds-mrna-covid-vaccine-boosters-significantly-increase-protection-against-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9461206793785095
12/23/2021 8:00:14 AM,Janssen terminates izencitinib deal with Theravance Biopharma,Seeking Alpha,https://seekingalpha.com/news/3782899-janssen-terminates-izencitinib-deal-with-theravance-biopharma?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8456547260284424
12/23/2021 12:27:47 PM,Top 10 Blockbuster Drugs In 2021 ,RTTNews,/news/stocks/top-10-blockbuster-drugs-in-2021-1031063755,neutral,0.7226235270500183
12/23/2021 1:13:05 PM,South Africa approves J&J's COVID-19 booster shot - Reuters,Seeking Alpha,https://seekingalpha.com/news/3782987-south-africa-approves-jjs-covid-19-booster-shot-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8205553293228149
12/23/2021 3:07:25 PM,Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table,Benzinga,/news/stocks/corporate-cannabis-takeover-assessing-5-big-industries-already-at-the-table-1031064194,neutral,0.9278658628463745
12/23/2021 8:53:48 PM,Endo to pay $63M to settle Texas opioid claims,Seeking Alpha,https://seekingalpha.com/news/3783297-endo-to-pay-63m-to-settle-texas-opioid-claims?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8478437662124634
12/27/2021 8:18:53 AM,Global COVID-19 cases break records as Omicron variant spreads,Seeking Alpha,https://seekingalpha.com/news/3783344-global-covid-19-cases-break-records-as-omicron-variant-spreads?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5463666319847107
12/27/2021 5:32:41 PM,Number of daily COVID-19 cases now on par when Delta variant was surging,Seeking Alpha,https://seekingalpha.com/news/3783469-number-of-daily-covid-19-cases-now-on-par-when-delta-variant-was-surging?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4611019194126129
12/27/2021 8:11:30 PM,"If You Invested $1,000 In Inovio Stock One Year Ago, Here's How Much You'd Have Now",Benzinga,/news/stocks/if-you-invested-1-000-in-inovio-stock-one-year-ago-here-s-how-much-you-d-have-now-1031067341,neutral,0.93653804063797
12/28/2021 9:55:54 AM,New York expands COVID-19 testing as cases continue to rise,Seeking Alpha,https://seekingalpha.com/news/3783547-new-york-expands-covid-19-testing-as-cases-continue-to-rise?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7552241683006287
12/28/2021 11:36:01 AM,Omicron enhances neutralizing immunity against Delta variant: South Africa study,Seeking Alpha,https://seekingalpha.com/news/3783567-omicron-enhances-neutralizing-immunity-against-delta-variant-south-africa-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8443626761436462
12/29/2021 9:38:52 AM,NYC schools to ramp up testing to limit classroom closures - NYT,Seeking Alpha,https://seekingalpha.com/news/3783823-nyc-schools-to-ramp-up-testing-to-limit-classroom-closures-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.712414562702179
12/29/2021 1:29:24 PM,Johnson & Johnson seeks FDA approval for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/3783872-johnson-johnson-seeks-fda-approval-for-multiple-myeloma-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8891640901565552
12/29/2021 2:50:46 PM,COVID-19 cases 7-day moving average reaches level not seen since January,Seeking Alpha,https://seekingalpha.com/news/3783910-covid-19-cases-7-day-moving-average-reaches-level-not-seen-since-january?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8182684779167175
12/30/2021 9:11:05 AM,J&J COVID-19 booster dose slashes Omicron hospital stay: South African study,Seeking Alpha,https://seekingalpha.com/news/3784064-jj-covid-19-booster-dose-slashes-omicron-hospital-stay-south-african-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4996170401573181
12/30/2021 9:52:37 AM,Omicron COVID surge could peak in U.S. by January end: Fauci,Seeking Alpha,https://seekingalpha.com/news/3784080-omicron-covid-surge-could-peak-in-us-by-january-end-fauci?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8277069330215454
12/30/2021 12:30:00 PM,Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was Dominant,PR Newswire,/news/stocks/johnson-johnson-covid-19-vaccine-demonstrates-85-percent-effectiveness-against-hospitalization-in-south-africa-when-omicron-was-dominant-1031071002,positive,0.9503253102302551
12/30/2021 1:11:18 PM,"J&J's COVID-19 Booster Shot 85% Effective Against Hospitalization, In South Africa Phase 3 Study ",RTTNews,/news/stocks/j-j-s-covid-19-booster-shot-85-effective-against-hospitalization-in-south-africa-phase-3-study-1031071067,positive,0.8822844624519348
1/2/2022 5:00:00 PM,Can COVID-19 vaccine makers stellar 2021 continue in 2022?,Seeking Alpha,https://seekingalpha.com/news/3784267-can-covid-19-vaccine-makers-stellar-2021-continue-in-2022?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8817173838615417
1/3/2022 11:00:54 AM,Some Investors Should Buy Novavax Stock on the Dip,InvestorPlace,/news/stocks/some-investors-should-buy-nvax-stock-on-the-dip-1031073881,neutral,0.8837239146232605
1/3/2022 4:19:37 PM,Theravance up 9% on 3x higher than normal volume,Seeking Alpha,https://seekingalpha.com/news/3784627-theravance-up-10-on-3x-higher-than-normal-volume?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9502735137939453
1/3/2022 8:55:57 PM,States siding with McKinsey to block local governments' opioid cases,Seeking Alpha,https://seekingalpha.com/news/3784696-states-siding-with-mckinsey-to-block-local-governments-opioid-cases?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6529672145843506
1/4/2022 8:42:50 AM,U.S. schools delay openings amid COVID-19 surge driven by Omicron variant,Seeking Alpha,https://seekingalpha.com/news/3784800-us-schools-delay-openings-amid-covid-19-surge-driven-by-omicron-variant?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9318064451217651
1/4/2022 1:34:30 PM,Johnson & Johnson declares $1.06 dividend,Seeking Alpha,https://seekingalpha.com/news/3784864-johnson-and-johnson-declares-1_06-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9299405813217163
1/4/2022 2:00:00 PM,Johnson & Johnson Announces Quarterly Dividend for First Quarter 2022,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-first-quarter-2022-1031076008,neutral,0.6034680604934692
1/4/2022 4:02:18 PM,CDC backs use of a third Pfizer/BioNTech COVID-19 shot for certain children,Seeking Alpha,https://seekingalpha.com/news/3785056-cdc-backs-use-of-a-third-pfizerbiontech-covid-19-shot-for-certain-children?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7740054726600647
1/4/2022 5:07:32 PM,"Store Capital falls as CNBC commentator sells shares, buys Carlyle Group, recommends Viper Energy (update)",Seeking Alpha,https://seekingalpha.com/news/3785136-store-capital-falls-after-cnbc-commentator-sells-shares-buys-carlyle-group?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8120027780532837
1/4/2022 8:59:04 PM,Biden says vaccinated people shouldn't be 'alarmed' by COVID-19,Seeking Alpha,https://seekingalpha.com/news/3785196-biden-says-vaccinated-people-shouldnt-be-alarmed-by-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7648681998252869
1/5/2022 1:22:15 PM,"Nevada joins Johnson & Johnson, drug distributors $26B opioid settlement",Seeking Alpha,https://seekingalpha.com/news/3785354-johnson-johnson-drug-distributors-win-nevada-for-26b-opioid-deal?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.49819445610046387
1/5/2022 7:49:53 PM,Global M&A deals annual volume reach highest level since 2008: Willis Towers,Seeking Alpha,https://seekingalpha.com/news/3785549-global-ma-deals-annual-volume-reach-highest-level-since-2008-willis-towers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9062774181365967
1/5/2022 9:41:23 PM,"J&J Janssen unit, SRI International to collaborate on drug discovery using AI",Seeking Alpha,https://seekingalpha.com/news/3785625-johnson-johnson-janssen-unit-sri-international-to-collaborate-drug-discovery-using-ai?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7386318445205688
1/6/2022 12:33:59 PM,7 Best Stocks to Buy to Kick Off the New Year,InvestorPlace,/news/stocks/7-best-stocks-to-buy-to-kick-off-new-year-1031081283,neutral,0.650601327419281
1/6/2022 12:38:01 PM,"Meta, Netflix move up list of crowded trades, even as funds dump tech: At the Open",Seeking Alpha,https://seekingalpha.com/news/3785535-meta-netflix-move-up-the-list-of-ubs-most-crowded-trades?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8725168108940125
1/6/2022 10:03:32 PM,"J&J touts data on durable protection of COVID shot against infections, hospitalization",Seeking Alpha,https://seekingalpha.com/news/3786033-johnson-johnson-touts-data-on-durable-protection-of-covid-shot-against-infections-hospitalization?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9006162285804749
1/6/2022 10:10:00 PM,"Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States",PR Newswire,/news/stocks/real-world-evidence-shows-johnson-johnson-covid-19-vaccine-demonstrates-durable-protection-against-breakthrough-infection-hospitalization-and-intensive-care-unit-admission-in-the-united-states-1031082512,positive,0.9494941234588623
1/7/2022 4:07:19 AM,Johnson & Johnson Vaccine Protects Up To Six Months Against COVID-19 Breakthrough Infections ,RTTNews,/news/stocks/johnson-johnson-vaccine-protects-up-to-six-months-against-covid-19-breakthrough-infections-1031082696,neutral,0.7034169435501099
1/7/2022 5:59:39 PM,Some Supreme Court justices take issue with Biden vaccine mandates,Seeking Alpha,https://seekingalpha.com/news/3786332-some-supreme-court-justices-take-issue-with-biden-vaccine-mandates?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6542564630508423
1/7/2022 6:17:06 PM,Biden administration to ask Congress for more COVID funding - WaPo,Seeking Alpha,https://seekingalpha.com/news/3786338-biden-administration-to-ask-congress-for-more-covid-funding?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7112751007080078
1/7/2022 6:34:48 PM,Judge allows Purdue to immediately appeal bankruptcy settlement rejection,Seeking Alpha,https://seekingalpha.com/news/3786345-judge-gives-purdue-right-to-immediately-appeal-bankruptcy-opioid-settlement-rejection?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6980217695236206
1/11/2022 11:10:02 AM,U.S. COVID-19 hospitalizations surpass last winter record as Omicron surges,Seeking Alpha,https://seekingalpha.com/news/3786959-us-covid-19-hospitalizations-surpass-last-winter-record-as-omicron-surges?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9084091782569885
1/11/2022 8:46:55 PM,FDA mandates warning of risk of blood clotting disorder with J&J COVID vaccine,Seeking Alpha,https://seekingalpha.com/news/3787247-fda-mandates-warning-of-risk-of-blood-clotting-disorder-with-jj-covid-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7607711553573608
1/12/2022 4:57:30 PM,Theravance Biopharma continues slide; down another 12% today,Seeking Alpha,https://seekingalpha.com/news/3787576-theravance-biosciences-continues-slide-down-another-12-today?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9742461442947388
1/13/2022 8:52:18 AM,Calls grow to treat COVID like an 'endemic' illness,Seeking Alpha,https://seekingalpha.com/news/3787737-calls-grow-to-treat-covid-like-an-endemic-illness?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5648311376571655
1/13/2022 6:43:38 PM,FDA document outlines testing of cosmetics containing talc for asbestos,Seeking Alpha,https://seekingalpha.com/news/3788023-fda-document-outlines-testing-of-cosmetics-containing-talc-for-asbestos?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9340897798538208
1/13/2022 7:42:56 PM,"Supreme Court blocks COVID vaccine mandate for businesses, but OK for healthcare workers",Seeking Alpha,https://seekingalpha.com/news/3788042-supreme-court-blocks-covid-vaccine-mandate-for-businesses-but-ok-for-healthcare-workers?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8305372595787048
1/14/2022 5:24:27 PM,What To Expect When Johnson & Johnson Unveils Q4 Performance This Month,Benzinga,/news/stocks/what-to-expect-when-johnson-johnson-unveils-q4-performance-this-month-1031103799,neutral,0.9391925930976868
1/14/2022 5:48:39 PM,AstraZeneca COVID-19 vaccine linked to rare spinal condition - European regulator,Seeking Alpha,https://seekingalpha.com/news/3788370-astrazeneca-covid-19-vaccine-linked-to-rare-spinal-condition-european-regulator?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7813329100608826
1/14/2022 6:18:54 PM,Johnson & Johnson set to hear bankruptcy ruling for talc claims by Feb. 28,Seeking Alpha,https://seekingalpha.com/news/3788379-johnson-johnson-set-to-hear-bankruptcy-ruling-for-talc-claims-by-feb-28?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7623165845870972
1/14/2022 8:35:57 PM,Novavax Still Has Not Received an FDA EUA as the Market Waits,InvestorPlace,/news/stocks/nvax-stock-could-be-a-buy-here-before-the-fda-eua-for-its-vaccine-1031104155,neutral,0.8519639372825623
1/20/2022 3:10:01 PM,CDC study finds prior infection provides better immunity against COVID than vaccines,Seeking Alpha,https://seekingalpha.com/news/3789643-cdc-report-finds-prior-infection-provides-better-immunity-against-covid-than-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8891788125038147
1/20/2022 8:33:40 PM,7 Bull Market Stocks to Buy for a Continued Run Higher in 2022¬†,InvestorPlace,/news/stocks/7-bull-market-stocks-to-buy-for-a-continued-run-higher-in-2022-1031117463,positive,0.875851035118103
1/21/2022 7:04:31 PM,Judge blocks Biden mandate requiring COVID vaccination for federal employees,Seeking Alpha,https://seekingalpha.com/news/3790408-judge-blocks-biden-mandate-requiring-covid-vaccination-for-federal-employees?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7862682342529297
1/21/2022 7:42:11 PM,Worldwide Adoption of Novavax Vaccines Makes It a Winner,InvestorPlace,/news/stocks/worldwide-adoption-of-nvax-stock-vaccines-makes-it-a-winner-1031119838,positive,0.8301922678947449
1/24/2022 3:41:46 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3790744-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8660829067230225
1/24/2022 4:25:26 PM,"AstraZeneca, Pfizer/ BioNTech or J&J shots found to boost effect of Sinovac COVID-19 vaccine",Seeking Alpha,https://seekingalpha.com/news/3790763-astrazeneca-pfizer-biontech-or-jj-shots-found-to-boost-effect-of-sinovac-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.938286304473877
1/24/2022 5:07:29 PM,"Omicron blunts rise in vaccine sales for 2022, health analytics firm says",Seeking Alpha,https://seekingalpha.com/news/3790796-omicron-blunts-rise-in-vaccine-sales-for-2022-health-analytics-firm-says?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9460015296936035
1/24/2022 5:58:07 PM,All eyes on J&J Q4 results with new CEO and plans of company split,Seeking Alpha,https://seekingalpha.com/news/3790850-all-eyes-on-jj-q4-results-with-new-ceo-and-plans-of-company-split?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9325414896011353
1/25/2022 8:16:59 AM,New York judge blocks statewide mask mandate - Reuters,Seeking Alpha,https://seekingalpha.com/news/3791053-new-york-judge-blocks-statewide-mask-mandate-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6777533888816833
1/25/2022 11:31:49 AM,"Johnson & Johnson Non-GAAP EPS of $2.13 beats by $0.01, revenue of $24.8B misses by $490M",Seeking Alpha,https://seekingalpha.com/news/3791095-johnson-and-johnson-non-gaap-eps-of-2_13-beats-0_01-revenue-of-24_8b-misses-490m?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7000035643577576
1/25/2022 12:17:12 PM,Johnson & Johnson down 2% on top-line miss; FY22 guidance tops consensus,Seeking Alpha,https://seekingalpha.com/news/3791124-johnson-johnson-down-2-on-top-line-miss-fy22-guidance-tops-consensus?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9721747040748596
1/25/2022 12:25:00 PM,Johnson & Johnson Reports Q4 and Full-Year 2021 Results,PR Newswire,/news/stocks/johnson-johnson-reports-q4-and-full-year-2021-results-1031125670,neutral,0.7945529222488403
1/25/2022 12:30:17 PM,"Johnson & Johnson Q4 Profit Increases, beats estimates",RTTNews,/news/stocks/johnson-johnson-q4-profit-increases-beats-estimates-1031125675,positive,0.9294189214706421
1/25/2022 12:59:24 PM,Johnson & Johnson Projects 2022 Adj. Operational EPS Growth Of 9.2% ,RTTNews,/news/stocks/johnson-johnson-projects-2022-adj-operational-eps-growth-of-9-2-1031125779,positive,0.8339584469795227
1/25/2022 1:46:12 PM,"The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-starts-omicron-specific-vaccine-study-j-j-misses-on-topline-sierra-oncology-reports-positive-data-1031126033,positive,0.6391031742095947
1/25/2022 2:21:16 PM,Genmab announces Darzalex 2021 sales rise 43.8% Y/Y,Seeking Alpha,https://seekingalpha.com/news/3791243-genmab-announces-darzalex-2021-sales-rise-438-yy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9477242827415466
1/25/2022 2:26:33 PM,"Stocks to Watch Tuesday: What‚Äôs Moving VZ, JNJ, GE, IBM and MMM Today",InvestorPlace,/news/stocks/stocks-to-watch-tuesday-whats-moving-vz-jnj-ge-ibm-and-mmm-today-1031126757,neutral,0.922569215297699
1/25/2022 3:01:13 PM,Johnson Johnson earnings preview: what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-q4-quarterly-earnings-preview-stock-1031126392,neutral,0.9182448983192444
1/25/2022 4:05:21 PM,Mid-Morning Market Update: Markets Open Lower; Johnson & Johnson Sales Miss Views,Benzinga,/news/stocks/mid-morning-market-update-markets-open-lower-johnson-johnson-sales-miss-views-1031126925,negative,0.9701696634292603
1/25/2022 5:21:17 PM,OSHA withdraws private employee vaccine mandate following Supreme Court ruling,Seeking Alpha,https://seekingalpha.com/news/3791386-osha-withdraws-private-employee-vaccine-mandate-following-supreme-court-ruling?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8788094520568848
1/25/2022 6:14:35 PM,Mid-Day Market Update: Nasdaq Tumbles 300 Points; Sierra Oncology Shares Jump,Benzinga,/news/stocks/mid-day-market-update-nasdaq-tumbles-300-points-sierra-oncology-shares-jump-1031127368,negative,0.954439640045166
1/25/2022 6:50:12 PM,Biopharmas need to personalize engagement in competitive oncology landscape - Accenture,Seeking Alpha,https://seekingalpha.com/news/3791441-biopharmas-need-to-personalize-engagement-in-competitive-oncology-landscape-accenture?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7529731392860413
1/25/2022 8:30:27 PM,Mid-Afternoon Market Update: Dow Turns Higher; General Electric Shares Slide,Benzinga,/news/stocks/mid-afternoon-market-update-dow-turns-higher-general-electric-shares-slide-1031127641,negative,0.764313280582428
1/25/2022 9:07:36 PM,Uncertain Market Conditions And Good News Make Novavax A Cautious Buy,InvestorPlace,/news/stocks/uncertain-market-conditions-and-good-news-make-novavax-a-cautious-buy-1031127797,negative,0.3703708350658417
1/25/2022 10:11:19 PM,"4 Top Stock Trades for Wednesday: S&P 500, XOM, DOGE, JNJ",InvestorPlace,/news/stocks/4-top-stock-trades-for-wednesday-sp-500-xom-doge-jnj-1031127979,neutral,0.9164509177207947
1/26/2022 5:59:16 AM,New York mask mandate temporarily restored by Appeals Court judge - Reuters,Seeking Alpha,https://seekingalpha.com/news/3791615-new-york-mask-mandate-temporarily-restored-by-appeals-court-judge-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7119890451431274
1/26/2022 1:36:25 PM,10 Biggest Price Target Changes For Wednesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-wednesday-1031130439,neutral,0.8142693638801575
1/26/2022 3:51:12 PM,Denmark and Austria become latest European countries to lift COVID restrictions,Seeking Alpha,https://seekingalpha.com/news/3791864-denmark-and-austria-become-latest-european-countries-to-lift-covid-restrictions?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7081279158592224
1/26/2022 9:09:20 PM,Galapagos ropes in former J&J science chief Paul Stoffels as CEO,Seeking Alpha,https://seekingalpha.com/news/3792070-galapagos-ropes-in-paul-stoffels-as-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.91583251953125
1/27/2022 7:48:36 AM,Two-thirds of Omicron COVID cases are reinfections: English study,Seeking Alpha,https://seekingalpha.com/news/3792249-two-thirds-of-omicron-covid-cases-are-reinfections-english-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8890379071235657
1/27/2022 11:47:08 AM,Most U.S. local governments join opioid deal with J&J and drug distributors,Seeking Alpha,https://seekingalpha.com/news/3792302-most-us-local-governments-join-opioid-deal-with-jj-and-drug-distributors?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8565735220909119
1/27/2022 1:57:50 PM,"The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study",Benzinga,/news/stocks/the-daily-biotech-pulse-galapagos-appoints-j-j-exec-as-ceo-aridis-gets-funding-for-antiviral-treatment-moderna-starts-omicron-specific-booster-study-1031135162,neutral,0.7180483341217041
1/27/2022 2:01:54 PM,MeiraGTx secures $30M milestone from Janssen under gene therapies collaboration,Seeking Alpha,https://seekingalpha.com/news/3792460-meiragtx-secures-30m-milestone-from-janssen-under-gene-therapies-collaboration?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8896133303642273
1/27/2022 3:56:38 PM,Galapagos at a six-month high after naming former J&J science chief as CEO,Seeking Alpha,https://seekingalpha.com/news/3792569-galapagos-at-a-six-month-high-after-naming-former-jj-science-chief-as-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7416486740112305
1/27/2022 7:04:30 PM,"Inflation - what have we learned from earnings so far, and which stocks could benefit",Seeking Alpha,https://seekingalpha.com/news/3792652-inflation-what-have-we-learned-from-earnings-so-far-and-who-could-benefit?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8946138620376587
1/27/2022 11:28:00 PM,Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-citi-s-2022-virtual-healthcare-conference-1031137355,neutral,0.8075878620147705
1/28/2022 7:00:54 AM,COVID-19 boosters give 95% protection from death due to Omicron in people over 50: UKHSA,Seeking Alpha,https://seekingalpha.com/news/3792885-covid-19-boosters-gives-95-protection-from-death-due-to-omicron-in-people-over-50-ukhsa?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8038747906684875
1/28/2022 8:40:11 AM,CDC study finds third dose of COVID-19 vaccine reduce risk of hospitalizations in immunocompromised people,Seeking Alpha,https://seekingalpha.com/news/3792890-cdc-study-finds-third-dose-of-covid-19-vaccine-reduce-risk-of-hospitalizations-in-immunocompromised-people?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8042193651199341
1/28/2022 5:05:31 PM,Novavax Could Be the Biggest Bargain in the Market Right Now,InvestorPlace,/news/stocks/nvax-stock-could-be-biggest-bargain-in-the-market-right-now-1031140035,neutral,0.5751538276672363
1/28/2022 6:15:32 PM,7 Technology Stocks Reporting Earnings the Week of January 31,InvestorPlace,/news/stocks/earnings-reports-to-watch-next-week-1028709625,neutral,0.5936216115951538
1/29/2022 9:00:00 PM,"Vaccines to dominate pharma sales this year, but Bristol could have most best-sellers",Seeking Alpha,https://seekingalpha.com/news/3793190-vaccines-to-have-highest-pharma-sales-this-year-but-bristol-could-have-most-best-sellers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7369601130485535
1/31/2022 11:40:24 AM,"Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target",Benzinga,/news/stocks/kaleido-halts-upcoming-phase-2-copd-trial-piper-sandler-cuts-price-target-1031143668,negative,0.9175760746002197
1/31/2022 2:20:54 PM,"The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-31-feb-5-merck-bristol-myers-squibb-lilly-novartis-headline-large-cap-biopharma-earnings-news-1031144306,neutral,0.9110233187675476
2/1/2022 11:00:48 AM,7 Stocks to Watch in This Current Earnings Season,InvestorPlace,/news/stocks/7-stocks-to-watch-in-this-current-earnings-season-aal-sq-nvax-panw-pins-tgt-wday-1031148366,neutral,0.9132385849952698
2/1/2022 2:23:56 PM,ViiV Healthcare announces FDA approval of two-month dosing of Cabenuva for HIV,Seeking Alpha,https://seekingalpha.com/news/3794065-viiv-healthcare-announces-fda-approval-of-two-month-dosing-of-cabenuva-for-hiv?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8925979733467102
2/1/2022 3:29:20 PM,WHO: Omicron subvariant BA.2 not more severe than original variant,Seeking Alpha,https://seekingalpha.com/news/3794130-who-omicron-subvariant-ba2-not-more-severe-than-original-variant?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4296252429485321
2/1/2022 4:51:04 PM,WHO warns on lifting COVID curbs quickly as many countries have not reached Omicron peak,Seeking Alpha,https://seekingalpha.com/news/3794208-who-warns-on-lifting-covid-curbs-as-many-countries-have-not-reached-omicron-peak?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8374766111373901
2/1/2022 5:39:58 PM,"Johnson & Johnson, drug distributors in $590M deal with U.S. tribes to settle opioid claims",Seeking Alpha,https://seekingalpha.com/news/3794268-johnson-johnson-drug-distributors-in-590m-deal-with-us-tribes-to-settle-opioid-claims?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9083294868469238
2/2/2022 4:35:37 PM,GOOG vs. GOOGL: Everything You Need to Know About the Google Stock Split,InvestorPlace,/news/stocks/goog-googl-stock-split-google-stock-split-1030992513,neutral,0.9411597847938538
2/2/2022 9:13:21 PM,"Avoid Novavax for Now, Until the Picture Clears Up",InvestorPlace,/news/stocks/avoid-novavax-for-now-until-the-picture-clears-up-1031155602,neutral,0.8661520481109619
2/2/2022 11:22:25 PM,J&J to record $610M impairment charge from terminating development of therapy,Seeking Alpha,https://seekingalpha.com/news/3795276-johnson-johnson-to-record-610m-impairment-charge-from-terminating-development-of-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9527277946472168
2/3/2022 2:07:09 PM,Johnson & Johnson‚Äôs Jannsen unit in pact with Mersana for antibody-drug conjugates,Seeking Alpha,https://seekingalpha.com/news/3795540-johnson-johnsons-jannsen-unit-in-pact-with-mersana-for-antibody-drug-conjugates?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7232833504676819
2/3/2022 2:13:03 PM,"The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation",Benzinga,/news/stocks/the-daily-biotech-pulse-big-pharma-earnings-prove-lackluster-mersana-inks-1b-adc-r-d-deal-syros-gets-orphan-drug-designation-1031158702,negative,0.9289474487304688
2/3/2022 7:39:45 PM,Janssen Inks Over $1B Pact For Mersana's ADC Technology In Three targets,Benzinga,/news/stocks/janssen-inks-over-1b-pact-for-mersana-s-adc-technology-in-three-targets-1031160035,positive,0.8045792579650879
2/4/2022 9:34:01 PM,"J&J hatched plan, ""Project Plato,"" to stem payouts in talc lawsuits: Reuters",Seeking Alpha,https://seekingalpha.com/news/3796255-johnson-johnson-hatched-plan-project-plato-to-stem-payouts-in-talc-lawsuits-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6912686824798584
2/7/2022 3:20:50 PM,"Teva in $225 million opioid deal with Texas, Attorney General says",Seeking Alpha,https://seekingalpha.com/news/3796575-teva-in-225-million-opioid-deal-with-texas-attorney-general-says?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5596031546592712
2/7/2022 10:51:00 PM,Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-cowen-42nd-annual-health-care-virtual-conference-1031168722,neutral,0.8095104694366455
2/8/2022 4:10:30 PM,J&J shut production of COVID vaccine at only plant making usable batches - NY Times,Seeking Alpha,https://seekingalpha.com/news/3797306-johnson-johnson-shut-production-of-covid-vaccine-at-only-plant-making-usable-batches-ny-times?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.713401734828949
2/8/2022 7:58:13 PM,Take a Leap Into Novavax Stock After Vaccine Sales Start,InvestorPlace,/news/stocks/take-a-leap-into-nvax-stock-after-vaccine-sales-start-1031173149,neutral,0.895214855670929
2/8/2022 9:18:39 PM,"J&J Stops Production Of Its COVID-19 Vaccine, Says NYT ",RTTNews,/news/stocks/j-j-stops-production-of-its-covid-19-vaccine-says-nyt-1031173174,negative,0.9534153938293457
2/9/2022 10:28:00 PM,Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-raymond-james-43rd-annual-institutional-investors-conference-1031178736,neutral,0.8373598456382751
2/10/2022 11:48:15 AM,Teva eyes up to $3.6 billion to settle opioid claims - Reuters,Seeking Alpha,https://seekingalpha.com/news/3798416-teva-stock-lower-as-company-eyes-up-to-36-billion-to-settle-opioid-claims-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6728857159614563
2/10/2022 4:14:05 PM,J&J single-shot COVID vaccine has only ~53% efficacy based on final analysis,Seeking Alpha,https://seekingalpha.com/news/3798678-johnson-johnson-single-shot-vaccine-covid-has-only-53-efficacy-based-on-final-analysis?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9125441908836365
2/11/2022 9:50:14 AM,Purdue's Sacklers mulling to add extra $1B in opioid settlement - Bloomberg News,Seeking Alpha,https://seekingalpha.com/news/3799037-purdues-sacklers-mulling-to-add-extra-1b-in-opioid-settlement-bloomberg-news?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8301594257354736
2/11/2022 1:52:42 PM,Legend Biotech hits two milestones under its deal with Janssen for CAR-T therapy,Seeking Alpha,https://seekingalpha.com/news/3799161-jnj-stock-down-as-legend-biotech-wins-milestones-under-car-t-deal?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9428876042366028
2/11/2022 8:00:38 PM,"Catalyst watch for next week: Spotlight on Nvidia, Intel, 3M, Mattel and Stablecoins",Seeking Alpha,https://seekingalpha.com/news/3799300-catalyst-watch-for-next-week-spotlight-on-nvidia-intel-3m-mattel-and-stablecoins?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9183595180511475
2/12/2022 9:00:00 PM,Cassava Sciences citizen petition saga shines light on alleged abuse of FDA program,Seeking Alpha,https://seekingalpha.com/news/3799281-cassava-sciences-citizen-petition-saga-shines-light-on-alleged-abuse-of-fda-program?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7945616245269775
2/14/2022 11:00:23 AM,7 Defensive Growth Stocks to Buy for February,InvestorPlace,/news/stocks/7-defensive-growth-stocks-to-buy-for-february-1031191037,neutral,0.8883936405181885
2/14/2022 1:31:39 PM,Cidara announces FDA acceptance of its request to study the flu candidate,Seeking Alpha,https://seekingalpha.com/news/3799514-cidara-announces-fda-acceptance-of-its-request-to-study-the-flu-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5267710089683533
2/14/2022 3:22:44 PM,COVID-19 vaccine makers decline after delay for FDA decision on vaccines for kids,Seeking Alpha,https://seekingalpha.com/news/3799593-covid-19-vaccine-makers-decline-after-delay-for-fda-decision-on-vaccines-for-kids?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9581160545349121
2/14/2022 7:29:44 PM,7 Dividend Aristocrats That Could Outpace This Volatile Market,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-could-outpace-this-volatile-market-1031192576,neutral,0.8186364769935608
2/15/2022 2:14:27 PM,J&J says bankruptcy is best way to resolve talc claims in trial,Seeking Alpha,https://seekingalpha.com/news/3800089-johnson-johnson-says-bankruptcy-is-best-way-to-resolve-talc-claims-in-trial?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8393346667289734
2/15/2022 8:06:26 PM,The Best Russell 2000 Stocks to Buy Before they Rebound,InvestorPlace,/news/stocks/the-best-russell-2000-stocks-to-buy-before-they-rebound-1031197231,neutral,0.8711791038513184
2/15/2022 8:54:13 PM,AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial,Benzinga,/news/stocks/ac-immune-janssen-partnered-alzheimer-s-vaccine-shows-tau-specific-antibodies-in-early-stage-trial-1031197200,positive,0.5086631774902344
2/15/2022 10:30:00 PM,"Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors",PR Newswire,/news/stocks/johnson-johnson-names-darius-adamczyk-chairman-and-chief-executive-officer-of-honeywell-to-its-board-of-directors-1031197406,neutral,0.9452979564666748
2/16/2022 10:57:17 AM,AstraZeneca COVID vaccine short shelf life complicates roll out in poor nations - Reuters,Seeking Alpha,https://seekingalpha.com/news/3800550-astrazeneca-covid-vaccine-short-shelf-life-complicates-roll-out-in-poor-nations-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5820578336715698
2/16/2022 3:39:01 PM,3 Desirable Drug Stocks With Very Promising Pipelines,InvestorPlace,/news/stocks/3-desirable-drug-stocks-with-very-promising-pipelines-1031201417,positive,0.9052234292030334
2/16/2022 6:31:52 PM,Johnson & Johnson's talc cases bankruptcy strategy attacked by Sen. Durbin,Seeking Alpha,https://seekingalpha.com/news/3800910-johnson-johnson-talc-cases-bankruptcy-strategy-attacked-by-sen-durbin?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9237436056137085
2/16/2022 6:57:55 PM,Novavax Stock Is at Risk Despite Positive Poll Results,InvestorPlace,/news/stocks/nvax-stock-is-at-risk-despite-positive-poll-results-1031201978,negative,0.8575950264930725
2/17/2022 12:40:36 PM,"DaVita study suggests J&J, Pfizer/BioNTech COVID vaccines at parity for kidney patients",Seeking Alpha,https://seekingalpha.com/news/3801363-davita-study-suggests-jj-pfizerbiontech-covid-vaccines-at-parity-for-kidney-patients?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.736613929271698
2/17/2022 12:57:47 PM,Johnson & Johnson‚Äôs Janssen unit and Remix Therapeutics strikes deal valued at up to $1B,Seeking Alpha,https://seekingalpha.com/news/3801376-johnson-johnsons-janssen-unit-and-remix-therapeutics-strikes-deal-valued-at-up-to-1b?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.49998271465301514
2/17/2022 2:00:05 PM,"The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-unit-announces-research-collaboration-with-remix-regencell-touts-covid-data-decision-day-for-agios-1031204785,neutral,0.8754624128341675
2/17/2022 3:07:36 PM,J&J says it may raise $2B settlement offer for talc cases - WSJ,Seeking Alpha,https://seekingalpha.com/news/3801476-johnson-johnson-says-it-may-raise-2b-settlement-offer-for-talc-cases-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8955899477005005
2/18/2022 9:46:54 AM,GSK pauses trials of RSV vaccine in pregnant women,Seeking Alpha,https://seekingalpha.com/news/3801834-gsk-pauses-trials-of-rsv-vaccine-in-pregnant-women?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.530795156955719
2/18/2022 4:03:41 PM,Ocugen Stock Is a Fairy Tale in Need of a Happy Ending,InvestorPlace,/news/stocks/ocgn-stock-is-a-fairy-tale-in-need-of-a-happy-ending-1031209187,neutral,0.7692316174507141
2/18/2022 4:14:58 PM,7 Low Volatility Stocks to Buy to Escape Wild Market Swings,InvestorPlace,/news/stocks/7-low-volatility-stocks-to-buy-to-escape-the-wild-market-swings-1031209185,neutral,0.8467485904693604
2/18/2022 4:19:05 PM,Johnson & Johnson‚Äôs Janssen unit posts 48-week data for Tremfya in Crohn‚Äôs disease,Seeking Alpha,https://seekingalpha.com/news/3801991-johnson-johnsons-janssen-unit-posts-48-week-data-for-tremfya-in-crohns-disease?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8941492438316345
2/22/2022 6:53:11 PM,J&J argues plaintiffs' attorneys don't support talc bankruptcy plan over more money,Seeking Alpha,https://seekingalpha.com/news/3802738-johnson-johnson-argues-plaintiffs-attorneys-dont-support-talc-bankruptcy-plan-over-more-money?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.723914623260498
2/23/2022 8:29:25 PM,How might a Sanofi-GSK COVID vaccine compete against mRNA shots?,Seeking Alpha,https://seekingalpha.com/news/3804505-how-might-a-sanofi-gsk-covid-vaccine-compete-against-mrna-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8816866278648376
2/25/2022 2:17:56 PM,Johnson & Johnson to pay $5B as part of landmark opioid settlement,Seeking Alpha,https://seekingalpha.com/news/3805932-johnson-johnson-to-pay-5b-as-part-of-landmark-opioid-settlement?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8307780027389526
2/25/2022 4:46:48 PM,Healthcare leads a rally in S&P 500 amid hopes of Russia - Ukraine talks,Seeking Alpha,https://seekingalpha.com/news/3806014-healthcare-leads-a-rally-in-sp-500-amid-hopes-of-russia-ukraine-talks?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7153179049491882
2/25/2022 4:56:18 PM,Johnson & Johnson given go-ahead for bankruptcy strategy on talc lawsuits,Seeking Alpha,https://seekingalpha.com/news/3806018-johnson-johnson-given-go-ahead-for-bankruptcy-strategy-on-talc-lawsuits?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7700974941253662
2/25/2022 11:47:08 PM,J&J Bankruptcy Ploy Upheld By NJ Court ,RTTNews,/news/stocks/j-j-bankruptcy-ploy-upheld-by-nj-court-1031233558,neutral,0.5461247563362122
2/27/2022 3:26:47 PM,"The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight",Benzinga,/news/stocks/the-week-ahead-in-biotech-feb-27-march-5-earnings-multiple-regulatory-decisions-take-the-spotlight-1031235310,neutral,0.8183647990226746
3/1/2022 12:22:00 PM,"Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease",PR Newswire,/news/stocks/pathalys-pharma-inc-launches-with-mission-to-address-high-priority-needs-in-chronic-kidney-disease-1031242156,positive,0.8995068073272705
3/1/2022 1:51:14 PM,"The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution",Benzinga,/news/stocks/the-daily-biotech-pulse-legend-biotech-cti-biopharma-receive-fda-approvals-abbvie-announces-delay-in-skyrizi-review-editas-gains-on-crispr-patent-resolution-1031242590,neutral,0.7575395107269287
3/2/2022 2:01:03 PM,J&J Acuvue Theravision with Ketotifen contact lens gets FDA nod to prevent eye itch,Seeking Alpha,https://seekingalpha.com/news/3808423-jj-acuvue-theravision-with-ketotifen-contact-lens-gets-fda-nod-to-prevent-eye-itch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8268513679504395
3/2/2022 5:02:09 PM,White House COVID pandemic plan aims to ease return to normalcy,Seeking Alpha,https://seekingalpha.com/news/3808551-white-house-covid-pandemic-plan-aims-to-ease-return-to-normalcy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8495838046073914
3/2/2022 8:48:55 PM,36 Stocks To Watch After Biden's First State of The Union Address,Benzinga,/news/stocks/36-stocks-to-watch-after-biden-s-first-state-of-the-union-address-1031248946,neutral,0.8909977078437805
3/3/2022 3:57:17 PM,U.S. to share government-backed COVID-19 tech with WHO - Washington Post,Seeking Alpha,https://seekingalpha.com/news/3809199-us-to-share-government-backed-covid-19-tech-with-who-washington-post?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6972874402999878
3/3/2022 6:10:33 PM,7 Funds to Buy to Sidestep the Stock Market Volatility,InvestorPlace,/news/stocks/7-funds-to-buy-to-sidestep-the-stock-market-volatility-1031252665,neutral,0.8566226363182068
3/3/2022 7:24:40 PM,"Purdue Pharma, Sacklers reach new $6B opioid settlement with states",Seeking Alpha,https://seekingalpha.com/news/3809272-purdue-pharma-sacklers-reach-new-6b-opioid-settlement-with-states?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9273517727851868
3/4/2022 1:48:11 PM,Humanigen gains as CEO more than doubles stake,Seeking Alpha,https://seekingalpha.com/news/3809582-hgen-stock-gains-as-ceo-more-than-doubles-stake?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8993645906448364
3/4/2022 2:09:47 PM,90% of U.S. counties experiencing low or medium COVID community spread,Seeking Alpha,https://seekingalpha.com/news/3809592-90-of-us-counties-experiencing-low-or-medium-covid-community-spread?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7930740714073181
3/4/2022 4:31:07 PM,"New York City to lift indoor vaccine mandate, school mask requirement on Monday",Seeking Alpha,https://seekingalpha.com/news/3809678-new-york-city-to-lift-indoor-vaccine-mandate-school-mask-requirement-on-monday?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8576472401618958
3/6/2022 12:16:50 PM,Johnson & Johnson is in talks for biotech deals in China - FT,Seeking Alpha,https://seekingalpha.com/news/3809928-johnson-johnson-is-in-talks-for-biotech-deals-in-china-ft?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6490335464477539
3/7/2022 4:39:22 PM,U.S. supplies of COVID-19 therapies and vaccines at risk amid funding dispute,Seeking Alpha,https://seekingalpha.com/news/3810273-dispute-with-gop-senators-could-jeopardize-additional-finding-for-covid-19-treatments?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9586585164070129
3/8/2022 4:26:46 PM,Johnson & Johnson inks deal with Aspen as COVID-19 vaccine makers focus on Africa,Seeking Alpha,https://seekingalpha.com/news/3810690-johnson-johnson-inks-deal-with-aspen-for-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.857204258441925
3/8/2022 8:58:16 PM,Mediators appointed in J&J bankruptcy talc case to determine amount of trust fund,Seeking Alpha,https://seekingalpha.com/news/3810788-mediators-appointed-in-johnson-johnson-bankruptcy-talc-case-to-determine-amount-of-trust-fund?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9426357746124268
3/9/2022 1:52:45 PM,"The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-begins-late-stage-pediatric-covid-pill-study-midatech-and-j-j-unit-expand-r-d-collaboration-abbvie-alvotech-settle-humira-dispute-1031266063,positive,0.6761943101882935
3/9/2022 3:37:30 PM,DoJ bankruptcy arm raises concerns with potential Purdue opioid settlement,Seeking Alpha,https://seekingalpha.com/news/3811173-doj-bankruptcy-arm-raises-concerns-with-potential-purdue-opioid-settlement?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9635820388793945
3/10/2022 12:35:12 PM,7 Drug Stocks to Consider After the Viatris Plunge,InvestorPlace,/news/stocks/7-drug-stocks-to-consider-after-the-viatris-plunge-abbv-bmy-gsk-vtrs-jnj-teva-pfe-nvs-mrk-1031269941,neutral,0.9267456531524658
3/10/2022 5:10:40 PM,J&J extends R&D collaboration with Midatech Pharma on second molecule,Seeking Alpha,https://seekingalpha.com/news/3812267-johnson-johnson-extends-research-development-collaboration-with-midatech-pharma-on-second-molecule?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9028666615486145
3/10/2022 7:41:24 PM,Is Roblox Stock a Game Bulls Want to Play?,InvestorPlace,/news/stocks/is-roblox-stock-a-game-bulls-want-to-play-1031271555,neutral,0.9188315868377686
3/11/2022 3:25:40 PM,More than 98% of U.S. in areas with low or medium COVID community spread,Seeking Alpha,https://seekingalpha.com/news/3812745-more-than-98-of-us-in-areas-with-low-or-medium-covid-community-spread?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8515693545341492
3/12/2022 7:20:14 PM,Drugmakers face clinical trial disruptions amid Russia - Ukraine conflict,Seeking Alpha,https://seekingalpha.com/news/3812903-drugmakers-face-clinical-trial-disruptions-amid-russia-ukraine-conflict?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9664651155471802
3/14/2022 2:50:43 PM,"Vaccine makers on the rise amid concerns over new variant, China outbreak",Seeking Alpha,https://seekingalpha.com/news/3813149-vaccine-makers-on-the-rise-amid-concerns-over-new-variant-china-outbreak?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6676835417747498
3/14/2022 3:10:39 PM,"Moderna, BioNTech on the rise amid concerns over new variant, China outbreak",Seeking Alpha,https://seekingalpha.com/news/3813149-moderna-biontech-on-the-rise-amid-concerns-over-new-variant-china-outbreak?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.85463947057724
3/14/2022 3:49:29 PM,"J&J, drug distributors draw lawmaker scrutiny over tax benefits linked to opioid deals",Seeking Alpha,https://seekingalpha.com/news/3813166-jj-drug-distributors-draw-lawmaker-scrutiny-on-tax-benefits-for-opioid-deals?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9206870198249817
3/15/2022 1:20:00 PM,Johnson & Johnson to Host Investor Conference Call on First-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-first-quarter-results-1031281088,neutral,0.9213519096374512
3/16/2022 2:29:24 PM,JNJ's DePuy Synthes adds 2 products to ATTUNE knee restoration portfolio,Seeking Alpha,https://seekingalpha.com/news/3814128-jnjs-unit-depuy-synthes-adds-new-technologies-to-attune-knee-restoration-portfolio?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5733078718185425
3/16/2022 4:05:40 PM,J&J downgraded to market perform at Bernstein on 'uphill battle' for Janssen,Seeking Alpha,https://seekingalpha.com/news/3814195-johnson-johnson-downgraded-to-market-perform-at-bernstein-on-uphill-battle-for-janssen?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9538598656654358
3/16/2022 4:07:50 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-16-2022-1031285835,negative,0.504859983921051
3/16/2022 4:08:51 PM,Expert Ratings For Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1031285834,neutral,0.7854138612747192
3/16/2022 4:15:15 PM,Wednesday Top Stock News: 8 Analyst Upgrades and Downgrades Today,InvestorPlace,/news/stocks/wednesday-top-stock-news-8-analyst-upgrades-and-downgrades-today-1031286037,negative,0.9303327798843384
3/16/2022 4:47:17 PM,Protagonist Therapeutics Earns $25M Milestone Payment From Janssen Biotech,Benzinga,/news/stocks/protagonist-therapeutics-earns-25m-milestone-payment-from-janssen-biotech-1031285958,positive,0.804243803024292
3/16/2022 5:30:02 PM,Genmab upgraded at UBS; says ‚Äúmost of the pipeline is for free‚Äù,Seeking Alpha,https://seekingalpha.com/news/3814233-genmab-upgraded-at-ubs-says-most-of-the-pipeline-is-for-free?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7088842988014221
3/16/2022 6:03:19 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1031286197,neutral,0.9169120192527771
3/17/2022 5:58:59 PM,AstraZeneca ready to drop plans for U.S. regulatory approval of COVID-19 shot - FT,Seeking Alpha,https://seekingalpha.com/news/3814697-astrazeneca-to-drop-plans-for-us-regulatory-approval-of-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.920452892780304
3/18/2022 11:59:11 AM,7 Stagflation Stocks to Buy to Combat Slow Growth and Inflation,InvestorPlace,/news/stocks/7-stagflation-stocks-to-buy-to-combat-slow-growth-and-inflation-1031291619,neutral,0.8505492806434631
3/21/2022 1:40:24 PM,FDA to hold AdCom meeting on COVID-19 booster shots next month,Seeking Alpha,https://seekingalpha.com/news/3815361-pfx-bntx-mrna-stocks-gain-on-adcom-meeting-on-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9316227436065674
3/22/2022 4:53:13 PM,COVID Omicron subvariant BA.2 accounts for growing share of new cases in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3816112-covid-omicron-subvariant-ba2-accounts-for-growing-share-of-new-cases-in-the-us-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.675920844078064
3/22/2022 11:06:45 PM,7 Reddit Stocks Likely to Withstand Any Recession in 2022,InvestorPlace,/news/stocks/7-reddit-stocks-likely-to-withstand-any-recession-in-2022-1031299733,positive,0.6739508509635925
3/23/2022 8:25:14 AM,U.S. weighs fourth booster as BA.2 subvariant threatens next COVID wave,Seeking Alpha,https://seekingalpha.com/news/3816282-us-weighs-fourth-booster-as-ba2-subvariant-threatens-next-covid-wave?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49391865730285645
3/23/2022 12:43:16 PM,"The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-reports-positive-ulcerative-colitis-study-data-novavax-covid-shot-authorized-for-adolescents-in-india-argenx-stock-sale-1031301077,neutral,0.5290572643280029
3/23/2022 5:36:32 PM,White House mulls fourth COVID-19 shot for older Americans - Politico,Seeking Alpha,https://seekingalpha.com/news/3816601-white-house-mulls-fourth-covid-19-shot-for-older-americans-politico?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9233742952346802
3/25/2022 3:29:01 AM,ViiV Healthcare : FDA Approves Label Update For Long-acting HIV Treatment Cabenuva ,RTTNews,/news/stocks/viiv-healthcare-fda-approves-label-update-for-long-acting-hiv-treatment-cabenuva-1031306584,positive,0.9180296659469604
3/25/2022 7:00:23 PM,"Catalyst watch: Tesla deliveries, XPeng earnings, Five Below event and Netflix at the Oscars",Seeking Alpha,https://seekingalpha.com/news/3817588-catalyst-watch-for-next-week-tesla-deliveries-xpeng-earnings-and-netflix-at-the-oscars?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9132758975028992
3/29/2022 2:53:29 PM,J&J to suspend supply of personal care products in Russia,Seeking Alpha,https://seekingalpha.com/news/3818471-jj-to-suspend-supply-of-personal-care-products-in-russia?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8334858417510986
3/29/2022 7:55:34 PM,Pfizer/BioNTech and Moderna win U.S. regulatory nod for second booster shot (updated),Seeking Alpha,https://seekingalpha.com/news/3818472-pfizerbiontech-and-moderna-granted-fda-ok-for-second-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5794879198074341
3/29/2022 8:11:57 PM,"Ukraine War Update: European ETFs rise, U.S. agriculture stocks fall amid peace talks",Seeking Alpha,https://seekingalpha.com/news/3818236-ukraine-war-update?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9617030620574951
3/30/2022 10:23:32 AM,Novavax Stock Is a Bet on Interest From Unvaccinated People,InvestorPlace,/news/stocks/novavax-stock-is-a-bet-on-interest-from-unvaccinated-people-1031318249,neutral,0.9361350536346436
3/30/2022 1:46:42 PM,"The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict",Benzinga,/news/stocks/the-daily-biotech-pulse-roche-s-lung-cancer-combo-therapy-flunks-late-stage-study-adagio-spikes-on-positive-covid-antibody-data-amylyx-awaits-adcom-verdict-1031318540,negative,0.5641227960586548
3/30/2022 9:38:30 PM,"CVS Health, Teva Settle Florida State's Opioid-Related Claims: Report",Benzinga,/news/stocks/cvs-health-teva-settle-florida-state-s-opioid-related-claims-report-1031320117,neutral,0.7778939604759216
3/31/2022 1:53:04 PM,Cidara doses first group in phase 1 trial of CD388 for treating/preventing influenza,Seeking Alpha,https://seekingalpha.com/news/3819296-cidara-therapeutics-doses-first-cohort-of-volunteers-in-phase-1-trial-of-antiviral-cd388?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5139254927635193
4/1/2022 10:37:35 AM,World's 1st COVID human challenge trial suggests spread of virus not correlated to symptoms,Seeking Alpha,https://seekingalpha.com/news/3819725-worlds-1st-covid-human-challenge-trial-suggests-spread-of-virus-not-correlated-to-symptoms?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8839459419250488
4/1/2022 12:56:59 PM,Cidara gains on dosing milestone in early-stage trial for flu candidate,Seeking Alpha,https://seekingalpha.com/news/3819826-cdtx-stock-gains-on-dosing-milestone-in-early-stage-trial-for-flu-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9503823518753052
4/1/2022 8:02:24 PM,How to Approach Trading Downtrodden Novavax Today,InvestorPlace,/news/stocks/how-to-approach-trading-downtrodden-novavax-nvax-stock-today-1031327433,neutral,0.9039691686630249
4/1/2022 10:00:43 PM,3 Low-Risk Mutual Funds to Buy for Volatile Times,InvestorPlace,/news/stocks/3-low-risk-mutual-funds-to-buy-for-volatile-times-1031327542,neutral,0.90739506483078
4/3/2022 4:19:55 PM,"10 Investor Questions About COVID-19, Answered",Benzinga,/news/stocks/10-investor-questions-about-covid-19-answered-1031328140,neutral,0.9415953755378723
4/4/2022 11:01:54 AM,DYAI: 2021 Results,Benzinga,/news/stocks/dyai-2021-results-1031329197,neutral,0.8392969965934753
4/4/2022 12:23:32 PM,Johnson & Johnson's Rybrevant gets conditional approval in Canada for lung cancer subtype,Seeking Alpha,https://seekingalpha.com/news/3820309-johnson-johnsons-rybrevant-gets-conditional-approval-in-canada-for-lung-cancer-subtype?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9030225276947021
4/4/2022 9:00:38 PM,Lawmakers agree on $10 billion additional funding for U.S. COVID response (Updated),Seeking Alpha,https://seekingalpha.com/news/3820489-lawmakers-set-to-announce-10-billion-additional-funding-for-us-covid-response?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6900171041488647
4/4/2022 9:09:14 PM,"West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters",Benzinga,/news/stocks/west-virginia-says-j-j-teva-abbvie-caused-tsunami-of-opioid-addiction-reuters-1031331125,neutral,0.6891770362854004
4/4/2022 9:17:18 PM,Moderna CEO predicts many people will eventually get annual COVID shots,Seeking Alpha,https://seekingalpha.com/news/3820563-moderna-ceo-predicts-many-people-will-eventually-get-annual-covid-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8011277914047241
4/5/2022 3:32:39 PM,3 Vanguard ETFs to Buy Now,InvestorPlace,/news/stocks/3-vanguard-etfs-to-buy-now-1031333971,neutral,0.9078019857406616
4/5/2022 9:37:56 PM,MindMed Appoints Francois Lilienthal As New CCO,Benzinga,/news/stocks/mindmed-appoints-francois-lilienthal-as-new-cco-1031334555,neutral,0.9311178922653198
4/6/2022 4:44:05 PM,Is NVAX Stock a Buy at 52-Week Low? Skip the Novavax Portfolio Injection,InvestorPlace,/news/stocks/is-nvax-stock-a-buy-at-52-week-low-skip-the-novavax-portfolio-injection-1031337591,neutral,0.5795311331748962
4/6/2022 5:57:27 PM,Royalty Pharma upgraded at Morgan Stanley on valuation,Seeking Alpha,https://seekingalpha.com/news/3821323-rprx-stock-gains-on-morgan-stanley-upgrade?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9007899165153503
4/7/2022 1:37:39 PM,Dear Biotech Investors: Novavax‚Äôs Comparable Vaccine Matters,InvestorPlace,/news/stocks/nvax-stock-dear-biotech-investors-novavaxs-comparable-vaccine-matters-1031340330,neutral,0.6512706279754639
4/7/2022 10:30:00 PM,Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-bofa-securities-2022-healthcare-conference-1031341306,neutral,0.8624881505966187
4/8/2022 1:52:26 PM,"The Daily Biotech Pulse: Evotec Earns $16M Milestone Payment, Genmab Hit With Adverse Tribunal Ruling, Quidel Announces Above-Consensus Q1 Revenues And More",Benzinga,/news/stocks/the-daily-biotech-pulse-evotec-earns-16m-milestone-payment-genmab-hit-with-adverse-tribunal-ruling-quidel-announces-above-consensus-q1-revenues-and-more-1031342792,positive,0.768593966960907
4/10/2022 1:39:55 PM,Demand for COVID-19 shots falls amid reluctance to boosters,Seeking Alpha,https://seekingalpha.com/news/3822183-demand-for-covid-19-shots-drop-amid-reluctance-to-boosters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9703908562660217
4/11/2022 11:48:55 AM,Goldman screens companies with best and worst pricing power into earnings season,Seeking Alpha,https://seekingalpha.com/news/3822185-godlman-screens-companies-with-best-and-worst-pricing-power-into-earnings-season?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9079515337944031
4/11/2022 2:25:59 PM,Beigene's Brukinsa bests Imbruvica in overall response in leukemia trial,Seeking Alpha,https://seekingalpha.com/news/3822346-beigene-brukinsa-bests-imbruvica-in-overall-response-in-leukemia-trial?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9112858772277832
4/13/2022 9:59:35 PM,J&J Ordered To Pay $302 Mln Penalty For Wrong Pelvic Mesh Implant Ads ,RTTNews,/news/stocks/j-j-ordered-to-pay-302-mln-penalty-for-wrong-pelvic-mesh-implant-ads-1031354675,negative,0.960316002368927
4/14/2022 3:13:06 PM,What 6 Analyst Ratings Have To Say About Johnson & Johnson,Benzinga,/news/stocks/what-6-analyst-ratings-have-to-say-about-johnson-johnson-1031356974,neutral,0.9408949017524719
4/14/2022 9:18:41 PM,7 Earnings Reports to Watch the Week of April 18,InvestorPlace,/news/stocks/7-earnings-reports-to-watch-the-week-of-april-18-1031358951,neutral,0.9081540703773499
4/14/2022 9:27:57 PM,Raymond James Thinks Med Tech Investors are Somewhat 'Paralyzed' Ahead Of Q1 Earnings,Benzinga,/news/stocks/raymond-james-thinks-med-tech-investors-are-somewhat-paralyzed-ahead-of-q1-earnings-1031357902,negative,0.9467341303825378
4/17/2022 4:00:26 PM,Pfizer draws skeptics amid concerns over outlook for COVID-related sales,Seeking Alpha,https://seekingalpha.com/news/3823672-pfe-stock-in-focus-amid-concerns-over-outlook-for-covid-related-sales?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9677928686141968
4/17/2022 8:31:32 PM,"The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-april-17-april-23-j-j-abbott-earnings-adcom-test-for-tg-therapeutics-and-more-1031359853,neutral,0.9330936670303345
4/18/2022 12:54:24 AM,Johnson & Johnson COVID-19 shot holds its ground amid breakthrough cases,Seeking Alpha,https://seekingalpha.com/news/3823676-johnson-johnson-covid-19-shot-holds-its-ground-amid-breakthrough-cases?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6651394963264465
4/18/2022 11:59:23 AM,Eli Lilly expects $165 million in charges related to in-process R&D projects,Seeking Alpha,https://seekingalpha.com/news/3823792-eli-lilly-to-recognize-165-million-in-charges-related-to-in-process-rd-projects?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9416849613189697
4/18/2022 1:42:17 PM,Johnson & Johnson to pay $99M to resolve opioid suits with West Virginia,Seeking Alpha,https://seekingalpha.com/news/3823864-johnson-johnson-to-pay-99m-to-resolve-opioid-suits-with-west-virginia?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8576889634132385
4/18/2022 2:45:16 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3823892-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8660829067230225
4/18/2022 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-q1-earnings-preview-1031361015,neutral,0.9338979721069336
4/18/2022 4:54:52 PM,J&J to report Q1 result amid lingering pandemic headwinds,Seeking Alpha,https://seekingalpha.com/news/3823909-jj-to-report-q1-result-amid-lingering-pandemic-headwinds?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8833299279212952
4/18/2022 8:27:58 PM,Amgen's biosimilar candidate to Stelara shows no clinically meaningful differences in study,Seeking Alpha,https://seekingalpha.com/news/3824066-amgens-biosimilar-candidate-to-stelara-shows-no-clinically-meaningful-differences-in-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.645556628704071
4/19/2022 10:02:33 AM,"5 Stocks To Watch For April 19, 2022",Benzinga,/news/stocks/5-stocks-to-watch-for-april-19-2022-1031363148,neutral,0.9184240698814392
4/19/2022 10:26:07 AM,"Johnson & Johnson Non-GAAP EPS of $2.67 beats by $0.10, revenue of $23.4B misses by $210M",Seeking Alpha,https://seekingalpha.com/news/3824178-johnson-amp-johnson-non-gaap-eps-of-267-beats-by-010-revenue-of-234b-misses-by-210m-reaffirms-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6653621792793274
4/19/2022 10:26:18 AM,Johnson & Johnson raises dividend by 6.6% to $1.13,Seeking Alpha,https://seekingalpha.com/news/3824174-johnson-and-johnson-declares-1_13-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9212925434112549
4/19/2022 11:13:13 AM,A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mixed-ahead-of-earnings-1031363262,negative,0.8922842741012573
4/19/2022 11:17:54 AM,Moderna says its first bivalent booster vaccine outperformed current COVID-19 booster,Seeking Alpha,https://seekingalpha.com/news/3824200-moderna-says-first-bivalent-booster-shot-trumped-current-covid-19-booster?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9529901146888733
4/19/2022 11:27:48 AM,"J&J stock rises on Q1 earnings beat; lowers adjusted EPS outlook, suspends COVID vaccine guidance",Seeking Alpha,https://seekingalpha.com/news/3824205-jj-stock-dips-on-q1-revenue-miss-lowers-adjusted-eps-outlook-suspends-covid-vaccine-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9392329454421997
4/19/2022 12:20:00 PM,Johnson & Johnson Announces Dividend Increase of 6.6%,PR Newswire,/news/stocks/johnson-johnson-announces-dividend-increase-of-6-6-1031363386,positive,0.9070661664009094
4/19/2022 12:25:00 PM,Johnson & Johnson Reports Q1 2022 Results,PR Newswire,/news/stocks/johnson-johnson-reports-q1-2022-results-1031363397,neutral,0.9008098244667053
4/19/2022 12:30:45 PM,"Johnson & Johnson Q1 Profit Decreases, but beats estimates",RTTNews,/news/stocks/johnson-johnson-q1-profit-decreases-but-beats-estimates-1031363436,negative,0.9713038206100464
4/19/2022 12:53:40 PM,Johnson & Johnson Suspends Guidance On Its COVID-19 Vaccine Sales ,RTTNews,/news/stocks/johnson-johnson-suspends-guidance-on-its-covid-19-vaccine-sales-1031363479,negative,0.9130454659461975
4/19/2022 1:55:40 PM,"Morning Brief: Top Financial Stories Dominating on Tuesday, April 19",Benzinga,/news/stocks/morning-brief-top-financial-stories-dominating-on-tuesday-april-19-1031363748,neutral,0.9060149192810059
4/19/2022 2:29:32 PM,Why Is Johnson & Johnson (JNJ) Stock in Focus Today?,InvestorPlace,/news/stocks/why-is-johnson-johnson-jnj-stock-in-focus-today-1031364592,neutral,0.719818651676178
4/19/2022 2:57:17 PM,Why Is ToughBuilt Industries (TBLT) Stock Up 65% Today?,InvestorPlace,/news/stocks/why-is-toughbuilt-industries-tblt-stock-up-65-today-1031364637,positive,0.8866286277770996
4/19/2022 3:05:03 PM,"The Daily Biotech Pulse: Regeneron Acquires Checkmate Pharma, Moderna's Bivalent Booster COVID-19 Vaccine Update, Priority Review For AstraZeneca's Enhertu",Benzinga,/news/stocks/the-daily-biotech-pulse-regeneron-acquires-checkmate-pharma-moderna-s-bivalent-booster-covid-19-vaccine-update-priority-review-for-astrazeneca-s-enhertu-1031364260,neutral,0.606445848941803
4/19/2022 3:19:35 PM,AbbVie falls as partner Johnson & Johnson cites pressure on Imbruvica sales,Seeking Alpha,https://seekingalpha.com/news/3824338-abbv-stock-falls-as-johnson--johnson-as-imbruvica-sales-drop?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9588532447814941
4/19/2022 3:32:59 PM,"Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More",Benzinga,/news/stocks/benzinga-s-daily-brief-on-trending-tickers-for-april-19-2022-plug-power-twitter-cassava-sciences-and-more-1031364340,neutral,0.9473868012428284
4/19/2022 4:59:32 PM,Mid-Morning Market Update: Markets Open Higher; Dow Jumps 400 Points,Benzinga,/news/stocks/mid-morning-market-update-markets-open-higher-dow-jumps-400-points-1031364642,positive,0.9157251119613647
4/19/2022 5:21:14 PM,Johnson & Johnson‚Äôs MedTech performance rallies industry,Seeking Alpha,https://seekingalpha.com/news/3824408-johnson-johnsons-medtech-performance-rallies-industry?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8827807307243347
4/19/2022 6:37:08 PM,Mid-Day Market Update: Crude Oil Down Over 5%; Checkmate Pharmaceuticals Shares Spike Higher,Benzinga,/news/stocks/mid-day-market-update-crud-oil-down-over-5-checkmate-pharmaceuticals-shares-spike-higher-1031364910,negative,0.7409906387329102
4/19/2022 8:41:10 PM,Mid-Afternoon Market Update: Nasdaq Surges 200 Points; Dentsply Sirona Shares Plunge,Benzinga,/news/stocks/mid-afternoon-market-update-nasdaq-surges-200-points-dentsply-sirona-shares-plunge-1031365143,positive,0.8773632645606995
4/20/2022 9:03:27 AM,"Alabama reaches $276M settlement with J&J, McKesson, Endo over opioid claims - Waff",Seeking Alpha,https://seekingalpha.com/news/3824600-alabama-reaches-276m-settlement-with-jj-mckesson-endo-over-opioid-claims-waff?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.47749003767967224
4/20/2022 5:03:06 PM,Bank of America is cautious on life sciences companies ahead of earnings,Seeking Alpha,https://seekingalpha.com/news/3824851-bank-of-america-is-cautious-on-life-sciences-companies-ahead-of-earnings?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6708788871765137
4/20/2022 6:42:37 PM,Novavax has plunged amid falling demand for COVID vaccines. Is it time to buy?,Seeking Alpha,https://seekingalpha.com/news/3824544-novavax-has-plunged-amid-falling-demand-for-covid-vaccines-is-it-time-to-buy-pandemic?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8309868574142456
4/20/2022 9:51:56 PM,"JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters",Benzinga,/news/stocks/jnj-mckesson-endo-settle-275m-opioid-claims-with-alabama-reuters-1031369258,neutral,0.9004382491111755
4/20/2022 10:30:00 PM,Johnson & Johnson to Participate in the UBS Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-ubs-global-healthcare-conference-1031369405,neutral,0.7695388197898865
4/22/2022 4:58:09 PM,Intuitive Surgical sheds over 10% most in over two years despite earnings beat,Seeking Alpha,https://seekingalpha.com/news/3825875-isrg-stock-plunges-despite-earnings-beat?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9702205061912537
4/25/2022 1:30:00 PM,"Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance (AMR)",PR Newswire,/news/stocks/johnson-johnson-launches-next-satellite-center-for-global-health-discovery-at-holistic-drug-discovery-and-development-centre-university-of-cape-town-focused-on-antimicrobial-resistance-amr-1031379719,neutral,0.5379602313041687
4/25/2022 10:11:22 PM,"San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters",Benzinga,/news/stocks/san-francisco-to-start-opioid-epidemic-trial-against-teva-walgreen-reuters-1031381415,neutral,0.8948364853858948
4/26/2022 10:16:16 AM,3 Dividend Stocks for Value Investors Seeking Regular Income,InvestorPlace,/news/stocks/dividend-stocks-investors-seeking-income-1031384022,neutral,0.9316470623016357
4/26/2022 12:06:10 PM,Novavax price target lowered at B. Riley amid demand uncertainty for COVID-19 shots,Seeking Alpha,https://seekingalpha.com/news/3826692-nvax-stock-lower-as-b-riley-cuts-target-amid-uncertainty-for-covid-19-shots?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8622010350227356
4/28/2022 10:15:22 AM,7 Long-Term Stocks to Buy for a Robust Retirement,InvestorPlace,/news/stocks/long-term-stocks-7-to-buy-for-a-robust-retirement-1031396460,positive,0.7817786931991577
4/28/2022 2:13:40 PM,J&J seeks approval of Zytiga/Zejula combination for prostate cancer to EMA,Seeking Alpha,https://seekingalpha.com/news/3828664-johnson-johnson-janssen-seeks-approval-of-zytiga-zejula-combination-for-prostate-cancer-to-ema?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8659051060676575
4/29/2022 9:05:06 PM,Emergent BioSolutions Suspends CDMO Guidance As It Awaits Clarity On COVID-19 Vaccine Requirements,Benzinga,/news/stocks/emergent-biosolutions-suspends-cdmo-guidance-as-it-awaits-clarity-on-covid-19-vaccine-requirements-1031403521,negative,0.9262125492095947
5/2/2022 9:34:31 AM,J&J stockholders reject proposal to discontinue global sales of baby powder,Seeking Alpha,https://seekingalpha.com/news/3829831-jj-stockholders-reject-proposal-to-discontinue-global-sales-of-baby-powder?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7449491024017334
5/2/2022 3:56:44 PM,First COVID-19 vaccine plant in Africa at risk of closure with no orders,Seeking Alpha,https://seekingalpha.com/news/3830207-aspen-covid-19-vaccine-plant-at-risk-of-closure-with-no-orders?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8862282633781433
5/2/2022 7:55:14 PM,It Pays to Be Greedy,InvestorPlace,/news/stocks/it-pays-to-be-greedy-1031410830,neutral,0.9091590642929077
5/2/2022 10:30:00 PM,Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-bernstein-38th-annual-strategic-decisions-conference-1031410351,neutral,0.8181660771369934
5/3/2022 11:32:50 PM,3 Mighty Mutual Funds to Buy for Q2,InvestorPlace,/news/stocks/3-mighty-mutual-funds-to-buy-for-q2-1031415970,neutral,0.9155589938163757
5/5/2022 10:39:18 AM,What ETF Is Best? 7 Great Funds to Consider.,InvestorPlace,/news/stocks/what-etf-is-best-7-great-funds-to-consider-1031424937,neutral,0.9087047576904297
5/5/2022 11:33:44 AM,J&J files suit against drug-benefit provider over use of copay assistance program - WSJ,Seeking Alpha,https://seekingalpha.com/news/3833202-jj-files-suit-against-drug-benefit-provider-over-use-of-copay-assistance-program-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9036819934844971
5/5/2022 5:46:53 PM,COVID-19 Omicron variant is as severe as previous variants - study,Seeking Alpha,https://seekingalpha.com/news/3833571-covid-19-omicron-variant-is-as-severe-as-previous-variants-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5023320317268372
5/5/2022 9:49:27 PM,FDA limits use of J&J COVID-19 vaccine due to risk of blood clot,Seeking Alpha,https://seekingalpha.com/news/3834009-fda-limits-use-of-jj-covid-19-vaccine-due-to-risk-of-blood-clot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5108435153961182
5/6/2022 5:24:20 AM,FDA Limits Use Of Johnson & Johnson COVID-19 Vaccine Due To Blood Clot Risk ,RTTNews,/news/stocks/fda-limits-use-of-johnson-johnson-covid-19-vaccine-due-to-blood-clot-risk-1031428218,negative,0.6692811250686646
5/6/2022 2:50:26 PM,"Cramer Gives His Opinion On CoreCivic, SGHC And More",Benzinga,/news/stocks/cramer-gives-his-opinion-on-corecivic-sghc-and-more-1031430970,neutral,0.9499825239181519
5/6/2022 2:54:29 PM,"The Daily Biotech Pulse: Limited Use Of JNJ's COVID-19 Shot, Myovant-Pfizer's Relugolix Application Delayed, Gain Therapeutics' Parkinson's Data",Benzinga,/news/stocks/the-daily-biotech-pulse-limited-use-of-jnj-s-covid-19-shot-myovant-pfizer-s-relugolix-application-delayed-gain-therapeutics-parkinson-s-data-1031431013,negative,0.9153578281402588
5/9/2022 11:10:25 AM,4 Blue-Chip Stocks to Buy for May 2022,InvestorPlace,/news/stocks/4-blue-chip-stocks-to-buy-for-may-2022-1031436095,neutral,0.9117697477340698
5/10/2022 4:20:07 PM,More Emergent BioSolutions produced COVID vaccines destroyed than previously reported,Seeking Alpha,https://seekingalpha.com/news/3836074-more-emergent-biosolutions-produced-covid-vaccines-destroyed-than-previously-reported?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.45733577013015747
5/11/2022 11:17:13 AM,Johnson & Johnson appoints CEO and CFO for consumer spinoff,Seeking Alpha,https://seekingalpha.com/news/3836685-johnson-johnson-appoints-ceo-and-cfo-for-new-consumer-spinoff?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8280388116836548
5/11/2022 12:30:00 PM,Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company,PR Newswire,/news/stocks/johnson-johnson-appoints-thibaut-mongon-as-ceo-designate-of-planned-new-consumer-health-company-1031447377,neutral,0.9239776134490967
5/11/2022 12:53:04 PM,"Johnson & Johnson Names CEO, CFO Designates Of New Consumer Health Company ",RTTNews,/news/stocks/johnson-johnson-names-ceo-cfo-designates-of-new-consumer-health-company-1031447454,neutral,0.9015932083129883
5/11/2022 2:19:09 PM,Novanta raised to Outperform at William Blair on valuation,Seeking Alpha,https://seekingalpha.com/news/3836853-novt-stock-gains-after-first-bullish-view-on-wall-street?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.847324550151825
5/11/2022 10:06:01 PM,Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco,Benzinga,/news/stocks/almost-400m-covid-19-vaccine-doses-lost-due-to-emergent-s-baltimore-plant-fiasco-1031449913,negative,0.9734439849853516
5/12/2022 2:14:54 PM,Federal flags to fly at half-staff to mark one million COVID deaths,Seeking Alpha,https://seekingalpha.com/news/3837849-federal-flags-to-fly-at-half-staff-to-mark-one-million-covid-deaths?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9106364250183105
5/12/2022 9:36:40 PM,Read Why HC Wainwright Lowered Price Target On This Small Biotech Stock,Benzinga,/news/stocks/read-why-hc-wainwright-lowered-price-target-on-this-small-biotech-stock-1031455130,neutral,0.7953481078147888
5/12/2022 10:30:00 PM,Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-goldman-sachs-43rd-annual-global-healthcare-conference-1031455370,neutral,0.7441597580909729
5/14/2022 10:00:15 AM,Johnson & Johnson Stock: A Rare Bright Spot in the Market,InvestorPlace,/news/stocks/jnj-stock-a-rare-bright-spot-in-the-market-1031459931,positive,0.8548755049705505
5/16/2022 3:55:45 PM,"Dalio's Bridgewater invests in Berkshire Hathaway, exits Tesla in Q1",Seeking Alpha,https://seekingalpha.com/news/3839310-dalios-bridgewater-invests-in-berkshire-hathaway-exits-tesla-in-q1?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8687259554862976
5/16/2022 8:24:57 PM,Inflation May Have Peaked: What to Do Now,InvestorPlace,/news/stocks/inflation-may-have-peaked-what-to-do-now-1031466390,neutral,0.5189405083656311
5/16/2022 9:02:02 PM,"Investing Mistakes Were Made on Wall Street, and Now Opportunity Abounds",InvestorPlace,/news/stocks/investing-mistakes-were-made-on-wall-street-and-now-opportunity-abounds-1031466055,neutral,0.5214936137199402
5/17/2022 11:26:03 AM,"J&J, BARDA program gives a spot to Australian antiviral nasal spray developer ENA Respiratory",Seeking Alpha,https://seekingalpha.com/news/3839858-jj-barda-program-gives-a-spot-to-australian-antiviral-nasal-spray-developer-ena-respiratory?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8552398681640625
5/17/2022 4:42:38 PM,New York City reaches ‚Äúhigh‚Äù COVID alert level; indoor masking urged,Seeking Alpha,https://seekingalpha.com/news/3840091-new-york-city-reaches-high-covid-alert-level-indoor-masking-urged?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6301849484443665
5/17/2022 5:15:04 PM,8 Analysts Have This to Say About Johnson & Johnson,Benzinga,/news/stocks/8-analysts-have-this-to-say-about-johnson-johnson-1031469249,neutral,0.9010958671569824
5/18/2022 10:00:43 PM,5 Stocks to Buy for the Coming Recession,InvestorPlace,/news/stocks/5-stocks-to-buy-for-the-coming-recession-1031473821,neutral,0.8992704749107361
5/19/2022 12:43:36 AM,Sector Rotation And 9 Stocks To Watch During A Recession,Benzinga,/news/stocks/sector-rotation-and-9-stocks-to-watch-during-a-recession-1031473832,neutral,0.9143869876861572
5/19/2022 2:34:59 PM,J&J touts Tremfya in-vitro studies differentiating it from AbbVie's Skyrizi,Seeking Alpha,https://seekingalpha.com/news/3840978-johnson-johnson-janssen-touts-tremfya-in-vitro-studies-as-differentiating-it-from-abbvie-skyrizi?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5675074458122253
5/20/2022 1:32:01 PM,ImmixBio surges on mice data for lead candidate in connective tissue cancer,Seeking Alpha,https://seekingalpha.com/news/3841363-immx-stock-soars-on-mice-data-for-lead-candidate-in-connective-tissue-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7588210105895996
5/20/2022 3:02:43 PM,ImmixBio: IMX-110 Shows Improved Survival In Connective Tissue Cancer Soft Tissue Sarcoma Mice Study ,RTTNews,/news/stocks/immixbio-imx-110-shows-improved-survival-in-connective-tissue-cancer-soft-tissue-sarcoma-mice-study-1031478642,positive,0.9560171961784363
5/20/2022 6:19:05 PM,Is Johnson & Johnson a buy amid rising COVID cases and a shift towards defensive stocks?,Seeking Alpha,https://seekingalpha.com/news/3841381-covid-cases-rise-healthcare-defends-against-downturns-so-is-johnson-johnson-a-buy?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6821420192718506
5/23/2022 6:31:20 PM,"Amid Monkeypox Outbreak, This 3X Leveraged ETF Provides Exposure To Health Sector: What To Watch",Benzinga,/news/etf/amid-monkeypox-outbreak-this-3x-leveraged-etf-provides-exposure-to-health-sector-what-to-watch-1031482614,neutral,0.9194397926330566
5/24/2022 1:29:05 PM,COVID-19 sales boom for vaccine and drug makers might be over - analysts,Seeking Alpha,https://seekingalpha.com/news/3842211-covid-19-sales-boom-for-vaccine-and-drug-makers-might-be-over?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.39463916420936584
5/24/2022 1:36:13 PM,Alvotech's biosimilar candidate AVT04 shows therapeutic equivalence to J&J's Stelara,Seeking Alpha,https://seekingalpha.com/news/3842220-alvotechs-biosimilar-candidate-avt04-shows-therapeutic-equivalence-to-jjs-stelara?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.879271388053894
5/24/2022 8:22:39 PM,"4 Top Stock Trades for Wednesday: FB, JNJ, CCL, NCLH",InvestorPlace,/news/stocks/4-top-stock-trades-for-wednesday-fb-jnj-ccl-nclh-1031486514,neutral,0.9281865954399109
5/24/2022 9:56:54 PM,J&J's Janssen presents new data at Digestive Disease Week for Tremfya in Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/3842456-jjs-janssen-presents-new-data-at-digestive-disease-week-for-tremfya-in-crohns-disease?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8237860202789307
5/25/2022 7:57:03 PM,"Long COVID risk drops only slightly after vaccination, large study shows",Seeking Alpha,https://seekingalpha.com/news/3842802-long-covid-risk-drops-only-slightly-after-vaccination-large-study-shows?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6331464648246765
5/27/2022 3:31:11 PM,"Boston Scientific upgraded to buy at Needham on new products, potential M&A target",Seeking Alpha,https://seekingalpha.com/news/3843519-boston-scientific-upgraded-to-buy-at-needham-on-new-products-potential-ma-target?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7786822319030762
5/31/2022 2:49:12 PM,7 Safe Dividend Stocks With High Yields to Buy Now,InvestorPlace,/news/stocks/7-safe-dividend-stocks-with-high-yields-to-buy-now-1031498852,neutral,0.8103081583976746
5/31/2022 6:12:38 PM,3 Stocks to Buy if You Think a Recession is Imminent,InvestorPlace,/news/stocks/3-stocks-to-buy-if-you-think-a-recession-is-imminent-1031499549,neutral,0.7947942018508911
6/1/2022 10:15:24 AM,3 Biotech Stocks to Buy Before They Boom,InvestorPlace,/news/stocks/3-biotech-stocks-to-buy-before-they-boom-1031501085,neutral,0.9286603927612305
6/1/2022 1:18:29 PM,7 Stocks to Buy to Avoid Being Mauled by a Bear Market,InvestorPlace,/news/stocks/7-stocks-to-buy-to-avoid-being-mauled-by-a-bear-market-1031502160,neutral,0.8878899216651917
6/1/2022 1:51:49 PM,Johnson & Johnson's Tremfya demonstrates long-term benefit in psoriatric arthritis,Seeking Alpha,https://seekingalpha.com/news/3844409-johnson-johnson-janssen-tremfya-demonstrates-long-term-benefit-in-psoriatric-arthritis?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9507307410240173
6/1/2022 1:52:13 PM,Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off,Benzinga,/news/stocks/pfizer-to-quit-gsk-s-consumer-health-jv-following-its-spin-off-1031501411,negative,0.6700360774993896
6/1/2022 4:13:50 PM,Legend Biotech clinical hold on CAR-T lymphoma candidate lifted by FDA,Seeking Alpha,https://seekingalpha.com/news/3844471-legend-biotech-clinical-hold-on-car-t-lymphoma-candidate-lifted-by-fda?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6795568466186523
6/2/2022 4:25:53 PM,Johnson & Johnson arthritis drug leads to clinical improvement in hospitalized COVID-19,Seeking Alpha,https://seekingalpha.com/news/3845099-johnson-johnson-arthritis-drug-leads-to-clinical-improvement-in-hospitalized-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.950898289680481
6/2/2022 9:00:50 PM,3 Value Stocks That Could 2x in a Recession,InvestorPlace,/news/stocks/3-value-stocks-that-could-2x-in-a-recession-1031506774,neutral,0.921826183795929
6/3/2022 3:19:26 PM,"J&J/AbbVie's Imbruvica 'significantly' cuts risk of disease progression in rare lymphoma, in trial",Seeking Alpha,https://seekingalpha.com/news/3845546-jjabbvies-imbruvica-significantly-cuts-risk-of-disease-progression-in-rare-lymphoma-in-trial?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9347519278526306
6/6/2022 10:48:57 AM,Curis gains over 20% as majority of patients respond to blood cancer drug,Seeking Alpha,https://seekingalpha.com/news/3845814-cris-stock-gains-as-majority-of-patients-respond-to-blood-cancer-drug?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9540716409683228
6/6/2022 2:57:39 PM,Jim Cramer Prefers This Oil Stock Over Occidental Petroleum,Benzinga,/news/stocks/jim-cramer-prefers-this-oil-stock-over-occidental-petroleum-1031510963,neutral,0.9195356965065002
6/6/2022 3:27:21 PM,J&J's Carvykti demonstrates durable response in heavily pretreated multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3845973-johnson-johnson-carvykti-demonstrates-durable-response-in-heavily-pretreated-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.951839029788971
6/6/2022 4:14:08 PM,"Benzinga's Premarket Brief On Trending Tickers: Amazon, Alibaba, DiDi, Solaredge, And More",Benzinga,/news/stocks/benzinga-s-premarket-brief-on-trending-tickers-amazon-alibaba-didi-solaredge-and-more-1031511219,neutral,0.9456880688667297
6/6/2022 4:55:31 PM,"Johnson & Johnson breached vaccine contract, Emergent says",Seeking Alpha,https://seekingalpha.com/news/3846012-ebs-stock-slips-after-announcing-johnson--johnson-breached-vaccine-contract?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8976988792419434
6/6/2022 5:20:10 PM,Emergent Bio Says Johnson & Johnson Breached COVID-19 Vaccine Contract,Benzinga,/news/stocks/emergent-bio-says-johnson-johnson-breached-covid-19-vaccine-contract-1031511342,negative,0.9409345984458923
6/7/2022 1:35:11 PM,J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement,Benzinga,/news/stocks/j-j-serves-notice-to-emergent-for-terminating-covid-19-shot-contract-as-two-accuse-each-other-of-breach-of-agreement-1031513069,negative,0.956477701663971
6/7/2022 2:07:41 PM,"Morning Brief: Top Financial Stories Dominating on Tuesday, June 7",Benzinga,/news/stocks/morning-brief-top-financial-stories-dominating-on-tuesday-june-7-1031513234,neutral,0.9139137864112854
6/7/2022 4:24:00 PM,Johnson & Johnson posts interim data for cancer drug to indicate 29% overall response,Seeking Alpha,https://seekingalpha.com/news/3846371-jnj-posts-interim-data-for-cancer-drug-to-indicate-29-overall-response?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.41091451048851013
6/8/2022 10:29:23 AM,7 Dividend Stocks to Buy for a Rich Retirement,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-for-a-rich-retirement-mcd-wmt-cat-jnj-gpc-adp-ko-1031515667,neutral,0.8789957165718079
6/8/2022 2:00:00 PM,Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ESG Priorities and Progress Against Public Commitments,PR Newswire,/news/stocks/johnson-johnson-releases-2021-health-for-humanity-report-highlighting-performance-on-esg-priorities-and-progress-against-public-commitments-1031516039,positive,0.8726730346679688
6/8/2022 3:06:22 PM,NVAX Stock Price Predictions: Where Will Novavax Go From Here?,InvestorPlace,/news/stocks/nvax-stock-price-predictions-where-will-novavax-go-from-here-1031516951,neutral,0.9283915162086487
6/9/2022 11:48:19 AM,Novavax slips amid concerns over delay for FDA decision on COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3847111-nvax-stock-slips-amid-concerns-over-delay-for-fda-decision-on-covid-19-shot?utm_source=businessinsider&utm_medium=referral,negative,0.9470019936561584
6/9/2022 10:10:03 PM,Genmab seeks $405M award under new arbitration with J&J over cancer drug,Seeking Alpha,https://seekingalpha.com/news/3847542-genmab-seeks-405m-award-under-new-arbitration-with-jj-over-cancer-drug?utm_source=businessinsider&utm_medium=referral,positive,0.8692795634269714
6/10/2022 2:57:48 PM,7 Great ETFs to Buy Now for Momentum in Q2,InvestorPlace,/news/stocks/7-great-etfs-to-buy-now-for-momentum-in-q2-1031522477,positive,0.6736832857131958
6/13/2022 5:16:00 PM,EU public health agency warns of probable increase in COVID cases in coming weeks,Seeking Alpha,https://seekingalpha.com/news/3848128-eu-public-health-agency-warns-of-probable-increase-in-covid-cases-in-coming-weeks?utm_source=businessinsider&utm_medium=referral,negative,0.9631182551383972
6/14/2022 1:28:36 PM,Bristol Myers tops S&P 500 with largest intangible adjustment in 2021,Seeking Alpha,https://seekingalpha.com/news/3848429-bristol-myers-tops-sp-500-with-largest-intangible-adjustment-in-2021?utm_source=businessinsider&utm_medium=referral,positive,0.8711013197898865
6/14/2022 1:57:38 PM,Wells Fargo unveils its recession stock portfolio,Seeking Alpha,https://seekingalpha.com/news/3848418-wells-fargo-unveils-its-recession-stock-portfolio?utm_source=businessinsider&utm_medium=referral,neutral,0.9255277514457703
6/14/2022 6:37:16 PM,"Newer, more contagious Omicron subvariants gaining traction in U.S.",Seeking Alpha,https://seekingalpha.com/news/3848543-newer-more-contagious-omicron-subvariants-gaining-traction-in-us?utm_source=businessinsider&utm_medium=referral,positive,0.7365714907646179
6/14/2022 6:47:03 PM,"Klobuchar, Porter want investigation into Bristol-Myers Squibb, Pfizer, Janssen price hikes",Seeking Alpha,https://seekingalpha.com/news/3848541-klobuchar-porter-want-investigation-bristol-myers-squibb-pfizer-janssen-price-hikes-stat?utm_source=businessinsider&utm_medium=referral,neutral,0.908916711807251
6/15/2022 10:31:43 AM,3 Super-Safe Dividend Stocks to Buy,InvestorPlace,/news/stocks/3-super-safe-dividend-stocks-to-buy-fdx-jnj-low-1031530085,neutral,0.8627341389656067
6/15/2022 6:58:44 PM,Dr. Fauci tests positive for COVID-19,Seeking Alpha,https://seekingalpha.com/news/3848965-dr-fauci-tests-positive-for-covid-19?utm_source=businessinsider&utm_medium=referral,neutral,0.8345177173614502
6/17/2022 7:00:44 PM,"Catalyst watch: FedEx earnings, Revlon drama and huge Polestar SPAC deal goes to a vote",Seeking Alpha,https://seekingalpha.com/news/3849682-catalyst-watch-fedex-earnings-revlon-drama-and-huge-polestar-spac-deal-goes-to-a-vote?utm_source=businessinsider&utm_medium=referral,neutral,0.8127104640007019
6/17/2022 8:24:28 PM,Legend Biotech Shares Move Higher After Bullish BMO Pitch,Benzinga,/news/stocks/legend-biotech-shares-move-higher-after-bullish-bmo-pitch-1031536189,positive,0.8915047645568848
6/20/2022 10:00:07 AM,"7 Stocks to Buy If You Have $1,000 to Invest",InvestorPlace,/news/stocks/7-stocks-to-buy-if-you-have-1000-to-invest-1031537752,neutral,0.938369631767273
6/21/2022 2:00:00 AM,Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific at Duke-NUS to Advance Dengue Research,PR Newswire,/news/stocks/johnson-johnson-opens-first-satellite-center-for-global-health-discovery-in-asia-pacific-at-duke-nus-to-advance-dengue-research-1031538632,neutral,0.5898447632789612
6/21/2022 3:18:22 AM,J&J Opens Satellite Center For Global Health Discovery In Asia Pacific To Advance Dengue Research ,RTTNews,/news/stocks/j-j-opens-satellite-center-for-global-health-discovery-in-asia-pacific-to-advance-dengue-research-1031538650,neutral,0.533249020576477
6/21/2022 2:45:52 PM,"A '70s style recession would push S&P 500 to 2,525 - SocGen",Seeking Alpha,https://seekingalpha.com/news/3850076-a-70s-style-recession-would-push-sp-500-to-2525-socgen?utm_source=businessinsider&utm_medium=referral,negative,0.9232693910598755
6/22/2022 11:12:49 AM,Bear Market 2022: Is There Anything Left to Invest In?,InvestorPlace,/news/stocks/bear-market-2022-is-there-anything-left-to-invest-in-1031542804,neutral,0.9250609278678894
6/22/2022 12:15:20 PM,Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money,InvestorPlace,/news/stocks/economic-hurricane-ahead-7-profitable-places-to-hide-your-money-1031543188,neutral,0.8941921591758728
6/23/2022 10:46:58 AM,7 Retirement Stocks to Buy After Age 30,InvestorPlace,/news/stocks/7-retirement-stocks-to-buy-after-age-30-v-deo-ecl-amt-nke-mmm-jnj-1031545576,neutral,0.9380730986595154
6/23/2022 9:03:48 PM,Why Did HC Wainwright Downgrade Addex Therapeutics,Benzinga,/news/stocks/why-did-hc-wainwright-downgrade-addex-therapeutics-1031547234,neutral,0.8334774374961853
6/24/2022 10:46:13 AM,7 Large-Cap Stocks to Buy After the Next Big Correction,InvestorPlace,/news/stocks/7-large-cap-stocks-to-buy-after-the-next-big-correction-ko-tsla-intc-jnj-cvx-cost-cd-1031548398,neutral,0.8699837923049927
6/24/2022 2:01:11 PM,EMA panel recommends extending indication for J&J's blood cancer medicine Imbruvica,Seeking Alpha,https://seekingalpha.com/news/3851592-ema-panel-recommends-extending-indication-for-jjs-blood-cancer-medicine-imbruvica?utm_source=businessinsider&utm_medium=referral,neutral,0.7502485513687134
6/28/2022 9:08:38 AM,"AmerisourceBergen, McKesson, Cardinal to pay Oklahoma $250M to resolve opioid claims",Seeking Alpha,https://seekingalpha.com/news/3852297-amerisourcebergen-mckesson-cardinal-to-pay-oklahoma-250m-to-resolve-opioid-claims?utm_source=businessinsider&utm_medium=referral,positive,0.6288777589797974
6/28/2022 1:42:09 PM,"Enovis initiated at Argus with a hold citing EPS growth, competition",Seeking Alpha,https://seekingalpha.com/news/3852453-enovis-initiated-at-argus-with-a-hold-citing-eps-growth-competition?utm_source=businessinsider&utm_medium=referral,neutral,0.7556706666946411
6/28/2022 8:28:42 PM,MeiraGTx Posts Encouraging Gene Therapy Data From Eye Disorder Trial,Benzinga,/news/stocks/meiragtx-posts-encouraging-gene-therapy-data-from-eye-disorder-trial-1031555651,positive,0.9504925608634949
6/29/2022 10:30:13 AM,Novavax Stock Is in Prime Position For Speculation,InvestorPlace,/news/stocks/nvax-stock-is-in-prime-position-for-speculation-1031557041,neutral,0.7913815975189209
6/29/2022 1:55:26 PM,J&J multiple myeloma candidate for talquetamab granted Breakthrough Therapy Designation,Seeking Alpha,https://seekingalpha.com/news/3852832-johnson-johnson-janssen-multiple-myeloma-candidate-for-talquetamab-granted-breakthrough-therapy-designation?utm_source=businessinsider&utm_medium=referral,positive,0.7745898962020874
6/30/2022 2:41:30 PM,FDA requests manufacturers to update vaccines for latest Omicron subvariants,Seeking Alpha,https://seekingalpha.com/news/3853297-fda-requests-manufacturers-to-update-vaccines-for-latest-omicron-subvariants?utm_source=businessinsider&utm_medium=referral,neutral,0.8827484250068665
7/1/2022 4:34:01 PM,What Companies Will Pay for Abortion Travel?,InvestorPlace,/news/stocks/what-companies-will-pay-for-abortion-travel-1031563754,neutral,0.9037445783615112
7/1/2022 10:45:50 PM,"Only 8 Of The 30 Dow Jones Stocks Were Positive In The First Half Of 2022: Chevron Leads, But Who Else Was Up?",Benzinga,/news/etf/only-8-of-the-30-dow-jones-stocks-were-positive-in-the-first-half-of-2022-chevron-leads-but-who-else-was-up-1031564229,neutral,0.862562894821167
7/2/2022 6:00:00 PM,"As amyloid-targeting therapies for Alzheimer's fail, where might success lie?",Seeking Alpha,https://seekingalpha.com/news/3853361-as-amyloid-targeting-therapies-for-alzheimers-fail-where-might-success-lie?utm_source=businessinsider&utm_medium=referral,neutral,0.8673626780509949
7/5/2022 9:47:06 AM,US judge rules in favor of drug distributors in West Virginia county opioid suit - AP,Seeking Alpha,https://seekingalpha.com/news/3854023-us-judge-rules-in-favor-of-drug-distributors-in-west-virginia-county-opioid-suit-ap?utm_source=businessinsider&utm_medium=referral,neutral,0.5534678101539612
7/5/2022 3:25:45 PM,Geron extends winning streak to reach 52-week high,Seeking Alpha,https://seekingalpha.com/news/3854229-gern-stock-extends-wining-streak-to-reach-52-week-high?utm_source=businessinsider&utm_medium=referral,positive,0.888187050819397
7/8/2022 2:42:25 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1031575494,neutral,0.7854138612747192
7/8/2022 2:58:24 PM,EMA looking into neurodevelopmental risks associated with J&J's seizure med Topamax,Seeking Alpha,https://seekingalpha.com/news/3855388-ema-looking-into-neurodevelopmental-risks-associated-with-johnson-jonhson-seizure-med-topamax?utm_source=businessinsider&utm_medium=referral,neutral,0.8624535799026489
7/11/2022 10:25:17 AM,EU recommends second COVID boosters for ages 60-79,Seeking Alpha,https://seekingalpha.com/news/3855582-eu-recommends-second-covid-boosters-for-ages-60-79?utm_source=businessinsider&utm_medium=referral,neutral,0.8949840664863586
7/14/2022 2:40:41 PM,What Is Going on With Novavax (NVAX) Stock Today?,InvestorPlace,/news/stocks/what-is-going-on-with-novavax-nvax-stock-today-2-1031588212,negative,0.63912034034729
7/14/2022 11:40:15 PM,7 Best S&P 500 Stocks to Buy in July,InvestorPlace,/news/stocks/best-sp-500-stocks-1031588965,neutral,0.8335539698600769
7/15/2022 12:15:59 PM,7 Best Long-Term Dividend Stocks to Buy Right Now,InvestorPlace,/news/stocks/best-long-term-dividend-stocks-1031590160,neutral,0.922290027141571
7/18/2022 10:57:31 AM,Top sticky stocks most immune to big earnings misses and beats,Seeking Alpha,https://seekingalpha.com/news/3857382-top-sticky-stocks-most-immune-to-big-earnings-misses-and-beats?utm_source=businessinsider&utm_medium=referral,negative,0.696194052696228
7/18/2022 2:31:54 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3857597-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral,positive,0.8660829067230225
7/18/2022 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-q2-earnings-preview-1031594009,neutral,0.9335330724716187
7/18/2022 4:34:51 PM,J&J to report Q2 results amid several macro factors that threaten to diminish near-term growth,Seeking Alpha,https://seekingalpha.com/news/3857655-jj-to-report-q2-result-amid-several-macro-factors-that-threaten-to-diminish-near-term-growth?utm_source=businessinsider&utm_medium=referral,negative,0.8223949074745178
7/18/2022 6:58:43 PM,Top pharma lobby says R&D spending reached a peak in 2021,Seeking Alpha,https://seekingalpha.com/news/3857699-top-pharma-lobby-says-rd-spending-reached-a-peak-in-2021?utm_source=businessinsider&utm_medium=referral,positive,0.9346282482147217
7/19/2022 9:36:04 AM,"Netflix, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/netflix-johnson-johnson-and-3-stocks-to-watch-heading-into-tuesday-1031596292,neutral,0.9321652054786682
7/19/2022 10:26:44 AM,"Johnson & Johnson beats on earnings, maintains FY22 Adj. op. EPS and op. sales, cuts FY22 revenue and Adj. EPS guidance",Seeking Alpha,https://seekingalpha.com/news/3857915-johnson-amp-johnson-non-gaap-eps-of-259-beats-by-004-revenue-of-24b-beats-by-180m-cuts-fy22-guidance?utm_source=businessinsider&utm_medium=referral,negative,0.9676589369773865
7/19/2022 11:00:27 AM,Johnson & Johnson cuts 2022 guidance as MedTech underperforms in 2Q,Seeking Alpha,https://seekingalpha.com/news/3857931-jnj-stock-slips-as-company-cuts-2022-guidance?utm_source=businessinsider&utm_medium=referral,negative,0.9692668318748474
7/19/2022 11:05:42 AM,Genmab reports Q2 worldwide net sales of DARZALEX $1.99B,Seeking Alpha,https://seekingalpha.com/news/3857936-genmab-reports-q2-worldwide-net-sales-of-darzalex-199b?utm_source=businessinsider&utm_medium=referral,neutral,0.8929373621940613
7/19/2022 12:06:34 PM,"US Stock Futures Higher Ahead of J&J, Netflix Earnings",Benzinga,/news/stocks/us-stock-futures-higher-ahead-of-j-j-netflix-earnings-1031596560,positive,0.6534056663513184
7/19/2022 12:35:43 PM,"Johnson & Johnson Q2 Profit Decreases, but beats estimates",RTTNews,/news/stocks/johnson-johnson-q2-profit-decreases-but-beats-estimates-1031596637,negative,0.972167432308197
7/19/2022 3:12:33 PM,"The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-tentatively-approves-avadel-s-narcolepsy-drug-european-approval-broadens-astrazeneca-s-enhertu-in-breast-cancer-pharma-giants-earnings-1031597418,positive,0.8786946535110474
7/19/2022 6:18:59 PM,Dow Surges 500 Points; Johnson & Johnson Lowers Guidance,Benzinga,/news/stocks/dow-surges-500-points-johnson-johnson-lowers-guidance-1031598024,negative,0.4752216637134552
7/19/2022 7:06:34 PM,2 Big Reasons Novavax (NVAX) Stock Is Shooting Higher Today,InvestorPlace,/news/stocks/2-big-reasons-novavax-nvax-stock-is-shooting-higher-today-1031598337,positive,0.9454616904258728
7/19/2022 8:19:52 PM,Johnson & Johnson executive chairman elected to JPMorgan Chase board,Seeking Alpha,https://seekingalpha.com/news/3858273-johnson-johnson-executive-chairman-elected-to-jpmorgan-chase-board?utm_source=businessinsider&utm_medium=referral,neutral,0.8991519212722778
7/19/2022 8:30:26 PM,Nasdaq Rises More Than 300 Points; Crude Oil Moves Higher,Benzinga,/news/stocks/nasdaq-rises-more-than-300-points-crude-oil-moves-higher-1031598272,positive,0.8984714150428772
7/20/2022 10:30:37 AM,7 Best Stocks for College Graduates,InvestorPlace,/news/stocks/best-stocks-for-college-graduates-1031600455,neutral,0.8849568963050842
7/20/2022 1:41:28 PM,The Valens Company Nominates Independent Director To Board Of Directors,Benzinga,/news/stocks/the-valens-company-nominates-independent-director-to-board-of-directors-1031600634,neutral,0.9482685923576355
7/20/2022 1:46:13 PM,JP Morgan Calls For Coca-Cola to $70: Here Are 4 Other Price Target Changes for Wednesday,Benzinga,/news/stocks/jp-morgan-calls-for-coca-cola-to-70-here-are-4-other-price-target-changes-for-wednesday-1031600653,neutral,0.9247291088104248
7/20/2022 4:18:23 PM,Arcellx named new buy at Canaccord Genuity on multiple myeloma candidate,Seeking Alpha,https://seekingalpha.com/news/3858614-arcellx-named-new-buy-at-canaccord-genuity-on-multiple-myeloma-candidate?utm_source=businessinsider&utm_medium=referral,neutral,0.7260497212409973
7/20/2022 6:02:48 PM,4 Analysts Takeaways From Johnson & Johnson's Quarterly Results: What Investors Need To Know,Benzinga,/news/stocks/4-analysts-takeaways-from-johnson-johnson-s-quarterly-results-what-investors-need-to-know-1031601822,neutral,0.9131668210029602
7/22/2022 12:26:47 PM,J&J gets EMA panel nod for conditional approval of Tecvayli for blood cancer subtype,Seeking Alpha,https://seekingalpha.com/news/3859583-jj-gets-ema-panel-nod-for-conditional-approval-of-tecvayli-for-blood-cancer-subtype?utm_source=businessinsider&utm_medium=referral,positive,0.8599414825439453
7/22/2022 1:49:29 PM,7 Seriously Undervalued Retirement Stocks to Buy Now,InvestorPlace,/news/stocks/undervalued-retirement-stocks-1031607886,positive,0.45634421706199646
7/23/2022 8:15:00 PM,"Drug pricing legislation will affect biopharma revenue, but impact is manageable - RBC",Seeking Alpha,https://seekingalpha.com/news/3859761-drug-pricing-legislation-will-affect-biopharma-revenue-but-impact-is-manageable-rbc?utm_source=businessinsider&utm_medium=referral,neutral,0.8448387384414673
7/24/2022 4:00:31 PM,"Pfizer, Moderna to see sales decline for COVID shots before recovery",Seeking Alpha,https://seekingalpha.com/news/3859843-pfizer-moderna-to-see-sales-decline-for-covid-shots-before-recovery?utm_source=businessinsider&utm_medium=referral,negative,0.9530166387557983
7/25/2022 6:35:07 PM,Follow Nancy Pelosi and Watch These 8 Stocks That Lawmakers Are Buying,InvestorPlace,/news/stocks/follow-nancy-pelosi-and-watch-these-8-stocks-that-lawmakers-are-buying-1031612506,neutral,0.9443630576133728
7/26/2022 3:17:27 PM,JNJ Stock Alert: What to Know as Johnson & Johnson Releases Clinical Trial Data,InvestorPlace,/news/stocks/jnj-stock-alert-what-to-know-as-johnson-johnson-releases-clinical-trial-data-1031616136,neutral,0.9352126717567444
7/27/2022 2:06:05 AM,"Teva Pharmaceutical in $4.35B opioid settlement with states, Native American tribes",Seeking Alpha,https://seekingalpha.com/news/3861061-teva-pharmaceutical-in-435-opioid-settlement-with-states-native-american-tribes?utm_source=businessinsider&utm_medium=referral,positive,0.8210893273353577
7/27/2022 11:10:39 AM,7 Large-Cap Stocks to Buy on the Dip,InvestorPlace,/news/stocks/large-cap-stocks-to-buy-on-the-dip-1031619962,neutral,0.7422235012054443
7/27/2022 2:05:04 PM,"Jim Cramer Says This Stock Costs About $3, But 'If You Wait Long Enough' You Can Buy It For $2",Benzinga,/news/stocks/jim-cramer-says-this-stock-costs-about-3-but-if-you-wait-long-enough-you-can-buy-it-for-2-1031620221,neutral,0.9445028901100159
7/28/2022 4:37:49 PM,"Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate",Benzinga,/news/stocks/daily-biotech-pulse-gsk-s-kidney-disease-drug-approved-for-children-tonix-pharma-to-launch-monkeypox-vaccine-study-in-kenya-positive-effect-of-cyclerion-s-schizophrenia-candidate-1031626482,positive,0.8644790053367615
7/28/2022 8:20:28 PM,Senate Democrats propose $21B funding for next phase of COVID-19 response,Seeking Alpha,https://seekingalpha.com/news/3862718-senate-democrats-propose-21b-funding-for-next-phase-of-covid-19-response?utm_source=businessinsider&utm_medium=referral,positive,0.6786970496177673
7/29/2022 1:50:18 AM,Biden administration mulls updated booster rollout in September ‚Äì NYT,Seeking Alpha,https://seekingalpha.com/news/3862940-biden-administration-mulls-updated-booster-rollout-in-september-nyt?utm_source=businessinsider&utm_medium=referral,neutral,0.9154930710792542
7/31/2022 3:21:24 PM,Biotech Investors: August's Key PDUFA Catalysts You Must Know,Benzinga,/news/stocks/biotech-investors-august-s-key-pdufa-catalysts-you-must-know-1031631857,neutral,0.8776606917381287
8/1/2022 5:12:52 PM,Johnson & Johnson unit‚Äôs arthritis injection now indicated for children in U.S.,Seeking Alpha,https://seekingalpha.com/news/3863900-johnson-johnson-units-arthritis-injection-now-indicated-for-children-in-us?utm_source=businessinsider&utm_medium=referral,positive,0.612470805644989
8/1/2022 8:04:35 PM,Is Vanguard Dividend Appreciation ETF (VIG) A Strong ETF Right Now?,Benzinga,/news/stocks/is-vanguard-dividend-appreciation-etf-vig-a-strong-etf-right-now-1031636436,positive,0.5317437648773193
8/1/2022 11:23:06 PM,Emergent BioSolutions misses on top and bottom lines as it swings to quarterly loss,Seeking Alpha,https://seekingalpha.com/news/3864300-emergent-biosolutions-misses-on-top-and-bottom-lines-as-it-swings-to-quarterly-loss?utm_source=businessinsider&utm_medium=referral,negative,0.8896704912185669
8/2/2022 7:50:15 PM,"Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus",Benzinga,/news/stocks/emergent-biosolutions-posts-q2-loss-on-lower-sales-q3-forecasts-below-consensus-1031641002,negative,0.9742521047592163
8/9/2022 1:38:04 AM,The 3 Best Vanguard Funds to Buy in August,InvestorPlace,/news/stocks/best-vanguard-funds-1031663161,neutral,0.8945894241333008
8/9/2022 11:00:11 AM,3 Dividend Stocks to Buy to Beat Runaway Inflation,InvestorPlace,/news/stocks/dividend-stocks-to-buy-to-beat-runaway-inflation-1031665050,neutral,0.4956301748752594
8/9/2022 1:35:38 PM,Why Is Novavax (NVAX) Stock Plunging 30%?,InvestorPlace,/news/stocks/why-is-novavax-nvax-stock-plunging-30-1031666251,negative,0.9357144236564636
8/9/2022 3:00:47 PM,HCA Healthcare Signs Strategic Collaboration With Johnson & Johnson ,RTTNews,/news/stocks/hca-healthcare-signs-strategic-collaboration-with-johnson-johnson-1031665887,positive,0.8088445663452148
8/10/2022 4:36:56 PM,The 3 Best Sectors for a Bear Market,InvestorPlace,/news/stocks/the-3-best-sectors-for-a-bear-market-1031671637,neutral,0.8772345185279846
8/10/2022 8:02:05 PM,Johnson & Johnson partner Aspen risks closure of COVID vaccine plant as orders dry up,Seeking Alpha,https://seekingalpha.com/news/3870976-jj-partner-aspen-risks-closure-of-covid-vaccine-plant-as-orders-dry-up?utm_source=businessinsider&utm_medium=referral,negative,0.9509630799293518
8/11/2022 7:26:06 PM,CDC eases COVID guidance for unvaccinated people,Seeking Alpha,https://seekingalpha.com/news/3871779-cdc-eases-covid-guidance-for-unvaccinated-people?utm_source=businessinsider&utm_medium=referral,negative,0.8480912446975708
8/11/2022 9:22:02 PM,"J&J, Merck, Regeneron most exposed to Medicare drug price negotiation - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3871983-johnson-johnson-merck-regeneron-most-exposed-to-medicare-drug-price-negotiation-bloomberg?utm_source=businessinsider&utm_medium=referral,neutral,0.9089528918266296
8/11/2022 9:23:05 PM,Johnson & Johnson to end sales of talc-based baby powder globally in 2023,Seeking Alpha,https://seekingalpha.com/news/3872014-johnson--johnson-to-stop-selling-talc-based-baby-powder-globally-in-2023?utm_source=businessinsider&utm_medium=referral,negative,0.8280433416366577
8/12/2022 9:10:44 AM,Johnson & Johnson To Discontinue Talc-based Baby Powder ,RTTNews,/news/stocks/johnson-johnson-to-discontinue-talc-based-baby-powder-1031679050,neutral,0.8274681568145752
8/12/2022 1:28:51 PM,Additional 135M COVID-19 vaccine doses destroyed at Emergent BioSolutions Baltimore plant,Seeking Alpha,https://seekingalpha.com/news/3872367-additional-135m-covid-19-vaccine-doses-destroyed-at-emergent-biosolutions-baltimore-plant?utm_source=businessinsider&utm_medium=referral,negative,0.6232168078422546
8/12/2022 10:45:00 PM,"Johnson & Johnson Ends Global Sales of Cancer-Causing Baby Powder Amid Increased Scrutiny from Consumer Litigation, Science",PR Newswire,/news/stocks/johnson-johnson-ends-global-sales-of-cancer-causing-baby-powder-amid-increased-scrutiny-from-consumer-litigation-science-1031680779,negative,0.8821862936019897
8/14/2022 5:48:06 PM,Analysts rule out major industry impact from drug pricing negotiations,Seeking Alpha,https://seekingalpha.com/news/3872629-analysts-rule-out-major-industry-impact-from-drug-pricing-negotiations?utm_source=businessinsider&utm_medium=referral,negative,0.8447354435920715
8/15/2022 2:41:21 PM,Emergent ticks lower after FDA warning on Baltimore facility,Seeking Alpha,https://seekingalpha.com/news/3872985-emergent-ticks-lower-after-fda-warning-on-baltimore-facility?utm_source=businessinsider&utm_medium=referral,negative,0.8761324286460876
8/16/2022 8:20:19 AM,AstraZeneca/Merck's Lynparza gets FDA priority review to treat prostate cancer subtype,Seeking Alpha,https://seekingalpha.com/news/3873395-astrazenecamercks-lynparza-gets-fda-priority-review-to-treat-prostate-cancer-subtype?utm_source=businessinsider&utm_medium=referral,positive,0.8315349817276001
8/17/2022 10:54:23 AM,"U.S. govt. to stop buying COVID-19 vaccines, therapies, tests from this fall ‚Äì Jha",Seeking Alpha,https://seekingalpha.com/news/3874012-us-govt-to-stop-buying-covid-19-vaccines-therapies-tests-from-this-fall-jha?utm_source=businessinsider&utm_medium=referral,neutral,0.775935173034668
8/17/2022 5:10:23 PM,CDC seeks reforms to correct COVID missteps,Seeking Alpha,https://seekingalpha.com/news/3874241-cdc-to-implement-reforms-to-correct-covid-missteps?utm_source=businessinsider&utm_medium=referral,positive,0.7855807542800903
8/18/2022 4:59:56 PM,7 Stocks That Win When the Fed Hikes Interest Rates,InvestorPlace,/news/stocks/7-stocks-that-win-when-the-fed-hikes-interest-rates-1031693784,neutral,0.8210757970809937
8/19/2022 12:31:52 PM,"HHS sets Aug. 30 meeting as costs for COVID products to shift to payors, individuals ‚Äì WSJ",Seeking Alpha,https://seekingalpha.com/news/3875015-hhs-sets-aug-meeting-as-covid-products-head-for-commercialization-wsj?utm_source=businessinsider&utm_medium=referral,neutral,0.9202150106430054
8/19/2022 2:17:52 PM,Johnson & Johnson goes ex-dividend on Monday,Seeking Alpha,https://seekingalpha.com/news/3875073-johnson--johnson-goes-ex-dividend-on-monday?utm_source=businessinsider&utm_medium=referral,neutral,0.5367696285247803
8/22/2022 11:22:03 AM,Johnson & Johnson to use Texas bankruptcy plan to fight two states‚Äô talc cases,Seeking Alpha,https://seekingalpha.com/news/3875309-johnson-johnson-to-use-texas-bankruptcy-plan-to-fight-two-states-talc-cases?utm_source=businessinsider&utm_medium=referral,neutral,0.7610474228858948
8/22/2022 2:28:02 PM,"Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday,...",Benzinga,/news/stocks/benzinga-before-the-bell-apple-employees-resist-calls-for-return-to-office-tesla-about-to-hike-fsd-prices-again-mgm-china-injects-594m-into-macau-unit-and-other-top-financial-stories-monday-august-22-1031697874,neutral,0.411722868680954
8/24/2022 10:53:47 AM,JNJ adds former CVS CEO as non-executive chair of new consumer spinoff,Seeking Alpha,https://seekingalpha.com/news/3876108-jnj-adds-former-cvs-ceo-non-executive-chair-new-consumer-spinoff?utm_source=businessinsider&utm_medium=referral,neutral,0.9350612163543701
8/24/2022 12:16:25 PM,Pfizer said to have had bidding war with Johnson & Johnson for Global Blood,Seeking Alpha,https://seekingalpha.com/news/3876151-pfizer-said-to-have-had-bidding-war-with-johnson-johnson-for-global-blood?utm_source=businessinsider&utm_medium=referral,neutral,0.7914672493934631
8/24/2022 2:40:20 PM,Johnson & Johnson Names Larry Merlo Chair Designate Of Planned New Consumer Health Company ,RTTNews,/news/stocks/johnson-johnson-names-larry-merlo-chair-designate-of-planned-new-consumer-health-company-1031703127,neutral,0.9368777871131897
8/24/2022 4:30:36 PM,Congressman wants DoJ update on Johnson & Johnson talc powder investigation,Seeking Alpha,https://seekingalpha.com/news/3876289-congressman-wants-doj-update-on-johnson-johnson-talc-powder-investigation?utm_source=businessinsider&utm_medium=referral,neutral,0.9358670711517334
8/24/2022 7:45:18 PM,Billionaire Steven Cohen Just Made a Big Bet on Minerva Neurosciences (NERV) Stock,InvestorPlace,/news/stocks/billionaire-steven-cohen-just-made-a-big-bet-on-minerva-neurosciences-nerv-stock-1031704192,neutral,0.8234988451004028
8/25/2022 12:53:45 AM,Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary,Benzinga,/news/stocks/recap-of-wednesday-s-biotech-catalysts---end-of-the-day-summary-1031704410,neutral,0.9346833229064941
8/25/2022 3:48:30 AM,Ligand : Janssen's Tecvayli Gets Conditional Approval In Europe For R/R Multiple Myeloma Treatment ,RTTNews,/news/stocks/ligand-janssen-s-tecvayli-gets-conditional-approval-in-europe-for-r-r-multiple-myeloma-treatment-1031704454,positive,0.9393503665924072
8/25/2022 9:38:03 AM,"AbbVie, J&J Imbruvica gets FDA nod to treat graft-versus-host disease in kids",Seeking Alpha,https://seekingalpha.com/news/3876504-abbvie-jj-imbruvica-gets-fda-nod-to-treat-graft-versus-host-disease-in-kids?utm_source=businessinsider&utm_medium=referral,positive,0.8829076290130615
8/25/2022 11:12:25 AM,Pfizer posts 86% efficacy for respiratory syncytial virus vaccine,Seeking Alpha,https://seekingalpha.com/news/3876550-pfizer-posts-efficacy-for-respiratory-syncytial-virus-vaccine?utm_source=businessinsider&utm_medium=referral,positive,0.9164323806762695
8/25/2022 4:32:25 PM,Janssen Scores Conditional Approval For Multiple Myeloma Treatment In Pretreated Patients,Benzinga,/news/stocks/janssen-scores-conditional-approval-for-multiple-myeloma-treatment-in-pretreated-patients-1031706261,positive,0.9233115911483765
8/28/2022 4:00:00 PM,Pfizer eyes $10B-plus market for RSV vaccines with two-prong approach,Seeking Alpha,https://seekingalpha.com/news/3877243-pfizer-eyes-10b-plus-market-for-rsv-vaccines-with-pandemic-era-model?utm_source=businessinsider&utm_medium=referral,neutral,0.6486813426017761
8/29/2022 4:44:50 PM,"Bristol-Myers falls 5%, most in two years, after mid-stage data for blood thinner",Seeking Alpha,https://seekingalpha.com/news/3877518-bmy-stock-falls-after-mid-stage-data-for-blood-thinner?utm_source=businessinsider&utm_medium=referral,negative,0.9234603047370911
8/31/2022 3:41:46 PM,Pfizer snatches first chief marketing officer from Google's Verily,Seeking Alpha,https://seekingalpha.com/news/3878965-pfizer-snatches-first-chief-marketing-officer-from-googles-verily?utm_source=businessinsider&utm_medium=referral,neutral,0.9217296242713928
8/31/2022 8:52:36 PM,"Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know",Benzinga,/news/stocks/bluebird-bio-seeks-back-to-back-nods-go-or-no-go-for-revance-s-botox-rival-amylyx-twin-hurdles-and-more-september-s-key-pdufa-catalysts-biotech-investors-must-know-1031717312,neutral,0.7547867894172668
9/1/2022 2:49:57 PM,Johnson & Johnson to pay $40.5M over opioid claims in New Hampshire,Seeking Alpha,https://seekingalpha.com/news/3879416-johnson-johnson-to-pay-405m-over-opioid-claims-in-new-hampshire?utm_source=businessinsider&utm_medium=referral,negative,0.8123184442520142
9/2/2022 1:10:56 PM,EMA committee starts review of use of epileptic seizures drug topiramate in pregnancy,Seeking Alpha,https://seekingalpha.com/news/3879806-ema-committee-starts-review-of-use-of-epileptic-seizures-drug-topiramate-in-pregnancy?utm_source=businessinsider&utm_medium=referral,neutral,0.8862842917442322
9/4/2022 1:18:40 PM,"M&A may be a tailwind for biotech sector into end of year, analyst says",Seeking Alpha,https://seekingalpha.com/news/3880197-ma-may-be-a-tailwind-for-biotech-sector-into-end-of-year-analyst-says?utm_source=businessinsider&utm_medium=referral,negative,0.929253339767456
9/6/2022 7:12:48 AM,The 7 Best Vanguard ETFs to Buy Now,InvestorPlace,/news/stocks/the-best-vanguard-etfs-1028807655,neutral,0.9007077217102051
9/6/2022 6:00:50 PM,6 Safe Stocks to Buy in September 2022,InvestorPlace,/news/stocks/best-safe-stocks-1031561144,neutral,0.9252723455429077
9/6/2022 6:55:35 PM,7 Dow Stocks With Superior Fundamentals,InvestorPlace,/news/stocks/7-dow-stocks-with-superior-fundamentals-1031727239,positive,0.7731029987335205
9/8/2022 2:48:04 PM,Shockwave Medical gains on vague takeover speculation,Seeking Alpha,https://seekingalpha.com/news/3881275-shockwave-medical-gains-on-vague-takeover-speculation?utm_source=businessinsider&utm_medium=referral,positive,0.6442201137542725
9/8/2022 9:01:53 PM,"FDA warns about skin cancer, various lymphomas in scar tissue around breast implants",Seeking Alpha,https://seekingalpha.com/news/3881442-fda-warns-about-skin-cancer-various-lymphomas-in-scar-tissue-around-breast-implants?utm_source=businessinsider&utm_medium=referral,negative,0.7986806035041809
9/9/2022 5:30:31 AM,The 3 Best Funds for Retirees,InvestorPlace,/news/stocks/best-funds-for-retirees-1031611261,neutral,0.8731857538223267
9/11/2022 11:03:19 PM,7 Blue-Chip Stocks to Buy Before the Bull Market Returns,InvestorPlace,/news/stocks/blue-chip-stocks-to-buy-before-bull-market-returns-1031630381,neutral,0.882673442363739
9/12/2022 9:05:45 AM,J&J reaches A$300M settlement in pelvic mesh implant class lawsuits in Australia,Seeking Alpha,https://seekingalpha.com/news/3881885-jj-reaches-a300m-settlement-in-pelvic-mesh-implant-class-lawsuits-in-australia?utm_source=businessinsider&utm_medium=referral,negative,0.9155973792076111
9/12/2022 12:36:04 PM,Shine Justice Agrees To Settle Australian J&J/Ethicon Mesh Class Actions ,RTTNews,/news/stocks/shine-justice-agrees-to-settle-australian-j-j-ethicon-mesh-class-actions-1031736803,neutral,0.42150580883026123
9/12/2022 11:05:24 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1031738400,neutral,0.9169120192527771
9/13/2022 3:49:07 PM,Cidara begins dosing of antiviral CD388 in trial for preventing influenza,Seeking Alpha,https://seekingalpha.com/news/3882393-cidara-begins-dosing-in-study-of-antiviral-cd388-for-preventing-influenza?utm_source=businessinsider&utm_medium=referral,positive,0.7078872919082642
9/13/2022 3:50:55 PM,3 Best Index Funds to Buy Now,InvestorPlace,/news/stocks/best-index-funds-1031567253,neutral,0.8933942317962646
9/14/2022 10:48:58 AM,J&J plans $5B stock buyback program; affirms FY22 outlook,Seeking Alpha,https://seekingalpha.com/news/3882616-jj-plans-5b-stock-buyback-program-affirms-fy22-outlook?utm_source=businessinsider&utm_medium=referral,positive,0.6116510629653931
9/14/2022 12:52:45 PM,Johnson & Johnson Reaffirms FY22 Outlook; Authorizes Up To $5 Bln Share Buyback ,RTTNews,/news/stocks/johnson-johnson-reaffirms-fy22-outlook-authorizes-up-to-5-bln-share-buyback-1031742257,positive,0.8278277516365051
9/14/2022 2:18:38 PM,"End in sight for COVID-19 pandemic, WHO chief says",Seeking Alpha,https://seekingalpha.com/news/3882728-end-in-sight-for-covid-19-pandemic-who-chief-says?utm_source=businessinsider&utm_medium=referral,neutral,0.8521959781646729
9/14/2022 8:24:39 PM,7 Dividend Stocks to Buy and Hold Forever¬†,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-and-hold-forever-2-1031743860,neutral,0.9479726552963257
9/15/2022 1:20:48 AM,The 3 Best Mutual Funds to Buy in September,InvestorPlace,/news/stocks/best-mutual-funds-1031587594,neutral,0.8449282050132751
9/17/2022 8:00:18 PM,"BioNTech, Moderna, Pfizer led biopharma revenue growth from 2020-2021",Seeking Alpha,https://seekingalpha.com/news/3883566-biontech-moderna-pfizer-led-biopharma-revenue-growth-from-2020-2021?utm_source=businessinsider&utm_medium=referral,positive,0.9150789976119995
9/19/2022 7:00:53 PM,COVID-19 vaccine makers fall as Biden says pandemic is over (update),Seeking Alpha,https://seekingalpha.com/news/3883793-mrna-stock-lead-selloff-covid-vaccine-makers-biden-says-pandemic-over?utm_source=businessinsider&utm_medium=referral,negative,0.961385190486908
9/20/2022 3:00:49 PM,Ethicon To Source Eastman Renew Materials For Medical Device Sterile-barrier Packaging ,RTTNews,/news/stocks/ethicon-to-source-eastman-renew-materials-for-medical-device-sterile-barrier-packaging-1031753633,neutral,0.8330996632575989
9/21/2022 4:20:56 PM,Want To Invest Like The World's Largest Hedge Fund? 2 High Yielders That Are Recession Proof,Benzinga,/news/stocks/want-to-invest-like-the-world-s-largest-hedge-fund-2-high-yielders-that-are-recession-proof-1031756914,neutral,0.8777663707733154
9/22/2022 11:00:14 AM,7 Safe Havens All Investors Should Have Exposure to in 2022,InvestorPlace,/news/stocks/7-safe-havens-for-investors-to-have-exposure-to-in-2022-1031758874,neutral,0.9260845184326172
9/22/2022 3:21:17 PM,Gracell Biotechnologies initiated at buy at Citi citing its autologous CAR-T platform,Seeking Alpha,https://seekingalpha.com/news/3885329-gracell-biotechnologies-initiated-at-buy-at-citi-citing-its-autologous-car-t-platform?utm_source=businessinsider&utm_medium=referral,neutral,0.87056565284729
9/22/2022 3:55:15 PM,"WHO chief reiterates belief that COVID-19 pandemic end near, says work still needed",Seeking Alpha,https://seekingalpha.com/news/3885339-who-chief-reiterates-belief-that-covid-19-pandemic-end-near-says-work-still-needed?utm_source=businessinsider&utm_medium=referral,neutral,0.579860508441925
9/22/2022 7:25:05 PM,Healthcare outperforms S&P 500 as large cap pharma rebounds,Seeking Alpha,https://seekingalpha.com/news/3885399-healthcare-outperforms-sp-500-as-large-cap-pharma-rebounds?utm_source=businessinsider&utm_medium=referral,positive,0.6939463019371033
9/23/2022 7:37:13 AM,NervGen Pharma appoints Bill Radvak as interim CEO,Seeking Alpha,https://seekingalpha.com/news/3885493-nervgen-pharma-appoints-bill-radvak-as-interim-ceo?utm_source=businessinsider&utm_medium=referral,neutral,0.7062072157859802
9/23/2022 11:08:24 AM,Biden administration allocates $1.5B to address U.S. opioid crisis,Seeking Alpha,https://seekingalpha.com/news/3885562-biden-administration-allocates-15b-to-address-us-opioid-crisis?utm_source=businessinsider&utm_medium=referral,positive,0.7172859311103821
9/23/2022 6:25:08 PM,7 Investments to FIRE Up a Fat Stash and Retire Early,InvestorPlace,/news/stocks/7-investments-for-fatfire-movement-1031762591,neutral,0.9077175259590149
9/25/2022 6:00:00 PM,The prostate cancer therapy market will soar. Here are the companies that could benefit.,Seeking Alpha,https://seekingalpha.com/news/3885824-the-prostate-cancer-therapy-market-will-soar-here-are-the-companies-that-could-benefit?utm_source=businessinsider&utm_medium=referral,neutral,0.9147647619247437
9/26/2022 11:29:08 AM,7 Stocks to Buy Before They Crush Q3 Earnings,InvestorPlace,/news/stocks/7-stocks-to-buy-before-they-crush-q3-earnings-1031764320,neutral,0.9280515909194946
9/26/2022 4:16:19 PM,3 Dividend Stocks to Buy Before the Bull Market Returns,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-before-the-bull-market-returns-1031765258,neutral,0.9164003729820251
9/27/2022 11:15:11 AM,The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market,InvestorPlace,/news/stocks/the-7-best-stocks-to-buy-to-tap-into-a-hidden-bull-market-1031766644,neutral,0.8398818373680115
9/27/2022 2:29:31 PM,Legend Biotech wins approval of Carvykti for multiple myeloma in Japan,Seeking Alpha,https://seekingalpha.com/news/3886395-legend-biotech-wins-approval-of-carvykti-for-multiple-myeloma-in-japan?utm_source=businessinsider&utm_medium=referral,positive,0.9239596128463745
9/27/2022 6:32:56 PM,Investors are pouring money into healthcare and other defensive sectors as market tanks,Seeking Alpha,https://seekingalpha.com/news/3886489-investors-are-pouring-money-into-healthcare-stocks-and-other-defensive-stocks-as-market-tanks?utm_source=businessinsider&utm_medium=referral,neutral,0.8531032800674438
9/27/2022 6:50:42 PM,7 Dow Stocks to Buy to Tap Into a Hidden Bull Market,InvestorPlace,/news/stocks/7-dow-stocks-to-buy-to-tap-into-a-hidden-bull-market-1031768144,neutral,0.8689263463020325
9/27/2022 11:13:29 PM,3 Blue-Chip Stocks to Buy to Tap Into a Hidden Bull Market,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-to-tap-into-a-hidden-bull-market-1031768461,neutral,0.8314662575721741
9/28/2022 12:03:25 PM,Johnson & Johnson names consumer health spinoff 'Kenvue',Seeking Alpha,https://seekingalpha.com/news/3886683-johnson-johnson-names-consumer-health-spinoff-kenvue?utm_source=businessinsider&utm_medium=referral,neutral,0.895499050617218
9/28/2022 1:44:40 PM,Johnson & Johnson wins FDA OK to expand use of myopia lenses,Seeking Alpha,https://seekingalpha.com/news/3886748-johnson-johnson-wins-fda-ok-to-expand-use-of-myopia-lenses?utm_source=businessinsider&utm_medium=referral,positive,0.8908851146697998
9/28/2022 2:06:53 PM,Johnson & Johnson Unveils Kenvue Brand Name For Planned Consumer Health Company ,RTTNews,/news/stocks/johnson-johnson-unveils-kenvue-brand-name-for-planned-consumer-health-company-1031769895,neutral,0.8508202433586121
9/28/2022 3:21:40 PM,5 Little-Known Dividend Kings,InvestorPlace,/news/stocks/5-little-known-dividend-kings-1031770642,neutral,0.9137552976608276
9/28/2022 10:01:13 PM,"Many Alzheimer's drug developers close significantly higher thanks to Biogen, Eisai data",Seeking Alpha,https://seekingalpha.com/news/3886925-many-alzheimers-drug-developers-close-significantly-higher-thanks-to-biogen-eisai-data?utm_source=businessinsider&utm_medium=referral,positive,0.9467376470565796
9/28/2022 10:45:22 PM,Aligos Therapeutics files court response and counterclaims to J&J's allegations of theft,Seeking Alpha,https://seekingalpha.com/news/3886939-aligos-therapeutics-files-court-response-and-counterclaims-to-jjs-allegations-of-theft?utm_source=businessinsider&utm_medium=referral,negative,0.7503809332847595
9/29/2022 12:09:01 PM,The 3 Best Dividend Stocks to Buy for Retirement,InvestorPlace,/news/stocks/the-3-best-dividend-stocks-to-buy-for-retirement-1031772709,neutral,0.86979740858078
9/29/2022 8:36:50 PM,"Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say",Benzinga,/news/stocks/immunovant-s-new-candidate-provides-some-strategic-flexibility-clarity-analysts-say-1031773948,positive,0.8338488936424255
10/2/2022 2:30:26 PM,7 S&P 500 Stocks to Sell Before They Die,InvestorPlace,/news/stocks/7-sp-500-stocks-to-sell-before-they-die-1031779874,neutral,0.7082478404045105
10/3/2022 10:14:22 AM,"Svante P√§√§bo gets Nobel Prize for Medicine for discoveries on genome, human evolution",Seeking Alpha,https://seekingalpha.com/news/3887839-svante-pbo-gets-nobel-prize-for-medicine-for-discoveries-on-genome-human-evolution?utm_source=businessinsider&utm_medium=referral,neutral,0.7340625524520874
10/3/2022 12:33:53 PM,Clovis stock rises 10% as Rubraca shows survival benefit in prostate cancer in confirmatory trial,Seeking Alpha,https://seekingalpha.com/news/3887902-clovis-stock-rises-as-rubraca-shows-survival-benefit-in-prostate-cancer-in-confirmatory-trial?utm_source=businessinsider&utm_medium=referral,positive,0.9503354430198669
10/3/2022 11:56:59 PM,The Short List Of Dow Jones Stocks That Are Actually Up This Year: Hint ‚Äî It's Very Short,Benzinga,/news/etf/the-short-list-of-dow-jones-stocks-that-are-actually-up-this-year-hint-‚Äî-it-s-very-short-1031780150,neutral,0.6578128933906555
10/4/2022 11:04:52 AM,7 Recession-Proof Stocks to Buy in October¬†,InvestorPlace,/news/stocks/7-recession-proof-stocks-to-buy-in-october-1031781197,neutral,0.801183819770813
10/5/2022 4:25:31 PM,Bankruptcy judge temporarily prevents two states from suing J&J over talc safety,Seeking Alpha,https://seekingalpha.com/news/3888954-bankruptcy-judge-temporarily-prevents-two-states-from-suing-johnson-johnson-over-talc-safety?utm_source=businessinsider&utm_medium=referral,negative,0.9268501996994019
10/5/2022 7:05:49 PM,Ray Dalio Is Stepping Down. Here Are His Top 5 Stock Bets.,InvestorPlace,/news/stocks/ray-dalio-is-stepping-down-here-are-his-top-5-stock-bets-1031785604,neutral,0.7984110116958618
10/6/2022 11:26:50 AM,7 Dividend Stocks That Are Too Cheap to Ignore,InvestorPlace,/news/stocks/7-dividend-stocks-that-are-too-cheap-to-ignore-1031787020,neutral,0.7287651300430298
10/6/2022 6:34:41 PM,Want to Bet Against Jim Cramer? Short These 10 Stocks.,InvestorPlace,/news/stocks/want-to-bet-against-jim-cramer-short-these-10-stocks-1031788455,neutral,0.8903868794441223
10/7/2022 5:40:40 PM,Former J&J executive is tipped to become Biogen CEO ‚Äì Stat News,Seeking Alpha,https://seekingalpha.com/news/3889747-former-jj-executive-is-tipped-to-become-biogen-ceo-stat-news?utm_source=businessinsider&utm_medium=referral,neutral,0.9377966523170471
10/7/2022 6:02:20 PM,U.S. report says COVID vaccines led to over 300K fewer deaths among Medicare beneficiaries,Seeking Alpha,https://seekingalpha.com/news/3889752-us-report-says-covid-vaccines-led-to-over-300k-fewer-deaths-among-medicare-beneficiaries?utm_source=businessinsider&utm_medium=referral,negative,0.6736575961112976
10/7/2022 9:46:21 PM,"JNJ, MDT: Are Their ~3% Dividend Yields Worth It?",TipRanks,/news/stocks/jnj-mdt-are-their-~3-dividend-yields-worth-it-1031790938,neutral,0.8682147264480591
10/10/2022 10:30:32 AM,This Is the Best Time to Buy These 7 Long-Term Blue-Chip Stocks,InvestorPlace,/news/stocks/this-is-the-best-time-to-buy-these-7-long-term-blue-chip-stocks-1031792717,neutral,0.7951258420944214
10/10/2022 3:21:50 PM,Johnson & Johnson highlights long-term effect of ulcerative colitis therapy,Seeking Alpha,https://seekingalpha.com/news/3890049-johnson-johnson-highlights-long-term-effect-of-ulcerative-colitis-therapy?utm_source=businessinsider&utm_medium=referral,neutral,0.701878011226654
10/10/2022 5:35:12 PM,"J&J says Tremfya, Simponi combination effective for ulcerative colitis",Seeking Alpha,https://seekingalpha.com/news/3890091-johnson-johnson-says-tremfya-simponi-combination-effective-for-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral,positive,0.9337752461433411
10/10/2022 6:09:22 PM,GOP senators introduce bill to undo Medicare prescription drug negotiation,Seeking Alpha,https://seekingalpha.com/news/3890099-gop-senators-introduce-bill-to-undo-medicare-prescription-drug-negotiation?utm_source=businessinsider&utm_medium=referral,neutral,0.5134311318397522
10/12/2022 11:57:47 AM,BeiGene Brukinsa shows better survival benefit vs Imbruvica in blood cancer patients in trial,Seeking Alpha,https://seekingalpha.com/news/3890655-beigene-brukinsa-shows-better-survival-benefit-vs-imbruvica-in-blood-cancer-patients-in-trial?utm_source=businessinsider&utm_medium=referral,positive,0.9531958699226379
10/12/2022 7:07:29 PM,What 7 Analyst Ratings Have To Say About Johnson & Johnson,Benzinga,/news/stocks/what-7-analyst-ratings-have-to-say-about-johnson-johnson-1031800562,neutral,0.9396771788597107
10/12/2022 8:19:14 PM,Analyst Casts Doubts On Merus' Lung Candidate Safety Profile,Benzinga,/news/stocks/analyst-casts-doubts-on-merus-lung-candidate-safety-profile-1031800674,negative,0.8004802465438843
10/13/2022 8:43:29 AM,GSK RSV vaccine for older adults shows 94.1% efficacy in severe disease in phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/3890968-gsk-rsv-vaccine-for-older-adults-shows-941-efficacy-in-severe-disease-in-phase-3-trial?utm_source=businessinsider&utm_medium=referral,positive,0.90916508436203
10/13/2022 10:07:43 AM,J&J's Biosense launches Heliostar balloon ablation catheter in Europe,Seeking Alpha,https://seekingalpha.com/news/3890979-jjs-biosense-launches-heliostar-balloon-ablation-catheter-in-europe?utm_source=businessinsider&utm_medium=referral,neutral,0.7248006463050842
10/13/2022 5:28:57 PM,BeiGene upgraded to buy at Guggenheim on improved confidence in Brukinsa potential,Seeking Alpha,https://seekingalpha.com/news/3891157-beigene-upgraded-to-buy-at-guggenheim-on-improved-confidence-in-brukinsa-potential?utm_source=businessinsider&utm_medium=referral,positive,0.9556883573532104
10/13/2022 9:46:53 PM,3 Dow Stocks to Buy if You Are Feeling Greedy,InvestorPlace,/news/stocks/3-dow-stocks-to-buy-if-you-are-feeling-greedy-1031804612,neutral,0.928457498550415
10/14/2022 3:55:21 AM,SVB Securities Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1031804731,neutral,0.7781380414962769
10/14/2022 12:24:33 PM,Biden to sign Executive Order tasking HHS to find additional ways to lower drug costs,Seeking Alpha,https://seekingalpha.com/news/3891387-biden-to-sign-executive-order-tasking-hhs-to-find-additional-ways-to-lower-drug-costs-medicare?utm_source=businessinsider&utm_medium=referral,positive,0.8669123649597168
10/14/2022 5:10:04 PM,"Earnings week ahead: Tesla, Netflix, Johnson & Johnson, AT&T and more",Seeking Alpha,https://seekingalpha.com/news/3891460-earnings-week-ahead-tesla-netflix-johnson-johnson-att-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9371859431266785
10/14/2022 6:30:00 PM,"Catalyst Watch: Tesla, Netflix, Fisker, TechCrunch Disrupt and Paris Motor Show headline big week",Seeking Alpha,https://seekingalpha.com/news/3891159-catalyst-watch-tesla-netflix-techcrunch-disrupt-and-paris-motor-show-headline-big-week?utm_source=businessinsider&utm_medium=referral,neutral,0.8451206088066101
10/17/2022 9:05:30 AM,Bill & Melinda Gates Foundation commits $1.2B to end polio,Seeking Alpha,https://seekingalpha.com/news/3891702-bill-melinda-gates-foundation-commit-12b-to-end-polio?utm_source=businessinsider&utm_medium=referral,positive,0.7355889081954956
10/17/2022 2:43:09 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3891864-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral,positive,0.8660829067230225
10/17/2022 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-stock-quarter-earnings-preview-q3-1031810009,neutral,0.9338979721069336
10/17/2022 4:15:31 PM,Johnson & Johnson to report Q3 earnings amid macro concerns on guidance,Seeking Alpha,https://seekingalpha.com/news/3891898-johnson-johnson-to-report-q3-earnings-amid-macro-concerns-on-guidance?utm_source=businessinsider&utm_medium=referral,negative,0.9430224299430847
10/18/2022 10:03:45 AM,"Goldman Sachs, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/goldman-sachs-johnson-johnson-and-3-stocks-to-watch-heading-into-tuesday-1031812521,neutral,0.9243104457855225
10/18/2022 10:27:49 AM,"Johnson & Johnson Non-GAAP EPS of $2.55 beats by $0.06, revenue of $23.8B beats by $360M",Seeking Alpha,https://seekingalpha.com/news/3892097-johnson-and-johnson-non-gaap-eps-of-2_55-beats-0_06-revenue-of-23_8b-beats-360m?utm_source=businessinsider&utm_medium=referral,neutral,0.5877429842948914
10/18/2022 11:07:24 AM,Johnson & Johnson lowers 2022 guidance amid inflationary and forex impact,Seeking Alpha,https://seekingalpha.com/news/3892112-johnson-johnson-lowers-2022-guidance-amid-inflationary-and-forex-impact?utm_source=businessinsider&utm_medium=referral,negative,0.9669351577758789
10/18/2022 12:04:15 PM,"US Stock Futures Surge Following Monday's Rally; Goldman Sachs, Johnson & Johnson Earnings In Focus",Benzinga,/news/stocks/us-stock-futures-surge-following-monday-s-rally-goldman-sachs-johnson-johnson-earnings-in-focus-1031812722,negative,0.5139555931091309
10/18/2022 12:34:33 PM,"Johnson & Johnson Q3 Profit Increases, beats estimates",RTTNews,/news/stocks/johnson-johnson-q3-profit-increases-beats-estimates-1031812774,positive,0.9267435073852539
10/18/2022 1:10:43 PM,Johnson & Johnson Q3 Profit Beats Estimates; Adj. Operational Sales Up 8.2%; Increases Guidance ,RTTNews,/news/stocks/johnson-johnson-q3-profit-beats-estimates-adj-operational-sales-up-8-2-increases-guidance-1031812929,positive,0.9485570788383484
10/18/2022 1:15:02 PM,"US Stocks' Momentum Set To Continue Tuesday As Nasdaq Futures Lead Rally ‚Äî Tesla, Goldman, J&J, United Airlines In Focus",Benzinga,/news/stocks/us-stocks-momentum-set-to-continue-tuesday-as-nasdaq-futures-lead-rally-‚Äî-tesla-goldman-j-j-united-airlines-in-focus-1031812959,positive,0.8691239356994629
10/18/2022 1:37:18 PM,Why Is Johnson & Johnson (JNJ) Stock Down Today?,InvestorPlace,/news/stocks/why-is-johnson-johnson-jnj-stock-down-today-1031813799,negative,0.9397313594818115
10/18/2022 1:38:42 PM,"AVEO Pharmaceuticals, Akouos And Some Other Big Stocks Moving Higher In Today's Pre-Market Session",Benzinga,/news/stocks/aveo-pharmaceuticals-akouos-and-some-other-big-stocks-moving-higher-in-today-s-pre-market-session-1031813041,positive,0.9316368103027344
10/18/2022 1:58:42 PM,CANO Stock Jumps Despite Rumors CVS Is Walking Away From Cano Health Acquisition,InvestorPlace,/news/stocks/cano-stock-jumps-despite-rumors-cvs-is-walking-away-from-cano-health-acquisition-1031813930,negative,0.8338810205459595
10/18/2022 2:30:39 PM,"Complete Exit For Exxon From Russia, Microsoft's Layoffs, Another Setback For Boeing's Potential 737 MAX 7 Approval, Visa & Mastercard Under FTC Probe: Top Stories Tuesday, Oct. 18",Benzinga,/news/stocks/complete-exit-for-exxon-from-russia-microsoft-s-layoffs-another-setback-for-boeing-s-potential-737-max-7-approval-visa-mastercard-under-ftc-probe-top-stories-tuesday-oct-18-1031813286,neutral,0.517366349697113
10/18/2022 4:09:22 PM,Johnson & Johnson weighs job cuts ahead of consumer health spinoff,Seeking Alpha,https://seekingalpha.com/news/3892300-johnson-johnson-weighs-job-cuts-ahead-of-consumer-health-spinoff?utm_source=businessinsider&utm_medium=referral,negative,0.9445424675941467
10/18/2022 6:03:51 PM,Colgate gains after activist Third Point takes stake (update),Seeking Alpha,https://seekingalpha.com/news/3892236-colgate-gains-on-report-activist-third-point-takes-stake-in-colgate?utm_source=businessinsider&utm_medium=referral,neutral,0.8447616100311279
10/18/2022 7:52:05 PM,Legend Biotech climbs as analysts probe JNJ Q3 results to estimate Carvykti sales,Seeking Alpha,https://seekingalpha.com/news/3892388-legn-stock-climbs-as-analysts-parse-jnj-q3-to-estimate-carvykti-sales?utm_source=businessinsider&utm_medium=referral,positive,0.9004184603691101
10/19/2022 12:25:40 PM,Johnson & Johnson (NYSE:JNJ) Eyes Job Cuts as Macro Pressures Persist,TipRanks,/news/stocks/johnson-johnson-nyse-jnj-eyes-job-cuts-as-macro-pressures-persist-1031817309,negative,0.9503217339515686
10/19/2022 12:35:55 PM,Atlantic Equities Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/atlantic-equities-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1031817392,neutral,0.5214512944221497
10/19/2022 12:40:36 PM,"Analysts Conflicted on These Healthcare Names: Amarin (AMRN), Johnson & Johnson (JNJ) and UnitedHealth (UNH)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-amarin-amrn-johnson-johnson-jnj-and-unitedhealth-unh-1031817383,negative,0.7145324945449829
10/19/2022 2:56:15 PM,Goldman Sachs To $410? Plus Credit Suisse Predicts $272 For McDonald's,Benzinga,/news/stocks/goldman-sachs-to-410-plus-credit-suisse-predicts-272-for-mcdonald-s-1031817530,positive,0.7087299823760986
10/19/2022 4:32:05 PM,"Analysts Are Neutral on These Healthcare Stocks: Intuitive Surgical (ISRG), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-neutral-on-these-healthcare-stocks-intuitive-surgical-isrg-johnson-johnson-jnj-1031818361,neutral,0.5577171444892883
10/19/2022 5:52:27 PM,The 3 Best Blue-Chip Stocks to Buy Now,InvestorPlace,/news/stocks/the-3-best-blue-chip-stocks-to-buy-now-1031818533,neutral,0.8018681406974792
10/20/2022 12:26:56 PM,J&J's Teligen system gets FDA clearance for use in spinal surgeries,Seeking Alpha,https://seekingalpha.com/news/3893113-jjs-teligen-system-gets-fda-clearance-for-use-in-spinal-surgeries?utm_source=businessinsider&utm_medium=referral,positive,0.9062905311584473
10/20/2022 1:36:54 PM,AbbVie to acquire DJS Antibodies for $255M to bolster immunology pipeline,Seeking Alpha,https://seekingalpha.com/news/3893196-abbvie-to-acquire-djs-antibodies-for-255m-to-bolster-immunology-pipeline?utm_source=businessinsider&utm_medium=referral,positive,0.8283439874649048
10/20/2022 5:19:54 PM,Prescription drugs make up a rising share of Medicare spending ‚Äì study,Seeking Alpha,https://seekingalpha.com/news/3893317-prescription-drugs-account-for-a-rising-chunk-of-medicare-spending-study?utm_source=businessinsider&utm_medium=referral,neutral,0.7574056386947632
10/20/2022 5:52:21 PM,CDC panel recommends adding COVID-19 vaccines to regular immunizations,Seeking Alpha,https://seekingalpha.com/news/3893337-cdc-panel-recommends-adding-covid-19-vaccines-to-regular-immunizations?utm_source=businessinsider&utm_medium=referral,neutral,0.8696174025535583
10/20/2022 9:34:45 PM,Johnson & Johnson bags $244M defense logistics contract,Seeking Alpha,https://seekingalpha.com/news/3893508-johnson-johnson-bags-244m-defense-logistics-contract?utm_source=businessinsider&utm_medium=referral,neutral,0.6649739742279053
10/21/2022 1:15:41 AM,Credit Suisse Reaffirms Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/credit-suisse-reaffirms-their-hold-rating-on-johnson-johnson-jnj-1031822861,neutral,0.6710560917854309
10/21/2022 5:56:11 PM,"Talks begin with pharma, health insurers over negotiating drug prices for Medicare",Seeking Alpha,https://seekingalpha.com/news/3893788-talks-begin-with-pharma-health-insurers-over-negotiating-drug-prices-for-medicare?utm_source=businessinsider&utm_medium=referral,neutral,0.670078456401825
10/22/2022 8:00:00 PM,"J&J, Alkermes, AbbVie, others set to benefit from expanding schizophrenia drug market",Seeking Alpha,https://seekingalpha.com/news/3893816-johnson-johnson-alkermes-abbvie-others-set-to-benefit-from-expanding-schizophrenia-drug-market?utm_source=businessinsider&utm_medium=referral,positive,0.7288215160369873
10/23/2022 4:00:00 PM,"Pfizer, Moderna bank on price hikes, updated shots to retain COVID vaccine duopoly",Seeking Alpha,https://seekingalpha.com/news/3893783-pfizer-moderna-bank-on-price-hikes-updated-shots-to-win-covid-vaccine-duopoly?utm_source=businessinsider&utm_medium=referral,neutral,0.9074084162712097
10/24/2022 1:58:47 PM,"'Right Now I Don't Want To Back Away From It,' Jim Cramer Says About This Stock Down Only 8% This Year",Benzinga,/news/stocks/right-now-i-don-t-want-to-back-away-from-it-jim-cramer-says-about-this-stock-down-only-8-this-year-1031828185,negative,0.9358142614364624
10/25/2022 7:01:39 PM,Updated COVID boosters did not outperform original COVID vaccines ‚Äì study,Seeking Alpha,https://seekingalpha.com/news/3895008-updated-covid-boosters-did-not-outperform-original-covid-vaccines-study?utm_source=businessinsider&utm_medium=referral,positive,0.7752231955528259
10/25/2022 8:01:58 PM,Johnson & Johnson wins FDA approval for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/3895052-johnson-johnson-wins-fda-approval-for-multiple-myeloma-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.9013036489486694
10/27/2022 6:06:16 AM,SVB Securities Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1031841991,neutral,0.7781380414962769
10/27/2022 8:37:46 PM,"Analyst Sees Market Potential For Arcellx Multiple Myeloma Candidate, Sees 50% Upside In Stock",Benzinga,/news/stocks/analyst-sees-market-potential-for-arcellx-multiple-myeloma-candidate-sees-50-upside-in-stock-1031844903,positive,0.9255241751670837
10/29/2022 10:19:32 AM,"Constructing a Stock Portfolio ‚Äî What to Consider, What to Avoid",TipRanks,/news/stocks/constructing-a-stock-portfolio-‚Äî-what-to-consider-what-to-avoid-1031849725,neutral,0.9421131014823914
10/29/2022 8:00:00 PM,"With medical devices market expected to soar, here are companies set to benefit the most",Seeking Alpha,https://seekingalpha.com/news/3897411-with-medical-devices-market-expected-to-soar-here-are-companies-set-to-benefit-the-most?utm_source=businessinsider&utm_medium=referral,neutral,0.7235874533653259
10/31/2022 11:15:50 AM,The 7 Best Bear Market Stocks to Buy Now,InvestorPlace,/news/stocks/the-7-best-bear-market-stocks-to-buy-now-1031853131,neutral,0.8821818232536316
10/31/2022 12:14:49 PM,ESSA drops 26% as Johnson & Johnson ends trial enrollment for lead asset,Seeking Alpha,https://seekingalpha.com/news/3897672-epix-stock-drops-after-johnson--johnson-setback-for-prostrate-cancer-drug?utm_source=businessinsider&utm_medium=referral,negative,0.9700499773025513
10/31/2022 12:37:03 PM,Sonnet stock soars 16% on collaboration with J&J for 3 drug compounds,Seeking Alpha,https://seekingalpha.com/news/3897688-sonnet-stock-soars-16-on-collaboration-with-jj-for-3-drug-compounds?utm_source=businessinsider&utm_medium=referral,positive,0.9261900782585144
10/31/2022 4:28:38 PM,7 Blue-Chip Stocks Set to Soar From 52-Week Lows,InvestorPlace,/news/stocks/7-blue-chip-stocks-set-to-soar-from-52-week-lows-1031854441,negative,0.5441234707832336
10/31/2022 6:30:10 PM,Why Is Sonnet BioTherapeutics (SONN) Stock Up 100% Today?,InvestorPlace,/news/stocks/why-is-sonnet-biotherapeutics-sonn-stock-up-100-today-1031854886,positive,0.8493720293045044
11/1/2022 4:31:30 AM,7 Cash-Rich Dividend Stocks to Buy Now,InvestorPlace,/news/stocks/7-cash-rich-dividend-stocks-to-buy-now-1031855561,neutral,0.9057661294937134
11/1/2022 11:54:21 AM,Abiomed climbs 52% on $380/ share buyout deal with Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3898357-abmd-stock-surges-on-buyout-deal-with-johnson--johnson?utm_source=businessinsider&utm_medium=referral,positive,0.9398698210716248
11/1/2022 12:37:04 PM,Abiomed To Be Bought By Johnson & Johnson In $16.6 Bln Deal; Stock Surges In Pre-market ,RTTNews,/news/stocks/abiomed-to-be-bought-by-johnson-johnson-in-16-6-bln-deal-stock-surges-in-pre-market-1031857889,positive,0.485740602016449
11/1/2022 1:42:21 PM,Why Is Abiomed (ABMD) Stock Up 50% Today?,InvestorPlace,/news/stocks/why-is-abiomed-abmd-stock-up-50-today-1031858696,positive,0.8174917101860046
11/1/2022 1:47:55 PM,Johnson & Johnson said to have approached Abiomed,Seeking Alpha,https://seekingalpha.com/news/3898558-johnson-johnson-said-to-have-approached-abiomed?utm_source=businessinsider&utm_medium=referral,neutral,0.9067540168762207
11/1/2022 5:26:53 PM,Legend Biotech initiated at outperform at Cowen on strength of Carvykti,Seeking Alpha,https://seekingalpha.com/news/3898764-legend-biotech-initiated-at-outperform-at-cowen-on-strength-of-carvykti?utm_source=businessinsider&utm_medium=referral,positive,0.9366981983184814
11/1/2022 5:51:17 PM,Abiomed unlikely to see higher bid given size of J&J premium - analyst,Seeking Alpha,https://seekingalpha.com/news/3898849-abiomed-unlikely-to-see-higher-bid-given-size-of-jj-premium-analyst?utm_source=businessinsider&utm_medium=referral,positive,0.9117242693901062
11/1/2022 9:28:16 PM,What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal,Benzinga,/news/etf/what-to-watch-in-the-s-p-biotech-etf-after-johnson-johnson-s-16-6b-abiomed-deal-1031860263,neutral,0.9295636415481567
11/2/2022 12:25:29 AM,Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.,InvestorPlace,/news/stocks/hurry-7-pitiful-nasdaq-stocks-to-sell-before-2022-ends-1031860759,negative,0.8560692667961121
11/3/2022 1:06:27 PM,Cramer's Take On This Stock That's Down 53% Year-To-Date: 'I Think Long-Term. I Don't Want To Own It',Benzinga,/news/stocks/cramer-s-take-on-this-stock-that-s-down-53-year-to-date-i-think-long-term-i-don-t-want-to-own-it-1031870171,negative,0.8992704749107361
11/3/2022 4:30:26 PM,"Cancer drugs launch prices soaring, straining Medicare, report finds",Seeking Alpha,https://seekingalpha.com/news/3901117-cancer-drugs-launch-prices-soaring-straining-medicare-report-finds?utm_source=businessinsider&utm_medium=referral,negative,0.5917274951934814
11/3/2022 7:34:14 PM,Why Is Provention Biosciences (PRVB) Stock Up 25% Today?,InvestorPlace,/news/stocks/why-is-provention-biosciences-prvb-stock-up-25-today-1031872165,positive,0.886052131652832
11/4/2022 5:30:43 PM,"Catalyst watch: CPI downtick, election ripples, Disney and Rivian earnings, Roblox conference call",Seeking Alpha,https://seekingalpha.com/news/3902134-catalyst-watch-cpi-downtick-election-ripples-disney-and-rivian-earnings-roblox-conference-call?utm_source=businessinsider&utm_medium=referral,neutral,0.6538471579551697
11/6/2022 2:00:31 PM,"M&A investors have tough, unexpected week with Rogers deal termination, Albertsons dividend",Seeking Alpha,https://seekingalpha.com/news/3902379-ma-investors-have-tough-unexpected-week-with-rogers-deal-termination-albertsons-dividend?utm_source=businessinsider&utm_medium=referral,negative,0.9502963423728943
11/6/2022 5:00:24 PM,"Off-patent drugs make up 91% of prescriptions, but only 18% of spending - report",Seeking Alpha,https://seekingalpha.com/news/3902378-off-patent-drugs-make-up-91-of-prescriptions-18-of-spending?utm_source=businessinsider&utm_medium=referral,neutral,0.8645550012588501
11/7/2022 2:05:19 PM,"Cramer On This Stock Up 138% Year-To-Date: 'Santa Can't Afford That Coal, It's Going Up Too Much'",Benzinga,/news/stocks/cramer-on-this-stock-up-138-year-to-date-santa-can-t-afford-that-coal-it-s-going-up-too-much-1031881232,positive,0.8951488137245178
11/7/2022 8:42:12 PM,Former J&J exec no longer seen as frontrunner for Biogen CEO position  - STAT,Seeking Alpha,https://seekingalpha.com/news/3902997-former-johnson-johnson-exec-no-longer-seen-as-frontrunner-for-biogen-ceo-position-stat?utm_source=businessinsider&utm_medium=referral,neutral,0.9084571599960327
11/8/2022 5:50:15 AM,"PFE, JNJ, or CVS: Which Healthcare Stock is a ‚ÄúStrong Buy‚Äù for Wall Street Pros?",TipRanks,/news/stocks/pfe-jnj-or-cvs-which-healthcare-stock-is-a-strong-buy-for-wall-street-pros-1031885165,neutral,0.826926052570343
11/8/2022 7:04:04 PM,The 7 Best Pharma Stocks to Buy Now,InvestorPlace,/news/stocks/the-7-best-pharma-stocks-to-buy-now-1031893081,neutral,0.8310680389404297
11/8/2022 8:37:59 PM,Election Day Is Here: Which Politicians Are Profiting (Or Losing) On Stocks?,Benzinga,/news/stocks/election-day-is-here-which-politicians-are-profiting-or-losing-on-stocks-1031888216,neutral,0.7142791152000427
11/9/2022 7:19:11 PM,"'Waiting Game Continues' In Emergent BioSolutions, Analysts Cut Price Target",Benzinga,/news/stocks/waiting-game-continues-in-emergent-biosolutions-analysts-cut-price-target-1031893444,negative,0.8034213185310364
11/11/2022 5:12:10 PM,J&J analysis: Early Tremfya efficacy in psoriatic arthritis can predict long-term response,Seeking Alpha,https://seekingalpha.com/news/3906562-johnson-johnson-analysis-early-tremfya-efficacy-in-psoriatric-arthritis-can-predict-long-term-response?utm_source=businessinsider&utm_medium=referral,positive,0.8279592990875244
11/11/2022 8:16:39 PM,"Healthcare stocks come off lows, worst performing sector among defensive losers (update)",Seeking Alpha,https://seekingalpha.com/news/3906637-healthcare-stocks-fall-across-the-board-as-traders-move-out-of-defensive-sectors?utm_source=businessinsider&utm_medium=referral,negative,0.8541244268417358
11/11/2022 11:34:31 PM,"These 2 Dividend Paying ETFs Have A Track Record For Increasing Payments, Can Help Diversify Against Industry Risk",Benzinga,/news/etf/these-2-dividend-paying-etfs-have-a-track-record-for-increasing-payments-can-help-diversify-against-industry-risk-1031905724,positive,0.9117459654808044
11/13/2022 1:59:54 AM,U.S. COVID health emergency to stay in place,Seeking Alpha,https://seekingalpha.com/news/3906753-us-covid-health-emergency-to-stay-in-place?utm_source=businessinsider&utm_medium=referral,negative,0.6932174563407898
11/15/2022 2:37:53 AM,The Top Dividend Stocks to Prepare for Retirement ‚Äì And How to Choose Them,TipRanks,/news/stocks/the-top-dividend-stocks-to-prepare-for-retirement-‚Äì-and-how-to-choose-them-1031912167,neutral,0.9443628191947937
11/16/2022 9:52:53 AM,"GSK tops Access to Medicine Index, to invest ¬£100M for initiatives in low income countries",Seeking Alpha,https://seekingalpha.com/news/3908464-gsk-tops-access-to-medicine-index-to-invest-100m-for-initiatives-in-low-income-countries?utm_source=businessinsider&utm_medium=referral,positive,0.7709416747093201
11/18/2022 5:03:50 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1031925789,neutral,0.9169120192527771
11/18/2022 5:58:37 PM,"Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-november-18-2022-1031925925,negative,0.5206901431083679
11/18/2022 6:01:11 PM,Analyst Ratings for Johnson & Johnson,Benzinga,/news/stocks/analyst-ratings-for-johnson-johnson-1031925921,neutral,0.8832270503044128
11/18/2022 8:01:50 PM,7 Analysts Have This to Say About Johnson & Johnson,Benzinga,/news/stocks/7-analysts-have-this-to-say-about-johnson-johnson-1031926149,neutral,0.9104386568069458
11/18/2022 8:54:31 PM,Analyst Expects Derisking Required Ahead Of Patent Expiry For This Large Pharma/MedTech Stock,Benzinga,/news/stocks/analyst-expects-derisking-required-ahead-of-patent-expiry-for-this-large-pharma-medtech-stock-1031926255,neutral,0.8591315746307373
11/21/2022 2:02:22 PM,7 Must-Own Safe Havens as Market Selloff Accelerates,InvestorPlace,/news/stocks/7-must-own-safe-havens-as-market-selloff-accelerates-1031928733,positive,0.483327716588974
11/30/2022 3:54:10 PM,Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?,InvestorPlace,/news/stocks/why-is-horizon-therapeutics-hznp-stock-up-30-today-1031945358,positive,0.9025951027870178
11/30/2022 7:52:36 PM,Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout,Benzinga,/news/stocks/analyst-forecasts-101-117-share-offer-price-for-horizon-therapeutics-buyout-1031946005,neutral,0.919748067855835
12/1/2022 2:42:14 AM,J&J Elects Its CEO Joaquin Duato To Assume Additional Position Of Chairman ,RTTNews,/news/stocks/j-j-elects-its-ceo-joaquin-duato-to-assume-additional-position-of-chairman-1031946511,neutral,0.9290662407875061
12/5/2022 4:30:33 PM,Why Is Yumanity Therapeutics (YMTX) Stock Up Today?,InvestorPlace,/news/stocks/why-is-yumanity-therapeutics-ymtx-stock-up-today-1031953540,neutral,0.691440761089325
12/5/2022 8:22:27 PM,7 Iron-Clad Stocks That Will Resist the Market Turmoil,InvestorPlace,/news/stocks/7-iron-clad-stocks-that-will-resist-the-market-turmoil-1031953891,neutral,0.8181341290473938
12/6/2022 4:25:35 PM,Morgan Stanley Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/morgan-stanley-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1031956250,neutral,0.8140199184417725
12/8/2022 1:43:23 PM,Abiomed ticks higher after HSR waiting period for Johnson & Johnson sale expires,Seeking Alpha,https://seekingalpha.com/news/3915276-abiomed-ticks-higher-after-hsr-waiting-period-for-johnson-johnson-sale-expires?utm_source=businessinsider&utm_medium=referral,positive,0.8065862059593201
12/8/2022 7:28:13 PM,"Gracell Biotech Stock Has Over 100% Upside On Next-Gen CAR-T Platforms, Analyst Claims",Benzinga,/news/stocks/gracell-biotech-stock-has-over-100-upside-on-next-gen-car-t-platforms-analyst-claims-1031961324,positive,0.8186198472976685
12/8/2022 7:28:42 PM,EU wants to delay medical device law amid supply challenges - Reuters,Seeking Alpha,https://seekingalpha.com/news/3915442-eu-wants-to-delay-medical-device-law-amid-supply-challenges-reuters?utm_source=businessinsider&utm_medium=referral,negative,0.8308999538421631
12/9/2022 6:56:26 PM,The 7 Best Stocks to Buy This Week,InvestorPlace,/news/stocks/stocks-to-buy-this-week-1031665405,neutral,0.8617549538612366
12/11/2022 7:24:02 PM,Amgen said in advanced talks to buy Horizon Therapeutics for well over $20B - WSJ,Seeking Alpha,https://seekingalpha.com/news/3915954-amgen-said-in-advanced-talks-to-buy-horizon-therapeutics-wsj?utm_source=businessinsider&utm_medium=referral,neutral,0.8048015236854553
12/12/2022 2:19:47 AM,Sanofi Says Doesn't Intend To Make Offer For Horizon; But Amgen Reportedly In Advanced Talks ,RTTNews,/news/stocks/sanofi-says-doesn-t-intend-to-make-offer-for-horizon-but-amgen-reportedly-in-advanced-talks-1031964257,neutral,0.913436770439148
12/12/2022 11:40:45 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Johnson & Johnson (JNJ), Surgery Partners (SGRY) and Reata Pharmaceuticals (RETA)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-johnson-johnson-jnj-surgery-partners-sgry-and-reata-pharmaceuticals-reta-1031965110,negative,0.8312995433807373
12/12/2022 2:47:43 PM,Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal,InvestorPlace,/news/stocks/horizon-therapeutics-hznp-stock-pops-on-huge-amgen-deal-1031967131,negative,0.87907874584198
12/12/2022 3:03:26 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1031965423,neutral,0.9169120192527771
12/12/2022 5:34:15 PM,Allogene down 11% following downgrade to underperform at BofA,Seeking Alpha,https://seekingalpha.com/news/3916226-allogene-down-11-downgraded-to-underperform-at-bofa-on-lack-of-catalysts-competitiveness-concerns?utm_source=businessinsider&utm_medium=referral,negative,0.9699710011482239
12/13/2022 6:50:12 PM,BeiGene says Brukinsa bests J&J's Imbruvica in progression-free survival for leukemia,Seeking Alpha,https://seekingalpha.com/news/3916643-beigene-says-brukinsa-bests-johnson-johnson-imbruvica-in-progression-free-survival-for-leukemia?utm_source=businessinsider&utm_medium=referral,positive,0.9209824204444885
12/13/2022 7:53:05 PM,The 7 Best Investment Funds to Navigate a Possible Recession,InvestorPlace,/news/stocks/the-7-best-investment-funds-to-navigate-possible-recession-1031970170,neutral,0.6435855031013489
12/14/2022 5:23:02 PM,WHO chief hopeful COVID emergency will end next year,Seeking Alpha,https://seekingalpha.com/news/3917016-who-chief-hopeful-covid-emergency-will-end-next-year?utm_source=businessinsider&utm_medium=referral,neutral,0.8428403735160828
12/14/2022 7:02:53 PM,Colorado becomes fourth state to ask feds to import drugs from Canada,Seeking Alpha,https://seekingalpha.com/news/3917055-colorado-becomes-fourth-state-to-ask-feds-to-import-drugs-from-canada?utm_source=businessinsider&utm_medium=referral,neutral,0.7342970371246338
12/15/2022 9:34:46 AM,FDA extends review of AstraZeneca/Merck's Lynparza's expanded use in prostate cancer,Seeking Alpha,https://seekingalpha.com/news/3917418-fda-extends-review-of-astrazenecamercks-lynparzas-expanded-use-in-prostate-cancer?utm_source=businessinsider&utm_medium=referral,neutral,0.8040944933891296
12/15/2022 11:08:17 AM,"J&J, Merck Ebola vaccines show lasting antibody response in kids, adults in trials",Seeking Alpha,https://seekingalpha.com/news/3917434-jj-merck-ebola-vaccines-show-lasting-antibody-response-in-kids-and-adults-in-trials?utm_source=businessinsider&utm_medium=referral,positive,0.8599140048027039
12/16/2022 11:25:27 AM,7 Top-Rated Large-Cap Stocks to Buy and Hold,InvestorPlace,/news/stocks/large-cap-stocks-to-buy-and-hold-1031827937,neutral,0.8808762431144714
12/16/2022 4:46:26 PM,FDA sets January meeting to consider further updates to COVID shots,Seeking Alpha,https://seekingalpha.com/news/3918097-fda-sets-january-meeting-to-consider-further-updates-to-covid-shots?utm_source=businessinsider&utm_medium=referral,neutral,0.9191787242889404
12/16/2022 6:04:34 PM,Time to start nibbling at stocks; 'this is not all gloom and doom' - Hightower's Stephanie Link,Seeking Alpha,https://seekingalpha.com/news/3918108-hightowers-stephanie-link-markets-will-sky-rocket-when-fed-will-pivot-but-not-very-soon?utm_source=businessinsider&utm_medium=referral,neutral,0.6496508121490479
12/18/2022 9:34:20 PM,The 7 Best Retirement Stocks to Buy Now,InvestorPlace,/news/stocks/best-retirement-stocks-1031562793,neutral,0.8736041188240051
12/19/2022 10:41:09 PM,"Abiomed leaving S&P 500, replaced by Steel Dynamics",Seeking Alpha,https://seekingalpha.com/news/3918757-abiomed-leaving-sp-500-replaced-by-steel-dynamics?utm_source=businessinsider&utm_medium=referral,negative,0.7958133220672607
12/20/2022 12:35:00 AM,Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400,PR Newswire,/news/stocks/steel-dynamics-set-to-join-s-p-500-super-micro-computer-to-join-s-p-midcap-400-1031981302,neutral,0.9075056314468384
12/20/2022 1:30:49 AM,Steel Dynamics To Replace Abiomed In S&P 500 ,RTTNews,/news/stocks/steel-dynamics-to-replace-abiomed-in-s-p-500-1031981329,neutral,0.5849702954292297
12/20/2022 3:12:22 PM,"CVS, Walgreens limiting purchases of children's pain relief meds on high demand",Seeking Alpha,https://seekingalpha.com/news/3918953-cvs-walgreens-limiting-purchases-of-childrens-pain-relief-meds-on-high-demand?utm_source=businessinsider&utm_medium=referral,negative,0.757850706577301
12/20/2022 5:00:22 PM,The 7 Best Bear Market Stocks to Buy Now,InvestorPlace,/news/stocks/best-bear-market-stocks-1031573318,neutral,0.8821818232536316
12/21/2022 7:00:40 PM,7 Dividend Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/dividend-stocks-to-buy-and-hold-1031557866,neutral,0.9479726552963257
12/22/2022 7:44:36 AM,Johnson & Johnson (NYSE:JNJ): This Dividend King is an Appealing Retirement Stock,TipRanks,/news/stocks/johnson-johnson-nyse-jnj-this-dividend-king-is-an-appealing-retirement-stock-1031986408,neutral,0.8710885643959045
12/22/2022 2:28:07 PM,Johnson & Johnson closes Abiomed acquisition,Seeking Alpha,https://seekingalpha.com/news/3919803-jnj-stock-dips-closes-abiomed-acquisition?utm_source=businessinsider&utm_medium=referral,neutral,0.5132487416267395
12/23/2022 4:51:10 PM,Immune-evasive Omicron subvariant XBB rapidly gaining ground in U.S.,Seeking Alpha,https://seekingalpha.com/news/3920398-immune-evasive-omicron-subvariant-xbb-rapidly-gaining-ground-in-us?utm_source=businessinsider&utm_medium=referral,positive,0.9495846629142761
12/23/2022 8:21:12 PM,"Tax-loss selling, window dressing will likely ruin Santa Claus rally - DCLA's Sarat Sethi",Seeking Alpha,https://seekingalpha.com/news/3920543-fed-spooks-santa-claus-rally-dclas-sarat-sethi?utm_source=businessinsider&utm_medium=referral,negative,0.6500754952430725
12/24/2022 6:17:58 PM,"Barron's Top Weekend Stock Picks: Costco, Johnson & Johnson, And How Tesla Could Become A Value Stock",Benzinga,/news/stocks/barron-s-top-weekend-stock-picks-costco-johnson-johnson-and-how-tesla-could-become-a-value-stock-1031989835,neutral,0.9280411005020142
12/26/2022 12:05:59 PM,The 7 Best Warren Buffett Stocks to Buy,InvestorPlace,/news/stocks/best-warren-buffett-stocks-1031570894,neutral,0.7930254340171814
12/30/2022 5:45:22 PM,Merck is best performing large U.S. pharma of 2022,Seeking Alpha,https://seekingalpha.com/news/3921306-merck-is-best-performing-large-us-pharma-of-2022?utm_source=businessinsider&utm_medium=referral,positive,0.9400242567062378
12/30/2022 6:19:49 PM,Omicron subvariant XBB becomes dominant COVID strain in U.S.,Seeking Alpha,https://seekingalpha.com/news/3921324-omicron-subvariant-xbb-becomes-dominant-covid-strain-in-us?utm_source=businessinsider&utm_medium=referral,positive,0.8420140743255615
12/31/2022 3:00:00 PM,"Align, Invitae among healthcare stocks SA contributors correctly said to avoid in 2022",Seeking Alpha,https://seekingalpha.com/news/3920820-align-invitae-among-health-names-sa-contributors-correctly-said-to-avoid-in-2022?utm_source=businessinsider&utm_medium=referral,neutral,0.8286208510398865
1/2/2023 11:33:02 AM,7 Stocks for Beginners to Buy Now,InvestorPlace,/news/stocks/best-stocks-for-beginners-1031607349,neutral,0.9169201254844666
1/3/2023 9:24:44 AM,"J&J, Legend Biotech's Carvykti for multiple myeloma gets review in China",Seeking Alpha,https://seekingalpha.com/news/3921428-jj-legend-biotechs-carvykti-for-multiple-myeloma-gets-review-in-china?utm_source=businessinsider&utm_medium=referral,neutral,0.5742108225822449
1/3/2023 7:20:31 PM,7 Must-Buy Dividend Stocks for Your January Buy List,InvestorPlace,/news/stocks/7-must-buy-dividend-stocks-for-your-january-buy-list-1031998516,neutral,0.9449601769447327
1/3/2023 7:43:16 PM,Immunovant gains as Wells Fargo names as a top SMID cap biotech pick,Seeking Alpha,https://seekingalpha.com/news/3921686-imvt-stock-gains-wells-fargo-names-top-smid-cap-biotech-pick?utm_source=businessinsider&utm_medium=referral,positive,0.9111081957817078
1/4/2023 5:30:15 PM,The 10 Best Dividend Stocks of All Time¬†,InvestorPlace,/news/stocks/best-dividend-stocks-of-all-time-1031596593,neutral,0.7762684226036072
1/4/2023 6:55:55 PM,7 Safe Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/safe-stocks-to-buy-and-hold-1031612420,neutral,0.9261382222175598
1/4/2023 11:34:40 PM,J&J consumer health spinout Kenvue files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/3922164-jj-consumer-health-spinout-kenvue-files-for-100m-ipo?utm_source=businessinsider&utm_medium=referral,neutral,0.9252833724021912
1/5/2023 3:39:49 AM,Johnson & Johnson's Consumer Health Unit Kenvue Files For IPO ,RTTNews,/news/stocks/johnson-johnson-s-consumer-health-unit-kenvue-files-for-ipo-1032001078,neutral,0.9364380240440369
1/5/2023 10:42:21 PM,"Fate Therapeutics shares crater ~50% on ending tie-up with Janssen, layoffs",Seeking Alpha,https://seekingalpha.com/news/3922552-fate-therapeutics-shares-crater-50-on-ending-tie-up-with-janssen-layoffs?utm_source=businessinsider&utm_medium=referral,negative,0.9396839141845703
1/6/2023 10:26:55 AM,"Alvotech, Teva get FDA review for biosimilar to J&J's Stelara",Seeking Alpha,https://seekingalpha.com/news/3922582-alvotech-teva-get-fda-review-for-biosimilar-to-jjs-stelara?utm_source=businessinsider&utm_medium=referral,positive,0.857458233833313
1/6/2023 4:27:19 PM,"Fate Therapeutics Ends Collaboration Deal With Janssen, Cuts Staff",Benzinga,/news/stocks/fate-therapeutics-ends-collaboration-deal-with-janssen-cuts-staff-1032004507,negative,0.7803992033004761
1/6/2023 5:41:34 PM,Fate faces slew of analyst downgrades after J&J's Janssen unit ends agreement,Seeking Alpha,https://seekingalpha.com/news/3922756-fate-faces-slew-of-analyst-downgrades-after-johnson-johnson-janssen-unit-ends-agreement?utm_source=businessinsider&utm_medium=referral,negative,0.9644080996513367
1/6/2023 8:48:56 PM,"CRISPR Layoffs 2023: Job Cuts Hit Gene-Editing Stocks FATE, TCRR, IPSC",InvestorPlace,/news/stocks/crispr-layoffs-2023-job-cuts-hit-gene-editing-stocks-fate-tcrr-ipsc-1032005093,negative,0.8822424411773682
1/6/2023 11:26:24 PM,5 Top Pharma Stocks of 2022 to Buy for the Long Haul,InvestorPlace,/news/stocks/5-top-pharma-stocks-of-2022-to-buy-for-the-long-haul-1032005182,neutral,0.8010980486869812
1/10/2023 11:34:49 AM,7 Warren Buffet Stocks to Buy and Hold for the Next Decade,InvestorPlace,/news/stocks/warren-buffett-stocks-to-buy-and-hold-1031558120,neutral,0.9174212217330933
1/10/2023 1:08:28 PM,WHO sets Jan. 27 meeting to decide on COVID emergency,Seeking Alpha,https://seekingalpha.com/news/3923286-who-sets-jan-27-meeting-to-decide-on-covid-emergency?utm_source=businessinsider&utm_medium=referral,neutral,0.9474840760231018
1/10/2023 6:45:11 PM,Cosmos extends and updates deal to acquire Cana Laboratories,Seeking Alpha,https://seekingalpha.com/news/3923434-cosmos-extends-and-updates-deal-to-acquire-cana-laboratories?utm_source=businessinsider&utm_medium=referral,neutral,0.5548117160797119
1/10/2023 6:48:19 PM,"If You Invested $1,000 In Inovio Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now",Benzinga,/news/stocks/if-you-invested-1-000-in-inovio-stock-at-its-covid-19-pandemic-low-here-s-how-much-you-d-have-now-1032010420,neutral,0.911882221698761
1/11/2023 9:49:15 AM,Alvotech starts study of biosimilar of J&J's rheumatoid arthritis drug Simponi,Seeking Alpha,https://seekingalpha.com/news/3923570-alvotech-starts-study-of-biosimilar-of-jjs-rheumatoid-arthritis-drug-simponi?utm_source=businessinsider&utm_medium=referral,neutral,0.7315362691879272
1/11/2023 6:06:37 PM,7 Hot Healthcare Stocks to Watch in 2023,InvestorPlace,/news/stocks/7-hot-healthcare-stocks-to-watch-in-2023-1032013193,neutral,0.8813205361366272
1/11/2023 8:35:28 PM,Medicare to publish drugs targeted for pricing negotiations in September,Seeking Alpha,https://seekingalpha.com/news/3923880-medicare-publish-drugs-targeted-pricing-negotiations-in-september?utm_source=businessinsider&utm_medium=referral,neutral,0.9117304682731628
1/12/2023 6:52:33 PM,White House COVID coordinator warns winter surges of infections will be new normal,Seeking Alpha,https://seekingalpha.com/news/3924266-white-house-covid-coordinator-warns-winter-surges-of-infections-will-be-new-normal?utm_source=businessinsider&utm_medium=referral,negative,0.9300767779350281
1/13/2023 3:54:22 PM,Omicron subvariant XBB.1.5 makes up 43% of COVID cases in U.S. ‚Äì CDC,Seeking Alpha,https://seekingalpha.com/news/3924549-omicron-subvariant-xbb15-makes-up-43-of-covid-cases-in-us-cdc?utm_source=businessinsider&utm_medium=referral,neutral,0.933558464050293
1/13/2023 4:16:22 PM,Johnson & Johnson is scaling back COVID-19 vaccine production ‚Äì WSJ,Seeking Alpha,https://seekingalpha.com/news/3924553-jnj-stock-falls-as-company-scaling-back-covid-19-vaccine-production?utm_source=businessinsider&utm_medium=referral,negative,0.9495651721954346
1/13/2023 7:22:37 PM,"Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot",Benzinga,/news/stocks/johnson-johnson-cuts-production-ends-contracts-for-not-so-successful-covid-19-shot-1032018165,negative,0.9613111615180969
1/18/2023 12:34:06 PM,Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today,Benzinga,/news/stocks/moderna-gets-a-booster-shot-why-stock-is-up-nearly-7-today-1032025074,positive,0.9358070492744446
1/18/2023 4:12:04 PM,Johnson & Johnson scraps HIV vaccine program after Phase 3 setback,Seeking Alpha,https://seekingalpha.com/news/3925478-johnson-johnson-scraps-hiv-vaccine-program-after-phase-3-setback?utm_source=businessinsider&utm_medium=referral,negative,0.8535193204879761
1/19/2023 4:29:43 PM,3 Safe Stock Bets for an Unpredictable Market,InvestorPlace,/news/stocks/3-safe-stock-bets-for-an-unpredictable-market-1032029023,neutral,0.8828819990158081
1/19/2023 10:05:01 PM,BeiGene's Brukinsa gains approval for two additional types of leukemia,Seeking Alpha,https://seekingalpha.com/news/3926154-beigene-brukinsa-gains-approval-for-two-additional-types-of-leukemia?utm_source=businessinsider&utm_medium=referral,positive,0.9115501642227173
1/20/2023 12:30:20 PM,Japan to consider downgrading COVID to same level as seasonal flu,Seeking Alpha,https://seekingalpha.com/news/3926268-japan-to-consider-downgrading-covid-to-same-level-as-seasonal-flu?utm_source=businessinsider&utm_medium=referral,neutral,0.8910207748413086
1/20/2023 12:31:18 PM,"Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), BeiGene (BGNE)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-johnson-johnson-jnj-beigene-bgne-1032030702,neutral,0.4800037443637848
1/20/2023 2:30:47 PM,Draganfly To Rally Around 87%? Here Are 10 Other Analyst Forecasts For Friday,Benzinga,/news/stocks/draganfly-to-rally-around-87-here-are-10-other-analyst-forecasts-for-friday-1032030827,neutral,0.9135151505470276
1/20/2023 4:01:21 PM,What 5 Analyst Ratings Have To Say About Johnson & Johnson,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-johnson-johnson-1032031057,neutral,0.9377720355987549
1/20/2023 5:16:36 PM,"Earnings week ahead: Tesla, Microsoft, AT&T and more",Seeking Alpha,https://seekingalpha.com/news/3926380-earnings-week-ahead-tesla-microsoft-att-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9216915369033813
1/20/2023 7:30:11 PM,"Catalyst watch: Tesla reverberations, Intel earnings, Rocket Lab launch and Macau stocks on holiday",Seeking Alpha,https://seekingalpha.com/news/3926434-catalyst-watch-tesla-reverberations-intel-earnings-rocket-lab-launch-and-macau-stocks-on-holiday?utm_source=businessinsider&utm_medium=referral,neutral,0.8929740190505981
1/21/2023 9:40:00 PM,"AstraZeneca, Biogen, Bristol, and Eli Lilly among companies w/ blockbuster potential drugs",Seeking Alpha,https://seekingalpha.com/news/3926479-astrazeneca-biogen-bristol-and-eli-lilly-among-companies-with-blockbuster-potential-drugs?utm_source=businessinsider&utm_medium=referral,neutral,0.9066245555877686
1/23/2023 12:15:10 PM,Morphic says Johnson & Johnson unit ended research collaboration,Seeking Alpha,https://seekingalpha.com/news/3926626-morf-stock-slips-johnson--johnson-unit-end-research-deal?utm_source=businessinsider&utm_medium=referral,neutral,0.8502247929573059
1/23/2023 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-q4-quarterly-earnings-preview-stock-1032033991,neutral,0.9335330724716187
1/23/2023 3:01:19 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3926753-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral,positive,0.8660829067230225
1/23/2023 3:26:55 PM,"Nasdaq, S&P, and Dow move higher as Wall Street gears up for an earnings-packed week",Seeking Alpha,https://seekingalpha.com/news/3926606-sp500-nasdaq-dow-jones-stock-market?utm_source=businessinsider&utm_medium=referral,positive,0.6438301205635071
1/23/2023 3:33:42 PM,FDA plans an annual schedule for updated COVID shots,Seeking Alpha,https://seekingalpha.com/news/3926754-fda-plans-an-annual-schedule-for-updated-covid-shots?utm_source=businessinsider&utm_medium=referral,neutral,0.9269378781318665
1/23/2023 5:05:09 PM,Johnson & Johnson to report Q4 earnings amid macro concerns,Seeking Alpha,https://seekingalpha.com/news/3926788-johnson-johnson-to-report-q4-earnings-amid-macro-concerns?utm_source=businessinsider&utm_medium=referral,negative,0.9535406827926636
1/23/2023 9:04:41 PM,"Risk-on bet sends Dow, S&P 500, Nasdaq higher",Seeking Alpha,https://seekingalpha.com/news/3926863-risk-on-bet-sends-dow-sp-500-nasdaq-higher?utm_source=businessinsider&utm_medium=referral,positive,0.5778689980506897
1/23/2023 9:53:36 PM,The 7 Best Income Stocks to Buy in January,InvestorPlace,/news/stocks/the-7-best-income-stocks-to-buy-in-january-1032035035,neutral,0.9139778017997742
1/24/2023 10:02:31 AM,"Microsoft, Verizon Communications And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/microsoft-verizon-communications-and-3-stocks-to-watch-heading-into-tuesday-1032036073,neutral,0.9295194149017334
1/24/2023 11:26:17 AM,"Johnson & Johnson Non-GAAP EPS of $2.35 beats by $0.11, revenue of $23.7B misses by $200M",Seeking Alpha,https://seekingalpha.com/news/3927039-johnson-and-johnson-non-gaap-eps-of-2_35-beats-0_11-revenue-of-23_7b-misses-200m?utm_source=businessinsider&utm_medium=referral,neutral,0.730836808681488
1/24/2023 12:10:41 PM,"J&J trades higher despite Q4 revenue hit by forex, COVID vaccine impact, FY23 outlook above estimates",Seeking Alpha,https://seekingalpha.com/news/3927066-jj-trades-higher-despite-q4-revenue-hit-by-forex-covid-vaccine-impact-fy23-outlook-above-estimates?utm_source=businessinsider&utm_medium=referral,positive,0.9099159836769104
1/24/2023 12:39:27 PM,"Johnson & Johnson Q4 Profit Decreases, but beats estimates",RTTNews,/news/stocks/johnson-johnson-q4-profit-decreases-but-beats-estimates-1032036379,negative,0.9718552827835083
1/24/2023 1:23:33 PM,"Johnson & Johnson Q4 Profit Down 26%, But Adj. EPS Tops Estimates ",RTTNews,/news/stocks/johnson-johnson-q4-profit-down-26-but-adj-eps-tops-estimates-1032036523,negative,0.9724675416946411
1/24/2023 1:41:20 PM,Wall Street Might Open Lower ,RTTNews,/news/stocks/wall-street-might-open-lower-1032036579,neutral,0.5649076104164124
1/24/2023 3:07:45 PM,Why Are Stocks Down Today?,InvestorPlace,/news/stocks/why-are-stocks-down-today-14-1032037244,negative,0.9098418354988098
1/24/2023 3:20:26 PM,"Nasdaq, S&P, and Dow trade lower after sharp rally and stronger manufacturing data",Seeking Alpha,https://seekingalpha.com/news/3927033-sp500-nasdaq-dow-jones-stock-market-earnings?utm_source=businessinsider&utm_medium=referral,negative,0.9563793540000916
1/24/2023 7:36:56 PM,"CDC chief to add new offices, leadership in organizational revamp",Seeking Alpha,https://seekingalpha.com/news/3927373-cdc-chief-to-add-new-offices-leadership-in-organizational-revamp?utm_source=businessinsider&utm_medium=referral,positive,0.5872265100479126
1/24/2023 8:14:48 PM,"Nasdaq, S&P, Dow stumble after two-day win streak as earnings take spotlight",Seeking Alpha,https://seekingalpha.com/news/3927246-nasdaq-sp500-dow-jones-stock-market-earnings-economic-data?utm_source=businessinsider&utm_medium=referral,negative,0.9303020238876343
1/24/2023 9:06:22 PM,"Dow, S&P 500, Nasdaq finish mixed as earnings season picks up steam",Seeking Alpha,https://seekingalpha.com/news/3927392-dow-sp-500-nasdaq-finish-mixed-as-earnings-season-picks-up-steam?utm_source=businessinsider&utm_medium=referral,negative,0.9387121796607971
1/25/2023 12:25:24 PM,Atlantic Equities Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/atlantic-equities-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032040034,neutral,0.5214512944221497
1/25/2023 1:37:14 PM,Union Pacific To Rally Over 11%? Here Are 10 Other Analyst Forecasts For Wednesday,Benzinga,/news/stocks/union-pacific-to-rally-over-11-here-are-10-other-analyst-forecasts-for-wednesday-1032040092,neutral,0.9079694151878357
1/25/2023 4:31:36 PM,"Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Idexx Laboratories (IDXX) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-danaher-dhr-idexx-laboratories-idxx-and-johnson-johnson-jnj-1032041134,neutral,0.911987841129303
1/26/2023 8:39:21 AM,Evotec Partners With Janssen Biotech To Develop Immune-based Cancer Therapies ,RTTNews,/news/stocks/evotec-partners-with-janssen-biotech-to-develop-immune-based-cancer-therapies-1032042835,positive,0.6961009502410889
1/26/2023 10:52:21 AM,Evotec stock rises on licensing deal with J&J to develop immune-based drugs,Seeking Alpha,https://seekingalpha.com/news/3928233-evotec-stock-rises-on-licensing-deal-with-jj-to-develop-immune-based-drugs?utm_source=businessinsider&utm_medium=referral,positive,0.8805683851242065
1/26/2023 11:06:46 PM,The 3 Best Biotech Stocks Under $1 to Buy for January,InvestorPlace,/news/stocks/the-3-best-biotech-stocks-under-1-to-buy-for-january-1032045234,neutral,0.7229999303817749
1/27/2023 1:15:17 AM,Barclays Reaffirms Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/barclays-reaffirms-their-hold-rating-on-johnson-johnson-jnj-1032045301,neutral,0.7761661410331726
1/27/2023 4:31:13 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Aurinia Pharmaceuticals (AUPH) and POINT Biopharma Global (PNT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-aurinia-pharmaceuticals-auph-and-point-biopharma-global-pnt-1032045403,neutral,0.9008321166038513
1/27/2023 12:52:31 PM,J&J pulls Imbruvica combo filing in EU as EMA cites potential 'serious side effects',Seeking Alpha,https://seekingalpha.com/news/3928895-jj-pulls-imbruvica-combo-filing-in-eu-as-ema-cites-potential-serious-side-effects?utm_source=businessinsider&utm_medium=referral,negative,0.9580039381980896
1/27/2023 2:09:13 PM,JNJ/ Legend CAR-T therapy succeeds in Phase 3 multiple myeloma trial,Seeking Alpha,https://seekingalpha.com/news/3928956-jnj-legend-car-t-therapy-succeeds-late-stage-multiple-myeloma-trial?utm_source=businessinsider&utm_medium=referral,positive,0.9411073327064514
1/28/2023 6:00:40 PM,The use of artificial intelligence in medical devices and drug development,Seeking Alpha,https://seekingalpha.com/news/3929184-the-growing-use-of-artificial-intelligence-in-medical-devices-diagnostics-drug-development?utm_source=businessinsider&utm_medium=referral,neutral,0.9313576817512512
1/29/2023 5:00:25 PM,AbbVie‚Äôs global bestseller to face knockoffs starting this week,Seeking Alpha,https://seekingalpha.com/news/3929211-abbvies-global-bestseller-to-face-knockoffs-starting-this-week?utm_source=businessinsider&utm_medium=referral,negative,0.4311594069004059
1/30/2023 9:54:14 AM,Are You Seeking Passive Income? Try These 2 Dividend Kings,TipRanks,/news/stocks/are-you-seeking-passive-income-try-these-2-dividend-kings-1032050273,neutral,0.934408962726593
1/30/2023 12:00:56 PM,WHO maintains public health emergency on COVID but sees pandemic at 'transition point',Seeking Alpha,https://seekingalpha.com/news/3929274-who-maintains-public-health-emergency-on-covid-with-3-years-into-pandemic?utm_source=businessinsider&utm_medium=referral,neutral,0.7437374591827393
1/30/2023 4:28:17 PM,"$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns",Benzinga,/news/stocks/1-000-invested-in-4-of-the-5-vaccine-developers-back-when-who-declared-covid-19-an-emergency-yielded-returns-1032051302,neutral,0.8757469058036804
1/30/2023 7:57:21 PM,Why Is Johnson & Johnson (JNJ) Stock Down Today?,InvestorPlace,/news/stocks/why-is-johnson-johnson-jnj-stock-down-today-2-1032051840,negative,0.9397313594818115
1/30/2023 9:32:36 PM,J&J falls after appeals court rules company can't use bankruptcy to end cancer suits (update),Seeking Alpha,https://seekingalpha.com/news/3929431-jj-falls-after-losing-appeals-court-ruling-in-talc-litigation?utm_source=businessinsider&utm_medium=referral,negative,0.7513042092323303
1/30/2023 11:04:00 PM,Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits,PR Newswire,/news/stocks/federal-appellate-court-rejects-controversial-j-j-ploy-to-dodge-talc-cancer-lawsuits-1032052020,negative,0.7720087170600891
1/31/2023 10:34:31 AM,Court Rejects J&J Bankruptcy Petition To End Talc Cancer Lawsuits ,RTTNews,/news/stocks/court-rejects-j-j-bankruptcy-petition-to-end-talc-cancer-lawsuits-1032053415,negative,0.6374331116676331
1/31/2023 12:35:28 PM,Bank of America Securities Keeps Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/bank-of-america-securities-keeps-their-hold-rating-on-johnson-johnson-jnj-1032053930,neutral,0.9087796807289124
1/31/2023 2:24:45 PM,Haleon said to evaluate potential deals to increase its size - report,Seeking Alpha,https://seekingalpha.com/news/3929851-haleon-said-to-evaluate-potential-deals-to-increase-its-size-report?utm_source=businessinsider&utm_medium=referral,positive,0.9144662022590637
1/31/2023 3:29:00 PM,Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits,PR Newswire,/news/stocks/federal-appellate-court-rejects-controversial-j-j-ploy-to-dodge-talc-cancer-lawsuits-1032054544,negative,0.7720087170600891
1/31/2023 11:17:47 PM,The 7 Best Climate Change Stocks to Buy for 2023,InvestorPlace,/news/stocks/the-7-best-climate-change-stocks-to-buy-for-2023-1032055998,neutral,0.852171003818512
2/1/2023 3:16:38 AM,Johnson & Johnson Stock (NYSE:JNJ): Time Heals All Wounds,TipRanks,/news/stocks/johnson-johnson-stock-nyse-jnj-time-heals-all-wounds-1032056074,neutral,0.804232120513916
2/1/2023 4:18:52 PM,"Novavax, JNJ dispute pre-payments for canceled COVID shots sought for world‚Äôs poor - NYT",Seeking Alpha,https://seekingalpha.com/news/3930507-novavax-jnj-dispute-pre-payments-cancelled-covid-shots-worlds-poor?utm_source=businessinsider&utm_medium=referral,neutral,0.4863014221191406
2/1/2023 4:48:33 PM,The most overbought and oversold S&P 500 stocks to start February,Seeking Alpha,https://seekingalpha.com/news/3930472-tmost-overbought-oversold-sp500-stocks-february?utm_source=businessinsider&utm_medium=referral,negative,0.9532690048217773
2/2/2023 5:44:50 PM,3 Defensive Stocks to Buy If You Think the Market Is Headed Lower,InvestorPlace,/news/stocks/3-defensive-stocks-to-buy-if-you-think-the-market-is-headed-lower-1032063814,neutral,0.8958901166915894
2/2/2023 7:11:33 PM,U.K. pharma lobby urges govt. to halt plans to raise revenue recovery rates,Seeking Alpha,https://seekingalpha.com/news/3931486-uk-pharma-lobby-urges-govt-to-halt-plans-to-raise-revenue-recovery-rates?utm_source=businessinsider&utm_medium=referral,negative,0.927677571773529
2/2/2023 7:21:22 PM,"Johnson & Johnson's Upcoming Lung Cancer Data Could Offer Another Blockbuster Opportunity, Says Analyst",Benzinga,/news/stocks/johnson-johnson-s-upcoming-lung-cancer-data-could-offer-another-blockbuster-opportunity-says-analyst-1032063869,positive,0.9062609672546387
2/4/2023 9:00:00 PM,"Ambulatory surgery centers, robotics seen as trends for orthopedic devices in 2023",Seeking Alpha,https://seekingalpha.com/news/3932049-ambulatory-surgery-centers-robotics-seen-as-trends-for-orthopedic-devices-in-2023?utm_source=businessinsider&utm_medium=referral,neutral,0.6374903321266174
2/5/2023 12:13:24 AM,Danaher said to be interested in acquiring contract manufacturer Catalent,Seeking Alpha,https://seekingalpha.com/news/3932097-danaher-shows-takeover-interest-contract-manufacturer-catalent?utm_source=businessinsider&utm_medium=referral,neutral,0.8199102282524109
2/5/2023 5:00:57 PM,Drug price inflation continues upward momentum at 3.8% ‚Äì report,Seeking Alpha,https://seekingalpha.com/news/3932101-drug-price-inflation-continues-upward-momentum-at-38-report?utm_source=businessinsider&utm_medium=referral,positive,0.9158607125282288
2/6/2023 2:15:33 PM,Johnson & Johnson succeeds in mid-stage trial for fetal disorder candidate,Seeking Alpha,https://seekingalpha.com/news/3932298-johnson-johnson-succeeds-mid-stage-trial-fetal-disorder-candidate?utm_source=businessinsider&utm_medium=referral,positive,0.6848247051239014
2/6/2023 3:48:48 PM,Why Is Catalent (NYSE:CTLT) Stock Up 20% Today?,InvestorPlace,/news/stocks/why-is-catalent-nysectlt-stock-up-20-today-1032070835,positive,0.8154944181442261
2/6/2023 5:56:09 PM,Teva follows AbbVie to leave top pharma industry group,Seeking Alpha,https://seekingalpha.com/news/3932426-teva-follows-abbvie-to-leave-top-pharma-industry-group?utm_source=businessinsider&utm_medium=referral,neutral,0.6935393214225769
2/6/2023 6:15:50 PM,How to Score Profits In Every Trade With Minimal Risk,InvestorPlace,/news/stocks/how-to-score-profits-in-every-trade-with-minimal-risk-1032071173,neutral,0.9093331098556519
2/6/2023 7:49:01 PM,Arrowhead drops as Cantor flags risks to Johnson & Johnson licensing deal,Seeking Alpha,https://seekingalpha.com/news/3932504-arwr-stock-drops-cantor-flags-risks-johnson-johnson-licensing-deal?utm_source=businessinsider&utm_medium=referral,negative,0.8852106928825378
2/7/2023 3:01:23 AM,The 3 Best Forever Stocks to Buy for February 2023,InvestorPlace,/news/stocks/the-3-best-forever-stocks-to-buy-for-february-2023-1032071770,neutral,0.9316399097442627
2/8/2023 11:49:09 AM,Australia to offer fifth COVID shot to all adults later this month,Seeking Alpha,https://seekingalpha.com/news/3933402-australia-to-offer-fifth-covid-shot-to-all-adults-later-this-month?utm_source=businessinsider&utm_medium=referral,neutral,0.7316169142723083
2/8/2023 4:26:42 PM,Johnson & Johnson reports positive mid-stage data for rare fetus disease drug nipocalimab,Seeking Alpha,https://seekingalpha.com/news/3933603-johnson-johnson-reports-positive-mid-stage-data-for-rare-fetus-disease-drug-nipocalimab?utm_source=businessinsider&utm_medium=referral,positive,0.9470141530036926
2/9/2023 7:36:13 AM,"Roche, Janssen Biotech To Advance Personalised Healthcare Through Companion Diagnostics ",RTTNews,/news/stocks/roche-janssen-biotech-to-advance-personalised-healthcare-through-companion-diagnostics-1032081753,neutral,0.7894526124000549
2/9/2023 10:07:22 AM,7 Dividend Stocks to Buy for a Reliable Income Stream,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-for-a-reliable-income-stream-1032082235,neutral,0.8049968481063843
2/9/2023 10:39:40 AM,"Alvotech, Stada get EMA review for biosimilar to J&J's Stelara",Seeking Alpha,https://seekingalpha.com/news/3934076-alvotech-stada-get-ema-review-for-biosimilar-to-jjs-stelara?utm_source=businessinsider&utm_medium=referral,neutral,0.5782992243766785
2/10/2023 12:18:08 PM,Medicare mulls rebates in 2025 for drug prices rising faster than inflation,Seeking Alpha,https://seekingalpha.com/news/3934728-medicare-mulls-rebates-in-2025-for-drug-prices-rising-faster-than-inflation?utm_source=businessinsider&utm_medium=referral,neutral,0.5336914658546448
2/10/2023 4:46:18 PM,"Bristol-Myers, 2seventy post late-stage data for CAR-T therapy in multiple myeloma",Seeking Alpha,https://seekingalpha.com/news/3934866-bristol-myers-2seventy-late-stage-data-car-t-therapy-multiple-myeloma?utm_source=businessinsider&utm_medium=referral,positive,0.7861089110374451
2/10/2023 6:19:06 PM,3 of the Best Dividend Stocks to Buy for February¬†,InvestorPlace,/news/stocks/3-of-the-best-dividend-stocks-to-buy-for-february-1032087085,neutral,0.7848629951477051
2/12/2023 5:00:59 PM,COVID-19 emergency is ending; What it means for free vaccines and drugs,Seeking Alpha,https://seekingalpha.com/news/3935039-pandemic-emergency-ending-impact-covid-shots-drugs?utm_source=businessinsider&utm_medium=referral,neutral,0.9084373116493225
2/13/2023 4:11:05 AM,"Alcon, J&J Surgical To Settle Litigation On Femtosecond Laser Assisted Cataract Surgery Devices ",RTTNews,/news/stocks/alcon-j-j-surgical-to-settle-litigation-on-femtosecond-laser-assisted-cataract-surgery-devices-1032088325,neutral,0.7195116877555847
2/13/2023 3:57:12 PM,"Wainwright initiates Arcellx with a buy on CAR-T pipeline, partnership with Gilead's Kite",Seeking Alpha,https://seekingalpha.com/news/3935243-wainwright-initiates-arcellx-with-a-buy-on-car-t-pipeline-partnership-with-gilead-kite?utm_source=businessinsider&utm_medium=referral,positive,0.524689257144928
2/13/2023 7:18:57 PM,"OmniAb initiated with a buy at H.C. Wainwright on antibody collaborations, partnerships",Seeking Alpha,https://seekingalpha.com/news/3935341-omniab-initiated-with-a-buy-at-hc-wainwright-on-antibody-collaborations-partnerships?utm_source=businessinsider&utm_medium=referral,neutral,0.7189424633979797
2/14/2023 10:40:47 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ), Mettler-Toledo (MTD) and Bioxcel Therapeutics (BTAI)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-johnson-johnson-jnj-mettler-toledo-mtd-and-bioxcel-therapeutics-btai-1032094127,negative,0.9326804280281067
2/14/2023 12:21:21 PM,Johnson & Johnson poaches Sanofi R&D head,Seeking Alpha,https://seekingalpha.com/news/3935652-johnson-johnson-poaches-sanofi-rd-head?utm_source=businessinsider&utm_medium=referral,neutral,0.9347676038742065
2/14/2023 6:59:53 PM,J&J faces dismissal in talc unit bankruptcy filing after appeals court ruling,Seeking Alpha,https://seekingalpha.com/news/3935926-johnson-johnson-faces-dismissal-in-talc-unit-bankruptcy-filing-after-appeals-court-ruling?utm_source=businessinsider&utm_medium=referral,negative,0.9546217918395996
2/15/2023 2:12:03 PM,J&J returns rights to NASH RNAi candidate to Arrowhead Pharmaceuticals,Seeking Alpha,https://seekingalpha.com/news/3936329-johnson-johnson-returns-rights-to-nash-rnai-candidate-to-arrowhead-pharmaceuticals?utm_source=businessinsider&utm_medium=referral,neutral,0.9146599769592285
2/15/2023 6:14:32 PM,Medicare mulls limiting per month costs for generic drugs at $2,Seeking Alpha,https://seekingalpha.com/news/3936542-medicare-mulls-limiting-per-month-costs-for-generic-drugs-at-2?utm_source=businessinsider&utm_medium=referral,neutral,0.4218200445175171
2/15/2023 7:09:07 PM,3 ETFs Investors Can Buy to Weather a Recession,TipRanks,/news/stocks/3-etfs-investors-can-buy-to-weather-a-recession-1032100105,neutral,0.8542205691337585
2/15/2023 7:15:00 PM,"Immunovant Could Potentially Be An M&A Target, Writes Analyst",Benzinga,/news/stocks/immunovant-could-potentially-be-an-m-a-target-writes-analyst-1032100005,neutral,0.7652800679206848
2/16/2023 11:17:26 PM,Johnson & Johnson files for debt securities offering,Seeking Alpha,https://seekingalpha.com/news/3937530-johnson-johnson-files-for-debt-securities-offering?utm_source=businessinsider&utm_medium=referral,negative,0.5772462487220764
2/17/2023 9:05:38 PM,"S&P 500, Dow, Nasdaq finish mixed as Fed debate continues",Seeking Alpha,https://seekingalpha.com/news/3937828-sp-500-dow-nasdaq-finish-mixed-as-fed-debate-continues?utm_source=businessinsider&utm_medium=referral,negative,0.8176477551460266
2/19/2023 5:00:10 PM,The next big wave of patent cliffs is ahead; expect biopharma M&A to rise ‚Äì report,Seeking Alpha,https://seekingalpha.com/news/3937885-next-big-wave-of-patent-cliffs-ahead-biopharma-m-and-a-to-rise?utm_source=businessinsider&utm_medium=referral,positive,0.9136704802513123
2/20/2023 7:40:55 PM,The 3 Best Dividend Stocks for Beginner Investors,InvestorPlace,/news/stocks/ko-jnj-mmm-the-3-best-dividend-stocks-for-beginner-investors-1032109636,neutral,0.8241356611251831
2/20/2023 7:40:55 PM,The 3 Best Dividend Stocks for Beginner Investors,InvestorPlace,/news/stocks/the-3-best-dividend-stocks-for-beginner-investors-1032109629,neutral,0.8241356611251831
2/21/2023 4:15:14 PM,Johnson & Johnson fails in bid to overturn $302M vaginal-mesh award ‚Äì Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3938462-johnson-johnson-fails-overturn-302m-vaginal-mesh-award?utm_source=businessinsider&utm_medium=referral,negative,0.9332296252250671
2/24/2023 7:12:47 PM,Johnson & Johnson wins EU nod for prostate cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3940807-johnson-johnson-wins-eu-nod-for-prostate-cancer-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.8188332915306091
2/25/2023 9:00:00 PM,"Pharmas, medtechs dominate list of innovation leaders thanks to patents",Seeking Alpha,https://seekingalpha.com/news/3940793-pharmas-medtechs-dominate-list-of-innovation-leaders-thanks-to-patents?utm_source=businessinsider&utm_medium=referral,neutral,0.6739816069602966
2/27/2023 10:34:00 PM,Emergent BioSolutions off 4% on Q4 2022 bottom line miss,Seeking Alpha,https://seekingalpha.com/news/3941487-emergent-biosolutions-off-4-on-q4-2022-bottom-line-miss?utm_source=businessinsider&utm_medium=referral,negative,0.9636859893798828
3/1/2023 11:39:48 AM,FBI Director says novel coronavirus likely originated from China lab leak,Seeking Alpha,https://seekingalpha.com/news/3942433-fbi-director-says-novel-coronavirus-likely-originated-from-china-lab-leak?utm_source=businessinsider&utm_medium=referral,neutral,0.9219886064529419
3/1/2023 1:00:35 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1032135739,neutral,0.9169120192527771
3/1/2023 2:12:06 PM,7 Stocks to Protect Against the Massive Inflation Shock of 2023,InvestorPlace,/news/stocks/7-stocks-to-protect-against-the-massive-inflation-shock-of-2023-1032136605,neutral,0.6057939529418945
3/1/2023 2:23:39 PM,Cidara stock pops as CD388 helps cut influenza risk in phase 2a trial,Seeking Alpha,https://seekingalpha.com/news/3942600-cidara-stock-pops-as-cd388-helps-cut-influenza-risk-in-phase-2a-trial?utm_source=businessinsider&utm_medium=referral,positive,0.8663570880889893
3/1/2023 3:21:14 PM,"J&J initiated at neutral at Guggenheim on need for pharma, medtech growth visibility",Seeking Alpha,https://seekingalpha.com/news/3942649-johnson-johnson-initiated-at-neutral-at-guggenheim-on-need-for-pharma-medtech-growth-visibility?utm_source=businessinsider&utm_medium=referral,neutral,0.7360726594924927
3/1/2023 4:00:51 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-1-2023-1032136808,neutral,0.5188179016113281
3/1/2023 7:21:42 PM,"Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional'",Benzinga,/news/stocks/jim-cramer-says-he-s-known-novavax-is-worthless-for-very-long-time-trashes-company-for-being-too-promotional-1032137450,negative,0.8620641827583313
3/1/2023 8:55:25 PM,JNJ's Consumer Health Business Separation Will Remove Uncertainty Cloud From Company: Why This Analyst Wants Visibility,Benzinga,/news/stocks/jnj-s-consumer-health-business-separation-will-remove-uncertainty-cloud-from-company-why-this-analyst-wants-visibility-1032137596,neutral,0.9205656051635742
3/2/2023 1:01:02 PM,"Bristol-Myers, Janssen launch late-stage Librexia program evaluating milvexian",Seeking Alpha,https://seekingalpha.com/news/3943202-bristol-myers-janssen-launch-late-stage-librexia-program-evaluating-milvexian?utm_source=businessinsider&utm_medium=referral,neutral,0.6535266637802124
3/2/2023 2:39:19 PM,Merck and AstraZeneca to face FDA AdCom meeting for prostate cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3943282-merck-astrazeneca-face-fda-adcom-meeting-prostate-cancer-therapy?utm_source=businessinsider&utm_medium=referral,neutral,0.9068241715431213
3/4/2023 5:21:29 PM,Johnson & Johnson's Stelara demonstrates long-term efficacy in Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/3944202-johnson-johnson-stelara-demonstrates-long-term-efficacy-in-crohns-disease?utm_source=businessinsider&utm_medium=referral,positive,0.9443408250808716
3/4/2023 6:45:00 PM,Pharma R&D funding soared to a new record in 2022 as oncology candidates dominate pipelines,Seeking Alpha,https://seekingalpha.com/news/3944195-pharma-research-developmeny-funding-soared-to-a-new-record-in-2022-as-oncology-candidates-dominate-pipelines?utm_source=businessinsider&utm_medium=referral,positive,0.9410833716392517
3/6/2023 3:00:29 PM,"Janssen's macitentan, tadalafil combo improves pulmonary hemodynamics vs. monotherapies",Seeking Alpha,https://seekingalpha.com/news/3944464-janssens-macitentan-tadalafil-combo-improves-pulmonary-hemodynamics-vs-monotherapies?utm_source=businessinsider&utm_medium=referral,positive,0.9429464340209961
3/6/2023 7:24:23 PM,5 Stocks ChatGPT Says Will Make Me Rich in 20 Years,InvestorPlace,/news/stocks/5-growth-stocks-to-buy-according-to-chatgpt-1032148311,neutral,0.7920085787773132
3/6/2023 9:51:35 PM,7 Dividend Kings to Buy for an Uncertain Market Environment,InvestorPlace,/news/stocks/7-dividend-kings-to-buy-for-an-uncertain-market-environment-1032148499,neutral,0.6553320288658142
3/6/2023 10:07:52 PM,7 Stocks to Buy for the Worrying Climate Change Crisis,InvestorPlace,/news/stocks/7-stocks-to-buy-for-the-worrying-climate-change-crisis-1032148516,neutral,0.8517789840698242
3/7/2023 12:33:25 PM,Biden to announce plan to keep Medicare solvent beyond 2050,Seeking Alpha,https://seekingalpha.com/news/3944823-biden-to-announce-plan-to-keep-medicare-solvent-beyond-2050?utm_source=businessinsider&utm_medium=referral,positive,0.5336605906486511
3/7/2023 3:54:10 PM,Why Protagonist Therapeutics Shares Are Trading Higher Today,Benzinga,/news/stocks/why-protagonist-therapeutics-shares-are-trading-higher-today-1032150761,positive,0.7465007305145264
3/8/2023 11:41:29 AM,Sleep-at-night stocks for those hedging or risk averse,Seeking Alpha,https://seekingalpha.com/news/3945026-sleep-at-night-stocks-for-those-hedging-or-risk-averse?utm_source=businessinsider&utm_medium=referral,neutral,0.7829478979110718
3/8/2023 12:27:39 PM,Johnson & Johnson in pact with Biocytogen for antibody-based therapeutics,Seeking Alpha,https://seekingalpha.com/news/3945267-johnson-johnson-pact-with-biocytogen-antibody-based-therapeutics?utm_source=businessinsider&utm_medium=referral,positive,0.7741842269897461
3/8/2023 1:31:08 PM,Wall Street Analysts Are Neutral on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-neutral-on-top-healthcare-picks-1032153556,negative,0.7003459334373474
3/8/2023 1:33:18 PM,3 Must-Buy Income Champs as Fed Rates Head to 5%,InvestorPlace,/news/stocks/3-must-buy-income-champs-as-fed-rates-head-to-5-1032153538,positive,0.5246713161468506
3/8/2023 4:35:41 PM,J&J consumer health spinoff Kenvue begins bond sale to fund separation - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3945427-johnson-johnson-consumer-health-spinoff-kenvue-begins-bond-sale-to-fund-separation-bloomberg?utm_source=businessinsider&utm_medium=referral,neutral,0.8761558532714844
3/8/2023 9:05:24 PM,7 Stocks at 52-Week Lows and Highly Attractive From Here,InvestorPlace,/news/stocks/7-stocks-at-52-week-lows-and-highly-attractive-from-here-1032154824,negative,0.8883254528045654
3/9/2023 4:05:45 AM,Johnson & Johnson (JNJ) Gets a Buy from SVB Securities,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-svb-securities-1032155153,neutral,0.7031823396682739
3/9/2023 7:58:02 AM,How to Invest in 2023 If You Are Looking To Avoid Losses,TipRanks,/news/stocks/how-to-invest-in-2023-if-you-are-looking-to-avoid-losses-1032155910,neutral,0.9234216809272766
3/9/2023 10:36:32 AM,Kenvue prices $7.75B offering in a series of senior unsecured notes to fund separation,Seeking Alpha,https://seekingalpha.com/news/3945803-kenvue-prices-775b-offering-in-a-series-of-senior-unsecured-notes-to-fund-separation?utm_source=businessinsider&utm_medium=referral,neutral,0.9099307656288147
3/10/2023 11:42:47 AM,"3 of the Best Dividend Stocks, According to Analysts‚Äî3/10/2023",TipRanks,/news/stocks/3-of-the-best-dividend-stocks-according-to-analysts‚Äî3-10-2023-1032159708,positive,0.7050849795341492
3/10/2023 1:25:42 PM,Zimmer Biomet upgraded at Piper Sandler citing conservative guidance,Seeking Alpha,https://seekingalpha.com/news/3946438-zbh-stock-upgraded-piper-sandler-conservative-guidance?utm_source=businessinsider&utm_medium=referral,positive,0.6740034818649292
3/10/2023 3:59:27 PM,Johnson & Johnson Layoffs 2023: What to Know About the Latest JNJ Job Cuts,InvestorPlace,/news/stocks/johnson-johnson-layoffs-2023-what-to-know-about-the-latest-jnj-job-cuts-1032160387,negative,0.832728922367096
3/10/2023 4:17:44 PM,Halted Stocks Alert: Nasdaq Halts Trading in SVB Financial (SIVB) Stock,InvestorPlace,/news/stocks/halted-stocks-alert-nasdaq-halts-trading-in-svb-financial-sivb-stock-1032160421,negative,0.918716549873352
3/12/2023 2:00:00 PM,Biosimilars expected to save $180B over next five years as more gain approval,Seeking Alpha,https://seekingalpha.com/news/3946583-biosimilars-expected-to-save-180b-over-next-five-years-as-more-gain-approval?utm_source=businessinsider&utm_medium=referral,positive,0.8129685521125793
3/13/2023 2:05:19 AM,7 Blue-Chip Stocks to Buy in March,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-in-march-1032161708,neutral,0.8409128785133362
3/13/2023 12:07:25 PM,"Pfizer, AbbVie, BMS among firms at risk of U.S. drug price negotiations - report",Seeking Alpha,https://seekingalpha.com/news/3946793-pfizer-abbvie-bristol-myers-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,neutral,0.6864010691642761
3/15/2023 1:32:54 PM,Halozyme sees no impact on royalties after EU body revokes J&J's Darzalex patent,Seeking Alpha,https://seekingalpha.com/news/3947661-halozyme-sees-no-impact-on-royalties-after-eu-body-revokes-jjs-darzalex-patent?utm_source=businessinsider&utm_medium=referral,neutral,0.5855165719985962
3/15/2023 2:03:55 PM,3 Blue-Chip Dividend Stocks to Buy on the Dip Now,InvestorPlace,/news/stocks/jnj-low-o-blue-chip-dividend-stocks-to-buy-on-the-dip-now-1032169816,neutral,0.7667728066444397
3/15/2023 4:18:45 PM,7 Blue-Chip Stocks to Buy and Hold for Decades,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-and-hold-for-decades-1032170208,neutral,0.9110873341560364
3/15/2023 4:40:00 PM,Protagonist Therapeutics Touts Positive Data From Bone Marrow Disorder Study,Benzinga,/news/stocks/protagonist-therapeutics-touts-positive-data-from-bone-marrow-disorder-study-1032170095,positive,0.5547569990158081
3/15/2023 6:07:56 PM,Johnson & Johnson oral dengue therapy enters mid-stage trials,Seeking Alpha,https://seekingalpha.com/news/3947805-johnson-johnson-oral-dengue-therapy-enters-mid-stage-trials?utm_source=businessinsider&utm_medium=referral,neutral,0.7046951055526733
3/16/2023 6:15:32 PM,Medicare publishes initial guidance on drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/3948265-medicare-publishes-initial-guidance-on-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,neutral,0.9513847827911377
3/19/2023 4:00:30 PM,Pfizer CEO pockets $33M for 2022 after 36% pay hike,Seeking Alpha,https://seekingalpha.com/news/3948694-pfizer-ceo-pockets-33m-for-2022-after-36-percent-pay-hike?utm_source=businessinsider&utm_medium=referral,neutral,0.5718111395835876
3/19/2023 7:47:43 PM,Easing COVID pandemic sees many pharmas seeking alternate revenue streams,Seeking Alpha,https://seekingalpha.com/news/3948704-easing-covid-pandemic-pfizer-astrazeneca-seeking-alternate-revenue-streams?utm_source=businessinsider&utm_medium=referral,neutral,0.795910120010376
3/21/2023 4:44:41 PM,FDA may authorize another round of COVID booster shots - WSJ,Seeking Alpha,https://seekingalpha.com/news/3949556-fda-may-authorize-another-round-covid-booster-shots-wsj?utm_source=businessinsider&utm_medium=referral,neutral,0.7868635058403015
3/21/2023 10:28:03 PM,Johnson & Johnson‚Äôs (NYSE:JNJ) Decade-Low P/E Ratio Deserves Your Attention,TipRanks,/news/stocks/johnson-johnson-s-nyse-jnj-decade-low-p-e-ratio-deserves-your-attention-1032183355,negative,0.6601040363311768
3/22/2023 6:21:00 PM,J&J turns to Supreme Court to OK unit bankruptcy plan for talc lawsuits - report,Seeking Alpha,https://seekingalpha.com/news/3950072-jnj-turns-to-supreme-court-ok-unit-bankruptcy-plan-for-talc-lawsuits?utm_source=businessinsider&utm_medium=referral,neutral,0.8062607049942017
3/22/2023 9:27:00 PM,Talc Plaintiffs Will Press to Reopen Courthouse Doors,PR Newswire,/news/stocks/talc-plaintiffs-will-press-to-reopen-courthouse-doors-1032186045,neutral,0.8477206826210022
3/23/2023 6:33:09 PM,White House seeking alternative supply chains for pharmaceutical ingredients,Seeking Alpha,https://seekingalpha.com/news/3950575-white-house-alternative-supply-chains-pharmaceutical-ingredients-drug-shortages?utm_source=businessinsider&utm_medium=referral,neutral,0.6495416760444641
3/23/2023 9:57:53 PM,"J&J, AbbVie's Imbruvica gets expanded blood cancer indication in Canada",Seeking Alpha,https://seekingalpha.com/news/3950766-johnson-johnson-abbvie-imbruvica-expanded-blood-cancer-indication-canada?utm_source=businessinsider&utm_medium=referral,positive,0.8477422595024109
3/24/2023 2:44:49 PM,"Binance Suspends Trading, European Bank Trouble, Twitter To Remove Legacy Verified Checkmarks: Today's Top Stories",Benzinga,/news/stocks/binance-suspends-trading-european-bank-trouble-twitter-to-remove-legacy-verified-checkmarks-today-s-top-stories-1032190957,negative,0.6646182537078857
3/27/2023 12:20:41 PM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV), Eli Lilly & Co (LLY) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-elevance-health-elv-eli-lilly-co-lly-and-johnson-johnson-jnj-1032193916,negative,0.939370334148407
3/27/2023 10:03:59 PM,3 Blue-Chip Stocks to Buy for Stability and Safety,InvestorPlace,/news/stocks/3-safe-blue-chip-stocks-to-buy-1032195324,neutral,0.8334360718727112
3/28/2023 10:51:51 AM,argenx sells global rights for cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3951760-argenx-stock-sells-global-rights-for-cancer-therapy?utm_source=businessinsider&utm_medium=referral,neutral,0.8628824949264526
3/28/2023 4:05:00 PM,WHO updates COVID vaccine guidance; low priority for children and adolescents,Seeking Alpha,https://seekingalpha.com/news/3951932-who-updates-covid-vaccine-guidance-low-priority-for-children?utm_source=businessinsider&utm_medium=referral,neutral,0.790100634098053
3/28/2023 6:29:37 PM,7 Dividend Aristocrats to Buy for Consistent Income Growth,InvestorPlace,/news/stocks/7-dividend-aristocrats-to-buy-for-consistent-income-growth-1032198244,neutral,0.8812668323516846
3/29/2023 1:25:57 PM,Johnson & Johnson drops RSV vaccine program,Seeking Alpha,https://seekingalpha.com/news/3952263-jnj-stock-drops-rsv-vaccine-program?utm_source=businessinsider&utm_medium=referral,neutral,0.8142905831336975
3/29/2023 4:01:29 PM,Analyst Expectations for Johnson & Johnson's Future,Benzinga,/news/stocks/analyst-expectations-for-johnson-johnson-s-future-1032200727,positive,0.8650718927383423
3/29/2023 5:00:39 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-29-2023-1032200913,negative,0.4950518012046814
3/29/2023 8:13:14 PM,J&J unveils long-term data on Rybrevant for non-small cell lung cancer,Seeking Alpha,https://seekingalpha.com/news/3952439-johnson-johnson-unveils-long-term-data-on-rybrevant-for-non-small-cell-lung-cancer?utm_source=businessinsider&utm_medium=referral,neutral,0.8282192349433899
3/30/2023 2:32:15 PM,The 3 Best Stocks to Buy if You Want to Retire Early,InvestorPlace,/news/stocks/the-3-best-stocks-to-buy-if-you-want-to-retire-early-1032204079,neutral,0.9333821535110474
3/31/2023 7:00:41 PM,"Catalyst watch: Tesla deliveries, Walmart event and jobs report headline big week",Seeking Alpha,https://seekingalpha.com/news/3953276-catalyst-watch-tesla-deliveries-walmart-event-and-jobs-report-headline-big-week?utm_source=businessinsider&utm_medium=referral,negative,0.7487087249755859
3/31/2023 8:44:06 PM,3 Top Dividend Stocks to Buy Now for an Income-Based Portfolio,InvestorPlace,/news/stocks/3-top-dividend-stocks-to-buy-now-for-an-income-based-portfolio-1032208246,neutral,0.8999694585800171
4/3/2023 9:45:11 AM,Morgan Stanley Keeps Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/morgan-stanley-keeps-their-hold-rating-on-johnson-johnson-jnj-1032210053,neutral,0.896385908126831
4/3/2023 8:47:21 PM,Delaware court finds in favor of Bayer in talc disagreement with Merck,Seeking Alpha,https://seekingalpha.com/news/3953932-delaware-court-finds-in-favor-of-bayer-in-talc-disagreement-with-merck?utm_source=businessinsider&utm_medium=referral,negative,0.8480778932571411
4/4/2023 4:20:43 PM,Biogen names Adam Keeney to head corporate development,Seeking Alpha,https://seekingalpha.com/news/3954410-biogen-names-adam-keeney-head-corporate-development?utm_source=businessinsider&utm_medium=referral,neutral,0.9434019923210144
4/4/2023 5:56:20 PM,JNJ weighs second bankruptcy to halt talc-related cancer suits,Seeking Alpha,https://seekingalpha.com/news/3954443-jnj-weighs-second-bankruptcy-halt-talc-cancer-suits?utm_source=businessinsider&utm_medium=referral,neutral,0.5137022137641907
4/4/2023 8:26:08 PM,J&J unit refiles for bankruptcy over talc litigation; offers to pay $8.9B,Seeking Alpha,https://seekingalpha.com/news/3954482-johnson-johnson-unit-ltl-refile-bankruptcy-talc-litigation-offers-to-pay-89b?utm_source=businessinsider&utm_medium=referral,negative,0.6573425531387329
4/4/2023 10:57:02 PM,Johnson & Johnson To Set Aside $8.9 Bln To Resolve Talc-based Cancer Lawsuits ,RTTNews,/news/stocks/johnson-johnson-to-set-aside-8-9-bln-to-resolve-talc-based-cancer-lawsuits-1032215019,positive,0.7969405055046082
4/5/2023 9:05:12 AM,Bank of America Securities Keeps Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/bank-of-america-securities-keeps-their-hold-rating-on-johnson-johnson-jnj-1032215938,neutral,0.9087796807289124
4/5/2023 1:24:37 PM,JNJ Stock: The $8.9 Billion Reason Johnson & Johnson Is Up Today,InvestorPlace,/news/stocks/jnj-stock-the-8-9-billion-reason-johnson-johnson-is-up-today-1032216845,neutral,0.8035885691642761
4/5/2023 2:06:55 PM,InflaRx (IFRX) Stock Pops as FDA Grants Emergency Use Authorization,InvestorPlace,/news/stocks/inflarx-ifrx-stock-pops-as-fda-grants-emergency-use-authorization-1032217011,positive,0.5155983567237854
4/5/2023 2:11:22 PM,J&J's potential talc litigation settlement draws mostly positive Street reaction,Seeking Alpha,https://seekingalpha.com/news/3954668-johnson-johnson-talc-litigation-settlement-mostly-positive-street-reaction?utm_source=businessinsider&utm_medium=referral,positive,0.7541142702102661
4/5/2023 3:55:10 PM,Johnson & Johnson (JNJ) Receives a Hold from Bernstein,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-hold-from-bernstein-1032217283,neutral,0.8810334801673889
4/5/2023 8:38:01 PM,The 3 Most Undervalued Blue-Chip Stocks to Buy in April 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-blue-chip-stocks-to-buy-in-april-2023-1032217741,neutral,0.7892098426818848
4/5/2023 8:42:41 PM,The 3 Most Undervalued Warren Buffett Stocks to Buy in April 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-warren-buffett-stocks-to-buy-in-april-2023-1032217789,neutral,0.8118656873703003
4/5/2023 9:00:58 PM,Why did Johnson & Johnson stock go up today? Renewed hope for talc settlements,Seeking Alpha,https://seekingalpha.com/news/3954829-why-did-johnson-johnson-stock-go-up-today-renewed-hope-talc-settlements?utm_source=businessinsider&utm_medium=referral,positive,0.894320547580719
4/6/2023 7:50:24 AM,"Analysts‚Äô Top Healthcare Picks: Johnson & Johnson (JNJ), AbbVie (ABBV)",TipRanks,/news/stocks/analysts-top-healthcare-picks-johnson-johnson-jnj-abbvie-abbv-1032218380,positive,0.7094586491584778
4/6/2023 2:14:00 PM,The 3 Best Bargain Stocks to Buy for April 2023,InvestorPlace,/news/stocks/the-3-best-bargain-stocks-to-buy-for-april-2023-1032219441,neutral,0.9225842952728271
4/6/2023 6:14:11 PM,WHO chief expects COVID emergency to end this year,Seeking Alpha,https://seekingalpha.com/news/3955102-who-chief-expects-covid-emergency-end-this-year?utm_source=businessinsider&utm_medium=referral,neutral,0.9115643501281738
4/7/2023 6:45:24 AM,SVB Securities Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1032220374,neutral,0.7513430118560791
4/7/2023 9:20:34 PM,S&P 500 Volatility Continues As Investors Digest Latest Labor Market Data,Benzinga,/news/stocks/s-p-500-volatility-continues-as-investors-digest-latest-labor-market-data-1032220884,neutral,0.5696764588356018
4/10/2023 6:57:17 PM,3 Best Stocks to Buy in April for the Looming Recession,InvestorPlace,/news/stocks/3-best-stocks-to-buy-in-april-for-the-looming-recession-1032222569,neutral,0.7968236804008484
4/10/2023 7:00:37 PM,Morgan Stanley Maintains Equal-Weight Rating for Johnson & Johnson: Here's What You Need To Know,Benzinga,/news/stocks/morgan-stanley-maintains-equal-weight-rating-for-johnson-johnson-here-s-what-you-need-to-know-1032222446,neutral,0.9249480366706848
4/11/2023 2:25:44 AM,U.S. launches $5B program to speed up development of next-gen COVID vaccines,Seeking Alpha,https://seekingalpha.com/news/3955481-us-launches-5b-program-develop-next-gen-covid-vaccines?utm_source=businessinsider&utm_medium=referral,positive,0.8896021246910095
4/11/2023 11:30:32 AM,3 Blue-Chip Stocks to Buy at an All-Time Low in April,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-at-an-all-time-low-in-april-1032224051,negative,0.9109978079795837
4/11/2023 12:00:38 PM,Biden signs bill to end COVID national emergency,Seeking Alpha,https://seekingalpha.com/news/3955581-biden-signs-bill-end-covid-national-emergency?utm_source=businessinsider&utm_medium=referral,negative,0.5366856455802917
4/11/2023 12:56:42 PM,US DOJ asks appeals court to block Texas judge abortion pill ruling,Seeking Alpha,https://seekingalpha.com/news/3955611-us-doj-asks-appeals-court-block-texas-judge-abortion-pill-ruling?utm_source=businessinsider&utm_medium=referral,negative,0.7583171725273132
4/11/2023 5:40:48 PM,Johnson & Johnson talc victims seek dismissal of latest bankruptcy bid,Seeking Alpha,https://seekingalpha.com/news/3955718-jnj-talc-victims-seek-dismissal-latest-bankruptcy-bid?utm_source=businessinsider&utm_medium=referral,negative,0.8371520042419434
4/13/2023 9:02:47 AM,"Appeals court permits limited access to abortion pill, blocks part of Texas ruling",Seeking Alpha,https://seekingalpha.com/news/3956187-appeals-court-partially-allows-access-abortion-pill?utm_source=businessinsider&utm_medium=referral,neutral,0.5150930881500244
4/14/2023 9:32:00 AM,Ghana 1st in world to approve new malaria vaccine by Oxford,Seeking Alpha,https://seekingalpha.com/news/3956507-ghana-1st-in-world-approve-new-malaria-vaccine-oxford?utm_source=businessinsider&utm_medium=referral,positive,0.6195570826530457
4/14/2023 5:30:11 PM,"Catalyst Watch: Earnings season picks up steam, housing data due",Seeking Alpha,https://seekingalpha.com/news/3956620-catalyst-watch-earnings-season-picks-up-steam-housing-data-due?utm_source=businessinsider&utm_medium=referral,neutral,0.5577757954597473
4/14/2023 6:30:56 PM,"Earnings Week Ahead: Tesla, AT&T, Charles Schwab, Netflix, and more",Seeking Alpha,https://seekingalpha.com/news/3956682-earnings-week-ahead-tesla-att-charles-schwab-netflix-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9345334768295288
4/15/2023 1:38:31 PM,3 Dividend Stocks to Buy for a Recession-Proof Portfolio,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-for-a-recession-proof-portfolio-1032234092,neutral,0.8344523906707764
4/17/2023 7:03:15 AM,Could Johnson & Johnson (NYSE:JNJ) Once Again Beat Earnings Forecast?,TipRanks,/news/stocks/could-johnson-johnson-nyse-jnj-once-again-beat-earnings-forecast-1032235509,positive,0.9500194191932678
4/17/2023 7:20:14 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: UnitedHealth (UNH), Johnson & Johnson (JNJ) and Merck & Company (MRK)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-unitedhealth-unh-johnson-johnson-jnj-and-merck-company-mrk-1032235548,negative,0.8450902700424194
4/17/2023 1:11:16 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3956915-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral,positive,0.8660829067230225
4/17/2023 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-q1-earnings-preview-1032236413,neutral,0.9338979721069336
4/17/2023 5:27:26 PM,Johnson & Johnson Q1 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3957017-johnson-johnson-q1-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral,neutral,0.8090161681175232
4/17/2023 5:49:38 PM,JNJ vs. PG: Which Blue-Chip Stock is Better?,TipRanks,/news/stocks/jnj-vs-pg-which-blue-chip-stock-is-better-1032237284,neutral,0.8236487507820129
4/18/2023 10:22:27 AM,"Johnson & Johnson Non-GAAP EPS of $2.68 beats by $0.18, revenue of $24.7B beats by $1.09B, raises FY23 guidance",Seeking Alpha,https://seekingalpha.com/news/3957230-johnson-and-johnson-non-gaap-eps-of-2_68-beats-0_18-revenue-of-24_7b-beats-1_09b?utm_source=businessinsider&utm_medium=referral,positive,0.8800494074821472
4/18/2023 10:35:59 AM,3 Dividend Stocks to Sell Before They Get Sued by Customers,InvestorPlace,/news/stocks/3-dividend-stocks-to-sell-before-they-get-sued-by-customers-1032239171,neutral,0.6566091775894165
4/18/2023 10:44:16 AM,Johnson & Johnson lifts dividend by 5.3% to $1.19/share,Seeking Alpha,https://seekingalpha.com/news/3957233-johnson--johnson-lifts-dividend-by-53-to-119share?utm_source=businessinsider&utm_medium=referral,positive,0.9097081422805786
4/18/2023 11:18:21 AM,"J&J stock pops as Q1 revenue boosted by Darzalex, COVID vaccine; raises FY23 outlook",Seeking Alpha,https://seekingalpha.com/news/3957246-jj-stock-pops-revenue-boosted-by-darzalex-covid-shot-raises-outlook?utm_source=businessinsider&utm_medium=referral,positive,0.9441673755645752
4/18/2023 12:30:10 PM,Johnson & Johnson Q1 Earnings Summary,RTTNews,/news/stocks/johnson-johnson-q1-earnings-summary-1032239142,neutral,0.5952150225639343
4/18/2023 1:04:58 PM,Johnson & Johnson Q1 Profit Tops Estimates; Raises 2023 Guidance Midpoints ,RTTNews,/news/stocks/johnson-johnson-q1-profit-tops-estimates-raises-2023-guidance-midpoints-1032239244,positive,0.9084107279777527
4/18/2023 4:51:53 PM,"Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday",Benzinga,/news/stocks/ericsson-johnson-johnson-goldman-sachs-and-other-big-stocks-moving-lower-on-tuesday-1032240248,negative,0.9675535559654236
4/18/2023 5:10:07 PM,"Nasdaq, S&P, Dow fluctuate as traders parse earnings reports from major names",Seeking Alpha,https://seekingalpha.com/news/3957380-nasdaq-sp500-dow-jones-stock-market-first-quarter-earnings?utm_source=businessinsider&utm_medium=referral,negative,0.8083467483520508
4/19/2023 1:20:23 AM,"Analysts‚Äô Top Healthcare Picks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-top-healthcare-picks-johnson-johnson-jnj-vertex-pharmaceuticals-vrtx-1032241274,positive,0.8078634142875671
4/19/2023 1:44:12 AM,Judge to decide if he will halt J&J talc lawsuits on Thursday,Seeking Alpha,https://seekingalpha.com/news/3957545-judge-to-decide-if-he-will-halt-jj-talc-lawsuits-on-thursday?utm_source=businessinsider&utm_medium=referral,negative,0.5278109312057495
4/19/2023 8:45:04 AM,Morgan Stanley Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/morgan-stanley-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032242698,neutral,0.8109606504440308
4/19/2023 10:04:20 AM,Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-intuitive-surgical-isrg-and-johnson-johnson-jnj-1032242868,neutral,0.9180742502212524
4/19/2023 11:48:49 AM,Legend Biotech adds 18% after leaked report on JNJ-partnered CAR-T therapy,Seeking Alpha,https://seekingalpha.com/news/3957646-jnj-stock-legend-biotech-stock-gain-on-leaked-carvykti-data?utm_source=businessinsider&utm_medium=referral,neutral,0.7947260141372681
4/19/2023 2:32:27 PM,Legend Biotech announces private placement for ~7.7M shares,Seeking Alpha,https://seekingalpha.com/news/3957778-legend-biotech-stock-private-placement?utm_source=businessinsider&utm_medium=referral,neutral,0.81399005651474
4/19/2023 4:25:57 PM,Atlantic Equities Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/atlantic-equities-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1032244205,neutral,0.5489503741264343
4/19/2023 6:00:09 PM,"Geron, CTI rally after leaked data for Legend Biotech‚Äôs blood cancer drug",Seeking Alpha,https://seekingalpha.com/news/3957879-geron-stock-cti-stock-rally-after-leaked-carvykti-data?utm_source=businessinsider&utm_medium=referral,negative,0.8521280884742737
4/19/2023 7:00:57 PM,Analyst Ratings for Johnson & Johnson,Benzinga,/news/stocks/analyst-ratings-for-johnson-johnson-1032244305,neutral,0.8832270503044128
4/20/2023 2:07:07 PM,Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names,Benzinga,/news/etf/where-is-the-current-bull-market-scan-of-stocks-gaining-over-20-over-the-past-week-almost-exclusively-yields-biotech-names-1032246765,neutral,0.8985141515731812
4/20/2023 4:37:01 PM,Judge extends stay for Johnson & Johnson talc claims another 60 days,Seeking Alpha,https://seekingalpha.com/news/3958357-judge-extends-stay-johnson-johnson-talc-claims-another-60-days?utm_source=businessinsider&utm_medium=referral,neutral,0.6576924920082092
4/21/2023 10:55:13 AM,Genmab's claims dismissed by arbitral tribunal in Darzalex royalty feud with J&J,Seeking Alpha,https://seekingalpha.com/news/3958594-genmab-claims-dismissed-arbitral-tribunal-darzalex-royalty-feud-with-jj?utm_source=businessinsider&utm_medium=referral,negative,0.8423674702644348
4/21/2023 12:30:59 PM,"Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Johnson & Johnson (JNJ) and Lucid Diagnostics (LUCD)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insmed-insm-johnson-johnson-jnj-and-lucid-diagnostics-lucd-1032249875,neutral,0.9254684448242188
4/21/2023 2:36:56 PM,OmniAb a new buy at Benchmark on technology to develop monoclonal antibodies,Seeking Alpha,https://seekingalpha.com/news/3958719-omniab-new-buy-benchmark-technology-develop-monoclonal-antibodies?utm_source=businessinsider&utm_medium=referral,positive,0.692419707775116
4/21/2023 5:09:23 PM,Legend Biotech up 10% on confirming Carvykti multiple myeloma data,Seeking Alpha,https://seekingalpha.com/news/3958762-legend-biotech-up-10-confirming-carvykti-multiple-myeloma-data?utm_source=businessinsider&utm_medium=referral,positive,0.935459554195404
4/21/2023 5:51:00 PM,Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc Committee to Support J&J Settlement,PR Newswire,/news/stocks/plaintiffs-attorneys-representing-talc-cancer-victims-form-ad-hoc-committee-to-support-j-j-settlement-1032250401,neutral,0.8924500942230225
4/22/2023 8:00:00 PM,Ulcerative colitis market set to hit $9.6B by 2031,Seeking Alpha,https://seekingalpha.com/news/3958777-ulcerative-colitis-market-set-to-hit-96b-by-2031?utm_source=businessinsider&utm_medium=referral,positive,0.7096782326698303
4/24/2023 12:50:13 AM,Johnson & Johnson to launch IPO roadshow for consumer health unit ‚Äì WSJ,Seeking Alpha,https://seekingalpha.com/news/3958878-johnson-johnson-ipo-roadshow-consumer-health-unit-kenvue?utm_source=businessinsider&utm_medium=referral,neutral,0.7828719615936279
4/24/2023 9:37:42 AM,Genmab to file appeal against tribunal award in Darzalex royalty dispute with J&J,Seeking Alpha,https://seekingalpha.com/news/3958915-genmab-file-appeal-tribunal-award-in-darzalex-royalty-dispute-jj?utm_source=businessinsider&utm_medium=referral,negative,0.9227257966995239
4/24/2023 12:39:37 PM,"Lantheus, POINT Biopharma receive FDA Fast Track status for prostate cancer candidate",Seeking Alpha,https://seekingalpha.com/news/3959032-lantheus-point-biopharma-receive-fda-fast-track-status-prostate-cancer-candidate?utm_source=businessinsider&utm_medium=referral,positive,0.853259801864624
4/24/2023 1:35:06 PM,DBS Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/dbs-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032254479,neutral,0.7421090006828308
4/24/2023 5:22:16 PM,The 3 Greatest Dividend Stocks to Buy Now,InvestorPlace,/news/stocks/the-3-greatest-dividend-stocks-to-buy-now-1032255133,neutral,0.8922625184059143
4/24/2023 8:53:12 PM,J&J's Kenvue consumer health spinoff sets IPO terms,Seeking Alpha,https://seekingalpha.com/news/3959418-johnson-johnson-kenvue-consumer-health-spinoff-sets-ipo-terms?utm_source=businessinsider&utm_medium=referral,neutral,0.9073188900947571
4/24/2023 9:16:11 PM,Focus On Genmab's Pipeline If Darzalex Arbitration with Janssen Goes Sideways: Analyst,Benzinga,/news/stocks/focus-on-genmab-s-pipeline-if-darzalex-arbitration-with-janssen-goes-sideways-analyst-1032255374,neutral,0.6623655557632446
4/25/2023 1:42:32 PM,Alkermes gets tribunal award in J&J license deal arbitration,Seeking Alpha,https://seekingalpha.com/news/3959713-alkermes-gets-tribunal-award-in-jj-license-deal-arbitration?utm_source=businessinsider&utm_medium=referral,positive,0.655781090259552
4/25/2023 3:38:42 PM,Bipartisan agreement reached in Senate prescription drug price legislation,Seeking Alpha,https://seekingalpha.com/news/3959793-bipartisan-agreement-reached-senate-prescription-drug-price-legislation?utm_source=businessinsider&utm_medium=referral,positive,0.8105083107948303
4/25/2023 6:40:22 PM,3 Dividend Aristocrats to Buy for Consistent Income,InvestorPlace,/news/stocks/3-dividend-aristocrats-to-buy-for-consistent-income-1032259710,neutral,0.8953858613967896
4/26/2023 5:15:33 PM,"Pfizer, BioNTech hit new 52-week lows",Seeking Alpha,https://seekingalpha.com/news/3960630-pfizer-stock-biontech-stock-hit-new-52-week-lows?utm_source=businessinsider&utm_medium=referral,negative,0.8583168983459473
4/26/2023 5:21:35 PM,Democratic senators introduce bill to enhance CMS drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/3960629-democratic-senators-introduce-bill-enhance-cms-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,positive,0.8721351027488708
4/26/2023 9:35:22 PM,7 Stocks That Are Strong Buys on the Heels of Impressive Earnings,InvestorPlace,/news/stocks/7-stocks-that-are-strong-buys-on-the-heels-of-impressive-earnings-1032265412,positive,0.9171772003173828
4/27/2023 12:50:04 AM,Get Defensive with These 3 Cash Flow Producing Machines,InvestorPlace,/news/stocks/get-defensive-with-these-3-cash-flow-producing-machines-1032265641,neutral,0.7586257457733154
4/27/2023 7:16:00 PM,3 Long-Term Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/3-long-term-stocks-to-buy-and-hold-forever-1032270173,neutral,0.9384225606918335
4/28/2023 2:51:27 PM,J&J to 'indemnify' Kenvue from any talc-related costs,Seeking Alpha,https://seekingalpha.com/news/3962118-johnson-johnson-indemnify-kenvue-talc-related-costs?utm_source=businessinsider&utm_medium=referral,neutral,0.9191356301307678
4/29/2023 8:00:00 PM,"Pfizer, GSK, AbbVie among pharmas set to rise with May catalysts",Seeking Alpha,https://seekingalpha.com/news/3962345-pfizer-gsk-abbvie-among-pharmas-rise-may-catalysts?utm_source=businessinsider&utm_medium=referral,positive,0.9250966310501099
4/29/2023 11:19:13 PM,Here Are The Best Sector ETFs And Major Sector-Moving Stocks In April,Benzinga,/news/etf/here-are-the-best-sector-etfs-and-major-sector-moving-stocks-in-april-1032275372,neutral,0.9359046816825867
4/30/2023 6:48:26 PM,7 High-Yield Dividend Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-to-buy-and-hold-forever-1032276200,neutral,0.9397074580192566
5/1/2023 4:17:45 PM,Johnson & Johnson reports 73% complete remission for bladder cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3962692-jnj-stock-posts-complete-remission-bladder-cancer-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.725939929485321
5/1/2023 5:32:54 PM,KVUE Stock IPO: When Does Kenvue Go Public? What Is the Kenvue IPO Price Range?,InvestorPlace,/news/stocks/kvue-stock-ipo-when-does-kenvue-go-public-what-is-the-kenvue-ipo-price-range-1032279016,neutral,0.9321880340576172
5/1/2023 6:22:43 PM,The 7 Best Dividend Stocks to Buy for May 2023,InvestorPlace,/news/stocks/7-best-dividend-stocks-to-buy-for-may-2023-1032279106,neutral,0.918582558631897
5/2/2023 1:41:11 AM,"U.S. to end COVID vaccine mandates for foreign travelers, others next week",Seeking Alpha,https://seekingalpha.com/news/3963092-us-to-end-covid-vaccine-mandate-foreign-travelers-others?utm_source=businessinsider&utm_medium=referral,neutral,0.7654039859771729
5/2/2023 12:47:50 PM,Johnson & Johnson projects earnings impact from CAR-T deal,Seeking Alpha,https://seekingalpha.com/news/3963317-jnj-stock-projects-earnings-impact-car-t-deal?utm_source=businessinsider&utm_medium=referral,negative,0.9070722460746765
5/2/2023 6:20:57 PM,"EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations",Benzinga,/news/stocks/exclusive-ama-moves-toward-psychedelic-therapy-reimbursement-filing-a-gap-in-regulations-1032283416,positive,0.850521981716156
5/3/2023 10:08:01 AM,"Fentanyl overdose deaths rose 279%, oxycodone deaths fell in 5 years",Seeking Alpha,https://seekingalpha.com/news/3964240-fentanyl-overdose-deaths-rose-279-oxycodone-deaths-fell-in-5-years?utm_source=businessinsider&utm_medium=referral,positive,0.921043872833252
5/3/2023 1:43:13 PM,Artificial Intelligence Engine Predicts LYTS Stock to Gain 9% by May 30,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-lyts-stock-to-gain-9-by-may-30-1032288024,positive,0.9435632824897766
5/3/2023 1:50:11 PM,Artificial Intelligence Engine Predicts HUYA Stock to Gain 6.4% by May 30,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-huya-stock-to-gain-6-by-may-30-1032288022,positive,0.9391216039657593
5/3/2023 1:57:50 PM,Artificial Intelligence Engine Predicts TCMD Stock to Gain 5.6% by May 30,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-tcmd-stock-to-gain-5-by-may-30-1032288068,positive,0.9418113231658936
5/3/2023 3:00:54 PM,KVUE Stock: Should You Buy Into the Kenvue IPO?,InvestorPlace,/news/stocks/kvue-stock-should-you-buy-into-the-kenvue-ipo-1032288193,neutral,0.9308770895004272
5/4/2023 1:10:17 AM,"J&J spinout Kenvue raises $3.8B through upsized IPO, making it largest of year",Seeking Alpha,https://seekingalpha.com/news/3965269-jj-spinout-kenvue-raises-4b-through-upsized-ipo-making-it-largest-of-year?utm_source=businessinsider&utm_medium=referral,positive,0.8234387636184692
5/4/2023 9:04:27 AM,3 Must-Buy Blue-Chip Stocks if the Market Retests 2022 Lows,InvestorPlace,/news/stocks/3-must-buy-blue-chip-stocks-if-the-market-retests-2022-lows-1032291477,neutral,0.6090176701545715
5/4/2023 10:04:53 AM,Alvotech starts confirmatory patient trial of J&J Simponi biosimilar,Seeking Alpha,https://seekingalpha.com/news/3965372-alvotech-starts-confirmatory-trial-of-jj-simponi-biosimilar?utm_source=businessinsider&utm_medium=referral,neutral,0.6271525621414185
5/4/2023 2:42:44 PM,Artificial Intelligence Engine Predicts ATEC Stock to Gain 5.5% by June 1,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-atec-stock-to-gain-5-by-june-1-1032293386,positive,0.9415457844734192
5/4/2023 2:49:03 PM,Artificial Intelligence Engine Predicts EGHT Stock to Gain 4% by June 1,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-eght-stock-to-gain-4-by-june-1-1032293385,positive,0.93818199634552
5/4/2023 2:53:11 PM,KVUE Stock Alert: 10 Things to Know as Kenvue Starts Trading,InvestorPlace,/news/stocks/kvue-stock-alert-10-things-to-know-as-kenvue-starts-trading-1032293384,neutral,0.9425822496414185
5/4/2023 2:54:21 PM,Artificial Intelligence Engine Predicts ASRT Stock to Gain 3% by June 1,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-asrt-stock-to-gain-3-by-june-1-1032293383,positive,0.9397422075271606
5/4/2023 3:42:31 PM,The 3 Most Undervalued Blue-Chip Stocks to Buy in May 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-blue-chip-stocks-to-buy-in-may-2023-1032293508,neutral,0.7964186668395996
5/4/2023 6:28:34 PM,WHO meeting is set to decide whether to end COVID emergency,Seeking Alpha,https://seekingalpha.com/news/3965903-who-meeting-is-set-to-decide-whether-to-end-covid-emergency?utm_source=businessinsider&utm_medium=referral,neutral,0.8873202204704285
5/4/2023 6:52:18 PM,SLRN Stock IPO: When Does Acelyrin Go Public? What Is the Acelyrin IPO Price Range?,InvestorPlace,/news/stocks/slrn-stock-ipo-when-does-acelyrin-go-public-what-is-the-acelyrin-ipo-price-range-1032294002,neutral,0.9366522431373596
5/4/2023 7:29:16 PM,Which Healthcare Stock Is a Compelling Pick for the Long Haul?,InvestorPlace,/news/stocks/which-healthcare-stock-is-a-compelling-pick-for-the-long-haul-1032294048,neutral,0.8750476837158203
5/4/2023 8:19:47 PM,J&J spinout Kenvue shares climb 22% following $3.8B upsized IPO (update),Seeking Alpha,https://seekingalpha.com/news/3965768-jnj-spinout-kenvue-shares-jump-following-upsized-ipo?utm_source=businessinsider&utm_medium=referral,positive,0.5227307081222534
5/4/2023 10:31:43 PM,3 Dividend Stocks to Count on No Matter What the Market Does¬†,InvestorPlace,/news/stocks/3-dividend-stocks-to-count-on-no-matter-what-the-market-does-1032294553,neutral,0.886148989200592
5/5/2023 5:32:36 PM,Rochelle Walensky stepping down as CDC director on June 30,Seeking Alpha,https://seekingalpha.com/news/3966632-rochelle-walensky-stepping-down-cdc-director-june-30?utm_source=businessinsider&utm_medium=referral,negative,0.6770881414413452
5/5/2023 5:41:20 PM,Artificial Intelligence Engine Predicts GOOG Stock to Gain 2.6% by June 2,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-goog-stock-to-gain-2-by-june-2-1032298453,positive,0.9432927370071411
5/5/2023 5:45:07 PM,Artificial Intelligence Engine Predicts IQ Stock to Gain 3% by June 2,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-iq-stock-to-gain-3-by-june-2-1032298452,positive,0.9405497312545776
5/5/2023 5:57:16 PM,Artificial Intelligence Engine Predicts TME Stock to Gain 3% by June 2,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-tme-stock-to-gain-3-by-june-2-1032298451,positive,0.9378937482833862
5/5/2023 6:07:27 PM,Artificial Intelligence Engine Predicts GENI Stock to Gain 2% by June 2,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-geni-stock-to-gain-2-by-june-2-1032298450,positive,0.9445680975914001
5/5/2023 6:30:34 PM,Kenvue cools off on second trading day,Seeking Alpha,https://seekingalpha.com/news/3966653-kenvue-cools-off-second-trading-day?utm_source=businessinsider&utm_medium=referral,positive,0.7372142672538757
5/5/2023 9:59:37 PM,S&P 500 Finishes Strong Following Wild Week Of Bank Stock Volatility,Benzinga,/news/stocks/s-p-500-finishes-strong-following-wild-week-of-bank-stock-volatility-1032298618,positive,0.912020742893219
5/8/2023 10:15:58 AM,The 7 Best Long-Term Dividend Stocks to Buy in May,InvestorPlace,/news/stocks/the-7-best-long-term-dividend-stocks-to-buy-in-may-1032301505,neutral,0.8631595969200134
5/9/2023 12:43:07 AM,The 7 Best Mutual Funds to Invest in for May 2023,InvestorPlace,/news/stocks/the-7-best-mutual-funds-to-invest-in-for-may-2023-1032303980,neutral,0.8613656759262085
5/9/2023 10:45:43 AM,3 Dividend Stocks to Buy as the Healthcare Sector Booms in 2023,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-as-the-healthcare-sector-booms-in-2023-1032306053,neutral,0.6284561157226562
5/9/2023 11:00:36 AM,"Analysts Offer Insights on Healthcare Companies: Cigna (CI), Johnson & Johnson (JNJ) and Crinetics Pharmaceuticals (CRNX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-cigna-ci-johnson-johnson-jnj-and-crinetics-pharmaceuticals-crnx-1032306181,neutral,0.9201359748840332
5/9/2023 12:56:49 PM,Big pharma maps legal strategy against U.S. drug pricing regulation ‚Äì Reuters,Seeking Alpha,https://seekingalpha.com/news/3967966-big-pharma-maps-legal-strategy-against-drug-pricing-regulation?utm_source=businessinsider&utm_medium=referral,neutral,0.9252361059188843
5/9/2023 2:38:56 PM,J&J's Tremfya succeeds in late-stage trial for ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/3968060-johnson-johnson-janssen-tremfya-succeeds-late-stage-trial-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral,positive,0.925291121006012
5/10/2023 1:19:15 PM,Halozyme gains as Piper Sandler upgrades despite Q1 miss,Seeking Alpha,https://seekingalpha.com/news/3969086-halozyme-stock-gains-piper-sandler-upgrades-despite-q1-miss?utm_source=businessinsider&utm_medium=referral,positive,0.932376503944397
5/10/2023 2:32:01 PM,Artificial Intelligence Engine Predicts PACW Stock to Gain 11% by June 7,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-pacw-stock-to-gain-11-by-june-7-1032313141,positive,0.9430858492851257
5/10/2023 4:57:05 PM,3 Dividend Stocks Set to Hike Payouts in 2023,InvestorPlace,/news/stocks/3-dividend-stocks-set-to-hike-payouts-in-2023-1032313635,neutral,0.46038752794265747
5/10/2023 8:23:34 PM,Shockwave Medical ticks higher amid takeover speculation,Seeking Alpha,https://seekingalpha.com/news/3969501-shockwave-medical-ticks-higher-amid-takeover-speculation?utm_source=businessinsider&utm_medium=referral,positive,0.4460280239582062
5/10/2023 8:33:44 PM,Is ChatGPT A Better Financial Advisor? We're Going To Find Out,Benzinga,/news/etf/is-chatgpt-a-better-financial-advisor-we-re-going-to-find-out-1032313893,neutral,0.8116569519042969
5/11/2023 10:28:29 PM,J&J talc victim group seeking $30B in fraudulent conveyance complaint,Seeking Alpha,https://seekingalpha.com/news/3970598-johnson-johnson-talc-group-seeking-30b-fraudulent-conveyance-complaint?utm_source=businessinsider&utm_medium=referral,negative,0.8056340217590332
5/12/2023 7:00:44 PM,"Catalyst watch: AI talk, ON Semiconductor event, hedge fund reports and Walmart earnings",Seeking Alpha,https://seekingalpha.com/news/3970895-catalyst-watch-ai-talk-on-semiconductor-event-hedge-fund-reports-and-walmart-earnings?utm_source=businessinsider&utm_medium=referral,neutral,0.93155437707901
5/12/2023 7:14:31 PM,Promising Phase 1 Results: Protagonist Therapeutics and Janssen Biotech Unlock New Potential in Colitis and Inflammation Treatment,Benzinga,/news/stocks/promising-phase-1-results-protagonist-therapeutics-and-janssen-biotech-unlock-new-potential-in-colitis-and-inflammation-treatment-1032323629,positive,0.931587278842926
5/13/2023 8:00:00 PM,Cancer therapies spending set to surge through end of decade,Seeking Alpha,https://seekingalpha.com/news/3971001-cancer-therapies-spending-set-surge-through-end-decade?utm_source=businessinsider&utm_medium=referral,positive,0.9407323002815247
5/14/2023 7:16:13 PM,3 Bargain Dividend Stocks to Boost Your Passive Income,InvestorPlace,/news/stocks/3-bargain-dividend-stocks-to-boost-your-passive-income-1032324953,positive,0.6923310160636902
5/14/2023 7:30:40 PM,Investing for the Long-Term? Here are 7 Must-Have Dividend Stocks,InvestorPlace,/news/stocks/investing-for-the-long-term-here-are-7-must-have-dividend-stocks-1032324961,neutral,0.943790078163147
5/16/2023 12:52:10 PM,AstraZeneca to exit leading U.S. drug industry group PhRMA,Seeking Alpha,https://seekingalpha.com/news/3972045-astrazeneca-stock-exits-leading-us-drug-lobby-phrma?utm_source=businessinsider&utm_medium=referral,neutral,0.6984083652496338
5/16/2023 9:53:16 PM,Don‚Äôt Panic. 3 Defensive Stocks to Diversify Into ASAP,InvestorPlace,/news/stocks/dont-panic-3-defensive-stocks-to-diversify-into-asap-1032332746,positive,0.5954738259315491
5/17/2023 4:55:50 PM,Billionaire Paul Tudor Jones Pours Millions Into These 2 Stocks Amid Recession Fears,TipRanks,/news/stocks/billionaire-paul-tudor-jones-pours-millions-into-these-2-stocks-amid-recession-fears-1032335705,neutral,0.8901799321174622
5/18/2023 10:20:56 AM,3 Reliable Dividend Stocks That Fit in Any Investor‚Äôs Portfolio,InvestorPlace,/news/stocks/3-reliable-dividend-stocks-that-fit-in-any-investors-portfolio-1032336948,neutral,0.8946051001548767
5/18/2023 11:13:15 AM,7 High-Quality Dow Stocks to Buy on the Dip,InvestorPlace,/news/stocks/7-high-quality-dow-stocks-to-buy-on-the-dip-1032337109,neutral,0.8502820730209351
5/18/2023 3:23:30 PM,Arcellx a buy at Truist on unique cancer cell therapies,Seeking Alpha,https://seekingalpha.com/news/3973091-arcellx-buy-at-truist-unique-cancer-cell-therapies?utm_source=businessinsider&utm_medium=referral,neutral,0.8696115016937256
5/18/2023 3:50:47 PM,Artificial Intelligence Engine Predicts NVAX Stock to Gain 7% by June 15,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-nvax-stock-to-gain-7-by-june-15-1032337978,positive,0.9422798752784729
5/18/2023 4:13:46 PM,Supreme Court rules against Amgen in Repatha patent dispute with Sanofi/ Regeneron,Seeking Alpha,https://seekingalpha.com/news/3973082-supreme-court-rules-against-amgen-rapatha-patent-dispute?utm_source=businessinsider&utm_medium=referral,negative,0.7930803298950195
5/18/2023 6:13:29 PM,WHO recommends updating COVID shots to add XBB.1 variants,Seeking Alpha,https://seekingalpha.com/news/3973169-who-recommends-updating-covid-shots-to-add-xbb1-variants?utm_source=businessinsider&utm_medium=referral,neutral,0.9085716009140015
5/19/2023 11:22:36 AM,"Dividend Roundup: Johnson & Johnson, Northrop Grumman, JPMorgan and more",Seeking Alpha,https://seekingalpha.com/news/3973203-dividend-roundup-johnson--johnson-northrop-grumman-jpmorgan-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9473076462745667
5/19/2023 4:51:21 PM,"WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake",Benzinga,/news/stocks/who-recommends-new-covid-booster-shots-to-target-xbb-variants-despite-slower-uptake-1032340045,positive,0.6635177731513977
5/20/2023 8:32:40 PM,Teva long-acting schizophrenia drug Uzedy reduces relapse risk up to 80%,Seeking Alpha,https://seekingalpha.com/news/3973618-teva-long-acting-schizophrenia-drug-uzedy-reduces-relapse-risk?utm_source=businessinsider&utm_medium=referral,positive,0.9459611773490906
5/21/2023 4:00:17 PM,Billions of dollars at stake as FDA shortcut allows half-proven drugs - report,Seeking Alpha,https://seekingalpha.com/news/3973623-billions-fda-shortcut-allows-half-proven-drugs?utm_source=businessinsider&utm_medium=referral,negative,0.7357136607170105
5/22/2023 12:58:00 AM,HDV: This Dividend ETF Proves That High Yield Isn‚Äôt Always Best,TipRanks,/news/stocks/hdv-this-dividend-etf-proves-that-high-yield-isn-t-always-best-1032341360,neutral,0.7474882006645203
5/23/2023 9:50:11 AM,Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ) and Coherus Biosciences (CHRS),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-and-coherus-biosciences-chrs-1032344701,negative,0.6040846705436707
5/23/2023 11:15:28 AM,Debt ceiling crisis is already changing market dynamics - what could come next?,Seeking Alpha,https://seekingalpha.com/news/3974100-debt-ceiling-crisis-is-already-changing-market-dynamics-what-could-come-next?utm_source=businessinsider&utm_medium=referral,negative,0.5529866814613342
5/23/2023 11:39:57 AM,Goldman Sachs picks top stocks in case of a hard landing,Seeking Alpha,https://seekingalpha.com/news/3973813-goldman-sachs-picks-top-stocks-in-case-of-a-hard-landing?utm_source=businessinsider&utm_medium=referral,neutral,0.9123035073280334
5/23/2023 6:30:03 PM,"Amgen, J&J settle lawsuit over Stelara biosimilar",Seeking Alpha,https://seekingalpha.com/news/3974310-amgen-johnson-johnson-settle-lawsuit-stelara-biosimilar?utm_source=businessinsider&utm_medium=referral,negative,0.7305141687393188
5/23/2023 11:18:50 PM,7 Safe-Haven Stocks to Buy for Protection From a U.S. Debt Default Disaster,InvestorPlace,/news/stocks/7-safe-haven-stocks-to-buy-for-protection-from-a-u-s-debt-default-disaster-1032346801,neutral,0.8192455768585205
5/24/2023 10:33:55 AM,"Alvotech, Advanz Pharma ink pact for five potential biosimilars in Europe",Seeking Alpha,https://seekingalpha.com/news/3974490-alvotech-advanz-pharma-ink-pact-five-potential-biosimilars-in-europe?utm_source=businessinsider&utm_medium=referral,positive,0.8917078375816345
5/24/2023 2:35:39 PM,Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-say-buy-these-3-health-care-stocks-with-over-3-dividend-yields-1032348428,positive,0.5285112857818604
5/25/2023 1:22:09 PM,"Bristol Myers, J&J's blood clot therapy milvexian gets FDA fast track status",Seeking Alpha,https://seekingalpha.com/news/3975069-bristol-myers-jjs-blood-clot-drug-milvexian-gets-fda-fast-track-tag?utm_source=businessinsider&utm_medium=referral,positive,0.8501817584037781
5/25/2023 5:00:55 PM,Legend Biotech a market perform at William Blair on commercial execution,Seeking Alpha,https://seekingalpha.com/news/3975167-legend-biotech-market-perform-william-blair-commercial-execution?utm_source=businessinsider&utm_medium=referral,neutral,0.9171211123466492
5/25/2023 6:07:05 PM,J&J files for expanded approval of blood cancer drug Carvykti in EU,Seeking Alpha,https://seekingalpha.com/news/3975181-jj-files-for-expanded-use-of-blood-cancer-drug-carvykti-in-eu?utm_source=businessinsider&utm_medium=referral,positive,0.5963737964630127
5/26/2023 10:38:37 AM,Elon Musk's Neuralink gets FDA nod to start human trial of brain implant,Seeking Alpha,https://seekingalpha.com/news/3975338-elon-musks-neuralink-gets-fda-nod-to-start-human-trial-of-brain-implant?utm_source=businessinsider&utm_medium=referral,positive,0.5858261585235596
5/26/2023 12:03:25 PM,J&J Janssen unit net drug prices decline for sixth straight year,Seeking Alpha,https://seekingalpha.com/news/3975379-johnson-johnson-janssen-net-drug-prices-decline-sixth-straight-year?utm_source=businessinsider&utm_medium=referral,negative,0.9720507264137268
5/26/2023 6:03:49 PM,3 Dow Stocks Poised for a Roaring Relief Rally,InvestorPlace,/news/stocks/3-dow-stocks-poised-for-a-roaring-relief-rally-1032355012,positive,0.4424188435077667
5/26/2023 7:00:30 PM,"Catalyst watch: C3.ai and Salesforce earnings, Knife River debut, Kenvue ratings & Faraday Future event",Seeking Alpha,https://seekingalpha.com/news/3975507-catalyst-watch-c3ai-and-salesforce-earnings-knife-river-debut-kenvue-ratings-faraday-future-event?utm_source=businessinsider&utm_medium=referral,neutral,0.9356293082237244
5/27/2023 8:00:00 PM,Why 2023 is turning into the year of the healthcare spinoff,Seeking Alpha,https://seekingalpha.com/news/3975499-why-2023-turning-into-year-healthcare-spinout?utm_source=businessinsider&utm_medium=referral,neutral,0.9217715859413147
5/28/2023 11:27:47 PM,7 Undervalued Blue-Chip Stocks to Buy for June 2023,InvestorPlace,/news/stocks/7-undervalued-blue-chip-stocks-to-buy-for-june-2023-1032355843,neutral,0.7179726958274841
5/30/2023 8:55:12 AM,Johnson & Johnson (JNJ) Receives a New Rating from Citi,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-new-rating-from-citi-1032357663,positive,0.8577377200126648
5/30/2023 10:56:03 AM,Next set of COVID boosters to target new Omicron variants ‚Äì WSJ,Seeking Alpha,https://seekingalpha.com/news/3975713-next-set-of-covid-boosters-to-target-new-omicron-variants?utm_source=businessinsider&utm_medium=referral,neutral,0.8483840823173523
5/30/2023 3:17:57 PM,JP Morgan starts coverage of Kenvue with Overweight rating,Seeking Alpha,https://seekingalpha.com/news/3975845-jp-morgan-kenvue-overweight-rating?utm_source=businessinsider&utm_medium=referral,neutral,0.8599451780319214
5/30/2023 4:40:22 PM,"Goldman starts Kenvue at neutral, cites J&J divestiture as potential overhang",Seeking Alpha,https://seekingalpha.com/news/3975876-goldman-starts-kenvue-neutral-jj-divestiture-potential-overhang?utm_source=businessinsider&utm_medium=referral,neutral,0.6710658669471741
5/30/2023 5:59:07 PM,"Citi starts Kenvue at neutral, cites uncertainly around brand performance",Seeking Alpha,https://seekingalpha.com/news/3975904-citi-starts-kenvue-at-neutral-cites-uncertainly-around-brand-performance?utm_source=businessinsider&utm_medium=referral,neutral,0.7210702300071716
5/30/2023 6:02:18 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1032358850,neutral,0.7854138612747192
5/30/2023 7:30:57 PM,Eli Lilly partners with XtalPi on AI drug discovery in up to $250M deal,Seeking Alpha,https://seekingalpha.com/news/3975939-eli-lilly-partners-xtalpi-artificial-intelligence-drug-discovery-250m-deal?utm_source=businessinsider&utm_medium=referral,positive,0.7498099207878113
5/30/2023 7:57:28 PM,Kenvue's Growth Forecast: Exploring The Future Of Johnson & Johnson's Carve-Out,Benzinga,/news/stocks/kenvue-s-growth-forecast-exploring-the-future-of-johnson-johnson-s-carve-out-1032359086,neutral,0.8243672847747803
5/30/2023 8:53:50 PM,"RBC Capital starts Kenvue at overweight, sees significant upside to stock",Seeking Alpha,https://seekingalpha.com/news/3975988-rbc-capital-starts-kenvue-at-overweight-sees-significant-upside-to-stock?utm_source=businessinsider&utm_medium=referral,negative,0.5588759779930115
5/30/2023 9:11:02 PM,"RBC Capital starts Kenvue at outperform, sees significant upside to stock",Seeking Alpha,https://seekingalpha.com/news/3975988-rbc-capital-starts-kenvue-outperform-sees-significant-upside-stock?utm_source=businessinsider&utm_medium=referral,negative,0.5742207169532776
5/31/2023 3:24:07 PM,Johnson & Johnson says Tremfya sustained improvements in psoriatic arthritis,Seeking Alpha,https://seekingalpha.com/news/3976262-jnj-tremfya-sustains-improvements-psoriatic-arthritis?utm_source=businessinsider&utm_medium=referral,positive,0.9559144377708435
6/1/2023 6:25:38 AM,Bernstein Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/bernstein-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032363218,neutral,0.8197978734970093
6/1/2023 4:49:40 PM,3 Warren Buffett Stocks to Buy (and Never Sell)¬†,InvestorPlace,/news/stocks/3-warren-buffett-stocks-to-buy-and-never-sell-1032365360,neutral,0.9296533465385437
6/1/2023 5:01:15 PM,Eli Lilly beats Johnson & Johnson to become world's most valuable drugmaker,Seeking Alpha,https://seekingalpha.com/news/3976741-lilly-stock-pips-jnj-stock-become-most-valuable-pharma?utm_source=businessinsider&utm_medium=referral,positive,0.8911046385765076
6/1/2023 6:59:10 PM,"AI, Tech Fuel Rebound Of Vanguard Growth ETF, Eroding Value's 2022 Outperformance",Benzinga,/news/etf/ai-tech-fuel-rebound-of-vanguard-growth-etf-eroding-value-s-2022-outperformance-1032365404,negative,0.688828706741333
6/2/2023 10:30:45 AM,3 Retirement Stocks to Buy to Sleep Like a Baby,InvestorPlace,/news/stocks/3-retirement-stocks-to-buy-to-sleep-like-a-baby-1032366907,neutral,0.917079508304596
6/2/2023 11:20:06 AM,Whistleblower lawsuit against Johnson & Johnson dismissed over leaked trade secrets,Seeking Alpha,https://seekingalpha.com/news/3977056-johnson-johnson-wins-dismissal-whistleblower-case?utm_source=businessinsider&utm_medium=referral,negative,0.8569039702415466
6/2/2023 3:37:31 PM,Lava Therapeutics up 26% as J&J chooses antibody candidate for development,Seeking Alpha,https://seekingalpha.com/news/3977175-lava-therapeutics-up-26-johnson-johnson-janssen-chooses-antibody-candidate?utm_source=businessinsider&utm_medium=referral,positive,0.9465381503105164
6/2/2023 7:26:08 PM,3 Stocks That High-Yield ETFs Are Betting On,InvestorPlace,/news/stocks/3-stocks-that-high-yield-etfs-are-betting-on-1032368191,neutral,0.8910282850265503
6/2/2023 8:18:41 PM,Johnson & Johnson COVID vaccine authorization revoked by FDA,Seeking Alpha,https://seekingalpha.com/news/3977355-johnson-johnson-janssen-covid-vaccine-authorization-revoked-by-fda?utm_source=businessinsider&utm_medium=referral,negative,0.8185674548149109
6/3/2023 12:55:55 PM,SVB Securities Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-keeps-their-buy-rating-on-johnson-johnson-jnj-1032368564,neutral,0.9082261919975281
6/4/2023 2:21:49 PM,The 3 Best Bargain Stocks to Buy in June 2023,InvestorPlace,/news/stocks/the-3-best-bargain-stocks-to-buy-in-june-2023-1032368900,neutral,0.9125636219978333
6/4/2023 4:00:08 PM,Morgan Stanley sees broader MedTech impact from weight loss drugs,Seeking Alpha,https://seekingalpha.com/news/3977410-morgan-stanley-sees-medtech-impact-from-weight-loss-drugs?utm_source=businessinsider&utm_medium=referral,neutral,0.4478132426738739
6/6/2023 9:11:58 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Sight Sciences (SGHT), Johnson & Johnson (JNJ) and Ultragenyx Pharmaceutical (RARE)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-sight-sciences-sght-johnson-johnson-jnj-and-ultragenyx-pharmaceutical-rare-1032372220,negative,0.7949761152267456
6/6/2023 10:42:00 AM,"Narrow market proving a headwind for mutual funds, opportunity for hedge funds",Seeking Alpha,https://seekingalpha.com/news/3977589-narrow-market-a-headwind-for-active-mutual-funds-opportunity-for-hedge-funds?utm_source=businessinsider&utm_medium=referral,neutral,0.5176433324813843
6/6/2023 11:25:55 AM,Alkermes lifts outlook after arbitration payment from Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3977816-alkermes-lifts-outlook-after-arbitration-payment-jnj?utm_source=businessinsider&utm_medium=referral,positive,0.8656364679336548
6/6/2023 1:20:37 PM,Alkermes Raises FY23 Guidance With Final Award In Johnson & Johnson Unit Arbitration ,RTTNews,/news/stocks/alkermes-raises-fy23-guidance-with-final-award-in-johnson-johnson-unit-arbitration-1032372582,neutral,0.7990686893463135
6/7/2023 9:55:41 AM,Johnson & Johnson (JNJ) Gets a Buy from SVB Securities,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-svb-securities-1032375291,neutral,0.7031823396682739
6/7/2023 1:28:17 PM,3 Defensive Stocks to Guard Against Too Much Market Optimism,InvestorPlace,/news/stocks/3-defensive-stocks-to-guard-against-too-much-market-optimism-1032376095,neutral,0.8900692462921143
6/7/2023 4:23:36 PM,J&J's Abiomed unit recalls Impella 5.5 heart pumps over safety concerns,Seeking Alpha,https://seekingalpha.com/news/3978270-jnj-abiomed-unit-recalls-impella-heart-pumps-over-safety-concerns?utm_source=businessinsider&utm_medium=referral,negative,0.9697669148445129
6/8/2023 10:30:23 AM,The 3 Best Long-Term Dividend Stocks to Buy in June,InvestorPlace,/news/stocks/the-3-best-long-term-dividend-stocks-to-buy-in-june-1032378017,neutral,0.8550143241882324
6/8/2023 10:33:33 AM,3 Blue-Chip Stocks to Buy for 100% Returns¬†,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-for-100-returns-1032378016,neutral,0.7669534087181091
6/8/2023 3:47:28 PM,3 Bargain Stocks to Buy in June Before They Bounce,InvestorPlace,/news/stocks/3-bargain-stocks-to-buy-in-june-before-they-bounce-1032379049,neutral,0.9151996970176697
6/9/2023 1:26:24 PM,"AbbVie, Amgen among firms targeted for Medicare inflation penalties",Seeking Alpha,https://seekingalpha.com/news/3978943-abbvie-among-firms-targeted-for-medicare-inflation-penalties?utm_source=businessinsider&utm_medium=referral,neutral,0.5447231531143188
6/11/2023 8:25:20 PM,7 Top Blue-Chip Stocks to Buy in June 2023,InvestorPlace,/news/stocks/7-top-blue-chip-stocks-to-buy-in-june-2023-1032382217,neutral,0.9089648127555847
6/12/2023 11:58:31 AM,"Teva, Alvotech in pact with Johnson & Johnson over Stelara knockoff",Seeking Alpha,https://seekingalpha.com/news/3979152-teva-stock-alvotech-pact-jnj-stelara-knockoff?utm_source=businessinsider&utm_medium=referral,positive,0.7931340336799622
6/12/2023 7:43:39 PM,"COVID shots should be updated for XBB variants, FDA says",Seeking Alpha,https://seekingalpha.com/news/3979315-covid-shots-should-reflect-xbb-variants-fda?utm_source=businessinsider&utm_medium=referral,neutral,0.861748218536377
6/12/2023 7:55:55 PM,Build a Millionaire‚Äôs Portfolio With These 3 Dividend-Paying Stocks,InvestorPlace,/news/stocks/build-a-millionaires-portfolio-with-these-3-dividend-paying-stocks-1032384457,neutral,0.7952935099601746
6/14/2023 9:57:16 AM,"Biggest stock movers today: MicroVision, UnitedHealth and more",Seeking Alpha,https://seekingalpha.com/news/3979733-biggest-stock-movers-today-microvision-unitedhealth-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.8944841027259827
6/14/2023 2:48:24 PM,Johnson & Johnson wins conditional nod for prostate cancer therapy in Canada,Seeking Alpha,https://seekingalpha.com/news/3979858-jj-stock-wins-canadian-nod-prostate-cancer-drug?utm_source=businessinsider&utm_medium=referral,positive,0.8990929126739502
6/14/2023 3:21:47 PM,3 Long-term Healthcare Stocks to Add to Your Portfolio,InvestorPlace,/news/stocks/3-long-term-healthcare-stocks-to-add-to-your-portfolio-1032389488,neutral,0.8907879590988159
6/15/2023 12:51:12 AM,Amgen reportedly hires Moderna chief medical officer as new CMO,Seeking Alpha,https://seekingalpha.com/news/3980001-amgen-reportedly-hires-moderna-chief-medical-officer-as-new-cmo?utm_source=businessinsider&utm_medium=referral,neutral,0.9183226227760315
6/15/2023 10:54:18 AM,AbbVie files patent lawsuit over BeiGene‚Äôs cancer drug - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3980076-beigene-stock-down-abbvie-patent-lawsuit-brukinsa?utm_source=businessinsider&utm_medium=referral,negative,0.8246314525604248
6/15/2023 11:26:41 AM,What Are the 3 Top Dividend Aristocrat Stocks That Are Too Cheap to Ignore?,TipRanks,/news/stocks/what-are-the-3-top-dividend-aristocrat-stocks-that-are-too-cheap-to-ignore-1032391402,neutral,0.8695238828659058
6/16/2023 5:10:44 PM,"3 Stocks to Buy for Long-Term, Life-Changing Returns¬†",InvestorPlace,/news/stocks/3-stocks-to-buy-for-long-term-life-changing-returns-1032394970,neutral,0.8141587972640991
6/17/2023 8:00:00 PM,Biologic drugs will lead European pharmas to surpass US counterparts in sales,Seeking Alpha,https://seekingalpha.com/news/3979912-biologic-drugs-lead-european-pharmas-surpass-us-counterparts-sales?utm_source=businessinsider&utm_medium=referral,positive,0.9524824023246765
6/21/2023 3:44:52 PM,Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations,Seeking Alpha,https://seekingalpha.com/news/3981469-top-pharma-lobby-sues-us-over-medicare-drug-pricing?utm_source=businessinsider&utm_medium=referral,negative,0.9452309608459473
6/22/2023 9:55:26 AM,SVB Securities Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1032403910,neutral,0.7513430118560791
6/22/2023 12:51:40 PM,Cidara gains as FDA grants fast track status for flu candidate,Seeking Alpha,https://seekingalpha.com/news/3981898-cidara-stock-gains-fda-fast-track-status-flu-asset?utm_source=businessinsider&utm_medium=referral,positive,0.9368841052055359
6/22/2023 10:25:30 PM,J&J talc bankruptcy unit to establish $750M trust fund with insurers,Seeking Alpha,https://seekingalpha.com/news/3982247-johnson-johnson-talc-bankruptcy-unit-establishes-750m-trust-fund-insurers?utm_source=businessinsider&utm_medium=referral,neutral,0.8200174570083618
6/23/2023 2:13:12 PM,"Cramer Says Datadog Will 'Put Up Some Good Numbers,' And 9 More Stock Takes From 'Mad Money' Host",Benzinga,/news/stocks/cramer-says-datadog-will-put-up-some-good-numbers-and-9-more-stock-takes-from-mad-money-host-1032406785,positive,0.8705770373344421
6/23/2023 8:30:41 PM,The AI Tool That Beat Out Top Wall Street Analysts,InvestorPlace,/news/stocks/ai-tool-that-beat-wall-street-analysts-1032407726,neutral,0.7457811236381531
6/25/2023 4:00:43 PM,What is behind big pharma's underperformance?,Seeking Alpha,https://seekingalpha.com/news/3982575-pharma-underperforms-amid-regulatory-woes?utm_source=businessinsider&utm_medium=referral,negative,0.6917397379875183
6/26/2023 3:10:25 PM,J&J submits application to EMA for combination PAH drug,Seeking Alpha,https://seekingalpha.com/news/3982795-johnson-johnson-janssen-submits-application-ema-combination-pah-drug?utm_source=businessinsider&utm_medium=referral,neutral,0.87294602394104
6/29/2023 9:08:31 AM,Morgan Stanley shakes up its global dividend portfolio,Seeking Alpha,https://seekingalpha.com/news/3983853-morgan-stanley-shakes-up-its-global-dividend-portfolio?utm_source=businessinsider&utm_medium=referral,negative,0.947080135345459
6/29/2023 12:27:46 PM,The 3 Most Undervalued Dow Stocks to Buy Now: June 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-dow-stocks-to-buy-now-june-2023-1032417770,neutral,0.8877401947975159
6/29/2023 8:49:59 PM,7 Up-and-Coming Stocks to Buy for the Next Decade,InvestorPlace,/news/stocks/7-up-and-coming-stocks-to-buy-for-the-next-decade-1032418996,neutral,0.8767547607421875
6/30/2023 4:41:16 PM,Medicare revises guidance on drug price negotiations amid lawsuits,Seeking Alpha,https://seekingalpha.com/news/3984642-medicare-revises-guidance-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,negative,0.9015730619430542
6/30/2023 6:06:43 PM,"15 Stocks Up, 15 Stocks Down: A Look At The Dow Jones Industrial Average Halfway Through 2023",Benzinga,/news/etf/15-stocks-up-15-stocks-down-a-look-at-the-dow-jones-industrial-average-halfway-through-2023-1032421047,neutral,0.7704199552536011
6/30/2023 8:34:52 PM,3 Dividend Stocks to Buy Right This Minute,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-right-this-minute-1032421610,neutral,0.9140511751174927
7/3/2023 4:25:13 PM,Johnson & Johnson psoriasis pill disappoints in phase 2 trial,Seeking Alpha,https://seekingalpha.com/news/3985036-johnson-johnson-psoriasis-pill-disappoints-phase-2-trial?utm_source=businessinsider&utm_medium=referral,negative,0.6571664810180664
7/3/2023 7:59:21 PM,3 Long-Term Stocks to Make Your ‚ÄòGet Rich‚Äô Dreams Come True,InvestorPlace,/news/stocks/3-long-term-stocks-to-make-your-get-rich-dreams-come-true-1032424274,neutral,0.8697237968444824
7/5/2023 1:33:37 PM,Protagonist Therapeutics-Janssen Partnered Psoriasis Candidate Fall Short Of Rival Treatment,Benzinga,/news/stocks/protagonist-therapeutics-janssen-partnered-psoriasis-candidate-fall-short-of-rival-treatment-1032427164,positive,0.7201281189918518
7/5/2023 4:02:44 PM,Sorrento sees promising phase 2 results for abivertinib for lymphoma,Seeking Alpha,https://seekingalpha.com/news/3985616-sorrento-promising-phase-2-results-abivertinib-lymphoma?utm_source=businessinsider&utm_medium=referral,positive,0.9508057236671448
7/6/2023 7:25:11 AM,Johnson & Johnson (JNJ) Gets a Buy from SVB Securities,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-svb-securities-1032429223,neutral,0.7031823396682739
7/6/2023 11:52:22 AM,Bausch + Lomb buys Blink eye drops from Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3985886-bausch--lomb-buys-blink-eye-drops-from-johnson--johnson?utm_source=businessinsider&utm_medium=referral,neutral,0.8260248899459839
7/6/2023 3:53:25 PM,3 Super-Safe Dividend Stocks to Buy for the Rest of 2023,InvestorPlace,/news/stocks/3-super-safe-dividend-stocks-to-buy-for-the-rest-of-2023-1032430565,neutral,0.9106165766716003
7/6/2023 6:50:32 PM,The 3 Best Defensive Stocks to Buy Now (and Never Sell),InvestorPlace,/news/stocks/the-3-best-defensive-stocks-to-buy-now-and-never-sell-1032430906,neutral,0.9005292057991028
7/7/2023 10:07:14 PM,3 Beaten-Down Dividend Stocks Primed for a Profitable Comeback¬†,InvestorPlace,/news/stocks/3-beaten-down-dividend-stocks-primed-for-a-profitable-comeback-1032433010,positive,0.46542391180992126
7/9/2023 4:00:00 PM,Goldman Sachs sees rays of hope in underperforming health sector,Seeking Alpha,https://seekingalpha.com/news/3986286-goldman-sachs-sees-hope-underperforming-health-sector?utm_source=businessinsider&utm_medium=referral,positive,0.937191367149353
7/10/2023 11:46:52 AM,"Dividend Stocks: Here‚Äôs Where to Invest $1,000 Right Now",InvestorPlace,/news/stocks/dividend-stocks-heres-where-to-invest-1000-right-now-1032434675,neutral,0.9439989924430847
7/10/2023 12:54:19 PM,Nanobiotix In License Deal With Johnson & Johnson Unit; Stock Climbs In Pre Market ,RTTNews,/news/stocks/nanobiotix-in-license-deal-with-johnson-johnson-unit-stock-climbs-in-pre-market-1032434507,positive,0.8803575038909912
7/12/2023 3:26:59 PM,FDA classifies J&J electrode recall as most serious type,Seeking Alpha,https://seekingalpha.com/news/3987100-fda-classifies-johnson-johnson-electrode-recall-most-serious-type?utm_source=businessinsider&utm_medium=referral,negative,0.5898086428642273
7/13/2023 8:00:47 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1032445607,neutral,0.7854138612747192
7/14/2023 12:15:24 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1032445946,neutral,0.5040143728256226
7/14/2023 9:35:13 AM,SVB Securities Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-remains-a-buy-on-johnson-johnson-jnj-1032446893,neutral,0.9401717185974121
7/14/2023 11:21:59 AM,"7 Failing Dividend Stocks to Stay Far, Far Away From",InvestorPlace,/news/stocks/7-failing-dividend-stocks-to-stay-far-far-away-from-1032447153,negative,0.5381700992584229
7/14/2023 7:00:24 PM,"Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown",Seeking Alpha,https://seekingalpha.com/news/3987769-catalyst-watch-microsoft-activision-blizzard-drama-splunk-event-and-nasdaq-100-rebalancing-countdown?utm_source=businessinsider&utm_medium=referral,neutral,0.9405461549758911
7/15/2023 6:00:00 PM,Atrial fibrillation drug market expected to decline as brand therapies go generic,Seeking Alpha,https://seekingalpha.com/news/3987824-atrial-fibrillation-drug-market-expected-decline-brand-therapies-generic?utm_source=businessinsider&utm_medium=referral,negative,0.9694817066192627
7/17/2023 2:13:13 PM,"Biggest stock movers today: Ford, BridgeBio Pharma, Acumen Pharmaceuticals and more",Seeking Alpha,https://seekingalpha.com/news/3987892-biggest-stock-movers-today-bridgebio-pharma-zai-lab-argenx-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.8726924657821655
7/18/2023 4:33:38 AM,3 Healthcare Stocks to Buy as the Market Gets Defensive,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-as-the-market-gets-defensive-1032453336,neutral,0.7916937470436096
7/18/2023 10:22:03 AM,3 Biotech Stocks for Getting Rich in 2023,InvestorPlace,/news/stocks/3-biotech-stocks-for-getting-rich-in-2023-1032454309,neutral,0.7535068392753601
7/18/2023 2:26:11 PM,Nanobiotix partners with J&J's Janssen for radiotherapy treatment,Seeking Alpha,https://seekingalpha.com/news/3988403-nanobiotix-lianbio-partners-johnson-johnson-janssen-radiotherapy?utm_source=businessinsider&utm_medium=referral,neutral,0.5920919179916382
7/18/2023 5:33:04 PM,J&J becomes latest Big Pharma to sue over Medicare drug pricing,Seeking Alpha,https://seekingalpha.com/news/3988476-jj-becomes-latest-big-pharma-to-sue-over-medicare-drug-pricing?utm_source=businessinsider&utm_medium=referral,negative,0.9197932481765747
7/18/2023 11:30:37 PM,"J&J ordered to pay $18.8M over man's talc-cancer claim, jury rules",Seeking Alpha,https://seekingalpha.com/news/3988564-jj-requried-to-pay-188m-over-mans-talc-cancer-claim-jury-rules?utm_source=businessinsider&utm_medium=referral,negative,0.8258025646209717
7/19/2023 12:33:17 AM,"J&J ordered to pay $18.8M over baby powder cancer claim, jury rules (update)",Seeking Alpha,https://seekingalpha.com/news/3988566-jj-ordered-to-pay-188m-over-mans-talc-cancer-claim-jury-rules?utm_source=businessinsider&utm_medium=referral,negative,0.8142127990722656
7/19/2023 3:01:13 PM,Here's what Wall Street expects from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnson_johnson-stock-quarter-earnings-preview-q2-1032458861,neutral,0.9130298495292664
7/19/2023 3:12:42 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3988764-notable-earnings-before-thursdays-open?utm_source=businessinsider&utm_medium=referral,positive,0.8825730681419373
7/19/2023 5:35:35 PM,J&J looks to continue long streak of EPS beats with Q2 results,Seeking Alpha,https://seekingalpha.com/news/3988839-johnson-johnson-looks-continue-long-streak-eps-beats-q2-results?utm_source=businessinsider&utm_medium=referral,positive,0.9243155121803284
7/19/2023 8:20:28 PM,Johnson & Johnson Sues HHS Over Medicare Drug Price Negotiation Program ,RTTNews,/news/stocks/johnson-johnson-sues-hhs-over-medicare-drug-price-negotiation-program-1032460109,negative,0.9473912715911865
7/20/2023 10:25:11 AM,"Johnson & Johnson Non-GAAP EPS of $2.80 beats by $0.18, revenue of $25.53B beats by $860M",Seeking Alpha,https://seekingalpha.com/news/3989064-johnson-and-johnson-non-gaap-eps-of-2_80-beats-0_18-revenue-of-25_53b-beats-860m?utm_source=businessinsider&utm_medium=referral,neutral,0.7653636336326599
7/20/2023 11:07:34 AM,"Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform",Seeking Alpha,https://seekingalpha.com/news/3989091-johnson-johnson-posts-q2-thanks-to-pharma-medtech?utm_source=businessinsider&utm_medium=referral,positive,0.8973811864852905
7/20/2023 12:28:02 PM,"Johnson & Johnson Q2 Profit Increases, beats estimates",RTTNews,/news/stocks/johnson-johnson-q2-profit-increases-beats-estimates-1032461968,positive,0.9324467778205872
7/20/2023 1:12:12 PM,"Johnson & Johnson Raises Guidance For 2023 Adj. Operational EPS, Adj. Operational Sales ",RTTNews,/news/stocks/johnson-johnson-raises-guidance-for-2023-adj-operational-eps-adj-operational-sales-1032462138,neutral,0.8850256204605103
7/20/2023 1:24:00 PM,"4 stocks to watch on Thursday: Tesla, Johnson & Johnson and more",Seeking Alpha,https://seekingalpha.com/news/3989180-4-stocks-to-watch-on-thursday-tesla-johnson-johnson-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.920753538608551
7/20/2023 2:48:21 PM,"Biggest stock movers today: Netflix, American Airlines, Johnson & Johnson and more",Seeking Alpha,https://seekingalpha.com/news/3989052-biggest-stock-movers-today-tesla-discover-financial-services-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9130443930625916
7/20/2023 3:40:59 PM,"J&J could reportedly launch Kenvue exchange offer in ""coming days""",Seeking Alpha,https://seekingalpha.com/news/3989250-jj-could-reportedly-launch-kenvue-exchange-offer-in-coming-days?utm_source=businessinsider&utm_medium=referral,neutral,0.9057369828224182
7/20/2023 4:02:29 PM,"Johnson & Johnson, Zions Bancorporation, Heritage-Crystal Clean And Other Big Stocks Moving Higher On Thursday",Benzinga,/news/stocks/johnson-johnson-zions-bancorporation-heritage-crystal-clean-and-other-big-stocks-moving-higher-on-thursday-1032463026,positive,0.9184730052947998
7/20/2023 4:30:51 PM,"Johnson & Johnson Rises On Upbeat Quarterly Results, Outlook ",RTTNews,/news/stocks/johnson-johnson-rises-on-upbeat-quarterly-results-outlook-1032463165,positive,0.9007128477096558
7/20/2023 6:12:39 PM,Dow Surges 300 Points; Johnson & Johnson Posts Upbeat Earnings,Benzinga,/news/stocks/dow-surges-300-points-johnson-johnson-posts-upbeat-earnings-1032463441,positive,0.8416130542755127
7/20/2023 6:36:15 PM,Is Johnson & Johnson Giving Up on Kenvue (KVUE) Stock?,InvestorPlace,/news/stocks/is-johnson-johnson-giving-up-on-kenvue-kvue-stock-1032463738,neutral,0.8666500449180603
7/20/2023 7:09:02 PM,Legend Biotech up 7% on strong Carvykti Q2 sales,Seeking Alpha,https://seekingalpha.com/news/3989343-legend-biotech-up-7-on-strong-carvykti-q2-sales?utm_source=businessinsider&utm_medium=referral,positive,0.9481697678565979
7/20/2023 8:18:18 PM,3 of the Best Dividend Stocks to Buy for Passive Income Growth,InvestorPlace,/news/stocks/3-of-the-best-dividend-stocks-to-buy-for-passive-income-growth-1032463888,neutral,0.8181394338607788
7/20/2023 10:27:30 PM,Cidara says J&J development deal for CD388 remains intact,Seeking Alpha,https://seekingalpha.com/news/3989482-cidara-says-jj-development-deal-for-cd388-remains-intact?utm_source=businessinsider&utm_medium=referral,neutral,0.8444855213165283
7/21/2023 10:11:22 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Sangamo Biosciences (SGMO), Johnson & Johnson (JNJ) and Intuitive Surgical (ISRG)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sangamo-biosciences-sgmo-johnson-johnson-jnj-and-intuitive-surgical-isrg-1032465400,negative,0.9344778656959534
7/21/2023 10:21:28 AM,"Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Legend Biotech (LEGN) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-teladoc-tdoc-legend-biotech-legn-and-johnson-johnson-jnj-1032465431,neutral,0.9020241498947144
7/21/2023 4:00:58 PM,Jim Cramer Says It's Time To Buy This Financial Services Stock Down 32% YTD,Benzinga,/news/stocks/jim-cramer-says-it-s-time-to-buy-this-financial-services-stock-down-32-ytd-1032466285,negative,0.9643928408622742
7/21/2023 4:42:47 PM,J&J sues researchers who wrote talc powder linked to cancer,Seeking Alpha,https://seekingalpha.com/news/3989733-johnson-johnson-sues-researchers-talc-powder-linked-cancer?utm_source=businessinsider&utm_medium=referral,negative,0.8909031748771667
7/21/2023 7:32:16 PM,"Johnson & Johnson Medtech Business Has Promising Momentum, Analysts Say After Good Q2 Performance",Benzinga,/news/stocks/johnson-johnson-medtech-business-has-promising-momentum-analysts-say-after-good-q2-performance-1032466689,positive,0.9547784328460693
7/23/2023 4:00:31 PM,Johnson & Johnson‚Äôs Q2 is positive for MedTech - Baird,Seeking Alpha,https://seekingalpha.com/news/3989880-johnson-johnson-q2-positive-medtech-baird?utm_source=businessinsider&utm_medium=referral,positive,0.913131058216095
7/24/2023 10:41:39 AM,Johnson & Johnson launches Kenvue exchange offer,Seeking Alpha,https://seekingalpha.com/news/3989959-johnson-johnson-launches-kenvue-exchange-offer?utm_source=businessinsider&utm_medium=referral,neutral,0.9247993230819702
7/24/2023 12:28:09 PM,Syndax and Incyte gain on mid-stage win for immune disorder therapy,Seeking Alpha,https://seekingalpha.com/news/3990001-syndax-stock-incyte-stock-gain-on-mid-stage-win-gvhd?utm_source=businessinsider&utm_medium=referral,positive,0.8599017262458801
7/24/2023 1:10:36 PM,Johnson & Johnson Launches Exchange Offer To Separate Kenvue ,RTTNews,/news/stocks/johnson-johnson-launches-exchange-offer-to-separate-kenvue-1032469717,neutral,0.8557499051094055
7/24/2023 1:45:00 PM,Apple To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Monday,Benzinga,/news/stocks/apple-to-rally-over-17-here-are-10-other-analyst-forecasts-for-monday-1032469793,neutral,0.9058380126953125
7/24/2023 10:50:38 PM,"Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Biogen (BIIB) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-alnylam-pharma-alny-biogen-biib-and-johnson-johnson-jnj-1032471681,negative,0.7018152475357056
7/25/2023 12:20:27 PM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Tonix Pharma (TNXP) and Gilead Sciences (GILD)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-tonix-pharma-tnxp-and-gilead-sciences-gild-1032474207,neutral,0.9122291803359985
7/25/2023 4:25:00 PM,"GSK, J&J tout Cabenuva preference over Gilead's Biktarvy",Seeking Alpha,https://seekingalpha.com/news/3990613-gsk-johnson-johnson-tout-cabenuva-preference-over-gilead-biktarvy?utm_source=businessinsider&utm_medium=referral,positive,0.6511880159378052
7/25/2023 10:30:48 PM,Wall Street Goes the Irrational Route with Kenvue Stock (NYSE:KVUE),TipRanks,/news/stocks/wall-street-goes-the-irrational-route-with-kenvue-stock-nyse-kvue-1032476357,neutral,0.9114845991134644
7/27/2023 3:35:45 AM,‚ÄòSet It and Forget It‚Äô With These 3 Stocks to Buy,InvestorPlace,/news/stocks/set-it-and-forget-it-with-these-3-stocks-to-buy-1032482027,neutral,0.8908306360244751
7/27/2023 11:00:14 AM,3 Biotech Stocks You Better Be Buying on Each and Every Dip,InvestorPlace,/news/stocks/3-biotech-stocks-you-better-be-buying-on-each-and-every-dip-1032483984,neutral,0.930048942565918
7/27/2023 1:42:27 PM,7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes,InvestorPlace,/news/stocks/7-millionaire-maker-healthcare-stocks-to-buy-before-the-window-closes-1032484989,neutral,0.8679834604263306
7/28/2023 9:15:20 AM,The 3 Best Blue-Chip Dividend Stocks to Buy for July,InvestorPlace,/news/stocks/the-3-best-blue-chip-dividend-stocks-to-buy-for-july-1032489162,neutral,0.7511558532714844
7/28/2023 1:47:07 PM,2seventy bio downgraded at Morgan Stanley after Abecma sales,Seeking Alpha,https://seekingalpha.com/news/3992869-2seventy-bio-stock-downgraded-at-morgan-stanley-abecma?utm_source=businessinsider&utm_medium=referral,neutral,0.6446183323860168
7/28/2023 6:00:40 PM,"Catalyst Watch: Amazon earnings, jobs report, and will Apple talk AI?",Seeking Alpha,https://seekingalpha.com/news/3992944-catalyst-watch-amazon-earnings-jobs-report-and-will-apple-talk-ai?utm_source=businessinsider&utm_medium=referral,neutral,0.9321873784065247
7/28/2023 9:04:08 PM,J&J talc lawsuits bankruptcy plan rejected for a second time,Seeking Alpha,https://seekingalpha.com/news/3993189-johnson-johnson-talc-bankruptcy-plan-rejected-second-time?utm_source=businessinsider&utm_medium=referral,negative,0.7905769944190979
7/28/2023 9:32:26 PM,J&J seeks pediatric indication for HIV drug Edurant,Seeking Alpha,https://seekingalpha.com/news/3993196-johnson-johnson-janssen-seeks-pediatric-indication-hiv-drug-edurant?utm_source=businessinsider&utm_medium=referral,positive,0.6746100783348083
7/29/2023 2:01:46 PM,Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Zoetis (ZTS),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-and-zoetis-zts-1032491624,neutral,0.9071188569068909
7/31/2023 12:55:04 AM,Johnson & Johnson (JNJ) Gets a Buy from Citi,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-citi-1032492468,positive,0.6256207227706909
7/31/2023 1:24:00 PM,"5 stocks to watch on Monday: J&J, ON Semiconductor, Yum China and more",Seeking Alpha,https://seekingalpha.com/news/3993420-5-stocks-to-watch-on-monday-jj-on-semiconductor-yum-china-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9265987873077393
7/31/2023 5:57:09 PM,J&J falls after bankruptcy plan rejected for second time,Seeking Alpha,https://seekingalpha.com/news/3993571-jj-falls-after-bankruptcy-plan-rejected-for-second-time?utm_source=businessinsider&utm_medium=referral,negative,0.9431637525558472
7/31/2023 6:00:46 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1032496288,neutral,0.7854138612747192
7/31/2023 7:35:33 PM,"US Stocks Take A Breather, Nasdaq Notches Fifth Straight Month Of Gains: Investors Gear Up For Pivotal Week",Benzinga,/news/etf/us-stocks-take-a-breather-nasdaq-notches-fifth-straight-month-of-gains-investors-gear-up-for-pivotal-week-1032496673,positive,0.8377040028572083
7/31/2023 7:52:35 PM,7 Stocks to Buy Before They Surpass 2021 Highs,InvestorPlace,/news/stocks/7-stocks-to-buy-before-they-surpass-2021-highs-stocks-to-watch-before-new-peaks-1032496877,neutral,0.8164244890213013
7/31/2023 10:46:32 PM,Cidara antifungal drug Rezzayo launched in US by partner Melinta,Seeking Alpha,https://seekingalpha.com/news/3993866-cidara-antifungal-drug-rezzayo-launched-in-us-by-partner-melinta?utm_source=businessinsider&utm_medium=referral,neutral,0.8020392060279846
8/1/2023 4:20:24 AM,Analysts Offer Insights on Healthcare Companies: OrthoPediatrics (KIDS) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-orthopediatrics-kids-and-johnson-johnson-jnj-1032497694,neutral,0.9263848066329956
8/1/2023 3:45:48 PM,3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now,InvestorPlace,/news/stocks/healthcare-stocks-to-buy-2-1032501863,neutral,0.8402847647666931
8/2/2023 1:47:57 PM,3 Consumer Staples Stocks to Dump ASAP,InvestorPlace,/news/stocks/3-consumer-staples-stocks-to-dump-asap-1032507199,neutral,0.763423502445221
8/3/2023 10:00:39 AM,Sell Alert: 3 Healthcare Stocks to Dump ASAP,InvestorPlace,/news/stocks/sell-alert-3-healthcare-stocks-to-dump-asap-1032511779,neutral,0.7152864933013916
8/3/2023 11:40:27 AM,"Goldman in, Microsoft out of BofA Alpha Surprise Portfolio",Seeking Alpha,https://seekingalpha.com/news/3996317-goldman-in-microsoft-out-of-bofa-alpha-surprise-portfolio?utm_source=businessinsider&utm_medium=referral,neutral,0.6861006021499634
8/3/2023 1:24:55 PM,Buckle Up! 3 Healthcare Stocks Set to Soar to New Heights,InvestorPlace,/news/stocks/buckle-up-3-healthcare-stocks-set-to-soar-to-new-heights-1032512866,positive,0.584621787071228
8/3/2023 11:24:57 PM,Buckle Up! 3 Blue-Chip Stocks Set to Soar to New Heights.¬†,InvestorPlace,/news/stocks/buckle-up-3-blue-chip-stocks-set-to-soar-to-new-heights-1032514745,positive,0.849739670753479
8/4/2023 1:42:55 PM,Ralph Lauren To Rally 17%? Here Are 10 Other Analyst Forecasts For Friday,Benzinga,/news/stocks/ralph-lauren-to-rally-17-here-are-10-other-analyst-forecasts-for-friday-1032517652,neutral,0.8922441005706787
8/4/2023 3:42:21 PM,J&J gets expanded approval for cardiac ablation products,Seeking Alpha,https://seekingalpha.com/news/3997619-jj-gets-expanded-approval-for-cardiac-ablation-products?utm_source=businessinsider&utm_medium=referral,positive,0.9286589622497559
8/4/2023 7:35:57 PM,3 of the Safest Dividend Kings,InvestorPlace,/news/stocks/3-of-the-safest-dividend-kings-1032519166,neutral,0.8782747983932495
8/5/2023 8:25:28 AM,Atlantic Equities Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/atlantic-equities-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032519524,neutral,0.5214512944221497
8/8/2023 3:01:25 AM,WKLY: Want Weekly Dividends? Check Out This ETF from SoFi,TipRanks,/news/stocks/wkly-want-weekly-dividends-check-out-this-etf-from-sofi-1032525874,neutral,0.9403525590896606
8/8/2023 6:42:48 PM,The 7 Best Warren Buffett Stocks to Buy for August 2023,InvestorPlace,/news/stocks/the-7-best-warren-buffett-stocks-to-buy-for-august-2023-1032530460,neutral,0.9310842156410217
8/9/2023 1:18:29 PM,The Year‚Äôs Top 3 Value ETFs as of August 2023,InvestorPlace,/news/stocks/the-years-top-3-value-etfs-as-of-august-2023-1032535221,neutral,0.9192641377449036
8/9/2023 10:26:06 PM,Kenvue set to join S&P 500,Seeking Alpha,https://seekingalpha.com/news/4000663-kenvue-set-to-join-sp500?utm_source=businessinsider&utm_medium=referral,neutral,0.9363861680030823
8/10/2023 12:42:00 AM,Kenvue Set to Join S&P 500,PR Newswire,/news/stocks/kenvue-set-to-join-s-p-500-1032536990,neutral,0.9363861680030823
8/10/2023 2:43:43 AM,Kenvue To Join S&P 500 ,RTTNews,/news/stocks/kenvue-to-join-s-p-500-1032537031,neutral,0.9384469985961914
8/10/2023 9:15:25 AM,The 7 Safest Stocks to Buy in August,InvestorPlace,/news/stocks/the-7-safest-stocks-to-buy-in-august-1032539574,neutral,0.8219918608665466
8/10/2023 12:06:33 PM,Johnson & Johnson wins FDA nod for new multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4000875-johnson-johnson-wins-fda-nod-multiple-myeloma-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.8606274724006653
8/10/2023 1:53:32 PM,JNJ's Janssen Pharma Reports FDA Approval For TALVEY To Treat Heavily Pretreated Multiple Myeloma ,RTTNews,/news/stocks/jnj-s-janssen-pharma-reports-fda-approval-for-talvey-to-treat-heavily-pretreated-multiple-myeloma-1032540112,positive,0.9378800988197327
8/10/2023 2:25:52 PM,KVUE Stock Alert: Kenvue to Join the S&P 500,InvestorPlace,/news/stocks/kvue-stock-alert-kenvue-to-join-the-sp-500-1032541132,neutral,0.8870497941970825
8/10/2023 3:00:00 PM,Medicare Part D drug price increases far exceed inflation - AARP,Seeking Alpha,https://seekingalpha.com/news/4000101-medicare-part-d-drug-price-increases-far-exceed-inflation?utm_source=businessinsider&utm_medium=referral,positive,0.8962885141372681
8/10/2023 8:38:11 PM,Supreme Court to hear arguments on Purdue Pharma $6B bankruptcy settlement,Seeking Alpha,https://seekingalpha.com/news/4001356-supreme-court-hear-arguments-purdue-pharma-sacklers-6b-bankruptcy-settlement?utm_source=businessinsider&utm_medium=referral,neutral,0.7412410378456116
8/11/2023 8:52:36 AM,"Uber Crowded, Battleground and Sweet 16 stock portfolios from Jefferies",Seeking Alpha,https://seekingalpha.com/news/3999208-uber-crowded-battleground-and-sweet-16-stock-portfolios-from-jefferies?utm_source=businessinsider&utm_medium=referral,neutral,0.8961213231086731
8/11/2023 6:53:19 PM,Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval,Benzinga,/news/stocks/boston-scientific-s-farapulse-eyes-stronger-us-market-position-with-potential-fda-approval-1032547558,positive,0.9547473788261414
8/12/2023 1:52:53 PM,"HD, MSFT, or JNJ: Which Blue Chip Stock Earns Wall Street‚Äôs ‚ÄúStrong Buy‚Äù Rating?",TipRanks,/news/stocks/hd-msft-or-jnj-which-blue-chip-stock-earns-wall-street-s-strong-buy-rating-1032548261,neutral,0.8822726607322693
8/13/2023 4:00:00 PM,Inside COVID-19 vaccine makers: Hope vs hype,Seeking Alpha,https://seekingalpha.com/news/4002033-inside-covid-19-vaccine-makers-hope-vs-hype?utm_source=businessinsider&utm_medium=referral,neutral,0.8822358250617981
8/13/2023 6:00:00 PM,Pharma under threat from bill to expand drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4002034-pharma-under-threat-bill-expand-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,negative,0.5231537818908691
8/14/2023 12:58:36 PM,Johnson & Johnson wins FDA nod for new prostate cancer therapy,Seeking Alpha,https://seekingalpha.com/news/4002230-johnson-johnson-wins-fda-nod-prostate-cancer-drug-akeega?utm_source=businessinsider&utm_medium=referral,positive,0.8312838077545166
8/14/2023 7:08:13 PM,Pfizer wins FDA nod for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4002480-pfizer-wins-fda-nod-multiple-myeloma-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.8381553292274475
8/14/2023 7:38:52 PM,7 Dividend Stocks to Buy as Investor Sentiment Falters,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-as-investor-sentiment-falters-1032552786,negative,0.9288655519485474
8/14/2023 9:58:46 PM,Catalent accused of misleading investors in shareholder suit,Seeking Alpha,https://seekingalpha.com/news/4002679-catalent-accused-misleading-investors-shareholder-suit?utm_source=businessinsider&utm_medium=referral,neutral,0.4857172966003418
8/15/2023 3:17:38 PM,Citi sees Kenvue stock outperforming after exchange offer closes,Seeking Alpha,https://seekingalpha.com/news/4003018-citi-sees-kenvue-stock-outperforming-after-exchange-offer-closes?utm_source=businessinsider&utm_medium=referral,negative,0.5142212510108948
8/15/2023 5:24:19 PM,"What investors need to know about Johnson & Johnson, Kenvue exchange offer",Seeking Alpha,https://seekingalpha.com/news/4003103-investors-need-know-johnson-johnson-kenvue-exchange-offer?utm_source=businessinsider&utm_medium=referral,neutral,0.9408960938453674
8/16/2023 8:14:29 PM,The 3 Most Undervalued Retirement Stocks to Buy Now: August 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-retirement-stocks-to-buy-now-august-2023-1032561164,neutral,0.9002806544303894
8/17/2023 6:28:12 AM,Johnson & Johnson finalizes an exchange ratio of 8.0324 in Kenvue split-off,Seeking Alpha,https://seekingalpha.com/news/4003772-johnson-johnson-finalizes-an-exchange-ratio-of-80324-in-kenvue-split-off?utm_source=businessinsider&utm_medium=referral,neutral,0.9141678214073181
8/18/2023 2:45:09 PM,Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet,Benzinga,/news/stocks/benzinga-s-stock-whisper-index-5-stocks-investors-are-secretly-monitoring-but-not-talking-about-yet-1032566457,neutral,0.9360675811767578
8/20/2023 8:52:21 PM,The 7 Most Undervalued Dividend Stocks to Buy Now: August 2023,InvestorPlace,/news/stocks/the-7-most-undervalued-dividend-stocks-to-buy-now-august-2023-1032568162,neutral,0.8986774682998657
8/21/2023 10:48:51 AM,"Johnson & Johnson, Kenvue share exchange offer oversubscribed",Seeking Alpha,https://seekingalpha.com/news/4004598-johnson-johnson-kenvue-share-exchange-offer-oversubscribed?utm_source=businessinsider&utm_medium=referral,negative,0.8298049569129944
8/21/2023 1:21:00 PM,"4 stocks to watch on Monday: Kenvue, VMware and more",Seeking Alpha,https://seekingalpha.com/news/4004696-4-stocks-to-watch-on-monday-kenvue-vmware-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9081899523735046
8/21/2023 5:38:12 PM,KVUE Stock Alert: Johnson & Johnson Reveals Results of Kenvue Exchange Offer,InvestorPlace,/news/stocks/kvue-stock-alert-johnson-johnson-reveals-results-of-kenvue-exchange-offer-1032570776,neutral,0.9158301949501038
8/21/2023 6:27:40 PM,Kenvue rises on exchange offer oversubscription; JNJ falls,Seeking Alpha,https://seekingalpha.com/news/4004886-kenvue-rises-exchange-offer-oversubscription-jnj-falls?utm_source=businessinsider&utm_medium=referral,negative,0.6862751841545105
8/21/2023 7:26:37 PM,Lawsuits unlikely to hinder Medicare drug price negotiations ‚Äì UBS,Seeking Alpha,https://seekingalpha.com/news/4004908-lawsuits-wont-hurt-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,negative,0.8472161293029785
8/21/2023 7:58:31 PM,"Lilly's market cap soared 36% in Q2, eclipsing J&J, Merck, Novo Nordisk",Seeking Alpha,https://seekingalpha.com/news/4004913-lillys-market-cap-soared-in-q2-eclipsing-jnj-merck-novo-nordisk?utm_source=businessinsider&utm_medium=referral,positive,0.9460121989250183
8/21/2023 8:02:32 PM,These Are the ONLY 7 Warren Buffett Stocks to Consider in August 2023,InvestorPlace,/news/stocks/these-are-the-only-7-warren-buffett-stocks-to-consider-in-august-2023-1032570974,neutral,0.9501304626464844
8/21/2023 10:12:53 PM,"Kenvue to join S&P 500, replacing Advance Auto Parts",Seeking Alpha,https://seekingalpha.com/news/4004990-kenvue-join-sp-500-replacing-advance-auto-parts?utm_source=businessinsider&utm_medium=referral,neutral,0.8982610106468201
8/22/2023 12:01:00 AM,Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600,PR Newswire,/news/stocks/kenvue-set-to-join-s-p-500-advance-auto-parts-to-join-s-p-smallcap-600-1032571156,neutral,0.9121206998825073
8/22/2023 6:52:24 PM,"Regeneron, J&J receive millions to develop new COVID therapies",Seeking Alpha,https://seekingalpha.com/news/4005267-regeneron-johnson-johnson-receive-millions-develop-covid-therapies?utm_source=businessinsider&utm_medium=referral,positive,0.799380362033844
8/22/2023 9:00:56 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1032574267,neutral,0.9169120192527771
8/22/2023 10:31:00 PM,"Did Apple Shower Warren Buffett With $645M This Year? Yes, They Did: The Power Of Dividends",Benzinga,/news/etf/did-apple-shower-warren-buffett-with-645m-this-year-yes-they-did-the-power-of-dividends-1032574433,neutral,0.9092034101486206
8/23/2023 8:25:29 AM,Cantor Fitzgerald Reaffirms Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-reaffirms-their-buy-rating-on-johnson-johnson-jnj-1032575468,neutral,0.8143643736839294
8/23/2023 11:00:39 AM,Johnson & Johnson completes Kenvue separation,Seeking Alpha,https://seekingalpha.com/news/4005442-johnson-johnson-completes-kenvue-separation?utm_source=businessinsider&utm_medium=referral,neutral,0.9327482581138611
8/23/2023 12:06:02 PM,Megacap stocks setting up for potential breakout - Wells Fargo,Seeking Alpha,https://seekingalpha.com/news/4005201-megacap-stocks-setting-up-for-potential-breakout?utm_source=businessinsider&utm_medium=referral,neutral,0.7690653800964355
8/23/2023 1:15:00 PM,"4 stocks to watch on Wednesday: NVIDIA, Kohl's and more",Seeking Alpha,https://seekingalpha.com/news/4005510-4-stocks-to-watch-on-wednesday-nvidia-kohls-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9125043749809265
8/23/2023 7:11:32 PM,J&J‚Äôs Janssen said to be closing much of Dutch vaccine division,Seeking Alpha,https://seekingalpha.com/news/4005711-jnj-close-much-dutch-vaccine-division?utm_source=businessinsider&utm_medium=referral,negative,0.7419073581695557
8/24/2023 1:44:18 PM,Drugs picked for Medicare price negotiations to be announced on Tuesday ‚Äì Politico,Seeking Alpha,https://seekingalpha.com/news/4005992-drug-list-picked-medicare-price-negotiations-due-tuesday?utm_source=businessinsider&utm_medium=referral,neutral,0.9293888211250305
8/24/2023 2:12:30 PM,Johnson & Johnson goes ex-dividend tomorrow,Seeking Alpha,https://seekingalpha.com/news/4005984-johnson-and-johnson-declares-missing-dividend?utm_source=businessinsider&utm_medium=referral,neutral,0.5648842453956604
8/24/2023 2:55:38 PM,Galapagos cut to Neutral at Citi on lack of catalysts,Seeking Alpha,https://seekingalpha.com/news/4006038-galapagos-stock-cut-neutral-citi-lack-of-catalysts?utm_source=businessinsider&utm_medium=referral,negative,0.9433589577674866
8/25/2023 1:05:20 PM,J&J submits sBLA for Rybrevant for first-line non-small cell lung cancer,Seeking Alpha,https://seekingalpha.com/news/4006326-johnson-johnson-janssen-sbla-rybrevant-first-line-non-small-cell-lung-cancer?utm_source=businessinsider&utm_medium=referral,neutral,0.7817997336387634
8/25/2023 3:54:51 PM,AstraZeneca latest drugmaker to challenge Medicare drug price negotiation,Seeking Alpha,https://seekingalpha.com/news/4006445-astrazeneca-latest-drugmaker-challenge-medicare-drug-price-negotiation?utm_source=businessinsider&utm_medium=referral,negative,0.43026357889175415
8/26/2023 6:00:00 PM,Crohn's disease drugmakers set to benefit from expected rise in cases,Seeking Alpha,https://seekingalpha.com/news/4006563-crohns-disease-drugmakers-benefit-expected-rise-cases?utm_source=businessinsider&utm_medium=referral,positive,0.9470041394233704
8/27/2023 4:00:00 PM,Wall Street lists potential targets for Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4006581-wall-street-lists-targets-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,neutral,0.8904427289962769
8/27/2023 6:33:00 PM,7 Very Oversold Warren Buffett Stocks to Buy Right Now,InvestorPlace,/news/stocks/7-very-oversold-warren-buffett-stocks-to-buy-right-now-1032584294,negative,0.7626887559890747
8/28/2023 10:35:42 AM,Hedge and mutual funds rotate from tech; see the stocks they love and shun,Seeking Alpha,https://seekingalpha.com/news/4006637-hedge-and-mutual-funds-rotate-from-tech-see-the-stocks-they-love-and-shun?utm_source=businessinsider&utm_medium=referral,neutral,0.6943780779838562
8/28/2023 4:37:09 PM,"Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories",Benzinga,/news/stocks/hawaiian-electric-says-power-lines-not-responsible-for-deadly-lahaina-fire-china-targets-stock-market-revival-ftc-pauses-legal-battle-with-amgen-s-28b-horizon-deal-today-s-top-stories-1032586588,neutral,0.9021694660186768
8/28/2023 9:11:59 PM,Johnson & Johnson seeks full approval of Balversa for bladder cancer,Seeking Alpha,https://seekingalpha.com/news/4006866-johnson-johnson-janssen-seeks-full-approval-balversa-bladder-cancer?utm_source=businessinsider&utm_medium=referral,positive,0.7911973595619202
8/29/2023 1:58:53 AM,7 Reliable Retirement Stocks to Secure a Golden Future,InvestorPlace,/news/stocks/7-reliable-retirement-stocks-to-secure-a-golden-future-1032587337,positive,0.809566080570221
8/29/2023 2:36:45 AM,The 7 Most Promising Blue-Chip Stocks to Own Now,InvestorPlace,/news/stocks/the-7-most-promising-blue-chip-stocks-to-own-now-1032587347,neutral,0.7528961896896362
8/29/2023 11:45:20 AM,Medicare lists first ten drugs selected for pricing negotiations,Seeking Alpha,https://seekingalpha.com/news/4006764-medicare-lists-first-ten-drugs-picked-pricing-talks?utm_source=businessinsider&utm_medium=referral,neutral,0.9310519099235535
8/29/2023 5:29:41 PM,JPMorgan says time to buy MedTech based on past,Seeking Alpha,https://seekingalpha.com/news/4007211-jpmorgan-says-buy-medtech-stocks?utm_source=businessinsider&utm_medium=referral,neutral,0.9078740477561951
8/29/2023 6:31:22 PM,Initial Medications Chosen By HHS For Medicare Drug Price Negotiations ,RTTNews,/news/stocks/initial-medications-chosen-by-hhs-for-medicare-drug-price-negotiations-1032590160,neutral,0.9237469434738159
8/29/2023 7:29:57 PM,Republicans say Medicare drug negotiations will mean fewer new meds,Seeking Alpha,https://seekingalpha.com/news/4007245-republicans-say-medicare-drug-negotiations-fewer-new-meds?utm_source=businessinsider&utm_medium=referral,negative,0.8554675579071045
8/30/2023 12:58:15 AM,SPLG: The Market‚Äôs Lowest-Cost S&P 500 ETF,TipRanks,/news/stocks/splg-the-market-s-lowest-cost-s-p-500-etf-1032590792,neutral,0.7738189697265625
8/30/2023 11:29:28 AM,Johnson & Johnson updates financials and outlook after Kenvue separation,Seeking Alpha,https://seekingalpha.com/news/4007395-jj-updates-financials-outlook-kenvue-separation?utm_source=businessinsider&utm_medium=referral,neutral,0.8613182902336121
8/30/2023 1:07:00 PM,"4 stocks to watch on Wednesday: Salesforce, Texas Instruments and more",Seeking Alpha,https://seekingalpha.com/news/4007444-4-stocks-to-watch-on-wednesday-salesforce-texas-instruments-and-more?utm_source=businessinsider&utm_medium=referral,neutral,0.9178857207298279
8/30/2023 1:07:39 PM,"Johnson & Johnson Trims FY23 Earnings, Net Sales Outlook ",RTTNews,/news/stocks/johnson-johnson-trims-fy23-earnings-net-sales-outlook-1032592301,negative,0.9403153657913208
8/30/2023 9:36:41 PM,Set and Forget: 3 Dividend Stocks Perfect for Your IRA,InvestorPlace,/news/stocks/set-and-forget-3-dividend-stocks-perfect-for-your-ira-1032594347,neutral,0.9052367210388184
8/31/2023 12:15:32 AM,Johnson & Johnson (JNJ) Gets a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-cantor-fitzgerald-1032594434,neutral,0.651216447353363
8/31/2023 12:55:17 AM,Johnson & Johnson (JNJ) Gets a Hold from Bank of America Securities,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-hold-from-bank-of-america-securities-1032594449,neutral,0.8853208422660828
8/31/2023 1:02:33 AM,"Analysts Offer Insights on Healthcare Companies: Patterson Companies (PDCO), BioMarin Pharmaceutical (BMRN) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-patterson-companies-pdco-biomarin-pharmaceutical-bmrn-and-johnson-johnson-jnj-1032594470,neutral,0.9202441573143005
8/31/2023 1:10:06 AM,"Analysts‚Äô Top Healthcare Picks: Johnson & Johnson (JNJ), PTC Therapeutics (PTCT)",TipRanks,/news/stocks/analysts-top-healthcare-picks-johnson-johnson-jnj-ptc-therapeutics-ptct-1032594464,positive,0.6867535710334778
8/31/2023 11:00:10 AM,When ChatGPT Misses the Mark: 3 Stocks It Got Very Wrong,InvestorPlace,/news/stocks/when-chatgpt-misses-the-mark-3-stocks-it-got-very-wrong-1032595840,negative,0.5253112316131592
8/31/2023 6:33:14 PM,3 Brilliant Blue-Chip Stocks for Lucrative Long-Term Growth,InvestorPlace,/news/stocks/3-brilliant-blue-chip-stocks-for-lucrative-long-term-growth-1032597634,neutral,0.5362842679023743
9/1/2023 2:47:51 PM,EU regulators warn pregnant women not to use topiramate,Seeking Alpha,https://seekingalpha.com/news/4008363-eu-regulators-warn-pregnant-women-not-to-use-topiramate?utm_source=businessinsider&utm_medium=referral,neutral,0.7635952234268188
9/1/2023 4:51:41 PM,7 Cash Cow Stocks for Recession-Resilient Dividends,InvestorPlace,/news/stocks/7-cash-cow-stocks-for-recession-resilient-dividends-1032600357,neutral,0.8772007822990417
9/2/2023 6:00:00 PM,"Lilly, Novo Nordisk top pharma performers in August; AstraZeneca, Roche lag",Seeking Alpha,https://seekingalpha.com/news/4008548-lilly-novo-nordisk-top-pharma-performers-august-astrazeneca-roche-lag?utm_source=businessinsider&utm_medium=referral,positive,0.8847640156745911
9/3/2023 4:00:00 PM,Why is big pharma unmoved despite Medicare pricing threat?,Seeking Alpha,https://seekingalpha.com/news/4008703-why-big-pharma-unmoved-despite-medicare-pricing-threat?utm_source=businessinsider&utm_medium=referral,neutral,0.78722083568573
9/4/2023 2:05:22 AM,Stifel Nicolaus Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/stifel-nicolaus-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1032601422,positive,0.5205020904541016
9/4/2023 4:00:00 PM,AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley,Seeking Alpha,https://seekingalpha.com/news/4008712-ai-eleven-percent-healthcare-budgets-2024-morgan-stanley?utm_source=businessinsider&utm_medium=referral,neutral,0.8714703321456909
9/4/2023 4:21:00 PM,"Despite a slower Q2, Needham sees medtech market growing 7% in 2023",Seeking Alpha,https://seekingalpha.com/news/4008713-despite-slower-q2-needham-sees-medtech-market-growing-7-percent-2023?utm_source=businessinsider&utm_medium=referral,positive,0.9523437023162842
9/4/2023 10:21:27 PM,3 Dow Stocks to Sell in September Before They Crash and Burn,InvestorPlace,/news/stocks/3-dow-stocks-to-sell-in-september-before-they-crash-and-burn-1032603561,neutral,0.7571303248405457
9/6/2023 12:26:49 AM,Cantor Fitzgerald Reaffirms Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-reaffirms-their-buy-rating-on-johnson-johnson-jnj-1032607025,neutral,0.8143643736839294
9/6/2023 12:26:57 AM,Raymond James Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/raymond-james-remains-a-buy-on-johnson-johnson-jnj-1032607021,neutral,0.9435840845108032
9/6/2023 12:27:41 PM,7 Retirement Stocks That Every Long-Term Investor Should Own Now,InvestorPlace,/news/stocks/7-retirement-stocks-that-every-long-term-investor-should-own-now-1032608972,neutral,0.9398009777069092
9/6/2023 12:53:21 PM,Idorsia In Deal With JNJ's Janssen Biotech For Return Of Rights For Aprocitentan; Stock Down ,RTTNews,/news/stocks/idorsia-in-deal-with-jnj-s-janssen-biotech-for-return-of-rights-for-aprocitentan-stock-down-1032608309,neutral,0.8972310423851013
9/6/2023 3:13:51 PM,Johnson & Johnson succeeds in lung cancer trial for Rybrevant,Seeking Alpha,https://seekingalpha.com/news/4009524-johnson-johnson-wins-lung-cancer-trial-rybrevant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.812588095664978
9/6/2023 5:00:38 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-6-2023-1032609929,neutral,0.5207836031913757
9/7/2023 11:08:02 AM,7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth,InvestorPlace,/news/stocks/7-pharma-stocks-to-buy-for-groundbreaking-treatments-and-robust-revenue-growth-1032612381,positive,0.9394681453704834
9/7/2023 7:39:56 PM,Astellas withdraws federal lawsuit over Medicare drug pricing,Seeking Alpha,https://seekingalpha.com/news/4010044-astellas-withdraws-federal-lawsuit-over-medicare-drug-pricing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.897549569606781
9/7/2023 9:29:38 PM,"Canaccord starts Kenvue at buy; cites global reach, consumer demand",Seeking Alpha,https://seekingalpha.com/news/4010111-canaccord-starts-kenvue-at-buy-cites-global-reach-consumer-demand?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7382115125656128
9/8/2023 10:00:13 AM,The 7 Best Dow Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-7-best-dow-stocks-to-buy-now-september-2023-1032615597,neutral,0.9287469983100891
9/8/2023 10:17:43 AM,3 Shaky Stocks to Sell in September Before It‚Äôs Too Late,InvestorPlace,/news/stocks/3-shaky-stocks-to-sell-in-september-before-its-too-late-1032615594,neutral,0.8130618333816528
9/8/2023 12:14:43 PM,Janssen Pharma Submits Marketing Authorisation Application For Erdafitinib ,RTTNews,/news/stocks/janssen-pharma-submits-marketing-authorisation-application-for-erdafitinib-1032615568,neutral,0.8274352550506592
9/8/2023 3:56:55 PM,September Rally? 3 Healthcare Stocks to Buy Before Liftoff.,InvestorPlace,/news/stocks/september-rally-3-healthcare-stocks-to-buy-before-liftoff-1032616887,positive,0.7377055883407593
9/8/2023 11:00:31 PM,Analyst Ratings for Johnson & Johnson,Benzinga,/news/stocks/analyst-ratings-for-johnson-johnson-1032617279,neutral,0.8832270503044128
9/8/2023 11:13:21 PM,The 5 Best Healthcare Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-5-best-healthcare-stocks-to-buy-now-september-2023-1032617337,neutral,0.9341099262237549
9/10/2023 5:54:29 PM,The 7 Best Warren Buffett Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-7-best-warren-buffett-stocks-to-buy-now-september-2023-1032618280,neutral,0.9295060634613037
9/10/2023 7:17:31 PM,"HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead",Seeking Alpha,https://seekingalpha.com/news/4010430-hsbc-bullish-on-iqvia-zoetis-bluebird-actinium-bearish-on-gilead?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.551216721534729
9/11/2023 12:28:17 AM,Kenvue shares may gain after FDA comments in Tylenol-Autism warning label  lawsuit,Seeking Alpha,https://seekingalpha.com/news/4010432-kenvue-shares-may-gain-after-fda-comments-in-tylenol-autisim-warning-label-lawsuit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5332697033882141
9/11/2023 10:27:12 AM,3 Bulletproof Stocks to Buy Before the Next Recession Strikes,InvestorPlace,/news/stocks/3-bulletproof-stocks-to-buy-before-the-next-recession-strikes-1032619507,neutral,0.90968257188797
9/11/2023 1:28:48 PM,"Kenvue gains after upgrade, bullish notes on Tylenol-Autism warning label suit",Seeking Alpha,https://seekingalpha.com/news/4010574-kenvue-gains-after-upgrade-bullish-notes-on-tylenol-autism-warning-label-suit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9204012751579285
9/11/2023 4:04:11 PM,Sandoz to commercialize biosimilar to J&J blockbuster drug Stelara,Seeking Alpha,https://seekingalpha.com/news/4010646-sandoz-to-commercialize-biosimilar-to-jnj-blockbuster-drug-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.690517008304596
9/11/2023 7:30:31 PM,AI Integration In Biotech & Pharma: Companies Positioned To Benefit,Benzinga,/news/stocks/ai-integration-in-biotech-pharma-companies-positioned-to-benefit-1032621068,positive,0.5679944157600403
9/11/2023 8:31:10 PM,AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst,Benzinga,/news/stocks/astrazeneca-s-tagrisso-chemo-combo-data-in-lung-cancer-sets-high-bar-for-johnson-johnson-s-cancer-drug-analyst-1032621133,positive,0.8292716145515442
9/12/2023 2:22:07 PM,AbbVie's Skyrizi outperforms JNJ‚Äôs Stelara in Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/4010983-abbvie-skyrizi-bested-jnj-stelara-crohns-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9411660432815552
9/12/2023 10:35:45 PM,"Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years, NY Consulting Firm Predicts",Benzinga,/news/stocks/ny-consulting-firm-predicts-psychedelic-drugs-market-will-generate-over-12b-in-next-12-years-1032624903,positive,0.784831166267395
9/13/2023 8:23:48 PM,Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains,InvestorPlace,/news/stocks/buy-the-dip-3-healthcare-stocks-to-snag-now-for-supercharged-gains-1032628467,neutral,0.7510806322097778
9/14/2023 7:05:25 PM,3 Blue-Chip Stocks to Watch in the ‚ÄòGreen Zone‚Äô,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-watch-in-the-tradesmith-green-zone-1032631792,neutral,0.6509931087493896
9/15/2023 9:10:49 AM,The 3 Most Undervalued Dow Stocks to Buy in September 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-dow-stocks-to-buy-in-september-2023-1032632969,neutral,0.828874409198761
9/15/2023 9:26:39 PM,"VTI ETF: This Diversified Powerhouse Owns Over 3,800 Stocks",TipRanks,/news/stocks/vti-etf-this-diversified-powerhouse-owns-over-3-800-stocks-1032634771,neutral,0.9168491959571838
9/15/2023 10:39:20 PM,Johnson & Johnson Unveils Modernized Logo After 135 Years ,RTTNews,/news/stocks/johnson-johnson-unveils-modernized-logo-after-135-years-1032634743,neutral,0.8629745244979858
9/19/2023 12:15:28 AM,Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1032638337,neutral,0.8271589279174805
9/19/2023 3:36:33 PM,7 Safe and Steady Dividend Stocks to Buy for Volatile Time,InvestorPlace,/news/stocks/7-safe-and-steady-dividend-stocks-to-buy-for-volatile-time-1032641007,neutral,0.7342789769172668
9/26/2023 3:13:34 PM,This Is the Holy Grail of Investing,InvestorPlace,/news/stocks/this-is-the-holy-grail-of-investing-1032656835,neutral,0.9053852558135986
9/27/2023 7:05:22 PM,What's Going On Pfizer's Subsidiary Biohaven Stock?,Benzinga,/news/stocks/what-s-going-on-pfizer-s-subsidiary-biohaven-stock-1032660550,neutral,0.5377779006958008
9/28/2023 7:30:23 PM,What to Note in the AI Megatrend,InvestorPlace,/news/stocks/what-to-note-in-the-ai-megatrend-1032664425,neutral,0.9303689002990723
9/29/2023 1:52:14 AM,SCHX ETF: A Large-Cap ETF for Large Gains,TipRanks,/news/stocks/schx-etf-a-large-cap-etf-for-large-gains-1032664747,neutral,0.9166260957717896
9/29/2023 10:01:12 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Maravai Lifesciences Holdings (MRVI), Johnson & Johnson (JNJ) and Amicus (FOLD)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-maravai-lifesciences-holdings-mrvi-johnson-johnson-jnj-and-amicus-fold-1032665877,negative,0.7983165383338928
9/29/2023 12:12:49 PM,Don‚Äôt Miss Out: 3 Dividend Stocks to Buy on EVERY. SINGLE. DIP.,InvestorPlace,/news/stocks/dont-miss-out-3-dividend-stocks-to-buy-on-every-single-dip-1032666285,neutral,0.9223251342773438
9/29/2023 12:31:59 PM,Recession-Proof Royals: 3 Stocks That Thrive in Tough Economic Times,InvestorPlace,/news/stocks/recession-proof-royals-3-stocks-that-thrive-in-tough-economic-times-1032666337,neutral,0.8587892651557922
10/1/2023 2:32:42 AM,"LLY, ISRG, or JNJ: Which Healthcare Stock Could Generate the Best Returns?",TipRanks,/news/stocks/lly-isrg-or-jnj-which-healthcare-stock-could-generate-the-best-returns-1032668067,neutral,0.8824886679649353
10/2/2023 9:31:15 AM,Food Stocks: Worth a Bite,TipRanks,/news/stocks/food-stocks-worth-a-bite-1032669628,neutral,0.6609483957290649
10/3/2023 4:15:23 AM,Cantor Fitzgerald Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-johnson-johnson-jnj-1032672066,neutral,0.941351056098938
10/3/2023 3:13:57 PM,"Higher Rates, Lower Leverage: Growth Stocks To Struggle While AI Offers Hope, Goldman Sachs Analysts Say",Benzinga,/news/stocks/higher-rates-lower-leverage-growth-stocks-to-struggle-while-ai-offers-hope-goldman-sachs-analysts-say-1032674601,positive,0.9077005386352539
10/3/2023 4:11:21 PM,"'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories",Benzinga,/news/stocks/airbnb-has-foundational-cracks-disney+-follows-netflix-on-subscription-sharing-crackdown-microsoft-s-nadella-criticizes-google-s-exclusive-content-deals-today-s-top-stories-1032675117,negative,0.9165230989456177
10/5/2023 12:08:41 AM,7 Top Healthcare Stocks That Pay Dividends,InvestorPlace,/news/stocks/7-top-healthcare-stocks-that-pay-dividends-1032679547,neutral,0.9341466426849365
10/5/2023 2:01:04 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1032681119,neutral,0.7854138612747192
10/5/2023 5:00:46 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-5-2023-1032682175,neutral,0.518395185470581
10/5/2023 6:40:12 PM,"Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst",Benzinga,/news/stocks/johnson-johnson-has-potential-to-drive-its-pharma-and-medtech-franchises-says-bullish-analyst-1032682493,positive,0.9369540810585022
10/8/2023 12:00:48 PM,3 Pharma Stocks to Dump Before the Damage Is Done,InvestorPlace,/news/stocks/3-pharma-stocks-to-dump-before-the-damage-is-done-1032686332,neutral,0.8428282737731934
10/8/2023 7:18:42 PM,J&J : Data Suggest Esketamine More Effective Than Typical Treatments In Major Depressive Disorder ,RTTNews,/news/stocks/j-j-data-suggest-esketamine-more-effective-than-typical-treatments-in-major-depressive-disorder-1032686618,positive,0.9397390484809875
10/9/2023 6:46:32 PM,3 Artificial Intelligence Stocks That Could Outperform the ‚ÄòGodfather of AI‚Äô,InvestorPlace,/news/stocks/3-artificial-intelligence-stocks-that-could-outperform-the-godfather-of-ai-1032689930,neutral,0.520642876625061
10/10/2023 4:20:34 AM,"Analysts Are Bullish on Top Healthcare Stocks: Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-bristol-myers-squibb-bmy-johnson-johnson-jnj-1032690640,neutral,0.5469264984130859
10/10/2023 5:55:05 AM,Johnson & Johnson (JNJ) Receives a Hold from DBS,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-hold-from-dbs-1032690762,neutral,0.7648741006851196
10/12/2023 5:52:18 PM,7 High-Growth S&P 500 Stocks to Buy Now,InvestorPlace,/news/stocks/7-high-growth-sp-500-stocks-to-buy-now-1032701698,neutral,0.8599169254302979
10/12/2023 6:41:33 PM,Beat the Market With These 7 Warren Buffett Stocks,InvestorPlace,/news/stocks/beat-the-market-with-these-7-warren-buffett-stocks-1032701803,neutral,0.752809464931488
10/13/2023 10:33:32 PM,"Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets",Benzinga,/news/etf/israel-hamas-war-shakes-middle-east-inflation-reawakens-oil-surges-the-week-in-the-markets-1032705050,negative,0.5841968655586243
10/14/2023 1:00:44 PM,Johnson & Johnson Stock: Is Now the Time to Sell?,InvestorPlace,/news/stocks/johnson-johnson-stock-is-now-the-time-to-sell-1032705305,neutral,0.8125900626182556
10/16/2023 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-q3-earnings-preview-stock-1032708397,neutral,0.9335330724716187
10/16/2023 10:50:24 PM,"Analysts Conflicted on These Healthcare Names: Merus (MRUS), Elevance Health (ELV) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-merus-mrus-elevance-health-elv-and-johnson-johnson-jnj-1032710047,negative,0.7575360536575317
10/17/2023 9:45:54 AM,"Bank of America, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/bank-of-america-johnson-johnson-and-3-stocks-to-watch-heading-into-tuesday-1032711225,neutral,0.9264112114906311
10/17/2023 12:28:37 PM,Johnson & Johnson Q3 Profit Beats Estimates,RTTNews,/news/stocks/johnson-johnson-q3-profit-beats-estimates-1032711846,positive,0.5837106108665466
10/17/2023 12:56:57 PM,"Johnson & Johnson Lifts 2023 Guidance Midpoints For Sales, Adj. EPS ",RTTNews,/news/stocks/johnson-johnson-lifts-2023-guidance-midpoints-for-sales-adj-eps-1032711920,neutral,0.4933289587497711
10/17/2023 6:57:12 PM,Johnson & Johnson‚Äôs Strong Q3 Performance and Upward Guidance Evokes Buy Rating: An Analysis of the Innovative Medicine Sector‚Äôs Influence,TipRanks,/news/stocks/johnson-johnson-s-strong-q3-performance-and-upward-guidance-evokes-buy-rating-an-analysis-of-the-innovative-medicine-sector-s-influence-1032713926,neutral,0.5418809652328491
10/17/2023 7:46:33 PM,"Stocks Rise On Positive Earnings; Treasury Volatility Returns, Nvidia Stumbles: What's Driving Markets Tuesday?",Benzinga,/news/stocks/stocks-rise-on-positive-earnings-treasury-volatility-returns-nvidia-stumbles-what-s-driving-markets-tuesday-1032713829,negative,0.5387625098228455
10/18/2023 1:01:28 AM,"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Johnson & Johnson (JNJ) and Thermo Fisher (TMO)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-johnson-johnson-jnj-and-thermo-fisher-tmo-1032714341,neutral,0.9067949056625366
10/18/2023 6:27:59 AM,Hold Rating for Johnson & Johnson: A Balance of Strong Performance and Ongoing Challenges,TipRanks,/news/stocks/hold-rating-for-johnson-johnson-a-balance-of-strong-performance-and-ongoing-challenges-1032715487,positive,0.9066937565803528
10/18/2023 6:36:32 AM,Positive Analyst Outlook on Johnson & Johnson: Accelerated Growth and Raised Guidance Despite Potential Challenges,TipRanks,/news/stocks/positive-analyst-outlook-on-johnson-johnson-accelerated-growth-and-raised-guidance-despite-potential-challenges-1032715508,positive,0.9550530314445496
10/18/2023 2:01:37 PM,"Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-ligand-pharma-lgnd-johnson-johnson-jnj-1032717614,positive,0.5795178413391113
10/18/2023 8:44:06 PM,Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug,Benzinga,/news/stocks/positive-outlook-on-johnson-johnson-s-partner-legend-biotech-analyst-confident-on-blood-cancer-drug-1032718213,positive,0.6799636483192444
10/19/2023 12:15:26 AM,Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1032718609,neutral,0.8271589279174805
10/19/2023 10:45:10 AM,7 Dividend Aristocrats That Are Built to Last,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-are-built-to-last-1032720311,neutral,0.8798190355300903
10/19/2023 12:00:23 PM,Johnson & Johnson‚Äôs Stock Receives Buy Rating Amid Promising MARIPOSA Trial Results and Potential Market Share Gain,TipRanks,/news/stocks/johnson-johnson-s-stock-receives-buy-rating-amid-promising-mariposa-trial-results-and-potential-market-share-gain-1032720633,positive,0.9526110291481018
10/19/2023 8:11:36 PM,7 Healthcare Stocks That Can Cure a Lackluster Portfolio,InvestorPlace,/news/stocks/healthcare-stocks-to-buy-4-1032722294,neutral,0.7649614810943604
10/19/2023 8:36:20 PM,The 7 Best Forever Stocks To Buy Now: October 2023,InvestorPlace,/news/stocks/7-best-forever-stocks-to-buy-now-october-2023-1032722370,neutral,0.9350667595863342
10/20/2023 1:53:35 PM,3 Mutual Funds to Invest in for Pro Management and Low Fees,InvestorPlace,/news/stocks/3-mutual-funds-to-invest-in-for-pro-management-and-low-fees-1032724440,neutral,0.8983345031738281
10/24/2023 12:15:53 AM,Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-keeps-their-buy-rating-on-johnson-johnson-jnj-1032734736,neutral,0.9096185564994812
10/24/2023 10:56:18 AM,Johnson & Johnson‚Äôs Stock: A Stable Transition and Promising Future Despite Leadership Change,TipRanks,/news/stocks/johnson-johnson-s-stock-a-stable-transition-and-promising-future-despite-leadership-change-1032735321,positive,0.9448173642158508
10/25/2023 1:43:12 AM,VTV: A Must-Watch ETF for Value Investors,TipRanks,/news/stocks/vtv-a-must-watch-etf-for-value-investors-1032739060,neutral,0.8936379551887512
10/25/2023 6:18:06 AM,Positive Prospects for Johnson & Johnson: Buy Rating Assigned Due to Superior Performance of Rybrevant in MARIPOSA Trials,TipRanks,/news/stocks/positive-prospects-for-johnson-johnson-buy-rating-assigned-due-to-superior-performance-of-rybrevant-in-mariposa-trials-1032740152,positive,0.957366943359375
10/25/2023 10:15:00 AM,The 7 Best Forever Stocks to Buy for October 2023,InvestorPlace,/news/stocks/the-7-best-forever-stocks-to-buy-for-october-2023-1032737998,neutral,0.9330435395240784
10/25/2023 8:04:04 PM,Dow Jones Bear Market: 3 Cheap Stocks to Buy Now,InvestorPlace,/news/stocks/dow-jones-bear-market-3-cheap-stocks-to-buy-now-1032740344,neutral,0.8925117254257202
10/26/2023 5:21:52 PM,3 Stocks to Buy (and Never Ever Sell),InvestorPlace,/news/stocks/3-stocks-to-buy-and-never-ever-sell-1032745222,neutral,0.9382155537605286
10/27/2023 6:19:56 AM,Goldman Sachs Reaffirms Their Sell Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/goldman-sachs-reaffirms-their-sell-rating-on-johnson-johnson-jnj-1032749668,neutral,0.7924532890319824
10/27/2023 1:25:10 PM,SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff,InvestorPlace,/news/stocks/sny-stock-sinks-15-as-sanofi-plans-consumer-unit-spinoff-1032748736,negative,0.9670206308364868
10/27/2023 1:30:30 PM,"Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Insmed (INSM) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-universal-health-uhs-insmed-insm-and-johnson-johnson-jnj-1032750294,neutral,0.9281283617019653
10/30/2023 9:50:50 AM,"Analysts Are Bullish on Top Healthcare Stocks: Arcellx Inc (ACLX), Biogen (BIIB)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-arcellx-inc-aclx-biogen-biib-1032755860,neutral,0.498972624540329
10/31/2023 6:30:49 AM,"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Boston Scientific (BSX) and PTC Therapeutics (PTCT)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-boston-scientific-bsx-and-ptc-therapeutics-ptct-1032760969,negative,0.759351372718811
11/2/2023 7:25:38 PM,"EXCLUSIVE: Roundhill Launches Dividend Kings ETF With 'The Gold Standard Of Dividend Growers,' Companies With 'Incredible Resilience'",Benzinga,/news/etf/exclusive-roundhill-launches-dividend-kings-etf-with-the-gold-standard-of-dividend-growers-companies-with-incredible-resilience-1032771912,positive,0.8681635856628418
11/2/2023 8:01:04 PM,"Amgen Wins Big With FDA, Analyst Sees Soaring Potential",Benzinga,/news/stocks/amgen-wins-big-with-fda-analyst-sees-soaring-potential-1032771966,positive,0.9449009895324707
11/2/2023 10:52:30 PM,Johnson & Johnson Stock (NYSE:JNJ): Time to Buy the Dip?,TipRanks,/news/stocks/johnson-johnson-stock-nyse-jnj-time-to-buy-the-dip-1032775761,neutral,0.9170476198196411
11/3/2023 12:42:56 PM,The 3 Best Forever Stocks to Buy in November,InvestorPlace,/news/stocks/the-3-best-forever-stocks-to-buy-in-november-1032776148,neutral,0.890318751335144
11/6/2023 6:30:58 PM,Long-Term Winners: Ray Dalio‚Äôs Top 3 Stock Recommendations for a Prosperous Future,InvestorPlace,/news/stocks/long-term-winners-ray-dalios-top-3-stock-recommendations-for-a-prosperous-future-1032783431,neutral,0.7622930407524109
11/8/2023 10:12:22 AM,"Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), Biogen (BIIB) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-bluebird-bio-blue-biogen-biib-and-johnson-johnson-jnj-1032796738,neutral,0.9149225354194641
11/8/2023 11:29:22 AM,Johnson & Johnson‚Äôs Growth Potential: Ottava Robotic System and Untapped General Surgery Robotics Market,TipRanks,/news/stocks/johnson-johnson-s-growth-potential-ottava-robotic-system-and-untapped-general-surgery-robotics-market-1032796865,neutral,0.6383065581321716
11/9/2023 10:35:00 AM,3 Dividend Stocks to Buy for Consistent Income,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-for-consistent-income-1032799884,neutral,0.9006801247596741
11/9/2023 12:52:37 PM,3 Dividend Stocks That Could Pay for Your Holiday Shopping,InvestorPlace,/news/stocks/3-dividend-stocks-that-could-pay-for-your-holiday-shopping-1032800353,neutral,0.9139618873596191
11/9/2023 2:26:17 PM,7 Safe Stocks to Buy if You Think Q3‚Äôs Gangbuster Growth Won‚Äôt Last,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-if-you-think-q3s-gangbuster-growth-wont-last-1032801059,neutral,0.7254758477210999
11/15/2023 2:10:36 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Cormedix (CRMD), Immatics (IMTX) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-cormedix-crmd-immatics-imtx-and-johnson-johnson-jnj-1032823185,negative,0.9384737014770508
11/15/2023 3:20:10 AM,It‚Äôs Time to Buy These 3 Dividend Aristocrats Trading Near 52-Week Lows,InvestorPlace,/news/stocks/its-time-to-buy-these-3-dividend-aristocrats-trading-near-52-week-lows-1032819984,neutral,0.5707411766052246
11/15/2023 4:23:44 AM,Blue-Chip Bargains: Top 3 Oversold Aristocrats for Value Investors,InvestorPlace,/news/stocks/blue-chip-bargains-top-3-oversold-aristocrats-for-value-investors-1032820035,neutral,0.7906441688537598
11/15/2023 7:20:34 AM,Buffett‚Äôs Berkshire Sells JNJ and UPS Stocks; Should You Follow?,TipRanks,/news/stocks/buffett-s-berkshire-sells-jnj-and-ups-stocks-should-you-follow-1032824425,neutral,0.9389862418174744
11/16/2023 2:07:22 AM,Storm-Proof Income: 7 Dividend Aristocrats to Fortify Your Portfolio,InvestorPlace,/news/stocks/storm-proof-income-7-dividend-aristocrats-to-fortify-your-portfolio-1032825013,neutral,0.9027332663536072
11/16/2023 6:09:48 PM,3 Strong-Buy Dividend Stocks That Analysts Love,InvestorPlace,/news/stocks/3-strong-buy-dividend-stocks-that-analysts-love-1032828896,neutral,0.7452504634857178
11/16/2023 6:31:57 PM,3 Must-Buy Stocks on Every Market Dip,InvestorPlace,/news/stocks/3-must-buy-stocks-on-every-market-dip-1032828986,neutral,0.9271240234375
11/17/2023 8:23:34 PM,7 High-Yield Blue Chips Suitable for Any Retiree,InvestorPlace,/news/stocks/7-high-yield-blue-chip-stocks-suitable-for-any-reitree-1032832622,neutral,0.8566920757293701
11/17/2023 9:00:13 PM,21 Analysts Have This to Say About Johnson & Johnson,Benzinga,/news/stocks/21-analysts-have-this-to-say-about-johnson-johnson-1032832598,neutral,0.92400062084198
11/18/2023 8:25:40 AM,Cantor Fitzgerald Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1032833159,neutral,0.8304359316825867
11/28/2023 2:29:47 AM,The Shocking Stock That Warren Buffet Just Bought (and 2 He Sold),InvestorPlace,/news/stocks/the-shocking-stock-that-warren-buffet-just-bought-and-2-he-sold-1032852883,neutral,0.9324578642845154
11/28/2023 10:10:00 AM,3 Robotics Stocks That Could Be Multibaggers in the Making,InvestorPlace,/news/stocks/3-robotics-stocks-that-could-be-multibaggers-in-the-making-1032853990,neutral,0.836942195892334
11/28/2023 10:20:30 AM,"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Masimo (MASI) and Regeneron (REGN)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-masimo-masi-and-regeneron-regn-1032856472,negative,0.7661237716674805
11/29/2023 11:42:45 AM,The 7 Biggest Dividend Stocks in Warren Buffett‚Äôs Portfolio,InvestorPlace,/news/stocks/the-7-biggest-dividend-stocks-in-warren-buffetts-portfolio-1032857965,neutral,0.9281255006790161
11/30/2023 9:21:06 AM,Analysts Offer Insights on Healthcare Companies: Hyperfine (HYPR) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-hyperfine-hypr-and-johnson-johnson-jnj-1032864340,neutral,0.9027352929115295
11/30/2023 9:31:01 AM,Analysts Offer Insights on Healthcare Companies: Hyperfine (HYPR) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-hyperfine-hypr-and-johnson-johnson-jnj-1032864431,neutral,0.9027352929115295
11/30/2023 2:06:00 PM,Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF,InvestorPlace,/news/stocks/fresh-on-the-market-3-top-picks-from-the-renaissance-ipo-etf-1032862745,neutral,0.694316565990448
11/30/2023 3:52:29 PM,"Johnson & Johnson MedTech Completes Laminar Acquisition, Sees $0.15/share Negative Impact In FY24 ",RTTNews,/news/stocks/johnson-johnson-medtech-completes-laminar-acquisition-sees-0-15-share-negative-impact-in-fy24-1032862857,negative,0.9698890447616577
11/30/2023 4:06:08 PM,Income Kings: 7 Blue-Chip Dividend Stocks for Reliable Returns,InvestorPlace,/news/stocks/income-kings-7-blue-chip-dividend-stocks-for-reliable-returns-1032863431,neutral,0.7976706624031067
11/30/2023 5:23:00 PM,"7 Blue-Chip Stocks to Buy for 2024, According to AI",InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-for-2024-according-to-ai-1032863884,neutral,0.9224819540977478
12/1/2023 2:40:05 AM,Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Johnson & Johnson (JNJ) and Walgreens Boots Alliance (WBA),TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-johnson-johnson-jnj-and-walgreens-boots-alliance-wba-1032866516,negative,0.7764856219291687
12/1/2023 10:05:34 AM,"Analysts Are Bullish on Top Healthcare Stocks: Johnson & Johnson (JNJ), Humana (HUM)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-johnson-johnson-jnj-humana-hum-1032867703,positive,0.4709150791168213
12/1/2023 12:04:04 PM,"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Harmony Biosciences Holdings (HRMY) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-harmony-biosciences-holdings-hrmy-and-johnson-johnson-jnj-1032867821,neutral,0.913899838924408
12/1/2023 1:59:46 PM,Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio,InvestorPlace,/news/stocks/wealth-from-wellness-7-healthcare-stocks-to-inoculate-your-portfolio-1032866432,neutral,0.9037390351295471
12/1/2023 7:05:11 PM,Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections,Benzinga,/news/stocks/johnson-johnson-gets-analyst-upgrade-noting-bullish-pharma-medtech-projections-1032867327,positive,0.9138108491897583
12/4/2023 2:21:11 PM,"The 7 Best Ways to Invest $1,000 in the Stock Market Now",InvestorPlace,/news/stocks/the-7-best-ways-to-invest-1000-in-the-stock-market-now-1032870680,neutral,0.9286323189735413
12/5/2023 8:56:06 AM,Johnson & Johnson: Navigating Growth and Regulatory Challenges in Medical Technology,TipRanks,/news/stocks/johnson-johnson-navigating-growth-and-regulatory-challenges-in-medical-technology-1032875925,neutral,0.7990163564682007
12/5/2023 2:15:16 PM,Johnson & Johnson Guides FY24 Adj. EPS Below Estimates ,RTTNews,/news/stocks/johnson-johnson-guides-fy24-adj-eps-below-estimates-1032874082,neutral,0.9216665625572205
12/5/2023 10:40:36 PM,Is Buffett Turning Bearish? 7 Stocks Warren Completely Dumped in Q3,InvestorPlace,/news/stocks/is-buffett-turning-bearish-7-stocks-warren-completely-dumped-in-q3-1032876122,negative,0.9592518210411072
12/6/2023 3:06:08 AM,Buy Rating Affirmed for Johnson & Johnson: Long-Term Growth and Strategic Positioning Underpin Optimistic Outlook,TipRanks,/news/stocks/buy-rating-affirmed-for-johnson-johnson-long-term-growth-and-strategic-positioning-underpin-optimistic-outlook-1032878894,positive,0.9499220848083496
12/6/2023 10:20:29 AM,"Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Johnson & Johnson (JNJ) and IGM Biosciences (IGMS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-merus-mrus-johnson-johnson-jnj-and-igm-biosciences-igms-1032879903,neutral,0.9225835204124451
12/6/2023 11:50:15 AM,"Analysts Offer Insights on Healthcare Companies: Ping An Healthcare and Technology Company (OtherPANHF), Healthequity (HQY) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-ping-an-healthcare-and-technology-company-otherpanhf-healthequity-hqy-and-johnson-johnson-jnj-1032879985,neutral,0.9092282652854919
12/6/2023 12:41:32 PM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), CVS Health (CVS) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-cvs-health-cvs-and-vertex-pharmaceuticals-vrtx-1032880041,neutral,0.9053109884262085
12/6/2023 1:56:21 PM,Bargain Buys: 7 Stocks Lagging the S&P 500 With Big Potential,InvestorPlace,/news/stocks/bargain-buys-7-stocks-lagging-the-sp-500-with-big-potential-1032878330,negative,0.7779294848442078
12/6/2023 5:23:37 PM,"JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities",Benzinga,/news/stocks/jnj-ceo-signals-no-rush-into-weight-loss-drug-realm-emphasizes-different-priorities-1032879077,neutral,0.8401649594306946
12/7/2023 8:02:26 AM,Strong Growth Ahead: Buy Rating for Johnson & Johnson Amid Exceeding Long-Term Projections,TipRanks,/news/stocks/strong-growth-ahead-buy-rating-for-johnson-johnson-amid-exceeding-long-term-projections-1032883435,positive,0.9562548398971558
12/7/2023 12:21:03 PM,"Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Johnson & Johnson (JNJ) and Veeva Systems (VEEV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-johnson-johnson-jnj-and-veeva-systems-veev-1032883851,neutral,0.9108095765113831
12/7/2023 12:50:14 PM,"Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Johnson & Johnson (JNJ) and Elanco Animal Health (ELAN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-qiagen-qgen-johnson-johnson-jnj-and-elanco-animal-health-elan-1032883942,neutral,0.9157578945159912
12/7/2023 1:19:15 PM,"Vanda Pharmaceuticals Acquires U.S., Canadian Rights To PONVORY From Janssen ",RTTNews,/news/stocks/vanda-pharmaceuticals-acquires-u-s-canadian-rights-to-ponvory-from-janssen-1032881574,neutral,0.8584516048431396
12/7/2023 6:53:44 PM,Investing in the Aging Population: 3 Healthcare Stocks to Watch,InvestorPlace,/news/stocks/investing-in-the-aging-population-3-healthcare-stocks-to-watch-1032883283,neutral,0.88970947265625
12/8/2023 12:30:00 PM,7 Tech Stocks to Light Up Your Portfolio This Holiday Season,InvestorPlace,/news/stocks/7-tech-stocks-to-light-up-your-portfolio-this-holiday-season-1032885360,neutral,0.7529712915420532
12/11/2023 8:33:58 PM,"Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say",Benzinga,/news/stocks/blood-cancer-player-arcellx-s-lead-product-exceeds-expectations-analysts-say-1032890784,positive,0.9527626037597656
12/11/2023 8:42:45 PM,Life-Changing Investments: 3 Stocks That Will Set You Up for the Long Haul,InvestorPlace,/news/stocks/life-changing-investments-3-stocks-that-will-set-you-up-for-the-long-haul-1032890918,neutral,0.8189628720283508
12/13/2023 12:00:00 PM,Seeking Passive Income? 7 Dividend Stocks You Don‚Äôt Want to Miss.,InvestorPlace,/news/stocks/seeking-passive-income-7-dividend-stocks-you-dont-want-to-miss-1032896670,neutral,0.8886903524398804
12/13/2023 12:37:44 PM,Integra LifeSciences To Acquire Acclarent For $275 Mln Cash ,RTTNews,/news/stocks/integra-lifesciences-to-acquire-acclarent-for-275-mln-cash-1032896532,neutral,0.9330462217330933
12/13/2023 1:44:23 PM,D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday,Benzinga,/news/stocks/d-r-horton-to-rally-around-19-here-are-10-top-analyst-forecasts-for-wednesday-1032896816,neutral,0.9061914682388306
12/13/2023 1:44:56 PM,Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability,InvestorPlace,/news/stocks/economic-safety-nets-7-defensive-stocks-providing-portfolio-stability-1032897100,neutral,0.8506568670272827
12/14/2023 1:30:00 PM,Ryan Cohen Plans to Save GameStop By Becoming Warren Buffett,InvestorPlace,/news/stocks/ryan-cohen-plans-to-save-gamestop-by-becoming-warren-buffett-1032900985,neutral,0.925405740737915
12/14/2023 7:56:41 PM,3 Dow Stocks I Wouldn‚Äôt Touch With a 10-Foot Pole,InvestorPlace,/news/stocks/3-dow-stocks-i-wouldnt-touch-with-a-10-foot-pole-1032902603,neutral,0.9152519106864929
12/15/2023 2:28:33 PM,AC Immune Advances Anti-pTau Active Immunotherapy For Alzheimer's Disease Into Phase 2b Trial ,RTTNews,/news/stocks/ac-immune-advances-anti-ptau-active-immunotherapy-for-alzheimer-s-disease-into-phase-2b-trial-1032904707,positive,0.6032789349555969
12/15/2023 4:58:43 PM,"AC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b Trial",Benzinga,/news/stocks/ac-immune-raises-50m-its-alzheimer-s-targeting-immunotherapy-advances-into-phase-2b-trial-1032905427,positive,0.8615201711654663
12/15/2023 5:26:22 PM,The 7 Most Undervalued Dividend Stocks to Buy in December,InvestorPlace,/news/stocks/the-7-most-undervalued-dividend-stocks-to-buy-in-december-1032905710,neutral,0.5166016221046448
12/15/2023 8:01:28 PM,The Dogs of the Dow May Pay Big Dividends in 2024,InvestorPlace,/news/stocks/the-dogs-of-the-dow-may-pay-big-dividends-in-2024-1032905944,neutral,0.7251582741737366
12/17/2023 7:00:00 PM,3 of the Most Attractive Dividend Stocks in the Pharma Space,InvestorPlace,/news/stocks/3-of-the-most-attractive-dividend-stocks-in-the-pharma-space-1032907116,positive,0.585766613483429
12/19/2023 1:51:10 PM,7 New Year‚Äôs Stocks to Buy to Get 2024 Off to a Bright Start,InvestorPlace,/news/stocks/7-new-years-stocks-to-buy-to-get-2024-off-to-a-bright-start-1032912438,positive,0.869455099105835
12/19/2023 10:00:50 PM,Forever Favorites: 7 Dividend Stocks to Buy and Never Sell,InvestorPlace,/news/stocks/forever-favorites-7-dividend-stocks-to-buy-and-never-sell-1032914179,neutral,0.9393635988235474
12/21/2023 2:02:22 PM,7 Stocks That Might Win on Election Year Uncertainty,InvestorPlace,/news/stocks/7-stocks-that-might-win-on-election-year-uncertainty-1032919400,neutral,0.8125710487365723
12/21/2023 5:11:14 PM,Why Is Eye Disease Related Gene Therapy Focused MeiraGTx Stock Soaring Today?,Benzinga,/news/stocks/why-is-eye-disease-related-gene-therapy-focused-meiragtx-stock-soaring-today-1032920039,neutral,0.5965177416801453
12/21/2023 9:45:14 PM,Build Your Future Portfolio: 3 Generous Dividend Stocks,InvestorPlace,/news/stocks/build-your-future-portfolio-3-generous-dividend-stocks-1032920683,neutral,0.9033442139625549
12/22/2023 2:53:47 AM,Johnson & Johnson Stock (NYSE:JNJ): A Smart Dividend Pick for 2024,TipRanks,/news/stocks/johnson-johnson-stock-nyse-jnj-a-smart-dividend-pick-for-2024-1032922422,neutral,0.5898594856262207
12/26/2023 2:37:48 AM,7 Rock-Solid Dividend Stocks to Trust in Difficult Times,InvestorPlace,/news/stocks/7-rock-solid-dividend-stocks-to-trust-in-difficult-times-1032925151,positive,0.8322290778160095
12/26/2023 10:44:33 AM,LianBio Transfers Rights For NBTXR3 In China And Other Asian Markets To Janssen Pharma; Stock Up ,RTTNews,/news/stocks/lianbio-transfers-rights-for-nbtxr3-in-china-and-other-asian-markets-to-janssen-pharma-stock-up-1032925465,neutral,0.607565701007843
12/27/2023 10:31:53 PM,Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness,InvestorPlace,/news/stocks/healthcare-heroes-3-stocks-innovating-in-medicine-and-wellness-1032928865,neutral,0.8069812655448914
12/28/2023 1:33:14 PM,"Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts",Benzinga,/news/stocks/eli-lilly-johnson-johnson-and-other-health-care-stocks-from-wall-street-s-most-accurate-analysts-1032929866,neutral,0.8699533939361572
12/28/2023 6:16:37 PM,Safe Havens: 3 Fixed-Income Securities for a Balanced Portfolio in 2024,InvestorPlace,/news/stocks/safe-havens-3-fixed-income-securities-for-a-balanced-portfolio-in-2024-1032930815,neutral,0.547278642654419
12/29/2023 10:01:50 AM,Disaster-Proof Dividends: 3 Stocks with Resilient Payouts in Tough Times,InvestorPlace,/news/stocks/disaster-proof-dividends-3-stocks-with-resilient-payouts-in-tough-times-1032931885,positive,0.6306286454200745
12/31/2023 11:00:00 AM,Legacy Investments: 7 Stocks to Make Your Grandkids Millionaires,InvestorPlace,/news/stocks/legacy-investments-7-stocks-to-make-your-grandkids-millionaires-1032933656,neutral,0.9170663952827454
1/1/2024 7:15:07 PM,2024‚Äôs Blue-Chip Winners: Top 3 Stocks for Rock-Solid Returns,InvestorPlace,/news/stocks/2024s-blue-chip-winners-top-3-stocks-for-rock-solid-returns-1032935426,positive,0.778913140296936
1/2/2024 7:22:32 PM,"Dogs Of The Dow: Top 10 Highest Yielding Dow Jones Stocks, How To Get Dividends Of 3% to 7.4% In 2024",Benzinga,/news/etf/dogs-of-the-dow-top-10-highest-yielding-dow-jones-stocks-how-to-get-dividends-of-3-to-7-4-in-2024-1032937754,neutral,0.9235051274299622
1/3/2024 4:26:53 PM,Tech Sell-Off Triggers Market Reset: Value Stocks Reach 7-Month High Versus Growth,Benzinga,/news/etf/tech-sell-off-triggers-market-reset-value-stocks-reach-7-month-high-versus-growth-1032940596,positive,0.8445477485656738
1/3/2024 6:29:31 PM,"This Analyst Downgrades Bristol-Myers Squibb, Cautions Amid Product Launch And Revenue Concerns",Benzinga,/news/stocks/this-analyst-downgrades-bristol-myers-squibb-cautions-amid-product-launch-and-revenue-concerns-1032940889,negative,0.9435458779335022
1/3/2024 7:43:03 PM,The 3 Best Blue-Chip Stocks to Buy Now,InvestorPlace,/news/stocks/best-blue-chip-stocks-1031627772,neutral,0.8018681406974792
1/3/2024 9:00:19 PM,Revenge of the Boring Stocks! Dividends Are Sexy Again.,InvestorPlace,/news/stocks/revenge-of-the-boring-stocks-dividends-are-sexy-again-1032941212,neutral,0.7992132902145386
1/3/2024 10:42:40 PM,The 7 Best Meme Stocks to Buy Now,InvestorPlace,/news/stocks/best-meme-stocks-1031269612,neutral,0.9085869193077087
1/4/2024 8:15:24 AM,Johnson & Johnson (JNJ) Gets a Buy from Raymond James,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-raymond-james-1032944360,neutral,0.5320760011672974
1/4/2024 11:28:12 PM,Still Worried About a 2024 Recession? 7 Stocks to Watch.,InvestorPlace,/news/stocks/still-worried-about-a-2024-recession-7-stocks-to-watch-1032944595,negative,0.6595353484153748
1/6/2024 8:00:00 PM,Dow Darlings: Top 3 Stocks That Will Lead the Charge in 2024,InvestorPlace,/news/stocks/dow-darlings-top-3-stocks-that-will-lead-the-charge-in-2024-1032947480,neutral,0.8988953232765198
1/8/2024 1:57:22 PM,Johnson & Johnson To Acquire Ambrx For $28.00 Per Share - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-to-acquire-ambrx-for-28-00-per-share-quick-facts-1032950099,neutral,0.9276778697967529
1/8/2024 4:18:52 PM,Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal,Benzinga,/news/stocks/today-is-cancer-focused-deals-day-johnson-johnson-scoops-up-ambrx-biopharma-as-merck-boosts-cancer-portfolio-with-harpoon-deal-1032950939,positive,0.5216544270515442
1/8/2024 5:22:00 PM,Why Is Ambrx Biopharma (AMAM) Stock Up 100% Today?,InvestorPlace,/news/stocks/why-is-ambrx-biopharma-amam-stock-up-100-today-1032951235,positive,0.8520812392234802
1/9/2024 10:06:31 AM,Johnson & Johnson: A Steady Hold Amidst Strategic Expansion and Pipeline Potential,TipRanks,/news/stocks/johnson-johnson-a-steady-hold-amidst-strategic-expansion-and-pipeline-potential-1032955160,positive,0.9275665879249573
1/9/2024 12:20:15 PM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Prothena (PRTA), Johnson & Johnson (JNJ) and Zimmer Biomet Holdings (ZBH)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-prothena-prta-johnson-johnson-jnj-and-zimmer-biomet-holdings-zbh-1032955314,negative,0.9387431740760803
1/10/2024 10:22:51 PM,7 Stable Stocks to Buy No Matter What Happens to Interest Rates,InvestorPlace,/news/stocks/7-stable-stocks-to-buy-no-matter-what-happens-to-interest-rates-1032958678,neutral,0.9042826890945435
1/10/2024 10:49:21 PM,3 Unshakeable Dividend Stocks for Lifelong Wealth,InvestorPlace,/news/stocks/3-unshakeable-dividend-stocks-for-lifelong-wealth-1032958695,neutral,0.8588069081306458
1/11/2024 6:37:42 AM,Buy Rating on Johnson & Johnson: Strategic Oncology Acquisition Promises Growth,TipRanks,/news/stocks/buy-rating-on-johnson-johnson-strategic-oncology-acquisition-promises-growth-1032959789,positive,0.897979736328125
1/11/2024 8:05:07 PM,Dividend Dynasty: 7 High-Yield Stocks for Long-Term Wealth Accumulation,InvestorPlace,/news/stocks/dividend-dynasty-7-high-yield-stocks-for-long-term-wealth-accumulation-1032961916,neutral,0.9331802129745483
1/13/2024 1:11:11 PM,"Analysts Conflicted on These Healthcare Names: UnitedHealth (UNH), Johnson & Johnson (JNJ) and Idexx Laboratories (IDXX)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-unitedhealth-unh-johnson-johnson-jnj-and-idexx-laboratories-idxx-1032965145,negative,0.6438891291618347
1/14/2024 11:15:00 AM,Hidden High-Yielders: 7 Overlooked Stocks with Attractive Dividends¬†,InvestorPlace,/news/stocks/7-overlooked-high-yield-dividend-stocks-for-your-2024-portfolio-1032965321,neutral,0.8044859170913696
1/15/2024 10:29:48 PM,The 3 Most Undervalued Value Stocks to Buy in January,InvestorPlace,/news/stocks/the-3-most-undervalued-value-stocks-to-buy-in-january-1032968457,neutral,0.5055691003799438
1/16/2024 1:50:47 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), GoodRx Holdings (GDRX) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-arrowhead-pharmaceuticals-arwr-goodrx-holdings-gdrx-and-johnson-johnson-jnj-1032968640,negative,0.9448198080062866
1/18/2024 7:17:40 PM,7 Must-Have Stocks for Serious Wealth Accumulation,InvestorPlace,/news/stocks/7-must-have-stocks-for-serious-wealth-accumulation-1032978135,neutral,0.7609947919845581
1/18/2024 10:24:47 PM,3 Reasons to Rely on Dividend Stocks,InvestorPlace,/news/stocks/3-reasons-to-rely-on-dividend-stocks-1032978398,neutral,0.9319899082183838
1/19/2024 1:05:15 PM,Senate panel to consider subpoenas for J&J and Merck CEOs,Seeking Alpha,https://seekingalpha.com/news/4056351-sen-bernie-sanders-weighs-subpoenas-jj-merck-ceos?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5767501592636108
1/19/2024 4:18:03 PM,Eli Lilly production plant said to be under renewed FDA scrutiny,Seeking Alpha,https://seekingalpha.com/news/4056498-eli-lilly-plant-renewed-fda-scrutiny?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5291783213615417
1/19/2024 8:00:29 PM,"Catalyst Watch: Tesla, Netflix and Procter & Gamble head into the earnings confessional",Seeking Alpha,https://seekingalpha.com/news/4056553-catalyst-watch-tesla-netflix-and-procter-gamble-head-into-the-earnings-confessional?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9108691215515137
1/19/2024 8:10:19 PM,"Alvotech stock jumps 15% on Stelara, Humira biosimilars updates (update)",Seeking Alpha,https://seekingalpha.com/news/4056530-fda-flags-possible-violation-at-alvotech-biosimilars-plant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8388013243675232
1/19/2024 8:39:27 PM,Johnson & Johnson wins full FDA approval for bladder cancer therapy Balversa,Seeking Alpha,https://seekingalpha.com/news/4056579-johnson--johnson-fda-approval-for-bladder-cancer-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9164641499519348
1/21/2024 1:00:00 PM,"Earnings week ahead: Tesla, Netflix, AT&T, Johnson & Johnson, GE and more",Seeking Alpha,https://seekingalpha.com/news/4056510-earnings-week-ahead-tesla-netflix-att-johnson-johnson-general-electric-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9366970062255859
1/21/2024 5:00:01 PM,Anti-obesity meds can expand the market for weight loss surgery: Bernstein,Seeking Alpha,https://seekingalpha.com/news/4056663-glp-1s-can-expand-market-weight-loss-surgery-bernstein?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8208276033401489
1/21/2024 6:30:00 PM,New ADHD drugs could pay off for pharmaceutical companies,Seeking Alpha,https://seekingalpha.com/news/4056645-new-adhd-drugs-could-pay-off-pharmaceutical-companies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9085960984230042
1/22/2024 3:01:13 PM,Johnson Johnson earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/johnson_johnson-stock-q4-earnings-preview-1032983615,neutral,0.9109315872192383
1/22/2024 3:23:05 PM,"BoFA picks Johnson & Johnson, Halliburton and Tesla for options opportunity ahead of earnings",Seeking Alpha,https://seekingalpha.com/news/4056847-bofa-picks-johnson-johnson-halliburton-and-tesla-for-options-opportunity-ahead-of-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8573928475379944
1/22/2024 3:55:24 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/4056909-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8660829067230225
1/22/2024 4:48:10 PM,JNJ looking to move talc powder unit to Texas ahead of bankruptcy filing: report,Seeking Alpha,https://seekingalpha.com/news/4056938-jnj-looking-to-move-talc-powder-unit-to-texas-ahead-of-bankruptcy-filing-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9445784687995911
1/22/2024 5:21:31 PM,Johnson & Johnson to kick off pharma earnings season amid talc overhang,Seeking Alpha,https://seekingalpha.com/news/4056961-johnson-johnson-q4-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9020541906356812
1/22/2024 7:34:59 PM,"S&P 500, Nasdaq, Dow Jones Strike All-Time Highs Ahead Of Key Earnings This Week: What's Driving Markets Monday?",Benzinga,/news/etf/stock-indexes-trade-at-all-time-highs-ahead-of-key-earnings-this-week-what-s-driving-markets-monday-1032984660,neutral,0.7300148606300354
1/23/2024 4:09:28 AM,CAR-T therapies to get boxed warning on blood cancer risk,Seeking Alpha,https://seekingalpha.com/news/4057175-car-t-therapies-get-boxed-warning-blood-cancer-risk?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7862139344215393
1/23/2024 11:24:18 AM,Johnson & Johnson beats top and bottom line estimates; reaffirms FY24 outlook,Seeking Alpha,https://seekingalpha.com/news/4057235-johnson-johnson-beats-top-and-bottom-line-estimates-reaffirms-fy24-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8630649447441101
1/23/2024 11:41:22 AM,Johnson & Johnson in charts: MedTech segment sales surged 13% Y/Y in Q4,Seeking Alpha,https://seekingalpha.com/news/4057244-johnson-johnson-in-charts-medtech-segment-sales-surged-13-yy-in-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9549142122268677
1/23/2024 12:08:06 PM,Johnson & Johnson posts Q4 beat as pharma and MedTech outperform,Seeking Alpha,https://seekingalpha.com/news/4057264-johnson-johnson-posts-q4-beat-pharma-medtech-outperform?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6140116453170776
1/23/2024 12:36:49 PM,"Johnson & Johnson Q4 Profit Increases, beats estimates",RTTNews,/news/stocks/johnson-johnson-q4-profit-increases-beats-estimates-1032986879,positive,0.9294189214706421
1/23/2024 12:56:29 PM,Johnson & Johnson wins arbitration appeal against Genmab,Seeking Alpha,https://seekingalpha.com/news/4057288-johnson-johnson-wins-arbitration-appeal-against-genmab?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6583656072616577
1/23/2024 1:29:22 PM,Teva raised to Buy at Jefferies citing a positive setup ahead of 2024 outlook,Seeking Alpha,https://seekingalpha.com/news/4057313-teva-stock-raised-buy-jefferies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.882779061794281
1/23/2024 1:51:06 PM,"Johnson & Johnson Backs FY24 Earnings View, Sales To Rise ",RTTNews,/news/stocks/johnson-johnson-backs-fy24-earnings-view-sales-to-rise-1032987558,positive,0.9462853670120239
1/23/2024 2:18:00 PM,"5 stocks to watch on Tuesday: 3M, Johnson & Johnson, Netflix and more",Seeking Alpha,https://seekingalpha.com/news/4057367-5-stocks-to-watch-on-tuesday-3m-johnson-johnson-netflix-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9314146041870117
1/23/2024 2:35:39 PM,Strong Performance and Growth Prospects Justify Buy Rating for Johnson & Johnson,TipRanks,/news/stocks/strong-performance-and-growth-prospects-justify-buy-rating-for-johnson-johnson-1032989073,positive,0.8342694044113159
1/23/2024 5:23:49 PM,Johnson & Johnson‚Äôs MedTech performance augurs well for industry: analysts,Seeking Alpha,https://seekingalpha.com/news/4057471-johnson--johnsons-medtech-beat-augurs-well-industry?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8705831170082092
1/23/2024 5:29:14 PM,J&J may pay $700M to settle state AG probe into talcum powder marketing,Seeking Alpha,https://seekingalpha.com/news/4057476-jj-may-pay-700m-to-settle-state-ag-probe-into-talcum-powder-marketing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5708287358283997
1/23/2024 8:07:44 PM,"US Stocks Pause As Treasury Yields, Dollar Surge On Trimmed Fed Rate Cut Bets: What's Driving Markets Tuesday?",Benzinga,/news/etf/us-stocks-pause-as-treasury-yields-dollar-surge-on-trimmed-fed-rate-cut-bets-what-s-driving-markets-tuesday-1032989224,negative,0.6083813905715942
1/24/2024 4:15:44 AM,Cantor Fitzgerald Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1032990861,neutral,0.8304359316825867
1/24/2024 4:20:18 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032990859,positive,0.5521672964096069
1/24/2024 12:15:16 PM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1032993143,neutral,0.9046739339828491
1/24/2024 12:36:46 PM,Hold Rating on Johnson & Johnson Amid Moderate Growth Projections and Upcoming Exclusivity Challenges,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-moderate-growth-projections-and-upcoming-exclusivity-challenges-1032993190,negative,0.8443642258644104
1/24/2024 8:57:44 PM,Johnson & Johnson inks ~$150M deal with Washington State to settle opioid claims,Seeking Alpha,https://seekingalpha.com/news/4058114-jj-inks-150m-deal-washington-state-opioid-claims?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8612930178642273
1/24/2024 9:31:05 PM,JNJ Agrees To $700 Mln Settlement To Resolve Talc Consumer Protection Claims ,RTTNews,/news/stocks/jnj-agrees-to-700-mln-settlement-to-resolve-talc-consumer-protection-claims-1032993979,positive,0.9157109260559082
1/24/2024 10:01:32 PM,The Analyst Verdict: Johnson & Johnson In The Eyes Of 12 Experts,Benzinga,/news/stocks/the-analyst-verdict-johnson-johnson-in-the-eyes-of-12-experts-1032994021,neutral,0.8900991678237915
1/25/2024 8:55:30 AM,Market-Perform Rating for Johnson & Johnson Amid Mixed Financial Signals and MedTech Margin Concerns,TipRanks,/news/stocks/market-perform-rating-for-johnson-johnson-amid-mixed-financial-signals-and-medtech-margin-concerns-1032996242,negative,0.8497227430343628
1/25/2024 11:22:00 AM,7 Dividend Stocks to Buy and Never Sell: January 2024 Edition,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-and-never-sell-january-2024-edition-1032996124,neutral,0.9479760527610779
1/26/2024 5:50:28 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV), Johnson & Johnson (JNJ) and Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-elevance-health-elv-johnson-johnson-jnj-and-abbott-labs-abt-1032999669,negative,0.9338067173957825
1/26/2024 12:16:34 PM,PBMs ramp up lobbying efforts amid growing public scrutiny,Seeking Alpha,https://seekingalpha.com/news/4058952-pbms-ramp-up-lobbying-amid-growing-public-scrutiny?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9376139640808105
1/26/2024 10:03:52 PM,Dividend Dynamos- 7 Stocks Delivering Consistent Cash Flow This Year,InvestorPlace,/news/stocks/dividend-dynamos-7-stocks-delivering-consistent-cash-flow-this-year-1033002407,positive,0.9497070908546448
1/27/2024 12:24:31 AM,JNJ Stock: What to Consider Before Its Next Dividend Hike,TipRanks,/news/stocks/jnj-stock-what-to-consider-before-its-next-dividend-hike-1033002499,neutral,0.9422739744186401
1/28/2024 5:00:53 PM,Big Pharma earnings season in spotlight amid positive sentiment,Seeking Alpha,https://seekingalpha.com/news/4059361-big-pharma-earnings-spotlight-positive-sentiment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8954369425773621
1/29/2024 1:30:18 PM,AbbVie raised to Outperform at William Blair ahead of earnings,Seeking Alpha,https://seekingalpha.com/news/4059465-abbvie-stock-upgraded-william-blair?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8045333027839661
1/29/2024 6:28:50 PM,"Evolus, Alvotech gain as Barclays raises to Ovrweight",Seeking Alpha,https://seekingalpha.com/news/4059650-evolus-stock-alvotech-stock-gain-barclays-upgrades?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9156692624092102
1/29/2024 9:02:31 PM,Hedge Fund Favorites: 7 Stocks the Big Money Is Loving Now,InvestorPlace,/news/stocks/hedge-fund-favorites-7-stocks-the-big-money-is-loving-now-1033007086,neutral,0.8953907489776611
1/30/2024 7:14:41 PM,Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot,InvestorPlace,/news/stocks/buy-alert-3-healthcare-stocks-sitting-in-the-sweet-spot-1033011521,neutral,0.768621563911438
1/30/2024 9:40:26 PM,J&J seeks expanded FDA approval of Darzalex Faspro for multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/4060348-jj-seeks-expanded-fda-approval-of-darzalex-faspro-for-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8494065403938293
1/31/2024 4:56:52 PM,The 7 Best Blue-Chip Stocks to Invest In for Big Gains in 2024,InvestorPlace,/news/stocks/the-7-best-blue-chip-stocks-to-invest-in-for-big-gains-in-2024-1033016372,positive,0.8946985602378845
2/1/2024 3:13:39 PM,U.S. govt. opens bids in Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4061377-ppening-bids-sent-drugs-picked-medicare-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.4905848801136017
2/1/2024 3:13:39 PM,U.S. govt. opens bids in Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4061377-opening-bids-sent-drugs-picked-medicare-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.4905848801136017
2/1/2024 6:22:16 PM,"Lilly, Zoetis, Abbott least shorted stocks in S&P 500 health sector in mid-Jan",Seeking Alpha,https://seekingalpha.com/news/4061498-lilly-zoetis-abbott-least-shorted-stocks-in-health-sector-till-mid-jan?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7107223868370056
2/4/2024 5:00:49 PM,Pharma giants turn to China in search of targeted cancer drugs,Seeking Alpha,https://seekingalpha.com/news/4062374-pharma-antibody-drug-conjugates-china?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8160380125045776
2/5/2024 3:24:50 PM,Johnson & Johnson succeeds in trials for autoimmune drug,Seeking Alpha,https://seekingalpha.com/news/4062626-johnson-johnson-wins-studies-autoimmune-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8428152203559875
2/5/2024 9:08:41 PM,J&J releases positive data on PFA system for arrhythmia,Seeking Alpha,https://seekingalpha.com/news/4062841-jj-releases-positive-data-on-pfa-system-for-arrhythmia?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7533016204833984
2/6/2024 11:15:00 AM,The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024,InvestorPlace,/news/stocks/the-7-best-healthcare-stocks-to-invest-in-for-big-gains-in-2024-1033035941,positive,0.8954084515571594
2/6/2024 12:38:17 PM,GSK blood cancer therapy nearly triples survival in late stage trial,Seeking Alpha,https://seekingalpha.com/news/4063050-gsk-blood-cancer-therapy-nearly-triples-survival?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5269631743431091
2/6/2024 12:46:21 PM,Johnson & Johnson (JNJ) Gets a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-cantor-fitzgerald-1033036045,neutral,0.651216447353363
2/6/2024 2:11:29 PM,7 Dividend Stocks Worth Holding for the Long Haul,InvestorPlace,/news/stocks/7-dividend-stocks-worth-holding-for-the-long-haul-1033035440,neutral,0.8526890277862549
2/6/2024 3:07:57 PM,Johnson & Johnson sued over mismanaging company‚Äôs health plan,Seeking Alpha,https://seekingalpha.com/news/4063173-johnson-johnson-sued-over-mismanaging-companys-health-plan?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9531071782112122
2/8/2024 7:07:57 PM,The Watch List: Is Warren Buffett Still Selling These 3 Stocks?,InvestorPlace,/news/stocks/the-watch-list-is-warren-buffett-still-selling-these-3-stocks-1033048002,neutral,0.8674057126045227
2/9/2024 11:30:00 AM,3 Dividend Stocks to Cling to This Year,InvestorPlace,/news/stocks/3-dividend-stocks-to-cling-to-this-year-1033050512,neutral,0.6638278365135193
2/9/2024 12:24:06 PM,Pharma CEOs defend high drug prices; blame PBMs at Senate hearing,Seeking Alpha,https://seekingalpha.com/news/4065061-pharma-ceos-defend-high-drug-prices-blame-pbms-senate-hearing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6773592233657837
2/9/2024 1:27:08 PM,Johnson & Johnson antibody therapy gets FDA breakthrough designation for HDFN indication,Seeking Alpha,https://seekingalpha.com/news/4065092-johnson-johnson-antibody-therapy-gets-fda-breakthrough-designation-for-hdfn-indication?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9108508229255676
2/9/2024 1:57:00 PM,"7 stocks to watch on Friday: Major drugmakers on Senate hearing, PepsiCo and more",Seeking Alpha,https://seekingalpha.com/news/4065116-7-stocks-to-watch-on-friday-major-drugmakers-on-senate-hearing-pepsico-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9030510187149048
2/9/2024 2:12:32 PM,Dividend Dynasties: 3 Stocks Set to Deliver Consistent Income,InvestorPlace,/news/stocks/dividend-dynasties-3-stocks-set-to-deliver-consistent-income-1033051230,positive,0.9241905808448792
2/12/2024 11:10:00 AM,Passive Income Powerhouses: 7 Blue-Chip Stocks to Own Now,InvestorPlace,/news/stocks/passive-income-powerhouses-7-blue-chip-stocks-to-own-now-1033056427,neutral,0.8919640779495239
2/13/2024 2:01:27 AM,Federal judge dismisses PhRMA challenge to Medicare price negotiations,Seeking Alpha,https://seekingalpha.com/news/4065840-federal-judge-tosses-phrma-lawsuit-medicare-price-talks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6178924441337585
2/13/2024 2:30:44 PM,GSK raised to Buy at Citi after cancer drug data,Seeking Alpha,https://seekingalpha.com/news/4066061-gsk-stock-raised-buy-citi-blenrep-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6113852262496948
2/13/2024 7:13:49 PM,7 Stable Dividend Stocks to Ease Lingering Market Jitters,InvestorPlace,/news/stocks/7-stable-dividend-stocks-to-ease-lingering-market-jitters-1033062743,positive,0.6929730176925659
2/14/2024 6:07:31 PM,Johnson & Johnson wins FDA nod for first frostbite therapy,Seeking Alpha,https://seekingalpha.com/news/4066959-jj-wins-fda-nod-first-frostbite-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8305537104606628
2/14/2024 9:14:33 PM,"Dalio's Bridgewater adds Apple, Wells Fargo; exits Netflix, Thermo Fisher",Seeking Alpha,https://seekingalpha.com/news/4067120-dalios-bridgewater-adds-apple-wells-fargo-exits-netflix-thermo-fisher?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8667406439781189
2/15/2024 2:05:35 AM,Buy Rating Justified by Johnson & Johnson‚Äôs Strong Performance and Growth Prospects,TipRanks,/news/stocks/buy-rating-justified-by-johnson-johnson-s-strong-performance-and-growth-prospects-1033068841,positive,0.9120549559593201
2/15/2024 3:04:10 PM,7 Small-Cap Stocks With Significant Upside Potential in 2024,InvestorPlace,/news/stocks/7-small-cap-stocks-with-significant-upside-potential-in-2024-1033072455,positive,0.8417984247207642
2/15/2024 3:10:42 PM,Johnson & Johnson settles with Alvotech for off-patent Stelara,Seeking Alpha,https://seekingalpha.com/news/4067680-alvotech-stock-gains-deals-jj-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.549759030342102
2/15/2024 4:57:01 PM,The 3 Biotech Stocks That Could Make Your February Unforgettable,InvestorPlace,/news/stocks/the-3-biotech-stocks-that-could-make-your-february-unforgettable-1033073000,neutral,0.8924353122711182
2/18/2024 5:00:00 PM,Medtronic Q3 in focus amid MedTech‚Äôs post-COVID gains,Seeking Alpha,https://seekingalpha.com/news/4068521-medtronic-q3-in-focus-amid-medtechs-gains?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6916518211364746
2/18/2024 6:49:00 PM,Steady Eddies: 3 Blue-Chip Stocks to Buy for the Long Haul,InvestorPlace,/news/stocks/steady-eddies-3-blue-chip-stocks-to-buy-for-the-long-haul-1033078317,neutral,0.8211291432380676
2/20/2024 11:25:00 AM,Income Lover‚Äôs Paradise: 3 Dividend Stocks with Stellar Track Records,InvestorPlace,/news/stocks/income-lovers-paradise-3-dividend-stocks-with-stellar-track-records-1033082598,neutral,0.689414381980896
2/20/2024 6:54:06 PM,Top 7 Contenders to Join the Trillion-Dollar Club,InvestorPlace,/news/stocks/top-7-contenders-to-join-the-trillion-dollar-club-1033084666,neutral,0.8761575818061829
2/20/2024 9:39:11 PM,"Cantor starts CG Oncology at overweight, cites bladder cancer treatment",Seeking Alpha,https://seekingalpha.com/news/4069286-cantor-starts-cg-oncology-at-overweight-cites-bladder-cancer-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8835943341255188
2/20/2024 10:13:56 PM,FDA approves biweekly dosing of J&J multiple myeloma drug,Seeking Alpha,https://seekingalpha.com/news/4069329-fda-approves-biweekly-dosing-of-jj-multiple-myeloma-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8577062487602234
2/21/2024 8:20:05 AM,"Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-johnson-johnson-jnj-vertex-pharmaceuticals-vrtx-1033087099,positive,0.5155619978904724
2/22/2024 2:40:53 PM,Ambrx Biopharma ticks higher as HSR waiting period for J&J deal expires,Seeking Alpha,https://seekingalpha.com/news/4070360-ambrx-biopharma-ticks-higher-as-hsr-waiting-period-for-jj-deal-expires?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8999305367469788
2/22/2024 10:33:00 PM,3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List,InvestorPlace,/news/stocks/3-undervalued-small-cap-stocks-to-add-to-your-must-buy-list-1033095199,neutral,0.7965864539146423
2/23/2024 1:03:10 PM,Janssen Pharma's Carvykti Gets Positive CHMP Opinion For Earlier Multiple Myeloma Treatment ,RTTNews,/news/stocks/janssen-pharma-s-carvykti-gets-positive-chmp-opinion-for-earlier-multiple-myeloma-treatment-1033097034,positive,0.9466878771781921
2/23/2024 2:58:33 PM,Johnson & Johnson wins EU backing to expand labeling for CAR-T therapy,Seeking Alpha,https://seekingalpha.com/news/4071098-jj-wins-eu-backing-expand-labeling-car-t-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9276671409606934
2/23/2024 6:22:45 PM,Legend Biotech stock rises after EU backs label expansion for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4071255-legend-biotech-stock-rises-after-eu-backs-label-expansion-for-multiple-myeloma-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7345476150512695
2/23/2024 7:08:15 PM,"BMO upgrades Genmab to outperform, cites diversification potential",Seeking Alpha,https://seekingalpha.com/news/4071279-bmo-upgrades-genmab-to-outperform-cites-diversification-potential?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9533355236053467
2/24/2024 1:30:00 PM,Pension Plan Redux: 3 Companies That Could Take a Page From IBM‚Äôs Playbook,InvestorPlace,/news/stocks/pension-plan-redux-3-companies-that-could-take-a-page-from-ibms-playbook-1033099231,neutral,0.9334598779678345
2/25/2024 7:30:22 PM,7 Stocks to Buy Now if You Think the S&P 500‚Äôs Winning Streak Will Continue,InvestorPlace,/news/stocks/7-stocks-to-buy-now-if-you-think-the-sp-500s-winning-streak-will-continue-1033099958,neutral,0.7368102669715881
2/25/2024 11:50:34 PM,"Needham sees orthopedics market slowing; favors Enovis, Paragon 28",Seeking Alpha,https://seekingalpha.com/news/4071389-needham-sees-orthopedics-market-slowing-favors-enovis-paragon-28?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7138682007789612
2/26/2024 5:53:41 PM,3 Dividend Stocks That Are Too Good to Ignore: Q1 Edition,InvestorPlace,/news/stocks/3-dividend-stocks-that-are-too-good-to-ignore-q1-edition-1033104041,neutral,0.8810009360313416
2/27/2024 9:00:02 PM,"Waters, Moderna most shorted stocks in S&P 500 health sector till Jan-end",Seeking Alpha,https://seekingalpha.com/news/4072568-waters-moderna-most-shorted-stocks-in-sp-500-health-sector-till-jan-end?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.525510847568512
2/27/2024 10:12:21 PM,7 Dividend Stocks Every Investor Should Own to Survive a Market Crash,InvestorPlace,/news/stocks/7-dividend-stocks-every-investor-should-own-to-survive-a-market-crash-2-1033109768,neutral,0.9202567934989929
2/28/2024 9:52:49 AM,Biotech Stocks Facing FDA Decision In March 2024 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-march-2024-1033111344,neutral,0.9174320697784424
2/28/2024 10:38:50 AM,Hold Rating on Johnson & Johnson Amid Anticipated Varipulse Approval and Afib Market Dynamics,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-anticipated-varipulse-approval-and-afib-market-dynamics-1033112661,positive,0.6876389384269714
2/28/2024 12:23:37 PM,"Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Masimo (MASI) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-viridian-therapeutics-vrdn-masimo-masi-and-johnson-johnson-jnj-1033113716,neutral,0.9184691309928894
2/28/2024 5:00:16 PM,Beyond The Numbers: 13 Analysts Discuss Johnson & Johnson Stock,Benzinga,/news/stocks/beyond-the-numbers-13-analysts-discuss-johnson-johnson-stock-1033114014,neutral,0.9462097883224487
2/29/2024 11:32:10 AM,Barclays Keeps Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/barclays-keeps-their-hold-rating-on-johnson-johnson-jnj-1033118567,neutral,0.9075490236282349
2/29/2024 7:26:32 PM,Don‚Äôt Panic! 7 Smart Stocks to Buy if the Markets Take a Tumble.,InvestorPlace,/news/stocks/dont-panic-7-smart-stocks-to-buy-if-the-markets-take-a-tumble-1033120307,neutral,0.8638187646865845
3/1/2024 6:10:27 PM,Medicare price negotiations survive another legal challenge,Seeking Alpha,https://seekingalpha.com/news/4074801-medicare-price-negotiations-survive-legal-challenge?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8509962558746338
3/1/2024 9:30:02 PM,J&J gets full approval for Rybrevant for EGFR exon 20 lung cancer,Seeking Alpha,https://seekingalpha.com/news/4074903-jnj-gets-full-approval-for-rebrevant-for-egfr-exon-20-lung-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.912289023399353
3/1/2024 10:34:27 PM,Johnson & Johnson's Rybrevant Gets FDA Approval For Lung Cancer Treatment ,RTTNews,/news/stocks/johnson-johnson-s-rybrevant-gets-fda-approval-for-lung-cancer-treatment-1033125304,positive,0.9090991616249084
3/4/2024 11:25:00 AM,Secure Your Future: 7 Dividend Kings with Solid Growth Potential,InvestorPlace,/news/stocks/7-dividend-kings-that-offer-more-than-just-a-pretty-dividend-1033127903,positive,0.8111754059791565
3/4/2024 7:08:25 PM,Biden says drugmakers to continue to engage in Medicare drug price negoiations,Seeking Alpha,https://seekingalpha.com/news/4075531-biden-says-drugmakers-continue-engage-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8006857633590698
3/5/2024 9:08:02 PM,7 No-Frills Dividend Stocks for Your Must-Own List,InvestorPlace,/news/stocks/7-no-frills-dividend-stocks-for-your-must-own-list-1033134714,neutral,0.9344366788864136
3/6/2024 11:17:00 AM,The Top 7 Dividend Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-7-dividend-stocks-to-buy-in-march-2024-1033136900,neutral,0.9411417245864868
3/6/2024 3:18:51 PM,J&J Seeks EMA Approval For DARZALEX Quadruplet Therapy For Multiple Myeloma ,RTTNews,/news/stocks/j-j-seeks-ema-approval-for-darzalex-quadruplet-therapy-for-multiple-myeloma-1033137717,positive,0.9085599780082703
3/6/2024 7:31:39 PM,ViiV‚Äôs long-acting HIV therapy outperforms daily therapy in Phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/4076783-viivs-long-acting-hiv-therapy-outperforms-daily-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9460234045982361
3/6/2024 10:40:54 PM,Biden to push for expanding Medicare drug pricing program,Seeking Alpha,https://seekingalpha.com/news/4076912-biden-to-push-for-expanding-medicare-drug-pricing-program?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7659500241279602
3/7/2024 2:48:43 PM,Johnson & Johnson Buys Ambrx Biopharma In $2 Bln Cash Deal ,RTTNews,/news/stocks/johnson-johnson-buys-ambrx-biopharma-in-2-bln-cash-deal-1033142226,neutral,0.8821579813957214
3/7/2024 3:50:14 PM,J&J completes $2B acquisition of ADC developer Ambrx,Seeking Alpha,https://seekingalpha.com/news/4077247-jj-completes-acquisition-of-adc-developer-ambrx?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7245914340019226
3/7/2024 4:11:38 PM,The Top 3 Blue-Chip Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-3-blue-chip-stocks-to-buy-in-march-2024-1033143201,neutral,0.9116476774215698
3/7/2024 5:27:11 PM,The Top 3 Healthcare Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-3-healthcare-stocks-to-buy-in-march-2024-1033143533,neutral,0.920172393321991
3/7/2024 8:52:40 PM,"Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley",Benzinga,/news/stocks/arcellx-s-lead-asset-can-potentially-outperform-bristol-myers-squibb-johnson-johnson-s-multiple-myeloma-cell-therapies-morgan-stanley-1033143791,positive,0.620534360408783
3/8/2024 9:32:49 PM,3 Dividend Aristocrat Stocks to Buy And Hold: March 2024,InvestorPlace,/news/stocks/3-dividend-aristocrat-stocks-to-buy-and-hold-march-2024-1033147709,neutral,0.9455958604812622
3/9/2024 6:00:00 PM,The Top 3 Pharma Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-3-pharma-stocks-to-buy-in-march2024-1033148079,neutral,0.9020587801933289
3/9/2024 6:34:43 PM,Johnson & Johnson highlights psoriasis candidate with long-term data,Seeking Alpha,https://seekingalpha.com/news/4077809-jj-psoriasis-drug-long-term-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5312929749488831
3/10/2024 5:08:00 PM,Cantor sees strong year ahead for oncology M&A,Seeking Alpha,https://seekingalpha.com/news/4077812-patent-cliffs-could-fuel-increased-ma-in-oncology-this-year-cantor-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9445049166679382
3/11/2024 4:03:46 PM,The Dow‚Äôs Best Friends: 3 ‚ÄòDogs‚Äô Ready to Fetch Huge Returns,InvestorPlace,/news/stocks/the-dows-best-friends-3-dogs-ready-to-fetch-huge-returns-1033151926,neutral,0.853887677192688
3/11/2024 10:10:18 PM,J&J submits sBLA for Tremfya for ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/4078241-johnson-johnson-submits-sbla-tremfya-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9233540892601013
3/12/2024 12:09:00 PM,3 Must-Have Dividend Kings for a Steady Income Stream,InvestorPlace,/news/stocks/3-must-have-dividend-kings-for-a-steady-income-stream-1033154748,neutral,0.6209174990653992
3/12/2024 7:41:22 PM,7 High-Quality Blue-Chip Stocks to Buy if You‚Äôre Looking for Stability,InvestorPlace,/news/stocks/7-high-quality-blue-chip-stocks-to-buy-if-youre-looking-for-stability-1033156716,neutral,0.9206485748291016
3/13/2024 1:44:45 PM,"J&J, Bristol Myers slip as FDA comments on CAR-T drugs ahead of AdCom",Seeking Alpha,https://seekingalpha.com/news/4078882-jj-bristol-myers-slip-fda-comments-car-t-drugs-adcom?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9218680262565613
3/14/2024 4:15:21 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1033162448,neutral,0.5040143728256226
3/14/2024 12:02:33 PM,The 3 Most Undervalued Healthcare Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-healthcare-stocks-to-buy-in-march-2024-1033163673,neutral,0.7171453237533569
3/15/2024 1:29:14 PM,"Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end",Seeking Alpha,https://seekingalpha.com/news/4079885-johnson-johnson-boston-scientific-least-shorted-stocks-in-sp-500-healthcare-sector-for-feb-end?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6527541875839233
3/15/2024 4:56:13 PM,The Taxman Cometh: 3 Stocks to Soften the Blow and Grow Your Dough,InvestorPlace,/news/stocks/the-taxman-cometh-3-stocks-to-soften-the-blow-and-grow-your-dough-1033169255,neutral,0.7794737815856934
3/15/2024 5:25:53 PM,Johnson & Johnson wins FDA AdCom backing for Carvykti label expansion,Seeking Alpha,https://seekingalpha.com/news/4080088-jj-wins-fda-adcom-carvykti-label-expansion?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8676288723945618
3/16/2024 11:58:13 AM,Bristol Myers wins FDA AdCom backing for Abecma label expansion,Seeking Alpha,https://seekingalpha.com/news/4080229-bristol-myers-wins-fda-adcom-backing-abecma-labeling?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8285635113716125
3/16/2024 7:00:00 PM,Guardians of Your Golden Years: 7 Stocks Every Retiree Needs to Own,InvestorPlace,/news/stocks/guardians-of-your-golden-years-7-stocks-every-retiree-needs-to-own-1033169872,neutral,0.9161511659622192
3/18/2024 10:50:06 AM,Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Aveanna Healthcare Holdings (AVAH),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-and-aveanna-healthcare-holdings-avah-1033172494,neutral,0.9175691604614258
3/19/2024 5:18:58 PM,"Johnson & Johnson, Nvidia ink AI deal for surgical applications",Seeking Alpha,https://seekingalpha.com/news/4081225-johnson-johnson-nvidia-ink-ai-deal-for-surgical-applications?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9136435389518738
3/19/2024 5:40:16 PM,MS drug developer Contineum files for $150M IPO,Seeking Alpha,https://seekingalpha.com/news/4081227-ms-drug-developer-contineum-files-for-150m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9261872172355652
3/19/2024 6:18:28 PM,7 Defensive Stocks to Build a Moat Around Your Portfolio,InvestorPlace,/news/stocks/7-defensive-stocks-to-build-a-moat-around-your-portfolio-1033177894,neutral,0.9084606766700745
3/19/2024 7:25:59 PM,A New Frontier: Nvidia Reveals the ‚ÄòWorld‚Äôs Most Powerful‚Äô AI Chip,InvestorPlace,/news/stocks/a-new-frontier-nvidia-reveals-the-worlds-most-powerful-ai-chip-1033178025,neutral,0.7236118912696838
3/20/2024 1:35:50 PM,J&J alleges ex-staffer downloaded thousands of files in move to Pfizer,Seeking Alpha,https://seekingalpha.com/news/4081583-jj-alleges-staffer-downloaded-thousands-files-pfizer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5282168984413147
3/21/2024 4:17:03 PM,"Dear 3M Stock Fans, Mark Your Calendars for April 1",InvestorPlace,/news/stocks/dear-3m-stock-fans-mark-your-calendars-for-april-1-1033185826,neutral,0.9394966959953308
3/21/2024 8:03:47 PM,Johnson & Johnson stock closes in red for a seventh consecutive session,Seeking Alpha,https://seekingalpha.com/news/4082384-johnson-and-johnson-stock-closes-in-red-for-seventh-consecutive-session?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9520698189735413
3/22/2024 2:14:46 AM,Wall Street‚Äôs Favorite Long-Term Stocks? 3 Names That Could Make You Filthy Rich,InvestorPlace,/news/stocks/wall-streets-favorite-long-term-stocks-3-names-that-could-make-you-filthy-rich-1033186874,neutral,0.8669961094856262
3/22/2024 6:42:10 PM,3M Stock Alert: 7 Things to Know About the Upcoming 3M Healthcare Spinoff,InvestorPlace,/news/stocks/3m-stock-alert-7-things-to-know-about-the-upcoming-3m-healthcare-spinoff-1033189957,neutral,0.9421712160110474
3/23/2024 12:44:57 PM,"J&J wins FDA nod for blood vessel disorder therapy, Opsynvi",Seeking Alpha,https://seekingalpha.com/news/4083065-jj-wins-fda-nod-blood-vessel-disorder-therapy-opsynvi?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9152443408966064
3/24/2024 2:13:20 PM,7 Dividend Darlings to Scoop Up Every Time the Market Dips,InvestorPlace,/news/stocks/7-dividend-darlings-to-scoop-up-every-time-the-market-dips-1033191000,neutral,0.4691237509250641
3/25/2024 2:47:11 PM,Hot Stocks: The 3 Best Opportunities for Investing in the S&P 500¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†,InvestorPlace,/news/stocks/hot-stocks-the-3-best-opportunities-for-investing-in-the-sp-500-1033193515,neutral,0.8056520819664001
3/26/2024 12:24:47 PM,J&J experimental therapy gets FDA fast track status to reduce FNAIT in pregnancy,Seeking Alpha,https://seekingalpha.com/news/4083654-jj-experimental-therapy-gets-fda-fast-track-to-reduce-fnait-in-pregnancy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9419540166854858
3/26/2024 5:30:34 PM,7 Dividend Aristocrats That Can Safeguard Your Income Through Any Crisis,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-can-safeguard-your-income-through-any-crisis-1033198293,neutral,0.8984200358390808
3/26/2024 6:01:03 PM,Cytokinetics gains amid renewed takeover speculation,Seeking Alpha,https://seekingalpha.com/news/4083918-cytokinetics-gains-amid-renewed-takeover-speculation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9322801232337952
3/26/2024 7:12:20 PM,Shockwave Medical surges as Johnson & Johnson in talks to acquire - report,Seeking Alpha,https://seekingalpha.com/news/4083938-shockwave-medical-surges-johnson-johnson-talks-acquire?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5301548838615417
3/27/2024 12:02:08 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Healthequity (HQY) and Bluebird Bio (BLUE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-healthequity-hqy-and-bluebird-bio-blue-1033199008,neutral,0.9078883528709412
3/27/2024 10:00:00 AM,7 Dow Stocks to Buy on the Dip: March 2024,InvestorPlace,/news/stocks/7-dow-stocks-to-buy-on-the-dip-march-2024-1033200339,neutral,0.903117835521698
3/27/2024 1:13:34 PM,Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-views-on-3-health-care-stocks-delivering-high-dividend-yields-1033200819,neutral,0.7807834148406982
3/27/2024 1:50:45 PM,Merck hits all-time high after FDA nod for lung disease therapy,Seeking Alpha,https://seekingalpha.com/news/4084361-merck-stock-jumps-fda-nod-winrevair?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7051712870597839
3/27/2024 7:04:20 PM,J&J-Shockwave deal makes strategic sense: analysts,Seeking Alpha,https://seekingalpha.com/news/4084616-shockwave-medical-stock-gains-jj-deal-makes-sense?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8605666756629944
3/27/2024 8:14:11 PM,Johnson & Johnson gets major break in talc cancer link cases,Seeking Alpha,https://seekingalpha.com/news/4084630-johnson-johnson-gets-major-break-talc-cancer-link-cases?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8642134666442871
3/27/2024 9:23:27 PM,"Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst",Benzinga,/news/stocks/johnson-johnson-strong-strategic-fit-for-shockwave-medical-but-medtronic-boston-scientific-could-be-other-bidder-says-analyst-1033202897,positive,0.8615245819091797
3/28/2024 2:28:44 PM,J&J to settle Mississippi baby powder suit for $75M: report,Seeking Alpha,https://seekingalpha.com/news/4084978-jj-to-settle-mississippi-baby-powder-suit-for-75m-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8610203862190247
3/28/2024 4:55:21 PM,J&J Agrees To Pay $75 Mln In Mississippi's Baby Powder Case ,RTTNews,/news/stocks/j-j-agrees-to-pay-75-mln-in-mississippi-s-baby-powder-case-1033206269,neutral,0.6169881224632263
3/28/2024 6:46:33 PM,3 Value Stocks to Buy on the Dip: March 2024,InvestorPlace,/news/stocks/3-value-stocks-to-buy-on-the-dip-march-2024-1033206804,neutral,0.9236919283866882
3/28/2024 7:00:00 PM,"Catalyst Watch: Tesla deliveries, Disney board vote, DJT drama and Fortinet event",Seeking Alpha,https://seekingalpha.com/news/4084622-catalyst-watch-tesla-deliveries-disney-board-vote-djt-drama-and-fortinet-event?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9371157884597778
4/1/2024 4:17:16 PM,Teva and Viatris revives chance to dispute J&J's schizophrenia drug patent,Seeking Alpha,https://seekingalpha.com/news/4085739-teva-and-viatris-revives-chance-to-dispute-jjs-schizophrenia-drug-patent?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6067025065422058
4/4/2024 12:48:00 AM,Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows,InvestorPlace,/news/stocks/rich-returns-at-a-discount-3-dividend-aristocrats-trading-at-52-week-lows-1033220639,negative,0.9408700466156006
4/5/2024 12:41:50 AM,Johnson & Johnson urges shareholders to rebuff TRC Capital mini-tender,Seeking Alpha,https://seekingalpha.com/news/4087441-johnson-johnson-urges-shareholders-rebuff-trc-capital-mini-tender?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5660077929496765
4/5/2024 1:00:19 PM,Johnson & Johnson To Buy Shockwave In $13.1 Bln Deal ,RTTNews,/news/stocks/johnson-johnson-to-buy-shockwave-in-13-1-bln-deal-1033225311,neutral,0.9261618256568909
4/5/2024 1:13:00 PM,"4 stocks to watch on Friday: SWAV on JNJ deal, NFLX and more",Seeking Alpha,https://seekingalpha.com/news/4087566-4-stocks-to-watch-on-friday-swav-on-jnj-deal-nflx-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9346986413002014
4/5/2024 1:31:18 PM,SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson,InvestorPlace,/news/stocks/swav-stock-alert-shockwave-medical-lands-big-buyer-in-johnson-johnson-1033225858,positive,0.549613356590271
4/5/2024 2:00:01 PM,Johnson & Johnson to acquire Shockwave Medical for $13.1B (update),Seeking Alpha,https://seekingalpha.com/news/4087511-johnson--johnson-acquire-shockwave-medical-13b-cash?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9432154297828674
4/5/2024 5:20:47 PM,Contineum Therapeutics stock slides 10% following $110M IPO,Seeking Alpha,https://seekingalpha.com/news/4087646-contineum-therapeutics-stock-slides-following-110m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9595815539360046
4/5/2024 8:30:00 PM,The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024,InvestorPlace,/news/stocks/the-7-most-undervalued-russell-2000-stocks-to-buy-in-april-1033226998,neutral,0.7935519218444824
4/6/2024 12:38:09 PM,Johnson & Johnson wins FDA nod for Carvykti label expansion,Seeking Alpha,https://seekingalpha.com/news/4087716-jj-wins-fda-nod-carvykti-label-expansion?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8747888207435608
4/7/2024 5:31:00 PM,Morgan Stanley sees Fed rate cut fueling biotech stocks,Seeking Alpha,https://seekingalpha.com/news/4087727-fed-rate-cut-should-fuel-biotech-outperformance-morgan-stanley-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5271198153495789
4/8/2024 7:27:10 PM,"Johnson & Johnson's $13B Shockwave Medical Deal Accelerates MedTech Strategy, Analyst Says",Benzinga,/news/stocks/johnson-johnson-s-13b-shockwave-medical-deal-accelerates-medtech-strategy-analyst-says-1033230884,positive,0.9131452441215515
4/8/2024 8:19:36 PM,Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population,Benzinga,/news/stocks/johnson-johnson-s-carvykti-stands-ahead-of-bristol-myers-rival-blood-cancer-therapy-with-fda-approval-for-wider-population-1033230972,positive,0.7435811161994934
4/9/2024 8:15:32 PM,Johnson and Johnson traded in the green after six day of losses,Seeking Alpha,https://seekingalpha.com/news/4088363-johnson-and-johnson-traded-in-the-green-after-six-day-of-losses?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5100762248039246
4/10/2024 6:21:13 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Axsome Therapeutics (AXSM) and Premier (PINC)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-axsome-therapeutics-axsm-and-premier-pinc-1033236272,neutral,0.9106097221374512
4/10/2024 10:25:00 AM,"If You Can Only Buy One Dividend Stock in April, It Better Be One of These 3 Names",InvestorPlace,/news/stocks/if-you-can-only-buy-one-dividend-stock-in-april-it-better-be-one-of-these-3-names-1033236532,neutral,0.9411826133728027
4/10/2024 4:10:12 PM,"Analysts Conflicted on These Healthcare Names: Shattuck Labs (STTK), Johnson & Johnson (JNJ) and Tilray (TLRY)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-shattuck-labs-sttk-johnson-johnson-jnj-and-tilray-tlry-1033238690,negative,0.8158356547355652
4/10/2024 4:50:16 PM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), PainReform (PRFX) and IN8bio (INAB)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-painreform-prfx-and-in8bio-inab-1033238738,neutral,0.8915198445320129
4/10/2024 5:22:18 PM,7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape,InvestorPlace,/news/stocks/7-healthcare-stocks-to-keep-your-portfolio-in-tip-top-shape-1033238450,neutral,0.9137315154075623
4/10/2024 7:27:29 PM,Johnson & Johnson cough syrup recalled in Nigeria over toxicity concerns,Seeking Alpha,https://seekingalpha.com/news/4088708-johnson-johnson-cough-syrup-recalled-in-nigeria-over-toxicity-concerns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.955694317817688
4/10/2024 9:45:00 PM,Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024,InvestorPlace,/news/stocks/wall-street-favorites-3-dividend-stocks-with-strong-buy-ratings-for-april-2024-1033238979,neutral,0.5842981338500977
4/11/2024 1:08:17 AM,Maintaining Stability Amidst Challenges: Hold Rating for Johnson & Johnson,TipRanks,/news/stocks/maintaining-stability-amidst-challenges-hold-rating-for-johnson-johnson-1033239177,neutral,0.8066759705543518
4/11/2024 1:45:35 AM,RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1033239503,neutral,0.7207147479057312
4/11/2024 10:50:00 AM,Joby‚Äôs $3.5B Air Taxi Dream Worth Less Than Trump‚Äôs Truth Social Nightmare?,InvestorPlace,/news/stocks/jobys-3-5b-air-taxi-dream-worth-less-than-trumps-truth-social-nightmare-1033240436,neutral,0.8324084877967834
4/11/2024 11:00:37 AM,Rallybio shares gain on investment from J&J for rare fetal condition treatment,Seeking Alpha,https://seekingalpha.com/news/4088840-rallybio-shares-gain-on-investment-from-jj-for-rare-fetal-condition-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8396921157836914
4/11/2024 11:19:51 AM,Today‚Äôs Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on¬†Thursday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-april-11th-1033240549,negative,0.48035508394241333
4/11/2024 11:43:59 AM,Why Is Rallybio (RLYB) Stock Up 93% Today?,InvestorPlace,/news/stocks/why-is-rallybio-rlyb-stock-up-93-today-1033240640,positive,0.6625134944915771
4/11/2024 1:47:56 PM,The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today,InvestorPlace,/news/stocks/the-5-billion-reason-alpine-immune-sciences-alpn-stock-is-up-30-today-1033241236,positive,0.9471536874771118
4/11/2024 4:17:59 PM,All-Time High Flyers: 7 Stocks to Buy as the Market Peaks,InvestorPlace,/news/stocks/all-time-high-flyers-7-stocks-to-buy-as-the-market-peaks-1033242102,positive,0.5958545804023743
4/11/2024 5:10:22 PM,Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024,InvestorPlace,/news/stocks/wall-street-favorites-3-biotech-stocks-with-strong-buy-ratings-for-april-2024-1033242187,positive,0.8188546299934387
4/12/2024 5:17:44 PM,"Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in March",Seeking Alpha,https://seekingalpha.com/news/4089272-short-interest-in-sp-500-healthcare-sector-rises-lilly-least-shorted-industry-at-march-end?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8770031332969666
4/12/2024 7:00:09 PM,"Catalyst Watch: Boeing hearing, Bitcoin halving event and new eyes on Reddit",Seeking Alpha,https://seekingalpha.com/news/4089283-catalyst-watch-boeing-hearing-bitcoin-halving-event-and-new-eyes-on-reddit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9150034785270691
4/13/2024 7:56:54 PM,J&J cough syrup recall classified as most serious in South Africa,Seeking Alpha,https://seekingalpha.com/news/4089418-jj-cough-syrup-recall-most-serious-south-africa?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8986765146255493
4/14/2024 12:00:00 PM,"Earnings week ahead: BAC, JNJ, TSM, UNH, ABT, SLB, UAL, PG, NFLX and more",Seeking Alpha,https://seekingalpha.com/news/4089249-earnings-week-ahead-bac-jnj-tsm-unh-abt-slb-ual-pg-nflx-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9342080354690552
4/14/2024 1:00:00 PM,The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash,InvestorPlace,/news/stocks/the-3-best-stocks-to-buy-to-survive-the-coming-sp-500-crash-1033246554,neutral,0.744608461856842
4/15/2024 11:45:10 AM,Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-keeps-their-buy-rating-on-johnson-johnson-jnj-1033250034,neutral,0.9096185564994812
4/15/2024 3:01:13 PM,Johnson Johnson is about to announce earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-q1-quarterly-earnings-preview-stock-1033249247,neutral,0.9342256188392639
4/15/2024 3:36:45 PM,Tanzania and Rwanda join its African counterparts to recall J&J's cough syrup - report,Seeking Alpha,https://seekingalpha.com/news/4089679-tanzania-and-rwanda-join-its-african-counterparts-to-recall-jjs-cough-syrup-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7760083675384521
4/15/2024 4:11:23 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/4089690-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8660829067230225
4/15/2024 5:01:07 PM,A Closer Look at 9 Analyst Recommendations For Johnson & Johnson,Benzinga,/news/stocks/a-closer-look-at-9-analyst-recommendations-for-johnson-johnson-1033250047,neutral,0.9109458327293396
4/15/2024 5:49:52 PM,JNJ Q1 earnings preview: A lot of moving factors expected to bring in-line results,Seeking Alpha,https://seekingalpha.com/news/4089736-jnj-q1-earnings-preview-a-lot-of-moving-factors-expected-to-bring-in-line-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8610859513282776
4/15/2024 8:42:59 PM,"Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA",Benzinga,/news/stocks/medical-device-manufacture-integer-to-gain-from-expanding-pulsed-field-ablation-market-earns-upgrade-from-bofa-1033250649,positive,0.9486805200576782
4/16/2024 8:09:47 AM,Fear & Greed Index Moves To 'Fear' Zone; S&P 500 Down Over 1%,Benzinga,/news/stocks/fear-greed-index-moves-to-fear-zone-s-p-500-down-over-1-1033251804,negative,0.9559407830238342
4/16/2024 8:10:20 AM,"Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/bank-of-america-morgan-stanley-and-3-stocks-to-watch-heading-into-tuesday-1033251803,neutral,0.9294854402542114
4/16/2024 8:15:29 AM,Johnson & Johnson Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts,Benzinga,/news/stocks/johnson-johnson-likely-to-report-higher-q1-earnings-here-are-the-recent-forecast-changes-from-wall-street-s-most-accurate-analysts-1033251805,neutral,0.8407147526741028
4/16/2024 9:32:32 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Amylyx Pharmaceuticals Inc (AMLX) and Rhythm Pharmaceuticals (RYTM)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-amylyx-pharmaceuticals-inc-amlx-and-rhythm-pharmaceuticals-rytm-1033253120,neutral,0.9184883236885071
4/16/2024 10:21:57 AM,"Johnson & Johnson Non-GAAP EPS of $2.71 beats by $0.06, revenue of $21.4B in-line",Seeking Alpha,https://seekingalpha.com/news/4089941-johnson-and-johnson-non-gaap-eps-of-2_71-beats-0_06-revenue-of-21_4b-in-line?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6028456687927246
4/16/2024 10:44:48 AM,Johnson & Johnson raises dividend by 4% to $1.24,Seeking Alpha,https://seekingalpha.com/news/4089942-johnson-and-johnson-declares-1_24-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9272828698158264
4/16/2024 10:46:28 AM,Johnson & Johnson in charts: Q1 Y/Y revenue growth slows across all categories,Seeking Alpha,https://seekingalpha.com/news/4089946-johnson-johnson-in-charts?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9680745601654053
4/16/2024 11:20:23 AM,J&J sets guidance below consensus as MedTech underperforms,Seeking Alpha,https://seekingalpha.com/news/4089962-jj-stock-slips-medtech-underperforms?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9453667402267456
4/16/2024 12:15:24 PM,Balancing Act: Hold Rating on Johnson & Johnson Amid Steady Growth and Legal Challenges,TipRanks,/news/stocks/balancing-act-hold-rating-on-johnson-johnson-amid-steady-growth-and-legal-challenges-1033254214,positive,0.6636544466018677
4/16/2024 12:25:00 PM,Buyback Bonanza: The Top 7 ETFs to Profit From Corporate Cash Splurges,InvestorPlace,/news/stocks/buyback-bonanza-the-top-7-etfs-to-profit-from-corporate-cash-splurges-1033253162,positive,0.9295156002044678
4/16/2024 12:26:20 PM,Johnson & Johnson Q1 Earnings Summary,RTTNews,/news/stocks/johnson-johnson-q1-earnings-summary-1033252603,neutral,0.5952150225639343
4/16/2024 1:17:00 PM,"4 stocks to watch on Tuesday: JNJ, BAC and more",Seeking Alpha,https://seekingalpha.com/news/4090040-4-stocks-to-watch-on-tuesday-jnj-bac-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.916082501411438
4/16/2024 1:19:00 PM,Genmab's Q1 Darzalex Sales By Johnson & Johnson Reach $2.692 Bln ,RTTNews,/news/stocks/genmab-s-q1-darzalex-sales-by-johnson-johnson-reach-2-692-bln-1033252793,positive,0.700703501701355
4/16/2024 1:22:39 PM,"Johnson & Johnson Updates FY24 Earnings, Sales Outlook - Update ",RTTNews,/news/stocks/johnson-johnson-updates-fy24-earnings-sales-outlook-update-1033252806,neutral,0.8971285820007324
4/16/2024 2:45:00 PM,Johnson & Johnson hosts conference call for investors,Markets Insider Automation,/news/stocks/johnson_johnson_conference-1032643375,neutral,0.9340064525604248
4/16/2024 2:52:55 PM,"JNJ Stock Earnings: Johnson & Johnson Beats EPS, Misses Revenue for Q1 2024",InvestorPlace,/news/stocks/jnj-stock-earnings-johnson-johnson-for-q1-of-2024-1033254073,positive,0.5507783889770508
4/16/2024 4:23:16 PM,Bayer dethroned as Germany‚Äôs top drugmaker,Seeking Alpha,https://seekingalpha.com/news/4090165-bayer-beaten-top-german-pharma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.42287859320640564
4/16/2024 5:30:12 PM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Cullinan Management (CGEM), Johnson & Johnson (JNJ) and UnitedHealth (UNH)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-cullinan-management-cgem-johnson-johnson-jnj-and-unitedhealth-unh-1033255011,negative,0.8386662006378174
4/16/2024 5:35:45 PM,Steady Performance and Aligned Guidance Justify Hold Rating for Johnson & Johnson,TipRanks,/news/stocks/steady-performance-and-aligned-guidance-justify-hold-rating-for-johnson-johnson-1033255008,positive,0.6981499791145325
4/16/2024 7:28:15 PM,"Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?",Benzinga,/news/etf/stocks-grapple-with-geopolitical-pressures-gold-eyes-2-400-bitcoin-falls-below-62-000-what-s-driving-markets-tuesday-1033254617,neutral,0.579872727394104
4/16/2024 10:22:06 PM,FDA approves Alvotech biosimilar of J&J top-selling drug Stelara,Seeking Alpha,https://seekingalpha.com/news/4090292-fda-approves-alvotech-biosimilar-of-jj-top-selling-drug-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8266173005104065
4/17/2024 7:59:36 AM,RBC Capital Reaffirms Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-reaffirms-their-buy-rating-on-johnson-johnson-jnj-1033257341,neutral,0.7240310311317444
4/17/2024 9:20:09 AM,Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Intra-Cellular Therapies (ITCI),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-and-intra-cellular-therapies-itci-1033257677,neutral,0.9179283976554871
4/17/2024 12:58:00 PM,"Put $10,000 in These 3 Dividend Stocks by 2025",InvestorPlace,/news/stocks/put-10000-in-these-3-dividend-stocks-by-2025-1033257941,neutral,0.9497615098953247
4/17/2024 2:21:45 PM,Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday,Benzinga,/news/stocks/visa-to-rally-around-18-here-are-10-top-analyst-forecasts-for-wednesday-1033257667,neutral,0.9166499376296997
4/17/2024 4:55:22 PM,Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough,InvestorPlace,/news/stocks/invest-like-a-hawk-7-stocks-to-own-if-the-fed-stays-tough-1033259055,neutral,0.9229927659034729
4/17/2024 7:51:24 PM,Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results,Benzinga,/news/stocks/johnson-johnson-analysts-cut-their-forecasts-after-q1-results-1033259210,negative,0.9550800919532776
4/17/2024 8:35:54 PM,Scotiabank upgrades Legend Biotech to sector outperform,Seeking Alpha,https://seekingalpha.com/news/4090714-scotiabank-upgrades-legend-biotech-to-sector-outperform?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9255075454711914
4/17/2024 9:37:35 PM,"Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future",Benzinga,/news/stocks/johnson-johnson-shares-hold-steady-after-q1-earnings-analysts-optimistic-about-future-1033259391,positive,0.9223558902740479
4/18/2024 4:30:44 AM,"Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Johnson & Johnson (JNJ) and Lantheus (LNTH)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-savara-svra-johnson-johnson-jnj-and-lantheus-lnth-1033260721,neutral,0.912319004535675
4/18/2024 5:56:25 AM,"Hold Rating on Johnson & Johnson Amidst Growth, Competition, and Legal Challenges",TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amidst-growth-competition-and-legal-challenges-1033261085,neutral,0.8242545127868652
4/18/2024 2:23:15 PM,Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.,InvestorPlace,/news/stocks/want-to-double-your-tax-refund-in-2024-7-stocks-to-buy-now-1033262864,neutral,0.8406463265419006
4/18/2024 4:08:11 PM,Recession-Proof Riches: 3 Stocks That Thrive in Any Economy,InvestorPlace,/news/stocks/recession-proof-riches-3-stocks-that-thrive-in-any-economy-1033263265,neutral,0.9118908643722534
4/19/2024 10:13:03 AM,FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk,Seeking Alpha,https://seekingalpha.com/news/4091378-fda-requires-changes-car-t-cell-therapy-boxed-warning?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9190294742584229
4/19/2024 12:13:02 PM,"Dividend Roundup: Johnson & Johnson, Dell, Lowe‚Äôs, Qualcomm and more",Seeking Alpha,https://seekingalpha.com/news/4091414-dividend-roundup-johnson-johnson-dell-lowes-qualcomm-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9432069063186646
4/19/2024 3:51:54 PM,Johnson & Johnson wins trial over talc-related cancer claim in Florida,Seeking Alpha,https://seekingalpha.com/news/4091543-johnson-johnson-wins-trial-talc-related-cancer-claim-florida?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.49596357345581055
4/19/2024 6:30:20 PM,These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?,InvestorPlace,/news/stocks/these-3-small-cap-stocks-are-up-304-in-2024-can-they-run-higher-1033267239,positive,0.6921044588088989
4/19/2024 6:48:52 PM,WHO considering safety alert on Kenvue kids cough syrup (update),Seeking Alpha,https://seekingalpha.com/news/4091569-who-considering-safety-alert-on-kenvue-kids-cough-syrup?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8983694911003113
4/19/2024 7:00:19 PM,"Catalyst Watch: Tesla, Boeing and General Motors brace for earnings fireworks",Seeking Alpha,https://seekingalpha.com/news/4091531-catalyst-watch-tesla-boeing-and-general-motors-brace-for-earnings-fireworks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8319833874702454
4/20/2024 10:37:00 AM,Investing for the Long-Term: 3 Stocks With Proven Track Records,InvestorPlace,/news/stocks/investing-for-the-long-term-3-stocks-with-proven-track-records-1033267570,neutral,0.6395660042762756
4/20/2024 7:38:42 PM,J&J and Kenvue ordered to pay $45M in latest talc-related cancer claim,Seeking Alpha,https://seekingalpha.com/news/4091712-jj-kenvue-told-pay-45m--talc-related-cancer-claim?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9596076607704163
4/21/2024 6:42:04 PM,Goldman picks top capex and R&D stocks,Seeking Alpha,https://seekingalpha.com/news/4091724-goldman-picks-top-capex-and-rd-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9173787832260132
4/22/2024 12:00:00 PM,5 Crash-Proof Stocks to Buy Immediately,InvestorPlace,/news/stocks/5-crash-proof-stocks-to-buy-immediately-1033270786,neutral,0.8640130758285522
4/22/2024 12:00:00 PM,3 Dividend Kings Down 11% You‚Äôll Regret Not Buying on the Dip,InvestorPlace,/news/stocks/3-dividend-kings-down-11-youll-regret-not-buying-on-the-dip-1033270787,negative,0.9647072553634644
4/22/2024 2:59:00 PM,3 Dividend Stocks to Buy Now for Lifelong Income,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-now-for-lifelong-income-1033272979,neutral,0.9048328995704651
4/22/2024 6:21:51 PM,WHO no longer planning safety alert on Kenvue cough syrup: report,Seeking Alpha,https://seekingalpha.com/news/4092121-who-no-longer-planning-safety-alert-on-kenvue-cough-syrup-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9229660630226135
4/23/2024 5:32:13 PM,Sanofi reportedly lining up banks for consumer products spinoff,Seeking Alpha,https://seekingalpha.com/news/4092701-sanofi-reportedly-lining-up-banks-for-consumer-products-spinoff?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7626510858535767
4/23/2024 8:30:00 PM,Warning! These 3 Blue-Chip Stocks Will Have You Seeing Red,InvestorPlace,/news/stocks/warning-these-3-blue-chip-stocks-will-have-you-seeing-red-1033278030,neutral,0.8795261979103088
4/24/2024 11:25:00 AM,The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth,InvestorPlace,/news/stocks/the-top-7-dividend-stocks-to-buy-in-2024-to-build-lasting-wealth-1033281279,positive,0.7226213812828064
4/24/2024 3:59:30 PM,Neurocrine Biosciences upgraded at Wells Fargo on pipeline,Seeking Alpha,https://seekingalpha.com/news/4093140-neurocrine-bioscienes-upgraded-wells-fargo-pipeline?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8787778615951538
4/24/2024 8:45:57 PM,"Cidara stock rallies amid $240M private placement, drug update",Seeking Alpha,https://seekingalpha.com/news/4093687-cidara-stock-rallies-amid-240m-private-placement-drug-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5627385377883911
4/24/2024 10:40:03 PM,Surprise! These 3 Dividend Giants Are at 52-Week Lows. Buy Them Before They Soar,InvestorPlace,/news/stocks/surprise-these-3-dividend-giants-are-at-52-week-lows-buy-them-before-they-soar-1033284469,negative,0.5322871208190918
4/25/2024 10:00:00 AM,Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024,InvestorPlace,/news/stocks/medtech-marvels-3-groundbreaking-medical-device-stocks-to-watch-in-2024-1033286961,neutral,0.7955983281135559
4/25/2024 10:50:00 AM,7 Blue-Chip Stocks to Buy on the Dip: April 2024,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-on-the-dip-april-2024-1033287300,neutral,0.8795628547668457
4/25/2024 3:14:00 PM,3 Long-Term Stocks to Buy on the Dip: April 2024,InvestorPlace,/news/stocks/3-long-term-stocks-to-buy-on-the-dip-april-2024-1033290693,neutral,0.9089171290397644
4/25/2024 7:00:00 PM,The Top 3 Small-Cap Stocks to Buy in April 2024,InvestorPlace,/news/stocks/the-top-3-small-cap-stocks-to-buy-in-april-2024-1033290120,neutral,0.9173219203948975
4/26/2024 10:00:00 AM,How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025?,InvestorPlace,/news/stocks/how-much-will-10k-invested-in-these-dividend-aristocrats-grow-to-by-2025-1033293175,neutral,0.9260013103485107
4/26/2024 10:00:00 AM,Steady Eddies: 7 Rock-Solid Stocks to Anchor Your Portfolio in April,InvestorPlace,/news/stocks/steady-eddies-7-rock-solid-stocks-to-anchor-your-portfolio-in-april-1033293172,neutral,0.7653394341468811
4/26/2024 3:41:48 PM,JNJ Receives Positive CHMP Opinion For Rybrevant For Treatment Of Patients With Advanced NSCLC ,RTTNews,/news/stocks/jnj-receives-positive-chmp-opinion-for-rybrevant-for-treatment-of-patients-with-advanced-nsclc-1033294244,positive,0.9503191709518433
4/27/2024 10:00:00 AM,Generational Wealth Builders: 3 Stocks to Own for Decades of Gains,InvestorPlace,/news/stocks/three-stocks-to-own-for-decades-of-gains-1033296018,neutral,0.9077432751655579
4/27/2024 10:38:00 AM,7 Stocks to Buy if Inflation Continues to Reign in 2024¬†,InvestorPlace,/news/stocks/7-stocks-to-buy-if-inflation-continues-to-be-a-problem-in-2024-1033296028,neutral,0.8385613560676575
4/28/2024 5:00:22 PM,"J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade",Seeking Alpha,https://seekingalpha.com/news/4095228-johnson-johnson-roche-astrazeneca-poised-have-highest-orphan-drug-sales-by-end-decade?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9317449927330017
4/29/2024 2:03:13 PM,7 Retirement Stocks to Buy at a 52-Week Low in April,InvestorPlace,/news/stocks/7-retirement-stocks-to-buy-at-a-52-week-low-in-april-1033300969,negative,0.8338465690612793
4/29/2024 3:20:01 PM,EU regulators recommend full approval for J&J TB drug Sirturo,Seeking Alpha,https://seekingalpha.com/news/4095555-eu-regulators-recommend-full-approval-for-jj-tb-drug-sirturo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5746012926101685
4/29/2024 4:01:27 PM,Addex stock plunges 50% on failed study for epilepsy drug,Seeking Alpha,https://seekingalpha.com/news/4095619-addex-stock-plunges-50-on-failed-study-for-epilepsy-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9640821814537048
4/29/2024 9:07:42 PM,Cutting Edge Picks: 3 Med Tech Stocks With Room to Run,InvestorPlace,/news/stocks/cutting-edge-picks-3-med-tech-stocks-with-room-to-run-1033302252,neutral,0.5270034074783325
4/30/2024 11:17:00 AM,Slump Survivors: 3 Stocks That Will Outlast the S&P 500 Downturn,InvestorPlace,/news/stocks/slump-survivors-3-stocks-that-will-outlast-the-sp-500-downturn-1033305592,neutral,0.7039688229560852
4/30/2024 1:42:51 PM,Stock Market Crash Warning: Don‚Äôt Get Caught Holding These 3 Healthcare Stocks,InvestorPlace,/news/stocks/stock-market-crash-warning-dont-get-caught-holding-these-3-healthcare-stocks-1033306829,neutral,0.49059462547302246
4/30/2024 1:49:06 PM,"J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations",Seeking Alpha,https://seekingalpha.com/news/4096283-jj-bristol-myers-lose-bid-halt-medicare-price-talks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9564803242683411
4/30/2024 5:10:58 PM,"Stifel, Morgan Stanley bullish on newly public Contineum",Seeking Alpha,https://seekingalpha.com/news/4096594-stifel-morgan-stanley-bullish-on-newly-public-contineum?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7740719318389893
4/30/2024 8:30:00 PM,7 Dividend Aristocrats Paying Sky-High Yields: April 2024,InvestorPlace,/news/stocks/7-dividend-aristocrats-paying-sky-high-yields-april-2024-1033308879,neutral,0.9212493300437927
5/1/2024 11:45:36 AM,J&J seeks over $6B settlement to resolve talc-related cancer claims,Seeking Alpha,https://seekingalpha.com/news/4097160-jj-plans-6b-deal-talc-related-cancer-claims?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9038745760917664
5/1/2024 12:18:08 PM,J&J's proposed $6B+ talc settlement negatively impacts some Q1 results,Seeking Alpha,https://seekingalpha.com/news/4097204-johnson-johnson-proposed-6b-talc-settlement-negatively-impacts-some-q1-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9620087742805481
5/1/2024 3:26:33 PM,JNJ Stock: J&J Proposes $6.5 Billion Settlement for Talc Cancer Lawsuits,InvestorPlace,/news/stocks/jnj-stock-jj-proposes-6-5-billion-settlement-for-talc-cancer-lawsuits-1033314430,neutral,0.4038093686103821
5/1/2024 3:43:59 PM,Why Is CytomX (CTMX) Stock Up 180% Today?,InvestorPlace,/news/stocks/why-is-cytomx-ctmx-stock-up-180-today-1033314629,positive,0.7880539894104004
5/1/2024 4:11:15 PM,"Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally",InvestorPlace,/news/stocks/cannabis-stocks-cgc-acb-tlry-drop-after-huge-rescheduling-rally-1033314763,negative,0.9616374969482422
5/1/2024 7:57:17 PM,Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge,InvestorPlace,/news/stocks/stock-market-crash-alert-3-must-buy-healthcare-stocks-when-prices-plunge-1033315341,neutral,0.727178156375885
5/1/2024 8:12:21 PM,"BeiGene, AbbVie patent spat to get trial from USPTO appeals board",Seeking Alpha,https://seekingalpha.com/news/4097839-beigene-abbvie-patent-spat-get-trial-uspto-appeals-board?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6186603903770447
5/1/2024 9:09:50 PM,J&J Proposes $6.475 Bln To Settle Ovarian Cancer Lawsuits ,RTTNews,/news/stocks/j-j-proposes-6-475-bln-to-settle-ovarian-cancer-lawsuits-1033315188,neutral,0.5723955035209656
5/2/2024 9:16:46 AM,Hold Rating on Johnson & Johnson Amid Ongoing Talc Litigation Uncertainties and Settlement Efforts,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-ongoing-talc-litigation-uncertainties-and-settlement-efforts-1033319546,negative,0.909286379814148
5/2/2024 9:19:33 AM,Johnson & Johnson‚Äôs Strategic Settlement Plan for Ovarian Cancer Talc Claims: Financial Implications and Outlook,TipRanks,/news/stocks/johnson-johnson-s-strategic-settlement-plan-for-ovarian-cancer-talc-claims-financial-implications-and-outlook-1033319538,neutral,0.910418689250946
5/3/2024 5:04:03 PM,J&J releases new Erleada data buoying benefit of prostate cancer treatment,Seeking Alpha,https://seekingalpha.com/news/4099835-johnson-johnson-releases-new-erleada-data-buoying-benefit-prostate-cancer-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.565252423286438
5/4/2024 7:30:00 PM,Pharma R&D productivity seen improving for the first time in years - Deloitte,Seeking Alpha,https://seekingalpha.com/news/4099974-pharma-research-development-productivity-improving-first-time-years?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9528806805610657
5/5/2024 10:45:44 AM,Johnson & Johnson‚Äôs Strategic Settlement Plan Bolsters Buy Rating,TipRanks,/news/stocks/johnson-johnson-s-strategic-settlement-plan-bolsters-buy-rating-1033329616,positive,0.9511063694953918
5/5/2024 8:50:40 PM,J&J delivers promising phase 1 data for localized bladder cancer treatment,Seeking Alpha,https://seekingalpha.com/news/4100058-jj-delivers-promising-phase-1-data-for-localized-bladder-cancer-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.934122622013092
5/6/2024 10:58:00 AM,Investor Alert: Are These 3 Spinoff Stocks Destined to Sizzle or Fizzle?,InvestorPlace,/news/stocks/investor-alert-are-these-3-spinoff-stocks-destined-to-sizzle-or-fizzle-1033332372,neutral,0.7610770463943481
5/6/2024 5:37:50 PM,Steady Dividend Plays: 3 Aristocrat Stocks to Own Now,InvestorPlace,/news/stocks/steady-dividend-plays-3-aristocrat-stocks-to-own-now-1033334877,neutral,0.8748055100440979
5/6/2024 6:06:06 PM,How the Medical Industry Could Produce the Biggest AI Stock Winners,InvestorPlace,/news/stocks/how-the-medical-industry-could-produce-the-biggest-ai-stock-winners-1032600921,neutral,0.8881736993789673
5/6/2024 6:30:17 PM,3 Biotech Stocks to Double Your Money in the Next 24 Months,InvestorPlace,/news/stocks/3-biotech-stocks-to-double-your-money-in-the-next-24-months-1033334986,positive,0.7702025771141052
5/7/2024 4:15:32 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1033337550,neutral,0.5040143728256226
5/7/2024 9:16:02 AM,Johnson & Johnson: Navigating Legal Challenges with a Strategic Settlement Outlook,TipRanks,/news/stocks/johnson-johnson-navigating-legal-challenges-with-a-strategic-settlement-outlook-1033339000,positive,0.8645827174186707
5/7/2024 12:03:23 PM,"Analysts Offer Insights on Healthcare Companies: Pliant Therapeutics (PLRX), Johnson & Johnson (JNJ) and Hims & Hers Health (HIMS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pliant-therapeutics-plrx-johnson-johnson-jnj-and-hims-hers-health-hims-1033340734,neutral,0.9216951131820679
5/7/2024 4:51:32 PM,Kenvue to slash global workforce by 4% in cost savings move,Seeking Alpha,https://seekingalpha.com/news/4101532-kenvue-slash-global-workforc-4-cost-savings-move?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5167437195777893
5/7/2024 7:35:37 PM,Kenvue Layoffs 2024: What to Know About the Latest KVUE Job Cuts,InvestorPlace,/news/stocks/kenvue-layoffs-2024-what-to-know-about-the-latest-kvue-job-cuts-1033341843,negative,0.852870762348175
5/7/2024 8:31:51 PM,Johnson & Johnson's TARIS Platform - Goldman Sachs Outlines Potential For The Bladder Cancer Therapy,Benzinga,/news/stocks/johnson-johnson-s-taris-platform---goldman-sachs-outlines-potential-for-the-bladder-cancer-therapy-1033341693,neutral,0.6163769960403442
5/8/2024 4:00:05 AM,Buy Rating Affirmed: Johnson & Johnson‚Äôs Bladder Cancer Treatments Poised to Transform Standard of Care,TipRanks,/news/stocks/buy-rating-affirmed-johnson-johnson-s-bladder-cancer-treatments-poised-to-transform-standard-of-care-1033345376,positive,0.8366358280181885
5/8/2024 11:06:13 AM,AstraZeneca is withdrawing COVID shot worldwide due to vaccine glut,Seeking Alpha,https://seekingalpha.com/news/4102264-astrazeneca-withdrawing-covid-shot-vaccine-glut?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9458288550376892
5/8/2024 5:55:30 PM,Steady Dividend Plays: 3 Stocks Promising Reliable Payouts in 2024,InvestorPlace,/news/stocks/three-stocks-promising-reliable-payouts-in-2024-1033349779,positive,0.9295637011528015
5/8/2024 8:39:38 PM,The 3 Most Undervalued S&P 500 Stocks to Buy in May 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-sp-500-stocks-to-buy-in-may-2024-1033350343,neutral,0.7427200078964233
5/9/2024 10:47:57 AM,Hold Rating on Johnson & Johnson Amid Varipulse PFA Catheter Recall and Approval Uncertainties,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-varipulse-pfa-catheter-recall-and-approval-uncertainties-1033356512,negative,0.9455834031105042
5/9/2024 10:49:00 AM,Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine,InvestorPlace,/news/stocks/biotech-breakthroughs-3-stocks-on-the-verge-of-revolutionizing-medicine-1033355184,neutral,0.7897725701332092
5/9/2024 4:41:08 PM,A Look at Pharma ETFs Post Q1 Earnings,Benzinga,/news/etf/a-look-at-pharma-etfs-post-q1-earnings-1033357001,neutral,0.9325219988822937
5/10/2024 10:30:00 AM,3 Biotech Stocks to Sell in May Before They Crash & Burn,InvestorPlace,/news/stocks/3-biotech-stocks-to-sell-in-may-before-they-crash-burn-1033362353,neutral,0.8534220457077026
5/10/2024 11:10:00 AM,The 3 Most Undervalued Stocks to Buy in May 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-stocks-to-buy-in-may-2024-1033362566,neutral,0.7456104755401611
5/11/2024 1:46:00 PM,The 3 Best Mutual Funds to Buy in May 2024,InvestorPlace,/news/stocks/the-3-best-mutual-funds-to-buy-in-may-2024-1033365205,neutral,0.8726626634597778
5/13/2024 10:00:00 AM,7 Reliable Dividend Stocks to Keep Your Portfolio Upright,InvestorPlace,/news/stocks/7-reliable-dividend-stocks-to-keep-your-portfolio-upright-1033369987,neutral,0.8991883397102356
5/13/2024 10:00:00 AM,The 7 Most Undervalued Stocks With Strong Fundamentals to Buy in May 2024,InvestorPlace,/news/stocks/the-7-most-undervalued-stocks-with-strong-fundamentals-to-buy-in-may-2024-1033369992,positive,0.9053457975387573
5/13/2024 11:34:21 AM,Johnson & Johnson to exit Kenvue in debt-for-equity deal,Seeking Alpha,https://seekingalpha.com/news/4105044-johnson-johnson-to-exit-kenvue-in-debt-for-equity-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9484728574752808
5/13/2024 2:39:45 PM,Johnson & Johnson Is Officially Getting Out of Kenvue (KVUE) Stock,InvestorPlace,/news/stocks/johnson-johnson-is-officially-getting-out-of-kenvue-kvue-stock-1033371606,neutral,0.8822925090789795
5/15/2024 7:01:54 AM,Kenvue prices secondary stock offering as Johnson & Johnson exits,Seeking Alpha,https://seekingalpha.com/news/4106258-kenvue-prices-secondary-stock-offering-johnson-johnson-exit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9433025121688843
5/15/2024 2:21:25 PM,"Short interest in S&P 500 healthcare sector dips in April, biotechnology companies most shorted",Seeking Alpha,https://seekingalpha.com/news/4106501-short-interest-in-sp-500-healthcare-sector-dips-in-april-biotechnology-companies-most-shorted?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.96722412109375
5/16/2024 10:30:00 AM,Consumer Staples Standouts: 3 Defensive Gems to Safeguard Your Portfolio,InvestorPlace,/news/stocks/consumer-staples-standouts-3-defensive-gems-to-safeguard-your-portfolio-1033392042,neutral,0.8648034334182739
5/16/2024 10:30:53 AM,Johnson & Johnson (JNJ) Receives a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-rbc-capital-1033393200,positive,0.49460798501968384
5/16/2024 10:31:42 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Cullinan Management (CGEM) and Omeros (OMER)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-cullinan-management-cgem-and-omeros-omer-1033393197,neutral,0.917633056640625
5/16/2024 12:24:55 PM,Johnson & Johnson to buy dermatology-focused biotech Proteologix,Seeking Alpha,https://seekingalpha.com/news/4107278-j-j-to-buy-dermatology-biotech-proteologix?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9180812835693359
5/16/2024 2:18:27 PM,Johnson & Johnson To Acquire Proteologix For $850 Mln ,RTTNews,/news/stocks/johnson-johnson-to-acquire-proteologix-for-850-mln-1033392575,neutral,0.921402633190155
5/16/2024 8:37:23 PM,Divide and Conquer: 3 Stock Spinoffs Set to Trounce the Market,InvestorPlace,/news/stocks/divide-and-conquer-3-stock-spinoffs-set-to-trounce-the-market-1033395145,negative,0.844009280204773
5/17/2024 10:24:00 AM,3 Robotics and Automation Stocks to Sell in May Before They Crash & Burn,InvestorPlace,/news/stocks/3-robotics-and-automation-stocks-to-sell-in-may-before-they-crash-burn-1033398672,neutral,0.7464299201965332
5/17/2024 10:30:00 AM,3 Cheap Healthcare Stocks to Buy Now: May 2024,InvestorPlace,/news/stocks/3-cheap-healthcare-stocks-to-buy-now-may-2024-1033398668,neutral,0.9228615760803223
5/17/2024 11:11:00 AM,7 Value Stocks to Buy and Hold for a Decade of Dominance,InvestorPlace,/news/stocks/7-value-stocks-to-buy-and-hold-for-a-decade-of-dominance-1033398745,neutral,0.9146936535835266
5/17/2024 12:04:10 PM,"Dividend Roundup: Home Depot, Alibaba, Johnson & Johnson, Yum! Brands, and more",Seeking Alpha,https://seekingalpha.com/news/4107861-dividend-roundup-home-depot-alibaba-johnson-johnson-yum-brands-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9402797222137451
5/17/2024 9:05:31 PM,Medtronic study of Affera Sphere-9 Catheter meets endpoints,Seeking Alpha,https://seekingalpha.com/news/4108078-medtronic-study-of-affera-sphere-9-catheter-meets-endpoints?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8244130611419678
5/18/2024 12:55:42 PM,Johnson & Johnson-backed Rapport Therapeutics files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/4108103-jj-backed-rapport-therapeutics-seeks-100m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8918170928955078
5/18/2024 4:19:14 PM,"Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch",Benzinga,/news/stocks/cannabis-meets-prescription-drugs-steroids-and-ketamine-in-schedule-iii-what-it-means-key-stocks-to-watch-1033400987,neutral,0.9329438805580139
5/18/2024 6:52:07 PM,"Novo Nordisk, J&J lead R&D rankings in big pharma: report",Seeking Alpha,https://seekingalpha.com/news/4108110-novo-nordisk-j-j-lead-rd-big-pharma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8400072455406189
5/19/2024 6:00:55 PM,Biopharma M&A surges year over year in Q1,Seeking Alpha,https://seekingalpha.com/news/4108148-biopharma-mergers-acquisitions-surges-year-over-year-q1?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9248523712158203
5/19/2024 7:05:03 PM,SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?,Seeking Alpha,https://seekingalpha.com/news/4108152-sa-roundtable-are-eli-lilly-and-novo-nordisk-overvalued?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8515275120735168
5/20/2024 10:02:10 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Johnson & Johnson (JNJ), Eli Lilly & Co (LLY) and Coherus Biosciences (CHRS)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-johnson-johnson-jnj-eli-lilly-co-lly-and-coherus-biosciences-chrs-1033403373,negative,0.8155580759048462
5/20/2024 11:17:08 AM,Citi Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/citi-keeps-their-buy-rating-on-johnson-johnson-jnj-1033403924,neutral,0.9060527682304382
5/20/2024 3:51:21 PM,Johnson & Johnson's Tremfya meets goals in late-stage trial for ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/4108390-johnson-johnson-tremfya-meets-goals-late-stage-trial-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8924790024757385
5/20/2024 5:22:03 PM,The AI Stock Underdogs: 7 Underappreciated Companies Poised for Greatness,InvestorPlace,/news/stocks/the-ai-stock-underdogs-7-underappreciated-companies-poised-for-greatness-1033404434,neutral,0.752781093120575
5/20/2024 7:18:17 PM,Should You Invest in the Vanguard Health Care ETF?,Benzinga,/news/etf/should-you-invest-in-the-vanguard-health-care-etf-1033404417,neutral,0.9077762961387634
5/20/2024 10:40:41 PM,J&J-backed Rapport Therapeutics files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/4108575-jj-backed-rapport-therapeutics-files-for-100m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9082724452018738
5/21/2024 10:51:13 AM,"Teva, Alvotech launch biosimilar against AbbVie‚Äôs Humira",Seeking Alpha,https://seekingalpha.com/news/4108668-teva-alvotech-launch-biosimilar-against-humira?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5384870767593384
5/21/2024 5:41:34 PM,7 Dividend Kings to Buy for Royal Passive Income: May Edition,InvestorPlace,/news/stocks/7-dividend-kings-to-buy-for-royal-passive-income-may-edition-1033408667,neutral,0.9310621023178101
5/21/2024 7:35:16 PM,Buy Recommendation for Johnson & Johnson on Promising Tremfya Clinical Data and Market Expansion Potential,TipRanks,/news/stocks/buy-recommendation-for-johnson-johnson-on-promising-tremfya-clinical-data-and-market-expansion-potential-1033409089,positive,0.9455034732818604
5/21/2024 8:46:22 PM,Shockwave Medical gains after HSR waiting period for sale to J&J expires,Seeking Alpha,https://seekingalpha.com/news/4109075-shockwave-medical-gains-after-hsr-waiting-period-for-sale-to-jj-expires?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8469678163528442
5/22/2024 10:27:05 AM,RBC Capital Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1033411707,neutral,0.5954959392547607
5/22/2024 1:48:14 PM,7 Safe-Haven Stocks to Weather Any Storm,InvestorPlace,/news/stocks/7-safe-haven-stocks-to-weather-any-storm-1033411814,neutral,0.6809394955635071
5/22/2024 3:11:31 PM,"The 500 Top Stocks to Buy in May, According to AI",InvestorPlace,/news/stocks/the-500-top-stocks-to-buy-in-may-according-to-ai-1033412478,neutral,0.9145967364311218
5/22/2024 5:00:57 PM,Expert Ratings For Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1033412391,neutral,0.7854138612747192
5/23/2024 11:16:29 AM,J&J faces lawsuit over talc-related bankruptcy filings,Seeking Alpha,https://seekingalpha.com/news/4109765-j-j-faces-lawsuit-over-talc-related-bankruptcies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9526470899581909
5/23/2024 3:59:46 PM,Legend Biotech a new buy at Deutsche Bank on Carvykti sales,Seeking Alpha,https://seekingalpha.com/news/4109908-legend-biotech-new-buy-deutsche-bank-carvykti-sales?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.85442715883255
5/23/2024 7:23:43 PM,DD Stock Separation Plan: What to Know as DuPont Splits Into 3 Companies,InvestorPlace,/news/stocks/dd-stock-separation-plan-what-to-know-as-dupont-splits-into-3-companies-1033417299,neutral,0.9410980343818665
5/23/2024 7:41:25 PM,The Time Traveler‚Äôs Portfolio: 3 Stocks to Buy Now for Massive Returns by 2034,InvestorPlace,/news/stocks/the-time-travelers-portfolio-3-stocks-to-buy-now-for-massive-returns-by-2034-1033417347,neutral,0.8680709600448608
5/23/2024 8:16:31 PM,"ADHD diagnoses increasing, becoming an 'expanding public health concern': CDC",Seeking Alpha,https://seekingalpha.com/news/4110015-adhd-diagnoses-increasing-becoming-expanding-public-health-concern-cdc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9134584069252014
5/24/2024 5:50:59 AM,Optimistic Buy Rating for JNJ‚Äôs Tremfya Based on Strong Market Penetration Potential in IBD,TipRanks,/news/stocks/optimistic-buy-rating-for-jnj-s-tremfya-based-on-strong-market-penetration-potential-in-ibd-1033419153,positive,0.9352256059646606
5/24/2024 5:00:00 PM,3 Stocks to Safeguard Your Investments During a Market Meltdown,InvestorPlace,/news/stocks/3-stocks-to-safeguard-your-investments-during-a-market-meltdown-1033420974,neutral,0.9141861796379089
5/25/2024 11:30:00 AM,3 Dow Stocks to Buy on the Dip: May 2024,InvestorPlace,/news/stocks/3-dow-stocks-to-buy-on-the-dip-may-2024-1033421474,neutral,0.9106268286705017
5/27/2024 10:00:00 AM,7 Dividend Stocks That Could Soar After Q1 Earnings Reports,InvestorPlace,/news/stocks/7-dividend-stocks-that-could-soar-after-q1-earnings-reports-1033423794,negative,0.7725805044174194
5/28/2024 12:01:49 PM,J&J to buy eczema drug developer Yellow Jersey for over $1B,Seeking Alpha,https://seekingalpha.com/news/4110675-jj-buy-yellow-jersey-over-1b?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8568068146705627
5/28/2024 2:13:43 PM,Johnson & Johnson To Acquire Rights To Numab Therapeutics' Clinical-Stage Bispecific Antibody NM26 ,RTTNews,/news/stocks/johnson-johnson-to-acquire-rights-to-numab-therapeutics-clinical-stage-bispecific-antibody-nm26-1033426797,neutral,0.6984283924102783
5/28/2024 6:15:48 PM,HealthTech Heroes: 3 Medical Technology Stocks to Buy Before They Boom,InvestorPlace,/news/stocks/healthtech-heroes-3-medical-technology-stocks-to-buy-before-they-boom-1033428394,neutral,0.9281883239746094
5/29/2024 9:10:25 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Insmed (INSM), Arcturus Therapeutics (ARCT) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-insmed-insm-arcturus-therapeutics-arct-and-johnson-johnson-jnj-1033431427,negative,0.832337498664856
5/29/2024 12:48:00 PM,Johnson & Johnson depression candidate seltorexant meets phase 3 goals,Seeking Alpha,https://seekingalpha.com/news/4111111-johnson-johnson-depression-candidate-seltorexant-meets-phase-3-goals?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6205320358276367
5/30/2024 6:45:27 AM,Sarepta Therapeutics set to join S&P MidCap 400,Seeking Alpha,https://seekingalpha.com/news/4111366-sarepta-therapeutics-set-to-join-sp-midcap-400?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9157516956329346
5/30/2024 11:30:00 AM,Blue-Chip Bubble Trouble: 7 Stocks to Short as Valuations Stretch to the Limit,InvestorPlace,/news/stocks/blue-chip-bubble-trouble-7-stocks-to-short-as-valuations-stretch-to-the-limit-1033435720,negative,0.9286768436431885
5/30/2024 11:41:20 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Immunovant (IMVT), Johnson & Johnson (JNJ) and American Well (AMWL)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-immunovant-imvt-johnson-johnson-jnj-and-american-well-amwl-1033436795,negative,0.8602162599563599
5/30/2024 7:03:57 PM,Should You Invest in the iShares U.S. Healthcare ETF?,Benzinga,/news/stocks/should-you-invest-in-the-ishares-u-s-healthcare-etf-1033437375,neutral,0.9228520393371582
5/30/2024 9:57:18 PM,"J&J transfers Ponvory FDA applications to Vanda, launch seen in Q3",Seeking Alpha,https://seekingalpha.com/news/4111797-jj-transfers-ponvory-fda-applications-to-vanda-launch-seen-in-q3?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6591008901596069
5/31/2024 11:00:00 AM,3 Sorry Biotech Stocks to Sell in May While You Still Can,InvestorPlace,/news/stocks/3-sorry-biotech-stocks-to-sell-in-may-while-you-still-can-1033440710,neutral,0.7874515652656555
5/31/2024 1:35:26 PM,J&J completes acquisition of cardiac device maker Shockwave,Seeking Alpha,https://seekingalpha.com/news/4111939-jj-completes-acquisition-of-medtech-shockwave?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8457753658294678
5/31/2024 3:00:25 PM,Boring Is Beautiful: 3 Blue-Chip Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/boring-is-beautiful-3-blue-chip-stocks-to-buy-and-hold-forever-1033441780,neutral,0.9015207290649414
5/31/2024 6:05:44 PM,Psychedelic stocks mixed as FDA comments on MDMA therapy (update),Seeking Alpha,https://seekingalpha.com/news/4111983-psychedelic-stocks-mixed-fda-comments-mdma-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6598251461982727
5/31/2024 9:53:13 PM,J&J says Rybrevant combo bests AstraZeneca's Tagrisso in type of lung cancer,Seeking Alpha,https://seekingalpha.com/news/4112105-johnson-johnson-says-rybrevant-combo-bests-astrazeneca-tagrisso-lung-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.4514372944831848
6/3/2024 10:00:00 AM,7 Overlooked Stocks That Belong in Every Portfolio¬†,InvestorPlace,/news/stocks/7-must-own-overlooked-stocks-that-can-work-in-any-portfolio-1033445074,neutral,0.9365252256393433
6/3/2024 4:03:10 PM,"GSK says Blenrep combo cuts disease progression, death in multiple myeloma",Seeking Alpha,https://seekingalpha.com/news/4112369-gsk-says-belnrep-combo-cuts-disease-progression-death-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.41479185223579407
6/3/2024 5:06:04 PM,J&J-backed Rapport Therapeutics sets terms for $136M IPO,Seeking Alpha,https://seekingalpha.com/news/4112393-jj-backed-rapport-therapeutics-sets-terms-for-136m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9252532720565796
6/3/2024 6:46:53 PM,Sell ideas in Staples and Health Care - Oppenheimer,Seeking Alpha,https://seekingalpha.com/news/4112419-sell-ideas-in-staples-and-health-care-oppenheimer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9165979027748108
6/3/2024 10:09:10 PM,"J&J, Legend release promising results on Carvykti in earlier treatment line",Seeking Alpha,https://seekingalpha.com/news/4112513-johnson-johnson-legend-release-promising-results-carvykti-earlier-treatment-line?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9506963491439819
6/3/2024 10:42:13 PM,Sanofi says Sarclisa improves progression-free survival in some multiple myeloma patients,Seeking Alpha,https://seekingalpha.com/news/4112515-sanofi-says-sarclisa-improves-progression-free-survival-in-some-multiple-myeloma-patients?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9524927139282227
6/4/2024 2:03:20 AM,Oregon jury awards talc plaintiff $260M in verdict against Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/4112519-oregon-jury-awards-talc-plaintiff-260m-verdict-against-johnson-johnson?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5113431811332703
6/4/2024 10:00:00 AM,3 Dividend Aristocrats to Scoop Up During Market Pullbacks in June,InvestorPlace,/news/stocks/3-dividend-aristocrats-to-scoop-up-during-market-pullbacks-in-june-1033448656,positive,0.5079554319381714
6/4/2024 12:06:20 PM,RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1033450356,neutral,0.7207147479057312
6/4/2024 2:00:00 PM,The 3 Most Undervalued Dow Stocks to Buy in June 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-dow-stocks-to-buy-in-june-2024-1033450053,neutral,0.821574330329895
6/4/2024 8:56:46 PM,J&J seeks to expand HIV med Prezcobix indication to children as young as six,Seeking Alpha,https://seekingalpha.com/news/4112875-johnson-johnson-seeks-expand-hiv-med-prezcobix-indication-children-young-six?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7908774614334106
6/5/2024 3:21:33 PM,The most crowded longs and shorts in U.S. Med-Tech for May - UBS,Seeking Alpha,https://seekingalpha.com/news/4113240-the-most-crowded-longs-and-shorts-in-us-med-tech-for-may-ubs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8358554244041443
6/5/2024 9:31:08 PM,"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Vir Biotechnology (VIR) and Madrigal Pharmaceuticals (MDGL)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-vir-biotechnology-vir-and-madrigal-pharmaceuticals-mdgl-1033455521,negative,0.6890162825584412
6/6/2024 10:55:44 AM,Sleep Easy: 3 Safe Stocks That Won‚Äôt Have You Stressin‚Äô,InvestorPlace,/news/stocks/sleep-easy-3-safe-stocks-that-wont-have-you-stressin-1033458349,neutral,0.8836331963539124
6/6/2024 2:47:18 PM,"Goldman cuts 2seventy bio to neutral, cites competition concerns",Seeking Alpha,https://seekingalpha.com/news/4113699-goldman-cuts-2seventy-bio-to-neutral-cites-competition-concerns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.600622832775116
6/6/2024 4:51:08 PM,Halozyme hits 52-week high as patent win prompts guidance raise,Seeking Alpha,https://seekingalpha.com/news/4113757-halozyme-stock-hits-52-week-guidance-raise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8896650075912476
6/6/2024 9:36:29 PM,Halozyme's ENHANZE Product Gets New Patent Grant in EU,Benzinga,/news/stocks/halozyme-s-enhanze-product-gets-new-patent-grant-in-eu-1033459113,positive,0.7392569780349731
6/7/2024 5:44:02 AM,J&J-backed Rapport Therapeutics prices IPO at $17 per share,Seeking Alpha,https://seekingalpha.com/news/4113928-jj-backed-rapport-therapeutics-prices-ipo-at-17-per-share?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.950134813785553
6/7/2024 11:10:00 AM,The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash,InvestorPlace,/news/stocks/the-dividend-darlings-3-stocks-that-will-shower-your-portfolio-with-cash-1033460743,neutral,0.9295212626457214
6/7/2024 12:40:30 PM,J&J cleared to expand use of Velys robotic system in U.S.,Seeking Alpha,https://seekingalpha.com/news/4114053-jj-cleared-expand-use-velys-robotic-system?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.869916558265686
6/7/2024 1:16:13 PM,Halozyme downgraded at Piper Sandler despite guidance raise,Seeking Alpha,https://seekingalpha.com/news/4114090-halozyme-stock-slips-piper-sandler-downgrades?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8291919827461243
6/7/2024 4:04:12 PM,Rapport Therapeutics starts trading above IPO price,Seeking Alpha,https://seekingalpha.com/news/4114176-rapport-therapeutics-starts-trading-above-ipo-price?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8803956508636475
6/7/2024 4:39:04 PM,The 3 Best Dow Stocks to Buy in June 2024,InvestorPlace,/news/stocks/the-3-best-dow-stocks-to-buy-in-june-2024-1033462133,neutral,0.9145510792732239
6/10/2024 10:00:00 AM,The Safety Net Seven: 7 Stocks to Own for Unshakeable Returns,InvestorPlace,/news/stocks/the-safety-net-seven-7-stocks-to-own-for-unshakeable-returns-1033464998,neutral,0.8958709836006165
6/10/2024 10:36:12 AM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1033465708,neutral,0.9046739339828491
6/11/2024 1:20:17 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ), Oculis Holding (OCS) and Moderna (MRNA)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-johnson-johnson-jnj-oculis-holding-ocs-and-moderna-mrna-1033467355,negative,0.9350318312644958
6/11/2024 8:33:48 AM,Alvotech and Stada add to strategic alliance through denosumab partnership,Seeking Alpha,https://seekingalpha.com/news/4114679-alvotech-and-stada-add-to-strategic-alliance-through-denosumab-partnership?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8855558037757874
6/11/2024 5:00:00 PM,The 3 Most Undervalued Robinhood Stocks to Buy in June 2024,InvestorPlace,/news/stocks/undervalued-robinhood-stocks-3-names-skeptics-may-not-expect-1033470123,neutral,0.8524705767631531
6/11/2024 6:04:25 PM,J&J in $700M settlement with states over marketing of talc products,Seeking Alpha,https://seekingalpha.com/news/4114930-johnson-johnson-700m-settlement-states-marketing-talc-products?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8745493292808533
6/11/2024 6:49:39 PM,7 Recession-Proof Stocks to Buy Now for Peace of Mind,InvestorPlace,/news/stocks/7-recession-proof-stocks-to-buy-now-for-peace-of-mind-1033470311,neutral,0.8757135272026062
6/12/2024 6:41:22 AM,"Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), Insmed (INSM)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-johnson-johnson-jnj-insmed-insm-1033471867,neutral,0.7039995789527893
6/12/2024 3:15:53 PM,Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-spotlight-on-3-health-care-stocks-delivering-high-dividend-yields-1033472721,positive,0.7499573230743408
6/12/2024 7:34:26 PM,Cancer victims seek court order to block J&J‚Äôs bankruptcy bid,Seeking Alpha,https://seekingalpha.com/news/4115339-cancer-victims-seek-court-order-block-jjs-talc-bankruptcy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.738409698009491
6/13/2024 11:10:00 AM,Dividend Heaven: 7 Standout Stocks for Income Investors to Buy in June,InvestorPlace,/news/stocks/dividend-heaven-7-standout-stocks-for-income-investors-to-buy-in-june-1033475672,neutral,0.8555639982223511
6/13/2024 6:23:10 PM,Payout Powerhouses: 7 Dividend Stocks to Buy Now,InvestorPlace,/news/stocks/payout-powerhouses-7-dividend-stocks-to-buy-now-1033477569,neutral,0.9005997180938721
6/13/2024 7:02:59 PM,Xencor to regain rights from J&J for plamotamab,Seeking Alpha,https://seekingalpha.com/news/4115886-xencor-to-regain-rights-from-jj-for-plamotamab?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6350581049919128
6/14/2024 2:25:58 PM,Johnson & Johnson Reports Long-term Data From Phase 1/2 Study With TALVEY ,RTTNews,/news/stocks/johnson-johnson-reports-long-term-data-from-phase-1-2-study-with-talvey-1033479488,neutral,0.9045435190200806
6/14/2024 3:23:25 PM,J&J's Talvey demonstrates robust long-term response in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/4116283-johnson-johnson-talvey-demonstrates-robust-long-term-response-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9522587060928345
6/14/2024 7:55:36 PM,EU to require additional cancer risk labeling on CAR T therapies,Seeking Alpha,https://seekingalpha.com/news/4116402-eu-to-require-additional-cancer-risk-labeling-on-car-t-therapies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8998956084251404
6/15/2024 10:00:00 AM,Blue-Chip Jackpots: 3 Top-Notch Stocks at Bottom-Barrel Prices,InvestorPlace,/news/stocks/blue-chip-jackpots-3-top-notch-stocks-at-bottom-barrel-prices-1033481228,neutral,0.8667089343070984
6/15/2024 10:42:00 AM,The 7 Best Under $20 Stocks to Buy in June 2024,InvestorPlace,/news/stocks/the-7-best-under-20-stocks-to-buy-in-june-2024-1033481242,neutral,0.8961836695671082
6/16/2024 12:05:29 PM,Wells Fargo Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/wells-fargo-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1033481640,neutral,0.837287187576294
6/17/2024 10:40:58 AM,RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1033483787,neutral,0.7207147479057312
6/17/2024 3:25:08 PM,J&J Submits BLA For Subcutaneous Amivantamab Combination In EGFR-mutated NSCLC Patients ,RTTNews,/news/stocks/j-j-submits-bla-for-subcutaneous-amivantamab-combination-in-egfr-mutated-nsclc-patients-1033483713,neutral,0.710997462272644
6/17/2024 4:01:29 PM,In-Depth Examination Of 11 Analyst Recommendations For Johnson & Johnson,Benzinga,/news/stocks/in-depth-examination-of-11-analyst-recommendations-for-johnson-johnson-1033484211,neutral,0.8954975008964539
6/17/2024 6:15:06 PM,"Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst",Benzinga,/news/stocks/legend-biotech-s-cancer-drug-the-most-attractive-product-set-for-growth-analyst-1033484619,positive,0.6228742599487305
6/20/2024 11:30:00 AM,7 High-Value Blue-Chip Stocks to Boost Your Wealth by 2027,InvestorPlace,/news/stocks/7-high-value-blue-chip-stocks-to-boost-your-wealth-by-2027-1033492560,positive,0.8014848232269287
6/20/2024 12:39:51 PM,3 Healthcare Stocks to Buy Now: June 2024,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-now-june-2024-1033492821,neutral,0.9365812540054321
6/20/2024 2:29:07 PM,J&J Phase 3 study shows subcutaneous Tremfya effective in Crohn's,Seeking Alpha,https://seekingalpha.com/news/4117538-jnj-phase-3-study-shows-subcutaneous-tremfya-effective-in-crohns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6943614482879639
6/20/2024 2:32:08 PM,Johnson & Johnson: TREMFYA Phase 3 Study Meets Primary And Secondary Endpoints ,RTTNews,/news/stocks/johnson-johnson-tremfya-phase-3-study-meets-primary-and-secondary-endpoints-1033492766,neutral,0.9017637968063354
6/20/2024 9:11:21 PM,J&J applies for FDA approval of Tremfya for Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/4117764-jj-applies-for-fda-approval-of-tremfya-for-crohns-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5259242653846741
6/21/2024 3:00:32 AM,Johnson & Johnson Seeks FDA Approval For Tremfya For Moderate To Severe Crohn's Disease ,RTTNews,/news/stocks/johnson-johnson-seeks-fda-approval-for-tremfya-for-moderate-to-severe-crohn-s-disease-1033494558,positive,0.9123551845550537
6/21/2024 4:25:45 AM,Cantor Fitzgerald Reaffirms Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-reaffirms-their-buy-rating-on-johnson-johnson-jnj-1033494966,neutral,0.8143643736839294
6/21/2024 11:47:27 AM,Johnson & Johnson closes acquisition of biotechnology company Proteologix,Seeking Alpha,https://seekingalpha.com/news/4117872-johnson-johnson-closes-acquisition-of-biotechnology-company-proteologix?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.909875214099884
6/21/2024 9:31:14 PM,"The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly",Benzinga,/news/stocks/the-zacks-analyst-blog-highlights-pfizer-johnson-johnson-and-eli-lilly-1033497156,neutral,0.9443087577819824
6/25/2024 7:03:18 PM,J&J mid-stage trial for Tremfya against immune disorder fails,Seeking Alpha,https://seekingalpha.com/news/4119121-jj-stock-drops-as-tremfya-fails-clinical-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5539382100105286
6/26/2024 4:25:57 AM,Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-keeps-their-buy-rating-on-johnson-johnson-jnj-1033506194,neutral,0.9096185564994812
6/26/2024 4:53:40 PM,The 3 Smartest Dow Stocks to Buy With $1000 Right Now,InvestorPlace,/news/stocks/the-3-smartest-dow-stocks-to-buy-with-1000-right-now-1033508753,neutral,0.8763496279716492
6/27/2024 7:22:09 PM,"AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway",Benzinga,/news/stocks/abbvie-genmab-s-epkinly-fda-approval-is-a-positive-step-analyst-says-additional-expansion-opportunities-underway-1033512703,positive,0.9408528208732605
6/28/2024 1:30:58 PM,Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-give-their-take-on-3-health-care-stocks-with-over-3-dividend-yields-1033514650,neutral,0.9256895780563354
6/28/2024 1:58:24 PM,Janssen-Cilag Says CHMP Recommended Balversa For Urothelial Carcinoma ,RTTNews,/news/stocks/janssen-cilag-says-chmp-recommended-balversa-for-urothelial-carcinoma-1033514717,neutral,0.7052542567253113
6/28/2024 4:45:53 PM,J&J reports positive phase 3 data for nipocalimab for neuromuscular disease,Seeking Alpha,https://seekingalpha.com/news/4120678-johnson-johnson-reports-positive-phase-3-data-nipocalimab-neuromuscular-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9483676552772522
6/28/2024 5:13:58 PM,J&J: Rybrevant In Combination Gets Approval In Europe For First-Line Treatment Of NSCLC ,RTTNews,/news/stocks/j-j-rybrevant-in-combination-gets-approval-in-europe-for-first-line-treatment-of-nsclc-1033515841,positive,0.9460901618003845
6/29/2024 1:11:15 PM,J&J talc claimants lose bid to block company's bankruptcy bid,Seeking Alpha,https://seekingalpha.com/news/4120801-jj-talc-victims-lose-bid-block-bankruptcy-bid?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9375767707824707
6/29/2024 7:44:55 PM,Rising drug costs force a third of Americans to leave prescriptions unfilled: report,Seeking Alpha,https://seekingalpha.com/news/4120808-many-prescriptions-remain-unfilled-amid-soaring-drug-costs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7290319204330444
6/30/2024 2:13:35 PM,Treasure Hunt: 3 Small-Cap Stocks Wall Street Hasn‚Äôt Discovered Yet,InvestorPlace,/news/stocks/treasure-hunt-3-small-cap-stocks-wall-street-hasnt-discovered-yet-1033517243,neutral,0.9144802689552307
7/1/2024 12:30:56 AM,"Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2",Seeking Alpha,https://seekingalpha.com/news/4120874-alnylam-lilly-astrzeneca-best-performing-pharmas-biotechs-q2?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7701660394668579
7/1/2024 7:31:13 AM,Sandoz To Commercialize Samsung Bioepis' FDA Approved Biosimilar Pyzchiva In US ,RTTNews,/news/stocks/sandoz-to-commercialize-samsung-bioepis-fda-approved-biosimilar-pyzchiva-in-us-1033518094,positive,0.6302055716514587
7/1/2024 10:00:00 AM,Boing! 7 Undervalued Stocks That Could Surprise the Skeptics.,InvestorPlace,/news/stocks/boing-7-undervalued-stocks-that-could-surprise-the-skeptics-1033518931,negative,0.5502821207046509
7/1/2024 10:08:03 AM,Hold Rating on Johnson & Johnson‚Äôs Nipocalimab: Weighing Efficacy Against Uncertainties and Market Potential,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-s-nipocalimab-weighing-efficacy-against-uncertainties-and-market-potential-1033519619,positive,0.8147929310798645
7/1/2024 4:19:57 PM,3 Dividend Stocks Yielding Over 3% With Multi-Decade Payout Growth Streaks,InvestorPlace,/news/stocks/3-dividend-stocks-yielding-over-3-with-multi-decade-payout-growth-streaks-1033520688,positive,0.9196975231170654
7/1/2024 4:35:40 PM,"Piper downgrades Zimmer to neutral, cites lack of catalysts",Seeking Alpha,https://seekingalpha.com/news/4121268-piper-downgrades-zimmer-to-neutral-cites-lack-of-catalysts?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.4901331961154938
7/1/2024 8:30:00 PM,3 Retirement All-Stars for Steady Growth and Income,InvestorPlace,/news/stocks/3-retirement-all-stars-for-steady-growth-and-income-1033521039,positive,0.5756708979606628
7/2/2024 12:23:40 PM,J&J says Carvykti beat standard drugs in late-stage blood cancer trial,Seeking Alpha,https://seekingalpha.com/news/4121567-jj-carvykti-beat-standard-drugs-blood-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9461309313774109
7/2/2024 1:51:44 PM,J&J Reports Positive Data From Phase 3 CARTITUDE-4 Study Of Carvykti In Multiple Myeloma ,RTTNews,/news/stocks/j-j-reports-positive-data-from-phase-3-cartitude-4-study-of-carvykti-in-multiple-myeloma-1033522603,positive,0.9439729452133179
7/2/2024 8:45:00 PM,7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-will-have-investors-in-high-yield-heaven-1033524556,neutral,0.8748615384101868
7/3/2024 2:00:00 PM,7 Safe Haven Stocks to Buy Before the Next Market Correction,InvestorPlace,/news/stocks/7-safe-haven-stocks-to-buy-before-the-next-market-correction-1033527117,neutral,0.9112621545791626
7/3/2024 2:10:23 PM,Johnson & Johnson Announces Health Canada NOC For RYBREVANT Combination - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-announces-health-canada-noc-for-rybrevant-combination-quick-facts-1033526326,neutral,0.8484709858894348
7/3/2024 3:06:31 PM,U.S. indicated dividend payments rose in Q2 led by Alphabet's initiation,Seeking Alpha,https://seekingalpha.com/news/4122113-common-indicated-dividend-payments-rise-in-q2-driven-by-alphabets-initiation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9523624777793884
7/3/2024 7:21:43 PM,Johnson & Johnson receives Canadian approval for Rybrevant in first-line NSCLC,Seeking Alpha,https://seekingalpha.com/news/4122211-johnson-johnson-receives-canadian-approval-for-rybrevant-in-first-line-nsclc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.889198899269104
7/3/2024 7:32:59 PM,7 Blue-Chip Cash Cows to Milk for Steady Income,InvestorPlace,/news/stocks/7-blue-chip-cash-cows-to-milk-for-steady-income-1033527829,neutral,0.8842483758926392
7/4/2024 4:00:00 PM,Upcoming Stock Spinoffs: Should You Pounce or Pass?¬†,InvestorPlace,/news/stocks/upcoming-stock-spinoffs-should-you-pounce-or-pass-1033530130,neutral,0.7419286966323853
7/4/2024 6:13:23 PM,FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals,InvestorPlace,/news/stocks/fda-favorites-3-biotech-stocks-on-the-verge-of-major-approvals-1033530265,positive,0.4162515699863434
7/5/2024 3:32:01 PM,3 Dividend Aristocrats Now Cheaper Than During the 2008 Financial Crisis,InvestorPlace,/news/stocks/3-dividend-aristocrats-now-cheaper-than-during-the-2008-financial-crisis-1033532641,positive,0.6507638692855835
7/5/2024 5:43:24 PM,3 Rock-Solid Income Machines to Hold for Decades,InvestorPlace,/news/stocks/3-rock-solid-income-machines-to-hold-for-decades-1033532857,neutral,0.8576841354370117
7/8/2024 9:26:24 AM,Maintaining Hold on JNJ: Anticipated EPS Beat Offset by Medtech and Currency Challenges,TipRanks,/news/stocks/maintaining-hold-on-jnj-anticipated-eps-beat-offset-by-medtech-and-currency-challenges-1033535629,positive,0.9134267568588257
7/8/2024 10:45:00 AM,7 Diversified Income Powerhouses for Lifelong Cash Flow,InvestorPlace,/news/stocks/7-diversified-income-powerhouses-for-lifelong-cash-flow-1033535386,neutral,0.7933666706085205
7/8/2024 11:45:19 AM,Johnson & Johnson Q2 Outlook: Steady Growth Amid Challenges with a Hold Rating,TipRanks,/news/stocks/johnson-johnson-q2-outlook-steady-growth-amid-challenges-with-a-hold-rating-1033536453,positive,0.9492027759552002
7/8/2024 2:41:56 PM,Pulse stock rallies 22% on FDA breakthrough designation,Seeking Alpha,https://seekingalpha.com/news/4122631-pulse-stock-rallies-on-fda-breakthrough-designation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8892569541931152
7/9/2024 10:00:29 AM,"Emergent, J&J resolve dispute over COVID vaccine manufacturing deal",Seeking Alpha,https://seekingalpha.com/news/4122799-emergent-jj-resolve-dispute-over-covid-vaccine-manufacturing-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.48645517230033875
7/9/2024 8:53:43 PM,Johnson & Johnson Faces MedTech Challenges But Is 'On Track' To Meet 2024 Guidance: Goldman Sachs,Benzinga,/news/stocks/johnson-johnson-faces-medtech-challenges-but-is-on-track-to-meet-2024-guidance-goldman-sachs-1033540847,positive,0.5195904970169067
7/10/2024 10:37:55 AM,Wells Fargo Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/wells-fargo-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1033543393,neutral,0.8170982003211975
7/10/2024 11:00:00 AM,3 Undervalued Stocks Set to Outperform the Market in 2024,InvestorPlace,/news/stocks/3-undervalued-stocks-set-to-outperform-the-market-in-2024-1033542723,positive,0.859822154045105
7/11/2024 12:45:34 PM,Morgan Stanley Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/morgan-stanley-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1033548030,neutral,0.8109606504440308
7/11/2024 1:17:59 PM,J&J to recognize $1.25B impact from Yellow Jersey acquisition,Seeking Alpha,https://seekingalpha.com/news/4123663-jj-to-recognize-125b-impact-yellow-jersey-acquisition?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8527374863624573
7/12/2024 10:23:00 AM,3 Essential Stocks for Building a Recession-Proof Portfolio,InvestorPlace,/news/stocks/3-essential-stocks-for-building-a-recession-proof-portfolio-1033549924,neutral,0.8081364035606384
7/12/2024 11:05:58 AM,Stifel Nicolaus Remains a Hold on Johnson & Johnson (JNJ),TipRanks,/news/stocks/stifel-nicolaus-remains-a-hold-on-johnson-johnson-jnj-1033550894,neutral,0.7302681803703308
7/12/2024 6:50:39 PM,Legend Biotech surges amid takeover speculation (update),Seeking Alpha,https://seekingalpha.com/news/4124018-legend-biotech-surges-amid-takeover-speculation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7466819882392883
7/12/2024 7:00:29 PM,"Catalyst Watch: Netflix, Taiwan Semi, Amazon, and HashiCorp are in the spotlight",Seeking Alpha,https://seekingalpha.com/news/4123992-catalyst-watch-netflix-taiwan-semi-amazon-and-hashicorp-are-in-the-spotlight?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9270133972167969
7/13/2024 2:47:00 PM,Financial stocks deliver profits in Q2 amid rebound in investments - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4124042-wall-street-closes-higher-as-financials-stocks-deliver-profits-with-a-rebound-in-investments-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9113974571228027
7/13/2024 6:03:47 PM,"Morgan Stanley sees $180B patent cliff, $380B deal capacity fueling biopharma M&A",Seeking Alpha,https://seekingalpha.com/news/4124109-morgan-stanley-sees-180b-patent-cliff-380b-deal-capacity-fueling-biopharma-ma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8902467489242554
7/14/2024 12:00:00 PM,"Earnings week ahead: BAC, GS, JNJ, TSM, UNH, ABT, UAL, NFLX, AXP and more",Seeking Alpha,https://seekingalpha.com/news/4124006-earnings-week-ahead-bac-gs-jnj-tsm-unh-abt-ual-nflx-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9305751323699951
7/15/2024 9:45:47 AM,Hold Rating Maintained Amid Johnson & Johnson Acquisition and Foreign Exchange Concerns,TipRanks,/news/stocks/hold-rating-maintained-amid-johnson-johnson-acquisition-and-foreign-exchange-concerns-1033555232,negative,0.9361741542816162
7/15/2024 9:08:59 PM,Genmab upgraded at RBC on valuation,Seeking Alpha,https://seekingalpha.com/news/4124419-genmab-upgraded-rbc-valuation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8370265364646912
7/16/2024 10:13:10 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Envista Holdings (NVST), Johnson & Johnson (JNJ) and CVS Health (CVS)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-envista-holdings-nvst-johnson-johnson-jnj-and-cvs-health-cvs-1033559368,negative,0.8213568925857544
7/16/2024 10:15:00 AM,"If You Can Only Buy One Dow Stock in July, It Better Be One of These 3 Names",InvestorPlace,/news/stocks/if-you-can-only-buy-one-dow-stock-in-july-it-better-be-one-of-these-3-names-1033558594,neutral,0.9345142245292664
7/16/2024 2:35:17 PM,Johnson & Johnson Q2 Preview: Focus on SWAV deal implications and guidance,Seeking Alpha,https://seekingalpha.com/news/4124636-johnson-johnson-q2-preview-focus-on-swav-deal-implications-and-guidance?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9415112137794495
7/16/2024 3:01:13 PM,Johnson Johnson earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-quarter-earnings-preview-q2-1033559159,neutral,0.9340363144874573
7/16/2024 3:29:28 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/4124676-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8558874130249023
7/16/2024 6:46:17 PM,Johnson & Johnson: Bullish Charts Signal Strong Setup Before Q2 Earnings,Benzinga,/news/stocks/johnson-johnson-bullish-charts-signal-strong-setup-before-q2-earnings-1033560469,positive,0.933714747428894
7/16/2024 7:04:01 PM,3 Safe Dividend Kings to Recession-Proof Your Portfolio,InvestorPlace,/news/stocks/3-safe-dividend-kings-to-recession-proof-your-portfolio-1033560680,neutral,0.551302433013916
7/16/2024 9:07:10 PM,Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?,Benzinga,/news/stocks/johnson-johnson-q2-earnings-preview-can-new-drugs-lift-sagging-stock-1033560686,positive,0.8256781101226807
7/16/2024 9:59:38 PM,"ORIC collaborates with Bayer, J&J on prostate cancer study",Seeking Alpha,https://seekingalpha.com/news/4124823-oric-collaborates-with-bayer-jj-on-prostate-cancer-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8389740586280823
7/17/2024 5:26:18 AM,"ORIC Enters Into Clinical Trial Collaboration And Supply Agreements With Bayer
and J&J; Stock Up ",RTTNews,/news/stocks/oric-enters-into-clinical-trial-collaboration-and-supply-agreements-with-bayer-and-j-j-stock-up-1033561062,positive,0.7721460461616516
7/17/2024 10:22:07 AM,"Johnson & Johnson Non-GAAP EPS of $2.82 beats by $0.12, revenue of $22.4B beats by $60M",Seeking Alpha,https://seekingalpha.com/news/4124888-johnson-and-johnson-non-gaap-eps-of-2_82-beats-0_12-revenue-of-22_4b-beats-60m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7225979566574097
7/17/2024 10:29:46 AM,Johnson & Johnson declares $1.24 dividend,Seeking Alpha,https://seekingalpha.com/news/4124891-johnson-and-johnson-declares-1_24-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9268330335617065
7/17/2024 10:40:16 AM,"Earnings Summary: Johnson & Johnson tops consensus in Q2, updates FY2024 outlook",Seeking Alpha,https://seekingalpha.com/news/4124896-earnings-summary-johnson-johnson-tops-consensus-in-q2-updates-fy2024-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7132927775382996
7/17/2024 10:51:43 AM,"Johnson & Johnson in charts: Innovative Medicine, MedTech and total U.S. sales highest in Q2",Seeking Alpha,https://seekingalpha.com/news/4124903-johnson-johnson-in-charts-innovative-medicine-medtech-and-total-us-sales-highest-in-q2?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8125784397125244
7/17/2024 11:05:00 AM,3 Dividend Stocks With 3%+ Yields to Upgrade Your Annual Income,InvestorPlace,/news/stocks/3-dividend-stocks-with-3-yields-to-upgrade-your-annual-income-1033563483,neutral,0.711679220199585
7/17/2024 12:27:48 PM,"Johnson & Johnson Q2 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/johnson-johnson-q2-profit-decreases-but-beats-estimates-1033563319,negative,0.972167432308197
7/17/2024 1:17:00 PM,"4 stocks to watch on Wednesday: JNJ, UAL and more",Seeking Alpha,https://seekingalpha.com/news/4125011-4-stocks-to-watch-on-wednesday-jnj-ual-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9138116240501404
7/17/2024 1:47:03 PM,"Johnson & Johnson Q2 Adj. EPS Beats View, Cuts FY24 Earnings Forecast ",RTTNews,/news/stocks/johnson-johnson-q2-adj-eps-beats-view-cuts-fy24-earnings-forecast-1033563555,negative,0.7243626713752747
7/17/2024 1:52:11 PM,J&J beats in Q2 as pharma segment outperforms,Seeking Alpha,https://seekingalpha.com/news/4124925-jj-stock-focus-after-q2-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8718149662017822
7/17/2024 3:51:26 PM,"Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Elevance Health (ELV) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-crinetics-pharmaceuticals-crnx-elevance-health-elv-and-johnson-johnson-jnj-1033565293,neutral,0.9131537079811096
7/17/2024 6:09:20 PM,Big pharma rally after J&J earnings,Seeking Alpha,https://seekingalpha.com/news/4125149-big-pharma-rally-after-jj-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5109472274780273
7/17/2024 6:15:30 PM,Watchful Optimism: Balancing Johnson & Johnson‚Äôs Innovative Success and MedTech Challenges,TipRanks,/news/stocks/watchful-optimism-balancing-johnson-johnson-s-innovative-success-and-medtech-challenges-1033565874,neutral,0.633030354976654
7/17/2024 8:27:47 PM,Nasdaq 100 Suffers Worst Day In 11 Months As Chipmakers Tumble On China Curbs; Magnificent 7 Wipe Out $500B : What's Driving Markets Wednesday?,Benzinga,/news/etf/nasdaq-100-suffers-worst-day-in-11-months-as-chipmakers-tumble-on-china-curbs-magnificent-7-wipe-out-500b-what-s-driving-markets-wednesday-1033565208,negative,0.9158585071563721
7/17/2024 9:05:24 PM,Buy Rating Affirmed for Johnson & Johnson on Robust Q2 Performance and Strategic Growth Outlook,TipRanks,/news/stocks/buy-rating-affirmed-for-johnson-johnson-on-robust-q2-performance-and-strategic-growth-outlook-1033565943,positive,0.951103925704956
7/18/2024 12:37:17 AM,Positive Outlook: Joanne Wuensch Recommends ‚ÄòBuy‚Äô on Johnson & Johnson Amid Strong Q2 Performance and Promising Growth Prospects,TipRanks,/news/stocks/positive-outlook-joanne-wuensch-recommends-buy-on-johnson-johnson-amid-strong-q2-performance-and-promising-growth-prospects-1033566071,positive,0.9172462821006775
7/18/2024 12:38:52 AM,Maintaining Hold on Johnson & Johnson: Balancing MedTech Challenges with Pharmaceutical Strengths and Steady Long-Term Growth,TipRanks,/news/stocks/maintaining-hold-on-johnson-johnson-balancing-medtech-challenges-with-pharmaceutical-strengths-and-steady-long-term-growth-1033566064,positive,0.8863285779953003
7/18/2024 10:39:36 AM,Johnson & Johnson (JNJ) Gets a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-rbc-capital-1033568691,neutral,0.6571256518363953
7/18/2024 1:08:04 PM,Balanced Outlook for Johnson & Johnson: Hold Rating Amidst Growth and Challenges,TipRanks,/news/stocks/balanced-outlook-for-johnson-johnson-hold-rating-amidst-growth-and-challenges-1033569703,positive,0.5103445053100586
7/18/2024 1:08:41 PM,Johnson & Johnson (JNJ) Receives a Buy from Argus Research,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-argus-research-1033569698,neutral,0.49653974175453186
7/18/2024 1:45:20 PM,Maintaining Hold on Johnson & Johnson: A Balanced View Amidst Q2 Results and Future Challenges,TipRanks,/news/stocks/maintaining-hold-on-johnson-johnson-a-balanced-view-amidst-q2-results-and-future-challenges-1033569806,positive,0.5817448496818542
7/18/2024 2:36:47 PM,Microsoft To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Thursday,Benzinga,/news/stocks/microsoft-to-rally-around-12-here-are-10-top-analyst-forecasts-for-thursday-1033568315,neutral,0.9142047166824341
7/18/2024 3:00:00 PM,3 Blue-Chip Stocks to Buy If the Dow Crashes,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-if-the-dow-crashes-1033569354,neutral,0.9240256547927856
7/18/2024 3:34:12 PM,Med-tech and healthcare stocks with upside during 2Q earnings - Baird,Seeking Alpha,https://seekingalpha.com/news/4125556-med-tech-and-healthcare-stocks-with-upside-during-2q-earnings-baird?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8236992955207825
7/18/2024 6:09:15 PM,3 Dividend Stocks That Demand Investor Attention,InvestorPlace,/news/stocks/3-dividend-stocks-that-demand-investor-attention-1033569948,neutral,0.917388916015625
7/18/2024 6:12:41 PM,These Analysts Revise Their Forecasts On Johnson & Johnson After Q2 Results,Benzinga,/news/stocks/these-analysts-revise-their-forecasts-on-johnson-johnson-after-q2-results-1033569714,neutral,0.8847570419311523
7/18/2024 8:51:35 PM,"Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst",Benzinga,/news/stocks/johnson-johnson-prioritizes-sustainable-growth-in-m-a-amid-sector-diversification-says-analyst-1033569993,positive,0.9231750965118408
7/18/2024 9:52:22 PM,J&J ends work on Addex epilepsy drug candidate ADX71149: report,Seeking Alpha,https://seekingalpha.com/news/4125712-jj-ends-work-on-addex-epilepsy-drug-candidate-adx71149-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8010898232460022
7/19/2024 12:05:17 PM,"Dividend Roundup: Goldman Sachs, Johnson & Johnson, Qualcomm, Caterpillar, and more",Seeking Alpha,https://seekingalpha.com/news/4125792-dividend-roundup-goldman-sachs-johnson-johnson-qualcomm-caterpillar-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9485202431678772
7/19/2024 8:45:00 PM,7 Consumer Staples Stocks to Buy at a 52-Week Low in July,InvestorPlace,/news/stocks/7-consumer-staples-stocks-ready-for-sector-rotation-1033573603,negative,0.9345666766166687
7/19/2024 8:45:00 PM,3 Blue-Chip Stocks to Buy for Christmas in July,InvestorPlace,/news/stocks/blue-chip-stocks-to-buy-3-names-offering-a-gift-to-investors-1033573606,neutral,0.9014027118682861
7/21/2024 11:00:00 AM,Here are Big Pharma‚Äôs leading blockbuster makers,Seeking Alpha,https://seekingalpha.com/news/4126044-eli-lilly-astrazeneca-top-blockbuster-makers?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.773925244808197
7/22/2024 1:02:13 AM,Kamala Harris' potential impact on health care stocks,Seeking Alpha,https://seekingalpha.com/news/4126065-kamala-harris-potential-impact-health-care-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.49974900484085083
7/22/2024 5:45:56 AM,Buy Rating Affirmed for Johnson & Johnson on Strong Growth and Strategic Acquisitions,TipRanks,/news/stocks/buy-rating-affirmed-for-johnson-johnson-on-strong-growth-and-strategic-acquisitions-1033576818,positive,0.9514283537864685
7/22/2024 12:33:47 PM,Johnson & Johnson seeks FDA approval of Spravato as depression monotherapy,Seeking Alpha,https://seekingalpha.com/news/4126173-johnson-johnson-seeks-fda-approval-of-its-monotherapy-for-treatment-resistant-depression?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8449521660804749
7/22/2024 2:18:44 PM,Johnson & Johnson Seeks FDA Approval For SPRAVATO Nasal Spray For Treatment-Resistant Depression ,RTTNews,/news/stocks/johnson-johnson-seeks-fda-approval-for-spravato-nasal-spray-for-treatment-resistant-depression-1033577430,positive,0.9152528643608093
7/22/2024 3:34:24 PM,Alvotech launches first biosimilar of J&J's Stelara in Europe,Seeking Alpha,https://seekingalpha.com/news/4126333-alvotech-launches-first-biosimilar-of-johnson-johnson-stelara-europe?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6708689332008362
7/22/2024 7:11:56 PM,Oppenheimer starts ArriVent BioPharma at outperform,Seeking Alpha,https://seekingalpha.com/news/4126431-oppenheimer-starts-arrivent-biopharma-at-outperform?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6657834649085999
7/24/2024 5:06:57 PM,Bio-Thera biosimilar to J&J‚Äôs Stelara under FDA review,Seeking Alpha,https://seekingalpha.com/news/4127721-new-biosimilar-jjs-stelara-under-fda-review?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7594776153564453
7/24/2024 9:25:04 PM,Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation,Benzinga,/news/stocks/newly-listed-psoriasis-focused-alumis-attracts-analysts-attention-with-promising-lead-program-and-modest-valuation-1033590627,positive,0.9513866305351257
7/25/2024 11:45:00 AM,3 Beaten-Down Value Stocks Poised for a Massive Comeback: July 2024,InvestorPlace,/news/stocks/3-beaten-down-value-stocks-poised-for-a-massive-comeback-july-2024-1033594252,neutral,0.7219600081443787
7/25/2024 12:19:08 PM,AbbVie raises outlook as new immunology drugs offset Humira impact,Seeking Alpha,https://seekingalpha.com/news/4128262-abbvie-stock-in-focus-improved-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9508212208747864
7/25/2024 4:51:47 PM,AC Immune stock climbs 7% on FDA fast track status for Alzheimer's drug,Seeking Alpha,https://seekingalpha.com/news/4128487-ac-immune-stock-climbs-on-fda-fast-track-status-for-alzheimers-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9442577362060547
7/25/2024 7:19:00 PM,3 Stocks Reeling From Ruined Reputations: Can They Recover?,InvestorPlace,/news/stocks/3-stocks-reeling-from-ruined-reputations-can-they-recover-1033596326,negative,0.894749641418457
7/26/2024 2:31:45 AM,J&J talc bankruptcy plan appeal denied,Seeking Alpha,https://seekingalpha.com/news/4128759-johnson-johnson-talc-bankruptcy-plan-appeal-denied?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6504709720611572
7/26/2024 2:18:51 PM,Johnson & Johnson's Yuvanci Gets Positive CHMP Opinion In Europe For Pulmonary Arterial Hypertension ,RTTNews,/news/stocks/johnson-johnson-s-yuvanci-gets-positive-chmp-opinion-in-europe-for-pulmonary-arterial-hypertension-1033599993,positive,0.9511911273002625
7/26/2024 3:55:32 PM,J&J: CHMP Recommends RYBREVANT With Chemo To Treat Advanced EGFR-mutated NSCLC ,RTTNews,/news/stocks/j-j-chmp-recommends-rybrevant-with-chemo-to-treat-advanced-egfr-mutated-nsclc-1033600327,positive,0.8941521048545837
7/27/2024 4:00:00 PM,7 Long-Term Stocks to Buy on the Dip: July 2024,InvestorPlace,/news/stocks/7-long-term-stocks-that-may-lead-the-markets-next-move-higher-1033602115,neutral,0.9114879965782166
7/28/2024 2:00:00 PM,Most U.S. pharmas don't pay any U.S. income tax,Seeking Alpha,https://seekingalpha.com/news/4129257-most-us-pharmas-dont-pay-any-us-income-tax?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9261671304702759
7/30/2024 10:31:38 AM,Johnson & Johnson (JNJ) Receives a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-rbc-capital-1033612324,positive,0.49460798501968384
7/30/2024 10:34:26 AM,"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Sotera Health (SHC) and Hologic (HOLX)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-sotera-health-shc-and-hologic-holx-1033612314,negative,0.7883548736572266
7/30/2024 4:35:39 PM,Q3‚Äôs Rising Stars: 3 Dow Stocks for Your Must-Watch List,InvestorPlace,/news/stocks/q3s-rising-stars-3-dow-stocks-for-your-must-watch-list-1033613434,neutral,0.8960666060447693
7/30/2024 8:25:28 PM,Cantor Fitzgerald Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-johnson-johnson-jnj-1033614322,neutral,0.941351056098938
7/31/2024 5:34:24 AM,Johnson & Johnson : FDA Approves Darzalex Faspro Combination For Multiple Myeloma ,RTTNews,/news/stocks/johnson-johnson-fda-approves-darzalex-faspro-combination-for-multiple-myeloma-1033614529,positive,0.9072260856628418
7/31/2024 11:00:00 AM,Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?,InvestorPlace,/news/stocks/kazia-therapeutics-stock-is-kzia-a-buyout-candidate-in-the-making-1033617326,neutral,0.9267991185188293
7/31/2024 12:51:19 PM,J&J wins another FDA label expansion for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4131026-jj-wins-label-expansion-for-multiple-myeloma-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9137242436408997
7/31/2024 6:30:32 PM,7 Leading MedTech Stocks for Next-Gen Health Solutions,InvestorPlace,/news/stocks/7-leading-medtech-stocks-for-next-gen-health-solutions-1033620457,neutral,0.5478212237358093
8/1/2024 2:00:00 PM,Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore,InvestorPlace,/news/stocks/bargain-hunters-paradise-7-value-stocks-that-are-too-cheap-to-ignore-1033627397,neutral,0.9074240326881409
8/6/2024 10:17:00 AM,3 Dividend Growth Stocks to Accumulate on Dips: August Edition,InvestorPlace,/news/stocks/3-dividend-growth-stocks-to-accumulate-on-dips-august-edition-1033644207,neutral,0.47814393043518066
8/8/2024 11:00:00 AM,The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024,InvestorPlace,/news/stocks/the-3-best-dividend-aristocrats-to-buy-for-sustainable-income-august-2024-1033660107,neutral,0.9145475625991821
8/8/2024 11:35:39 AM,Maintaining Hold on J&J Amid Talc Litigation Developments and Settlement Prospects,TipRanks,/news/stocks/maintaining-hold-on-j-j-amid-talc-litigation-developments-and-settlement-prospects-1033661465,negative,0.7513934373855591
8/8/2024 6:46:23 PM,"J&J, Stryker among potential suitors for Nevro: Wolfe",Seeking Alpha,https://seekingalpha.com/news/4137462-nevro-stock-gains-wolfe-cites-buyout-potential?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9193214774131775
8/10/2024 12:13:27 PM,Gilead exits J&J royalty deal for liver drug ahead of potential FDA nod,Seeking Alpha,https://seekingalpha.com/news/4138389-gilead-exits-jj-royalty-deal-for-liver-drug-ahead-of-potential-fda-nod?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.45769262313842773
8/11/2024 2:27:02 PM,Johnson & Johnson (JNJ): An Undervalued Dividend King With Strong Financials,TipRanks,/news/stocks/johnson-johnson-jnj-an-undervalued-dividend-king-with-strong-financials-1033672043,positive,0.9504390358924866
8/12/2024 9:01:06 PM,J&J makes headway in settling talc baby powder litigation: reports,Seeking Alpha,https://seekingalpha.com/news/4138841-jnj-makes-headway-in-settling-talc-baby-powder-litigation-reports?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7629979252815247
8/13/2024 11:30:00 AM,3 Blue-Chip Stocks to Buy on the Dip: August 2024,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-on-the-dip-august-2024-1033681382,neutral,0.8941364884376526
8/13/2024 11:55:50 AM,Maintaining Hold on JNJ Amid Progress and Uncertainty in Talc Litigation,TipRanks,/news/stocks/maintaining-hold-on-jnj-amid-progress-and-uncertainty-in-talc-litigation-1033682808,negative,0.9061031937599182
8/13/2024 2:13:11 PM,Buy Rating Affirmed: Johnson & Johnson Nears Resolution of Talc Litigations,TipRanks,/news/stocks/buy-rating-affirmed-johnson-johnson-nears-resolution-of-talc-litigations-1033683489,negative,0.45365995168685913
8/14/2024 10:44:00 AM,7 Dependable Dividend Stocks for Long-Term Income,InvestorPlace,/news/stocks/7-dependable-dividend-stocks-for-long-term-income-1033687408,neutral,0.9273226261138916
8/14/2024 5:12:03 PM,J&J expected to declare voting support for talc bankruptcy plan as early as Friday,Seeking Alpha,https://seekingalpha.com/news/4139924-jnj-to-declare-win-talc-bankruptcy-plan-friday?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8929800391197205
8/15/2024 11:00:00 AM,7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024,InvestorPlace,/news/stocks/7-recession-resistant-stocks-to-hold-onto-for-dear-life-in-2024-1033694445,neutral,0.47594505548477173
8/15/2024 11:27:19 AM,U.S. government targets $6B in savings from first Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4140341-us-government-targets-6b-in-saving-from-first-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9052250981330872
8/15/2024 11:44:07 AM,U.S. announces final drug prices after Medicare negotiations,Seeking Alpha,https://seekingalpha.com/news/4140356-us-posts-final-drug-prices-medicare-talks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.802365779876709
8/17/2024 2:09:07 PM,Trending stocks this week as U.S. equities notch their best week of 2024,Seeking Alpha,https://seekingalpha.com/news/4141247-trending-stocks-this-week-as-us-equities-notch-their-best-week-of-2024?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7283952236175537
8/17/2024 6:00:44 PM,"J&J, Roche come out on top in S&P ratings of strongest pharma companies",Seeking Alpha,https://seekingalpha.com/news/4141255-johnson-johnson-roche-come-out-top-in-ratings-strongest-pharma-companies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8499217629432678
8/20/2024 11:30:03 AM,J&J‚Äôs chemotherapy-free drug combo wins FDA nod for advanced lung cancer,Seeking Alpha,https://seekingalpha.com/news/4141786-jjs-chemotherapy-free-drug-combo-wins-fda-nod-for-advanced-lung-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9194908738136292
8/20/2024 11:49:22 AM,J&J to acquire V-Wave for $600M upfront,Seeking Alpha,https://seekingalpha.com/news/4141793-jj-to-acquire-v-wave-for-600m-upfront?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9001185297966003
8/20/2024 1:51:45 PM,Johnson & Johnson's Chemotherapy-free Lung Cancer Treatment Rybrevant Plus Lazcluze Gets FDA Nod ,RTTNews,/news/stocks/johnson-johnson-s-chemotherapy-free-lung-cancer-treatment-rybrevant-plus-lazcluze-gets-fda-nod-1033706946,positive,0.7813289165496826
8/20/2024 2:09:23 PM,Johnson & Johnson To Acquire V-Wave For Initial Payment Of $600 Mln ,RTTNews,/news/stocks/johnson-johnson-to-acquire-v-wave-for-initial-payment-of-600-mln-1033707027,neutral,0.8983799815177917
8/20/2024 6:07:51 PM,"FTC says FDA biosimilar guidance would increase competition, lead to lower prices",Seeking Alpha,https://seekingalpha.com/news/4142026-ftc-says-fda-biosimilar-guidance-would-increase-competition-lead-lower-prices?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5784018635749817
8/23/2024 12:27:22 PM,"Dividend Roundup: Johnson & Johnson, Hyatt, Northrop Grumman, Altria Group, and more",Seeking Alpha,https://seekingalpha.com/news/4143257-dividend-roundup-johnson-johnson-hyatt-northrop-grumman-altria-group-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.944361686706543
8/23/2024 2:51:56 PM,Janssen-Cilag's Balversa Gets EC Approval For Metastatic Urothelial Carcinoma ,RTTNews,/news/stocks/janssen-cilag-s-balversa-gets-ec-approval-for-metastatic-urothelial-carcinoma-1033718013,positive,0.9254757165908813
8/23/2024 7:00:25 PM,J&J faces backlash from hospitals after revised drug-discount program: WSJ,Seeking Alpha,https://seekingalpha.com/news/4143479-jjs-drug-discount-program-criticized-hospitals?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9477693438529968
8/23/2024 7:43:10 PM,J&J reportedly seeking additional support for talc bankruptcy plan,Seeking Alpha,https://seekingalpha.com/news/4143484-jj-additional-support-talc-bankruptcy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8365818858146667
8/23/2024 8:12:11 PM,Johnson & Johnson continues gains for eight straight sessions,Seeking Alpha,https://seekingalpha.com/news/4143475-johnson-johnson-continues-gains-for-eight-straight-sessions?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9220125079154968
8/25/2024 5:57:37 AM,"Weekly Biotech Buzz: AADI Trims R&D Jobs, JNJ Loosens Purse Strings, FDA Snubs REGN's Myeloma Drug ",RTTNews,/news/stocks/weekly-biotech-buzz-aadi-trims-r-d-jobs-jnj-loosens-purse-strings-fda-snubs-regn-s-myeloma-drug-1033719571,negative,0.8108912706375122
8/27/2024 3:28:46 PM,Addex stock rallies 45% on Indivior collaboration update,Seeking Alpha,https://seekingalpha.com/news/4144187-addex-stock-rallies-on-indivior-collaboration-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8646686673164368
8/29/2024 10:26:46 AM,"New Medicare drug price caps could help seniors save over $1,000 a year - AARP",Seeking Alpha,https://seekingalpha.com/news/4144962-new-medicare-drug-price-caps-could-help-seniors-save-over-1000-a-year-aarp?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8434955477714539
8/29/2024 2:43:09 PM,J&J Files For FDA Approval Of Nipocalimab To Treat Generalized Myasthenia Gravis ,RTTNews,/news/stocks/j-j-files-for-fda-approval-of-nipocalimab-to-treat-generalized-myasthenia-gravis-1033732590,positive,0.821338951587677
8/29/2024 3:49:40 PM,J&J submits FDA application for myasthenia gravis drug nipocalimab,Seeking Alpha,https://seekingalpha.com/news/4145151-jj-submits-fda-application-for-myasthenia-gravis-drug-nipocalimab?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7476667165756226
9/1/2024 7:26:06 PM,"Weekly Biotech Buzz: BMRN Cuts Jobs, FDA Approves New Mpox Vaccine, MRK Halts 2 Keytruda Studies ",RTTNews,/news/stocks/weekly-biotech-buzz-bmrn-cuts-jobs-fda-approves-new-mpox-vaccine-mrk-halts-2-keytruda-studies-1033738673,negative,0.7506174445152283
9/3/2024 11:48:43 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1033744314,neutral,0.5040143728256226
9/3/2024 7:29:35 PM,Keros gains after trial update on lung disorder therapy,Seeking Alpha,https://seekingalpha.com/news/4146385-keros-stock-gains-trial-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.39402759075164795
9/4/2024 3:30:13 PM,"J&J owes over $1B in damages related to 2019 Auris deal, judge rules",Seeking Alpha,https://seekingalpha.com/news/4146914-jj-owes-over-1b-linked-auris-deal-judge-rules?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7210614085197449
9/4/2024 8:47:30 PM,J&J talc powder settlement backed by key attorney: report,Seeking Alpha,https://seekingalpha.com/news/4147074-jj-talc-powder-settlement-backed-by-key-attorney-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9013357162475586
9/5/2024 6:07:36 PM,Cigna to offer biosimilar to J&J‚Äôs arthritis drug Stelara at $0 out-of-pocket,Seeking Alpha,https://seekingalpha.com/news/4147414-cigna-touts-biosimilar-jj-arthritis-drug-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7320737838745117
9/6/2024 10:37:24 AM,Balancing Growth and Challenges: A Hold Rating for Johnson & Johnson‚Äôs Medtech Division Amidst China Headwinds,TipRanks,/news/stocks/balancing-growth-and-challenges-a-hold-rating-for-johnson-johnson-s-medtech-division-amidst-china-headwinds-1033753866,positive,0.7720273733139038
9/6/2024 7:00:22 PM,"Catalyst Watch: Apple's iPhone event, Oracle earnings, Google antitrust trial, and the August CPI print",Seeking Alpha,https://seekingalpha.com/news/4147709-catalyst-watch-apples-iphone-event-oracle-earnings-google-antitrust-trial-and-the-august-cpi-print?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7490692734718323
9/9/2024 3:06:44 AM,J&J : Phase 3 Data Show RYBREVANT + LAZCLUZE Outperforms Osimertinib In Non-small Cell Lung Cancer ,RTTNews,/news/stocks/j-j-phase-3-data-show-rybrevant-lazcluze-outperforms-osimertinib-in-non-small-cell-lung-cancer-1033755629,positive,0.9441449642181396
9/9/2024 12:25:43 PM,Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1033758084,neutral,0.8271589279174805
9/9/2024 5:25:27 PM,J&J Rybrevant/Lazcluze study shows superiority over Tagrisso,Seeking Alpha,https://seekingalpha.com/news/4148096-jj-rybrevant-lazcluze-study-shows-superiority-over-tagrisso?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9234210252761841
9/10/2024 10:56:30 PM,16 new GLP-1 weight-loss drugs could be launched by 2029: report,Seeking Alpha,https://seekingalpha.com/news/4148522-16-new-glp-1-weight-loss-drugs-could-be-launched-by-2029-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8558949828147888
9/11/2024 5:39:36 AM,J&J's Dexamethasone Regimen Reduces Infusion Reactions In EGFR-Mutated NSCLC Patients On RYBREVANT ,RTTNews,/news/stocks/j-j-s-dexamethasone-regimen-reduces-infusion-reactions-in-egfr-mutated-nsclc-patients-on-rybrevant-1033762197,positive,0.8002285361289978
9/11/2024 1:56:19 PM,J&J mid-stage trial for lung cancer drug Rybrevant hits main goal,Seeking Alpha,https://seekingalpha.com/news/4148686-jj-trial-lung-cancer-drug-rybrevant-succeeds?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5891919136047363
9/11/2024 8:55:28 PM,Wells Fargo Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/wells-fargo-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1033765212,neutral,0.837287187576294
9/12/2024 3:01:10 AM,J&J's TREMFYA Receives FDA Approval For Moderately To Severely Active Ulcerative Colitis In Adults ,RTTNews,/news/stocks/j-j-s-tremfya-receives-fda-approval-for-moderately-to-severely-active-ulcerative-colitis-in-adults-1033765228,positive,0.9439395666122437
9/12/2024 10:52:10 AM,J&J Tremfya label expanded in the U.S. for inflammatory bowel disease,Seeking Alpha,https://seekingalpha.com/news/4148926-jj-tremfya-us-label-expanded-bowel-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7951902151107788
9/12/2024 3:48:46 PM,Janssen-Cilag Announces First EMA Submission For Nipocalimab - Quick Facts ,RTTNews,/news/stocks/janssen-cilag-announces-first-ema-submission-for-nipocalimab-quick-facts-1033767160,neutral,0.8568757772445679
9/12/2024 4:28:27 PM,JNJ submits application to EMA for nipocalimab for generalized myasthenia gravis,Seeking Alpha,https://seekingalpha.com/news/4149162-johnson-johnson-submits-application-ema-nipocalimab-generalized-myasthenia-gravis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.77645343542099
9/14/2024 9:54:37 AM,J&J: RYBREVANT + Chemotherapy Shows Strong Benefits And Improved Survival In Phase 3 NSCLC Trial ,RTTNews,/news/stocks/j-j-rybrevant-chemotherapy-shows-strong-benefits-and-improved-survival-in-phase-3-nsclc-trial-1033771563,positive,0.957048237323761
9/14/2024 4:39:16 PM,J&J Announces Promising Phase 1b/2 Data For Amivantamab Combination In Metastatic Colorectal Cancer ,RTTNews,/news/stocks/j-j-announces-promising-phase-1b-2-data-for-amivantamab-combination-in-metastatic-colorectal-cancer-1033771648,positive,0.9336089491844177
9/14/2024 7:37:59 PM,J&J leads H1 healthcare deals as Big Pharma dealmaking returns: report,Seeking Alpha,https://seekingalpha.com/news/4149797-jj-leads-h1-2024-healthcare-dealmaking?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.91567063331604
9/15/2024 10:15:01 AM,J&J's TAR-200 Phase 2b SunRISe-1 Study Shows 84% Complete Response In High-Risk Bladder Cancer ,RTTNews,/news/stocks/j-j-s-tar-200-phase-2b-sunrise-1-study-shows-84-complete-response-in-high-risk-bladder-cancer-1033771793,positive,0.8650372624397278
9/15/2024 2:07:52 PM,Do queasy side effects mean the end of weight-loss drug stock hype?,Seeking Alpha,https://seekingalpha.com/news/4149819-do-nauseating-side-effects-mean-the-end-of-weight-loss-drug-stock-hype?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6545577645301819
9/16/2024 9:33:31 AM,Johnson & Johnson Reports Promising Interim Data From Phase 2 SunRISe-4 Study ,RTTNews,/news/stocks/johnson-johnson-reports-promising-interim-data-from-phase-2-sunrise-4-study-1033772973,positive,0.9425020217895508
9/16/2024 4:46:07 PM,CG Oncology surges 7%; seen benefitting from J&J bladder cancer asset data,Seeking Alpha,https://seekingalpha.com/news/4150038-cg-oncology-surges-7-seen-benefitting-from-johnson-johnson-bladder-cancer-asset-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9475256204605103
9/16/2024 4:54:08 PM,Edwards Lifesciences gains amid takeover speculation,Seeking Alpha,https://seekingalpha.com/news/4150042-edwards-lifesciences-gains-amid-takeover-speculation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8644942045211792
9/18/2024 10:36:38 AM,Citi Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/citi-keeps-their-buy-rating-on-johnson-johnson-jnj-1033780374,neutral,0.9060527682304382
9/18/2024 8:18:20 PM,BeiGene initiated at outperform at JMP Securities on strength of Brukinsa,Seeking Alpha,https://seekingalpha.com/news/4150909-beigene-initiated-outperform-jmp-securities-strength-brukinsa?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.905013382434845
9/19/2024 11:50:20 AM,Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Progyny (PGNY),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-and-progyny-pgny-1033784078,neutral,0.9127684831619263
9/20/2024 2:47:43 AM,FDA Okays J&J's RYBREVANT For Advanced Non-Small Cell Lung Cancer In Combination With Chemotherapy ,RTTNews,/news/stocks/fda-okays-j-j-s-rybrevant-for-advanced-non-small-cell-lung-cancer-in-combination-with-chemotherapy-1033784908,positive,0.5209254622459412
9/20/2024 7:10:29 AM,J&J said to boost offer to settle baby powder lawsuits to over $8.2B,Seeking Alpha,https://seekingalpha.com/news/4151443-johnson-johnson-settlement-offer-baby-powder-lawsuits?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9422388076782227
9/20/2024 10:47:13 AM,Johnson & Johnson (JNJ) Gets a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-rbc-capital-1033786632,neutral,0.6571256518363953
9/20/2024 2:04:14 PM,Janssen-Cilag Reports CHMP Recommendation For Daratumumab - Quick Facts ,RTTNews,/news/stocks/janssen-cilag-reports-chmp-recommendation-for-daratumumab-quick-facts-1033786211,neutral,0.7960816025733948
9/20/2024 8:07:36 PM,Johnson & Johnson unit seeks third Chapter 11 bankruptcy filing to settle talc claims,Seeking Alpha,https://seekingalpha.com/news/4151707-johnson-johnson-unit-seeks-third-chapter-11-bankruptcy-filing-settle-talc-claims?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7654343843460083
9/20/2024 8:43:49 PM,Sanofi Sarclisa combo gains approval as first-line multiple myeloma treatment,Seeking Alpha,https://seekingalpha.com/news/4151719-sanofi-sarclisa-combo-gains-approval-first-line-multiple-myeloma-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.950284481048584
9/21/2024 7:21:32 AM,J&J's Subsidiary Red River Talc Files For Chapter 11 Bankruptcy To Resolve Ovarian Cancer Claims ,RTTNews,/news/stocks/j-j-s-subsidiary-red-river-talc-files-for-chapter-11-bankruptcy-to-resolve-ovarian-cancer-claims-1033787796,negative,0.8271332383155823
9/21/2024 8:00:07 PM,Novartis' Pluvicto expected to dominate prostate cancer radiopharmaceutical market,Seeking Alpha,https://seekingalpha.com/news/4151752-novartis-pluvicto-expected-dominate-prostate-cancer-radiopharmaceutical-market?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6771222352981567
9/23/2024 7:17:40 PM,UCB gets expanded FDA approval for psoriasis drug Bimzelx,Seeking Alpha,https://seekingalpha.com/news/4152277-ucb-gets-expanded-fda-approval-for-psoriasis-drug-bimzelx?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9338517189025879
9/24/2024 9:10:15 AM,Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-and-johnson-johnson-jnj-1033793366,neutral,0.9118403196334839
9/24/2024 4:49:21 PM,J&J unit third bankruptcy attempt location to be determined by Texas judge,Seeking Alpha,https://seekingalpha.com/news/4152793-johnson-johnson-unit-third-bankruptcy-attempt-location-determined-texas-judge?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9387897849082947
9/25/2024 8:45:35 AM,Strategic Legal Maneuvers Brighten Johnson & Johnson‚Äôs Financial Outlook Amid Talc Litigation,TipRanks,/news/stocks/strategic-legal-maneuvers-brighten-johnson-johnson-s-financial-outlook-amid-talc-litigation-1033796491,positive,0.9263923764228821
9/25/2024 10:49:50 AM,"Bristol Myers, 2seventy bio halt enrollment in Abecma late-stage trial",Seeking Alpha,https://seekingalpha.com/news/4153004-bristol-myers-2seventy-bio-halt-abecma-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7534785270690918
9/26/2024 2:27:34 PM,"J&J to shutter cardiovascular, metabolic drug unit: report",Seeking Alpha,https://seekingalpha.com/news/4153734-jj-to-shutter-cardiovascular-metabolic-drug-unit-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7109410166740417
9/26/2024 8:01:55 PM,J&J snaps six straight sessions of losses,Seeking Alpha,https://seekingalpha.com/news/4153849-jj-snaps-six-straight-sessions-of-losses?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8909398913383484
9/27/2024 2:30:36 PM,J&J Reports Data From Investigational Phase 1b RedirecTT-1 Study - Quick Facts ,RTTNews,/news/stocks/j-j-reports-data-from-investigational-phase-1b-redirectt-1-study-quick-facts-1033803603,neutral,0.9308199286460876
9/27/2024 2:48:53 PM,Johnson & Johnson Reports New Data From Phase 1b TRIMM-2 Study ,RTTNews,/news/stocks/johnson-johnson-reports-new-data-from-phase-1b-trimm-2-study-1033803657,neutral,0.9100855588912964
9/27/2024 5:59:43 PM,"Bristol Cobenfy approval draws optimism from Street, though with caveats",Seeking Alpha,https://seekingalpha.com/news/4154179-bristol-cobenfy-approval-draws-optimism-from-street-though-with-caveats?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8621546030044556
9/27/2024 8:42:26 PM,J&J releases encouraging data on Talvey combination therapies,Seeking Alpha,https://seekingalpha.com/news/4154260-jj-releases-encouraging-data-on-talvey-combination-therapies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.943537712097168
9/27/2024 9:18:34 PM,"J&J, Legend report Carvykti cut death risk by 45% in multiple myeloma study",Seeking Alpha,https://seekingalpha.com/news/4154285-jj-legend-report-carvykti-cut-death-risk-by-45-in-multiple-myeloma-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.95103520154953
9/27/2024 10:26:45 PM,Johnson & Johnson Says Darzalex Regimens Show Meaningful Responses In Patients With Multiple Myeloma ,RTTNews,/news/stocks/johnson-johnson-says-darzalex-regimens-show-meaningful-responses-in-patients-with-multiple-myeloma-1033804874,positive,0.9517240524291992
9/28/2024 8:14:19 AM,J&J : Phase 3 Trial Results Show CARVYKTI Extends Overall Survival In Relapsed Multiple Myeloma ,RTTNews,/news/stocks/j-j-phase-3-trial-results-show-carvykti-extends-overall-survival-in-relapsed-multiple-myeloma-1033805058,positive,0.9528326392173767
9/28/2024 9:01:55 AM,J&J : DARZALEX FASPRO Quadruplet Regimen Improves MRD Negativity In Newly Diagnosed Multiple Myeloma ,RTTNews,/news/stocks/j-j-darzalex-faspro-quadruplet-regimen-improves-mrd-negativity-in-newly-diagnosed-multiple-myeloma-1033805065,positive,0.9408559799194336
9/28/2024 5:06:10 PM,Here are the Medicare Part D drugs expected to face 2025 price negotiations,Seeking Alpha,https://seekingalpha.com/news/4154318-these-medicare-drugs-set-to-face-2025-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9413639307022095
9/30/2024 12:15:10 PM,Cantor Fitzgerald Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-johnson-johnson-jnj-1033808278,neutral,0.941351056098938
9/30/2024 3:04:44 PM,Johnson & Johnson Expands Roll-out Of TECNIS Odyssey IOL - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-expands-roll-out-of-tecnis-odyssey-iol-quick-facts-1033807447,neutral,0.7847442030906677
9/30/2024 8:42:43 PM,J&J submits supplemental BLA for Darzalex Faspro to FDA,Seeking Alpha,https://seekingalpha.com/news/4154769-jj-submits-supplemental-bla-for-darzalex-faspro-to-fda?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.940132200717926
10/1/2024 8:38:43 AM,Hold Rating on Johnson & Johnson Amid Market Potential and Competitive Positioning Analysis,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-market-potential-and-competitive-positioning-analysis-1033810782,positive,0.8160616159439087
10/1/2024 7:35:29 PM,U.S. port strike expected to have limited impact on healthcare supply chain: HHS,Seeking Alpha,https://seekingalpha.com/news/4155196-us-port-strike-have-limited-impact-medical-supplies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9400644898414612
10/2/2024 10:42:51 AM,J&J to invest over $2B to build new North Carolina plant,Seeking Alpha,https://seekingalpha.com/news/4155360-johnson-johnson-builds-2b-north-carolina-plant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7378947138786316
10/2/2024 2:07:42 PM,J&J prostate cancer therapy outperforms in real-world study,Seeking Alpha,https://seekingalpha.com/news/4155516-jj-prostate-cancer-therapy-outperforms-in-real-world-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8590226769447327
10/2/2024 4:31:17 PM,JNJ's Erleada Shows Statistically Significant Overall Survival In Metastatic Prostate Cancer ,RTTNews,/news/stocks/jnj-s-erleada-shows-statistically-significant-overall-survival-in-metastatic-prostate-cancer-1033815796,positive,0.9453341364860535
10/3/2024 12:02:11 PM,U.S. tweaks 2025 Medicare price negotiation process,Seeking Alpha,https://seekingalpha.com/news/4155891-us-tweaks-2025-medicare-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.782494068145752
10/4/2024 8:30:19 AM,"Analysts Conflicted on These Healthcare Names: LivaNova (LIVN), Johnson & Johnson (JNJ) and Avidity Biosciences (RNA)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-livanova-livn-johnson-johnson-jnj-and-avidity-biosciences-rna-1033820918,negative,0.6177178025245667
10/4/2024 9:33:39 AM,DBS Remains a Hold on Johnson & Johnson (JNJ),TipRanks,/news/stocks/dbs-remains-a-hold-on-johnson-johnson-jnj-1033821117,neutral,0.8509404063224792
10/4/2024 1:28:54 PM,Johnson & Johnson halts mid-stage study for dengue antiviral,Seeking Alpha,https://seekingalpha.com/news/4156465-johnson--johnson-halts-dengue-antiviral-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9374709129333496
10/4/2024 4:55:00 PM,JNJ To Terminate Phase 2 Field Study Of Mosnodenvir For Prevention Of Dengue Virus ,RTTNews,/news/stocks/jnj-to-terminate-phase-2-field-study-of-mosnodenvir-for-prevention-of-dengue-virus-1033821767,neutral,0.5871692299842834
10/7/2024 9:04:58 PM,J&J discontinues Phase 2 study for bladder cancer drug TAR-200,Seeking Alpha,https://seekingalpha.com/news/4156861-jj-discontinues-phase-2-study-for-bladder-cancer-drug-tar-200?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7050848603248596
10/8/2024 12:15:50 PM,Johnson & Johnson: Hold Rating Affirmed Amid Balanced Growth and Caution,TipRanks,/news/stocks/johnson-johnson-hold-rating-affirmed-amid-balanced-growth-and-caution-1033828860,positive,0.9525770545005798
10/8/2024 6:03:33 PM,Harris home health care benefit likely funded through Medicare drug negotiations savings,Seeking Alpha,https://seekingalpha.com/news/4157079-harris-home-health-care-benefit-could-funded-through-medicare-drug-negotiations-savings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8432393074035645
10/9/2024 12:26:28 PM,"J&J closes V-Wave deal, to incur IPR&D charge of $600M in Q4",Seeking Alpha,https://seekingalpha.com/news/4157237-jj-closes-v-wave-deal-to-incur-iprd-charge-of-600m-in-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.660377025604248
10/9/2024 2:32:12 PM,Johnson & Johnson Buys Privately-held V-Wave; Sees In-process R&D Charge Of Around $600 Mln In Q4 ,RTTNews,/news/stocks/johnson-johnson-buys-privately-held-v-wave-sees-in-process-r-d-charge-of-around-600-mln-in-q4-1033831535,positive,0.8456785082817078
10/10/2024 2:47:06 AM,Maintaining Buy Rating on Johnson & Johnson: Promising Pipeline and Financial Prospects Despite Clinical Setback,TipRanks,/news/stocks/maintaining-buy-rating-on-johnson-johnson-promising-pipeline-and-financial-prospects-despite-clinical-setback-1033834010,positive,0.9514312744140625
10/10/2024 9:26:21 AM,Johnson & Johnson: Hold Rating Justified by Subdued EPS Growth and Margin Pressures,TipRanks,/news/stocks/johnson-johnson-hold-rating-justified-by-subdued-eps-growth-and-margin-pressures-1033835260,positive,0.6891891360282898
10/10/2024 1:58:11 PM,J&J Submits For EMA Approval For DARZALEX SC Quadruplet Regimen In Newly Diagnosed Multiple Myeloma ,RTTNews,/news/stocks/j-j-submits-for-ema-approval-for-darzalex-sc-quadruplet-regimen-in-newly-diagnosed-multiple-myeloma-1033835175,positive,0.661032497882843
10/10/2024 3:12:01 PM,J&J Says TREMFYA Showed Strong Results In Biologic-Naive & Refractory Patients With CD And UC ,RTTNews,/news/stocks/j-j-says-tremfya-showed-strong-results-in-biologic-naive-refractory-patients-with-cd-and-uc-1033835517,positive,0.9552667140960693
10/11/2024 12:36:35 PM,Johnson & Johnson (JNJ) Gets a Hold from Morgan Stanley,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-hold-from-morgan-stanley-1033839274,neutral,0.8277878165245056
10/11/2024 2:04:36 PM,Texas court rules J&J didn't skirt bankruptcy rules in talc case: report,Seeking Alpha,https://seekingalpha.com/news/4157903-texas-court-rules-jj-didnt-skirt-bankruptcy-rules-in-talc-case-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8444399237632751
10/11/2024 7:00:23 PM,"Catalyst Watch: Netflix earnings, Lenovo tech event, Paris Motor Show, and eyes on oil",Seeking Alpha,https://seekingalpha.com/news/4157956-catalyst-watch-netflix-earnings-lenovo-tech-event-paris-motor-show-and-eyes-on-oil?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9386246800422668
10/13/2024 12:00:00 PM,"Earnings week ahead: BAC, GS, JNJ, TSM, UNH, ABT, UAL, NFLX, PG, AXP and more",Seeking Alpha,https://seekingalpha.com/news/4157923-earnings-week-ahead-bac-gs-jnj-tsm-unh-abt-ual-nflx-pg-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9303746819496155
10/14/2024 2:37:06 PM,Lilly reports positive data for Omvoh versus Stelara in Crohn's,Seeking Alpha,https://seekingalpha.com/news/4158237-lilly-reports-positive-data-for-omvoh-versus-stelara-in-crohns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.922605037689209
10/14/2024 2:42:56 PM,Earnings Scorecard: 7 out of 8 S&P 500 companies deliver EPS wins this week,Seeking Alpha,https://seekingalpha.com/news/4157977-7-out-of-8-sp-500-companies-deliver-eps-wins-this-week?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8163104057312012
10/14/2024 5:51:54 PM,Johnson & Johnson Q3 Preview: Decline in profit is in the cards,Seeking Alpha,https://seekingalpha.com/news/4158319-johnson-johnson-q3-preview-decline-in-profit-is-in-the-cards?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9737696647644043
10/14/2024 10:00:09 PM,Here's the major earnings before the open tomorrow,Seeking Alpha,https://seekingalpha.com/news/4158228-heres-the-major-earnings-before-the-open-tomorrow?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9330109357833862
10/15/2024 9:27:16 AM,Johnson & Johnson: Navigating Pharmaceutical Opportunities and Patent Challenges ‚Äì A Hold Rating Analysis,TipRanks,/news/stocks/johnson-johnson-navigating-pharmaceutical-opportunities-and-patent-challenges-‚Äì-a-hold-rating-analysis-1033846642,neutral,0.7757490277290344
10/15/2024 10:21:20 AM,"Johnson & Johnson Non-GAAP EPS of $2.42 beats by $0.21, revenue of $22.5B beats by $330M",Seeking Alpha,https://seekingalpha.com/news/4159016-johnson-and-johnson-non-gaap-eps-of-2_42-beats-0_21-revenue-of-22_5b-beats-330m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6936332583427429
10/15/2024 10:31:13 AM,Johnson & Johnson declares $1.24 dividend,Seeking Alpha,https://seekingalpha.com/news/4159095-johnson-and-johnson-declares-1_24-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9268330335617065
10/15/2024 10:37:10 AM,Johnson & Johnson in charts: Innovative Medicine recorded highest sales in Q3,Seeking Alpha,https://seekingalpha.com/news/4159099-johnson-johnson-in-charts-innovative-medicine-recorded-highest-sales-in-q3?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9165863394737244
10/15/2024 10:39:55 AM,Earnings Snapshot: Johnson & Johnson tops Q3 estimates as Darzalex sales surge; raises FY24 sales outlook,Seeking Alpha,https://seekingalpha.com/news/4159101-earnings-snapshot-johnson-johnson-tops-q3-estimates-as-darzalex-sales-surge?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9296291470527649
10/15/2024 10:39:55 AM,Earnings Snapshot: Johnson & Johnson tops Q3 estimates as Darzalex sales surge; raises FY24 sales outlook,Seeking Alpha,https://seekingalpha.com/news/4159101-earnings-snapshot-johnson-johnson-tops-q3-estimates-as-darzalex-sales-surge-raises-fy24-sales-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9296291470527649
10/15/2024 12:27:41 PM,"Johnson & Johnson Q3 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/johnson-johnson-q3-profit-decreases-but-beats-estimates-1033846024,negative,0.9718165993690491
10/15/2024 12:45:15 PM,Johnson & Johnson Hold Rating: Strong Pharma Gains Offset by MedTech Challenges and Acquisition Costs,TipRanks,/news/stocks/johnson-johnson-hold-rating-strong-pharma-gains-offset-by-medtech-challenges-and-acquisition-costs-1033847669,positive,0.9505274295806885
10/15/2024 12:53:22 PM,Johnson & Johnson posts Q3 beat; lowers earnings guidance amid M&A impact,Seeking Alpha,https://seekingalpha.com/news/4159512-jnj-stock-falls-amid-cut-to-earnings-guidance?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9698029160499573
10/15/2024 1:11:42 PM,"Johnson & Johnson Cuts FY24 Earnings View, Lifts Sales Forecast - Update ",RTTNews,/news/stocks/johnson-johnson-cuts-fy24-earnings-view-lifts-sales-forecast-update-1033846179,negative,0.9088245630264282
10/15/2024 1:18:00 PM,"4 stocks to watch on Tuesday: BAC, JNJ and more",Seeking Alpha,https://seekingalpha.com/news/4160035-4-stocks-to-watch-on-tuesday-bac-jnj-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9166877865791321
10/15/2024 5:09:53 PM,JNJ releases positive data on nipocalimab for myasthenia gravis in adolescents,Seeking Alpha,https://seekingalpha.com/news/4161434-jnj-releases-positive-data-nipocalimab-myasthenia-gravis-adolescents?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9245691895484924
10/15/2024 6:45:09 PM,"Johnson & Johnson: Strong Performance Yet Fairly Priced, Leading to Hold Rating",TipRanks,/news/stocks/johnson-johnson-strong-performance-yet-fairly-priced-leading-to-hold-rating-1033848306,negative,0.8912836313247681
10/15/2024 8:25:11 PM,Johnson & Johnson: Strong Q3 Performance and Upward Sales Guidance Bolster Buy Rating,TipRanks,/news/stocks/johnson-johnson-strong-q3-performance-and-upward-sales-guidance-bolster-buy-rating-1033848374,positive,0.9563630223274231
10/15/2024 11:55:13 PM,Johnson & Johnson: Balancing Growth Potential with Market Challenges and Legal Risks,TipRanks,/news/stocks/johnson-johnson-balancing-growth-potential-with-market-challenges-and-legal-risks-1033848437,positive,0.5840330719947815
10/15/2024 11:56:34 PM,Hold Rating Maintained for Johnson & Johnson Amid Mixed Sector Performance and EPS Guidance Concerns,TipRanks,/news/stocks/hold-rating-maintained-for-johnson-johnson-amid-mixed-sector-performance-and-eps-guidance-concerns-1033848428,negative,0.8926296830177307
10/15/2024 11:57:07 PM,Hold Rating for Johnson & Johnson Amid 2024 Growth Deceleration and 2025 Optimism,TipRanks,/news/stocks/hold-rating-for-johnson-johnson-amid-2024-growth-deceleration-and-2025-optimism-1033848461,neutral,0.6979522109031677
10/16/2024 10:45:51 AM,Johnson & Johnson (JNJ) Gets a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-rbc-capital-1033851665,neutral,0.6571256518363953
10/16/2024 11:26:25 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1033852068,neutral,0.5040143728256226
10/16/2024 12:25:29 PM,Johnson & Johnson‚Äôs Growth Potential Highlighted by Strong Q3 Earnings and Promising Pipeline,TipRanks,/news/stocks/johnson-johnson-s-growth-potential-highlighted-by-strong-q3-earnings-and-promising-pipeline-1033852299,positive,0.953405499458313
10/16/2024 4:21:34 PM,Least shorted S&P 500 stocks in September,Seeking Alpha,https://seekingalpha.com/news/4166027-least-shorted-sp-500-stocks-in-september?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6412549018859863
10/18/2024 7:37:15 PM,Tyra raised to buy by BofA ahead of TYRA-300 data readout,Seeking Alpha,https://seekingalpha.com/news/4176885-tyra-raised-to-buy-by-bofa-ahead-of-tyra-300-data-readout?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6651462912559509
10/19/2024 1:30:00 PM,Over 60% of companies that reported earnings this week beat EPS and revenue estimates - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4175834-over-60-of-companies-that-reported-earnings-this-week-beat-eps-and-revenue-estimates-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.52019202709198
10/20/2024 11:05:04 PM,Johnson & Johnson treatment of acute myeloid leukemia granted orphan status,TipRanks,/news/stocks/johnson-johnson-treatment-of-acute-myeloid-leukemia-granted-orphan-status-1033861351,neutral,0.8726484179496765
10/21/2024 12:49:18 AM,Activist investor Starboard takes stake in Kenvue - WSJ,Seeking Alpha,https://seekingalpha.com/news/4181820-activist-investor-starboard-takes-stake-in-kenvue-wsj?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9210695624351501
10/21/2024 10:30:16 AM,"Prescriptions Johnson & Johnson‚Äôs Spravato are booming, WSJ reports",TipRanks,/news/stocks/prescriptions-johnson-johnson-s-spravato-are-booming-wsj-reports-1033864764,positive,0.9327869415283203
10/21/2024 2:09:26 PM,"Biggest stock movers Monday: LUMN, VFC, BA, SAVE, and more",Seeking Alpha,https://seekingalpha.com/news/4182108-biggest-stock-movers-monday-ba-save-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9094532132148743
10/21/2024 6:15:19 PM,Boeing machinists announce proposal to end strike: Morning Buzz,TipRanks,/news/stocks/boeing-machinists-announce-proposal-to-end-strike-morning-buzz-1033866571,negative,0.6957008242607117
10/21/2024 8:08:24 PM,Johnson & Johnson snaps six straight days of gains,Seeking Alpha,https://seekingalpha.com/news/4187020-johnson-johnson-snaps-six-straight-days-of-gains?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7514910101890564
10/22/2024 10:55:28 AM,Kenvue price target raised to $27 from $24 at BofA,TipRanks,/news/stocks/kenvue-price-target-raised-to-27-from-24-at-bofa-1033871030,positive,0.9482654333114624
10/25/2024 12:37:01 PM,Johnson & Johnson reports results from Phase 3b SPECTREM study,TipRanks,/news/stocks/johnson-johnson-reports-results-from-phase-3b-spectrem-study-1033894082,neutral,0.8863972425460815
10/25/2024 1:56:25 PM,J&J reports positive data for Tremfya in low body surface area psoriasis,Seeking Alpha,https://seekingalpha.com/news/4204907-jj-reports-positive-data-for-tremfya-in-low-body-surface-area-psoriasis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9427927732467651
10/25/2024 3:01:57 PM,J&J Phase 3b SPECTREM Study Of Tremfya In Low Body Surface Area Plaque Psoriasis Meets Primary Goal ,RTTNews,/news/stocks/j-j-phase-3b-spectrem-study-of-tremfya-in-low-body-surface-area-plaque-psoriasis-meets-primary-goal-1033892577,neutral,0.8876165151596069
10/28/2024 11:35:21 AM,Johnson & Johnson‚Äôs Tremfya shows efficacy in Crohn‚Äôs disease Phase 3 study,TipRanks,/news/stocks/johnson-johnson-s-tremfya-shows-efficacy-in-crohn-s-disease-phase-3-study-1033902176,positive,0.9263942241668701
10/28/2024 12:51:07 PM,Johnson & Johnson says Impella ECP met primary endpoint in high-risk PCI study,TipRanks,/news/stocks/johnson-johnson-says-impella-ecp-met-primary-endpoint-in-high-risk-pci-study-1033902891,positive,0.7132708430290222
10/28/2024 1:21:21 PM,J&J Reports Positive Results From GRAVITI Study Of Tremfya In SC Induction And Maintenance Therapy ,RTTNews,/news/stocks/j-j-reports-positive-results-from-graviti-study-of-tremfya-in-sc-induction-and-maintenance-therapy-1033901277,positive,0.9529915452003479
10/28/2024 3:23:50 PM,JNJ's subcutaneous Tremfya demonstrates efficacy in Crohn's,Seeking Alpha,https://seekingalpha.com/news/4213133-johnson-johnson-subcutaneous-tremfya-demonstrates-efficacy-crohns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9477083086967468
10/28/2024 3:41:20 PM,J&J Impella ECP heart pump meets primary endpoint,Seeking Alpha,https://seekingalpha.com/news/4214084-johnson-johnson-abiomed-impella-ecp-heart-pump-meets-primary-endpoint?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8315331339836121
10/28/2024 7:33:46 PM,DOJ throws wrench into J&J bankruptcy plan to settle talc suits,Seeking Alpha,https://seekingalpha.com/news/4215334-doj-throws-wrench-into-johnson-johnson-bankruptcy-plan-settle-talc-suits?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5267001986503601
10/30/2024 12:10:44 PM,AbbVie lifts outlook again on immunology demand; dividend raised,Seeking Alpha,https://seekingalpha.com/news/4222641-abbvie-lifts-outlook-again-on-immunology-demand-dividend-raised?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9375719428062439
11/2/2024 7:36:20 PM,New study reveals another benefit in using Novo Nordisk‚Äôs Wegovy in obesity,Seeking Alpha,https://seekingalpha.com/news/4238084-novo-nordisk‚Äôs-wegovy-can-heal-joint-pain?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.836555004119873
11/4/2024 1:36:04 PM,Option Care Health downgraded to Neutral at Goldman on Stelara headwinds,TipRanks,/news/stocks/option-care-health-downgraded-to-neutral-at-goldman-on-stelara-headwinds-1033945678,negative,0.8751699328422546
11/4/2024 2:50:17 PM,"Roblox, Peloton upgraded: Wall Street‚Äôs top analyst calls",TipRanks,/news/stocks/roblox-peloton-upgraded-wall-street-s-top-analyst-calls-1033946237,neutral,0.7313933968544006
11/4/2024 6:23:55 PM,Alvotech application for Simponi biosimilar accepted by EMA,Seeking Alpha,https://seekingalpha.com/news/4243237-alvotech-application-simponi-biosimilar-accepted-ema?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7740418910980225
11/4/2024 6:41:14 PM,New study reveals another benefit in using Novo Nordisk‚Äôs Wegovy in obesity,Seeking Alpha,https://seekingalpha.com/news/4238084-novo-nordisk-wegovy-can-heal-joint-pain?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.836555004119873
11/5/2024 6:50:16 PM,Johnson & Johnson Darzalex shows efficacy in early-stage multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/4250819-johnson-and-johnson-darzalex-shows-efficacy-early-stage-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9178899526596069
11/6/2024 1:06:49 PM,Johnson & Johnson price target raised to $162 from $156 at Guggenheim,TipRanks,/news/stocks/johnson-johnson-price-target-raised-to-162-from-156-at-guggenheim-1033962578,positive,0.9413933157920837
11/6/2024 8:17:19 PM,SA Asks: How will the U.S. election results impact healthcare stocks?,Seeking Alpha,https://seekingalpha.com/news/4257322-sa-asks-how-will-the-us-election-results-impact-healthcare-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7067019939422607
11/7/2024 5:48:20 PM,J&J wins approval of Varipulse atrial fibrillation device,Seeking Alpha,https://seekingalpha.com/news/4261997-johnson-and-johnson-wins-approval-varipulse-atrial-fibrillation-device?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9174377918243408
11/8/2024 12:21:33 PM,Johnson & Johnson submits applications for new indications for Darzalex,TipRanks,/news/stocks/johnson-johnson-submits-applications-for-new-indications-for-darzalex-1033983117,neutral,0.871258020401001
11/8/2024 2:59:21 PM,J&J seeks approval of Darzalex for early-stage multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/4266211-johnson-and-johnson-seeks-approval-darzalex-early-stage-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7850332856178284
11/8/2024 3:25:08 PM,"Johnson & Johnson Seeks Approval Of Darzalex Faspro In US, Darzalex In EU For Myeloma Treatment ",RTTNews,/news/stocks/johnson-johnson-seeks-approval-of-darzalex-faspro-in-us-darzalex-in-eu-for-myeloma-treatment-1033982191,positive,0.658600926399231
11/11/2024 9:10:32 PM,Johnson & Johnson: FDA grants nipocalimab Breakthrough Therapy designation,TipRanks,/news/stocks/johnson-johnson-fda-grants-nipocalimab-breakthrough-therapy-designation-1033994750,positive,0.892691433429718
11/11/2024 9:28:05 PM,J&J gets FDA breakthrough therapy status for nipocalimab in Sjogren's,Seeking Alpha,https://seekingalpha.com/news/4276778-jj-gets-fda-breakthrough-therapy-status-for-nipocalimab-in-sjogrens?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8977115154266357
11/12/2024 8:43:07 PM,J&J sues HHS over 340B hospital drug-discount program,Seeking Alpha,https://seekingalpha.com/news/4281964-johnson-and-johnson-sues-hhs-over-340-b-hospital-drug-discount-program?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.890116274356842
11/12/2024 8:55:09 PM,Johnson & Johnson MedTech receives IDE approval for Ottava system,TipRanks,/news/stocks/johnson-johnson-medtech-receives-ide-approval-for-ottava-system-1034002797,positive,0.9180201292037964
11/13/2024 2:40:32 PM,"J&J sues government agency over payment terms for 340B hospitals, STAT says",TipRanks,/news/stocks/j-j-sues-government-agency-over-payment-terms-for-340b-hospitals-stat-says-1034010502,negative,0.9355283975601196
11/13/2024 5:16:07 PM,"Charter to acquire Liberty Broadband, Spotify reports Q3 beat: Morning Buzz",TipRanks,/news/stocks/charter-to-acquire-liberty-broadband-spotify-reports-q3-beat-morning-buzz-1034011067,neutral,0.8938796520233154
11/14/2024 3:12:05 PM,Johnson & Johnson announces results from analyses of Phase 2 DAHLIAS study,TipRanks,/news/stocks/johnson-johnson-announces-results-from-analyses-of-phase-2-dahlias-study-1034020093,neutral,0.8631780743598938
11/14/2024 4:39:41 PM,JNJ's Phase 2 Study Of Nipocalimab Shows Improvement In Disease Activity In Sj√∂gren's Disease ,RTTNews,/news/stocks/jnj-s-phase-2-study-of-nipocalimab-shows-improvement-in-disease-activity-in-sjoegren-s-disease-1034018859,positive,0.955245316028595
11/14/2024 9:15:44 PM,Johnson & Johnson initiated with an Outperform at Wolfe Research,TipRanks,/news/stocks/johnson-johnson-initiated-with-an-outperform-at-wolfe-research-1034021187,negative,0.6642287969589233
11/14/2024 10:48:03 PM,"Renaissance Tech adds Micron, exits Broadcom, among Q3 trades",Seeking Alpha,https://seekingalpha.com/news/4292581-renaissance-tech-adds-micron-exits-broadcom-among-q3-trades?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8644103407859802
11/14/2024 11:07:05 PM,Vaccine makers close lower amid reports RFK Jr may head HHS (update),Seeking Alpha,https://seekingalpha.com/news/4292433-vaccines-makers-close-lower-on-reports-rfk-jr-may-head-hhs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9338276982307434
11/14/2024 11:50:43 PM,"Wolfe starts J&J at Outperform, sees growth drivers as ‚Äòbest-in-class‚Äô",TipRanks,/news/stocks/wolfe-starts-j-j-at-outperform-sees-growth-drivers-as-best-in-class-1034021597,positive,0.8328936100006104
11/15/2024 12:19:45 PM,Eli Lilly follows JNJ in suing govt. over 340B drug-discount program,Seeking Alpha,https://seekingalpha.com/news/4294034-eli-lilly-follows-jnj-suing-over-340-b-program?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.3914443552494049
11/15/2024 3:32:00 PM,Least shorted S&P 500 stocks in October,Seeking Alpha,https://seekingalpha.com/news/4294512-least-shorted-sp-500-stocks-in-october?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5993227362632751
11/15/2024 5:26:07 PM,"Eli Lilly sues to change hospital drug discount payments, WSJ reports",TipRanks,/news/stocks/eli-lilly-sues-to-change-hospital-drug-discount-payments-wsj-reports-1034026316,negative,0.7439962029457092
11/15/2024 7:15:09 PM,"Medtech shouldn't be greatly impacted by RFK Jr. at HHS, Wells Fargo says",Seeking Alpha,https://seekingalpha.com/news/4296173-medtech-shouldnt-be-greatly-impacted-by-rfk-jr-at-hhs-wells-fargo-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9096673727035522
11/15/2024 7:29:29 PM,U.S. Pharma is largely immune from 'MAHA' impact: Wolfe,Seeking Alpha,https://seekingalpha.com/news/4296178-us-pharma-largely-immune-from-maha-impact-wolfe?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9049097895622253
11/15/2024 8:00:56 PM,"Catalyst Watch: Nvidia earnings, Microsoft Ignite, crypto confidence, and P&G event",Seeking Alpha,https://seekingalpha.com/news/4295258-catalyst-watch-nvidia-earnings-microsoft-ignite-crypto-confidence-and-pg-event?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8805453777313232
11/18/2024 1:25:07 PM,CHMP Recommends Approval Of Lazcluze + Rybrevant In EU For EGFR-mutated Advanced NSCLC ,RTTNews,/news/stocks/chmp-recommends-approval-of-lazcluze-rybrevant-in-eu-for-egfr-mutated-advanced-nsclc-1034029899,positive,0.6874971985816956
11/18/2024 9:36:09 PM,Johnson & Johnson announces results from ICONIC-LEADa Phase 3 study,TipRanks,/news/stocks/johnson-johnson-announces-results-from-iconic-leada-phase-3-study-1034033175,neutral,0.8161795735359192
11/18/2024 9:51:09 PM,Protagonist and JNJ say icotrokinra study for PsO meets endpoint,TipRanks,/news/stocks/protagonist-and-jnj-say-icotrokinra-study-for-pso-meets-endpoint-1034033226,neutral,0.8900492191314697
11/18/2024 9:59:37 PM,J&J unveils positive phase 3 results for icotrokinra for plaque psoriasis,Seeking Alpha,https://seekingalpha.com/news/4304472-johnson-and-johnson-unveils-positive-phase-3-results-icotrokinra-plaque-psoriasis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9279191493988037
11/19/2024 10:56:17 AM,Balanced Hold Rating for JNJ‚Äôs Icotrokinra Amid Efficacy Concerns and Healthcare Policy Uncertainties,TipRanks,/news/stocks/balanced-hold-rating-for-jnj-s-icotrokinra-amid-efficacy-concerns-and-healthcare-policy-uncertainties-1034036356,positive,0.9171440005302429
11/20/2024 9:56:25 AM,Johnson & Johnson‚Äôs M&A Strategy in Cardiovascular Devices Supports Hold Rating,TipRanks,/news/stocks/johnson-johnson-s-m-a-strategy-in-cardiovascular-devices-supports-hold-rating-1034041712,positive,0.6518313884735107
11/20/2024 2:36:50 PM,"Johnson & Johnson, Merck cutting jobs in China, Bloomberg reports",TipRanks,/news/stocks/johnson-johnson-merck-cutting-jobs-in-china-bloomberg-reports-1034043953,negative,0.90489262342453
11/20/2024 5:01:17 PM,"Target reports downbeat Q3, Comcast plans cable TV spinoff: Morning Buzz",TipRanks,/news/stocks/target-reports-downbeat-q3-comcast-plans-cable-tv-spinoff-morning-buzz-1034044336,neutral,0.8804402947425842
11/21/2024 6:17:53 AM,Johnson & Johnson‚Äôs Promising Pharmaceutical Developments Justify Buy Rating,TipRanks,/news/stocks/johnson-johnson-s-promising-pharmaceutical-developments-justify-buy-rating-1034047194,positive,0.848058819770813
11/21/2024 6:45:46 PM,Optimism over global healthcare sector rises: Jefferies,Seeking Alpha,https://seekingalpha.com/news/4318258-optimism-over-global-healthcare-sector-rise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7575291991233826
11/21/2024 10:29:47 PM,Zevra Niemann-Pick disease type C drug Miplyffa now available,Seeking Alpha,https://seekingalpha.com/news/4319157-zevra-niemann-pick-disease-type-c-drug-miplyffa-now-available?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8179040551185608
11/22/2024 1:42:34 AM,J&J : Canada Approves CARVYKTI For Relapsed Or Refractory Multiple Myeloma After 1-3 Prior Therapies ,RTTNews,/news/stocks/j-j-canada-approves-carvykti-for-relapsed-or-refractory-multiple-myeloma-after-1-3-prior-therapies-1034051780,positive,0.7840631008148193
11/22/2024 1:05:50 PM,JNJ seeks FDA approval of subcutaneous induction regimen of Tremfya,TipRanks,/news/stocks/jnj-seeks-fda-approval-of-subcutaneous-induction-regimen-of-tremfya-1034055824,positive,0.8239415287971497
11/22/2024 1:40:48 PM,"Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and others",Seeking Alpha,https://seekingalpha.com/news/4321067-dividend-roundup-general-mills-halliburton-johnson-johnson-coca-cola-and-others?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9470468759536743
11/22/2024 1:48:17 PM,Johnson & Johnson seeks FDA approval for its ulcerative colitis treatment,Seeking Alpha,https://seekingalpha.com/news/4321118-johnson-johnson-seeks-fda-approval-for-its-ulcerative-colitis-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8708747029304504
11/22/2024 2:39:02 PM,Johnson & Johnson Submits SBLA Seeking Approval Of TREMFYA In Ulcerative Colitis ,RTTNews,/news/stocks/johnson-johnson-submits-sbla-seeking-approval-of-tremfya-in-ulcerative-colitis-1034054545,neutral,0.4878973364830017
11/22/2024 4:35:10 PM,"Sanofi planning changes to 340B hospital drug discount plan, WSJ reports",TipRanks,/news/stocks/sanofi-planning-changes-to-340b-hospital-drug-discount-plan-wsj-reports-1034056551,neutral,0.9313058257102966
11/22/2024 4:50:49 PM,Sanofi becomes latest drugmaker to challenge HHS over 340B drug-discount program,Seeking Alpha,https://seekingalpha.com/news/4322264-sanofi-becomes-latest-drugmakert-challenge-hhs-340-b-drug-discount-program?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8740204572677612
11/23/2024 2:25:05 AM,"Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC",Seeking Alpha,https://seekingalpha.com/news/4323803-trump-picks-surgeon-makary-to-head-fda-rep-dave-weldon-to-lead-cdc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9368929862976074
11/27/2024 9:00:25 PM,Janssen treatment of multiple myeloma granted FDA orphan status,TipRanks,/news/stocks/janssen-treatment-of-multiple-myeloma-granted-fda-orphan-status-1034073527,neutral,0.5380859971046448
11/28/2024 3:33:22 PM,AstraZeneca cancer drug Enhertu added for reimbursement in China despite probe,Seeking Alpha,https://seekingalpha.com/news/4344692-astrazeneca-enhertu-added-for-china-reimbursement?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.865742027759552
12/2/2024 1:05:25 PM,J&J seeks U.S. FDA approval for pediatric indications for TREMFYA,TipRanks,/news/stocks/j-j-seeks-u-s-fda-approval-for-pediatric-indications-for-tremfya-1034087206,positive,0.8771636486053467
12/2/2024 1:40:00 PM,Johnson & Johnson seeks approval of pediatric indications for TREMFYA,Seeking Alpha,https://seekingalpha.com/news/4353860-johnson-johnson-seeks-approval-of-pediatric-indications-for-tremfya?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7969838380813599
12/2/2024 2:20:35 PM,Johnson & Johnson Files SBLAs In Pediatric Indications For TREMFYA - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-files-sblas-in-pediatric-indications-for-tremfya-quick-facts-1034085713,neutral,0.8039145469665527
12/6/2024 7:30:19 PM,"J&J trial news may have positive read for Neumora Therapeutics, says RBC Capital",TipRanks,/news/stocks/j-j-trial-news-may-have-positive-read-for-neumora-therapeutics-says-rbc-capital-1034110005,positive,0.9379510879516602
12/8/2024 9:30:10 PM,J&J announces new frontline data featuring TECVAYLI fro 2 studies in NDMM,TipRanks,/news/stocks/j-j-announces-new-frontline-data-featuring-tecvayli-fro-2-studies-in-ndmm-1034111198,neutral,0.9037200808525085
12/9/2024 1:48:06 AM,"J&J : DARZALEX FASPRO Regimens Improve MRD Negativity, Survival In Newly Diagnosed Multiple Myeloma ",RTTNews,/news/stocks/j-j-darzalex-faspro-regimens-improve-mrd-negativity-survival-in-newly-diagnosed-multiple-myeloma-1034111200,positive,0.8741030693054199
12/9/2024 4:27:45 AM,J&J : TECVAYLI Shows Promise As Frontline Therapy For Newly Diagnosed Multiple Myeloma ,RTTNews,/news/stocks/j-j-tecvayli-shows-promise-as-frontline-therapy-for-newly-diagnosed-multiple-myeloma-1034111388,positive,0.9411665201187134
12/9/2024 9:11:33 PM,Gilead price target raised to $115 from $105 at Oppenheimer,TipRanks,/news/stocks/gilead-price-target-raised-to-115-from-105-at-oppenheimer-1034116246,positive,0.9459822177886963
12/9/2024 9:13:31 PM,Johnson & Johnson snaps six days of losing streak,Seeking Alpha,https://seekingalpha.com/news/4379903-johnson-johnson-snaps-six-days-of-losing-streak?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9022813439369202
12/10/2024 12:50:15 AM,J&J‚Äôs CARVYKTI shows higher rates of minimal residual disease negativity,TipRanks,/news/stocks/j-j-s-carvykti-shows-higher-rates-of-minimal-residual-disease-negativity-1034116663,positive,0.9290939569473267
12/10/2024 1:43:21 AM,J&J : CARVYKTI Shows Higher MRD Negativity Rates Vs. Standard Therapies In Phase 3 Study ,RTTNews,/news/stocks/j-j-carvykti-shows-higher-mrd-negativity-rates-vs-standard-therapies-in-phase-3-study-1034116381,positive,0.9571582674980164
12/10/2024 2:45:24 PM,"eBay downgraded, GM upgraded: Wall Street‚Äôs top analyst calls",TipRanks,/news/stocks/ebay-downgraded-gm-upgraded-wall-street-s-top-analyst-calls-1034120783,neutral,0.8453132510185242
12/10/2024 10:01:32 PM,BofA restarts coverage of 11 large-cap biopharmas,Seeking Alpha,https://seekingalpha.com/news/4384456-bofa-restarts-coverage-of-11-large-cap-biopharmas?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8290334939956665
12/13/2024 12:08:04 PM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1034135636,neutral,0.9046739339828491
12/16/2024 2:51:27 PM,"Johnson & Johnson sues Cigna‚Äôs Express Scripts, Accredo, WSJ reports",TipRanks,/news/stocks/johnson-johnson-sues-cigna-s-express-scripts-accredo-wsj-reports-1034142231,neutral,0.4975610077381134
12/16/2024 3:15:24 PM,GSK‚Äôs ViiV Healthcare says the CHMP of EMA issued positive opinion for Vocabria,TipRanks,/news/stocks/gsk-s-viiv-healthcare-says-the-chmp-of-ema-issued-positive-opinion-for-vocabria-1034142336,positive,0.9320905208587646
12/16/2024 4:33:48 PM,J&J submits sBLA for pediatric indication for Simponi in ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/4386867-johnson-johnson-submits-sbla-pediatric-indication-simponi-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8067092299461365
12/16/2024 5:01:01 PM,"Honeywell still exploring alternatives, Capri weighs Versace sale: Morning Buzz",TipRanks,/news/stocks/honeywell-still-exploring-alternatives-capri-weighs-versace-sale-morning-buzz-1034142630,neutral,0.9130474328994751
12/16/2024 6:05:00 PM,Moderna remains the most shorted among S&P 500 healthcare stocks in November,Seeking Alpha,https://seekingalpha.com/news/4386556-moderna-remains-the-most-shorted-among-sp-500-healthcare-stocks-in-november?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9052240252494812
12/17/2024 11:48:13 AM,Johnson & Johnson says injectable Rybrevant rejected by FDA,Seeking Alpha,https://seekingalpha.com/news/4387220-johnson-johnson-rybrevant-version-rejected-fda?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6724568605422974
12/17/2024 1:10:11 PM,Analysts Offer Insights on Healthcare Companies: FibroGen (FGEN) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-fibrogen-fgen-and-johnson-johnson-jnj-1034146790,neutral,0.9146860837936401
12/17/2024 6:45:36 PM,Barclays fact-checked Trump comments on pharmacy benefit managers,TipRanks,/news/stocks/barclays-fact-checked-trump-comments-on-pharmacy-benefit-managers-1034148099,neutral,0.9219223260879517
12/18/2024 2:50:54 PM,"PBMs took payments from manufacturers to allow free flow of opioids, NYT reports",TipRanks,/news/stocks/pbms-took-payments-from-manufacturers-to-allow-free-flow-of-opioids-nyt-reports-1034152640,neutral,0.7021381855010986
12/18/2024 2:51:03 PM,FDA approves Celltrion's biosimilar of J&J's Stelara,Seeking Alpha,https://seekingalpha.com/news/4387650-fda-approves-celltrion-biosimilar-of-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5094982385635376
12/18/2024 3:20:29 PM,Trump Trade: Analyst says Trump win ‚Äònot as positive as you‚Äôd think‚Äô for Tesla,TipRanks,/news/stocks/trump-trade-analyst-says-trump-win-not-as-positive-as-you-d-think-for-tesla-1034152752,neutral,0.7262119054794312
12/18/2024 3:37:04 PM,Least shorted S&P 500 stocks in November,Seeking Alpha,https://seekingalpha.com/news/4387575-least-shorted-sp-500-stocks-in-november?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6016119122505188
12/19/2024 10:30:50 AM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1034155967,neutral,0.9046739339828491
12/20/2024 12:55:11 AM,RxSight downgraded to Hold from Buy at Stifel,TipRanks,/news/stocks/rxsight-downgraded-to-hold-from-buy-at-stifel-1034159325,neutral,0.6151778101921082
12/20/2024 3:43:03 PM,RxSight cut to hold at Stifel on competition concerns,Seeking Alpha,https://seekingalpha.com/news/4389305-rxsight-stock-cut-hold-at-stifel?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9298973083496094
12/23/2024 6:05:07 PM,Johnson & Johnson call volume above normal and directionally bullish,TipRanks,/news/stocks/johnson-johnson-call-volume-above-normal-and-directionally-bullish-1034169499,positive,0.9071226716041565
12/26/2024 1:05:19 PM,Johnson & Johnson licensing STAT6 program from Kaken Pharmaceutical,TipRanks,/news/stocks/johnson-johnson-licensing-stat6-program-from-kaken-pharmaceutical-1034174100,neutral,0.79978346824646
12/26/2024 9:25:06 PM,Leerink sees positive readthrough for Kymera Therapeutics from J&J-Kaken deal,TipRanks,/news/stocks/leerink-sees-positive-readthrough-for-kymera-therapeutics-from-j-j-kaken-deal-1034174495,positive,0.9524981379508972
12/26/2024 11:44:47 PM,FDA proposes asbestos-testing standards for talc products (update),Seeking Alpha,https://seekingalpha.com/news/4391021-fda-proposes-testing-talc-products-for-asbestos-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9258227944374084
12/30/2024 11:25:06 AM,Piper lowers sales estimates for Legend Biotech‚Äôs Carvykti,TipRanks,/news/stocks/piper-lowers-sales-estimates-for-legend-biotech-s-carvykti-1034179567,negative,0.9277219176292419
1/2/2025 1:00:59 PM,Johnson & Johnson declares $1.24 dividend,Seeking Alpha,https://seekingalpha.com/news/4391934-johnson-and-johnson-declares-1_24-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9268330335617065
1/2/2025 2:20:13 PM,"Neumora trial failure a ‚Äòbig blow‚Äô to bull case, says Stifel",TipRanks,/news/stocks/neumora-trial-failure-a-big-blow-to-bull-case-says-stifel-1034187755,negative,0.8435474038124084
1/2/2025 4:10:12 PM,RBC downgrades Neumora Therapeutics to Sector Perform after trial failure,TipRanks,/news/stocks/rbc-downgrades-neumora-therapeutics-to-sector-perform-after-trial-failure-1034188027,negative,0.9204875230789185
1/3/2025 1:29:47 PM,"Dividend Roundup: Johnson & Johnson, JPMorgan, Oracle, Mastercard, and more",Seeking Alpha,https://seekingalpha.com/news/4392264-dividend-roundup-johnson-johnson-jpmorgan-oracle-mastercard-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9496365785598755
1/5/2025 10:32:40 PM,SA Asks: Which biotechs are most likely to be acquired near-term?,Seeking Alpha,https://seekingalpha.com/news/4392553-sa-asks-which-biotechs-are-most-likely-to-be-acquired-near-term?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8929339051246643
1/7/2025 1:05:24 PM,Johnson & Johnson‚Äôs rybrevant plus lazcluze improve survival in lung cancer,TipRanks,/news/stocks/johnson-johnson-s-rybrevant-plus-lazcluze-improve-survival-in-lung-cancer-1034201090,positive,0.9200718402862549
1/7/2025 3:27:12 PM,J&J Rybrevant/Lazcluze combo bests AstraZeneca's Tagrisso in NSCLC,Seeking Alpha,https://seekingalpha.com/news/4393029-johnson-and-johnson-rybrevant-lazcluze-combo-bests-astrazeneca-tagrisso-nsclc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.788379430770874
1/8/2025 1:46:36 AM,Johnson & Johnson (JNJ) Gets a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-rbc-capital-1034202968,neutral,0.6571256518363953
1/8/2025 10:50:31 AM,Hold Recommendation for Johnson & Johnson Amid Promising Drug Trials and Regulatory Challenges,TipRanks,/news/stocks/hold-recommendation-for-johnson-johnson-amid-promising-drug-trials-and-regulatory-challenges-1034205057,positive,0.9129992723464966
1/8/2025 10:50:50 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Sana Biotechnology (SANA), Immuneering (IMRX) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sana-biotechnology-sana-immuneering-imrx-and-johnson-johnson-jnj-1034205054,negative,0.9323418736457825
1/8/2025 1:06:04 PM,Johnson & Johnson‚Äôs posdinemab granted FDA Fast Track designation,TipRanks,/news/stocks/johnson-johnson-s-posdinemab-granted-fda-fast-track-designation-1034206392,positive,0.8648466467857361
1/8/2025 1:43:55 PM,Johnson & Johnson's posdinemab receives FDA fast track designation for its Alzheimer's treatment,Seeking Alpha,https://seekingalpha.com/news/4393419-johnson-johnsons-posdinemab-receives-fda-fast-track-designation-for-its-alzheimers-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9372678399085999
1/8/2025 3:26:38 PM,J&J's Posdinemab Granted FDA Fast Track Designation For Alzheimer's Treatment ,RTTNews,/news/stocks/j-j-s-posdinemab-granted-fda-fast-track-designation-for-alzheimer-s-treatment-1034205345,positive,0.9306462407112122
1/8/2025 6:31:34 PM,Johnson & Johnson falls after pausing U.S. Varipulse cases,Seeking Alpha,https://seekingalpha.com/news/4393544-johnson-johnson-stock-slips-varipulse-pause?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9398268461227417
1/8/2025 9:00:26 PM,Johnson & Johnson announces pause of all U.S. Varipulse cases,TipRanks,/news/stocks/johnson-johnson-announces-pause-of-all-u-s-varipulse-cases-1034207742,negative,0.8646602630615234
1/8/2025 9:11:16 PM,"J&J pause ‚Äòvery good‚Äô for Boston Scientific, says Piper Sandler",TipRanks,/news/stocks/j-j-pause-very-good-for-boston-scientific-says-piper-sandler-1034207729,positive,0.8167752027511597
1/8/2025 11:30:40 PM,Johnson & Johnson price target lowered to $160 from $177 at Bernstein,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-160-from-177-at-bernstein-1034208061,negative,0.7236626744270325
1/9/2025 1:25:59 PM,Cautious Outlook on Johnson & Johnson Amid Currency and Legal Challenges,TipRanks,/news/stocks/cautious-outlook-on-johnson-johnson-amid-currency-and-legal-challenges-1034210893,negative,0.9068365693092346
1/9/2025 1:45:16 PM,Johnson & Johnson reports nipocalimab granted FDA Priority Review,TipRanks,/news/stocks/johnson-johnson-reports-nipocalimab-granted-fda-priority-review-1034211009,positive,0.9311649203300476
1/9/2025 1:56:22 PM,"Novo, Eli Lilly to dominate global pharma sales in 2025: report",Seeking Alpha,https://seekingalpha.com/news/4393716-novo-eli-lilly-lead-2025-global-pharma-sales?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6913232207298279
1/9/2025 2:49:28 PM,J&J gets Priority Review designation for nipocalimab BLA,Seeking Alpha,https://seekingalpha.com/news/4393771-jj-gets-priority-review-designation-for-nipocalimab-bla?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8153241872787476
1/9/2025 7:55:26 PM,Needham medtech & diagnostics analyst holds analyst/industry conference call,TipRanks,/news/stocks/needham-medtech-diagnostics-analyst-holds-analyst-industry-conference-call-1034211701,neutral,0.9362135529518127
1/10/2025 12:16:44 PM,Boston Scientific upgraded to Buy from Hold at Deutsche Bank,TipRanks,/news/stocks/boston-scientific-upgraded-to-buy-from-hold-at-deutsche-bank-1034215133,neutral,0.516848087310791
1/10/2025 6:39:09 PM,J&J gets EU okay for Dual Energy Thermocool Smarttouch Catheter,Seeking Alpha,https://seekingalpha.com/news/4394094-jj-gets-eu-okay-for-dual-energy-thermocool-smarttouch-catheter?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6384334564208984
1/12/2025 10:40:17 AM,"Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-immuneering-imrx-johnson-johnson-jnj-1034217592,positive,0.6631888151168823
1/12/2025 9:50:17 PM,Johnson & Johnson in talks to acquire Intra-Cellular - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/4394354-johnson-johnson-exploring-takeover-of-intra-cellular-bloomberg?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8463224768638611
1/12/2025 10:05:06 PM,"Johnson & Johnson exploring bid for Intra-Cellular Therapies, Bloomberg reports",TipRanks,/news/stocks/johnson-johnson-exploring-bid-for-intra-cellular-therapies-bloomberg-reports-1034217895,neutral,0.5851892828941345
1/13/2025 2:49:37 AM,Johnson & Johnson In Talks To Acquire Intra-Cellular Therapies : Report ,RTTNews,/news/stocks/johnson-johnson-in-talks-to-acquire-intra-cellular-therapies-report-1034217902,neutral,0.8573675751686096
1/13/2025 10:30:57 AM,"Illumina launches pilot proteomics program with UK Biobank, collaborators",TipRanks,/news/stocks/illumina-launches-pilot-proteomics-program-with-uk-biobank-collaborators-1034220270,positive,0.6957523226737976
1/13/2025 11:35:58 AM,Johnson & Johnson to acquire Intra-Cellular for $132.00 per share in cash,TipRanks,/news/stocks/johnson-johnson-to-acquire-intra-cellular-for-132-00-per-share-in-cash-1034220740,neutral,0.9279616475105286
1/13/2025 11:36:56 AM,Johnson & Johnson to acquire Intra-Cellular for $132.00 per share in cash,TipRanks,/news/stocks/johnson-johnson-to-acquire-intra-cellular-for-132-00-per-share-in-cash-1034220720,neutral,0.9279616475105286
1/13/2025 11:54:36 AM,J&J to buy Intra-Cellular for $132/share in cash,Seeking Alpha,https://seekingalpha.com/news/4394424-jj-to-buy-intra-cellular-for-132share-in-cash?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9091024398803711
1/13/2025 12:49:14 PM,Johnson & Johnson To Buy Intra-Cellular Therapies For $132.00/shr In $14.6 Bln All-cash Deal ,RTTNews,/news/stocks/johnson-johnson-to-buy-intra-cellular-therapies-for-132-00-shr-in-14-6-bln-all-cash-deal-1034219706,neutral,0.6398249268531799
1/13/2025 1:30:01 PM,M&A Snapshot: Johnson & Johnson to acquire Intra-Cellular Therapies in $14.6B CNS-focused deal,Seeking Alpha,https://seekingalpha.com/news/4394487-ma-snapshot-johnson-johnson-to-acquire-intra-cellular-therapies-in-146b-cns-focused-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.540980339050293
1/13/2025 1:35:42 PM,Oric Pharmaceuticals announces clinical supply agreement with Janssen,TipRanks,/news/stocks/oric-pharmaceuticals-announces-clinical-supply-agreement-with-janssen-1034221869,positive,0.5754786729812622
1/13/2025 2:06:33 PM,Morning Movers: Intra-Cellular surges following deal to be bought by J&J,TipRanks,/news/stocks/morning-movers-intra-cellular-surges-following-deal-to-be-bought-by-j-j-1034222103,neutral,0.6571683883666992
1/13/2025 2:27:15 PM,Johnson & Johnson made approach to Intra-Cellular 6 weeks to 2 months ago  - report,Seeking Alpha,https://seekingalpha.com/news/4394546-johnson-and-johnson-made-approach-to-intra-cellular-6-weeks-to-2-months-ago-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8613199591636658
1/13/2025 2:46:12 PM,Hold Rating on JNJ Amid Uncertainty over Intra-Cellular Therapies Acquisition Impact,TipRanks,/news/stocks/hold-rating-on-jnj-amid-uncertainty-over-intra-cellular-therapies-acquisition-impact-1034222391,negative,0.8385752439498901
1/13/2025 3:00:21 PM,Intra-Cellular downgraded to Equal Weight from Overweight at Morgan Stanley,TipRanks,/news/stocks/intra-cellular-downgraded-to-equal-weight-from-overweight-at-morgan-stanley-1034222444,neutral,0.4952797293663025
1/13/2025 5:10:43 PM,"J&J to acquire Intra-Cellular, Clearwater to buy Enfusion: Morning Buzz",TipRanks,/news/stocks/j-j-to-acquire-intra-cellular-clearwater-to-buy-enfusion-morning-buzz-1034222650,neutral,0.9126174449920654
1/13/2025 7:25:14 PM,BofA moves to No Rating on Intra-Cellular after Johnson & Johnson deal,TipRanks,/news/stocks/bofa-moves-to-no-rating-on-intra-cellular-after-johnson-johnson-deal-1034222909,neutral,0.8604660034179688
1/14/2025 1:06:45 AM,Cautious Optimism: Evaluating Johnson & Johnson‚Äôs Hold Rating Amid ITCI Acquisition Uncertainties,TipRanks,/news/stocks/cautious-optimism-evaluating-johnson-johnson-s-hold-rating-amid-itci-acquisition-uncertainties-1034223279,neutral,0.6671820282936096
1/14/2025 9:57:00 AM,Johnson & Johnson‚Äôs Strategic Acquisition of Intra-Cellular Therapies: Balancing Short-term Dilution with Long-term Growth Potential,TipRanks,/news/stocks/johnson-johnson-s-strategic-acquisition-of-intra-cellular-therapies-balancing-short-term-dilution-with-long-term-growth-potential-1034224942,positive,0.6879041194915771
1/14/2025 1:37:21 PM,ORIC Pharma Stock Climbs On Clinical Supply Deal With J&J's Janssen For ORIC-114 ,RTTNews,/news/stocks/oric-pharma-stock-climbs-on-clinical-supply-deal-with-j-j-s-janssen-for-oric-114-1034224824,positive,0.8372675776481628
1/14/2025 2:40:39 PM,"Drugmakers to push Trump to pause price negotiations, Bloomberg reports",TipRanks,/news/stocks/drugmakers-to-push-trump-to-pause-price-negotiations-bloomberg-reports-1034226968,negative,0.7503694295883179
1/15/2025 7:04:11 AM,Strategic Acquisition Boosts JNJ‚Äôs Neuroscience Portfolio: Analyst Recommends Buy,TipRanks,/news/stocks/strategic-acquisition-boosts-jnj-s-neuroscience-portfolio-analyst-recommends-buy-1034229544,positive,0.9492877125740051
1/15/2025 1:06:38 PM,Johnson & Johnson submits NDA with FDA for TAR-200,TipRanks,/news/stocks/johnson-johnson-submits-nda-with-fda-for-tar-200-1034231461,neutral,0.9270707368850708
1/15/2025 2:38:15 PM,Johnson & Johnson Initiates IND Submission Of TAR-200 To Treat High-risk Bladder Cancer ,RTTNews,/news/stocks/johnson-johnson-initiates-ind-submission-of-tar-200-to-treat-high-risk-bladder-cancer-1034230264,neutral,0.7623250484466553
1/15/2025 2:47:30 PM,J&J submits NDA for TAR-200 for bladder cancer,Seeking Alpha,https://seekingalpha.com/news/4395303-jj-submits-nda-for-tar-200-for-bladder-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9312337636947632
1/15/2025 3:00:00 PM,Moderna remains the most shorted stock among S&P 500 healthcare stocks in the last month of 2024,Seeking Alpha,https://seekingalpha.com/news/4395003-moderna-remains-the-most-shorted-stock-among-sp-500-healthcare-stocks-in-the-last-month-of-2024?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.784682035446167
1/16/2025 10:19:54 AM,Johnson & Johnson (JNJ) Gets a Hold from Barclays,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-hold-from-barclays-1034235106,neutral,0.8302936553955078
1/16/2025 4:22:28 PM,Johnson & Johnson's RYBREVANT Plus Chemotherapy Approved In Canada For Advanced Lung Cancer ,RTTNews,/news/stocks/johnson-johnson-s-rybrevant-plus-chemotherapy-approved-in-canada-for-advanced-lung-cancer-1034236239,positive,0.6888525485992432
1/16/2025 4:30:04 PM,Least shorted S&P 500 stocks in December,Seeking Alpha,https://seekingalpha.com/news/4395791-least-shorted-sp-500-stocks-in-december?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.581834077835083
1/16/2025 8:15:11 PM,Roth MKM biotech analyst holds an analyst/industry conference call,TipRanks,/news/stocks/roth-mkm-biotech-analyst-holds-an-analyst-industry-conference-call-1034237745,neutral,0.9455549716949463
1/17/2025 11:28:17 AM,Hold Rating for Johnson & Johnson Amid Modest Growth Outlook and Legal Uncertainties,TipRanks,/news/stocks/hold-rating-for-johnson-johnson-amid-modest-growth-outlook-and-legal-uncertainties-1034240120,positive,0.5316504240036011
1/17/2025 1:25:47 PM,Johnson & Johnson price target lowered to $160 from $166 at BofA,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-160-from-166-at-bofa-1034240867,negative,0.8026606440544128
1/17/2025 7:54:43 PM,Argenx cut to Sell at Deutsche Bank on valuation,Seeking Alpha,https://seekingalpha.com/news/4396303-argenx-stock-cut-sell-deutsche-bank?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8694919347763062
1/17/2025 8:00:19 PM,"Catalyst Watch: Netflix earnings, Monster Beverage event, drug data, and quantum volatility",Seeking Alpha,https://seekingalpha.com/news/4396184-catalyst-watch-netflix-earnings-monster-beverage-event-drug-data-and-quantum-volatility?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8700594902038574
1/17/2025 8:35:26 PM,Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations,TipRanks,/news/stocks/sector-spotlight-big-pharma-will-push-to-pause-medicare-drug-price-negotiations-1034241772,neutral,0.49024686217308044
1/17/2025 9:16:37 PM,Odyssey Therapeutics files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/4396327-odyssey-therapeutics-files-for-100m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9300026297569275
1/17/2025 10:01:19 PM,Count on Dividend King Pepsi (PEP) for Stability in a Volatile Market,TipRanks,/news/stocks/count-on-dividend-king-pepsi-pep-for-stability-in-a-volatile-market-1034241826,positive,0.7234768867492676
1/18/2025 6:05:00 PM,14 out of 20 names post earnings beat with blockbuster wins from banks-Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4396193-14-out-of-20-names-post-earnings-beat-with-blockbuster-wins-from-banks-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5247611999511719
1/19/2025 1:12:00 PM,"Earnings week ahead: JNJ, NFLX, AAL, UAL, AXP, ABT, VZ, PG, and more",Seeking Alpha,https://seekingalpha.com/news/4396093-earnings-week-ahead-jnj-nflx-aal-ual-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.933464527130127
1/21/2025 10:35:22 AM,Nanobiotix doses first patient in CONVERGE study,TipRanks,/news/stocks/nanobiotix-doses-first-patient-in-converge-study-1034249062,neutral,0.7712883949279785
1/21/2025 11:26:13 AM,Johnson & Johnson price target lowered to $159 from $160 at Barclays,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-159-from-160-at-barclays-1034249312,negative,0.881901741027832
1/21/2025 1:06:03 PM,Johnson & Johnson announces FDA approves sNDA for Spravato,TipRanks,/news/stocks/johnson-johnson-announces-fda-approves-snda-for-spravato-1034250428,neutral,0.7509943246841431
1/21/2025 1:18:09 PM,Johnson & Johnson (JNJ) Receives a Hold from Morgan Stanley,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-hold-from-morgan-stanley-1034250560,neutral,0.822955846786499
1/21/2025 1:54:12 PM,J&J wins label expansion for depression therapy Spravato,Seeking Alpha,https://seekingalpha.com/news/4396680-jj-stock-in-focus-spravato-label-expansion?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8369439244270325
1/21/2025 3:22:54 PM,JNJ's SNDA For Spravato Monotherapy Gets FDA Approval For Treatment-Resistant Depression ,RTTNews,/news/stocks/jnj-s-snda-for-spravato-monotherapy-gets-fda-approval-for-treatment-resistant-depression-1034249288,positive,0.9357669353485107
1/21/2025 5:45:00 PM,Top Seeking Alpha Quant picks in Technology ahead of Q4 earnings,Seeking Alpha,https://seekingalpha.com/news/4396470-top-seeking-alpha-quant-picks-in-technology-ahead-of-q4-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5815473794937134
1/21/2025 6:25:51 PM,Johnson & Johnson Q4 2024 Earnings Preview: Double-digit decline in profit expected,Seeking Alpha,https://seekingalpha.com/news/4397013-johnson-johnson-q4-2024-earnings-preview-double-digit-decline-in-profit-expected?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9726065397262573
1/21/2025 6:45:12 PM,Notable companies reporting before tomorrow‚Äôs open,TipRanks,/news/stocks/notable-companies-reporting-before-tomorrow-s-open-1034251583,neutral,0.9220909476280212
1/21/2025 9:25:51 PM,Intra-Cellular downgraded to Sector Perform from Outperform at RBC Capital,TipRanks,/news/stocks/intra-cellular-downgraded-to-sector-perform-from-outperform-at-rbc-capital-1034251809,negative,0.9313915967941284
1/21/2025 11:00:20 PM,Here's the major earnings before the open tomorrow,Seeking Alpha,https://seekingalpha.com/news/4396897-heres-the-major-earnings-before-the-open-tomorrow?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9330109357833862
1/22/2025 11:21:13 AM,Reviva Pharmaceuticals price target lowered to $11 from $14 at H.C. Wainwright,TipRanks,/news/stocks/reviva-pharmaceuticals-price-target-lowered-to-11-from-14-at-h-c-wainwright-1034254662,negative,0.6040470600128174
1/22/2025 11:21:18 AM,"Johnson & Johnson Non-GAAP EPS of $2.04 beats by $0.02, revenue of $22.5B beats by $50M",Seeking Alpha,https://seekingalpha.com/news/4397192-johnson-johnson-non-gaap-eps-of-204-beats-by-002-revenue-of-225b-beats-by-50m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6075144410133362
1/22/2025 11:25:28 AM,Johnson & Johnson sees FY25 operational revenue $90.9B-$91.7B,TipRanks,/news/stocks/johnson-johnson-sees-fy25-operational-revenue-90-9b--91-7b-1034254654,neutral,0.5936329960823059
1/22/2025 11:25:51 AM,"Johnson & Johnson sees FY25 adjusted EPS $10.75-$10.95, consensus $10.60",TipRanks,/news/stocks/johnson-johnson-sees-fy25-adjusted-eps-10-75--10-95-consensus-10-60-1034254650,neutral,0.609083890914917
1/22/2025 11:26:33 AM,"Johnson & Johnson reports Q4 adjusted EPS $2.04, consensus $2.02",TipRanks,/news/stocks/johnson-johnson-reports-q4-adjusted-eps-2-04-consensus-2-02-1034254646,negative,0.6128133535385132
1/22/2025 11:30:26 AM,Genmab reports 2024 net sales of Darzalex $11.67B,TipRanks,/news/stocks/genmab-reports-2024-net-sales-of-darzalex-11-67b-1034254735,neutral,0.923292875289917
1/22/2025 11:36:42 AM,Genmab says net sales of DARZALEX in 2024 totalled $11.67B,Seeking Alpha,https://seekingalpha.com/news/4397204-genmab-says-net-sales-of-darzalex-in-2024-totalled-1167b?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9288256168365479
1/22/2025 11:46:50 AM,Johnson & Johnson in Charts: DARZALEX sales surge 20.9% Y/Y in Q4,Seeking Alpha,https://seekingalpha.com/news/4397201-johnson-johnson-in-charts-darzalex-sales-surge-209-yy-in-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9410591721534729
1/22/2025 11:48:43 AM,Earnings Snapshot: Johnson & Johnson tops Q4 earnings estimate; initiates FY25 revenue below estimates,Seeking Alpha,https://seekingalpha.com/news/4397202-earnings-snapshot-johnson-johnson-tops-q4-earnings-estimate-initiates-fy25-revenue-below-estimates?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7954156994819641
1/22/2025 12:09:46 PM,Johnson & Johnson posts Q4 beat as drug sales offset MedTech weakness,Seeking Alpha,https://seekingalpha.com/news/4397193-jnj-stock-flat-despite-q4-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9301351308822632
1/22/2025 12:20:32 PM,Johnson & Johnson sees 2H25 operational sales growth higher than 1H25,TipRanks,/news/stocks/johnson-johnson-sees-2h25-operational-sales-growth-higher-than-1h25-1034255344,positive,0.9570475816726685
1/22/2025 12:32:59 PM,"Johnson & Johnson Q4 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/johnson-johnson-q4-profit-decreases-but-beats-estimates-1034253859,negative,0.9718552827835083
1/22/2025 1:25:43 PM,"Johnson & Johnson Projects 2025 Adj. Operational EPS Growth Of 8.7% At Midpoint, Excl. ITCI ",RTTNews,/news/stocks/johnson-johnson-projects-2025-adj-operational-eps-growth-of-8-7-at-midpoint-excl-itci-1034254050,positive,0.5524246692657471
1/22/2025 1:46:35 PM,Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond,TipRanks,/news/stocks/johnson-johnson-says-positioned-for-5--7-growth-through-2030-and-beyond-1034255944,positive,0.9421916007995605
1/22/2025 1:55:22 PM,Morning Movers: Netflix shares rise following subscriber blowout,TipRanks,/news/stocks/morning-movers-netflix-shares-rise-following-subscriber-blowout-1034255934,positive,0.6578748226165771
1/22/2025 2:47:47 PM,"4 stocks to watch on Wednesday: PG, JNJ and more",Seeking Alpha,https://seekingalpha.com/news/4397307-4-stocks-to-watch-on-wednesday-pg-jnj-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9242684841156006
1/22/2025 3:30:36 PM,Intra-Cellular ticks higher as J&J forecasts early Q2 close,Seeking Alpha,https://seekingalpha.com/news/4397347-intra-cellular-ticks-higher-as-jj-forecasts-early-q2-close?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6347705125808716
1/22/2025 4:04:42 PM,J&J beats in Q4 with in line guidance; so why is its stock falling?,Seeking Alpha,https://seekingalpha.com/news/4397351-jj-stock-falls-despite-q4-2024-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9330350160598755
1/22/2025 5:05:34 PM,"Netflix, Seagate, J&J report quarterly beats: Morning Buzz",TipRanks,/news/stocks/netflix-seagate-j-j-report-quarterly-beats-morning-buzz-1034256527,neutral,0.9156373739242554
1/22/2025 6:46:05 PM,Needham medtech & diagnostics analyst holds analyst/industry conference call,TipRanks,/news/stocks/needham-medtech-diagnostics-analyst-holds-analyst-industry-conference-call-1034256828,neutral,0.9362135529518127
1/23/2025 10:57:17 AM,Cautious Hold Rating for Johnson & Johnson Amid Conservative 2025 Outlook and Foreign Exchange Headwinds,TipRanks,/news/stocks/cautious-hold-rating-for-johnson-johnson-amid-conservative-2025-outlook-and-foreign-exchange-headwinds-1034259606,positive,0.7358037829399109
1/23/2025 11:05:55 AM,Balanced Expectations Amid Challenges and Opportunities for Johnson & Johnson: Hold Rating Issued,TipRanks,/news/stocks/balanced-expectations-amid-challenges-and-opportunities-for-johnson-johnson-hold-rating-issued-1034259768,positive,0.5642085671424866
1/23/2025 11:20:54 AM,Johnson & Johnson price target lowered to $152 from $166 at Wells Fargo,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-152-from-166-at-wells-fargo-1034259868,negative,0.907895565032959
1/23/2025 11:26:06 AM,Johnson & Johnson publishes nipocalimab study results in The Lancet Neurology,TipRanks,/news/stocks/johnson-johnson-publishes-nipocalimab-study-results-in-the-lancet-neurology-1034259858,neutral,0.8097341060638428
1/23/2025 11:26:46 AM,Johnson & Johnson price target lowered to $158 from $160 at Bernstein,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-158-from-160-at-bernstein-1034259849,negative,0.7430304288864136
1/23/2025 11:26:53 AM,Cautious Hold Recommendation for Johnson & Johnson Amid ITCI Acquisition Concerns and Market Challenges,TipRanks,/news/stocks/cautious-hold-recommendation-for-johnson-johnson-amid-itci-acquisition-concerns-and-market-challenges-1034259847,negative,0.7806571125984192
1/23/2025 11:30:12 AM,"Analysts Are Bullish on These Healthcare Stocks: AbbVie (ABBV), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-abbvie-abbv-johnson-johnson-jnj-1034260045,neutral,0.6329232454299927
1/23/2025 11:35:51 AM,Johnson & Johnson price target lowered to $163 from $175 at Morgan Stanley,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-163-from-175-at-morgan-stanley-1034260023,negative,0.8511569499969482
1/23/2025 11:55:20 AM,Johnson & Johnson price target lowered to $159 from $160 at BofA,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-159-from-160-at-bofa-1034260137,negative,0.8165045976638794
1/23/2025 11:55:52 AM,Johnson & Johnson: Hold Rating Amid Mixed Performance and Future Uncertainties,TipRanks,/news/stocks/johnson-johnson-hold-rating-amid-mixed-performance-and-future-uncertainties-1034260134,negative,0.9651723504066467
1/23/2025 11:56:45 AM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1034260121,neutral,0.9046739339828491
1/23/2025 12:30:20 PM,Johnson & Johnson price target lowered to $155 from $170 at Stifel,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-155-from-170-at-stifel-1034260728,negative,0.7850538492202759
1/23/2025 12:45:29 PM,Johnson & Johnson price target lowered to $165 from $170 at Raymond James,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-165-from-170-at-raymond-james-1034260811,negative,0.8372281789779663
1/24/2025 7:06:51 AM,"‚ÄúJohnson & Johnson: Buy Rating Reaffirmed Despite Price Target Cut, Growth Prospects Highlighted‚Äù",TipRanks,/news/stocks/johnson-johnson-buy-rating-reaffirmed-despite-price-target-cut-growth-prospects-highlighted-1034265012,positive,0.9433931112289429
1/24/2025 1:08:16 PM,Argus Research Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/argus-research-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1034266886,neutral,0.8815223574638367
1/25/2025 6:46:00 PM,Over 80% of companies deliver EPS wins this week-Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4398494-over-80-companies-deliver-eps-wins-this-week-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6900728940963745
1/27/2025 3:59:54 PM,"FDA accepts Teva, Alvotech BLAs for Simponi biosimilars",Seeking Alpha,https://seekingalpha.com/news/4398859-fda-accepts-teva-alvotech-blas-for-simponi-biosimilars?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6551010012626648
1/27/2025 8:28:45 PM,"J&J talc claimants urge judge to reject $8B settlement, bankruptcy plan",Seeking Alpha,https://seekingalpha.com/news/4399016-johnson-johnson-talc-claimants-urge-judge-to-reject-8b-settlement-bankruptcy-plan?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7643334269523621
1/27/2025 8:30:12 PM,"Johnson & Johnson-backed medical device company seeks U.S. IPO, Bloomberg says",TipRanks,/news/stocks/johnson-johnson-backed-medical-device-company-seeks-u-s-ipo-bloomberg-says-1034274082,neutral,0.735434889793396
1/28/2025 10:10:16 AM,Johnson & Johnson price target raised to $166 from $159 at Barclays,TipRanks,/news/stocks/johnson-johnson-price-target-raised-to-166-from-159-at-barclays-1034276588,positive,0.9457013010978699
1/29/2025 9:16:26 PM,"Artiva expands Board with appointment of Dan Baker, M.D",TipRanks,/news/stocks/artiva-expands-board-with-appointment-of-dan-baker-m-d-1034284784,neutral,0.9234890341758728
1/30/2025 5:19:44 PM,Alumis draws Outperform at Oppenheimer on valuation disconnect,Seeking Alpha,https://seekingalpha.com/news/4400899-alumis-draws-outperform-at-oppenheimer-on-valuation-disconnect?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6401673555374146
1/30/2025 5:27:47 PM,Global stocks with the highest market share within their product groups,Seeking Alpha,https://seekingalpha.com/news/4400904-global-stocks-with-the-highest-market-share-within-their-product-groups?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.699302077293396
1/31/2025 11:25:30 AM,European Commission authorizes Vocabria + Rekambys for HIV treatment,TipRanks,/news/stocks/european-commission-authorizes-vocabria-+-rekambys-for-hiv-treatment-1034294678,neutral,0.8628990054130554
1/31/2025 1:25:06 PM,AbbVie swings to Q4 loss amid Cerevel impact; sets in-line guidance,Seeking Alpha,https://seekingalpha.com/news/4401344-abbvie-stock-spikes-q4-revenue-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9237608909606934
1/31/2025 7:10:17 PM,Opening Day: Infinity Natural Resources valued at $1.3B in market debut,TipRanks,/news/stocks/opening-day-infinity-natural-resources-valued-at-1-3b-in-market-debut-1034297591,neutral,0.931483805179596
2/1/2025 12:53:24 PM,Are healthcare stocks on the rebound?,Seeking Alpha,https://seekingalpha.com/news/4401695-are-healthcare-stocks-rebound?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.711911678314209
2/1/2025 3:52:02 PM,HHS eyeing over $1B from J&J for talc cancer treatments: govt. attorney,Seeking Alpha,https://seekingalpha.com/news/4401703-hhs-seeks-1b-from-jj-talc-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6028185486793518
2/1/2025 5:30:29 PM,SA Asks: Which Big Pharmas would be most impacted by higher tariffs?,Seeking Alpha,https://seekingalpha.com/news/4401641-sa-asks-which-big-pharmas-would-be-most-impacted-by-higher-tariffs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9071416258811951
2/1/2025 11:45:00 PM,"Notable Healthcare headlines for the week: Moderna, AbbVie, Thermo Fisher, J&J in focus",Seeking Alpha,https://seekingalpha.com/news/4400864-notable-healthcare-headlines-for-the-week-moderna-thermo-fisher-jj-in-focus?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.912206768989563
2/3/2025 12:36:10 PM,Johnson & Johnson price target raised to $166 from $162 at Guggenheim,TipRanks,/news/stocks/johnson-johnson-price-target-raised-to-166-from-162-at-guggenheim-1034303204,positive,0.9425035715103149
2/3/2025 12:37:41 PM,Guggenheim Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/guggenheim-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1034303197,neutral,0.8120633363723755
2/3/2025 12:41:03 PM,Halozyme announces positive opinion in EU for rybrevant with Enhanze technology,TipRanks,/news/stocks/halozyme-announces-positive-opinion-in-eu-for-rybrevant-with-enhanze-technology-1034303178,positive,0.9410951733589172
2/3/2025 3:49:57 PM,J&J gets positive EU opinion for subcutaneous Rybrevant,Seeking Alpha,https://seekingalpha.com/news/4401949-jj-gets-positive-eu-opinion-for-subcutaneous-rybrevant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9508143663406372
2/4/2025 5:15:16 PM,"Senate panel advances Kennedy‚Äôs nomination for HHS secretary, CNBC reports",TipRanks,/news/stocks/senate-panel-advances-kennedy-s-nomination-for-hhs-secretary-cnbc-reports-1034310628,neutral,0.8860395550727844
2/5/2025 4:11:53 PM,Kenvue confirms activist Starboard nominations for board,Seeking Alpha,https://seekingalpha.com/news/4403582-kenvue-confirms-activist-starboard-nominations-for-board?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8843174576759338
2/6/2025 1:40:33 PM,Kura Oncology price target raised to $36 from $34 at Wedbush,TipRanks,/news/stocks/kura-oncology-price-target-raised-to-36-from-34-at-wedbush-1034322810,positive,0.9485723972320557
2/6/2025 5:07:38 PM,Dr. Reddy‚Äôs in licenses biosimilar for J&J‚Äôs multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4404547-dr-reddys-licenses-biosimilar-jjs-darzalex?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7299897074699402
2/6/2025 6:35:50 PM,"White House readying order to fire thousands of federal health workers, WSJ says",TipRanks,/news/stocks/white-house-readying-order-to-fire-thousands-of-federal-health-workers-wsj-says-1034324421,negative,0.9388384819030762
2/7/2025 3:21:13 PM,Trump Trade: President advocates to close carried interest tax loophole,TipRanks,/news/stocks/trump-trade-president-advocates-to-close-carried-interest-tax-loophole-1034328479,neutral,0.6031143069267273
2/10/2025 1:45:12 PM,Largest borrow rate increases among liquid names,TipRanks,/news/stocks/largest-borrow-rate-increases-among-liquid-names-1034335524,positive,0.7579149007797241
2/10/2025 6:56:52 PM,J&J business development exec sees China as major source of biotech innovation,Seeking Alpha,https://seekingalpha.com/news/4405712-johnson-johnson-business-development-exec-sees-china-major-source-biotech-innovation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6204398274421692
2/11/2025 7:43:47 AM,M&A News: Novartis Seals $3.1B Deal to Acquire Anthos,TipRanks,/news/stocks/m-a-news-novartis-seals-3-1b-deal-to-acquire-anthos-1034339714,positive,0.6791760921478271
2/11/2025 9:50:33 AM,Genmab upgraded to Neutral from Underperform at Exane BNP Paribas,TipRanks,/news/stocks/genmab-upgraded-to-neutral-from-underperform-at-exane-bnp-paribas-1034340321,positive,0.9394935369491577
2/11/2025 7:47:36 PM,J&J puts its stroke care business up for sale: report (Update),Seeking Alpha,https://seekingalpha.com/news/4406354-jj-puts-its-stroke-care-business-up-for-sale-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9287212491035461
2/11/2025 7:50:44 PM,"J&J puts stroke care unit up for sale, FT reports",TipRanks,/news/stocks/j-j-puts-stroke-care-unit-up-for-sale-ft-reports-1034343454,neutral,0.8975185751914978
2/11/2025 8:31:39 PM,Johnson & Johnson (JNJ) Plans $1 Billion Sale of ‚ÄòCerenovus‚Äô Stroke Unit,TipRanks,/news/stocks/johnson-johnson-jnj-plans-1-billion-sale-of-cerenovus-stroke-unit-1034343552,neutral,0.8091367483139038
2/12/2025 5:00:27 PM,"CVS Health, Lyft report Q4 results: Morning Buzz",TipRanks,/news/stocks/cvs-health-lyft-report-q4-results-morning-buzz-1034350077,neutral,0.8224381804466248
2/12/2025 6:00:02 PM,SA Asks: What are the most attractive AI-adjacent stocks?,Seeking Alpha,https://seekingalpha.com/news/4405878-sa-asks-what-are-the-most-attractive-ai-adjacent-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.932222843170166
2/13/2025 11:15:36 AM,Genmab upgraded to Outperform from Market Perform at Leerink,TipRanks,/news/stocks/genmab-upgraded-to-outperform-from-market-perform-at-leerink-1034355326,positive,0.9398646950721741
2/13/2025 4:35:38 PM,Senate votes to confirm Robert Kennedy as head of HHS,TipRanks,/news/stocks/senate-votes-to-confirm-robert-kennedy-as-head-of-hhs-1034357950,neutral,0.6617797017097473
2/13/2025 11:47:23 PM,"Ray Dalio's Bridgewater takes new stake in Tesla, exits Micron & Goldman Sachs in Q4 moves",Seeking Alpha,https://seekingalpha.com/news/4408291-ray-dalios-bridgewater-takes-new-stake-in-tesla-exits-micron-goldman-sachs-in-q4-moves?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9345493912696838
2/14/2025 1:43:11 PM,"Dividend Roundup: Meta Platforms, Nike, Ford, Johnson & Johnson, and more",Seeking Alpha,https://seekingalpha.com/news/4408520-dividend-roundup-meta-platforms-nike-ford-johnson-johnson-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.945925235748291
2/14/2025 5:23:56 PM,"Renaissance Technologies top Q4 moves include taking in Intel, exiting Arm & upping Nike",Seeking Alpha,https://seekingalpha.com/news/4408677-renaissance-technologies-top-q4-moves-include-taking-in-intel-exiting-arm-upping-nike?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7300604581832886
2/14/2025 9:30:39 PM,Moderna remains the most shorted stock among S&P 500 healthcare stocks in the first month of 2025,Seeking Alpha,https://seekingalpha.com/news/4408772-moderna-remains-the-most-shorted-stock-among-sp-500-healthcare-stocks-in-the-first-month-of-2025?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7803025841712952
2/15/2025 12:48:11 PM,Johnson & Johnson to resume U.S. Varipulse cases after safety review,Seeking Alpha,https://seekingalpha.com/news/4408937-johnson-johnson-resume-us-varipulse-cases?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5497410893440247
2/15/2025 5:15:10 PM,"Notable healthcare headlines for the week: J&J, CVS, Moderna, Biogen in focus",Seeking Alpha,https://seekingalpha.com/news/4408504-notable-healthcare-headlines-for-the-week-j-and-j-cvs-moderna-biogen-in-focus?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8897029757499695
2/15/2025 8:15:13 PM,"Key deals this week: Papa John's, Spirit Airlines, Novartis, Banco Santander and more",Seeking Alpha,https://seekingalpha.com/news/4408398-key-deals-this-week-papa-johns-spirit-airlines-novartis-banco-santander-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.885756254196167
2/18/2025 12:47:11 PM,Medtronic slips after reaffirming full-year guidance,Seeking Alpha,https://seekingalpha.com/news/4409197-medtronic-stock-slips-q3-revenue-miss?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.966757595539093
2/18/2025 1:06:16 PM,Johnson & Johnson (JNJ) Gets a Buy from TD Cowen,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-td-cowen-1034373635,neutral,0.6161684393882751
2/18/2025 1:59:56 PM,Johnson & Johnson (NYSE:JNJ) Goes to Court for Third Time over $10B Talc Bankruptcy Plan,TipRanks,/news/stocks/johnson-johnson-nyse-jnj-goes-to-court-for-third-time-over-10b-talc-bankruptcy-plan-1034374136,negative,0.9441869258880615
2/18/2025 9:07:00 PM,"Johnson & Johnson faces battle over $10B baby powder settlement, Reuters reports",TipRanks,/news/stocks/johnson-johnson-faces-battle-over-10b-baby-powder-settlement-reuters-reports-1034375966,negative,0.8315814733505249
2/19/2025 8:16:51 AM,Barclays Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/barclays-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1034378116,neutral,0.838411271572113
2/19/2025 11:53:33 AM,Johnson & Johnson (JNJ) Receives a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-rbc-capital-1034379288,positive,0.49460798501968384
2/21/2025 12:06:02 PM,Johnson & Johnson announces Phase 3 ASTRO study met primary endpoints,TipRanks,/news/stocks/johnson-johnson-announces-phase-3-astro-study-met-primary-endpoints-1034391421,neutral,0.9104001522064209
2/21/2025 12:06:07 PM,Teva/Alvotech follow Amgen in launching biosimilar for J&J‚Äôs Stelara,Seeking Alpha,https://seekingalpha.com/news/4411841-tevaalvotech-launch-biosimilar-jj-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8066015839576721
2/21/2025 5:00:24 PM,Big Pharma: Seeking Alpha Analysts vs. Wall Street,Seeking Alpha,https://seekingalpha.com/news/4411404-big-pharma-seeking-alpha-analysts-vs-wall-street?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5532337427139282
2/21/2025 6:01:17 PM,Healthcare sector takes the lead in 2025 as market volatility rises,Seeking Alpha,https://seekingalpha.com/news/4412110-healthcare-sector-takes-the-lead-in-2025-as-market-volatility-rises?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5033490061759949
2/22/2025 2:59:26 PM,Trump tells Big Pharma to bring production home or face tariffs: Bloomberg News,Seeking Alpha,https://seekingalpha.com/news/4412199-trump-tells-big-pharma-reshore-face-tariffs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9235791563987732
2/22/2025 8:41:56 PM,FDA said to be reversing terminations made last week,Seeking Alpha,https://seekingalpha.com/news/4412207-fda-said-to-be-reversing-terminations-made-last-week?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.738615870475769
2/24/2025 2:41:33 PM,"Alibaba upgraded, Rivian downgraded: Wall Street‚Äôs top analyst calls",TipRanks,/news/stocks/alibaba-upgraded-rivian-downgraded-wall-street-s-top-analyst-calls-1034399388,negative,0.591795802116394
2/25/2025 6:37:59 PM,J&J suing Samsung Bioepis over Stelara biosimilar (update),Seeking Alpha,https://seekingalpha.com/news/4412901-jj-suing-samsung-bioepis-over-stelara-biosimilar-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7487860918045044
2/27/2025 6:31:05 PM,Top performing dividend picks on Wall Street as markets fight to advance in 2025,Seeking Alpha,https://seekingalpha.com/news/4415037-top-performing-dividend-picks-on-wall-street-as-markets-fight-to-advance-in-2025?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.4891272783279419
2/27/2025 6:51:11 PM,Compass Pathways rises 10% as Stifel initiates with a buy,Seeking Alpha,https://seekingalpha.com/news/4415039-compass-pathways-rises-10-stifel-initiates-with-buy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8784638047218323
2/28/2025 3:06:28 PM,Johnson & Johnson‚Äôs DARZALEX SC gets positive CHMP opinion,Seeking Alpha,https://seekingalpha.com/news/4415655-johnson-johnsons-darzalex-sc-gets-positive-chmp-opinion?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9376145005226135
3/2/2025 5:27:09 PM,Play defense with Goldman's cheap healthcare picks,Seeking Alpha,https://seekingalpha.com/news/4415922-play-defense-with-goldmans-cheap-healthcare-picks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9198631048202515
3/4/2025 11:16:34 AM,"HHS increasing scrutiny of vaccines under RFK Jr., WSJ reports",TipRanks,/news/stocks/hhs-increasing-scrutiny-of-vaccines-under-rfk-jr-wsj-reports-1034437263,positive,0.8427558541297913
